<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />


<meta name="author" content="Steve Simon" />


<title>Translate blog files to html</title>

<script>/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:700}dfn{font-style:italic}h1{margin:.67em 0;font-size:2em}mark{color:#000;background:#ff0}small{font-size:80%}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sup{top:-.5em}sub{bottom:-.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{height:0;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace,monospace;font-size:1em}button,input,optgroup,select,textarea{margin:0;font:inherit;color:inherit}button{overflow:visible}button,select{text-transform:none}button,html input[type=button],input[type=reset],input[type=submit]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{padding:0;border:0}input{line-height:normal}input[type=checkbox],input[type=radio]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type=number]::-webkit-inner-spin-button,input[type=number]::-webkit-outer-spin-button{height:auto}input[type=search]{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-appearance:textfield}input[type=search]::-webkit-search-cancel-button,input[type=search]::-webkit-search-decoration{-webkit-appearance:none}fieldset{padding:.35em .625em .75em;margin:0 2px;border:1px solid silver}legend{padding:0;border:0}textarea{overflow:auto}optgroup{font-weight:700}table{border-spacing:0;border-collapse:collapse}td,th{padding:0}@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="javascript:"]:after,a[href^="#"]:after{content:""}blockquote,pre{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}img,tr{page-break-inside:avoid}img{max-width:100%!important}h2,h3,p{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000!important}.label{border:1px solid #000}.table{border-collapse:collapse!important}.table td,.table th{background-color:#fff!important}.table-bordered td,.table-bordered th{border:1px solid #ddd!important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,n04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ/LAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM/SEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ+pexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h/v4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs+LWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy+pRYVKGVS/1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr/Cm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB+lSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX+VSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G+KspT/FupEGGafCCwxSe6ZUa+073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B/EnCYu/TgCGmr7bMh8GfYL+BfcLvB0gRagC09w9elfldaIy/hNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4/BO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r+vnsV+372uf1xBLq4qU/45fTuqaAP+pssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ+Azok7B7O/f6J8AzYBySZQB/QHYUSA+EeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ+PKRWyFHHmg1Wi/6xzUgA0LREoKJChwnQa9B+5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl+KdDPbI6Ag4vLr+hjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq+MhrGxDLak0PrwYzSXtcuyhXEhwOYofiW+EcI/jw8P6IY6ed+etAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji+zDbo8x8HyIRUbXnwUcklFv51fvTymiV+MXLSmGH9d9+aXpD5X6lao41anWGig7IwIdnoBY2ht/pO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi+7u/jpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf+61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP/OfKnlk/Lkaid/O2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu/gFtuW0wR4cgd+ZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ+HW06H+tx+bQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543/FV6klQ6Tv1OoZGXLv0igKrl/CmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF/0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5/xTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ/1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb/Veyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6/xM+4Y67ngNBknxIPwuppgIhFcwJyr6EIj+LzNj/mfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h/C/PkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn/pdpgHKNGrGIdkRK+KPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho+EIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA+q/j9m3LM/O7WJka4tSidVCjsvo2lQ/2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3/5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho/bcwQdeboqfQartuU3CsCf+cXkgYAqp/0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid/NIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A+TRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC+JE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW/WDHA60cYFaI/PjpzquUqdaYGcIq+mLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC+1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A+P/oFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E/vwOiKxRtCWsDM+eTHUrmwrCK5BIfMzGkD+0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3/kFutpQGNc3pCR7gvC4sgwbupDu3DyEN+W6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc+h1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0+bC5zgpGz7Io+mjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO/ENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn+3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif+pZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx/k3QgnAFSq27/2i4GEBA+UvTJKK/9eISNvG46Em5RZfjTYLdeD8kdXHyrwId/DQZUaMCY4gGbke2C8vfjgV/Y9kkRQOJIn/xM9INZSpiBnqX0Q9GlQPpPKAyO5y+W5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W/N6l54qOynCqD3DpWQ+mpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE+7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv/8lbTIkkYpqKM9VOhp65ktYk+Q46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI+ejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5+7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu+vtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY/iOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v+6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ/qDQK+bfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam+WpHG+0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3+J1eCBay8IYZ0wQRKGAqvCuZ/UgbQPyllosq+XtfKIZOzmeJqRazpmmoP/76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t/I4Jktu0XSgifO2ozFOiwd/0SssJDn0dn4xqk4GDTTKX73/wQyBLdqgJ+Wx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy/qqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh/wkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml/R4yrzow1Q2A5G+kzo/RhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj/UMMc34IBqTKLDTp76WzL/dMjCxK7MjhiGjeYAC/kj/jY/Rde7hpSM1xChrog6yZ7OWTuD56xBJnGFE+pT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G+9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36/dBySis4m9/DR8izaLJW6bWCkVgm5T+ius3ZXq4xI+GnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te/r4dPYMCl5qtiHNTn+TPbh1jCBHH+dMJNhwNgs3nT+OhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF+uRIWyXjQMAs2chdpaKPNaB+kSezYt0+CA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6/TzoA1/ZBG9bIUVHLAbi/kdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh+epgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF+zkJHIA7PwCDk1gGVmGUZSSoPhNf+Tklauz98QofOlCIQ/tCD4dosHYPqtPCXB3agggQQIqQJsSkB+qn0rkQ1toJjON/OtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU+TQ6NIw3ej+AtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb++W6Uk4q6F7/rg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK+EfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l+wM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l+DMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg+EWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb+Mw76Qy29iQ5up/X7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa/xnsMYcIO/vEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz/Chp/Vlpj2P7jJQmQRwGnltkTV5dbF9fE3/fxoSqTROgq9wFUlbuYzYcasE0ouzBo+dDCDzxKAfhbAZYxQiHrLzV2iVexnDX/QnT1fsT/xuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR+CtGdkPwYN2o7DOw/VGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO/f9Qua+pDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD/prQ84B1pVGkIpVUAHCG+iz3Bn3qm2AVrYcYWhock4jso5+J7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk+UILT7+VoX5mdxxA5fS42gISQVi/HTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8/6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk/wdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt+Su9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ/BfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk/gc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B//lHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO+CvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd/p1gi/07h8qfwHrByuSxglc9cI4QIg2oqvC/qm0i7tjPLTgDhoWTAKDO2ONW5oe+/eKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2/j4ODUwRkqrtBBCrDsDpt8jhZdXoy/1BCqw3sSGhgGGy0a5Jw6BP/TExoCmNFYjZl248A0osgPyGEmRA+fAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd/ocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE/EZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ/Ugd/JZQK8lvAm43uDRAbyW8gZ+ZGq0EVerVGUKUSm/Idn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ+QATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm+oOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724+zUQ7+vkCpZB+pGA562hYQiDxHVWOq0oDQl/QsoiY+cuI7iWq/ZIBtHcXJ7kks+h2fCNUPA82BzjnqktNts+RLdk1VSu+tqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy/44XYXdI5noQoRcvjZ1RMPACRqYg2V1+OwOepcOknRLLFdYgTkT5UApt/JhLM3jeFYprZV+Zow2g8fP+U68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr/A1SY9dXFz4RjzoU9ExfJCmx/I9FKEGT3n2cmzl2X42L3Jh+AbQq6sA+Ss1kitoa4TAYgKHaoybHUDJ51oETdeI/9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB+Un44zExFE4vLytcu5NwpWrUxO/0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL+BDqMyaN3RJPh/anbx+Iv+qgQdAa3M9Z5JmvYlh4qop+Ho1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs+gs37sFvi0PPVvA5dnCBgILTwoKd/+DoL9F6inlM7H4rOTzD79KJgKlZO/Zgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno+gBoKVXgIL/VI8dB1O5o/R3Suez/gD7M781ShjKpIIORM/nxG+jjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4/QftDbEn+AucIr1oxrLabRj9q4ae0+fXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd+eNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz/6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT+mAUmiYbV3YQVqFVp9dorv+TsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp+xJyYLv1OsxQCZwTB4a8BZ/5EdxTBJthApqyfd9u3ifr/WILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj/qn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9+W8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4/YtowhEmTs0vrvlD/CrisnoBNDAcUi/teY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O/4DcgV/dZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk+tgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb/n7qwhvGnrHuf5bX6Vh/n3xffU3PeHdR+FA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E+YbfL0adwNtHP7dT7t7b46DVZIkzaRJOM+S6KcrzYVg+T3wSRFRQashjfU18NutrKa/7PXbtuJvpIjbgPeqd+pjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir/8tNXJ/OsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG+FZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx/GdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD/Qi/EmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4/asthNMK5UQKCOhU97oaOYNGsTah+jfCKsZnTRn5TbhFX8ghg8CBYt/BjeYYYUrtUZ5jVij/op7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM+3SW6Opll/wgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy+QbSKVJcqkia+GvDefFwMOmgnD7h81TUtMn+mRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d/QK7Cr4uoCeOQ7/8JfKT77KiDzLImESHw/0wf73QeHu74hxv7uihi4fTX+XEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo/oVH5ww5OzLFsiTPDns7fS6EURSSWd/92BxMYQ8sBaH+j+wthQPdVgDGpTfi+JQIWMD8xKqULliRH01rTeyF8x8q/GBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE+/7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV/yTDRRP8Y2ww5RO6d2D94o+6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt+kqdae76ViWe3STan69yaF9+fESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw/A1zEdjWquIsQXXGIVEH0thC5M+W9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF+RVmI8L4HUYk4x+67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8/p5qIQrEo/H+1l/0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud+tJUfdaZ4CWNijzZtlRa8+CkmO/EwHYfPZFU/hzjFWH7vnzHRMo+aF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce/+/9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs/GWJS6SwEN/ULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e+G2zor8l+YaMxSEomDdLHGcD6YVQPegTaA74H8+V4WvJkFUrjMLGLlvSZQWvi8/QA7yzQ8GPno//5SJHRP/OqKObPCo81s/+6WgLqykYpGAgQZhVDEBPXWgU/WzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M+GWn6ASobIWC+LbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg/kpf3+CnAXKiMgIE8Jk/Mhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo+RJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B+SkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE+VMd3b1fhCynD0pQNhCG6/WCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp/YbHjo++7/Wj8S4YNa+ZdqAw1hDrKWFXv9+zaXpf8ZTDSbiqsxnwN/CzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m/NCW/HILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO+5EJ7Z6bCiRoPedRZ/P0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn/LvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl+11PoFYnNv2HwAODeNRkHj+8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij+bsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur/eWHjiB7SOVdqMAVmpBvfRiebsFjger7DC+8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l+kXRZ0KLZaGsFSIdQz/HXDxf3/TE30+DgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH+RptvRMVRaahu4cySjS3P5wxAUCPkmn+rhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik/zbrTQk5KmgxCg/f45L0jywebOWUYFJQAJia7XzCV0x89rpp/f3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl+5tfUWZNwBpEPXghzbBggYCw/dhy0ntds2yeHCDKkF/YxQjNIL/F/37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD+qNOhwMlfARQUdJ2tUX+MNJqOwIciWalZsmEjt07tfa8ma4cji9sqz+Q9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe+jGDiNJQLWnfx+drTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf/bkvo8PLVBsZl152y5S8+HRDfZIMCbYZ1WDp4yrdchOJw8k6R+/2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB+M4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5/iYp3ZdrCf7fL+en+sIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv+NRiJc8JAKqqgCA/PNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN/hCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj+bYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5/zBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8/i+jHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2+JrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk+Mz7wwstg6RFZb+TZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm/7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk+9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx+whVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC+XYuqMBMUun5YezKbRKmEPwuK+CLzijPEQgfhahQswBBLfg/GBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX+RCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk/4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug/AbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM+Zu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX/pcsfwXbLze2+D+u33OGBoJyAAL3jn3RuEcdp5If8O+a4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT++tm+haBCikRUUMrMhYKZJKYoVuv/bsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV/DMUxd9uFZmBfKXMCn/SqkWJyKPnT6lq+4zBZni6fYRByJn6OK+OgPBGRAJluwGSk4wxjOOzyce/PKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO/cEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm+bddRQu5F9s0XftGEJ9JSuSk+ZachCbdU45fEqbugzTIUokwoAKvpUQF/CvLbWW5BNQFqFkJg2f30E/48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J+1pT0tLkvFVZaNzfhs/Kd3+A9YsImlO4XK4vpCo/elHQi/9gkFg07xxnuXLt21unCIpDV+bbRxb7FC6nWYTsMFF8+1LUg4JFjVt3vqbuhHmDKbgQ4e+RGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB/KVijd1ARWkFEf3yiUw1v/WaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G+ZManTqDLPjyrOse7WiiwOJCG+J0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj/6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j/N46f+S2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb/0jQbaHJ2YRK8A+ls6WMhWmpCXYG5jqapGs5/eOJErxi2/2KWVHiPellTgh/fNl/2KYPKb7DUcAg+mCOPQFCiU9Mq/WLcU1xxC8aLePFZZlE+PCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh/nFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW+oKFLvpyvTBMM69tN1Ydwv1LIEhHsC+ueVG+w+kyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw+H/AuOx+aH+tBL88H57D0MsqyiZxhOEQkF/8DR1d2hSPMj/sNOa5rxcUnBgH8ictv2J+cb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd/PjMMtQfyDNZsOPd6XcAsnBE/mRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl/XPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG/VanIvcwycVA7+BE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP/MVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX/5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c/F1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J/5wkjpkre727p5PTRX5FGrSBIfJqhJE/IS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug+oRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U/5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7/BQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN+nA7pvF78/RII5ZHA09OAiE/66MF6HQ+qVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe+hXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz+JV/4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB+K3wBP/ineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q/9uocGsx41O4IZhViw/2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY/cQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE/om7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi/caHSM3FPRGRf7dB7YC+cD2ho6oL2zGDCkjlf/DFoQVl8GS/56wur3rdV6ggtzZW60MRB3g+U1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg/gBQIZMG/YcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK/G7F3mUc3GOAKqh60zM0v34v+ELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND+/GTk6M56Ig4yMsU6LUW1EWE+fIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP/IoRIZ/F6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg/RrPD/d3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl+Mu4xf0ezqeXD2PtPDnwMPo86sbwDV+9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD/OwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d/UfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH+14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC+OA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6+vAUUBoGhY3CT2tgwehdPqU/4Q7ZLYvhRl/ogOvR9O2+wkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn/dFSWBWzQ/VYk+Gezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n/yJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET/Hh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j+DXfpi12m1RbzYLg9J2wFergEwOxFyD0/JstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT/cUP6pE/mujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB+HEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu+vqQ02+KpJBjaLt9ye1Ab+BbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC+UwkXOoAjneU/xHplMQo2cXUlrVNqJYczgYlaOEczVCs/OCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38+xsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9+b8fH6+b8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj/0Q7PFUcC8hDrxESWdfgFRm+7vvWbkEppHB4T/1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y+g3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR/Rrs/JLKXgEx+qkmeDlFOD1/yTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW+xz+5FElFxWB28VjYIGZ0Yd+5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ+lT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ+2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1+JpI9psyNYIFuJogZa0/1AhOWdlHQxdAgbwacsHqPZo8u/ngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2+RdM+MAaYaZ0Y/ADkbNCZuAyAVQa2OcXOeICmDn9Q/eFkDeFQg5MgHEDXq/tVjj+jtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2/Bc0UxvseQCO2pQ2i+Krfhu/WeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt/U0Wf+phiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7+ExseJauyqo30hs+1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j/e1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la/QCTiVelFnU6O/GCvykqS/wZJDhKN9gBtSOp/1SP5VRgJcoVj+kmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn+8p6+vBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H+gDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D/GvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P+jAgN5TB3haSifDcApp6yymEi6Ij/GsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x/pChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11/yxyw0UnGig3MFdZklN5FI/qiT65T+jOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5+bqWiAYiAv6Jsf79/VUs4cIl+n6+WOjcgB/2l5TreoAV2717JzZbQIR0W1cl/dEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW/PhoawJDrGAP0JYWHgAVUByo/bGdiv2T2EMg8gsS14/rAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq+SCcTSx5NDtbFwNlh8VhjGGDu7JG5/TAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9+ogD8Kk/W7QoRN1UWPqM4+xdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c+4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS+o3F8YVVeikw13w+OEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX++7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9/O53DYi/5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD+P8sNh6e+XYHJXT/lkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp+pT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS/2ToPjqkaq62/7WFG8advGlRRqxB9diP07JrXowKR9tpRa+jGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq+nsp3YMuXt/GkXxLx/P6+ZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar+gMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud+YlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl/zh575R5rsrmRnKAzq4POFdgbYBuEviM4+LVC15ssLNFghbTtHWerS1hDt5s4qkLUha/qpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI+yjEldJfSo4y0QhG4i4IwkRFGcjWY8+EzgYYJUK7BXQksLxAww/YYWBMhJILB9e8ePEJ4OP7z+4/wOQDl64iOYDp26DaONPxpKtBxq/aTzRGarm3VkPYTLJKx6Z/Mw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ+lPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k/UuGkNpP1DBI5ch/EehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv+J41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI+HYexTUevLUeta4/DqKrbMVS+Yqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ++KkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9/Wx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k/90B8+yRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB/mQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go/n6j0cS+a2gEU8gIHJ+BwfgZX4GL+Bd/gW34FZ+BS/gUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh/F062yJ7AAAAEDAWAAABWhJ+KPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg);src:url(data:application/vnd.ms-fontobject;base64,n04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ/LAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM/SEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ+pexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h/v4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs+LWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy+pRYVKGVS/1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr/Cm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB+lSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX+VSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G+KspT/FupEGGafCCwxSe6ZUa+073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B/EnCYu/TgCGmr7bMh8GfYL+BfcLvB0gRagC09w9elfldaIy/hNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4/BO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r+vnsV+372uf1xBLq4qU/45fTuqaAP+pssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ+Azok7B7O/f6J8AzYBySZQB/QHYUSA+EeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ+PKRWyFHHmg1Wi/6xzUgA0LREoKJChwnQa9B+5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl+KdDPbI6Ag4vLr+hjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq+MhrGxDLak0PrwYzSXtcuyhXEhwOYofiW+EcI/jw8P6IY6ed+etAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji+zDbo8x8HyIRUbXnwUcklFv51fvTymiV+MXLSmGH9d9+aXpD5X6lao41anWGig7IwIdnoBY2ht/pO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi+7u/jpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf+61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP/OfKnlk/Lkaid/O2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu/gFtuW0wR4cgd+ZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ+HW06H+tx+bQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543/FV6klQ6Tv1OoZGXLv0igKrl/CmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF/0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5/xTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ/1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb/Veyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6/xM+4Y67ngNBknxIPwuppgIhFcwJyr6EIj+LzNj/mfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h/C/PkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn/pdpgHKNGrGIdkRK+KPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho+EIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA+q/j9m3LM/O7WJka4tSidVCjsvo2lQ/2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3/5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho/bcwQdeboqfQartuU3CsCf+cXkgYAqp/0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid/NIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A+TRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC+JE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW/WDHA60cYFaI/PjpzquUqdaYGcIq+mLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC+1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A+P/oFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E/vwOiKxRtCWsDM+eTHUrmwrCK5BIfMzGkD+0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3/kFutpQGNc3pCR7gvC4sgwbupDu3DyEN+W6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc+h1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0+bC5zgpGz7Io+mjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO/ENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn+3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif+pZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx/k3QgnAFSq27/2i4GEBA+UvTJKK/9eISNvG46Em5RZfjTYLdeD8kdXHyrwId/DQZUaMCY4gGbke2C8vfjgV/Y9kkRQOJIn/xM9INZSpiBnqX0Q9GlQPpPKAyO5y+W5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W/N6l54qOynCqD3DpWQ+mpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE+7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv/8lbTIkkYpqKM9VOhp65ktYk+Q46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI+ejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5+7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu+vtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY/iOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v+6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ/qDQK+bfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam+WpHG+0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3+J1eCBay8IYZ0wQRKGAqvCuZ/UgbQPyllosq+XtfKIZOzmeJqRazpmmoP/76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t/I4Jktu0XSgifO2ozFOiwd/0SssJDn0dn4xqk4GDTTKX73/wQyBLdqgJ+Wx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy/qqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh/wkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml/R4yrzow1Q2A5G+kzo/RhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj/UMMc34IBqTKLDTp76WzL/dMjCxK7MjhiGjeYAC/kj/jY/Rde7hpSM1xChrog6yZ7OWTuD56xBJnGFE+pT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G+9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36/dBySis4m9/DR8izaLJW6bWCkVgm5T+ius3ZXq4xI+GnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te/r4dPYMCl5qtiHNTn+TPbh1jCBHH+dMJNhwNgs3nT+OhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF+uRIWyXjQMAs2chdpaKPNaB+kSezYt0+CA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6/TzoA1/ZBG9bIUVHLAbi/kdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh+epgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF+zkJHIA7PwCDk1gGVmGUZSSoPhNf+Tklauz98QofOlCIQ/tCD4dosHYPqtPCXB3agggQQIqQJsSkB+qn0rkQ1toJjON/OtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU+TQ6NIw3ej+AtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb++W6Uk4q6F7/rg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK+EfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l+wM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l+DMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg+EWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb+Mw76Qy29iQ5up/X7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa/xnsMYcIO/vEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz/Chp/Vlpj2P7jJQmQRwGnltkTV5dbF9fE3/fxoSqTROgq9wFUlbuYzYcasE0ouzBo+dDCDzxKAfhbAZYxQiHrLzV2iVexnDX/QnT1fsT/xuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR+CtGdkPwYN2o7DOw/VGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO/f9Qua+pDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD/prQ84B1pVGkIpVUAHCG+iz3Bn3qm2AVrYcYWhock4jso5+J7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk+UILT7+VoX5mdxxA5fS42gISQVi/HTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8/6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk/wdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt+Su9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ/BfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk/gc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B//lHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO+CvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd/p1gi/07h8qfwHrByuSxglc9cI4QIg2oqvC/qm0i7tjPLTgDhoWTAKDO2ONW5oe+/eKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2/j4ODUwRkqrtBBCrDsDpt8jhZdXoy/1BCqw3sSGhgGGy0a5Jw6BP/TExoCmNFYjZl248A0osgPyGEmRA+fAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd/ocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE/EZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ/Ugd/JZQK8lvAm43uDRAbyW8gZ+ZGq0EVerVGUKUSm/Idn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ+QATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm+oOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724+zUQ7+vkCpZB+pGA562hYQiDxHVWOq0oDQl/QsoiY+cuI7iWq/ZIBtHcXJ7kks+h2fCNUPA82BzjnqktNts+RLdk1VSu+tqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy/44XYXdI5noQoRcvjZ1RMPACRqYg2V1+OwOepcOknRLLFdYgTkT5UApt/JhLM3jeFYprZV+Zow2g8fP+U68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr/A1SY9dXFz4RjzoU9ExfJCmx/I9FKEGT3n2cmzl2X42L3Jh+AbQq6sA+Ss1kitoa4TAYgKHaoybHUDJ51oETdeI/9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB+Un44zExFE4vLytcu5NwpWrUxO/0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL+BDqMyaN3RJPh/anbx+Iv+qgQdAa3M9Z5JmvYlh4qop+Ho1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs+gs37sFvi0PPVvA5dnCBgILTwoKd/+DoL9F6inlM7H4rOTzD79KJgKlZO/Zgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno+gBoKVXgIL/VI8dB1O5o/R3Suez/gD7M781ShjKpIIORM/nxG+jjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4/QftDbEn+AucIr1oxrLabRj9q4ae0+fXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd+eNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz/6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT+mAUmiYbV3YQVqFVp9dorv+TsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp+xJyYLv1OsxQCZwTB4a8BZ/5EdxTBJthApqyfd9u3ifr/WILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj/qn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9+W8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4/YtowhEmTs0vrvlD/CrisnoBNDAcUi/teY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O/4DcgV/dZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk+tgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb/n7qwhvGnrHuf5bX6Vh/n3xffU3PeHdR+FA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E+YbfL0adwNtHP7dT7t7b46DVZIkzaRJOM+S6KcrzYVg+T3wSRFRQashjfU18NutrKa/7PXbtuJvpIjbgPeqd+pjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir/8tNXJ/OsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG+FZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx/GdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD/Qi/EmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4/asthNMK5UQKCOhU97oaOYNGsTah+jfCKsZnTRn5TbhFX8ghg8CBYt/BjeYYYUrtUZ5jVij/op7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM+3SW6Opll/wgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy+QbSKVJcqkia+GvDefFwMOmgnD7h81TUtMn+mRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d/QK7Cr4uoCeOQ7/8JfKT77KiDzLImESHw/0wf73QeHu74hxv7uihi4fTX+XEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo/oVH5ww5OzLFsiTPDns7fS6EURSSWd/92BxMYQ8sBaH+j+wthQPdVgDGpTfi+JQIWMD8xKqULliRH01rTeyF8x8q/GBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE+/7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV/yTDRRP8Y2ww5RO6d2D94o+6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt+kqdae76ViWe3STan69yaF9+fESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw/A1zEdjWquIsQXXGIVEH0thC5M+W9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF+RVmI8L4HUYk4x+67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8/p5qIQrEo/H+1l/0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud+tJUfdaZ4CWNijzZtlRa8+CkmO/EwHYfPZFU/hzjFWH7vnzHRMo+aF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce/+/9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs/GWJS6SwEN/ULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e+G2zor8l+YaMxSEomDdLHGcD6YVQPegTaA74H8+V4WvJkFUrjMLGLlvSZQWvi8/QA7yzQ8GPno//5SJHRP/OqKObPCo81s/+6WgLqykYpGAgQZhVDEBPXWgU/WzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M+GWn6ASobIWC+LbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg/kpf3+CnAXKiMgIE8Jk/Mhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo+RJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B+SkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE+VMd3b1fhCynD0pQNhCG6/WCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp/YbHjo++7/Wj8S4YNa+ZdqAw1hDrKWFXv9+zaXpf8ZTDSbiqsxnwN/CzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m/NCW/HILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO+5EJ7Z6bCiRoPedRZ/P0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn/LvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl+11PoFYnNv2HwAODeNRkHj+8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij+bsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur/eWHjiB7SOVdqMAVmpBvfRiebsFjger7DC+8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l+kXRZ0KLZaGsFSIdQz/HXDxf3/TE30+DgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH+RptvRMVRaahu4cySjS3P5wxAUCPkmn+rhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik/zbrTQk5KmgxCg/f45L0jywebOWUYFJQAJia7XzCV0x89rpp/f3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl+5tfUWZNwBpEPXghzbBggYCw/dhy0ntds2yeHCDKkF/YxQjNIL/F/37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD+qNOhwMlfARQUdJ2tUX+MNJqOwIciWalZsmEjt07tfa8ma4cji9sqz+Q9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe+jGDiNJQLWnfx+drTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf/bkvo8PLVBsZl152y5S8+HRDfZIMCbYZ1WDp4yrdchOJw8k6R+/2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB+M4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5/iYp3ZdrCf7fL+en+sIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv+NRiJc8JAKqqgCA/PNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN/hCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj+bYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5/zBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8/i+jHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2+JrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk+Mz7wwstg6RFZb+TZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm/7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk+9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx+whVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC+XYuqMBMUun5YezKbRKmEPwuK+CLzijPEQgfhahQswBBLfg/GBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX+RCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk/4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug/AbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM+Zu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX/pcsfwXbLze2+D+u33OGBoJyAAL3jn3RuEcdp5If8O+a4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT++tm+haBCikRUUMrMhYKZJKYoVuv/bsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV/DMUxd9uFZmBfKXMCn/SqkWJyKPnT6lq+4zBZni6fYRByJn6OK+OgPBGRAJluwGSk4wxjOOzyce/PKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO/cEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm+bddRQu5F9s0XftGEJ9JSuSk+ZachCbdU45fEqbugzTIUokwoAKvpUQF/CvLbWW5BNQFqFkJg2f30E/48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J+1pT0tLkvFVZaNzfhs/Kd3+A9YsImlO4XK4vpCo/elHQi/9gkFg07xxnuXLt21unCIpDV+bbRxb7FC6nWYTsMFF8+1LUg4JFjVt3vqbuhHmDKbgQ4e+RGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB/KVijd1ARWkFEf3yiUw1v/WaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G+ZManTqDLPjyrOse7WiiwOJCG+J0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj/6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j/N46f+S2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb/0jQbaHJ2YRK8A+ls6WMhWmpCXYG5jqapGs5/eOJErxi2/2KWVHiPellTgh/fNl/2KYPKb7DUcAg+mCOPQFCiU9Mq/WLcU1xxC8aLePFZZlE+PCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh/nFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW+oKFLvpyvTBMM69tN1Ydwv1LIEhHsC+ueVG+w+kyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw+H/AuOx+aH+tBL88H57D0MsqyiZxhOEQkF/8DR1d2hSPMj/sNOa5rxcUnBgH8ictv2J+cb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd/PjMMtQfyDNZsOPd6XcAsnBE/mRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl/XPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG/VanIvcwycVA7+BE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP/MVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX/5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c/F1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J/5wkjpkre727p5PTRX5FGrSBIfJqhJE/IS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug+oRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U/5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7/BQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN+nA7pvF78/RII5ZHA09OAiE/66MF6HQ+qVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe+hXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz+JV/4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB+K3wBP/ineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q/9uocGsx41O4IZhViw/2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY/cQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE/om7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi/caHSM3FPRGRf7dB7YC+cD2ho6oL2zGDCkjlf/DFoQVl8GS/56wur3rdV6ggtzZW60MRB3g+U1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg/gBQIZMG/YcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK/G7F3mUc3GOAKqh60zM0v34v+ELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND+/GTk6M56Ig4yMsU6LUW1EWE+fIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP/IoRIZ/F6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg/RrPD/d3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl+Mu4xf0ezqeXD2PtPDnwMPo86sbwDV+9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD/OwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d/UfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH+14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC+OA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6+vAUUBoGhY3CT2tgwehdPqU/4Q7ZLYvhRl/ogOvR9O2+wkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn/dFSWBWzQ/VYk+Gezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n/yJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET/Hh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j+DXfpi12m1RbzYLg9J2wFergEwOxFyD0/JstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT/cUP6pE/mujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB+HEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu+vqQ02+KpJBjaLt9ye1Ab+BbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC+UwkXOoAjneU/xHplMQo2cXUlrVNqJYczgYlaOEczVCs/OCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38+xsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9+b8fH6+b8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj/0Q7PFUcC8hDrxESWdfgFRm+7vvWbkEppHB4T/1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y+g3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR/Rrs/JLKXgEx+qkmeDlFOD1/yTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW+xz+5FElFxWB28VjYIGZ0Yd+5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ+lT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ+2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1+JpI9psyNYIFuJogZa0/1AhOWdlHQxdAgbwacsHqPZo8u/ngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2+RdM+MAaYaZ0Y/ADkbNCZuAyAVQa2OcXOeICmDn9Q/eFkDeFQg5MgHEDXq/tVjj+jtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2/Bc0UxvseQCO2pQ2i+Krfhu/WeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt/U0Wf+phiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7+ExseJauyqo30hs+1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j/e1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la/QCTiVelFnU6O/GCvykqS/wZJDhKN9gBtSOp/1SP5VRgJcoVj+kmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn+8p6+vBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H+gDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D/GvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P+jAgN5TB3haSifDcApp6yymEi6Ij/GsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x/pChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11/yxyw0UnGig3MFdZklN5FI/qiT65T+jOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5+bqWiAYiAv6Jsf79/VUs4cIl+n6+WOjcgB/2l5TreoAV2717JzZbQIR0W1cl/dEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW/PhoawJDrGAP0JYWHgAVUByo/bGdiv2T2EMg8gsS14/rAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq+SCcTSx5NDtbFwNlh8VhjGGDu7JG5/TAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9+ogD8Kk/W7QoRN1UWPqM4+xdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c+4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS+o3F8YVVeikw13w+OEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX++7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9/O53DYi/5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD+P8sNh6e+XYHJXT/lkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp+pT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS/2ToPjqkaq62/7WFG8advGlRRqxB9diP07JrXowKR9tpRa+jGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq+nsp3YMuXt/GkXxLx/P6+ZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar+gMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud+YlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl/zh575R5rsrmRnKAzq4POFdgbYBuEviM4+LVC15ssLNFghbTtHWerS1hDt5s4qkLUha/qpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI+yjEldJfSo4y0QhG4i4IwkRFGcjWY8+EzgYYJUK7BXQksLxAww/YYWBMhJILB9e8ePEJ4OP7z+4/wOQDl64iOYDp26DaONPxpKtBxq/aTzRGarm3VkPYTLJKx6Z/Mw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ+lPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k/UuGkNpP1DBI5ch/EehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv+J41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI+HYexTUevLUeta4/DqKrbMVS+Yqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ++KkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9/Wx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k/90B8+yRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB/mQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go/n6j0cS+a2gEU8gIHJ+BwfgZX4GL+Bd/gW34FZ+BS/gUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh/F062yJ7AAAAEDAWAAABWhJ+KPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg) format('embedded-opentype'),url(data:application/font-woff;base64,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) format('woff'),url(data:application/x-font-truetype;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:400;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\2a"}.glyphicon-plus:before{content:"\2b"}.glyphicon-eur:before,.glyphicon-euro:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}button,input,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.carousel-inner>.item>a>img,.carousel-inner>.item>img,.img-responsive,.thumbnail a>img,.thumbnail>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:6px}.img-thumbnail{display:inline-block;max-width:100%;height:auto;padding:4px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out}.img-circle{border-radius:50%}hr{margin-top:20px;margin-bottom:20px;border:0;border-top:1px solid #eee}.sr-only{position:absolute;width:1px;height:1px;padding:0;margin:-1px;overflow:hidden;clip:rect(0,0,0,0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role=button]{cursor:pointer}.h1,.h2,.h3,.h4,.h5,.h6,h1,h2,h3,h4,h5,h6{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-weight:400;line-height:1;color:#777}.h1,.h2,.h3,h1,h2,h3{margin-top:20px;margin-bottom:10px}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small{font-size:65%}.h4,.h5,.h6,h4,h5,h6{margin-top:10px;margin-bottom:10px}.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-size:75%}.h1,h1{font-size:36px}.h2,h2{font-size:30px}.h3,h3{font-size:24px}.h4,h4{font-size:18px}.h5,h5{font-size:14px}.h6,h6{font-size:12px}p{margin:0 0 10px}.lead{margin-bottom:20px;font-size:16px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:21px}}.small,small{font-size:85%}.mark,mark{padding:.2em;background-color:#fcf8e3}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#777}.text-primary{color:#337ab7}a.text-primary:focus,a.text-primary:hover{color:#286090}.text-success{color:#3c763d}a.text-success:focus,a.text-success:hover{color:#2b542c}.text-info{color:#31708f}a.text-info:focus,a.text-info:hover{color:#245269}.text-warning{color:#8a6d3b}a.text-warning:focus,a.text-warning:hover{color:#66512c}.text-danger{color:#a94442}a.text-danger:focus,a.text-danger:hover{color:#843534}.bg-primary{color:#fff;background-color:#337ab7}a.bg-primary:focus,a.bg-primary:hover{background-color:#286090}.bg-success{background-color:#dff0d8}a.bg-success:focus,a.bg-success:hover{background-color:#c1e2b3}.bg-info{background-color:#d9edf7}a.bg-info:focus,a.bg-info:hover{background-color:#afd9ee}.bg-warning{background-color:#fcf8e3}a.bg-warning:focus,a.bg-warning:hover{background-color:#f7ecb5}.bg-danger{background-color:#f2dede}a.bg-danger:focus,a.bg-danger:hover{background-color:#e4b9b9}.page-header{padding-bottom:9px;margin:40px 0 20px;border-bottom:1px solid #eee}ol,ul{margin-top:0;margin-bottom:10px}ol ol,ol ul,ul ol,ul ul{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;margin-left:-5px;list-style:none}.list-inline>li{display:inline-block;padding-right:5px;padding-left:5px}dl{margin-top:0;margin-bottom:20px}dd,dt{line-height:1.42857143}dt{font-weight:700}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;overflow:hidden;clear:left;text-align:right;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[data-original-title],abbr[title]{cursor:help;border-bottom:1px dotted #777}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:10px 20px;margin:0 0 20px;font-size:17.5px;border-left:5px solid #eee}blockquote ol:last-child,blockquote p:last-child,blockquote ul:last-child{margin-bottom:0}blockquote .small,blockquote footer,blockquote small{display:block;font-size:80%;line-height:1.42857143;color:#777}blockquote .small:before,blockquote footer:before,blockquote small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;text-align:right;border-right:5px solid #eee;border-left:0}.blockquote-reverse .small:before,.blockquote-reverse footer:before,.blockquote-reverse small:before,blockquote.pull-right .small:before,blockquote.pull-right footer:before,blockquote.pull-right small:before{content:''}.blockquote-reverse .small:after,.blockquote-reverse footer:after,.blockquote-reverse small:after,blockquote.pull-right .small:after,blockquote.pull-right footer:after,blockquote.pull-right small:after{content:'\00A0 \2014'}address{margin-bottom:20px;font-style:normal;line-height:1.42857143}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:4px}kbd{padding:2px 4px;font-size:90%;color:#fff;background-color:#333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,.25)}kbd kbd{padding:0;font-size:100%;font-weight:700;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:9.5px;margin:0 0 10px;font-size:13px;line-height:1.42857143;color:#333;word-break:break-all;word-wrap:break-word;background-color:#f5f5f5;border:1px solid #ccc;border-radius:4px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{position:relative;min-height:1px;padding-right:15px;padding-left:15px}.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0}@media (min-width:768px){.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0}}@media (min-width:992px){.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0}}@media (min-width:1200px){.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#777;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:20px}.table>tbody>tr>td,.table>tbody>tr>th,.table>tfoot>tr>td,.table>tfoot>tr>th,.table>thead>tr>td,.table>thead>tr>th{padding:8px;line-height:1.42857143;vertical-align:top;border-top:1px solid #ddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #ddd}.table>caption+thead>tr:first-child>td,.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>td,.table>thead:first-child>tr:first-child>th{border-top:0}.table>tbody+tbody{border-top:2px solid #ddd}.table .table{background-color:#fff}.table-condensed>tbody>tr>td,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>td,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>thead>tr>th{padding:5px}.table-bordered{border:1px solid #ddd}.table-bordered>tbody>tr>td,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>td,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border:1px solid #ddd}.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*=col-]{position:static;display:table-column;float:none}table td[class*=col-],table th[class*=col-]{position:static;display:table-cell;float:none}.table>tbody>tr.active>td,.table>tbody>tr.active>th,.table>tbody>tr>td.active,.table>tbody>tr>th.active,.table>tfoot>tr.active>td,.table>tfoot>tr.active>th,.table>tfoot>tr>td.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>thead>tr.active>th,.table>thead>tr>td.active,.table>thead>tr>th.active{background-color:#f5f5f5}.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr.active:hover>th,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover{background-color:#e8e8e8}.table>tbody>tr.success>td,.table>tbody>tr.success>th,.table>tbody>tr>td.success,.table>tbody>tr>th.success,.table>tfoot>tr.success>td,.table>tfoot>tr.success>th,.table>tfoot>tr>td.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>thead>tr.success>th,.table>thead>tr>td.success,.table>thead>tr>th.success{background-color:#dff0d8}.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr.success:hover>th,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover{background-color:#d0e9c6}.table>tbody>tr.info>td,.table>tbody>tr.info>th,.table>tbody>tr>td.info,.table>tbody>tr>th.info,.table>tfoot>tr.info>td,.table>tfoot>tr.info>th,.table>tfoot>tr>td.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>thead>tr.info>th,.table>thead>tr>td.info,.table>thead>tr>th.info{background-color:#d9edf7}.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr.info:hover>th,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover{background-color:#c4e3f3}.table>tbody>tr.warning>td,.table>tbody>tr.warning>th,.table>tbody>tr>td.warning,.table>tbody>tr>th.warning,.table>tfoot>tr.warning>td,.table>tfoot>tr.warning>th,.table>tfoot>tr>td.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>thead>tr.warning>th,.table>thead>tr>td.warning,.table>thead>tr>th.warning{background-color:#fcf8e3}.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr.warning:hover>th,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover{background-color:#faf2cc}.table>tbody>tr.danger>td,.table>tbody>tr.danger>th,.table>tbody>tr>td.danger,.table>tbody>tr>th.danger,.table>tfoot>tr.danger>td,.table>tfoot>tr.danger>th,.table>tfoot>tr>td.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>thead>tr.danger>th,.table>thead>tr>td.danger,.table>thead>tr>th.danger{background-color:#f2dede}.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr.danger:hover>th,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover{background-color:#ebcccc}.table-responsive{min-height:.01%;overflow-x:auto}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:15px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #ddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>td,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>thead>tr>th{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}}fieldset{min-width:0;padding:0;margin:0;border:0}legend{display:block;width:100%;padding:0;margin-bottom:20px;font-size:21px;line-height:inherit;color:#333;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:700}input[type=search]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type=checkbox],input[type=radio]{margin:4px 0 0;margin-top:1px\9;line-height:normal}input[type=file]{display:block}input[type=range]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type=file]:focus,input[type=checkbox]:focus,input[type=radio]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:14px;line-height:1.42857143;color:#555}.form-control{display:block;width:100%;height:34px;padding:6px 12px;font-size:14px;line-height:1.42857143;color:#555;background-color:#fff;background-image:none;border:1px solid #ccc;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6);box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6)}.form-control::-moz-placeholder{color:#999;opacity:1}.form-control:-ms-input-placeholder{color:#999}.form-control::-webkit-input-placeholder{color:#999}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:#eee;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type=search]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type=date].form-control,input[type=time].form-control,input[type=datetime-local].form-control,input[type=month].form-control{line-height:34px}.input-group-sm input[type=date],.input-group-sm input[type=time],.input-group-sm input[type=datetime-local],.input-group-sm input[type=month],input[type=date].input-sm,input[type=time].input-sm,input[type=datetime-local].input-sm,input[type=month].input-sm{line-height:30px}.input-group-lg input[type=date],.input-group-lg input[type=time],.input-group-lg input[type=datetime-local],.input-group-lg input[type=month],input[type=date].input-lg,input[type=time].input-lg,input[type=datetime-local].input-lg,input[type=month].input-lg{line-height:46px}}.form-group{margin-bottom:15px}.checkbox,.radio{position:relative;display:block;margin-top:10px;margin-bottom:10px}.checkbox label,.radio label{min-height:20px;padding-left:20px;margin-bottom:0;font-weight:400;cursor:pointer}.checkbox input[type=checkbox],.checkbox-inline input[type=checkbox],.radio input[type=radio],.radio-inline input[type=radio]{position:absolute;margin-top:4px\9;margin-left:-20px}.checkbox+.checkbox,.radio+.radio{margin-top:-5px}.checkbox-inline,.radio-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;font-weight:400;vertical-align:middle;cursor:pointer}.checkbox-inline+.checkbox-inline,.radio-inline+.radio-inline{margin-top:0;margin-left:10px}fieldset[disabled] input[type=checkbox],fieldset[disabled] input[type=radio],input[type=checkbox].disabled,input[type=checkbox][disabled],input[type=radio].disabled,input[type=radio][disabled]{cursor:not-allowed}.checkbox-inline.disabled,.radio-inline.disabled,fieldset[disabled] .checkbox-inline,fieldset[disabled] .radio-inline{cursor:not-allowed}.checkbox.disabled label,.radio.disabled label,fieldset[disabled] .checkbox label,fieldset[disabled] .radio label{cursor:not-allowed}.form-control-static{min-height:34px;padding-top:7px;padding-bottom:7px;margin-bottom:0}.form-control-static.input-lg,.form-control-static.input-sm{padding-right:0;padding-left:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}select[multiple].input-sm,textarea.input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm select[multiple].form-control,.form-group-sm textarea.form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:32px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-lg{height:46px;line-height:46px}select[multiple].input-lg,textarea.input-lg{height:auto}.form-group-lg .form-control{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.form-group-lg select.form-control{height:46px;line-height:46px}.form-group-lg select[multiple].form-control,.form-group-lg textarea.form-control{height:auto}.form-group-lg .form-control-static{height:46px;min-height:38px;padding:11px 16px;font-size:18px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:42.5px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:34px;height:34px;line-height:34px;text-align:center;pointer-events:none}.form-group-lg .form-control+.form-control-feedback,.input-group-lg+.form-control-feedback,.input-lg+.form-control-feedback{width:46px;height:46px;line-height:46px}.form-group-sm .form-control+.form-control-feedback,.input-group-sm+.form-control-feedback,.input-sm+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .checkbox,.has-success .checkbox-inline,.has-success .control-label,.has-success .help-block,.has-success .radio,.has-success .radio-inline,.has-success.checkbox label,.has-success.checkbox-inline label,.has-success.radio label,.has-success.radio-inline label{color:#3c763d}.has-success .form-control{border-color:#3c763d;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-success .form-control:focus{border-color:#2b542c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168}.has-success .input-group-addon{color:#3c763d;background-color:#dff0d8;border-color:#3c763d}.has-success .form-control-feedback{color:#3c763d}.has-warning .checkbox,.has-warning .checkbox-inline,.has-warning .control-label,.has-warning .help-block,.has-warning .radio,.has-warning .radio-inline,.has-warning.checkbox label,.has-warning.checkbox-inline label,.has-warning.radio label,.has-warning.radio-inline label{color:#8a6d3b}.has-warning .form-control{border-color:#8a6d3b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-warning .form-control:focus{border-color:#66512c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b}.has-warning .input-group-addon{color:#8a6d3b;background-color:#fcf8e3;border-color:#8a6d3b}.has-warning .form-control-feedback{color:#8a6d3b}.has-error .checkbox,.has-error .checkbox-inline,.has-error .control-label,.has-error .help-block,.has-error .radio,.has-error .radio-inline,.has-error.checkbox label,.has-error.checkbox-inline label,.has-error.radio label,.has-error.radio-inline label{color:#a94442}.has-error .form-control{border-color:#a94442;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-error .form-control:focus{border-color:#843534;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483}.has-error .input-group-addon{color:#a94442;background-color:#f2dede;border-color:#a94442}.has-error .form-control-feedback{color:#a94442}.has-feedback label~.form-control-feedback{top:25px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#737373}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .form-control,.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .checkbox,.form-inline .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .checkbox label,.form-inline .radio label{padding-left:0}.form-inline .checkbox input[type=checkbox],.form-inline .radio input[type=radio]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .checkbox,.form-horizontal .checkbox-inline,.form-horizontal .radio,.form-horizontal .radio-inline{padding-top:7px;margin-top:0;margin-bottom:0}.form-horizontal .checkbox,.form-horizontal .radio{min-height:27px}.form-horizontal .form-group{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.form-horizontal .control-label{padding-top:7px;margin-bottom:0;text-align:right}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:14.33px;font-size:18px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;padding:6px 12px;margin-bottom:0;font-size:14px;font-weight:400;line-height:1.42857143;text-align:center;white-space:nowrap;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;background-image:none;border:1px solid transparent;border-radius:4px}.btn.active.focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn:active:focus,.btn:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn.focus,.btn:focus,.btn:hover{color:#333;text-decoration:none}.btn.active,.btn:active{background-image:none;outline:0;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none;opacity:.65}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#333;background-color:#fff;border-color:#ccc}.btn-default.focus,.btn-default:focus{color:#333;background-color:#e6e6e6;border-color:#8c8c8c}.btn-default:hover{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active.focus,.btn-default.active:focus,.btn-default.active:hover,.btn-default:active.focus,.btn-default:active:focus,.btn-default:active:hover,.open>.dropdown-toggle.btn-default.focus,.open>.dropdown-toggle.btn-default:focus,.open>.dropdown-toggle.btn-default:hover{color:#333;background-color:#d4d4d4;border-color:#8c8c8c}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled,.btn-default.disabled.active,.btn-default.disabled.focus,.btn-default.disabled:active,.btn-default.disabled:focus,.btn-default.disabled:hover,.btn-default[disabled],.btn-default[disabled].active,.btn-default[disabled].focus,.btn-default[disabled]:active,.btn-default[disabled]:focus,.btn-default[disabled]:hover,fieldset[disabled] .btn-default,fieldset[disabled] .btn-default.active,fieldset[disabled] .btn-default.focus,fieldset[disabled] .btn-default:active,fieldset[disabled] .btn-default:focus,fieldset[disabled] .btn-default:hover{background-color:#fff;border-color:#ccc}.btn-default .badge{color:#fff;background-color:#333}.btn-primary{color:#fff;background-color:#337ab7;border-color:#2e6da4}.btn-primary.focus,.btn-primary:focus{color:#fff;background-color:#286090;border-color:#122b40}.btn-primary:hover{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active.focus,.btn-primary.active:focus,.btn-primary.active:hover,.btn-primary:active.focus,.btn-primary:active:focus,.btn-primary:active:hover,.open>.dropdown-toggle.btn-primary.focus,.open>.dropdown-toggle.btn-primary:focus,.open>.dropdown-toggle.btn-primary:hover{color:#fff;background-color:#204d74;border-color:#122b40}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled,.btn-primary.disabled.active,.btn-primary.disabled.focus,.btn-primary.disabled:active,.btn-primary.disabled:focus,.btn-primary.disabled:hover,.btn-primary[disabled],.btn-primary[disabled].active,.btn-primary[disabled].focus,.btn-primary[disabled]:active,.btn-primary[disabled]:focus,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary,fieldset[disabled] .btn-primary.active,fieldset[disabled] .btn-primary.focus,fieldset[disabled] .btn-primary:active,fieldset[disabled] .btn-primary:focus,fieldset[disabled] .btn-primary:hover{background-color:#337ab7;border-color:#2e6da4}.btn-primary .badge{color:#337ab7;background-color:#fff}.btn-success{color:#fff;background-color:#5cb85c;border-color:#4cae4c}.btn-success.focus,.btn-success:focus{color:#fff;background-color:#449d44;border-color:#255625}.btn-success:hover{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active.focus,.btn-success.active:focus,.btn-success.active:hover,.btn-success:active.focus,.btn-success:active:focus,.btn-success:active:hover,.open>.dropdown-toggle.btn-success.focus,.open>.dropdown-toggle.btn-success:focus,.open>.dropdown-toggle.btn-success:hover{color:#fff;background-color:#398439;border-color:#255625}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled,.btn-success.disabled.active,.btn-success.disabled.focus,.btn-success.disabled:active,.btn-success.disabled:focus,.btn-success.disabled:hover,.btn-success[disabled],.btn-success[disabled].active,.btn-success[disabled].focus,.btn-success[disabled]:active,.btn-success[disabled]:focus,.btn-success[disabled]:hover,fieldset[disabled] .btn-success,fieldset[disabled] .btn-success.active,fieldset[disabled] .btn-success.focus,fieldset[disabled] .btn-success:active,fieldset[disabled] .btn-success:focus,fieldset[disabled] .btn-success:hover{background-color:#5cb85c;border-color:#4cae4c}.btn-success .badge{color:#5cb85c;background-color:#fff}.btn-info{color:#fff;background-color:#5bc0de;border-color:#46b8da}.btn-info.focus,.btn-info:focus{color:#fff;background-color:#31b0d5;border-color:#1b6d85}.btn-info:hover{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active.focus,.btn-info.active:focus,.btn-info.active:hover,.btn-info:active.focus,.btn-info:active:focus,.btn-info:active:hover,.open>.dropdown-toggle.btn-info.focus,.open>.dropdown-toggle.btn-info:focus,.open>.dropdown-toggle.btn-info:hover{color:#fff;background-color:#269abc;border-color:#1b6d85}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled,.btn-info.disabled.active,.btn-info.disabled.focus,.btn-info.disabled:active,.btn-info.disabled:focus,.btn-info.disabled:hover,.btn-info[disabled],.btn-info[disabled].active,.btn-info[disabled].focus,.btn-info[disabled]:active,.btn-info[disabled]:focus,.btn-info[disabled]:hover,fieldset[disabled] .btn-info,fieldset[disabled] .btn-info.active,fieldset[disabled] .btn-info.focus,fieldset[disabled] .btn-info:active,fieldset[disabled] .btn-info:focus,fieldset[disabled] .btn-info:hover{background-color:#5bc0de;border-color:#46b8da}.btn-info .badge{color:#5bc0de;background-color:#fff}.btn-warning{color:#fff;background-color:#f0ad4e;border-color:#eea236}.btn-warning.focus,.btn-warning:focus{color:#fff;background-color:#ec971f;border-color:#985f0d}.btn-warning:hover{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active.focus,.btn-warning.active:focus,.btn-warning.active:hover,.btn-warning:active.focus,.btn-warning:active:focus,.btn-warning:active:hover,.open>.dropdown-toggle.btn-warning.focus,.open>.dropdown-toggle.btn-warning:focus,.open>.dropdown-toggle.btn-warning:hover{color:#fff;background-color:#d58512;border-color:#985f0d}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled,.btn-warning.disabled.active,.btn-warning.disabled.focus,.btn-warning.disabled:active,.btn-warning.disabled:focus,.btn-warning.disabled:hover,.btn-warning[disabled],.btn-warning[disabled].active,.btn-warning[disabled].focus,.btn-warning[disabled]:active,.btn-warning[disabled]:focus,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning,fieldset[disabled] .btn-warning.active,fieldset[disabled] .btn-warning.focus,fieldset[disabled] .btn-warning:active,fieldset[disabled] .btn-warning:focus,fieldset[disabled] .btn-warning:hover{background-color:#f0ad4e;border-color:#eea236}.btn-warning .badge{color:#f0ad4e;background-color:#fff}.btn-danger{color:#fff;background-color:#d9534f;border-color:#d43f3a}.btn-danger.focus,.btn-danger:focus{color:#fff;background-color:#c9302c;border-color:#761c19}.btn-danger:hover{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active.focus,.btn-danger.active:focus,.btn-danger.active:hover,.btn-danger:active.focus,.btn-danger:active:focus,.btn-danger:active:hover,.open>.dropdown-toggle.btn-danger.focus,.open>.dropdown-toggle.btn-danger:focus,.open>.dropdown-toggle.btn-danger:hover{color:#fff;background-color:#ac2925;border-color:#761c19}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled,.btn-danger.disabled.active,.btn-danger.disabled.focus,.btn-danger.disabled:active,.btn-danger.disabled:focus,.btn-danger.disabled:hover,.btn-danger[disabled],.btn-danger[disabled].active,.btn-danger[disabled].focus,.btn-danger[disabled]:active,.btn-danger[disabled]:focus,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger,fieldset[disabled] .btn-danger.active,fieldset[disabled] .btn-danger.focus,fieldset[disabled] .btn-danger:active,fieldset[disabled] .btn-danger:focus,fieldset[disabled] .btn-danger:hover{background-color:#d9534f;border-color:#d43f3a}.btn-danger .badge{color:#d9534f;background-color:#fff}.btn-link{font-weight:400;color:#337ab7;border-radius:0}.btn-link,.btn-link.active,.btn-link:active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:active,.btn-link:focus,.btn-link:hover{border-color:transparent}.btn-link:focus,.btn-link:hover{color:#23527c;text-decoration:underline;background-color:transparent}.btn-link[disabled]:focus,.btn-link[disabled]:hover,fieldset[disabled] .btn-link:focus,fieldset[disabled] .btn-link:hover{color:#777;text-decoration:none}.btn-group-lg>.btn,.btn-lg{padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.btn-group-sm>.btn,.btn-sm{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-group-xs>.btn,.btn-xs{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type=button].btn-block,input[type=reset].btn-block,input[type=submit].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity .15s linear;-o-transition:opacity .15s linear;transition:opacity .15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease;-webkit-transition-duration:.35s;-o-transition-duration:.35s;transition-duration:.35s;-webkit-transition-property:height,visibility;-o-transition-property:height,visibility;transition-property:height,visibility}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid\9;border-right:4px solid transparent;border-left:4px solid transparent}.dropdown,.dropup{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;font-size:14px;text-align:left;list-style:none;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.15);border-radius:4px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,.175);box-shadow:0 6px 12px rgba(0,0,0,.175)}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:400;line-height:1.42857143;color:#333;white-space:nowrap}.dropdown-menu>li>a:focus,.dropdown-menu>li>a:hover{color:#262626;text-decoration:none;background-color:#f5f5f5}.dropdown-menu>.active>a,.dropdown-menu>.active>a:focus,.dropdown-menu>.active>a:hover{color:#fff;text-decoration:none;background-color:#337ab7;outline:0}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{color:#777}.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{text-decoration:none;cursor:not-allowed;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false)}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{right:0;left:auto}.dropdown-menu-left{right:auto;left:0}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.42857143;color:#777;white-space:nowrap}.dropdown-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{content:"";border-top:0;border-bottom:4px dashed;border-bottom:4px solid\9}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{right:0;left:auto}.navbar-right .dropdown-menu-left{right:auto;left:0}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group-vertical>.btn,.btn-group>.btn{position:relative;float:left}.btn-group-vertical>.btn.active,.btn-group-vertical>.btn:active,.btn-group-vertical>.btn:focus,.btn-group-vertical>.btn:hover,.btn-group>.btn.active,.btn-group>.btn:active,.btn-group>.btn:focus,.btn-group>.btn:hover{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-top-left-radius:0;border-bottom-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-bottom-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-right:8px;padding-left:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-right:12px;padding-left:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-left-radius:0;border-top-right-radius:0;border-bottom-left-radius:4px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-top-right-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{display:table-cell;float:none;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle=buttons]>.btn input[type=checkbox],[data-toggle=buttons]>.btn input[type=radio],[data-toggle=buttons]>.btn-group>.btn input[type=checkbox],[data-toggle=buttons]>.btn-group>.btn input[type=radio]{position:absolute;clip:rect(0,0,0,0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*=col-]{float:none;padding-right:0;padding-left:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:46px;line-height:46px}select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn,textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn,textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn{height:auto}.input-group .form-control,.input-group-addon,.input-group-btn{display:table-cell}.input-group .form-control:not(:first-child):not(:last-child),.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 12px;font-size:14px;font-weight:400;line-height:1;color:#555;text-align:center;background-color:#eee;border:1px solid #ccc;border-radius:4px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:18px;border-radius:6px}.input-group-addon input[type=checkbox],.input-group-addon input[type=radio]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn-group:not(:last-child)>.btn,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:first-child>.btn-group:not(:first-child)>.btn,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle{border-top-left-radius:0;border-bottom-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:active,.input-group-btn>.btn:focus,.input-group-btn>.btn:hover{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.nav>li.disabled>a{color:#777}.nav>li.disabled>a:focus,.nav>li.disabled>a:hover{color:#777;text-decoration:none;cursor:not-allowed;background-color:transparent}.nav .open>a,.nav .open>a:focus,.nav .open>a:hover{background-color:#eee;border-color:#337ab7}.nav .nav-divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid #ddd}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.42857143;border:1px solid transparent;border-radius:4px 4px 0 0}.nav-tabs>li>a:hover{border-color:#eee #eee #ddd}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus,.nav-tabs>li.active>a:hover{color:#555;cursor:default;background-color:#fff;border:1px solid #ddd;border-bottom-color:transparent}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border-bottom-color:#fff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:4px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:focus,.nav-pills>li.active>a:hover{color:#fff;background-color:#337ab7}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border-bottom-color:#fff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-left-radius:0;border-top-right-radius:0}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse{padding-right:0;padding-left:0}}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:200px}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-bottom,.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-bottom,.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;padding:9px 10px;margin-top:8px;margin-right:15px;margin-bottom:8px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:4px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu .dropdown-header,.navbar-nav .open .dropdown-menu>li>a{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:20px}.navbar-nav .open .dropdown-menu>li>a:focus,.navbar-nav .open .dropdown-menu>li>a:hover{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}.navbar-form{padding:10px 15px;margin-top:8px;margin-right:-15px;margin-bottom:8px;margin-left:-15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .form-control,.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .checkbox,.navbar-form .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .checkbox label,.navbar-form .radio label{padding-left:0}.navbar-form .checkbox input[type=checkbox],.navbar-form .radio input[type=radio]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;padding-top:0;padding-bottom:0;margin-right:0;margin-left:0;border:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-left-radius:0;border-top-right-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:8px;margin-bottom:8px}.navbar-btn.btn-sm{margin-top:10px;margin-bottom:10px}.navbar-btn.btn-xs{margin-top:14px;margin-bottom:14px}.navbar-text{margin-top:15px;margin-bottom:15px}@media (min-width:768px){.navbar-text{float:left;margin-right:15px;margin-left:15px}}@media (min-width:768px){.navbar-left{float:left!important}.navbar-right{float:right!important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-text{color:#777}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:focus,.navbar-default .navbar-nav>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:focus,.navbar-default .navbar-nav>.disabled>a:hover{color:#ccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:#ddd}.navbar-default .navbar-toggle:focus,.navbar-default .navbar-toggle:hover{background-color:#ddd}.navbar-default .navbar-toggle .icon-bar{background-color:#888}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:#e7e7e7}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:focus,.navbar-default .navbar-nav>.open>a:hover{color:#555;background-color:#e7e7e7}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#777}.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#ccc;background-color:transparent}}.navbar-default .navbar-link{color:#777}.navbar-default .navbar-link:hover{color:#333}.navbar-default .btn-link{color:#777}.navbar-default .btn-link:focus,.navbar-default .btn-link:hover{color:#333}.navbar-default .btn-link[disabled]:focus,.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:focus,fieldset[disabled] .navbar-default .btn-link:hover{color:#ccc}.navbar-inverse{background-color:#222;border-color:#080808}.navbar-inverse .navbar-brand{color:#9d9d9d}.navbar-inverse .navbar-brand:focus,.navbar-inverse .navbar-brand:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-text{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a:focus,.navbar-inverse .navbar-nav>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:focus,.navbar-inverse .navbar-nav>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:focus,.navbar-inverse .navbar-nav>.disabled>a:hover{color:#444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:#333}.navbar-inverse .navbar-toggle:focus,.navbar-inverse .navbar-toggle:hover{background-color:#333}.navbar-inverse .navbar-toggle .icon-bar{background-color:#fff}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#101010}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:focus,.navbar-inverse .navbar-nav>.open>a:hover{color:#fff;background-color:#080808}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#444;background-color:transparent}}.navbar-inverse .navbar-link{color:#9d9d9d}.navbar-inverse .navbar-link:hover{color:#fff}.navbar-inverse .btn-link{color:#9d9d9d}.navbar-inverse .btn-link:focus,.navbar-inverse .btn-link:hover{color:#fff}.navbar-inverse .btn-link[disabled]:focus,.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:focus,fieldset[disabled] .navbar-inverse .btn-link:hover{color:#444}.breadcrumb{padding:8px 15px;margin-bottom:20px;list-style:none;background-color:#f5f5f5;border-radius:4px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{padding:0 5px;color:#ccc;content:"/\00a0"}.breadcrumb>.active{color:#777}.pagination{display:inline-block;padding-left:0;margin:20px 0;border-radius:4px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 12px;margin-left:-1px;line-height:1.42857143;color:#337ab7;text-decoration:none;background-color:#fff;border:1px solid #ddd}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-top-left-radius:4px;border-bottom-left-radius:4px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-top-right-radius:4px;border-bottom-right-radius:4px}.pagination>li>a:focus,.pagination>li>a:hover,.pagination>li>span:focus,.pagination>li>span:hover{z-index:3;color:#23527c;background-color:#eee;border-color:#ddd}.pagination>.active>a,.pagination>.active>a:focus,.pagination>.active>a:hover,.pagination>.active>span,.pagination>.active>span:focus,.pagination>.active>span:hover{z-index:2;color:#fff;cursor:default;background-color:#337ab7;border-color:#337ab7}.pagination>.disabled>a,.pagination>.disabled>a:focus,.pagination>.disabled>a:hover,.pagination>.disabled>span,.pagination>.disabled>span:focus,.pagination>.disabled>span:hover{color:#777;cursor:not-allowed;background-color:#fff;border-color:#ddd}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:18px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-top-left-radius:6px;border-bottom-left-radius:6px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-top-right-radius:6px;border-bottom-right-radius:6px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-top-left-radius:3px;border-bottom-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-top-right-radius:3px;border-bottom-right-radius:3px}.pager{padding-left:0;margin:20px 0;text-align:center;list-style:none}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#fff;border:1px solid #ddd;border-radius:15px}.pager li>a:focus,.pager li>a:hover{text-decoration:none;background-color:#eee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:focus,.pager .disabled>a:hover,.pager .disabled>span{color:#777;cursor:not-allowed;background-color:#fff}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:focus,a.label:hover{color:#fff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#777}.label-default[href]:focus,.label-default[href]:hover{background-color:#5e5e5e}.label-primary{background-color:#337ab7}.label-primary[href]:focus,.label-primary[href]:hover{background-color:#286090}.label-success{background-color:#5cb85c}.label-success[href]:focus,.label-success[href]:hover{background-color:#449d44}.label-info{background-color:#5bc0de}.label-info[href]:focus,.label-info[href]:hover{background-color:#31b0d5}.label-warning{background-color:#f0ad4e}.label-warning[href]:focus,.label-warning[href]:hover{background-color:#ec971f}.label-danger{background-color:#d9534f}.label-danger[href]:focus,.label-danger[href]:hover{background-color:#c9302c}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:middle;background-color:#777;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-group-xs>.btn .badge,.btn-xs .badge{top:0;padding:1px 5px}a.badge:focus,a.badge:hover{color:#fff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#337ab7;background-color:#fff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#eee}.jumbotron .h1,.jumbotron h1{color:inherit}.jumbotron p{margin-bottom:15px;font-size:21px;font-weight:200}.jumbotron>hr{border-top-color:#d5d5d5}.container .jumbotron,.container-fluid .jumbotron{border-radius:6px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-right:60px;padding-left:60px}.jumbotron .h1,.jumbotron h1{font-size:63px}}.thumbnail{display:block;padding:4px;margin-bottom:20px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail a>img,.thumbnail>img{margin-right:auto;margin-left:auto}a.thumbnail.active,a.thumbnail:focus,a.thumbnail:hover{border-color:#337ab7}.thumbnail .caption{padding:9px;color:#333}.alert{padding:15px;margin-bottom:20px;border:1px solid transparent;border-radius:4px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:700}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#2b542c}.alert-info{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.alert-info hr{border-top-color:#a6e1ec}.alert-info .alert-link{color:#245269}.alert-warning{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.alert-warning hr{border-top-color:#f7e1b5}.alert-warning .alert-link{color:#66512c}.alert-danger{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.alert-danger hr{border-top-color:#e4b9c0}.alert-danger .alert-link{color:#843534}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{height:20px;margin-bottom:20px;overflow:hidden;background-color:#f5f5f5;border-radius:4px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,.1);box-shadow:inset 0 1px 2px rgba(0,0,0,.1)}.progress-bar{float:left;width:0;height:100%;font-size:12px;line-height:20px;color:#fff;text-align:center;background-color:#337ab7;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);-webkit-transition:width .6s ease;-o-transition:width .6s ease;transition:width .6s ease}.progress-bar-striped,.progress-striped .progress-bar{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress-bar.active,.progress.active .progress-bar{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#5cb85c}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-info{background-color:#5bc0de}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-warning{background-color:#f0ad4e}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-danger{background-color:#d9534f}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{overflow:hidden;zoom:1}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-body,.media-left,.media-right{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{padding-left:0;margin-bottom:20px}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#fff;border:1px solid #ddd}.list-group-item:first-child{border-top-left-radius:4px;border-top-right-radius:4px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:4px;border-bottom-left-radius:4px}a.list-group-item,button.list-group-item{color:#555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333}a.list-group-item:focus,a.list-group-item:hover,button.list-group-item:focus,button.list-group-item:hover{color:#555;text-decoration:none;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:focus,.list-group-item.disabled:hover{color:#777;cursor:not-allowed;background-color:#eee}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text{color:#777}.list-group-item.active,.list-group-item.active:focus,.list-group-item.active:hover{z-index:2;color:#fff;background-color:#337ab7;border-color:#337ab7}.list-group-item.active .list-group-item-heading,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:focus .list-group-item-text,.list-group-item.active:hover .list-group-item-text{color:#c7ddef}.list-group-item-success{color:#3c763d;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#3c763d}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:focus,a.list-group-item-success:hover,button.list-group-item-success:focus,button.list-group-item-success:hover{color:#3c763d;background-color:#d0e9c6}a.list-group-item-success.active,a.list-group-item-success.active:focus,a.list-group-item-success.active:hover,button.list-group-item-success.active,button.list-group-item-success.active:focus,button.list-group-item-success.active:hover{color:#fff;background-color:#3c763d;border-color:#3c763d}.list-group-item-info{color:#31708f;background-color:#d9edf7}a.list-group-item-info,button.list-group-item-info{color:#31708f}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:focus,a.list-group-item-info:hover,button.list-group-item-info:focus,button.list-group-item-info:hover{color:#31708f;background-color:#c4e3f3}a.list-group-item-info.active,a.list-group-item-info.active:focus,a.list-group-item-info.active:hover,button.list-group-item-info.active,button.list-group-item-info.active:focus,button.list-group-item-info.active:hover{color:#fff;background-color:#31708f;border-color:#31708f}.list-group-item-warning{color:#8a6d3b;background-color:#fcf8e3}a.list-group-item-warning,button.list-group-item-warning{color:#8a6d3b}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:focus,a.list-group-item-warning:hover,button.list-group-item-warning:focus,button.list-group-item-warning:hover{color:#8a6d3b;background-color:#faf2cc}a.list-group-item-warning.active,a.list-group-item-warning.active:focus,a.list-group-item-warning.active:hover,button.list-group-item-warning.active,button.list-group-item-warning.active:focus,button.list-group-item-warning.active:hover{color:#fff;background-color:#8a6d3b;border-color:#8a6d3b}.list-group-item-danger{color:#a94442;background-color:#f2dede}a.list-group-item-danger,button.list-group-item-danger{color:#a94442}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:focus,a.list-group-item-danger:hover,button.list-group-item-danger:focus,button.list-group-item-danger:hover{color:#a94442;background-color:#ebcccc}a.list-group-item-danger.active,a.list-group-item-danger.active:focus,a.list-group-item-danger.active:hover,button.list-group-item-danger.active,button.list-group-item-danger.active:focus,button.list-group-item-danger.active:hover{color:#fff;background-color:#a94442;border-color:#a94442}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:20px;background-color:#fff;border:1px solid transparent;border-radius:4px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,.05);box-shadow:0 1px 1px rgba(0,0,0,.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-left-radius:3px;border-top-right-radius:3px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:16px;color:inherit}.panel-title>.small,.panel-title>.small>a,.panel-title>a,.panel-title>small,.panel-title>small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #ddd;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-left-radius:3px;border-top-right-radius:3px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-left-radius:0;border-top-right-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.panel-collapse>.table,.panel>.table,.panel>.table-responsive>.table{margin-bottom:0}.panel>.panel-collapse>.table caption,.panel>.table caption,.panel>.table-responsive>.table caption{padding-right:15px;padding-left:15px}.panel>.table-responsive:first-child>.table:first-child,.panel>.table:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table:first-child>thead:first-child>tr:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child{border-top-left-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child{border-top-right-radius:3px}.panel>.table-responsive:last-child>.table:last-child,.panel>.table:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:3px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #ddd}.panel>.table>tbody:first-child>tr:first-child td,.panel>.table>tbody:first-child>tr:first-child th{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{margin-bottom:0;border:0}.panel-group{margin-bottom:20px}.panel-group .panel{margin-bottom:0;border-radius:4px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.list-group,.panel-group .panel-heading+.panel-collapse>.panel-body{border-top:1px solid #ddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #ddd}.panel-default{border-color:#ddd}.panel-default>.panel-heading{color:#333;background-color:#f5f5f5;border-color:#ddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#333}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ddd}.panel-primary{border-color:#337ab7}.panel-primary>.panel-heading{color:#fff;background-color:#337ab7;border-color:#337ab7}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#337ab7}.panel-primary>.panel-heading .badge{color:#337ab7;background-color:#fff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#337ab7}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#dff0d8;background-color:#3c763d}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#bce8f1}.panel-info>.panel-heading{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#bce8f1}.panel-info>.panel-heading .badge{color:#d9edf7;background-color:#31708f}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#bce8f1}.panel-warning{border-color:#faebcc}.panel-warning>.panel-heading{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#faebcc}.panel-warning>.panel-heading .badge{color:#fcf8e3;background-color:#8a6d3b}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#faebcc}.panel-danger{border-color:#ebccd1}.panel-danger>.panel-heading{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ebccd1}.panel-danger>.panel-heading .badge{color:#f2dede;background-color:#a94442}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ebccd1}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive embed,.embed-responsive iframe,.embed-responsive object,.embed-responsive video{position:absolute;top:0;bottom:0;left:0;width:100%;height:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f5f5f5;border:1px solid #e3e3e3;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.05);box-shadow:inset 0 1px 1px rgba(0,0,0,.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,.15)}.well-lg{padding:24px;border-radius:6px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:21px;font-weight:700;line-height:1;color:#000;text-shadow:0 1px 0 #fff;filter:alpha(opacity=20);opacity:.2}.close:focus,.close:hover{color:#000;text-decoration:none;cursor:pointer;filter:alpha(opacity=50);opacity:.5}button.close{-webkit-appearance:none;padding:0;cursor:pointer;background:0 0;border:0}.modal-open{overflow:hidden}.modal{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;display:none;overflow:hidden;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out;-webkit-transform:translate(0,-25%);-ms-transform:translate(0,-25%);-o-transform:translate(0,-25%);transform:translate(0,-25%)}.modal.in .modal-dialog{-webkit-transform:translate(0,0);-ms-transform:translate(0,0);-o-transform:translate(0,0);transform:translate(0,0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #999;border:1px solid rgba(0,0,0,.2);border-radius:6px;outline:0;-webkit-box-shadow:0 3px 9px rgba(0,0,0,.5);box-shadow:0 3px 9px rgba(0,0,0,.5)}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000}.modal-backdrop.fade{filter:alpha(opacity=0);opacity:0}.modal-backdrop.in{filter:alpha(opacity=50);opacity:.5}.modal-header{min-height:16.43px;padding:15px;border-bottom:1px solid #e5e5e5}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.42857143}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid #e5e5e5}.modal-footer .btn+.btn{margin-bottom:0;margin-left:5px}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,.5);box-shadow:0 5px 15px rgba(0,0,0,.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:12px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;filter:alpha(opacity=0);opacity:0;line-break:auto}.tooltip.in{filter:alpha(opacity=90);opacity:.9}.tooltip.top{padding:5px 0;margin-top:-3px}.tooltip.right{padding:0 5px;margin-left:3px}.tooltip.bottom{padding:5px 0;margin-top:3px}.tooltip.left{padding:0 5px;margin-left:-3px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#fff;text-align:center;background-color:#000;border-radius:4px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-left .tooltip-arrow{right:5px;bottom:0;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#000}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#000}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.2);border-radius:6px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,.2);box-shadow:0 5px 10px rgba(0,0,0,.2);line-break:auto}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{padding:8px 14px;margin:0;font-size:14px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:5px 5px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{content:"";border-width:10px}.popover.top>.arrow{bottom:-11px;left:50%;margin-left:-11px;border-top-color:#999;border-top-color:rgba(0,0,0,.25);border-bottom-width:0}.popover.top>.arrow:after{bottom:1px;margin-left:-10px;content:" ";border-top-color:#fff;border-bottom-width:0}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-right-color:#999;border-right-color:rgba(0,0,0,.25);border-left-width:0}.popover.right>.arrow:after{bottom:-10px;left:1px;content:" ";border-right-color:#fff;border-left-width:0}.popover.bottom>.arrow{top:-11px;left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:#999;border-bottom-color:rgba(0,0,0,.25)}.popover.bottom>.arrow:after{top:1px;margin-left:-10px;content:" ";border-top-width:0;border-bottom-color:#fff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:#999;border-left-color:rgba(0,0,0,.25)}.popover.left>.arrow:after{right:1px;bottom:-10px;content:" ";border-right-width:0;border-left-color:#fff}.carousel{position:relative}.carousel-inner{position:relative;width:100%;overflow:hidden}.carousel-inner>.item{position:relative;display:none;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>a>img,.carousel-inner>.item>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.active.right,.carousel-inner>.item.next{left:0;-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.carousel-inner>.item.active.left,.carousel-inner>.item.prev{left:0;-webkit-transform:translate3d(-100%,0,0);transform:translate3d(-100%,0,0)}.carousel-inner>.item.active,.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right{left:0;-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;bottom:0;left:0;width:15%;font-size:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6);filter:alpha(opacity=50);opacity:.5}.carousel-control.left{background-image:-webkit-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.5)),to(rgba(0,0,0,.0001)));background-image:linear-gradient(to right,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);background-repeat:repeat-x}.carousel-control.right{right:0;left:auto;background-image:-webkit-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.0001)),to(rgba(0,0,0,.5)));background-image:linear-gradient(to right,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);background-repeat:repeat-x}.carousel-control:focus,.carousel-control:hover{color:#fff;text-decoration:none;filter:alpha(opacity=90);outline:0;opacity:.9}.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{position:absolute;top:50%;z-index:5;display:inline-block;margin-top:-10px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{left:50%;margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{right:50%;margin-right:-10px}.carousel-control .icon-next,.carousel-control .icon-prev{width:20px;height:20px;font-family:serif;line-height:1}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;padding-left:0;margin-left:-30%;text-align:center;list-style:none}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;cursor:pointer;background-color:#000\9;background-color:rgba(0,0,0,0);border:1px solid #fff;border-radius:10px}.carousel-indicators .active{width:12px;height:12px;margin:0;background-color:#fff}.carousel-caption{position:absolute;right:15%;bottom:20px;left:15%;z-index:10;padding-top:20px;padding-bottom:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{width:30px;height:30px;margin-top:-15px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-15px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-15px}.carousel-caption{right:20%;left:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.btn-group-vertical>.btn-group:after,.btn-group-vertical>.btn-group:before,.btn-toolbar:after,.btn-toolbar:before,.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.dl-horizontal dd:after,.dl-horizontal dd:before,.form-horizontal .form-group:after,.form-horizontal .form-group:before,.modal-footer:after,.modal-footer:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.pager:after,.pager:before,.panel-body:after,.panel-body:before,.row:after,.row:before{display:table;content:" "}.btn-group-vertical>.btn-group:after,.btn-toolbar:after,.clearfix:after,.container-fluid:after,.container:after,.dl-horizontal dd:after,.form-horizontal .form-group:after,.modal-footer:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.pager:after,.panel-body:after,.row:after{clear:both}.center-block{display:block;margin-right:auto;margin-left:auto}.pull-right{float:right!important}.pull-left{float:left!important}.hide{display:none!important}.show{display:block!important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none!important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-lg,.visible-md,.visible-sm,.visible-xs{display:none!important}.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block{display:none!important}@media (max-width:767px){.visible-xs{display:block!important}table.visible-xs{display:table!important}tr.visible-xs{display:table-row!important}td.visible-xs,th.visible-xs{display:table-cell!important}}@media (max-width:767px){.visible-xs-block{display:block!important}}@media (max-width:767px){.visible-xs-inline{display:inline!important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block!important}table.visible-sm{display:table!important}tr.visible-sm{display:table-row!important}td.visible-sm,th.visible-sm{display:table-cell!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block!important}table.visible-md{display:table!important}tr.visible-md{display:table-row!important}td.visible-md,th.visible-md{display:table-cell!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block!important}}@media (min-width:1200px){.visible-lg{display:block!important}table.visible-lg{display:table!important}tr.visible-lg{display:table-row!important}td.visible-lg,th.visible-lg{display:table-cell!important}}@media (min-width:1200px){.visible-lg-block{display:block!important}}@media (min-width:1200px){.visible-lg-inline{display:inline!important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block!important}}@media (max-width:767px){.hidden-xs{display:none!important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none!important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none!important}}@media (min-width:1200px){.hidden-lg{display:none!important}}.visible-print{display:none!important}@media print{.visible-print{display:block!important}table.visible-print{display:table!important}tr.visible-print{display:table-row!important}td.visible-print,th.visible-print{display:table-cell!important}}.visible-print-block{display:none!important}@media print{.visible-print-block{display:block!important}}.visible-print-inline{display:none!important}@media print{.visible-print-inline{display:inline!important}}.visible-print-inline-block{display:none!important}@media print{.visible-print-inline-block{display:inline-block!important}}@media print{.hidden-print{display:none!important}}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>
<style type="text/css">.hljs-literal {
color: #990073;
}
.hljs-number {
color: #099;
}
.hljs-comment {
color: #998;
font-style: italic;
}
.hljs-keyword {
color: #900;
font-weight: bold;
}
.hljs-string {
color: #d14;
}
</style>
<script src="data:application/javascript;base64,/*! highlight.js v9.12.0 | BSD3 License | git.io/hljslicense */
!function(e){var n="object"==typeof window&&window||"object"==typeof self&&self;"undefined"!=typeof exports?e(exports):n&&(n.hljs=e({}),"function"==typeof define&&define.amd&&define([],function(){return n.hljs}))}(function(e){function n(e){return e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;")}function t(e){return e.nodeName.toLowerCase()}function r(e,n){var t=e&&e.exec(n);return t&&0===t.index}function a(e){return k.test(e)}function i(e){var n,t,r,i,o=e.className+" ";if(o+=e.parentNode?e.parentNode.className:"",t=B.exec(o))return w(t[1])?t[1]:"no-highlight";for(o=o.split(/\s+/),n=0,r=o.length;r>n;n++)if(i=o[n],a(i)||w(i))return i}function o(e){var n,t={},r=Array.prototype.slice.call(arguments,1);for(n in e)t[n]=e[n];return r.forEach(function(e){for(n in e)t[n]=e[n]}),t}function u(e){var n=[];return function r(e,a){for(var i=e.firstChild;i;i=i.nextSibling)3===i.nodeType?a+=i.nodeValue.length:1===i.nodeType&&(n.push({event:"start",offset:a,node:i}),a=r(i,a),t(i).match(/br|hr|img|input/)||n.push({event:"stop",offset:a,node:i}));return a}(e,0),n}function c(e,r,a){function i(){return e.length&&r.length?e[0].offset!==r[0].offset?e[0].offset<r[0].offset?e:r:"start"===r[0].event?e:r:e.length?e:r}function o(e){function r(e){return" "+e.nodeName+'="'+n(e.value).replace('"',"&quot;")+'"'}s+="<"+t(e)+E.map.call(e.attributes,r).join("")+">"}function u(e){s+="</"+t(e)+">"}function c(e){("start"===e.event?o:u)(e.node)}for(var l=0,s="",f=[];e.length||r.length;){var g=i();if(s+=n(a.substring(l,g[0].offset)),l=g[0].offset,g===e){f.reverse().forEach(u);do c(g.splice(0,1)[0]),g=i();while(g===e&&g.length&&g[0].offset===l);f.reverse().forEach(o)}else"start"===g[0].event?f.push(g[0].node):f.pop(),c(g.splice(0,1)[0])}return s+n(a.substr(l))}function l(e){return e.v&&!e.cached_variants&&(e.cached_variants=e.v.map(function(n){return o(e,{v:null},n)})),e.cached_variants||e.eW&&[o(e)]||[e]}function s(e){function n(e){return e&&e.source||e}function t(t,r){return new RegExp(n(t),"m"+(e.cI?"i":"")+(r?"g":""))}function r(a,i){if(!a.compiled){if(a.compiled=!0,a.k=a.k||a.bK,a.k){var o={},u=function(n,t){e.cI&&(t=t.toLowerCase()),t.split(" ").forEach(function(e){var t=e.split("|");o[t[0]]=[n,t[1]?Number(t[1]):1]})};"string"==typeof a.k?u("keyword",a.k):x(a.k).forEach(function(e){u(e,a.k[e])}),a.k=o}a.lR=t(a.l||/\w+/,!0),i&&(a.bK&&(a.b="\\b("+a.bK.split(" ").join("|")+")\\b"),a.b||(a.b=/\B|\b/),a.bR=t(a.b),a.e||a.eW||(a.e=/\B|\b/),a.e&&(a.eR=t(a.e)),a.tE=n(a.e)||"",a.eW&&i.tE&&(a.tE+=(a.e?"|":"")+i.tE)),a.i&&(a.iR=t(a.i)),null==a.r&&(a.r=1),a.c||(a.c=[]),a.c=Array.prototype.concat.apply([],a.c.map(function(e){return l("self"===e?a:e)})),a.c.forEach(function(e){r(e,a)}),a.starts&&r(a.starts,i);var c=a.c.map(function(e){return e.bK?"\\.?("+e.b+")\\.?":e.b}).concat([a.tE,a.i]).map(n).filter(Boolean);a.t=c.length?t(c.join("|"),!0):{exec:function(){return null}}}}r(e)}function f(e,t,a,i){function o(e,n){var t,a;for(t=0,a=n.c.length;a>t;t++)if(r(n.c[t].bR,e))return n.c[t]}function u(e,n){if(r(e.eR,n)){for(;e.endsParent&&e.parent;)e=e.parent;return e}return e.eW?u(e.parent,n):void 0}function c(e,n){return!a&&r(n.iR,e)}function l(e,n){var t=N.cI?n[0].toLowerCase():n[0];return e.k.hasOwnProperty(t)&&e.k[t]}function p(e,n,t,r){var a=r?"":I.classPrefix,i='<span class="'+a,o=t?"":C;return i+=e+'">',i+n+o}function h(){var e,t,r,a;if(!E.k)return n(k);for(a="",t=0,E.lR.lastIndex=0,r=E.lR.exec(k);r;)a+=n(k.substring(t,r.index)),e=l(E,r),e?(B+=e[1],a+=p(e[0],n(r[0]))):a+=n(r[0]),t=E.lR.lastIndex,r=E.lR.exec(k);return a+n(k.substr(t))}function d(){var e="string"==typeof E.sL;if(e&&!y[E.sL])return n(k);var t=e?f(E.sL,k,!0,x[E.sL]):g(k,E.sL.length?E.sL:void 0);return E.r>0&&(B+=t.r),e&&(x[E.sL]=t.top),p(t.language,t.value,!1,!0)}function b(){L+=null!=E.sL?d():h(),k=""}function v(e){L+=e.cN?p(e.cN,"",!0):"",E=Object.create(e,{parent:{value:E}})}function m(e,n){if(k+=e,null==n)return b(),0;var t=o(n,E);if(t)return t.skip?k+=n:(t.eB&&(k+=n),b(),t.rB||t.eB||(k=n)),v(t,n),t.rB?0:n.length;var r=u(E,n);if(r){var a=E;a.skip?k+=n:(a.rE||a.eE||(k+=n),b(),a.eE&&(k=n));do E.cN&&(L+=C),E.skip||(B+=E.r),E=E.parent;while(E!==r.parent);return r.starts&&v(r.starts,""),a.rE?0:n.length}if(c(n,E))throw new Error('Illegal lexeme "'+n+'" for mode "'+(E.cN||"<unnamed>")+'"');return k+=n,n.length||1}var N=w(e);if(!N)throw new Error('Unknown language: "'+e+'"');s(N);var R,E=i||N,x={},L="";for(R=E;R!==N;R=R.parent)R.cN&&(L=p(R.cN,"",!0)+L);var k="",B=0;try{for(var M,j,O=0;;){if(E.t.lastIndex=O,M=E.t.exec(t),!M)break;j=m(t.substring(O,M.index),M[0]),O=M.index+j}for(m(t.substr(O)),R=E;R.parent;R=R.parent)R.cN&&(L+=C);return{r:B,value:L,language:e,top:E}}catch(T){if(T.message&&-1!==T.message.indexOf("Illegal"))return{r:0,value:n(t)};throw T}}function g(e,t){t=t||I.languages||x(y);var r={r:0,value:n(e)},a=r;return t.filter(w).forEach(function(n){var t=f(n,e,!1);t.language=n,t.r>a.r&&(a=t),t.r>r.r&&(a=r,r=t)}),a.language&&(r.second_best=a),r}function p(e){return I.tabReplace||I.useBR?e.replace(M,function(e,n){return I.useBR&&"\n"===e?"<br>":I.tabReplace?n.replace(/\t/g,I.tabReplace):""}):e}function h(e,n,t){var r=n?L[n]:t,a=[e.trim()];return e.match(/\bhljs\b/)||a.push("hljs"),-1===e.indexOf(r)&&a.push(r),a.join(" ").trim()}function d(e){var n,t,r,o,l,s=i(e);a(s)||(I.useBR?(n=document.createElementNS("http://www.w3.org/1999/xhtml","div"),n.innerHTML=e.innerHTML.replace(/\n/g,"").replace(/<br[ \/]*>/g,"\n")):n=e,l=n.textContent,r=s?f(s,l,!0):g(l),t=u(n),t.length&&(o=document.createElementNS("http://www.w3.org/1999/xhtml","div"),o.innerHTML=r.value,r.value=c(t,u(o),l)),r.value=p(r.value),e.innerHTML=r.value,e.className=h(e.className,s,r.language),e.result={language:r.language,re:r.r},r.second_best&&(e.second_best={language:r.second_best.language,re:r.second_best.r}))}function b(e){I=o(I,e)}function v(){if(!v.called){v.called=!0;var e=document.querySelectorAll("pre code");E.forEach.call(e,d)}}function m(){addEventListener("DOMContentLoaded",v,!1),addEventListener("load",v,!1)}function N(n,t){var r=y[n]=t(e);r.aliases&&r.aliases.forEach(function(e){L[e]=n})}function R(){return x(y)}function w(e){return e=(e||"").toLowerCase(),y[e]||y[L[e]]}var E=[],x=Object.keys,y={},L={},k=/^(no-?highlight|plain|text)$/i,B=/\blang(?:uage)?-([\w-]+)\b/i,M=/((^(<[^>]+>|\t|)+|(?:\n)))/gm,C="</span>",I={classPrefix:"hljs-",tabReplace:null,useBR:!1,languages:void 0};return e.highlight=f,e.highlightAuto=g,e.fixMarkup=p,e.highlightBlock=d,e.configure=b,e.initHighlighting=v,e.initHighlightingOnLoad=m,e.registerLanguage=N,e.listLanguages=R,e.getLanguage=w,e.inherit=o,e.IR="[a-zA-Z]\\w*",e.UIR="[a-zA-Z_]\\w*",e.NR="\\b\\d+(\\.\\d+)?",e.CNR="(-?)(\\b0[xX][a-fA-F0-9]+|(\\b\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)",e.BNR="\\b(0b[01]+)",e.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|-|-=|/=|/|:|;|<<|<<=|<=|<|===|==|=|>>>=|>>=|>=|>>>|>>|>|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~",e.BE={b:"\\\\[\\s\\S]",r:0},e.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[e.BE]},e.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[e.BE]},e.PWM={b:/\b(a|an|the|are|I'm|isn't|don't|doesn't|won't|but|just|should|pretty|simply|enough|gonna|going|wtf|so|such|will|you|your|they|like|more)\b/},e.C=function(n,t,r){var a=e.inherit({cN:"comment",b:n,e:t,c:[]},r||{});return a.c.push(e.PWM),a.c.push({cN:"doctag",b:"(?:TODO|FIXME|NOTE|BUG|XXX):",r:0}),a},e.CLCM=e.C("//","$"),e.CBCM=e.C("/\\*","\\*/"),e.HCM=e.C("#","$"),e.NM={cN:"number",b:e.NR,r:0},e.CNM={cN:"number",b:e.CNR,r:0},e.BNM={cN:"number",b:e.BNR,r:0},e.CSSNM={cN:"number",b:e.NR+"(%|em|ex|ch|rem|vw|vh|vmin|vmax|cm|mm|in|pt|pc|px|deg|grad|rad|turn|s|ms|Hz|kHz|dpi|dpcm|dppx)?",r:0},e.RM={cN:"regexp",b:/\//,e:/\/[gimuy]*/,i:/\n/,c:[e.BE,{b:/\[/,e:/\]/,r:0,c:[e.BE]}]},e.TM={cN:"title",b:e.IR,r:0},e.UTM={cN:"title",b:e.UIR,r:0},e.METHOD_GUARD={b:"\\.\\s*"+e.UIR,r:0},e});hljs.registerLanguage("sql",function(e){var t=e.C("--","$");return{cI:!0,i:/[<>{}*#]/,c:[{bK:"begin end start commit rollback savepoint lock alter create drop rename call delete do handler insert load replace select truncate update set show pragma grant merge describe use explain help declare prepare execute deallocate release unlock purge reset change stop analyze cache flush optimize repair kill install uninstall checksum restore check backup revoke comment",e:/;/,eW:!0,l:/[\w\.]+/,k:{keyword:"abort abs absolute acc acce accep accept access accessed accessible account acos action activate add addtime admin administer advanced advise aes_decrypt aes_encrypt after agent aggregate ali alia alias allocate allow alter always analyze ancillary and any anydata anydataset anyschema anytype apply archive archived archivelog are as asc ascii asin assembly assertion associate asynchronous at atan atn2 attr attri attrib attribu attribut attribute attributes audit authenticated authentication authid authors auto autoallocate autodblink autoextend automatic availability avg backup badfile basicfile before begin beginning benchmark between bfile bfile_base big bigfile bin binary_double binary_float binlog bit_and bit_count bit_length bit_or bit_xor bitmap blob_base block blocksize body both bound buffer_cache buffer_pool build bulk by byte byteordermark bytes cache caching call calling cancel capacity cascade cascaded case cast catalog category ceil ceiling chain change changed char_base char_length character_length characters characterset charindex charset charsetform charsetid check checksum checksum_agg child choose chr chunk class cleanup clear client clob clob_base clone close cluster_id cluster_probability cluster_set clustering coalesce coercibility col collate collation collect colu colum column column_value columns columns_updated comment commit compact compatibility compiled complete composite_limit compound compress compute concat concat_ws concurrent confirm conn connec connect connect_by_iscycle connect_by_isleaf connect_by_root connect_time connection consider consistent constant constraint constraints constructor container content contents context contributors controlfile conv convert convert_tz corr corr_k corr_s corresponding corruption cos cost count count_big counted covar_pop covar_samp cpu_per_call cpu_per_session crc32 create creation critical cross cube cume_dist curdate current current_date current_time current_timestamp current_user cursor curtime customdatum cycle data database databases datafile datafiles datalength date_add date_cache date_format date_sub dateadd datediff datefromparts datename datepart datetime2fromparts day day_to_second dayname dayofmonth dayofweek dayofyear days db_role_change dbtimezone ddl deallocate declare decode decompose decrement decrypt deduplicate def defa defau defaul default defaults deferred defi defin define degrees delayed delegate delete delete_all delimited demand dense_rank depth dequeue des_decrypt des_encrypt des_key_file desc descr descri describ describe descriptor deterministic diagnostics difference dimension direct_load directory disable disable_all disallow disassociate discardfile disconnect diskgroup distinct distinctrow distribute distributed div do document domain dotnet double downgrade drop dumpfile duplicate duration each edition editionable editions element ellipsis else elsif elt empty enable enable_all enclosed encode encoding encrypt end end-exec endian enforced engine engines enqueue enterprise entityescaping eomonth error errors escaped evalname evaluate event eventdata events except exception exceptions exchange exclude excluding execu execut execute exempt exists exit exp expire explain export export_set extended extent external external_1 external_2 externally extract failed failed_login_attempts failover failure far fast feature_set feature_value fetch field fields file file_name_convert filesystem_like_logging final finish first first_value fixed flash_cache flashback floor flush following follows for forall force form forma format found found_rows freelist freelists freepools fresh from from_base64 from_days ftp full function general generated get get_format get_lock getdate getutcdate global global_name globally go goto grant grants greatest group group_concat group_id grouping grouping_id groups gtid_subtract guarantee guard handler hash hashkeys having hea head headi headin heading heap help hex hierarchy high high_priority hosts hour http id ident_current ident_incr ident_seed identified identity idle_time if ifnull ignore iif ilike ilm immediate import in include including increment index indexes indexing indextype indicator indices inet6_aton inet6_ntoa inet_aton inet_ntoa infile initial initialized initially initrans inmemory inner innodb input insert install instance instantiable instr interface interleaved intersect into invalidate invisible is is_free_lock is_ipv4 is_ipv4_compat is_not is_not_null is_used_lock isdate isnull isolation iterate java join json json_exists keep keep_duplicates key keys kill language large last last_day last_insert_id last_value lax lcase lead leading least leaves left len lenght length less level levels library like like2 like4 likec limit lines link list listagg little ln load load_file lob lobs local localtime localtimestamp locate locator lock locked log log10 log2 logfile logfiles logging logical logical_reads_per_call logoff logon logs long loop low low_priority lower lpad lrtrim ltrim main make_set makedate maketime managed management manual map mapping mask master master_pos_wait match matched materialized max maxextents maximize maxinstances maxlen maxlogfiles maxloghistory maxlogmembers maxsize maxtrans md5 measures median medium member memcompress memory merge microsecond mid migration min minextents minimum mining minus minute minvalue missing mod mode model modification modify module monitoring month months mount move movement multiset mutex name name_const names nan national native natural nav nchar nclob nested never new newline next nextval no no_write_to_binlog noarchivelog noaudit nobadfile nocheck nocompress nocopy nocycle nodelay nodiscardfile noentityescaping noguarantee nokeep nologfile nomapping nomaxvalue nominimize nominvalue nomonitoring none noneditionable nonschema noorder nopr nopro noprom nopromp noprompt norely noresetlogs noreverse normal norowdependencies noschemacheck noswitch not nothing notice notrim novalidate now nowait nth_value nullif nulls num numb numbe nvarchar nvarchar2 object ocicoll ocidate ocidatetime ociduration ociinterval ociloblocator ocinumber ociref ocirefcursor ocirowid ocistring ocitype oct octet_length of off offline offset oid oidindex old on online only opaque open operations operator optimal optimize option optionally or oracle oracle_date oradata ord ordaudio orddicom orddoc order ordimage ordinality ordvideo organization orlany orlvary out outer outfile outline output over overflow overriding package pad parallel parallel_enable parameters parent parse partial partition partitions pascal passing password password_grace_time password_lock_time password_reuse_max password_reuse_time password_verify_function patch path patindex pctincrease pctthreshold pctused pctversion percent percent_rank percentile_cont percentile_disc performance period period_add period_diff permanent physical pi pipe pipelined pivot pluggable plugin policy position post_transaction pow power pragma prebuilt precedes preceding precision prediction prediction_cost prediction_details prediction_probability prediction_set prepare present preserve prior priority private private_sga privileges procedural procedure procedure_analyze processlist profiles project prompt protection public publishingservername purge quarter query quick quiesce quota quotename radians raise rand range rank raw read reads readsize rebuild record records recover recovery recursive recycle redo reduced ref reference referenced references referencing refresh regexp_like register regr_avgx regr_avgy regr_count regr_intercept regr_r2 regr_slope regr_sxx regr_sxy reject rekey relational relative relaylog release release_lock relies_on relocate rely rem remainder rename repair repeat replace replicate replication required reset resetlogs resize resource respect restore restricted result result_cache resumable resume retention return returning returns reuse reverse revoke right rlike role roles rollback rolling rollup round row row_count rowdependencies rowid rownum rows rtrim rules safe salt sample save savepoint sb1 sb2 sb4 scan schema schemacheck scn scope scroll sdo_georaster sdo_topo_geometry search sec_to_time second section securefile security seed segment select self sequence sequential serializable server servererror session session_user sessions_per_user set sets settings sha sha1 sha2 share shared shared_pool short show shrink shutdown si_averagecolor si_colorhistogram si_featurelist si_positionalcolor si_stillimage si_texture siblings sid sign sin size size_t sizes skip slave sleep smalldatetimefromparts smallfile snapshot some soname sort soundex source space sparse spfile split sql sql_big_result sql_buffer_result sql_cache sql_calc_found_rows sql_small_result sql_variant_property sqlcode sqldata sqlerror sqlname sqlstate sqrt square standalone standby start starting startup statement static statistics stats_binomial_test stats_crosstab stats_ks_test stats_mode stats_mw_test stats_one_way_anova stats_t_test_ stats_t_test_indep stats_t_test_one stats_t_test_paired stats_wsr_test status std stddev stddev_pop stddev_samp stdev stop storage store stored str str_to_date straight_join strcmp strict string struct stuff style subdate subpartition subpartitions substitutable substr substring subtime subtring_index subtype success sum suspend switch switchoffset switchover sync synchronous synonym sys sys_xmlagg sysasm sysaux sysdate sysdatetimeoffset sysdba sysoper system system_user sysutcdatetime table tables tablespace tan tdo template temporary terminated tertiary_weights test than then thread through tier ties time time_format time_zone timediff timefromparts timeout timestamp timestampadd timestampdiff timezone_abbr timezone_minute timezone_region to to_base64 to_date to_days to_seconds todatetimeoffset trace tracking transaction transactional translate translation treat trigger trigger_nestlevel triggers trim truncate try_cast try_convert try_parse type ub1 ub2 ub4 ucase unarchived unbounded uncompress under undo unhex unicode uniform uninstall union unique unix_timestamp unknown unlimited unlock unpivot unrecoverable unsafe unsigned until untrusted unusable unused update updated upgrade upped upper upsert url urowid usable usage use use_stored_outlines user user_data user_resources users using utc_date utc_timestamp uuid uuid_short validate validate_password_strength validation valist value values var var_samp varcharc vari varia variab variabl variable variables variance varp varraw varrawc varray verify version versions view virtual visible void wait wallet warning warnings week weekday weekofyear wellformed when whene whenev wheneve whenever where while whitespace with within without work wrapped xdb xml xmlagg xmlattributes xmlcast xmlcolattval xmlelement xmlexists xmlforest xmlindex xmlnamespaces xmlpi xmlquery xmlroot xmlschema xmlserialize xmltable xmltype xor year year_to_month years yearweek",literal:"true false null",built_in:"array bigint binary bit blob boolean char character date dec decimal float int int8 integer interval number numeric real record serial serial8 smallint text varchar varying void"},c:[{cN:"string",b:"'",e:"'",c:[e.BE,{b:"''"}]},{cN:"string",b:'"',e:'"',c:[e.BE,{b:'""'}]},{cN:"string",b:"`",e:"`",c:[e.BE]},e.CNM,e.CBCM,t]},e.CBCM,t]}});hljs.registerLanguage("r",function(e){var r="([a-zA-Z]|\\.[a-zA-Z.])[a-zA-Z0-9._]*";return{c:[e.HCM,{b:r,l:r,k:{keyword:"function if in break next repeat else for return switch while try tryCatch stop warning require library attach detach source setMethod setGeneric setGroupGeneric setClass ...",literal:"NULL NA TRUE FALSE T F Inf NaN NA_integer_|10 NA_real_|10 NA_character_|10 NA_complex_|10"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{b:"`",e:"`",r:0},{cN:"string",c:[e.BE],v:[{b:'"',e:'"'},{b:"'",e:"'"}]}]}});hljs.registerLanguage("perl",function(e){var t="getpwent getservent quotemeta msgrcv scalar kill dbmclose undef lc ma syswrite tr send umask sysopen shmwrite vec qx utime local oct semctl localtime readpipe do return format read sprintf dbmopen pop getpgrp not getpwnam rewinddir qqfileno qw endprotoent wait sethostent bless s|0 opendir continue each sleep endgrent shutdown dump chomp connect getsockname die socketpair close flock exists index shmgetsub for endpwent redo lstat msgctl setpgrp abs exit select print ref gethostbyaddr unshift fcntl syscall goto getnetbyaddr join gmtime symlink semget splice x|0 getpeername recv log setsockopt cos last reverse gethostbyname getgrnam study formline endhostent times chop length gethostent getnetent pack getprotoent getservbyname rand mkdir pos chmod y|0 substr endnetent printf next open msgsnd readdir use unlink getsockopt getpriority rindex wantarray hex system getservbyport endservent int chr untie rmdir prototype tell listen fork shmread ucfirst setprotoent else sysseek link getgrgid shmctl waitpid unpack getnetbyname reset chdir grep split require caller lcfirst until warn while values shift telldir getpwuid my getprotobynumber delete and sort uc defined srand accept package seekdir getprotobyname semop our rename seek if q|0 chroot sysread setpwent no crypt getc chown sqrt write setnetent setpriority foreach tie sin msgget map stat getlogin unless elsif truncate exec keys glob tied closedirioctl socket readlink eval xor readline binmode setservent eof ord bind alarm pipe atan2 getgrent exp time push setgrent gt lt or ne m|0 break given say state when",r={cN:"subst",b:"[$@]\\{",e:"\\}",k:t},s={b:"->{",e:"}"},n={v:[{b:/\$\d/},{b:/[\$%@](\^\w\b|#\w+(::\w+)*|{\w+}|\w+(::\w*)*)/},{b:/[\$%@][^\s\w{]/,r:0}]},i=[e.BE,r,n],o=[n,e.HCM,e.C("^\\=\\w","\\=cut",{eW:!0}),s,{cN:"string",c:i,v:[{b:"q[qwxr]?\\s*\\(",e:"\\)",r:5},{b:"q[qwxr]?\\s*\\[",e:"\\]",r:5},{b:"q[qwxr]?\\s*\\{",e:"\\}",r:5},{b:"q[qwxr]?\\s*\\|",e:"\\|",r:5},{b:"q[qwxr]?\\s*\\<",e:"\\>",r:5},{b:"qw\\s+q",e:"q",r:5},{b:"'",e:"'",c:[e.BE]},{b:'"',e:'"'},{b:"`",e:"`",c:[e.BE]},{b:"{\\w+}",c:[],r:0},{b:"-?\\w+\\s*\\=\\>",c:[],r:0}]},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\/\\/|"+e.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:"split return print reverse grep",r:0,c:[e.HCM,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[e.BE],r:0}]},{cN:"function",bK:"sub",e:"(\\s*\\(.*?\\))?[;{]",eE:!0,r:5,c:[e.TM]},{b:"-\\w\\b",r:0},{b:"^__DATA__$",e:"^__END__$",sL:"mojolicious",c:[{b:"^@@.*",e:"$",cN:"comment"}]}];return r.c=o,s.c=o,{aliases:["pl","pm"],l:/[\w\.]+/,k:t,c:o}});hljs.registerLanguage("ini",function(e){var b={cN:"string",c:[e.BE],v:[{b:"'''",e:"'''",r:10},{b:'"""',e:'"""',r:10},{b:'"',e:'"'},{b:"'",e:"'"}]};return{aliases:["toml"],cI:!0,i:/\S/,c:[e.C(";","$"),e.HCM,{cN:"section",b:/^\s*\[+/,e:/\]+/},{b:/^[a-z0-9\[\]_-]+\s*=\s*/,e:"$",rB:!0,c:[{cN:"attr",b:/[a-z0-9\[\]_-]+/},{b:/=/,eW:!0,r:0,c:[{cN:"literal",b:/\bon|off|true|false|yes|no\b/},{cN:"variable",v:[{b:/\$[\w\d"][\w\d_]*/},{b:/\$\{(.*?)}/}]},b,{cN:"number",b:/([\+\-]+)?[\d]+_[\d_]+/},e.NM]}]}]}});hljs.registerLanguage("diff",function(e){return{aliases:["patch"],c:[{cN:"meta",r:10,v:[{b:/^@@ +\-\d+,\d+ +\+\d+,\d+ +@@$/},{b:/^\*\*\* +\d+,\d+ +\*\*\*\*$/},{b:/^\-\-\- +\d+,\d+ +\-\-\-\-$/}]},{cN:"comment",v:[{b:/Index: /,e:/$/},{b:/={3,}/,e:/$/},{b:/^\-{3}/,e:/$/},{b:/^\*{3} /,e:/$/},{b:/^\+{3}/,e:/$/},{b:/\*{5}/,e:/\*{5}$/}]},{cN:"addition",b:"^\\+",e:"$"},{cN:"deletion",b:"^\\-",e:"$"},{cN:"addition",b:"^\\!",e:"$"}]}});hljs.registerLanguage("go",function(e){var t={keyword:"break default func interface select case map struct chan else goto package switch const fallthrough if range type continue for import return var go defer bool byte complex64 complex128 float32 float64 int8 int16 int32 int64 string uint8 uint16 uint32 uint64 int uint uintptr rune",literal:"true false iota nil",built_in:"append cap close complex copy imag len make new panic print println real recover delete"};return{aliases:["golang"],k:t,i:"</",c:[e.CLCM,e.CBCM,{cN:"string",v:[e.QSM,{b:"'",e:"[^\\\\]'"},{b:"`",e:"`"}]},{cN:"number",v:[{b:e.CNR+"[dflsi]",r:1},e.CNM]},{b:/:=/},{cN:"function",bK:"func",e:/\s*\{/,eE:!0,c:[e.TM,{cN:"params",b:/\(/,e:/\)/,k:t,i:/["']/}]}]}});hljs.registerLanguage("bash",function(e){var t={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},s={cN:"string",b:/"/,e:/"/,c:[e.BE,t,{cN:"variable",b:/\$\(/,e:/\)/,c:[e.BE]}]},a={cN:"string",b:/'/,e:/'/};return{aliases:["sh","zsh"],l:/\b-?[a-z\._]+\b/,k:{keyword:"if then else elif fi for while in do done case esac function",literal:"true false",built_in:"break cd continue eval exec exit export getopts hash pwd readonly return shift test times trap umask unset alias bind builtin caller command declare echo enable help let local logout mapfile printf read readarray source type typeset ulimit unalias set shopt autoload bg bindkey bye cap chdir clone comparguments compcall compctl compdescribe compfiles compgroups compquote comptags comptry compvalues dirs disable disown echotc echoti emulate fc fg float functions getcap getln history integer jobs kill limit log noglob popd print pushd pushln rehash sched setcap setopt stat suspend ttyctl unfunction unhash unlimit unsetopt vared wait whence where which zcompile zformat zftp zle zmodload zparseopts zprof zpty zregexparse zsocket zstyle ztcp",_:"-ne -eq -lt -gt -f -d -e -s -l -a"},c:[{cN:"meta",b:/^#![^\n]+sh\s*$/,r:10},{cN:"function",b:/\w[\w\d_]*\s*\(\s*\)\s*\{/,rB:!0,c:[e.inherit(e.TM,{b:/\w[\w\d_]*/})],r:0},e.HCM,s,a,t]}});hljs.registerLanguage("python",function(e){var r={keyword:"and elif is global as in if from raise for except finally print import pass return exec else break not with class assert yield try while continue del or def lambda async await nonlocal|10 None True False",built_in:"Ellipsis NotImplemented"},b={cN:"meta",b:/^(>>>|\.\.\.) /},c={cN:"subst",b:/\{/,e:/\}/,k:r,i:/#/},a={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,c:[b],r:10},{b:/(u|b)?r?"""/,e:/"""/,c:[b],r:10},{b:/(fr|rf|f)'''/,e:/'''/,c:[b,c]},{b:/(fr|rf|f)"""/,e:/"""/,c:[b,c]},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},{b:/(fr|rf|f)'/,e:/'/,c:[c]},{b:/(fr|rf|f)"/,e:/"/,c:[c]},e.ASM,e.QSM]},s={cN:"number",r:0,v:[{b:e.BNR+"[lLjJ]?"},{b:"\\b(0o[0-7]+)[lLjJ]?"},{b:e.CNR+"[lLjJ]?"}]},i={cN:"params",b:/\(/,e:/\)/,c:["self",b,s,a]};return c.c=[a,s,b],{aliases:["py","gyp"],k:r,i:/(<\/|->|\?)|=>/,c:[b,s,a,e.HCM,{v:[{cN:"function",bK:"def"},{cN:"class",bK:"class"}],e:/:/,i:/[${=;\n,]/,c:[e.UTM,i,{b:/->/,eW:!0,k:"None"}]},{cN:"meta",b:/^[\t ]*@/,e:/$/},{b:/\b(print|exec)\(/}]}});hljs.registerLanguage("julia",function(e){var r={keyword:"in isa where baremodule begin break catch ccall const continue do else elseif end export false finally for function global if import importall let local macro module quote return true try using while type immutable abstract bitstype typealias ",literal:"true false ARGS C_NULL DevNull ENDIAN_BOM ENV I Inf Inf16 Inf32 Inf64 InsertionSort JULIA_HOME LOAD_PATH MergeSort NaN NaN16 NaN32 NaN64 PROGRAM_FILE QuickSort RoundDown RoundFromZero RoundNearest RoundNearestTiesAway RoundNearestTiesUp RoundToZero RoundUp STDERR STDIN STDOUT VERSION catalan e|0 eu|0 eulergamma golden im nothing pi γ π φ ",built_in:"ANY AbstractArray AbstractChannel AbstractFloat AbstractMatrix AbstractRNG AbstractSerializer AbstractSet AbstractSparseArray AbstractSparseMatrix AbstractSparseVector AbstractString AbstractUnitRange AbstractVecOrMat AbstractVector Any ArgumentError Array AssertionError Associative Base64DecodePipe Base64EncodePipe Bidiagonal BigFloat BigInt BitArray BitMatrix BitVector Bool BoundsError BufferStream CachingPool CapturedException CartesianIndex CartesianRange Cchar Cdouble Cfloat Channel Char Cint Cintmax_t Clong Clonglong ClusterManager Cmd CodeInfo Colon Complex Complex128 Complex32 Complex64 CompositeException Condition ConjArray ConjMatrix ConjVector Cptrdiff_t Cshort Csize_t Cssize_t Cstring Cuchar Cuint Cuintmax_t Culong Culonglong Cushort Cwchar_t Cwstring DataType Date DateFormat DateTime DenseArray DenseMatrix DenseVecOrMat DenseVector Diagonal Dict DimensionMismatch Dims DirectIndexString Display DivideError DomainError EOFError EachLine Enum Enumerate ErrorException Exception ExponentialBackOff Expr Factorization FileMonitor Float16 Float32 Float64 Function Future GlobalRef GotoNode HTML Hermitian IO IOBuffer IOContext IOStream IPAddr IPv4 IPv6 IndexCartesian IndexLinear IndexStyle InexactError InitError Int Int128 Int16 Int32 Int64 Int8 IntSet Integer InterruptException InvalidStateException Irrational KeyError LabelNode LinSpace LineNumberNode LoadError LowerTriangular MIME Matrix MersenneTwister Method MethodError MethodTable Module NTuple NewvarNode NullException Nullable Number ObjectIdDict OrdinalRange OutOfMemoryError OverflowError Pair ParseError PartialQuickSort PermutedDimsArray Pipe PollingFileWatcher ProcessExitedException Ptr QuoteNode RandomDevice Range RangeIndex Rational RawFD ReadOnlyMemoryError Real ReentrantLock Ref Regex RegexMatch RemoteChannel RemoteException RevString RoundingMode RowVector SSAValue SegmentationFault SerializationState Set SharedArray SharedMatrix SharedVector Signed SimpleVector Slot SlotNumber SparseMatrixCSC SparseVector StackFrame StackOverflowError StackTrace StepRange StepRangeLen StridedArray StridedMatrix StridedVecOrMat StridedVector String SubArray SubString SymTridiagonal Symbol Symmetric SystemError TCPSocket Task Text TextDisplay Timer Tridiagonal Tuple Type TypeError TypeMapEntry TypeMapLevel TypeName TypeVar TypedSlot UDPSocket UInt UInt128 UInt16 UInt32 UInt64 UInt8 UndefRefError UndefVarError UnicodeError UniformScaling Union UnionAll UnitRange Unsigned UpperTriangular Val Vararg VecElement VecOrMat Vector VersionNumber Void WeakKeyDict WeakRef WorkerConfig WorkerPool "},t="[A-Za-z_\\u00A1-\\uFFFF][A-Za-z_0-9\\u00A1-\\uFFFF]*",a={l:t,k:r,i:/<\//},n={cN:"number",b:/(\b0x[\d_]*(\.[\d_]*)?|0x\.\d[\d_]*)p[-+]?\d+|\b0[box][a-fA-F0-9][a-fA-F0-9_]*|(\b\d[\d_]*(\.[\d_]*)?|\.\d[\d_]*)([eEfF][-+]?\d+)?/,r:0},o={cN:"string",b:/'(.|\\[xXuU][a-zA-Z0-9]+)'/},i={cN:"subst",b:/\$\(/,e:/\)/,k:r},l={cN:"variable",b:"\\$"+t},c={cN:"string",c:[e.BE,i,l],v:[{b:/\w*"""/,e:/"""\w*/,r:10},{b:/\w*"/,e:/"\w*/}]},s={cN:"string",c:[e.BE,i,l],b:"`",e:"`"},d={cN:"meta",b:"@"+t},u={cN:"comment",v:[{b:"#=",e:"=#",r:10},{b:"#",e:"$"}]};return a.c=[n,o,c,s,d,u,e.HCM,{cN:"keyword",b:"\\b(((abstract|primitive)\\s+)type|(mutable\\s+)?struct)\\b"},{b:/<:/}],i.c=a.c,a});hljs.registerLanguage("coffeescript",function(e){var c={keyword:"in if for while finally new do return else break catch instanceof throw try this switch continue typeof delete debugger super yield import export from as default await then unless until loop of by when and or is isnt not",literal:"true false null undefined yes no on off",built_in:"npm require console print module global window document"},n="[A-Za-z$_][0-9A-Za-z$_]*",r={cN:"subst",b:/#\{/,e:/}/,k:c},i=[e.BNM,e.inherit(e.CNM,{starts:{e:"(\\s*/)?",r:0}}),{cN:"string",v:[{b:/'''/,e:/'''/,c:[e.BE]},{b:/'/,e:/'/,c:[e.BE]},{b:/"""/,e:/"""/,c:[e.BE,r]},{b:/"/,e:/"/,c:[e.BE,r]}]},{cN:"regexp",v:[{b:"///",e:"///",c:[r,e.HCM]},{b:"//[gim]*",r:0},{b:/\/(?![ *])(\\\/|.)*?\/[gim]*(?=\W|$)/}]},{b:"@"+n},{sL:"javascript",eB:!0,eE:!0,v:[{b:"```",e:"```"},{b:"`",e:"`"}]}];r.c=i;var s=e.inherit(e.TM,{b:n}),t="(\\(.*\\))?\\s*\\B[-=]>",o={cN:"params",b:"\\([^\\(]",rB:!0,c:[{b:/\(/,e:/\)/,k:c,c:["self"].concat(i)}]};return{aliases:["coffee","cson","iced"],k:c,i:/\/\*/,c:i.concat([e.C("###","###"),e.HCM,{cN:"function",b:"^\\s*"+n+"\\s*=\\s*"+t,e:"[-=]>",rB:!0,c:[s,o]},{b:/[:\(,=]\s*/,r:0,c:[{cN:"function",b:t,e:"[-=]>",rB:!0,c:[o]}]},{cN:"class",bK:"class",e:"$",i:/[:="\[\]]/,c:[{bK:"extends",eW:!0,i:/[:="\[\]]/,c:[s]},s]},{b:n+":",e:":",rB:!0,rE:!0,r:0}])}});hljs.registerLanguage("cpp",function(t){var e={cN:"keyword",b:"\\b[a-z\\d_]*_t\\b"},r={cN:"string",v:[{b:'(u8?|U)?L?"',e:'"',i:"\\n",c:[t.BE]},{b:'(u8?|U)?R"',e:'"',c:[t.BE]},{b:"'\\\\?.",e:"'",i:"."}]},s={cN:"number",v:[{b:"\\b(0b[01']+)"},{b:"(-?)\\b([\\d']+(\\.[\\d']*)?|\\.[\\d']+)(u|U|l|L|ul|UL|f|F|b|B)"},{b:"(-?)(\\b0[xX][a-fA-F0-9']+|(\\b[\\d']+(\\.[\\d']*)?|\\.[\\d']+)([eE][-+]?[\\d']+)?)"}],r:0},i={cN:"meta",b:/#\s*[a-z]+\b/,e:/$/,k:{"meta-keyword":"if else elif endif define undef warning error line pragma ifdef ifndef include"},c:[{b:/\\\n/,r:0},t.inherit(r,{cN:"meta-string"}),{cN:"meta-string",b:/<[^\n>]*>/,e:/$/,i:"\\n"},t.CLCM,t.CBCM]},a=t.IR+"\\s*\\(",c={keyword:"int float while private char catch import module export virtual operator sizeof dynamic_cast|10 typedef const_cast|10 const for static_cast|10 union namespace unsigned long volatile static protected bool template mutable if public friend do goto auto void enum else break extern using asm case typeid short reinterpret_cast|10 default double register explicit signed typename try this switch continue inline delete alignof constexpr decltype noexcept static_assert thread_local restrict _Bool complex _Complex _Imaginary atomic_bool atomic_char atomic_schar atomic_uchar atomic_short atomic_ushort atomic_int atomic_uint atomic_long atomic_ulong atomic_llong atomic_ullong new throw return and or not",built_in:"std string cin cout cerr clog stdin stdout stderr stringstream istringstream ostringstream auto_ptr deque list queue stack vector map set bitset multiset multimap unordered_set unordered_map unordered_multiset unordered_multimap array shared_ptr abort abs acos asin atan2 atan calloc ceil cosh cos exit exp fabs floor fmod fprintf fputs free frexp fscanf isalnum isalpha iscntrl isdigit isgraph islower isprint ispunct isspace isupper isxdigit tolower toupper labs ldexp log10 log malloc realloc memchr memcmp memcpy memset modf pow printf putchar puts scanf sinh sin snprintf sprintf sqrt sscanf strcat strchr strcmp strcpy strcspn strlen strncat strncmp strncpy strpbrk strrchr strspn strstr tanh tan vfprintf vprintf vsprintf endl initializer_list unique_ptr",literal:"true false nullptr NULL"},n=[e,t.CLCM,t.CBCM,s,r];return{aliases:["c","cc","h","c++","h++","hpp"],k:c,i:"</",c:n.concat([i,{b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:c,c:["self",e]},{b:t.IR+"::",k:c},{v:[{b:/=/,e:/;/},{b:/\(/,e:/\)/},{bK:"new throw return else",e:/;/}],k:c,c:n.concat([{b:/\(/,e:/\)/,k:c,c:n.concat(["self"]),r:0}]),r:0},{cN:"function",b:"("+t.IR+"[\\*&\\s]+)+"+a,rB:!0,e:/[{;=]/,eE:!0,k:c,i:/[^\w\s\*&]/,c:[{b:a,rB:!0,c:[t.TM],r:0},{cN:"params",b:/\(/,e:/\)/,k:c,r:0,c:[t.CLCM,t.CBCM,r,s,e]},t.CLCM,t.CBCM,i]},{cN:"class",bK:"class struct",e:/[{;:]/,c:[{b:/</,e:/>/,c:["self"]},t.TM]}]),exports:{preprocessor:i,strings:r,k:c}}});hljs.registerLanguage("ruby",function(e){var b="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?",r={keyword:"and then defined module in return redo if BEGIN retry end for self when next until do begin unless END rescue else break undef not super class case require yield alias while ensure elsif or include attr_reader attr_writer attr_accessor",literal:"true false nil"},c={cN:"doctag",b:"@[A-Za-z]+"},a={b:"#<",e:">"},s=[e.C("#","$",{c:[c]}),e.C("^\\=begin","^\\=end",{c:[c],r:10}),e.C("^__END__","\\n$")],n={cN:"subst",b:"#\\{",e:"}",k:r},t={cN:"string",c:[e.BE,n],v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/`/,e:/`/},{b:"%[qQwWx]?\\(",e:"\\)"},{b:"%[qQwWx]?\\[",e:"\\]"},{b:"%[qQwWx]?{",e:"}"},{b:"%[qQwWx]?<",e:">"},{b:"%[qQwWx]?/",e:"/"},{b:"%[qQwWx]?%",e:"%"},{b:"%[qQwWx]?-",e:"-"},{b:"%[qQwWx]?\\|",e:"\\|"},{b:/\B\?(\\\d{1,3}|\\x[A-Fa-f0-9]{1,2}|\\u[A-Fa-f0-9]{4}|\\?\S)\b/},{b:/<<(-?)\w+$/,e:/^\s*\w+$/}]},i={cN:"params",b:"\\(",e:"\\)",endsParent:!0,k:r},d=[t,a,{cN:"class",bK:"class module",e:"$|;",i:/=/,c:[e.inherit(e.TM,{b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?"}),{b:"<\\s*",c:[{b:"("+e.IR+"::)?"+e.IR}]}].concat(s)},{cN:"function",bK:"def",e:"$|;",c:[e.inherit(e.TM,{b:b}),i].concat(s)},{b:e.IR+"::"},{cN:"symbol",b:e.UIR+"(\\!|\\?)?:",r:0},{cN:"symbol",b:":(?!\\s)",c:[t,{b:b}],r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},{cN:"params",b:/\|/,e:/\|/,k:r},{b:"("+e.RSR+"|unless)\\s*",k:"unless",c:[a,{cN:"regexp",c:[e.BE,n],i:/\n/,v:[{b:"/",e:"/[a-z]*"},{b:"%r{",e:"}[a-z]*"},{b:"%r\\(",e:"\\)[a-z]*"},{b:"%r!",e:"![a-z]*"},{b:"%r\\[",e:"\\][a-z]*"}]}].concat(s),r:0}].concat(s);n.c=d,i.c=d;var l="[>?]>",o="[\\w#]+\\(\\w+\\):\\d+:\\d+>",u="(\\w+-)?\\d+\\.\\d+\\.\\d(p\\d+)?[^>]+>",w=[{b:/^\s*=>/,starts:{e:"$",c:d}},{cN:"meta",b:"^("+l+"|"+o+"|"+u+")",starts:{e:"$",c:d}}];return{aliases:["rb","gemspec","podspec","thor","irb"],k:r,i:/\/\*/,c:s.concat(w).concat(d)}});hljs.registerLanguage("yaml",function(e){var b="true false yes no null",a="^[ \\-]*",r="[a-zA-Z_][\\w\\-]*",t={cN:"attr",v:[{b:a+r+":"},{b:a+'"'+r+'":'},{b:a+"'"+r+"':"}]},c={cN:"template-variable",v:[{b:"{{",e:"}}"},{b:"%{",e:"}"}]},l={cN:"string",r:0,v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/\S+/}],c:[e.BE,c]};return{cI:!0,aliases:["yml","YAML","yaml"],c:[t,{cN:"meta",b:"^---s*$",r:10},{cN:"string",b:"[\\|>] *$",rE:!0,c:l.c,e:t.v[0].b},{b:"<%[%=-]?",e:"[%-]?%>",sL:"ruby",eB:!0,eE:!0,r:0},{cN:"type",b:"!!"+e.UIR},{cN:"meta",b:"&"+e.UIR+"$"},{cN:"meta",b:"\\*"+e.UIR+"$"},{cN:"bullet",b:"^ *-",r:0},e.HCM,{bK:b,k:{literal:b}},e.CNM,l]}});hljs.registerLanguage("css",function(e){var c="[a-zA-Z-][a-zA-Z0-9_-]*",t={b:/[A-Z\_\.\-]+\s*:/,rB:!0,e:";",eW:!0,c:[{cN:"attribute",b:/\S/,e:":",eE:!0,starts:{eW:!0,eE:!0,c:[{b:/[\w-]+\(/,rB:!0,c:[{cN:"built_in",b:/[\w-]+/},{b:/\(/,e:/\)/,c:[e.ASM,e.QSM]}]},e.CSSNM,e.QSM,e.ASM,e.CBCM,{cN:"number",b:"#[0-9A-Fa-f]+"},{cN:"meta",b:"!important"}]}}]};return{cI:!0,i:/[=\/|'\$]/,c:[e.CBCM,{cN:"selector-id",b:/#[A-Za-z0-9_-]+/},{cN:"selector-class",b:/\.[A-Za-z0-9_-]+/},{cN:"selector-attr",b:/\[/,e:/\]/,i:"$"},{cN:"selector-pseudo",b:/:(:)?[a-zA-Z0-9\_\-\+\(\)"'.]+/},{b:"@(font-face|page)",l:"[a-z-]+",k:"font-face page"},{b:"@",e:"[{;]",i:/:/,c:[{cN:"keyword",b:/\w+/},{b:/\s/,eW:!0,eE:!0,r:0,c:[e.ASM,e.QSM,e.CSSNM]}]},{cN:"selector-tag",b:c,r:0},{b:"{",e:"}",i:/\S/,c:[e.CBCM,t]}]}});hljs.registerLanguage("fortran",function(e){var t={cN:"params",b:"\\(",e:"\\)"},n={literal:".False. .True.",keyword:"kind do while private call intrinsic where elsewhere type endtype endmodule endselect endinterface end enddo endif if forall endforall only contains default return stop then public subroutine|10 function program .and. .or. .not. .le. .eq. .ge. .gt. .lt. goto save else use module select case access blank direct exist file fmt form formatted iostat name named nextrec number opened rec recl sequential status unformatted unit continue format pause cycle exit c_null_char c_alert c_backspace c_form_feed flush wait decimal round iomsg synchronous nopass non_overridable pass protected volatile abstract extends import non_intrinsic value deferred generic final enumerator class associate bind enum c_int c_short c_long c_long_long c_signed_char c_size_t c_int8_t c_int16_t c_int32_t c_int64_t c_int_least8_t c_int_least16_t c_int_least32_t c_int_least64_t c_int_fast8_t c_int_fast16_t c_int_fast32_t c_int_fast64_t c_intmax_t C_intptr_t c_float c_double c_long_double c_float_complex c_double_complex c_long_double_complex c_bool c_char c_null_ptr c_null_funptr c_new_line c_carriage_return c_horizontal_tab c_vertical_tab iso_c_binding c_loc c_funloc c_associated  c_f_pointer c_ptr c_funptr iso_fortran_env character_storage_size error_unit file_storage_size input_unit iostat_end iostat_eor numeric_storage_size output_unit c_f_procpointer ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode newunit contiguous recursive pad position action delim readwrite eor advance nml interface procedure namelist include sequence elemental pure integer real character complex logical dimension allocatable|10 parameter external implicit|10 none double precision assign intent optional pointer target in out common equivalence data",built_in:"alog alog10 amax0 amax1 amin0 amin1 amod cabs ccos cexp clog csin csqrt dabs dacos dasin datan datan2 dcos dcosh ddim dexp dint dlog dlog10 dmax1 dmin1 dmod dnint dsign dsin dsinh dsqrt dtan dtanh float iabs idim idint idnint ifix isign max0 max1 min0 min1 sngl algama cdabs cdcos cdexp cdlog cdsin cdsqrt cqabs cqcos cqexp cqlog cqsin cqsqrt dcmplx dconjg derf derfc dfloat dgamma dimag dlgama iqint qabs qacos qasin qatan qatan2 qcmplx qconjg qcos qcosh qdim qerf qerfc qexp qgamma qimag qlgama qlog qlog10 qmax1 qmin1 qmod qnint qsign qsin qsinh qsqrt qtan qtanh abs acos aimag aint anint asin atan atan2 char cmplx conjg cos cosh exp ichar index int log log10 max min nint sign sin sinh sqrt tan tanh print write dim lge lgt lle llt mod nullify allocate deallocate adjustl adjustr all allocated any associated bit_size btest ceiling count cshift date_and_time digits dot_product eoshift epsilon exponent floor fraction huge iand ibclr ibits ibset ieor ior ishft ishftc lbound len_trim matmul maxexponent maxloc maxval merge minexponent minloc minval modulo mvbits nearest pack present product radix random_number random_seed range repeat reshape rrspacing scale scan selected_int_kind selected_real_kind set_exponent shape size spacing spread sum system_clock tiny transpose trim ubound unpack verify achar iachar transfer dble entry dprod cpu_time command_argument_count get_command get_command_argument get_environment_variable is_iostat_end ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode is_iostat_eor move_alloc new_line selected_char_kind same_type_as extends_type_ofacosh asinh atanh bessel_j0 bessel_j1 bessel_jn bessel_y0 bessel_y1 bessel_yn erf erfc erfc_scaled gamma log_gamma hypot norm2 atomic_define atomic_ref execute_command_line leadz trailz storage_size merge_bits bge bgt ble blt dshiftl dshiftr findloc iall iany iparity image_index lcobound ucobound maskl maskr num_images parity popcnt poppar shifta shiftl shiftr this_image"};return{cI:!0,aliases:["f90","f95"],k:n,i:/\/\*/,c:[e.inherit(e.ASM,{cN:"string",r:0}),e.inherit(e.QSM,{cN:"string",r:0}),{cN:"function",bK:"subroutine function program",i:"[${=\\n]",c:[e.UTM,t]},e.C("!","$",{r:0}),{cN:"number",b:"(?=\\b|\\+|\\-|\\.)(?=\\.\\d|\\d)(?:\\d+)?(?:\\.?\\d*)(?:[de][+-]?\\d+)?\\b\\.?",r:0}]}});hljs.registerLanguage("awk",function(e){var r={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},b="BEGIN END if else while do for in break continue delete next nextfile function func exit|10",n={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,r:10},{b:/(u|b)?r?"""/,e:/"""/,r:10},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},e.ASM,e.QSM]};return{k:{keyword:b},c:[r,n,e.RM,e.HCM,e.NM]}});hljs.registerLanguage("makefile",function(e){var i={cN:"variable",v:[{b:"\\$\\("+e.UIR+"\\)",c:[e.BE]},{b:/\$[@%<?\^\+\*]/}]},r={cN:"string",b:/"/,e:/"/,c:[e.BE,i]},a={cN:"variable",b:/\$\([\w-]+\s/,e:/\)/,k:{built_in:"subst patsubst strip findstring filter filter-out sort word wordlist firstword lastword dir notdir suffix basename addsuffix addprefix join wildcard realpath abspath error warning shell origin flavor foreach if or and call eval file value"},c:[i]},n={b:"^"+e.UIR+"\\s*[:+?]?=",i:"\\n",rB:!0,c:[{b:"^"+e.UIR,e:"[:+?]?=",eE:!0}]},t={cN:"meta",b:/^\.PHONY:/,e:/$/,k:{"meta-keyword":".PHONY"},l:/[\.\w]+/},l={cN:"section",b:/^[^\s]+:/,e:/$/,c:[i]};return{aliases:["mk","mak"],k:"define endef undefine ifdef ifndef ifeq ifneq else endif include -include sinclude override export unexport private vpath",l:/[\w-]+/,c:[e.HCM,i,r,a,n,t,l]}});hljs.registerLanguage("java",function(e){var a="[À-ʸa-zA-Z_$][À-ʸa-zA-Z_$0-9]*",t=a+"(<"+a+"(\\s*,\\s*"+a+")*>)?",r="false synchronized int abstract float private char boolean static null if const for true while long strictfp finally protected import native final void enum else break transient catch instanceof byte super volatile case assert short package default double public try this switch continue throws protected public private module requires exports do",s="\\b(0[bB]([01]+[01_]+[01]+|[01]+)|0[xX]([a-fA-F0-9]+[a-fA-F0-9_]+[a-fA-F0-9]+|[a-fA-F0-9]+)|(([\\d]+[\\d_]+[\\d]+|[\\d]+)(\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))?|\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))([eE][-+]?\\d+)?)[lLfF]?",c={cN:"number",b:s,r:0};return{aliases:["jsp"],k:r,i:/<\/|#/,c:[e.C("/\\*\\*","\\*/",{r:0,c:[{b:/\w+@/,r:0},{cN:"doctag",b:"@[A-Za-z]+"}]}),e.CLCM,e.CBCM,e.ASM,e.QSM,{cN:"class",bK:"class interface",e:/[{;=]/,eE:!0,k:"class interface",i:/[:"\[\]]/,c:[{bK:"extends implements"},e.UTM]},{bK:"new throw return else",r:0},{cN:"function",b:"("+t+"\\s+)+"+e.UIR+"\\s*\\(",rB:!0,e:/[{;=]/,eE:!0,k:r,c:[{b:e.UIR+"\\s*\\(",rB:!0,r:0,c:[e.UTM]},{cN:"params",b:/\(/,e:/\)/,k:r,r:0,c:[e.ASM,e.QSM,e.CNM,e.CBCM]},e.CLCM,e.CBCM]},c,{cN:"meta",b:"@[A-Za-z]+"}]}});hljs.registerLanguage("stan",function(e){return{c:[e.HCM,e.CLCM,e.CBCM,{b:e.UIR,l:e.UIR,k:{name:"for in while repeat until if then else",symbol:"bernoulli bernoulli_logit binomial binomial_logit beta_binomial hypergeometric categorical categorical_logit ordered_logistic neg_binomial neg_binomial_2 neg_binomial_2_log poisson poisson_log multinomial normal exp_mod_normal skew_normal student_t cauchy double_exponential logistic gumbel lognormal chi_square inv_chi_square scaled_inv_chi_square exponential inv_gamma weibull frechet rayleigh wiener pareto pareto_type_2 von_mises uniform multi_normal multi_normal_prec multi_normal_cholesky multi_gp multi_gp_cholesky multi_student_t gaussian_dlm_obs dirichlet lkj_corr lkj_corr_cholesky wishart inv_wishart","selector-tag":"int real vector simplex unit_vector ordered positive_ordered row_vector matrix cholesky_factor_corr cholesky_factor_cov corr_matrix cov_matrix",title:"functions model data parameters quantities transformed generated",literal:"true false"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0}]}});hljs.registerLanguage("javascript",function(e){var r="[A-Za-z$_][0-9A-Za-z$_]*",t={keyword:"in of if for while finally var new function do return void else break catch instanceof with throw case default try this switch continue typeof delete let yield const export super debugger as async await static import from as",literal:"true false null undefined NaN Infinity",built_in:"eval isFinite isNaN parseFloat parseInt decodeURI decodeURIComponent encodeURI encodeURIComponent escape unescape Object Function Boolean Error EvalError InternalError RangeError ReferenceError StopIteration SyntaxError TypeError URIError Number Math Date String RegExp Array Float32Array Float64Array Int16Array Int32Array Int8Array Uint16Array Uint32Array Uint8Array Uint8ClampedArray ArrayBuffer DataView JSON Intl arguments require module console window document Symbol Set Map WeakSet WeakMap Proxy Reflect Promise"},a={cN:"number",v:[{b:"\\b(0[bB][01]+)"},{b:"\\b(0[oO][0-7]+)"},{b:e.CNR}],r:0},n={cN:"subst",b:"\\$\\{",e:"\\}",k:t,c:[]},c={cN:"string",b:"`",e:"`",c:[e.BE,n]};n.c=[e.ASM,e.QSM,c,a,e.RM];var s=n.c.concat([e.CBCM,e.CLCM]);return{aliases:["js","jsx"],k:t,c:[{cN:"meta",r:10,b:/^\s*['"]use (strict|asm)['"]/},{cN:"meta",b:/^#!/,e:/$/},e.ASM,e.QSM,c,e.CLCM,e.CBCM,a,{b:/[{,]\s*/,r:0,c:[{b:r+"\\s*:",rB:!0,r:0,c:[{cN:"attr",b:r,r:0}]}]},{b:"("+e.RSR+"|\\b(case|return|throw)\\b)\\s*",k:"return throw case",c:[e.CLCM,e.CBCM,e.RM,{cN:"function",b:"(\\(.*?\\)|"+r+")\\s*=>",rB:!0,e:"\\s*=>",c:[{cN:"params",v:[{b:r},{b:/\(\s*\)/},{b:/\(/,e:/\)/,eB:!0,eE:!0,k:t,c:s}]}]},{b:/</,e:/(\/\w+|\w+\/)>/,sL:"xml",c:[{b:/<\w+\s*\/>/,skip:!0},{b:/<\w+/,e:/(\/\w+|\w+\/)>/,skip:!0,c:[{b:/<\w+\s*\/>/,skip:!0},"self"]}]}],r:0},{cN:"function",bK:"function",e:/\{/,eE:!0,c:[e.inherit(e.TM,{b:r}),{cN:"params",b:/\(/,e:/\)/,eB:!0,eE:!0,c:s}],i:/\[|%/},{b:/\$[(.]/},e.METHOD_GUARD,{cN:"class",bK:"class",e:/[{;=]/,eE:!0,i:/[:"\[\]]/,c:[{bK:"extends"},e.UTM]},{bK:"constructor",e:/\{/,eE:!0}],i:/#(?!!)/}});hljs.registerLanguage("tex",function(c){var e={cN:"tag",b:/\\/,r:0,c:[{cN:"name",v:[{b:/[a-zA-Zа-яА-я]+[*]?/},{b:/[^a-zA-Zа-яА-я0-9]/}],starts:{eW:!0,r:0,c:[{cN:"string",v:[{b:/\[/,e:/\]/},{b:/\{/,e:/\}/}]},{b:/\s*=\s*/,eW:!0,r:0,c:[{cN:"number",b:/-?\d*\.?\d+(pt|pc|mm|cm|in|dd|cc|ex|em)?/}]}]}}]};return{c:[e,{cN:"formula",c:[e],r:0,v:[{b:/\$\$/,e:/\$\$/},{b:/\$/,e:/\$/}]},c.C("%","$",{r:0})]}});hljs.registerLanguage("xml",function(s){var e="[A-Za-z0-9\\._:-]+",t={eW:!0,i:/</,r:0,c:[{cN:"attr",b:e,r:0},{b:/=\s*/,r:0,c:[{cN:"string",endsParent:!0,v:[{b:/"/,e:/"/},{b:/'/,e:/'/},{b:/[^\s"'=<>`]+/}]}]}]};return{aliases:["html","xhtml","rss","atom","xjb","xsd","xsl","plist"],cI:!0,c:[{cN:"meta",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},s.C("<!--","-->",{r:10}),{b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{b:/<\?(php)?/,e:/\?>/,sL:"php",c:[{b:"/\\*",e:"\\*/",skip:!0}]},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{name:"style"},c:[t],starts:{e:"</style>",rE:!0,sL:["css","xml"]}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{name:"script"},c:[t],starts:{e:"</script>",rE:!0,sL:["actionscript","javascript","handlebars","xml"]}},{cN:"meta",v:[{b:/<\?xml/,e:/\?>/,r:10},{b:/<\?\w+/,e:/\?>/}]},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"name",b:/[^\/><\s]+/,r:0},t]}]}});hljs.registerLanguage("markdown",function(e){return{aliases:["md","mkdown","mkd"],c:[{cN:"section",v:[{b:"^#{1,6}",e:"$"},{b:"^.+?\\n[=-]{2,}$"}]},{b:"<",e:">",sL:"xml",r:0},{cN:"bullet",b:"^([*+-]|(\\d+\\.))\\s+"},{cN:"strong",b:"[*_]{2}.+?[*_]{2}"},{cN:"emphasis",v:[{b:"\\*.+?\\*"},{b:"_.+?_",r:0}]},{cN:"quote",b:"^>\\s+",e:"$"},{cN:"code",v:[{b:"^```w*s*$",e:"^```s*$"},{b:"`.+?`"},{b:"^( {4}|	)",e:"$",r:0}]},{b:"^[-\\*]{3,}",e:"$"},{b:"\\[.+?\\][\\(\\[].*?[\\)\\]]",rB:!0,c:[{cN:"string",b:"\\[",e:"\\]",eB:!0,rE:!0,r:0},{cN:"link",b:"\\]\\(",e:"\\)",eB:!0,eE:!0},{cN:"symbol",b:"\\]\\[",e:"\\]",eB:!0,eE:!0}],r:10},{b:/^\[[^\n]+\]:/,rB:!0,c:[{cN:"symbol",b:/\[/,e:/\]/,eB:!0,eE:!0},{cN:"link",b:/:\s*/,e:/$/,eB:!0}]}]}});hljs.registerLanguage("json",function(e){var i={literal:"true false null"},n=[e.QSM,e.CNM],r={e:",",eW:!0,eE:!0,c:n,k:i},t={b:"{",e:"}",c:[{cN:"attr",b:/"/,e:/"/,c:[e.BE],i:"\\n"},e.inherit(r,{b:/:/})],i:"\\S"},c={b:"\\[",e:"\\]",c:[e.inherit(r)],i:"\\S"};return n.splice(n.length,0,t,c),{c:n,k:i,i:"\\S"}});"></script>

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
</style>




<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
</style>



<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  background: white;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open')
  });
});
</script>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="fluid-row" id="header">



<h1 class="title toc-ignore">Translate blog files to html</h1>
<h4 class="author">Steve Simon</h4>
<h4 class="date">6/18/2019</h4>

</div>


<pre class="r"><code>knitr::opts_chunk$set(echo=FALSE)
source(file=&quot;prelims.R&quot;, echo=FALSE)
verbose &lt;- TRUE</code></pre>
<pre><code>##    [1] &quot;11.html&quot;                             
##    [2] &quot;2008-11.html&quot;                        
##    [3] &quot;2008-12.html&quot;                        
##    [4] &quot;2009-01.html&quot;                        
##    [5] &quot;2009-02.html&quot;                        
##    [6] &quot;2009-03.html&quot;                        
##    [7] &quot;2009-04.html&quot;                        
##    [8] &quot;2009-05.html&quot;                        
##    [9] &quot;2009-06.html&quot;                        
##   [10] &quot;2009-07.html&quot;                        
##   [11] &quot;2009-08.html&quot;                        
##   [12] &quot;2009-09.html&quot;                        
##   [13] &quot;2009-10.html&quot;                        
##   [14] &quot;2009-11.html&quot;                        
##   [15] &quot;200912.html&quot;                         
##   [16] &quot;201001.html&quot;                         
##   [17] &quot;201002.html&quot;                         
##   [18] &quot;201003.html&quot;                         
##   [19] &quot;201004.html&quot;                         
##   [20] &quot;201005.html&quot;                         
##   [21] &quot;201006.html&quot;                         
##   [22] &quot;201007.html&quot;                         
##   [23] &quot;201008.html&quot;                         
##   [24] &quot;201009.html&quot;                         
##   [25] &quot;201010.html&quot;                         
##   [26] &quot;201010a.html&quot;                        
##   [27] &quot;201011.html&quot;                         
##   [28] &quot;201012.html&quot;                         
##   [29] &quot;201101.html&quot;                         
##   [30] &quot;201102.html&quot;                         
##   [31] &quot;201103.html&quot;                         
##   [32] &quot;201104.html&quot;                         
##   [33] &quot;201105.html&quot;                         
##   [34] &quot;201106.html&quot;                         
##   [35] &quot;201107.html&quot;                         
##   [36] &quot;201108.html&quot;                         
##   [37] &quot;201109.html&quot;                         
##   [38] &quot;201110.html&quot;                         
##   [39] &quot;201111.html&quot;                         
##   [40] &quot;201112.html&quot;                         
##   [41] &quot;201201.html&quot;                         
##   [42] &quot;201202.html&quot;                         
##   [43] &quot;201203.html&quot;                         
##   [44] &quot;201204.html&quot;                         
##   [45] &quot;201205.html&quot;                         
##   [46] &quot;201206.html&quot;                         
##   [47] &quot;201207.html&quot;                         
##   [48] &quot;201208.html&quot;                         
##   [49] &quot;201209.html&quot;                         
##   [50] &quot;201210.html&quot;                         
##   [51] &quot;201211.html&quot;                         
##   [52] &quot;201212.html&quot;                         
##   [53] &quot;201301.html&quot;                         
##   [54] &quot;201302.html&quot;                         
##   [55] &quot;201303.html&quot;                         
##   [56] &quot;201304.html&quot;                         
##   [57] &quot;201305.html&quot;                         
##   [58] &quot;201306.html&quot;                         
##   [59] &quot;201307.html&quot;                         
##   [60] &quot;201308.html&quot;                         
##   [61] &quot;201309.html&quot;                         
##   [62] &quot;201310.html&quot;                         
##   [63] &quot;201311.html&quot;                         
##   [64] &quot;201312.html&quot;                         
##   [65] &quot;aa.html&quot;                             
##   [66] &quot;AbandonFrontPage.html&quot;               
##   [67] &quot;AbsoluteRisk.html&quot;                   
##   [68] &quot;AbstainerErrors.html&quot;                
##   [69] &quot;abstracts.html&quot;                      
##   [70] &quot;abstracts01.html&quot;                    
##   [71] &quot;AcademicFreedomIRB.html&quot;             
##   [72] &quot;access.html&quot;                         
##   [73] &quot;AccountForDropouts.html&quot;             
##   [74] &quot;AccountingForClusters.html&quot;          
##   [75] &quot;AccrualGrantRound3.html&quot;             
##   [76] &quot;AccrualHelp.html&quot;                    
##   [77] &quot;AccrualProblems-06.html&quot;             
##   [78] &quot;AccrualProblems-category.html&quot;       
##   [79] &quot;AccrualProblems1.html&quot;               
##   [80] &quot;accuracy.html&quot;                       
##   [81] &quot;ack.html&quot;                            
##   [82] &quot;AcknowledgingContributions.html&quot;     
##   [83] &quot;Acknowledgments.html&quot;                
##   [84] &quot;acuity.html&quot;                         
##   [85] &quot;adaptive-04.html&quot;                    
##   [86] &quot;adaptive-12.html&quot;                    
##   [87] &quot;AdditionsImprovements.html&quot;          
##   [88] &quot;adjusted.html&quot;                       
##   [89] &quot;AdjustedHazardRatio.html&quot;            
##   [90] &quot;AdjustedOR.html&quot;                     
##   [91] &quot;AdjustingForAgeAndSex.html&quot;          
##   [92] &quot;AdmissionInstructions.html&quot;          
##   [93] &quot;adoption.html&quot;                       
##   [94] &quot;AdverseEvents-05.html&quot;               
##   [95] &quot;AdverseEvents-06.html&quot;               
##   [96] &quot;AdverseEvents-category.html&quot;         
##   [97] &quot;AdverseEvents1.html&quot;                 
##   [98] &quot;Advice.html&quot;                         
##   [99] &quot;AdviceSearching.html&quot;                
##  [100] &quot;agate.html&quot;                          
##  [101] &quot;AgreementWithConsensus.html&quot;         
##  [102] &quot;aipe.html&quot;                           
##  [103] &quot;aliasing.html&quot;                       
##  [104] &quot;all.html&quot;                            
##  [105] &quot;AllModelsAre.html&quot;                   
##  [106] &quot;AllScientificWork.html&quot;              
##  [107] &quot;AlphabeticalBookmarkList.html&quot;       
##  [108] &quot;alternate.html&quot;                      
##  [109] &quot;AlternateAccrual.html&quot;               
##  [110] &quot;AlternativeMedicine.html&quot;            
##  [111] &quot;AlternativePvalue-08.html&quot;           
##  [112] &quot;AlternativePvalue-08a.html&quot;          
##  [113] &quot;AlwaysAskWhy.html&quot;                   
##  [114] &quot;amateur.html&quot;                        
##  [115] &quot;AMathematicianIs.html&quot;               
##  [116] &quot;AmbiguousData.html&quot;                  
##  [117] &quot;AmbiguousDefinition.html&quot;            
##  [118] &quot;AmusingCorrelation.html&quot;             
##  [119] &quot;AnalysisOfMeans-06.html&quot;             
##  [120] &quot;AnalysisOfMeans-category.html&quot;       
##  [121] &quot;AnalysisOfSubgroupResults.html&quot;      
##  [122] &quot;AnalysisOfVariance.html&quot;             
##  [123] &quot;AnalyzeSafety-08.html&quot;               
##  [124] &quot;AnalyzeSafety-08a.html&quot;              
##  [125] &quot;AnalyzingItt.html&quot;                   
##  [126] &quot;AnecdotalEvidence.html&quot;              
##  [127] &quot;AnecdotalInformation.html&quot;           
##  [128] &quot;animal.html&quot;                         
##  [129] &quot;animations.html&quot;                     
##  [130] &quot;AnomAnswers.html&quot;                    
##  [131] &quot;AnomCalculations.html&quot;               
##  [132] &quot;AnomCalculations1.html&quot;              
##  [133] &quot;AnomExample.html&quot;                    
##  [134] &quot;AnomTable05Part1.html&quot;               
##  [135] &quot;AnomTable05Part2.html&quot;               
##  [136] &quot;AnotherPersonsGrant.html&quot;            
##  [137] &quot;anova.html&quot;                          
##  [138] &quot;AnovaPower.html&quot;                     
##  [139] &quot;answers.html&quot;                        
##  [140] &quot;AnswersChapter6.html&quot;                
##  [141] &quot;AnswersChapter7.html&quot;                
##  [142] &quot;AntiIntellectualism.html&quot;            
##  [143] &quot;AntiIntellectualismPart2.html&quot;       
##  [144] &quot;AnySize.html&quot;                        
##  [145] &quot;ApplyingLikelihoodRatios.html&quot;       
##  [146] &quot;AppropriateSampleSize.html&quot;          
##  [147] &quot;APRDRGs.html&quot;                        
##  [148] &quot;arachnologist.html&quot;                  
##  [149] &quot;archive-webinars.html&quot;               
##  [150] &quot;archive-weblog.html&quot;                 
##  [151] &quot;Archive.html&quot;                        
##  [152] &quot;Archive00.html&quot;                      
##  [153] &quot;Archive01.html&quot;                      
##  [154] &quot;Archive02.html&quot;                      
##  [155] &quot;Archive03.html&quot;                      
##  [156] &quot;Archive04.html&quot;                      
##  [157] &quot;Archive05.html&quot;                      
##  [158] &quot;Archive06.html&quot;                      
##  [159] &quot;Archive07.html&quot;                      
##  [160] &quot;Archive08.html&quot;                      
##  [161] &quot;Archive09.html&quot;                      
##  [162] &quot;Archive10.html&quot;                      
##  [163] &quot;Archive1999.html&quot;                    
##  [164] &quot;Archive2000.html&quot;                    
##  [165] &quot;Archive2001.html&quot;                    
##  [166] &quot;Archive2002.html&quot;                    
##  [167] &quot;Archive2003.html&quot;                    
##  [168] &quot;Archive2004.html&quot;                    
##  [169] &quot;Archive2005.html&quot;                    
##  [170] &quot;Archive2006.html&quot;                    
##  [171] &quot;Archive2007.html&quot;                    
##  [172] &quot;Archive2008.html&quot;                    
##  [173] &quot;Archive2009.html&quot;                    
##  [174] &quot;Archive2010.html&quot;                    
##  [175] &quot;Archive2011.html&quot;                    
##  [176] &quot;Archive99.html&quot;                      
##  [177] &quot;arguing.html&quot;                        
##  [178] &quot;array.html&quot;                          
##  [179] &quot;ArrayAnalyzer.html&quot;                  
##  [180] &quot;artist.html&quot;                         
##  [181] &quot;Asia.html&quot;                           
##  [182] &quot;AskProfessorMean.html&quot;               
##  [183] &quot;AssessingExponential-08.html&quot;        
##  [184] &quot;AssessingExponential-08a.html&quot;       
##  [185] &quot;asymmetric.html&quot;                     
##  [186] &quot;auc.html&quot;                            
##  [187] &quot;AuthorPays.html&quot;                     
##  [188] &quot;AutomatingAnalyses.html&quot;             
##  [189] &quot;axis.html&quot;                           
##  [190] &quot;backup.html&quot;                         
##  [191] &quot;BadAnalysis-08.html&quot;                 
##  [192] &quot;BadAnalysis-08a.html&quot;                
##  [193] &quot;BadCalculation.html&quot;                 
##  [194] &quot;BadControlGroups.html&quot;               
##  [195] &quot;BadData.html&quot;                        
##  [196] &quot;BadExamples-08.html&quot;                 
##  [197] &quot;BadExamples-08a.html&quot;                
##  [198] &quot;BadExamples1.html&quot;                   
##  [199] &quot;badroc.html&quot;                         
##  [200] &quot;BadSurvey.html&quot;                      
##  [201] &quot;BalestracciSeminar.html&quot;             
##  [202] &quot;barpie.html&quot;                         
##  [203] &quot;baseline.html&quot;                       
##  [204] &quot;BaselineAdjustment.html&quot;             
##  [205] &quot;BaselineImbalance.html&quot;              
##  [206] &quot;BasicScientists-08.html&quot;             
##  [207] &quot;BasicScientists-08a.html&quot;            
##  [208] &quot;battles.html&quot;                        
##  [209] &quot;bayesian.html&quot;                       
##  [210] &quot;BayesianAccrualModel.html&quot;           
##  [211] &quot;BayesianAnalysis.html&quot;               
##  [212] &quot;BayesianStatistics.html&quot;             
##  [213] &quot;BayesSmallSample.html&quot;               
##  [214] &quot;beaches.html&quot;                        
##  [215] &quot;bed.html&quot;                            
##  [216] &quot;BestEBM.html&quot;                        
##  [217] &quot;bestfit.html&quot;                        
##  [218] &quot;BestModel.html&quot;                      
##  [219] &quot;BetaCoefficient.html&quot;                
##  [220] &quot;bimodality.html&quot;                     
##  [221] &quot;binary.html&quot;                         
##  [222] &quot;BinaryCoding.html&quot;                   
##  [223] &quot;BindingImage.html&quot;                   
##  [224] &quot;binomial.html&quot;                       
##  [225] &quot;biography.html&quot;                      
##  [226] &quot;BioinformaticsDegree.html&quot;           
##  [227] &quot;BiostatisticsPrograms.html&quot;          
##  [228] &quot;BiplotFunction.html&quot;                 
##  [229] &quot;BiplotResources.html&quot;                
##  [230] &quot;blank.html&quot;                          
##  [231] &quot;blind.html&quot;                          
##  [232] &quot;BlindingInResearch.html&quot;             
##  [233] &quot;BlockRandomization.html&quot;             
##  [234] &quot;bonferroni.html&quot;                     
##  [235] &quot;BookSales.html&quot;                      
##  [236] &quot;BookSpss.html&quot;                       
##  [237] &quot;BookTitle.html&quot;                      
##  [238] &quot;BookUpdate.html&quot;                     
##  [239] &quot;bootstrap.html&quot;                      
##  [240] &quot;BootstrapStandardError-08.html&quot;      
##  [241] &quot;BootstrapStandardError-08a.html&quot;     
##  [242] &quot;borderline.html&quot;                     
##  [243] &quot;BoxQuote.html&quot;                       
##  [244] &quot;branson.html&quot;                        
##  [245] &quot;briefbio.html&quot;                       
##  [246] &quot;BugsBetaBinomial.html&quot;               
##  [247] &quot;BugsVersions.html&quot;                   
##  [248] &quot;BusinessAspects.html&quot;                
##  [249] &quot;BusinessCard.html&quot;                   
##  [250] &quot;CalculatingNnt-08.html&quot;              
##  [251] &quot;CalculatingNnt-08a.html&quot;             
##  [252] &quot;CalculatingRates.html&quot;               
##  [253] &quot;CalculatingWeights.html&quot;             
##  [254] &quot;CalculationsDiagnosticTest.html&quot;     
##  [255] &quot;calendar.html&quot;                       
##  [256] &quot;CanIAsk.html&quot;                        
##  [257] &quot;CanIRun-08.html&quot;                     
##  [258] &quot;CanIRun-08a.html&quot;                    
##  [259] &quot;CanIStop.html&quot;                       
##  [260] &quot;CanIUseYou.html&quot;                     
##  [261] &quot;cardiology.html&quot;                     
##  [262] &quot;Career.html&quot;                         
##  [263] &quot;CaseCohort.html&quot;                     
##  [264] &quot;CaseControl.html&quot;                    
##  [265] &quot;CaseStudies-08.html&quot;                 
##  [266] &quot;CaseStudies-08a.html&quot;                
##  [267] &quot;CaseStudiesChildren.html&quot;            
##  [268] &quot;CaseStudyOfAccrual.html&quot;             
##  [269] &quot;CaseStudyOfAccrualPart2.html&quot;        
##  [270] &quot;categorical.html&quot;                    
##  [271] &quot;CategorizingEntropy.html&quot;            
##  [272] &quot;CategorizingWeblog.html&quot;             
##  [273] &quot;causation.html&quot;                      
##  [274] &quot;CensoredValues.html&quot;                 
##  [275] &quot;CenteringData.html&quot;                  
##  [276] &quot;CentralLineInfections.html&quot;          
##  [277] &quot;centroids.html&quot;                      
##  [278] &quot;cer.html&quot;                            
##  [279] &quot;ChanceNews.html&quot;                     
##  [280] &quot;ChanceNews1.html&quot;                    
##  [281] &quot;ChanceWiki.html&quot;                     
##  [282] &quot;ChanceWikiA.html&quot;                    
##  [283] &quot;ChandraCasestudy.html&quot;               
##  [284] &quot;change.html&quot;                         
##  [285] &quot;ChangedYourMind-08.html&quot;             
##  [286] &quot;ChangedYourMind-08a.html&quot;            
##  [287] &quot;ChangesStatL.html&quot;                   
##  [288] &quot;Chapter01.html&quot;                      
##  [289] &quot;Chapter01a.html&quot;                     
##  [290] &quot;Chapter01b.html&quot;                     
##  [291] &quot;Chapter01c.html&quot;                     
##  [292] &quot;Chapter01d.html&quot;                     
##  [293] &quot;Chapter02.html&quot;                      
##  [294] &quot;Chapter03.html&quot;                      
##  [295] &quot;Chapter04.html&quot;                      
##  [296] &quot;Chapter05.html&quot;                      
##  [297] &quot;Chapter06.html&quot;                      
##  [298] &quot;Chapter07.html&quot;                      
##  [299] &quot;CheckingChisquare.html&quot;              
##  [300] &quot;CheckMetadata.html&quot;                  
##  [301] &quot;CherryPicking.html&quot;                  
##  [302] &quot;ChildrenInResearch.html&quot;             
##  [303] &quot;china_pictures.html&quot;                 
##  [304] &quot;chisquared.html&quot;                     
##  [305] &quot;Chores.html&quot;                         
##  [306] &quot;CIforP.html&quot;                         
##  [307] &quot;circle2.html&quot;                        
##  [308] &quot;circular.html&quot;                       
##  [309] &quot;CisSearch.html&quot;                      
##  [310] &quot;citation.html&quot;                       
##  [311] &quot;CitingSoftware.html&quot;                 
##  [312] &quot;ClassicReferences.html&quot;              
##  [313] &quot;ClassicReferencesForEbm.html&quot;        
##  [314] &quot;classroom.html&quot;                      
##  [315] &quot;ClinicalImportance-05.html&quot;          
##  [316] &quot;ClinicalImportance-category.html&quot;    
##  [317] &quot;ClinicalImportanceA.html&quot;            
##  [318] &quot;ClinicallyTrivial.html&quot;              
##  [319] &quot;ClinicalResearchTrack.html&quot;          
##  [320] &quot;Cloggers.html&quot;                       
##  [321] &quot;ClopperPearson.html&quot;                 
##  [322] &quot;ClosedForm.html&quot;                     
##  [323] &quot;clt-04.html&quot;                         
##  [324] &quot;clt-13.html&quot;                         
##  [325] &quot;ClumsyAnonymization.html&quot;            
##  [326] &quot;cluster-03.html&quot;                     
##  [327] &quot;cluster-04.html&quot;                     
##  [328] &quot;ClusteringAlgorithms.html&quot;           
##  [329] &quot;ClusterSize.html&quot;                    
##  [330] &quot;Coauthorship.html&quot;                   
##  [331] &quot;CodeForNewSlideRule.html&quot;            
##  [332] &quot;CoefficientDetermination.html&quot;       
##  [333] &quot;Collage.html&quot;                        
##  [334] &quot;CollectionStudies.html&quot;              
##  [335] &quot;collinearity.html&quot;                   
##  [336] &quot;ColloquialTone.html&quot;                 
##  [337] &quot;ColorsForR.html&quot;                     
##  [338] &quot;ComingSoon.html&quot;                     
##  [339] &quot;CompetingBooks.html&quot;                 
##  [340] &quot;complex-03.html&quot;                     
##  [341] &quot;complex-16.html&quot;                     
##  [342] &quot;ComplexDesigns.html&quot;                 
##  [343] &quot;compliments.html&quot;                    
##  [344] &quot;composite.html&quot;                      
##  [345] &quot;CompoundInterest.html&quot;               
##  [346] &quot;ComputationalTrack.html&quot;             
##  [347] &quot;ComputingDifference.html&quot;            
##  [348] &quot;ComputingPercentiles-08.html&quot;        
##  [349] &quot;ComputingPercentiles-08a.html&quot;       
##  [350] &quot;Conference.html&quot;                     
##  [351] &quot;ConferenceMaterials.html&quot;            
##  [352] &quot;confid.html&quot;                         
##  [353] &quot;confidence-04.html&quot;                  
##  [354] &quot;confidence-99.html&quot;                  
##  [355] &quot;ConfidenceInterval-05.html&quot;          
##  [356] &quot;ConfidenceInterval-08.html&quot;          
##  [357] &quot;ConfidenceIntervalA.html&quot;            
##  [358] &quot;ConfidenceIntervalB.html&quot;            
##  [359] &quot;ConfidenceIntervalForRate.html&quot;      
##  [360] &quot;ConfidenceIntervals-04.html&quot;         
##  [361] &quot;ConfidenceIntervals-category.html&quot;   
##  [362] &quot;conflict.html&quot;                       
##  [363] &quot;conflict1.html&quot;                      
##  [364] &quot;ConflictingAnalyses.html&quot;            
##  [365] &quot;ConflictInterest.html&quot;               
##  [366] &quot;ConflictInterestA.html&quot;              
##  [367] &quot;ConflictOfInterest-06.html&quot;          
##  [368] &quot;ConflictOfInterest-category.html&quot;    
##  [369] &quot;ConflictOfInterestList.html&quot;         
##  [370] &quot;ConflictOfInterestPolicy.html&quot;       
##  [371] &quot;confusion.html&quot;                      
##  [372] &quot;ConfusionPvalues.html&quot;               
##  [373] &quot;ConsecutiveDates.html&quot;               
##  [374] &quot;consent.html&quot;                        
##  [375] &quot;constraints.html&quot;                    
##  [376] &quot;ConstructValidity.html&quot;              
##  [377] &quot;consulting-03.html&quot;                  
##  [378] &quot;consulting-04.html&quot;                  
##  [379] &quot;ConsultingDifferences.html&quot;          
##  [380] &quot;ConsultingRemotely.html&quot;             
##  [381] &quot;ConsultingResources.html&quot;            
##  [382] &quot;ConsultingSop.html&quot;                  
##  [383] &quot;ConsultService.html&quot;                 
##  [384] &quot;contact.html&quot;                        
##  [385] &quot;Contents.html&quot;                       
##  [386] &quot;contest-11.html&quot;                     
##  [387] &quot;contest-12.html&quot;                     
##  [388] &quot;ContinuingEducationQuestions.html&quot;   
##  [389] &quot;ContinuityCorrection.html&quot;           
##  [390] &quot;ContinuousMonitoringNNH.html&quot;        
##  [391] &quot;ContinuousVariables.html&quot;            
##  [392] &quot;ContradictoryResearch.html&quot;          
##  [393] &quot;ControlChartAdvice.html&quot;             
##  [394] &quot;ControlCharts-05.html&quot;               
##  [395] &quot;ControlCharts-06.html&quot;               
##  [396] &quot;ControlCharts-category.html&quot;         
##  [397] &quot;ControlChartsA.html&quot;                 
##  [398] &quot;ControversialArea.html&quot;              
##  [399] &quot;ControversialMetaanalysis.html&quot;      
##  [400] &quot;ConvertOddsRatio.html&quot;               
##  [401] &quot;copyright.html&quot;                      
##  [402] &quot;CorrelatedNormalProbabilities.html&quot;  
##  [403] &quot;correlation.html&quot;                    
##  [404] &quot;CorrelationCoefficient-05.html&quot;      
##  [405] &quot;CorrelationCoefficient-07.html&quot;      
##  [406] &quot;correlations.html&quot;                   
##  [407] &quot;CorroboratingEvidence.html&quot;          
##  [408] &quot;CountData-07.html&quot;                   
##  [409] &quot;CountData-08.html&quot;                   
##  [410] &quot;Counterintuitive.html&quot;               
##  [411] &quot;counting-12.html&quot;                    
##  [412] &quot;counting-13.html&quot;                    
##  [413] &quot;CovariateAdjustment.html&quot;            
##  [414] &quot;CovariateImbalance.html&quot;             
##  [415] &quot;Craniosacral.html&quot;                   
##  [416] &quot;crayola.html&quot;                        
##  [417] &quot;CriticalAppraisal.html&quot;              
##  [418] &quot;CriticalThinking.html&quot;               
##  [419] &quot;CriticalValue-08.html&quot;               
##  [420] &quot;CriticalValue-08a.html&quot;              
##  [421] &quot;Criticism.html&quot;                      
##  [422] &quot;criticisms.html&quot;                     
##  [423] &quot;CronbachAlpha.html&quot;                  
##  [424] &quot;CronbachsAlpha.html&quot;                 
##  [425] &quot;CumulativeEntropy.html&quot;              
##  [426] &quot;CumulativeMetaanalysis.html&quot;         
##  [427] &quot;CumulativeProbabilities.html&quot;        
##  [428] &quot;cupcakes.html&quot;                       
##  [429] &quot;curve.html&quot;                          
##  [430] &quot;CusumChart.html&quot;                     
##  [431] &quot;CuttingCode.html&quot;                    
##  [432] &quot;CyclicalTrends.html&quot;                 
##  [433] &quot;CytelAccrual.html&quot;                   
##  [434] &quot;DadsDay.html&quot;                        
##  [435] &quot;DallasPostlude.html&quot;                 
##  [436] &quot;DangerUsingHumor.html&quot;               
##  [437] &quot;data_is.html&quot;                        
##  [438] &quot;DataEntryErrors.html&quot;                
##  [439] &quot;DataIrbs.html&quot;                       
##  [440] &quot;DataManagement.html&quot;                 
##  [441] &quot;datamining-03.html&quot;                  
##  [442] &quot;datamining-04.html&quot;                  
##  [443] &quot;DataMining-05.html&quot;                  
##  [444] &quot;DataMining-06.html&quot;                  
##  [445] &quot;DataMining-category.html&quot;            
##  [446] &quot;dates.html&quot;                          
##  [447] &quot;DatesInR.html&quot;                       
##  [448] &quot;DeafChairs.html&quot;                     
##  [449] &quot;DebateHistoricalControls.html&quot;       
##  [450] &quot;DecliningCount-08.html&quot;              
##  [451] &quot;DecliningCount-08a.html&quot;             
##  [452] &quot;DefendingBonferroni.html&quot;            
##  [453] &quot;Definitions.html&quot;                    
##  [454] &quot;DegreesFreedom.html&quot;                 
##  [455] &quot;des_spss.html&quot;                       
##  [456] &quot;DescribeWorkStatistician.html&quot;       
##  [457] &quot;descriptive-01.html&quot;                 
##  [458] &quot;descriptive-13.html&quot;                 
##  [459] &quot;DescriptiveAnalysis.html&quot;            
##  [460] &quot;DescriptiveStatistics.html&quot;          
##  [461] &quot;DesigningQuestionnaire.html&quot;         
##  [462] &quot;df.html&quot;                             
##  [463] &quot;diag.html&quot;                           
##  [464] &quot;diagnostic-03.html&quot;                  
##  [465] &quot;diagnostic-04.html&quot;                  
##  [466] &quot;diagnostic-99.html&quot;                  
##  [467] &quot;DiagnosticExercises.html&quot;            
##  [468] &quot;DiagnosticHandout.html&quot;              
##  [469] &quot;DiagnosticMetaanalysis.html&quot;         
##  [470] &quot;DiagnosticTalk.html&quot;                 
##  [471] &quot;DiagnosticTesting.html&quot;              
##  [472] &quot;DifferenceInExponentials.html&quot;       
##  [473] &quot;DifferencesBetweenTests.html&quot;        
##  [474] &quot;DifferencesInChildren.html&quot;          
##  [475] &quot;DigitalObjectIdentifier.html&quot;        
##  [476] &quot;DigitizingGraph.html&quot;                
##  [477] &quot;DimensionReduction.html&quot;             
##  [478] &quot;DisasterAverted.html&quot;                
##  [479] &quot;DisasterAvertedA.html&quot;               
##  [480] &quot;disclaimer.html&quot;                     
##  [481] &quot;discrepancy.html&quot;                    
##  [482] &quot;DishonestyResearch.html&quot;             
##  [483] &quot;DissertationConsulting.html&quot;         
##  [484] &quot;DistinctGroups.html&quot;                 
##  [485] &quot;distributions.html&quot;                  
##  [486] &quot;DistrustBayesian.html&quot;               
##  [487] &quot;document.html&quot;                       
##  [488] &quot;DontWantToRandomize.html&quot;            
##  [489] &quot;DoYourOwnPower.html&quot;                 
##  [490] &quot;DraftGrant.html&quot;                     
##  [491] &quot;dropouts.html&quot;                       
##  [492] &quot;DumpingData.html&quot;                    
##  [493] &quot;DuplicateRecords.html&quot;               
##  [494] &quot;duration.html&quot;                       
##  [495] &quot;Early Stopping1.html&quot;                
##  [496] &quot;EarlyDraft.html&quot;                     
##  [497] &quot;EarlyStopping-04.html&quot;               
##  [498] &quot;EarlyStopping-category.html&quot;         
##  [499] &quot;EarlyStopping1.html&quot;                 
##  [500] &quot;EarlyStoppingAnimal.html&quot;            
##  [501] &quot;EarlyStoppingControversy.html&quot;       
##  [502] &quot;ebcam.html&quot;                          
##  [503] &quot;EbmArticles2005.html&quot;                
##  [504] &quot;EbmForPatients-08.html&quot;              
##  [505] &quot;EbmForPatients-08a.html&quot;             
##  [506] &quot;EbmTooRigid.html&quot;                    
##  [507] &quot;EconomicEvaluations.html&quot;            
##  [508] &quot;Editorials.html&quot;                     
##  [509] &quot;educational.html&quot;                    
##  [510] &quot;EducationalOpportunities.html&quot;       
##  [511] &quot;EffectiveGraphs.html&quot;                
##  [512] &quot;egg.html&quot;                            
##  [513] &quot;elbow.html&quot;                          
##  [514] &quot;ElicitingPrior-08.html&quot;              
##  [515] &quot;ElicitingPrior-08a.html&quot;             
##  [516] &quot;em.html&quot;                             
##  [517] &quot;EmailAccounts.html&quot;                  
##  [518] &quot;EmailDiscussionGroup.html&quot;           
##  [519] &quot;EmailLists.html&quot;                     
##  [520] &quot;EmilyRosaExperiment.html&quot;            
##  [521] &quot;EndOfResearch.html&quot;                  
##  [522] &quot;EndSpam.html&quot;                        
##  [523] &quot;enotation.html&quot;                      
##  [524] &quot;EnoughData.html&quot;                     
##  [525] &quot;EnsemblSearch.html&quot;                  
##  [526] &quot;EntirePopulation.html&quot;               
##  [527] &quot;EntrenchedBeliefs.html&quot;              
##  [528] &quot;entry.html&quot;                          
##  [529] &quot;enumerative.html&quot;                    
##  [530] &quot;Epidemiology.html&quot;                   
##  [531] &quot;Equipoise.html&quot;                      
##  [532] &quot;EquipoiseA.html&quot;                     
##  [533] &quot;EquipoiseAlternatives.html&quot;          
##  [534] &quot;EquipoiseInResearch.html&quot;            
##  [535] &quot;equivalence.html&quot;                    
##  [536] &quot;EthicalConcernsChildren.html&quot;        
##  [537] &quot;ethics.html&quot;                         
##  [538] &quot;EthicsCAM.html&quot;                      
##  [539] &quot;EthicsInResearch.html&quot;               
##  [540] &quot;EthicsRandomization.html&quot;            
##  [541] &quot;evidence-08.html&quot;                    
##  [542] &quot;evidence-08a.html&quot;                   
##  [543] &quot;EvidenceBasedMedicine.html&quot;          
##  [544] &quot;excel.html&quot;                          
##  [545] &quot;ExcelMultinomial.html&quot;               
##  [546] &quot;exclusions.html&quot;                     
##  [547] &quot;ExclusionsInResearch.html&quot;           
##  [548] &quot;Expectations.html&quot;                   
##  [549] &quot;ExpertTestimony.html&quot;                
##  [550] &quot;ExplainingCart.html&quot;                 
##  [551] &quot;ExponentialAccrual-08.html&quot;          
##  [552] &quot;ExponentialAccrual-08a.html&quot;         
##  [553] &quot;ExponentialAmbiguity.html&quot;           
##  [554] &quot;ExponentialInterpolation.html&quot;       
##  [555] &quot;export.html&quot;                         
##  [556] &quot;ExtendingSPSS.html&quot;                  
##  [557] &quot;ExternalScholars.html&quot;               
##  [558] &quot;ExtrapolationsInResearch.html&quot;       
##  [559] &quot;ExtremeValue.html&quot;                   
##  [560] &quot;Facebook.html&quot;                       
##  [561] &quot;FacultyPage.html&quot;                    
##  [562] &quot;FacultyPromotion.html&quot;               
##  [563] &quot;FailureOption.html&quot;                  
##  [564] &quot;FairUse.html&quot;                        
##  [565] &quot;FalseFrugality.html&quot;                 
##  [566] &quot;FalsePositive.html&quot;                  
##  [567] &quot;FanPage.html&quot;                        
##  [568] &quot;FavoriteBooks08.html&quot;                
##  [569] &quot;FavoriteBooks09.html&quot;                
##  [570] &quot;FavoriteBooks10.html&quot;                
##  [571] &quot;FdaOnBayes.html&quot;                     
##  [572] &quot;feedback.html&quot;                       
##  [573] &quot;FewerThanTen.html&quot;                   
##  [574] &quot;FiduciaryObligation.html&quot;            
##  [575] &quot;filler.html&quot;                         
##  [576] &quot;FindingGenes.html&quot;                   
##  [577] &quot;FindingGenesB.html&quot;                  
##  [578] &quot;FirstMetaAnalysis.html&quot;              
##  [579] &quot;FirstPeek.html&quot;                      
##  [580] &quot;FirstSession.html&quot;                   
##  [581] &quot;fish.html&quot;                           
##  [582] &quot;Fishbone.html&quot;                       
##  [583] &quot;FishboneDiagram-06.html&quot;             
##  [584] &quot;FishboneDiagram-07.html&quot;             
##  [585] &quot;fishers-00.html&quot;                     
##  [586] &quot;fishers-12.html&quot;                     
##  [587] &quot;Fishers.html&quot;                        
##  [588] &quot;FishersExact.html&quot;                   
##  [589] &quot;fishmonger.html&quot;                     
##  [590] &quot;fishy.html&quot;                          
##  [591] &quot;flaws-00.html&quot;                       
##  [592] &quot;flaws-04.html&quot;                       
##  [593] &quot;FmriAnalysis.html&quot;                   
##  [594] &quot;FocusGroups-04.html&quot;                 
##  [595] &quot;FocusGroups-06.html&quot;                 
##  [596] &quot;ForestPlots.html&quot;                    
##  [597] &quot;FormatCodes.html&quot;                    
##  [598] &quot;FrailtyModel.html&quot;                   
##  [599] &quot;FraudInResearch.html&quot;                
##  [600] &quot;FraudulentImages.html&quot;               
##  [601] &quot;free.html&quot;                           
##  [602] &quot;FreeBooks.html&quot;                      
##  [603] &quot;frisbee.html&quot;                        
##  [604] &quot;FromMyAssociations.html&quot;             
##  [605] &quot;frontiers.html&quot;                      
##  [606] &quot;Frosty.html&quot;                         
##  [607] &quot;FullBodyScan.html&quot;                   
##  [608] &quot;FullText.html&quot;                       
##  [609] &quot;FundingSources.html&quot;                 
##  [610] &quot;FunnyFractions.html&quot;                 
##  [611] &quot;Futility.html&quot;                       
##  [612] &quot;future.html&quot;                         
##  [613] &quot;gee.html&quot;                            
##  [614] &quot;GeneExpression.html&quot;                 
##  [615] &quot;GeneralizingResearch.html&quot;           
##  [616] &quot;GenomicsTrack.html&quot;                  
##  [617] &quot;Geometric.html&quot;                      
##  [618] &quot;GeometricDistribution.html&quot;          
##  [619] &quot;GivingCredit.html&quot;                   
##  [620] &quot;Glossary.html&quot;                       
##  [621] &quot;GodwinsLaw.html&quot;                     
##  [622] &quot;GoldStandard.html&quot;                   
##  [623] &quot;good.html&quot;                           
##  [624] &quot;GoodBook-04.html&quot;                    
##  [625] &quot;GoodBook-06.html&quot;                    
##  [626] &quot;GoodConsultant.html&quot;                 
##  [627] &quot;GoodDiagnosticTest.html&quot;             
##  [628] &quot;GoodEvidence.html&quot;                   
##  [629] &quot;goodness.html&quot;                       
##  [630] &quot;GoodNews.html&quot;                       
##  [631] &quot;GoodWebsite.html&quot;                    
##  [632] &quot;GoogleDiagnosis.html&quot;                
##  [633] &quot;GoogleScholar.html&quot;                  
##  [634] &quot;GraduateCertificate.html&quot;            
##  [635] &quot;grants.html&quot;                         
##  [636] &quot;GrantWriting.html&quot;                   
##  [637] &quot;GraphicalDisplay.html&quot;               
##  [638] &quot;GraphicsOptionsR.html&quot;               
##  [639] &quot;GraphModifications.html&quot;             
##  [640] &quot;gravity.html&quot;                        
##  [641] &quot;GroupSequential-05.html&quot;             
##  [642] &quot;GroupSequential-11.html&quot;             
##  [643] &quot;GrowthCurves.html&quot;                   
##  [644] &quot;GrowUp.html&quot;                         
##  [645] &quot;hand17.html&quot;                         
##  [646] &quot;hand17d.html&quot;                        
##  [647] &quot;hand18.html&quot;                         
##  [648] &quot;hand18condensed.html&quot;                
##  [649] &quot;hand44.html&quot;                         
##  [650] &quot;hand52.html&quot;                         
##  [651] &quot;HandlingDropouts.html&quot;               
##  [652] &quot;HaplotypeAnalysis.html&quot;              
##  [653] &quot;HaplotypeAnalysis1.html&quot;             
##  [654] &quot;HapMap.html&quot;                         
##  [655] &quot;HardLessons.html&quot;                    
##  [656] &quot;HardwareRequirements.html&quot;           
##  [657] &quot;HarmonicMean.html&quot;                   
##  [658] &quot;HarrellPhilosophy.html&quot;              
##  [659] &quot;HarrellReferences.html&quot;              
##  [660] &quot;HarshSanctions.html&quot;                 
##  [661] &quot;HcupSeminar.html&quot;                    
##  [662] &quot;HealyViewpoint.html&quot;                 
##  [663] &quot;hedge.html&quot;                          
##  [664] &quot;HedgesG.html&quot;                        
##  [665] &quot;HeiserWebpages.html&quot;                 
##  [666] &quot;HelpForStatistics.html&quot;              
##  [667] &quot;HelpMyIrb.html&quot;                      
##  [668] &quot;Heterogeneity.html&quot;                  
##  [669] &quot;HeterogeneityInAnova-08.html&quot;        
##  [670] &quot;HeterogeneityInAnova-08a.html&quot;       
##  [671] &quot;HeteroscedasticTtest.html&quot;           
##  [672] &quot;HicklinOffice.html&quot;                  
##  [673] &quot;Hierarchical.html&quot;                   
##  [674] &quot;HighAltitude-08.html&quot;                
##  [675] &quot;HighAltitude-08a.html&quot;               
##  [676] &quot;HighLevel.html&quot;                      
##  [677] &quot;HighQuality.html&quot;                    
##  [678] &quot;HistogramPatterns.html&quot;              
##  [679] &quot;hobbies.html&quot;                        
##  [680] &quot;homogenous.html&quot;                     
##  [681] &quot;Hoop.html&quot;                           
##  [682] &quot;HowGood.html&quot;                        
##  [683] &quot;HowManyCharts.html&quot;                  
##  [684] &quot;HowManyFiles.html&quot;                   
##  [685] &quot;HowManyWebpages.html&quot;                
##  [686] &quot;howto.html&quot;                          
##  [687] &quot;HowWide-08.html&quot;                     
##  [688] &quot;HowWide-08a.html&quot;                    
##  [689] &quot;HtmlDebris.html&quot;                     
##  [690] &quot;HumanFace.html&quot;                      
##  [691] &quot;HumanSideStatistics.html&quot;            
##  [692] &quot;HumilityInResearch.html&quot;             
##  [693] &quot;HundredWords.html&quot;                   
##  [694] &quot;hypo.html&quot;                           
##  [695] &quot;HypothesisTesting.html&quot;              
##  [696] &quot;IbmPuzzle.html&quot;                      
##  [697] &quot;iceskater.html&quot;                      
##  [698] &quot;icf.html&quot;                            
##  [699] &quot;ideas.html&quot;                          
##  [700] &quot;IllustratedCaseStudies.html&quot;         
##  [701] &quot;IllustrationsForTgn1412.html&quot;        
##  [702] &quot;IllustrativeExamples.html&quot;           
##  [703] &quot;ImportantStudies-08.html&quot;            
##  [704] &quot;ImportantStudies-08a.html&quot;           
##  [705] &quot;ImpossibleResume-08.html&quot;            
##  [706] &quot;ImpossibleResume-08a.html&quot;           
##  [707] &quot;ImprovementsWeblogCategories.html&quot;   
##  [708] &quot;ImputationFormula.html&quot;              
##  [709] &quot;IncidenceDensity.html&quot;               
##  [710] &quot;IncompletePages.html&quot;                
##  [711] &quot;IncreasingTrend.html&quot;                
##  [712] &quot;index-cases.html&quot;                    
##  [713] &quot;index-informatics.html&quot;              
##  [714] &quot;index-news.html&quot;                     
##  [715] &quot;index-personal.html&quot;                 
##  [716] &quot;index-training.html&quot;                 
##  [717] &quot;index-webinars.html&quot;                 
##  [718] &quot;IneligiblePatients.html&quot;             
##  [719] &quot;InferentialDescriptive.html&quot;         
##  [720] &quot;InformaticsVision.html&quot;              
##  [721] &quot;information-04.html&quot;                 
##  [722] &quot;information-99.html&quot;                 
##  [723] &quot;information1.html&quot;                   
##  [724] &quot;InformationCalibration.html&quot;         
##  [725] &quot;InformationSearching.html&quot;           
##  [726] &quot;InformationSource.html&quot;              
##  [727] &quot;InformationTheory-05.html&quot;           
##  [728] &quot;InformationTheory-category.html&quot;     
##  [729] &quot;InformationTheoryA.html&quot;             
##  [730] &quot;InformationTheoryB.html&quot;             
##  [731] &quot;injury.html&quot;                         
##  [732] &quot;Instructions.html&quot;                   
##  [733] &quot;InstrumentalVariables-08.html&quot;       
##  [734] &quot;InstrumentalVariables-08a.html&quot;      
##  [735] &quot;InstrumentalVariables-10.html&quot;       
##  [736] &quot;InsufficientData.html&quot;               
##  [737] &quot;IntegratingEvidence.html&quot;            
##  [738] &quot;IntellectualCOI.html&quot;                
##  [739] &quot;IntelligentBackup.html&quot;              
##  [740] &quot;intention.html&quot;                      
##  [741] &quot;Interaction.html&quot;                    
##  [742] &quot;interactions.html&quot;                   
##  [743] &quot;Interesting2008.html&quot;                
##  [744] &quot;Interesting2009.html&quot;                
##  [745] &quot;Interesting2010.html&quot;                
##  [746] &quot;Interesting2011.html&quot;                
##  [747] &quot;InterestingApril.html&quot;               
##  [748] &quot;InterestingArticles.html&quot;            
##  [749] &quot;InterestingBooks.html&quot;               
##  [750] &quot;InterestingCaseStudies.html&quot;         
##  [751] &quot;InterestingMarch.html&quot;               
##  [752] &quot;InterestingMay.html&quot;                 
##  [753] &quot;InterestingQuotes.html&quot;              
##  [754] &quot;InterestingStuff.html&quot;               
##  [755] &quot;InterestingWebsites.html&quot;            
##  [756] &quot;interim.html&quot;                        
##  [757] &quot;InterpretationOddsRatio.html&quot;        
##  [758] &quot;InterpretCorrelation.html&quot;           
##  [759] &quot;InterpretingPart1.html&quot;              
##  [760] &quot;IntervalTooWide.html&quot;                
##  [761] &quot;InterveningVariable.html&quot;            
##  [762] &quot;InTheEnd.html&quot;                       
##  [763] &quot;Introduction-evidence.html&quot;          
##  [764] &quot;Introduction-webinars.html&quot;          
##  [765] &quot;Intuition-05.html&quot;                   
##  [766] &quot;Intuition-10.html&quot;                   
##  [767] &quot;inVitro.html&quot;                        
##  [768] &quot;IomReport.html&quot;                      
##  [769] &quot;IowaTalk.html&quot;                       
##  [770] &quot;irb-02.html&quot;                         
##  [771] &quot;irb-04.html&quot;                         
##  [772] &quot;IrbReviewPilot.html&quot;                 
##  [773] &quot;IrbStatistician.html&quot;                
##  [774] &quot;ironwoods.html&quot;                      
##  [775] &quot;ItemResponseTheory.html&quot;             
##  [776] &quot;ItSeemsToMeReasonable.html&quot;          
##  [777] &quot;JackknifeEntropy.html&quot;               
##  [778] &quot;jags.html&quot;                           
##  [779] &quot;jargon.html&quot;                         
##  [780] &quot;jayhawker.html&quot;                      
##  [781] &quot;JointEntropy.html&quot;                   
##  [782] &quot;JournalClub.html&quot;                    
##  [783] &quot;JumpStart.html&quot;                      
##  [784] &quot;kaplan.html&quot;                         
##  [785] &quot;KcalsiGrant.html&quot;                    
##  [786] &quot;KCStar.html&quot;                         
##  [787] &quot;KickAround.html&quot;                     
##  [788] &quot;KidneyBiopsy.html&quot;                   
##  [789] &quot;km.html&quot;                             
##  [790] &quot;km1a.html&quot;                           
##  [791] &quot;km1b.html&quot;                           
##  [792] &quot;km2a.html&quot;                           
##  [793] &quot;km2b.html&quot;                           
##  [794] &quot;km3a.html&quot;                           
##  [795] &quot;km3b.html&quot;                           
##  [796] &quot;km4a.html&quot;                           
##  [797] &quot;km4b.html&quot;                           
##  [798] &quot;km5a.html&quot;                           
##  [799] &quot;km5b.html&quot;                           
##  [800] &quot;km6a.html&quot;                           
##  [801] &quot;km6b.html&quot;                           
##  [802] &quot;KnockKnock.html&quot;                     
##  [803] &quot;Koan04.html&quot;                         
##  [804] &quot;Koan05.html&quot;                         
##  [805] &quot;KoanPage.html&quot;                       
##  [806] &quot;koans-08.html&quot;                       
##  [807] &quot;koans-08a.html&quot;                      
##  [808] &quot;Krauthammer.html&quot;                    
##  [809] &quot;KreamerAward-08.html&quot;                
##  [810] &quot;KreamerAward-08a.html&quot;               
##  [811] &quot;labor.html&quot;                          
##  [812] &quot;LanDeMets.html&quot;                      
##  [813] &quot;LanguageResources.html&quot;              
##  [814] &quot;LargeFile.html&quot;                      
##  [815] &quot;lasagna.html&quot;                        
##  [816] &quot;lasso-12.html&quot;                       
##  [817] &quot;lasso-16.html&quot;                       
##  [818] &quot;lassof1.html&quot;                        
##  [819] &quot;lassof2.html&quot;                        
##  [820] &quot;lassof3.html&quot;                        
##  [821] &quot;lassof4.html&quot;                        
##  [822] &quot;lassof5.html&quot;                        
##  [823] &quot;lassof6.html&quot;                        
##  [824] &quot;LatentGrowth.html&quot;                   
##  [825] &quot;LaTeX.html&quot;                          
##  [826] &quot;LearnMore.html&quot;                      
##  [827] &quot;LeastSquares.html&quot;                   
##  [828] &quot;legal.html&quot;                          
##  [829] &quot;Lessons.html&quot;                        
##  [830] &quot;LessonsLearned.html&quot;                 
##  [831] &quot;letter.html&quot;                         
##  [832] &quot;LetterCensus.html&quot;                   
##  [833] &quot;Letters.html&quot;                        
##  [834] &quot;LibrariesR.html&quot;                     
##  [835] &quot;likelihood_extra.html&quot;               
##  [836] &quot;LikelihoodSoftware.html&quot;             
##  [837] &quot;LikertAnova.html&quot;                    
##  [838] &quot;LikertScale.html&quot;                    
##  [839] &quot;LikertSum.html&quot;                      
##  [840] &quot;LimitingEnrollment.html&quot;             
##  [841] &quot;lin_coef-02.html&quot;                    
##  [842] &quot;lin_coef-99.html&quot;                    
##  [843] &quot;lin_int.html&quot;                        
##  [844] &quot;lin_spss.html&quot;                       
##  [845] &quot;linear.html&quot;                         
##  [846] &quot;LinearRegression-category.html&quot;      
##  [847] &quot;LinearRegression-webinars.html&quot;      
##  [848] &quot;links.html&quot;                          
##  [849] &quot;LinksAndReferences.html&quot;             
##  [850] &quot;LocatingRoc.html&quot;                    
##  [851] &quot;log-02.html&quot;                         
##  [852] &quot;log-personal.html&quot;                   
##  [853] &quot;log2011.html&quot;                        
##  [854] &quot;log2012.html&quot;                        
##  [855] &quot;log2012a.html&quot;                       
##  [856] &quot;log2012z.html&quot;                       
##  [857] &quot;logist_concepts.html&quot;                
##  [858] &quot;logist_spss.html&quot;                    
##  [859] &quot;logistic.html&quot;                       
##  [860] &quot;LogisticAssumptions.html&quot;            
##  [861] &quot;LogisticRegression-category.html&quot;    
##  [862] &quot;LogisticRegression-webinars.html&quot;    
##  [863] &quot;longitudinal-02.html&quot;                
##  [864] &quot;longitudinal-99.html&quot;                
##  [865] &quot;LongitudinalPart1.html&quot;              
##  [866] &quot;LongPageNames.html&quot;                  
##  [867] &quot;LosingWebPages-08.html&quot;              
##  [868] &quot;LosingWebPages-08a.html&quot;             
##  [869] &quot;LostFiles.html&quot;                      
##  [870] &quot;LoveToWrite.html&quot;                    
##  [871] &quot;LoweringPrevalence-08.html&quot;          
##  [872] &quot;LoweringPrevalence-08a.html&quot;         
##  [873] &quot;MachineLearning.html&quot;                
##  [874] &quot;MailSoftware.html&quot;                   
##  [875] &quot;MakingUpData.html&quot;                   
##  [876] &quot;ManipulationPeerReview-06.html&quot;      
##  [877] &quot;ManipulationPeerReview-07.html&quot;      
##  [878] &quot;mann.html&quot;                           
##  [879] &quot;maps.html&quot;                           
##  [880] &quot;MathematicalGraphs.html&quot;             
##  [881] &quot;MathematicaMatlab.html&quot;              
##  [882] &quot;MathError-08.html&quot;                   
##  [883] &quot;MathError-08a.html&quot;                  
##  [884] &quot;mcnemar.html&quot;                        
##  [885] &quot;mdac.html&quot;                           
##  [886] &quot;meanormedian-00.html&quot;                
##  [887] &quot;meanormedian-03.html&quot;                
##  [888] &quot;MeasuringAgreement-05.html&quot;          
##  [889] &quot;MeasuringAgreement-category.html&quot;    
##  [890] &quot;MeasuringBenefitRisk.html&quot;           
##  [891] &quot;mechanism.html&quot;                      
##  [892] &quot;medals.html&quot;                         
##  [893] &quot;MediaInterviews.html&quot;                
##  [894] &quot;MedicalConcernsChildren.html&quot;        
##  [895] &quot;MedicalGuidelines.html&quot;              
##  [896] &quot;MedlineVeryBusy.html&quot;                
##  [897] &quot;MedStats.html&quot;                       
##  [898] &quot;Mendenhall.html&quot;                     
##  [899] &quot;meps.html&quot;                           
##  [900] &quot;merging.html&quot;                        
##  [901] &quot;MergingInR.html&quot;                     
##  [902] &quot;metaanalysis.html&quot;                   
##  [903] &quot;MetaanalysisArticles.html&quot;           
##  [904] &quot;MetaanalysisCritique.html&quot;           
##  [905] &quot;MetaAnalysisDiagnostic.html&quot;         
##  [906] &quot;MetaanalysisTalk.html&quot;               
##  [907] &quot;MethodologicalFlaws.html&quot;            
##  [908] &quot;MethodologyErrors.html&quot;              
##  [909] &quot;methods.html&quot;                        
##  [910] &quot;MetropolisAlgorithm.html&quot;            
##  [911] &quot;microarray.html&quot;                     
##  [912] &quot;MicroArrayA.html&quot;                    
##  [913] &quot;MicroArrayB.html&quot;                    
##  [914] &quot;MicroarrayC.html&quot;                    
##  [915] &quot;MicroArrayD.html&quot;                    
##  [916] &quot;MicroArrayE.html&quot;                    
##  [917] &quot;MicroArrayF.html&quot;                    
##  [918] &quot;MicroarrayG.html&quot;                    
##  [919] &quot;Middle.html&quot;                         
##  [920] &quot;mind.html&quot;                           
##  [921] &quot;MisleadingBargraph.html&quot;             
##  [922] &quot;missing.html&quot;                        
##  [923] &quot;MissingData.html&quot;                    
##  [924] &quot;MissingValues.html&quot;                  
##  [925] &quot;MissingVerse.html&quot;                   
##  [926] &quot;MissouriTechnology.html&quot;             
##  [927] &quot;MistakesEBM.html&quot;                    
##  [928] &quot;MixedLinearModels.html&quot;              
##  [929] &quot;MixedLogistic.html&quot;                  
##  [930] &quot;MixedModels.html&quot;                    
##  [931] &quot;MixedSeminar.html&quot;                   
##  [932] &quot;mixture.html&quot;                        
##  [933] &quot;mle.html&quot;                            
##  [934] &quot;MMalgorithm.html&quot;                    
##  [935] &quot;ModelingIssues.html&quot;                 
##  [936] &quot;ModelMicroarray.html&quot;                
##  [937] &quot;ModeratorVariable.html&quot;              
##  [938] &quot;modify.html&quot;                         
##  [939] &quot;ModularArithmeticInR.html&quot;           
##  [940] &quot;MolassesMilk.html&quot;                   
##  [941] &quot;MolecularBiologists.html&quot;            
##  [942] &quot;Moments.html&quot;                        
##  [943] &quot;MonetaryIncentives.html&quot;             
##  [944] &quot;montecarlo.html&quot;                     
##  [945] &quot;MontyHall.html&quot;                      
##  [946] &quot;MooseShirt.html&quot;                     
##  [947] &quot;mortenson.html&quot;                      
##  [948] &quot;MovieGroup.html&quot;                     
##  [949] &quot;MovingContent-08.html&quot;               
##  [950] &quot;MovingContent-08a.html&quot;              
##  [951] &quot;MovingRObjects.html&quot;                 
##  [952] &quot;MSorPHD.html&quot;                        
##  [953] &quot;Multicollinearity.html&quot;              
##  [954] &quot;MultinomialProportions.html&quot;         
##  [955] &quot;MultipleComparisons-05.html&quot;         
##  [956] &quot;MultipleComparisons-06.html&quot;         
##  [957] &quot;MultipleComparisons-category.html&quot;   
##  [958] &quot;MultipleDF.html&quot;                     
##  [959] &quot;MultipleTimePoints.html&quot;             
##  [960] &quot;MultipleVariables.html&quot;              
##  [961] &quot;MultivariateModels.html&quot;             
##  [962] &quot;MyPromotionApplication.html&quot;         
##  [963] &quot;name.html&quot;                           
##  [964] &quot;NamesIntoModel.html&quot;                 
##  [965] &quot;NamingConventions.html&quot;              
##  [966] &quot;NamingGenes.html&quot;                    
##  [967] &quot;narrow.html&quot;                         
##  [968] &quot;negative.html&quot;                       
##  [969] &quot;NegativeAutocorrelation.html&quot;        
##  [970] &quot;NegativeInterval.html&quot;               
##  [971] &quot;NegativeMicroarray.html&quot;             
##  [972] &quot;negbin.html&quot;                         
##  [973] &quot;new04.html&quot;                          
##  [974] &quot;NewCategories.html&quot;                  
##  [975] &quot;NewComputer.html&quot;                    
##  [976] &quot;NewDog.html&quot;                         
##  [977] &quot;NewFlatRate.html&quot;                    
##  [978] &quot;NewForm.html&quot;                        
##  [979] &quot;NewFormat-08.html&quot;                   
##  [980] &quot;NewFormat-08a.html&quot;                  
##  [981] &quot;NewOffice-08.html&quot;                   
##  [982] &quot;NewOffice-08a.html&quot;                  
##  [983] &quot;newton.html&quot;                         
##  [984] &quot;NeymanBias.html&quot;                     
##  [985] &quot;nhamcs.html&quot;                         
##  [986] &quot;nih.html&quot;                            
##  [987] &quot;nihilism.html&quot;                       
##  [988] &quot;NineOfThirtySix.html&quot;                
##  [989] &quot;nnh.html&quot;                            
##  [990] &quot;NnhTalkUpdate.html&quot;                  
##  [991] &quot;nnt.html&quot;                            
##  [992] &quot;NntForIndirectComparisons.html&quot;      
##  [993] &quot;NntForRates.html&quot;                    
##  [994] &quot;nobrake.html&quot;                        
##  [995] &quot;NoHumanInvestigation.html&quot;           
##  [996] &quot;NoLongerAlone.html&quot;                  
##  [997] &quot;NoMechanism.html&quot;                    
##  [998] &quot;noncomparable.html&quot;                  
##  [999] &quot;NondestructiveEditing.html&quot;          
## [1000] &quot;nonlinear-04.html&quot;                   
## [1001] &quot;nonlinear-99.html&quot;                   
## [1002] &quot;Nonlinear.html&quot;                      
## [1003] &quot;nonlinear_growth.html&quot;               
## [1004] &quot;NonlinearRegression.html&quot;            
## [1005] &quot;NonrandomSamples.html&quot;               
## [1006] &quot;NonspecificDiagnostic.html&quot;          
## [1007] &quot;normal.html&quot;                         
## [1008] &quot;NormalityAssumption.html&quot;            
## [1009] &quot;NormalPlot.html&quot;                     
## [1010] &quot;NormalProbabilities.html&quot;            
## [1011] &quot;NormalSample.html&quot;                   
## [1012] &quot;NoStandardDeviation.html&quot;            
## [1013] &quot;NotBlackAndWhilte.html&quot;              
## [1014] &quot;NotEverything.html&quot;                  
## [1015] &quot;NotGatekeepers.html&quot;                 
## [1016] &quot;NotYetAvailable.html&quot;                
## [1017] &quot;NovelDiagnostic.html&quot;                
## [1018] &quot;NumbersTablesCharts.html&quot;            
## [1019] &quot;OATalk.html&quot;                         
## [1020] &quot;ObjectOrientedR.html&quot;                
## [1021] &quot;ObservationalStudies.html&quot;           
## [1022] &quot;ObsoleteImages.html&quot;                 
## [1023] &quot;ObsoletePages.html&quot;                  
## [1024] &quot;OctoberFun.html&quot;                     
## [1025] &quot;OddsFormBayes.html&quot;                  
## [1026] &quot;oddsratio.html&quot;                      
## [1027] &quot;OddsRatios.html&quot;                     
## [1028] &quot;OneOfTheNaturalists.html&quot;            
## [1029] &quot;OneTail.html&quot;                        
## [1030] &quot;OneTailed.html&quot;                      
## [1031] &quot;OneThird-08.html&quot;                    
## [1032] &quot;OneThird-08a.html&quot;                   
## [1033] &quot;OnlineCalculators.html&quot;              
## [1034] &quot;OpenAccessJournals.html&quot;             
## [1035] &quot;OpenAccessJournalsPart2.html&quot;        
## [1036] &quot;OpenAccessJournalsPart2a.html&quot;       
## [1037] &quot;OpenEndedQuestions.html&quot;             
## [1038] &quot;OpenMindedness.html&quot;                 
## [1039] &quot;OpenSite.html&quot;                       
## [1040] &quot;OppositeOddsRatio.html&quot;              
## [1041] &quot;OptimalThreshold.html&quot;               
## [1042] &quot;OrderEnteringInteractions.html&quot;      
## [1043] &quot;OrdinalData.html&quot;                    
## [1044] &quot;OrdinalEntropy.html&quot;                 
## [1045] &quot;OrdinalLogistic.html&quot;                
## [1046] &quot;OrdinalSurprisals.html&quot;              
## [1047] &quot;OutcomesResearch.html&quot;               
## [1048] &quot;outliers.html&quot;                       
## [1049] &quot;OvarianCancer.html&quot;                  
## [1050] &quot;overfit.html&quot;                        
## [1051] &quot;OverfittingExample.html&quot;             
## [1052] &quot;OvernightCamping.html&quot;               
## [1053] &quot;page.html&quot;                           
## [1054] &quot;PageBreaksSPSS.html&quot;                 
## [1055] &quot;PairedAvailability.html&quot;             
## [1056] &quot;PairedRandomization.html&quot;            
## [1057] &quot;Panhandler.html&quot;                     
## [1058] &quot;PapSmear.html&quot;                       
## [1059] &quot;ParallelControl.html&quot;                
## [1060] &quot;parametric-01.html&quot;                  
## [1061] &quot;parametric-04.html&quot;                  
## [1062] &quot;ParametricTestForRatio.html&quot;         
## [1063] &quot;ParetoCharts.html&quot;                   
## [1064] &quot;PastYear.html&quot;                       
## [1065] &quot;PatientsReactions.html&quot;              
## [1066] &quot;pca.html&quot;                            
## [1067] &quot;PControlChart.html&quot;                  
## [1068] &quot;PControlChartAnswers.html&quot;           
## [1069] &quot;PearsonCorrelation.html&quot;             
## [1070] &quot;PediatricResearch.html&quot;              
## [1071] &quot;PeerReview.html&quot;                     
## [1072] &quot;penston.html&quot;                        
## [1073] &quot;percentage-02.html&quot;                  
## [1074] &quot;percentage-04.html&quot;                  
## [1075] &quot;percentage-12.html&quot;                  
## [1076] &quot;PercentileFormula.html&quot;              
## [1077] &quot;PerfectionNotEnough.html&quot;            
## [1078] &quot;performance.html&quot;                    
## [1079] &quot;PeritonealDialysis.html&quot;             
## [1080] &quot;PermutationTests.html&quot;               
## [1081] &quot;PersonalPages.html&quot;                  
## [1082] &quot;pesky.html&quot;                          
## [1083] &quot;PharmacogeneticsResearchNetwork.html&quot;
## [1084] &quot;PharmaIqTalks.html&quot;                  
## [1085] &quot;PharmaIqTalksPart2.html&quot;             
## [1086] &quot;PharmaVersusAcademia.html&quot;           
## [1087] &quot;PharmedOutWebsite.html&quot;              
## [1088] &quot;photographer.html&quot;                   
## [1089] &quot;PiecewiseLinear.html&quot;                
## [1090] &quot;pilot-99.html&quot;                       
## [1091] &quot;pilot-personal.html&quot;                 
## [1092] &quot;pilot1.html&quot;                         
## [1093] &quot;PilotGrant.html&quot;                     
## [1094] &quot;PilotStudies.html&quot;                   
## [1095] &quot;PilotStudy.html&quot;                     
## [1096] &quot;Pinewood.html&quot;                       
## [1097] &quot;pivot.html&quot;                          
## [1098] &quot;placebo-01.html&quot;                     
## [1099] &quot;placebo-04.html&quot;                     
## [1100] &quot;PlaceboCartoon.html&quot;                 
## [1101] &quot;PlaceboControlledTrials.html&quot;        
## [1102] &quot;PlaceboRunIn.html&quot;                   
## [1103] &quot;Plagiarism.html&quot;                     
## [1104] &quot;PlanSurvey.html&quot;                     
## [1105] &quot;PlugForAccrual.html&quot;                 
## [1106] &quot;PocketCalculator.html&quot;               
## [1107] &quot;PointlessAnalysis.html&quot;              
## [1108] &quot;poiss_syntax.html&quot;                   
## [1109] &quot;poisson.html&quot;                        
## [1110] &quot;PoissonAccrual.html&quot;                 
## [1111] &quot;PoissonBugs.html&quot;                    
## [1112] &quot;PoissonInteractions.html&quot;            
## [1113] &quot;PoissonPower.html&quot;                   
## [1114] &quot;PoissonRegression-06.html&quot;           
## [1115] &quot;PoissonRegression-category.html&quot;     
## [1116] &quot;PoissonRegressionBooks.html&quot;         
## [1117] &quot;PolarBears.html&quot;                     
## [1118] &quot;PoliticalEnd.html&quot;                   
## [1119] &quot;PoliticalQuestions.html&quot;             
## [1120] &quot;PoolingRisk.html&quot;                    
## [1121] &quot;population.html&quot;                     
## [1122] &quot;PopulationBased.html&quot;                
## [1123] &quot;PositiveStatements.html&quot;             
## [1124] &quot;posthoc.html&quot;                        
## [1125] &quot;PostHocComparisons.html&quot;             
## [1126] &quot;PostHocPower-05.html&quot;                
## [1127] &quot;PostHocPower-category.html&quot;          
## [1128] &quot;PostModernAssault.html&quot;              
## [1129] &quot;PostModernAssaultPart2.html&quot;         
## [1130] &quot;PostModernAssaultPart3-07.html&quot;      
## [1131] &quot;PostModernAssaultPart3-08.html&quot;      
## [1132] &quot;PostModernAssaultPart3-08a.html&quot;     
## [1133] &quot;PostmodernThought.html&quot;              
## [1134] &quot;power.html&quot;                          
## [1135] &quot;PowerExample.html&quot;                   
## [1136] &quot;powerpoint.html&quot;                     
## [1137] &quot;powerpoint1.html&quot;                    
## [1138] &quot;powerpoint2.html&quot;                    
## [1139] &quot;PowerPointA.html&quot;                    
## [1140] &quot;PowerpointDefense.html&quot;              
## [1141] &quot;PowerStatements.html&quot;                
## [1142] &quot;PracticeGuidelines.html&quot;             
## [1143] &quot;PracticumOption.html&quot;                
## [1144] &quot;PrayerStudies.html&quot;                  
## [1145] &quot;predicted.html&quot;                      
## [1146] &quot;Preface.html&quot;                        
## [1147] &quot;prerequisites.html&quot;                  
## [1148] &quot;PresentingResearchData.html&quot;         
## [1149] &quot;prfnee.html&quot;                         
## [1150] &quot;PriceKaplanMeier.html&quot;               
## [1151] &quot;PrinterFriendly.html&quot;                
## [1152] &quot;Prisons.html&quot;                        
## [1153] &quot;privacy.html&quot;                        
## [1154] &quot;PrivacyHIPAA.html&quot;                   
## [1155] &quot;PrivacyInResearch.html&quot;              
## [1156] &quot;PrivateConflicts.html&quot;               
## [1157] &quot;ProbabilityConcepts.html&quot;            
## [1158] &quot;ProfessionalDetails.html&quot;            
## [1159] &quot;ProfileAnalysis.html&quot;                
## [1160] &quot;program.html&quot;                        
## [1161] &quot;ProgramOverview.html&quot;                
## [1162] &quot;PromoteBook.html&quot;                    
## [1163] &quot;promoting.html&quot;                      
## [1164] &quot;PromotingYourBook.html&quot;              
## [1165] &quot;Promotion.html&quot;                      
## [1166] &quot;PropensityScores.html&quot;               
## [1167] &quot;PropensityScores1.html&quot;              
## [1168] &quot;PropensityScores2.html&quot;              
## [1169] &quot;ProperTreatment.html&quot;                
## [1170] &quot;ProportionalVennDiagrams.html&quot;       
## [1171] &quot;ProposedPoster.html&quot;                 
## [1172] &quot;protocol.html&quot;                       
## [1173] &quot;ProvisionalMeans.html&quot;               
## [1174] &quot;psa.html&quot;                            
## [1175] &quot;PublicAccess.html&quot;                   
## [1176] &quot;PublicationBias-04.html&quot;             
## [1177] &quot;PublicationBias-category.html&quot;       
## [1178] &quot;PublicationBias1.html&quot;               
## [1179] &quot;PublicationBias2.html&quot;               
## [1180] &quot;PublicationQuality.html&quot;             
## [1181] &quot;Publicity.html&quot;                      
## [1182] &quot;Publicon.html&quot;                       
## [1183] &quot;PubMedTags.html&quot;                     
## [1184] &quot;pumpkin.html&quot;                        
## [1185] &quot;puzzle.html&quot;                         
## [1186] &quot;Puzzler.html&quot;                        
## [1187] &quot;PvalueEqualsOne.html&quot;                
## [1188] &quot;PvalueQuiz.html&quot;                     
## [1189] &quot;Pvalues.html&quot;                        
## [1190] &quot;qqplot.html&quot;                         
## [1191] &quot;QuadraticRegression.html&quot;            
## [1192] &quot;qualified.html&quot;                      
## [1193] &quot;qualitative.html&quot;                    
## [1194] &quot;QualitativeData.html&quot;                
## [1195] &quot;QualitativeReview.html&quot;              
## [1196] &quot;QualitativeSampleSize.html&quot;          
## [1197] &quot;quality-04.html&quot;                     
## [1198] &quot;quality-99.html&quot;                     
## [1199] &quot;QualityControl.html&quot;                 
## [1200] &quot;QualityControlExercises.html&quot;        
## [1201] &quot;QualityControlExercsiesPart2.html&quot;   
## [1202] &quot;QualityControlHumor.html&quot;            
## [1203] &quot;QuantifyingPredictions.html&quot;         
## [1204] &quot;questionnaire-02.html&quot;               
## [1205] &quot;questionnaire-12.html&quot;               
## [1206] &quot;questions.html&quot;                      
## [1207] &quot;quick.html&quot;                          
## [1208] &quot;QuietYear.html&quot;                      
## [1209] &quot;quota.html&quot;                          
## [1210] &quot;QuotesFebruary.html&quot;                 
## [1211] &quot;QuotesJanuary.html&quot;                  
## [1212] &quot;QuotesMarch.html&quot;                    
## [1213] &quot;QuotientRule.html&quot;                   
## [1214] &quot;r-syllabus.html&quot;                     
## [1215] &quot;r.html&quot;                              
## [1216] &quot;RaceEthnicity.html&quot;                  
## [1217] &quot;random.html&quot;                         
## [1218] &quot;random42.html&quot;                       
## [1219] &quot;RandomEffects-08.html&quot;               
## [1220] &quot;RandomEffects-08a.html&quot;              
## [1221] &quot;RandomID.html&quot;                       
## [1222] &quot;randomization.html&quot;                  
## [1223] &quot;RandomizationInResearch.html&quot;        
## [1224] &quot;RandomizedTrials.html&quot;               
## [1225] &quot;RandomizedTrialsA.html&quot;              
## [1226] &quot;RandomlyDividingData.html&quot;           
## [1227] &quot;RandomMath.html&quot;                     
## [1228] &quot;RandomSelection.html&quot;                
## [1229] &quot;RankingOrdinalScales.html&quot;           
## [1230] &quot;Rates.html&quot;                          
## [1231] &quot;RatioObsIvs.html&quot;                    
## [1232] &quot;ReadingAbstracts.html&quot;               
## [1233] &quot;readme.html&quot;                         
## [1234] &quot;ReadyToRace.html&quot;                    
## [1235] &quot;RebuttingReviewer.html&quot;              
## [1236] &quot;RecallBias.html&quot;                     
## [1237] &quot;RecommendationsSackett.html&quot;         
## [1238] &quot;redefined.html&quot;                      
## [1239] &quot;ReformingCoi.html&quot;                   
## [1240] &quot;RefusalReasons.html&quot;                 
## [1241] &quot;RefusalsAndExclusions-08.html&quot;       
## [1242] &quot;RefusalsAndExclusions-08a.html&quot;      
## [1243] &quot;RefusingToAnalyze.html&quot;              
## [1244] &quot;regression.html&quot;                     
## [1245] &quot;RegressionAndAnova.html&quot;             
## [1246] &quot;RegularExpressions-05.html&quot;          
## [1247] &quot;RegularExpressions-06.html&quot;          
## [1248] &quot;RegularExpressionsA.html&quot;            
## [1249] &quot;reliability.html&quot;                    
## [1250] &quot;ReliableDiagnosis.html&quot;              
## [1251] &quot;Reminder.html&quot;                       
## [1252] &quot;RepeatedMeasurements-08.html&quot;        
## [1253] &quot;RepeatedMeasurements-08a.html&quot;       
## [1254] &quot;RepeatedMeasures.html&quot;               
## [1255] &quot;RepeatedMeasuresPart2.html&quot;          
## [1256] &quot;RepeatedMeasuresPower.html&quot;          
## [1257] &quot;report.html&quot;                         
## [1258] &quot;ReportCards-04.html&quot;                 
## [1259] &quot;ReportCards-05.html&quot;                 
## [1260] &quot;ReportingFishersExact.html&quot;          
## [1261] &quot;ReportingTransformedData.html&quot;       
## [1262] &quot;ResamplingMethods.html&quot;              
## [1263] &quot;research.html&quot;                       
## [1264] &quot;ResearchDesigns.html&quot;                
## [1265] &quot;ResearchIntegrity.html&quot;              
## [1266] &quot;ResearchInvolvingChildren.html&quot;      
## [1267] &quot;ResidualConfounding.html&quot;            
## [1268] &quot;Resources-08.html&quot;                   
## [1269] &quot;Resources-evidence.html&quot;             
## [1270] &quot;ResourcesForFellows.html&quot;            
## [1271] &quot;ResourcesForGrantWriters.html&quot;       
## [1272] &quot;resume.html&quot;                         
## [1273] &quot;resume_extras.html&quot;                  
## [1274] &quot;RetractedArticles.html&quot;              
## [1275] &quot;RetroactivePrayer.html&quot;              
## [1276] &quot;retrospective.html&quot;                  
## [1277] &quot;reviews-08.html&quot;                     
## [1278] &quot;reviews-evidence.html&quot;               
## [1279] &quot;ReviewStatisticalMethods.html&quot;       
## [1280] &quot;RevisingDefinitions.html&quot;            
## [1281] &quot;ReweightingData.html&quot;                
## [1282] &quot;RiskFactorsDiagnosticTest.html&quot;      
## [1283] &quot;roc.html&quot;                            
## [1284] &quot;RocCurve-08.html&quot;                    
## [1285] &quot;RocCurve-08a.html&quot;                   
## [1286] &quot;ROCcurve.html&quot;                       
## [1287] &quot;RocLayout.html&quot;                      
## [1288] &quot;RotatingLocations.html&quot;              
## [1289] &quot;RoundingNumbers.html&quot;                
## [1290] &quot;RSoftware.html&quot;                      
## [1291] &quot;rsquared.html&quot;                       
## [1292] &quot;RunWithCows.html&quot;                    
## [1293] &quot;RWebServer-08.html&quot;                  
## [1294] &quot;RWebServer-08a.html&quot;                 
## [1295] &quot;RWiki.html&quot;                          
## [1296] &quot;Sackettisation.html&quot;                 
## [1297] &quot;SafetyMiner.html&quot;                    
## [1298] &quot;Salary.html&quot;                         
## [1299] &quot;samplesize-04.html&quot;                  
## [1300] &quot;SampleSize-05.html&quot;                  
## [1301] &quot;SampleSize-08.html&quot;                  
## [1302] &quot;SampleSize-10.html&quot;                  
## [1303] &quot;samplesize-13.html&quot;                  
## [1304] &quot;SampleSizeA.html&quot;                    
## [1305] &quot;SampleSizeB.html&quot;                    
## [1306] &quot;SampleSizeBinary.html&quot;               
## [1307] &quot;SampleSizeDiagnostic.html&quot;           
## [1308] &quot;SampleSizeJustification.html&quot;        
## [1309] &quot;SampleSizeLogistic.html&quot;             
## [1310] &quot;SampleSizeMicroarray.html&quot;           
## [1311] &quot;SampleSizeR.html&quot;                    
## [1312] &quot;sas.html&quot;                            
## [1313] &quot;SasOrR.html&quot;                         
## [1314] &quot;sbir.html&quot;                           
## [1315] &quot;ScholarshipProgram.html&quot;             
## [1316] &quot;ScienceBasedMedicine.html&quot;           
## [1317] &quot;ScienceBasedMedicinePt2.html&quot;        
## [1318] &quot;ScienceMentoring.html&quot;               
## [1319] &quot;ScientificBasis.html&quot;                
## [1320] &quot;ScientificMisconduct.html&quot;           
## [1321] &quot;ScientificPapersServe.html&quot;          
## [1322] &quot;ScientificValidity.html&quot;             
## [1323] &quot;scientist.html&quot;                      
## [1324] &quot;sculptor.html&quot;                       
## [1325] &quot;scurve-04.html&quot;                      
## [1326] &quot;scurve-99.html&quot;                      
## [1327] &quot;SdTooBig.html&quot;                       
## [1328] &quot;SearchingEvidence.html&quot;              
## [1329] &quot;SearchingPediatricArticles.html&quot;     
## [1330] &quot;SearchInternet.html&quot;                 
## [1331] &quot;SearchLiterature.html&quot;               
## [1332] &quot;SearchLiteratureA.html&quot;              
## [1333] &quot;SearchLiteratureB.html&quot;              
## [1334] &quot;SearchLiteratureC.html&quot;              
## [1335] &quot;secondary.html&quot;                      
## [1336] &quot;SecondaryAppointments.html&quot;          
## [1337] &quot;SecondaryUses.html&quot;                  
## [1338] &quot;SecondBook.html&quot;                     
## [1339] &quot;SecondGrant.html&quot;                    
## [1340] &quot;SecondGrantPart2.html&quot;               
## [1341] &quot;SecondGrantPart3.html&quot;               
## [1342] &quot;SecondInvitation.html&quot;               
## [1343] &quot;SecondReviewer.html&quot;                 
## [1344] &quot;SecurityTendsToBe.html&quot;              
## [1345] &quot;Segmented.html&quot;                      
## [1346] &quot;SelectionBias.html&quot;                  
## [1347] &quot;SelectiveReporting.html&quot;             
## [1348] &quot;SelfCritical.html&quot;                   
## [1349] &quot;SelfEvaluation.html&quot;                 
## [1350] &quot;SelfExperimentation.html&quot;            
## [1351] &quot;SensitivityError.html&quot;               
## [1352] &quot;SensitivityMoreImportant.html&quot;       
## [1353] &quot;SeOddsRatio.html&quot;                    
## [1354] &quot;SequenceLogo.html&quot;                   
## [1355] &quot;ses.html&quot;                            
## [1356] &quot;SessionProposal.html&quot;                
## [1357] &quot;SevenFormulas.html&quot;                  
## [1358] &quot;SevenSins.html&quot;                      
## [1359] &quot;SeventeenYears.html&quot;                 
## [1360] &quot;SexAsOutcome.html&quot;                   
## [1361] &quot;sharing.html&quot;                        
## [1362] &quot;sheet.html&quot;                          
## [1363] &quot;shoes.html&quot;                          
## [1364] &quot;ShortBio.html&quot;                       
## [1365] &quot;ShortBiography-08.html&quot;              
## [1366] &quot;ShortBiography-08a.html&quot;             
## [1367] &quot;ShortBiography-09.html&quot;              
## [1368] &quot;ShortfallSampleSize.html&quot;            
## [1369] &quot;Shovel.html&quot;                         
## [1370] &quot;shoveling.html&quot;                      
## [1371] &quot;SideEffects-04.html&quot;                 
## [1372] &quot;SideEffects-05.html&quot;                 
## [1373] &quot;sigma.html&quot;                          
## [1374] &quot;SignificantPilot.html&quot;               
## [1375] &quot;SignUp.html&quot;                         
## [1376] &quot;signup1.html&quot;                        
## [1377] &quot;SillyGraph.html&quot;                     
## [1378] &quot;simon.html&quot;                          
## [1379] &quot;SimpleCrossover.html&quot;                
## [1380] &quot;SimpleKm-08.html&quot;                    
## [1381] &quot;SimpleKm-08a.html&quot;                   
## [1382] &quot;SimpleMicroarray.html&quot;               
## [1383] &quot;SimpsonsParadox.html&quot;                
## [1384] &quot;SingleIdea.html&quot;                     
## [1385] &quot;SingleMean.html&quot;                     
## [1386] &quot;SingleModel.html&quot;                    
## [1387] &quot;SingleObservation.html&quot;              
## [1388] &quot;SixtyDegrees.html&quot;                   
## [1389] &quot;SixtyPercentDrop.html&quot;               
## [1390] &quot;SizeEquivalence.html&quot;                
## [1391] &quot;skater.html&quot;                         
## [1392] &quot;Skeptic.html&quot;                        
## [1393] &quot;skew.html&quot;                           
## [1394] &quot;skills.html&quot;                         
## [1395] &quot;SkipBonferroni.html&quot;                 
## [1396] &quot;SkipFields.html&quot;                     
## [1397] &quot;SlashAndBurn-06.html&quot;                
## [1398] &quot;SlashAndBurn-08.html&quot;                
## [1399] &quot;sledder.html&quot;                        
## [1400] &quot;sliderule.html&quot;                      
## [1401] &quot;SlippedDeadlines-08.html&quot;            
## [1402] &quot;SlippedDeadlines-08a.html&quot;           
## [1403] &quot;SlowMonth.html&quot;                      
## [1404] &quot;SlowProgress.html&quot;                   
## [1405] &quot;small.html&quot;                          
## [1406] &quot;SmallCellSizes.html&quot;                 
## [1407] &quot;SmallPvalue.html&quot;                    
## [1408] &quot;SmallRelativeRisk.html&quot;              
## [1409] &quot;SmallRisk.html&quot;                      
## [1410] &quot;SmallSample.html&quot;                    
## [1411] &quot;SmallSampleSizeIssues.html&quot;          
## [1412] &quot;SmallStdDev.html&quot;                    
## [1413] &quot;smoking.html&quot;                        
## [1414] &quot;snowball.html&quot;                       
## [1415] &quot;snowfun.html&quot;                        
## [1416] &quot;snowrun.html&quot;                        
## [1417] &quot;SocialMedia.html&quot;                    
## [1418] &quot;SocialNetworking.html&quot;               
## [1419] &quot;software-00.html&quot;                    
## [1420] &quot;software-04.html&quot;                    
## [1421] &quot;software-14.html&quot;                    
## [1422] &quot;Software.html&quot;                       
## [1423] &quot;SoftwareForBootstrap.html&quot;           
## [1424] &quot;SoftwarePatents.html&quot;                
## [1425] &quot;SoftwareSem.html&quot;                    
## [1426] &quot;SourcesOfConfusion.html&quot;             
## [1427] &quot;SpacingHtml.html&quot;                    
## [1428] &quot;SpcHealthcare.html&quot;                  
## [1429] &quot;SpecialSectionForQuotations.html&quot;    
## [1430] &quot;SpectrumBias.html&quot;                   
## [1431] &quot;SpermMorphology.html&quot;                
## [1432] &quot;SpittingMatches.html&quot;                
## [1433] &quot;splines.html&quot;                        
## [1434] &quot;SplusCorrelatedData.html&quot;            
## [1435] &quot;SplusVersion7.html&quot;                  
## [1436] &quot;spss.html&quot;                           
## [1437] &quot;Spss17.html&quot;                         
## [1438] &quot;SpssAdvantages.html&quot;                 
## [1439] &quot;SPSSorSTATA.html&quot;                    
## [1440] &quot;SpssPrice.html&quot;                      
## [1441] &quot;SpssSoftware.html&quot;                   
## [1442] &quot;SpssTtest.html&quot;                      
## [1443] &quot;SPSSversion13.html&quot;                  
## [1444] &quot;SPSSversion14.html&quot;                  
## [1445] &quot;srv_data-02.html&quot;                    
## [1446] &quot;srv_data-99.html&quot;                    
## [1447] &quot;StackOverflow.html&quot;                  
## [1448] &quot;StairStep.html&quot;                      
## [1449] &quot;StandardDeviation-06.html&quot;           
## [1450] &quot;StandardDeviation-08.html&quot;           
## [1451] &quot;StandardDeviation-11.html&quot;           
## [1452] &quot;StandardDeviationRatio.html&quot;         
## [1453] &quot;StandardError.html&quot;                  
## [1454] &quot;StandardizedBetas.html&quot;              
## [1455] &quot;startup.html&quot;                        
## [1456] &quot;stata.html&quot;                          
## [1457] &quot;StataMacro.html&quot;                     
## [1458] &quot;StatisticalComputing.html&quot;           
## [1459] &quot;StatisticalConcernsChildren.html&quot;    
## [1460] &quot;StatisticalConsultants.html&quot;         
## [1461] &quot;StatisticalEvidence.html&quot;            
## [1462] &quot;StatisticalEvidenceReview.html&quot;      
## [1463] &quot;StatisticalKoan1.html&quot;               
## [1464] &quot;StatisticalKoan2.html&quot;               
## [1465] &quot;StatisticalKoan3.html&quot;               
## [1466] &quot;StatisticalLiteracy.html&quot;            
## [1467] &quot;StatisticalSoftware.html&quot;            
## [1468] &quot;StatisticalTheory.html&quot;              
## [1469] &quot;StatisticGods.html&quot;                  
## [1470] &quot;StatisticsAgriculture.html&quot;          
## [1471] &quot;StatisticsForBoards-08.html&quot;         
## [1472] &quot;StatisticsForBoards-08a.html&quot;        
## [1473] &quot;StatisticsLibrarians.html&quot;           
## [1474] &quot;StatisticsSoftware.html&quot;             
## [1475] &quot;stein.html&quot;                          
## [1476] &quot;StepwiseRegression.html&quot;             
## [1477] &quot;stopearly.html&quot;                      
## [1478] &quot;StoppingRules.html&quot;                  
## [1479] &quot;StopStudy.html&quot;                      
## [1480] &quot;strata.html&quot;                         
## [1481] &quot;StratifiedCoxRegression.html&quot;        
## [1482] &quot;StratifiedRandomization.html&quot;        
## [1483] &quot;StringsR.html&quot;                       
## [1484] &quot;StubbornInsistence.html&quot;             
## [1485] &quot;subgroup.html&quot;                       
## [1486] &quot;SubgroupAnalysis.html&quot;               
## [1487] &quot;SubgroupsInResearch.html&quot;            
## [1488] &quot;SuboptimalApproach.html&quot;             
## [1489] &quot;subset.html&quot;                         
## [1490] &quot;SummaryROC.html&quot;                     
## [1491] &quot;summer.html&quot;                         
## [1492] &quot;SummitAbstract.html&quot;                 
## [1493] &quot;SurprisalMatrix.html&quot;                
## [1494] &quot;SurrogateOutcomes.html&quot;              
## [1495] &quot;SurromedDecisionSite.html&quot;           
## [1496] &quot;SurveyDesign.html&quot;                   
## [1497] &quot;SurveyLibrarians.html&quot;               
## [1498] &quot;SurveyMistakes.html&quot;                 
## [1499] &quot;SurveyScale.html&quot;                    
## [1500] &quot;survival-02.html&quot;                    
## [1501] &quot;survival-04.html&quot;                    
## [1502] &quot;SurvivalAnalysis.html&quot;               
## [1503] &quot;swimmer.html&quot;                        
## [1504] &quot;SystematicOverviews.html&quot;            
## [1505] &quot;t.html&quot;                              
## [1506] &quot;table.html&quot;                          
## [1507] &quot;TaguchiMethods.html&quot;                 
## [1508] &quot;tail-04.html&quot;                        
## [1509] &quot;tail-99.html&quot;                        
## [1510] &quot;TeachBayes.html&quot;                     
## [1511] &quot;TeachingClasses.html&quot;                
## [1512] &quot;TeachingPhilosophy.html&quot;             
## [1513] &quot;TeachingResources.html&quot;              
## [1514] &quot;TeachingStatistics.html&quot;             
## [1515] &quot;TeamExercise.html&quot;                   
## [1516] &quot;TechnometricsReview.html&quot;            
## [1517] &quot;template.html&quot;                       
## [1518] &quot;template201107.html&quot;                 
## [1519] &quot;template201107a.html&quot;                
## [1520] &quot;template201109.html&quot;                 
## [1521] &quot;template201111.html&quot;                 
## [1522] &quot;template20120101.html&quot;               
## [1523] &quot;template20120305.html&quot;               
## [1524] &quot;temporality.html&quot;                    
## [1525] &quot;TensionScienceEthics.html&quot;           
## [1526] &quot;TenStudies.html&quot;                     
## [1527] &quot;TenStudiesA.html&quot;                    
## [1528] &quot;TenStudiesB.html&quot;                    
## [1529] &quot;TenStudiesPart4.html&quot;                
## [1530] &quot;TentativeTraining.html&quot;              
## [1531] &quot;testing.html&quot;                        
## [1532] &quot;TestsNormality.html&quot;                 
## [1533] &quot;TextFiles.html&quot;                      
## [1534] &quot;tgn01.html&quot;                          
## [1535] &quot;tgn02.html&quot;                          
## [1536] &quot;tgn99.html&quot;                          
## [1537] &quot;ThanksToProofreaders.html&quot;           
## [1538] &quot;ThankYou.html&quot;                       
## [1539] &quot;TheGlitterOf.html&quot;                   
## [1540] &quot;TheoryOrPractice.html&quot;               
## [1541] &quot;TherapeuticOrphans.html&quot;             
## [1542] &quot;ThesisOption.html&quot;                   
## [1543] &quot;TheTest.html&quot;                        
## [1544] &quot;ThousandPages.html&quot;                  
## [1545] &quot;ThreeArmPower.html&quot;                  
## [1546] &quot;ThreeDimensionalCharts.html&quot;         
## [1547] &quot;ThreeLevels.html&quot;                    
## [1548] &quot;ThreeRows.html&quot;                      
## [1549] &quot;ThreeSimpleRules.html&quot;               
## [1550] &quot;TimeSeries.html&quot;                     
## [1551] &quot;tmp.html&quot;                            
## [1552] &quot;ToleranceAmbiguity.html&quot;             
## [1553] &quot;ToleranceLimits.html&quot;                
## [1554] &quot;TooManyToys.html&quot;                    
## [1555] &quot;TooMuchPower-08.html&quot;                
## [1556] &quot;TooMuchPower-08a.html&quot;               
## [1557] &quot;TooSensitive.html&quot;                   
## [1558] &quot;toothfairy.html&quot;                     
## [1559] &quot;toothless.html&quot;                      
## [1560] &quot;TopicListIsComplete.html&quot;            
## [1561] &quot;TouchscreenInterface.html&quot;           
## [1562] &quot;TrackingAdverseEvents.html&quot;          
## [1563] &quot;TrackingAdverseEventsPart2.html&quot;     
## [1564] &quot;traffic.html&quot;                        
## [1565] &quot;training-08.html&quot;                    
## [1566] &quot;training-08a.html&quot;                   
## [1567] &quot;TransformingThePrior.html&quot;           
## [1568] &quot;Translational.html&quot;                  
## [1569] &quot;translational1.html&quot;                 
## [1570] &quot;traveler.html&quot;                       
## [1571] &quot;TravelingCourse.html&quot;                
## [1572] &quot;TrialRegistration.html&quot;              
## [1573] &quot;TrickR.html&quot;                         
## [1574] &quot;TroubleWithApples.html&quot;              
## [1575] &quot;ttest-12.html&quot;                       
## [1576] &quot;ttest-16.html&quot;                       
## [1577] &quot;ttest-99.html&quot;                       
## [1578] &quot;TtestWith3and2.html&quot;                 
## [1579] &quot;TukeyTest.html&quot;                      
## [1580] &quot;TurkeyDay.html&quot;                      
## [1581] &quot;TwasTheNightBeforeSurgery.html&quot;      
## [1582] &quot;Twitter.html&quot;                        
## [1583] &quot;TwoByTwo.html&quot;                       
## [1584] &quot;TwoByTwoPart1.html&quot;                  
## [1585] &quot;TwoByTwoPart2.html&quot;                  
## [1586] &quot;TwoByTwoPart3.html&quot;                  
## [1587] &quot;TwoByTwoPart4.html&quot;                  
## [1588] &quot;TwoByTwoPart5.html&quot;                  
## [1589] &quot;TwoByTwoPart6.html&quot;                  
## [1590] &quot;TwoByTwoTable.html&quot;                  
## [1591] &quot;TwoControlGroups.html&quot;               
## [1592] &quot;TwoEventsWorrisome.html&quot;             
## [1593] &quot;TwoProportions.html&quot;                 
## [1594] &quot;TypeIand IIErrors.html&quot;              
## [1595] &quot;TypeIII-08.html&quot;                     
## [1596] &quot;TypeIII-08a.html&quot;                    
## [1597] &quot;typetwo.html&quot;                        
## [1598] &quot;UmkcOffice.html&quot;                     
## [1599] &quot;UnadjustedEstimates-08.html&quot;         
## [1600] &quot;UnadjustedEstimates-08a.html&quot;        
## [1601] &quot;UnblindingStudy.html&quot;                
## [1602] &quot;UndeclaredMissingCode.html&quot;          
## [1603] &quot;UndeservingOfFurtherStudy.html&quot;      
## [1604] &quot;unequal.html&quot;                        
## [1605] &quot;UnequalSampleSizes.html&quot;             
## [1606] &quot;UnivariateClustering.html&quot;           
## [1607] &quot;UnixHumor.html&quot;                      
## [1608] &quot;UnmeasuredCovariate.html&quot;            
## [1609] &quot;UnnecessaryTests.html&quot;               
## [1610] &quot;unrealistic.html&quot;                    
## [1611] &quot;UnscientificTherapies.html&quot;          
## [1612] &quot;UnusualData.html&quot;                    
## [1613] &quot;UpcomingTalks.html&quot;                  
## [1614] &quot;UpcomingTopics-08.html&quot;              
## [1615] &quot;UpcomingTopics-08a.html&quot;             
## [1616] &quot;update.html&quot;                         
## [1617] &quot;Update060228-08.html&quot;                
## [1618] &quot;Update060228-evidence.html&quot;          
## [1619] &quot;Update060308-08.html&quot;                
## [1620] &quot;Update060308-evidence.html&quot;          
## [1621] &quot;Update060315-08.html&quot;                
## [1622] &quot;Update060315-evidence.html&quot;          
## [1623] &quot;Update060802-08.html&quot;                
## [1624] &quot;Update060802-evidence.html&quot;          
## [1625] &quot;updates.html&quot;                        
## [1626] &quot;Updates2008.html&quot;                    
## [1627] &quot;Updates2009.html&quot;                    
## [1628] &quot;Updates2010.html&quot;                    
## [1629] &quot;UpTo.html&quot;                           
## [1630] &quot;UseForTalks.html&quot;                    
## [1631] &quot;UseMaterial.html&quot;                    
## [1632] &quot;User2007.html&quot;                       
## [1633] &quot;UsingGoogle.html&quot;                    
## [1634] &quot;UsingRealExamples.html&quot;              
## [1635] &quot;Validation.html&quot;                     
## [1636] &quot;validity.html&quot;                       
## [1637] &quot;ValidityReliabilitySampleSize.html&quot;  
## [1638] &quot;ValueLabels.html&quot;                    
## [1639] &quot;VariableNumberOfMeasures.html&quot;       
## [1640] &quot;VarianceRatio.html&quot;                  
## [1641] &quot;vegetable.html&quot;                      
## [1642] &quot;vet.html&quot;                            
## [1643] &quot;ViewingOutput.html&quot;                  
## [1644] &quot;voices2013.html&quot;                     
## [1645] &quot;volunteer.html&quot;                      
## [1646] &quot;VolunteerQuestions.html&quot;             
## [1647] &quot;VoteForMe.html&quot;                      
## [1648] &quot;WaiverInformedConsent.html&quot;          
## [1649] &quot;WakefieldMmrStudy.html&quot;              
## [1650] &quot;WarningMessage.html&quot;                 
## [1651] &quot;wavelet.html&quot;                        
## [1652] &quot;wavelets.html&quot;                       
## [1653] &quot;WeakEvidence.html&quot;                   
## [1654] &quot;wealth.html&quot;                         
## [1655] &quot;web20.html&quot;                          
## [1656] &quot;WebcastTopics.html&quot;                  
## [1657] &quot;WebLinksApril.html&quot;                  
## [1658] &quot;WebLinksAugust.html&quot;                 
## [1659] &quot;WebLinksDecember-04.html&quot;            
## [1660] &quot;WebLinksDecember-05.html&quot;            
## [1661] &quot;WebLinksFebruary-05.html&quot;            
## [1662] &quot;WebLinksFebruary-06.html&quot;            
## [1663] &quot;WebLinksJanuary-05.html&quot;             
## [1664] &quot;WebLinksJanuary-06.html&quot;             
## [1665] &quot;WebLinksJuly.html&quot;                   
## [1666] &quot;WebLinksJune.html&quot;                   
## [1667] &quot;WebLinksMarch.html&quot;                  
## [1668] &quot;WebLinksMay.html&quot;                    
## [1669] &quot;WeblinksOctober.html&quot;                
## [1670] &quot;WebLinksSeptember.html&quot;              
## [1671] &quot;webpoll.html&quot;                        
## [1672] &quot;WebResearch.html&quot;                    
## [1673] &quot;WebsiteDetails.html&quot;                 
## [1674] &quot;WebsiteLogo.html&quot;                    
## [1675] &quot;websites.html&quot;                       
## [1676] &quot;WebsiteTraffic.html&quot;                 
## [1677] &quot;WhaleWatching.html&quot;                  
## [1678] &quot;WhatDistribution.html&quot;               
## [1679] &quot;WhatDoYouCall.html&quot;                  
## [1680] &quot;WhatImWorkingOn.html&quot;                
## [1681] &quot;WhatIsAChild.html&quot;                   
## [1682] &quot;WhatStatistic-08.html&quot;               
## [1683] &quot;WhatStatistic-08a.html&quot;              
## [1684] &quot;WhatToMeasure.html&quot;                  
## [1685] &quot;WhenITalk.html&quot;                      
## [1686] &quot;WhenToLog.html&quot;                      
## [1687] &quot;WhereToGo.html&quot;                      
## [1688] &quot;WhichExpert.html&quot;                    
## [1689] &quot;WhichVersion.html&quot;                   
## [1690] &quot;whiskers.html&quot;                       
## [1691] &quot;WholeNumbers-08.html&quot;                
## [1692] &quot;WholeNumbers-08a.html&quot;               
## [1693] &quot;WhoWrote.html&quot;                       
## [1694] &quot;why95.html&quot;                          
## [1695] &quot;WhyBayesian-08.html&quot;                 
## [1696] &quot;WhyBayesian-08a.html&quot;                
## [1697] &quot;WhyResearch.html&quot;                    
## [1698] &quot;WideConfidenceInterval.html&quot;         
## [1699] &quot;WideInterval.html&quot;                   
## [1700] &quot;WikiPages.html&quot;                      
## [1701] &quot;Wikipedia.html&quot;                      
## [1702] &quot;WikipediaContribution.html&quot;          
## [1703] &quot;WikipediaEntry.html&quot;                 
## [1704] &quot;WikipediaEntryPt2.html&quot;              
## [1705] &quot;WikipediaEntryPt3.html&quot;              
## [1706] &quot;WikipediaEntryPt4.html&quot;              
## [1707] &quot;WinterBiker.html&quot;                    
## [1708] &quot;Withdawing.html&quot;                     
## [1709] &quot;WithholdingInformation.html&quot;         
## [1710] &quot;WithholdingPHI.html&quot;                 
## [1711] &quot;Within.html&quot;                         
## [1712] &quot;WorkshopHandouts.html&quot;               
## [1713] &quot;WriteGrant.html&quot;                     
## [1714] &quot;WritingResearchPapers.html&quot;          
## [1715] &quot;xAsaPressroom-0000images.html&quot;       
## [1716] &quot;xAsaPressroom-00files.html&quot;          
## [1717] &quot;xAsaPressroom-08.html&quot;               
## [1718] &quot;xAsaPressroom-08a.html&quot;              
## [1719] &quot;XbarSControlChart.html&quot;              
## [1720] &quot;XbarSControlChartAnswers.html&quot;       
## [1721] &quot;XbarSymbol.html&quot;                     
## [1722] &quot;xKidneyBiopsy-0000images.html&quot;       
## [1723] &quot;xKidneyBiopsy-00files.html&quot;          
## [1724] &quot;xKidneyBiopsy-08.html&quot;               
## [1725] &quot;xKidneyBiopsy-08a.html&quot;              
## [1726] &quot;xlin_int-0000images.html&quot;            
## [1727] &quot;xlin_int-00files.html&quot;               
## [1728] &quot;xlin_int-02.html&quot;                    
## [1729] &quot;xml-04.html&quot;                         
## [1730] &quot;xml-12.html&quot;                         
## [1731] &quot;xnonlinear.html&quot;                     
## [1732] &quot;xpilot1.html&quot;                        
## [1733] &quot;xswimmer.html&quot;                       
## [1734] &quot;xx.html&quot;                             
## [1735] &quot;xxHelpFromFriends-0000images.html&quot;   
## [1736] &quot;xxHelpFromFriends-00files.html&quot;      
## [1737] &quot;xxHelpFromFriends-08.html&quot;           
## [1738] &quot;YouHaveToMake.html&quot;                  
## [1739] &quot;zero.html&quot;                           
## [1740] &quot;zeroevents.html&quot;                     
## [1741] &quot;Zhenya.html&quot;                         
## [1742] &quot;ZoteroStyle.html&quot;                    
## [1743] &quot;zz-0000images.html&quot;                  
## [1744] &quot;zz-00files.html&quot;                     
## [1745] &quot;zz-01.html&quot;                          
## [1746] &quot;zz-02.html&quot;                          
## [1747] &quot;zz-03.html&quot;                          
## [1748] &quot;zz-04.html&quot;                          
## [1749] &quot;zz-05.html&quot;                          
## [1750] &quot;zz-06.html&quot;                          
## [1751] &quot;zz-07.html&quot;                          
## [1752] &quot;zz-08.html&quot;                          
## [1753] &quot;zz-10.html&quot;                          
## [1754] &quot;zz-11.html&quot;                          
## [1755] &quot;zz-12.html&quot;                          
## [1756] &quot;zz-13.html&quot;                          
## [1757] &quot;zz-99.html&quot;                          
## [1758] &quot;zz_copy(1)-0000images.html&quot;          
## [1759] &quot;zz_copy(1)-00files.html&quot;             
## [1760] &quot;zz_copy(1)-02.html&quot;                  
## [1761] &quot;zzz-00.html&quot;                         
## [1762] &quot;zzz-0000images.html&quot;                 
## [1763] &quot;zzz-00files.html&quot;                    
## [1764] &quot;zzz-01.html&quot;                         
## [1765] &quot;zzz-02.html&quot;                         
## [1766] &quot;zzz-03.html&quot;                         
## [1767] &quot;zzz-04.html&quot;                         
## [1768] &quot;zzz-05.html&quot;                         
## [1769] &quot;zzz-06.html&quot;                         
## [1770] &quot;zzz-07.html&quot;                         
## [1771] &quot;zzz-11.html&quot;                         
## [1772] &quot;zzz-12.html&quot;                         
## [1773] &quot;zzz-13.html&quot;                         
## [1774] &quot;zzz-99.html&quot;</code></pre>
<p>It looks like the sequence c2 a0 is causing a problem.</p>
<pre><code>## c:/web/p1-clean/11.html  [1] &quot;c:/web/p1/11.html&quot;
## [1] &quot;  &lt;li&gt;Rafael Campo. &lt;b&gt;“Anecdotal Evidence”: Why Narratives Matter to Medical &quot;
## [1] &quot;  &lt;li&gt;Rafael Campo. &lt;b&gt;\&quot;Anecdotal Evidence\&quot;: Why Narratives Matter to Medical &quot;
## [1] &quot;  University&lt;/b&gt;. &lt;i&gt;Excerpt: &amp;quot;“The Conflicted University” examines the &quot;
## [1] &quot;  University&lt;/b&gt;. &lt;i&gt;Excerpt: &amp;quot;\&quot;The Conflicted University\&quot; examines the &quot;
## [1] &quot;  nation’s experts in scientific conflicts of interest, teamed up with Academe &quot;
## [1] &quot;  nation&#39;s experts in scientific conflicts of interest, teamed up with Academe &quot;
## [1] &quot;  &lt;li&gt;Amélie Perron, Carol Fluet, Dave Holmes. &lt;b&gt;Agents of care and agents of &quot;
## [1] &quot;  &lt;li&gt;Amelie Perron, Carol Fluet, Dave Holmes. &lt;b&gt;Agents of care and agents of &quot;
## [1] &quot;  emerged. It wasn’t a secret weapon. It was a well-established treatment pill &quot;
## [1] &quot;  emerged. It wasn&#39;t a secret weapon. It was a well-established treatment pill &quot;
## [1] &quot;  regarding a treatment’s effect. Although randomization is not perfect in &quot;
## [1] &quot;  regarding a treatment&#39;s effect. Although randomization is not perfect in &quot;
## [1] &quot;  exercises designed to help reinforce the reader’s knowledge and a &quot;
## [1] &quot;  exercises designed to help reinforce the reader&#39;s knowledge and a &quot;
## [1] &quot;  New York Times. 2010. &lt;i&gt;Excerpt: &amp;quot;At Peter’s clinic, as elsewhere in Africa, &quot;
## [1] &quot;  New York Times. 2010. &lt;i&gt;Excerpt: &amp;quot;At Peter&#39;s clinic, as elsewhere in Africa, &quot;
## [1] &quot;  considered to have defaulted from treatment. As a “defaulter tracer,” Peter &quot;
## [1] &quot;  considered to have defaulted from treatment. As a \&quot;defaulter tracer,\&quot; Peter &quot;
## [1] &quot;  tries to track them down, find out what’s gone wrong and get them back into &quot;
## [1] &quot;  tries to track them down, find out what&#39;s gone wrong and get them back into &quot;
## [1] &quot;  treatment, if possible. Epidemiologists refer to such patients as “lost to &quot;
## [1] &quot;  treatment, if possible. Epidemiologists refer to such patients as \&quot;lost to &quot;
## [1] &quot;  follow-up,” and their increasing numbers in sub-Saharan Africa are causing &quot;
## [1] &quot;  follow-up,\&quot; and their increasing numbers in sub-Saharan Africa are causing &quot;
## [1] &quot;  and show that ‘the benefits of homeopathy are attributable to the &quot;
## [1] &quot;  and show that &#39;the benefits of homeopathy are attributable to the &quot;
## [1] &quot;  consultation’ [1]. Critics of homeopathy have always pointed out that &quot;
## [1] &quot;  consultation&#39; [1]. Critics of homeopathy have always pointed out that &quot;
## [1] &quot;  doctors—to a striking extent—still drawing upon misinformation in their &quot;
## [1] &quot;  doctors-to a striking extent-still drawing upon misinformation in their &quot;
## [1] &quot;  interests (sometimes called “private interests”) can be personal, political, &quot;
## [1] &quot;  interests (sometimes called \&quot;private interests\&quot;) can be personal, political, &quot;
## [1] &quot;  &lt;li&gt;Søren Højsgaard. &lt;b&gt;Miscellaneous material on R and StatWeave&lt;/b&gt;. &lt;i&gt;&quot;
## [1] &quot;  &lt;li&gt;Soren Hojsgaard. &lt;b&gt;Miscellaneous material on R and StatWeave&lt;/b&gt;. &lt;i&gt;&quot;
## [1] &quot;  &lt;li&gt;José Pinheiro, Douglas Bates. &lt;b&gt;Mixed-Effects Models in S and S-PLUS&lt;/b&gt;. &quot;
## [1] &quot;  &lt;li&gt;Jose Pinheiro, Douglas Bates. &lt;b&gt;Mixed-Effects Models in S and S-PLUS&lt;/b&gt;. &quot;
## [1] &quot;  “biased,” “hostile,” and “must feel threatened”) and its close relative, the &quot;
## [1] &quot;  \&quot;biased,\&quot; \&quot;hostile,\&quot; and \&quot;must feel threatened\&quot;) and its close relative, the &quot;
## [1] &quot;  so bad, “doesn&#39;t have all the answers,” etc.). They were also based on a &quot;
## [1] &quot;  so bad, \&quot;doesn&#39;t have all the answers,\&quot; etc.). They were also based on a &quot;
## [1] &quot;  &lt;li&gt;Dave Holmes, Amélie Perron, Gabrielle Michaud. &lt;b&gt;Nursing in corrections: &quot;
## [1] &quot;  &lt;li&gt;Dave Holmes, Amelie Perron, Gabrielle Michaud. &lt;b&gt;Nursing in corrections: &quot;
## [1] &quot;  &amp;quot;I’m not sure about the validity of this study: Free Access to U.S. Research &quot;
## [1] &quot;  &amp;quot;I&#39;m not sure about the validity of this study: Free Access to U.S. Research &quot;
## [1] &quot;  researcher, I’ve constantly fought the battle against firewalled journals. I &quot;
## [1] &quot;  researcher, I&#39;ve constantly fought the battle against firewalled journals. I &quot;
## [1] &quot;  researchers’ equivalent of the “blue screen of death”: the “login or purchase &quot;
## [1] &quot;  researchers&#39; equivalent of the \&quot;blue screen of death\&quot;: the \&quot;login or purchase &quot;
## [1] &quot;  Center’s charter would seem to make this inevitable. Ethics and the public &quot;
## [1] &quot;  Center&#39;s charter would seem to make this inevitable. Ethics and the public &quot;
## [1] &quot;  Foundation Fund 3929—Medical Reasoning.&amp;quot;&lt;/i&gt; [Accessed October 19, 2010]. &quot;
## [1] &quot;  Foundation Fund 3929-Medical Reasoning.&amp;quot;&lt;/i&gt; [Accessed October 19, 2010]. &quot;
## [1] &quot;  trials) are the “gold standard” for evaluation and that observational methods &quot;
## [1] &quot;  trials) are the \&quot;gold standard\&quot; for evaluation and that observational methods &quot;
## c:/web/p1-clean/2008-11.html  [1] &quot;c:/web/p1/2008-11.html&quot;
## [1] &quot;   attempting to learn biostatistics. Iï¿½ve been struggling with a &quot;
## [1] &quot;   attempting to learn biostatistics. Ii¿1/2ve been struggling with a &quot;
## [1] &quot;   analysis. Iï¿½m not sure if you are currently accepting questions of this &quot;
## [1] &quot;   analysis. Ii¿1/2m not sure if you are currently accepting questions of this &quot;
## c:/web/p1-clean/2008-12.html  [1] &quot;c:/web/p1/2008-12.html&quot;
## c:/web/p1-clean/2009-01.html  [1] &quot;c:/web/p1/2009-01.html&quot;
## [1] &quot;    Smith GD, and Harvey RF. ï¿½Inverse association between gastroesophageal &quot;
## [1] &quot;    Smith GD, and Harvey RF. i¿1/2Inverse association between gastroesophageal &quot;
## [1] &quot;    reflux and blood pressure: results of a large community based study..ï¿½ BMC &quot;
## [1] &quot;    reflux and blood pressure: results of a large community based study..i¿1/2 BMC &quot;
## c:/web/p1-clean/2009-02.html  [1] &quot;c:/web/p1/2009-02.html&quot;
## c:/web/p1-clean/2009-03.html  [1] &quot;c:/web/p1/2009-03.html&quot;
## c:/web/p1-clean/2009-04.html  [1] &quot;c:/web/p1/2009-04.html&quot;
## c:/web/p1-clean/2009-05.html  [1] &quot;c:/web/p1/2009-05.html&quot;
## [1] &quot;adjustments we donï¿½t want to shift by this extreme but rather by a smaller &quot;
## [1] &quot;adjustments we doni¿1/2t want to shift by this extreme but rather by a smaller &quot;
## c:/web/p1-clean/2009-06.html  [1] &quot;c:/web/p1/2009-06.html&quot;
## c:/web/p1-clean/2009-07.html  [1] &quot;c:/web/p1/2009-07.html&quot;
## c:/web/p1-clean/2009-08.html  [1] &quot;c:/web/p1/2009-08.html&quot;
## c:/web/p1-clean/2009-09.html  [1] &quot;c:/web/p1/2009-09.html&quot;
## [1] &quot;    5. &lt;a href=\&quot;#5\&quot;&gt;Monthly Mean Article (popular press): Donï¿½t Blame Flu Shots &quot;
## [1] &quot;    5. &lt;a href=\&quot;#5\&quot;&gt;Monthly Mean Article (popular press): Doni¿1/2t Blame Flu Shots &quot;
## [1] &quot;  &lt;p&gt;&lt;strong&gt;&lt;a name=\&quot;5\&quot;&gt;5&lt;/a&gt;. Monthly Mean Article (popular press): Donï¿½t Blame Flu Shots for &quot;
## [1] &quot;  &lt;p&gt;&lt;strong&gt;&lt;a name=\&quot;5\&quot;&gt;5&lt;/a&gt;. Monthly Mean Article (popular press): Doni¿1/2t Blame Flu Shots for &quot;
## [1] &quot;    &lt;p&gt;McNeil, Jr. DG. &lt;strong&gt;Donï¿½t Blame Flu Shots for All Ills, Officials Say&lt;/strong&gt;. &quot;
## [1] &quot;    &lt;p&gt;McNeil, Jr. DG. &lt;strong&gt;Doni¿1/2t Blame Flu Shots for All Ills, Officials Say&lt;/strong&gt;. &quot;
## c:/web/p1-clean/2009-10.html  [1] &quot;c:/web/p1/2009-10.html&quot;
## c:/web/p1-clean/2009-11.html  [1] &quot;c:/web/p1/2009-11.html&quot;
## [1] &quot;&lt;p&gt;You might think of this along the lines of the famous quote in ï¿½Animal Farmï¿½ &quot;
## [1] &quot;&lt;p&gt;You might think of this along the lines of the famous quote in i¿1/2Animal Farmi¿1/2 &quot;
## [1] &quot;others). A Type I school is ï¿½worthï¿½ more (about 28% more) than an average school &quot;
## [1] &quot;others). A Type I school is i¿1/2worthi¿1/2 more (about 28% more) than an average school &quot;
## [1] &quot;because thatï¿½s how much larger the salaries are (on average). A Type IIB school &quot;
## [1] &quot;because thati¿1/2s how much larger the salaries are (on average). A Type IIB school &quot;
## c:/web/p1-clean/200912.html  [1] &quot;c:/web/p1/200912.html&quot;
## [1] &quot;matching observations, though, the calculations are easyï¿½compare the average of &quot;
## [1] &quot;matching observations, though, the calculations are easyi¿1/2compare the average of &quot;
## c:/web/p1-clean/201001.html  [1] &quot;c:/web/p1/201001.html&quot;
## [1] &quot;  &lt;p&gt;It&#39;s easiest to understand these steps through an example. Letï¿½s construct &quot;
## [1] &quot;  &lt;p&gt;It&#39;s easiest to understand these steps through an example. Leti¿1/2s construct &quot;
## c:/web/p1-clean/201002.html  [1] &quot;c:/web/p1/201002.html&quot;
## c:/web/p1-clean/201003.html  [1] &quot;c:/web/p1/201003.html&quot;
## [1] &quot;  accessible to medical researchers. However, multiple imputationï¿½a relatively &quot;
## [1] &quot;  accessible to medical researchers. However, multiple imputationi¿1/2a relatively &quot;
## [1] &quot;  flexible, general purpose approach to dealing with missing dataï¿½is now &quot;
## [1] &quot;  flexible, general purpose approach to dealing with missing datai¿1/2is now &quot;
## [1] &quot;interact with and affect the experimental drugï¿½s effects, that same doctor as &quot;
## [1] &quot;interact with and affect the experimental drugi¿1/2s effects, that same doctor as &quot;
## [1] &quot;patient advocate might choose to ignore the list of ï¿½approvedï¿½ antinausea &quot;
## [1] &quot;patient advocate might choose to ignore the list of i¿1/2approvedi¿1/2 antinausea &quot;
## [1] &quot;improve a patientï¿½s care.&lt;/i&gt;&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;improve a patienti¿1/2s care.&lt;/i&gt;&amp;quot;&lt;/p&gt;&quot;
## c:/web/p1-clean/201004.html  [1] &quot;c:/web/p1/201004.html&quot;
## [1] &quot;itï¿½s not the evidence, stupid ï¿½ itï¿½s the narrative.&amp;quot;&lt;/i&gt; [Accessed April 20, &quot;
## [1] &quot;iti¿1/2s not the evidence, stupid i¿1/2 iti¿1/2s the narrative.&amp;quot;&lt;/i&gt; [Accessed April 20, &quot;
## c:/web/p1-clean/201005.html  [1] &quot;c:/web/p1/201005.html&quot;
## [1] &quot;users, keeps a running tally of how many times players ï¿½check inï¿½ at every &quot;
## [1] &quot;users, keeps a running tally of how many times players i¿1/2check ini¿1/2 at every &quot;
## [1] &quot;users publish these data widely. Nintendoï¿½s Wii Fit, a device that allows &quot;
## [1] &quot;users publish these data widely. Nintendoi¿1/2s Wii Fit, a device that allows &quot;
## c:/web/p1-clean/201006.html  [1] &quot;c:/web/p1/201006.html&quot;
## c:/web/p1-clean/201007.html  [1] &quot;c:/web/p1/201007.html&quot;
## [1] &quot;  expositor and philosopher who died May 22 at age 95. Fosheeï¿½s riddle is a &quot;
## [1] &quot;  expositor and philosopher who died May 22 at age 95. Fosheei¿1/2s riddle is a &quot;
## [1] &quot;donï¿½t even have to think about it. Sometimes, however, we do have to think about &quot;
## [1] &quot;doni¿1/2t even have to think about it. Sometimes, however, we do have to think about &quot;
## [1] &quot;give her your dollar and sheï¿½ll flip. Heads, you can have all three dollars. &quot;
## [1] &quot;give her your dollar and shei¿1/2ll flip. Heads, you can have all three dollars. &quot;
## [1] &quot;Tails, nothing. So thereï¿½s a 50 percent chance youï¿½ll triple your money. Yow. &quot;
## [1] &quot;Tails, nothing. So therei¿1/2s a 50 percent chance youi¿1/2ll triple your money. Yow. &quot;
## [1] &quot;Three dollars is pretty mad cash. But you could lose everything. Whatï¿½s the &quot;
## [1] &quot;Three dollars is pretty mad cash. But you could lose everything. Whati¿1/2s the &quot;
## c:/web/p1-clean/201008.html  [1] &quot;c:/web/p1/201008.html&quot;
## [1] &quot;Times. 2010. &lt;i&gt;Excerpt: &amp;quot;The program, called ï¿½continuous performance &quot;
## [1] &quot;Times. 2010. &lt;i&gt;Excerpt: &amp;quot;The program, called i¿1/2continuous performance &quot;
## [1] &quot;improvement,ï¿½ or C.P.I., examines every aspect of patientsï¿½ stays at the &quot;
## [1] &quot;improvement,i¿1/2 or C.P.I., examines every aspect of patientsi¿1/2 stays at the &quot;
## [1] &quot;Childrenï¿½s costs per patient by 3.7 percent, for a total savings of $23 million, &quot;
## [1] &quot;Childreni¿1/2s costs per patient by 3.7 percent, for a total savings of $23 million, &quot;
## [1] &quot;cultural subconscious even after theyï¿½ve been thoroughly discredited? And why, &quot;
## [1] &quot;cultural subconscious even after theyi¿1/2ve been thoroughly discredited? And why, &quot;
## [1] &quot;themselves into echo chambers that harbor diametrically different factsï¿½not &quot;
## [1] &quot;themselves into echo chambers that harbor diametrically different factsi¿1/2not &quot;
## [1] &quot;merely opinionsï¿½from those of the larger culture.&lt;/i&gt;&amp;quot;&quot;
## [1] &quot;merely opinionsi¿1/2from those of the larger culture.&lt;/i&gt;&amp;quot;&quot;
## [1] &quot;them, perhaps to create a ï¿½bestï¿½ model. One common method of dealing with this &quot;
## [1] &quot;them, perhaps to create a i¿1/2besti¿1/2 model. One common method of dealing with this &quot;
## c:/web/p1-clean/201009.html  [1] &quot;c:/web/p1/201009.html&quot;
## [1] &quot;  transformation for this type of data. You donï¿½t have to have a precedent, but &quot;
## [1] &quot;  transformation for this type of data. You doni¿1/2t have to have a precedent, but &quot;
## [1] &quot;  as the saying goes, &amp;quot;thereï¿½s safety in numbers.&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;  as the saying goes, &amp;quot;therei¿1/2s safety in numbers.&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;studies is misleading, exaggerated, or flat-out wrong. So why are doctorsï¿½to a &quot;
## [1] &quot;studies is misleading, exaggerated, or flat-out wrong. So why are doctorsi¿1/2to a &quot;
## [1] &quot;striking extentï¿½still drawing upon misinformation in their everyday practice? &quot;
## [1] &quot;striking extenti¿1/2still drawing upon misinformation in their everyday practice? &quot;
## [1] &quot;&lt;p&gt;Hereï¿½s a quote from the Greek physician Galen (c. 130-210 A.D.) &lt;i&gt;All who &quot;
## [1] &quot;&lt;p&gt;Herei¿1/2s a quote from the Greek physician Galen (c. 130-210 A.D.) &lt;i&gt;All who &quot;
## c:/web/p1-clean/201010.html  [1] &quot;c:/web/p1/201010.html&quot;
## c:/web/p1-clean/201010a.html  [1] &quot;c:/web/p1/201010a.html&quot;
## c:/web/p1-clean/201011.html  [1] &quot;c:/web/p1/201011.html&quot;
## c:/web/p1-clean/201012.html  [1] &quot;c:/web/p1/201012.html&quot;
## [1] &quot;emerged. It wasnï¿½t a secret weapon. It was a well-established treatment pill &quot;
## [1] &quot;emerged. It wasni¿1/2t a secret weapon. It was a well-established treatment pill &quot;
## c:/web/p1-clean/201101.html  [1] &quot;c:/web/p1/201101.html&quot;
## c:/web/p1-clean/201102.html  [1] &quot;c:/web/p1/201102.html&quot;
## [1] &quot;&lt;p&gt;&lt;b&gt;&lt;a name=\&quot;9\&quot;&gt;9&lt;/a&gt;. Monthly Mean Video: Hans RoslingÊ¼s 200 Countries, 200 Years, 4 Minutes - The Joy of Stats&lt;/b&gt;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;b&gt;&lt;a name=\&quot;9\&quot;&gt;9&lt;/a&gt;. Monthly Mean Video: Hans RoslingÊ1/4s 200 Countries, 200 Years, 4 Minutes - The Joy of Stats&lt;/b&gt;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;BBC Four. &lt;b&gt;Hans RoslingÊ¼s 200 Countries, 200 Years, 4 Minutes - The Joy of Stats.&lt;/b&gt; 2010. &lt;i&gt;Hans RoslingÊ¼s famous lectures combine enormous quantities of public data with a sport&#39;s commentator&#39;s style to reveal the story of the world&#39;s past, present and future development. Now he explores stats in a way he has never done before - using augmented reality animation. In this spectacular section of \&quot;The Joy of Stats\&quot; he tells the story of the world in 200 countries over 200 years using 120,000 numbers - in just four minutes. Plotting life expectancy against income for every country since 1810, Hans shows how the world we live in is radically different from the world most of us imagine.&lt;/i&gt; &lt;i&gt;More about this programme: &lt;a href=\&quot;http://www.bbc.co.uk/programmes/b00wgq0l\&quot;&gt;http://www.bbc.co.uk/programmes/b00wgq0l&lt;/a&gt;&lt;/i&gt; [Accessed December 2, 2010]. Available at: &lt;a href=\&quot;http://www.youtube.com/watch?v=jbkSRLYSojo\&quot;&gt;http://www.youtube.com/watch?v=jbkSRLYSojo&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;BBC Four. &lt;b&gt;Hans RoslingÊ1/4s 200 Countries, 200 Years, 4 Minutes - The Joy of Stats.&lt;/b&gt; 2010. &lt;i&gt;Hans RoslingÊ1/4s famous lectures combine enormous quantities of public data with a sport&#39;s commentator&#39;s style to reveal the story of the world&#39;s past, present and future development. Now he explores stats in a way he has never done before - using augmented reality animation. In this spectacular section of \&quot;The Joy of Stats\&quot; he tells the story of the world in 200 countries over 200 years using 120,000 numbers - in just four minutes. Plotting life expectancy against income for every country since 1810, Hans shows how the world we live in is radically different from the world most of us imagine.&lt;/i&gt; &lt;i&gt;More about this programme: &lt;a href=\&quot;http://www.bbc.co.uk/programmes/b00wgq0l\&quot;&gt;http://www.bbc.co.uk/programmes/b00wgq0l&lt;/a&gt;&lt;/i&gt; [Accessed December 2, 2010]. Available at: &lt;a href=\&quot;http://www.youtube.com/watch?v=jbkSRLYSojo\&quot;&gt;http://www.youtube.com/watch?v=jbkSRLYSojo&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/201103.html  [1] &quot;c:/web/p1/201103.html&quot;
## c:/web/p1-clean/201104.html  [1] &quot;c:/web/p1/201104.html&quot;
## c:/web/p1-clean/201105.html  [1] &quot;c:/web/p1/201105.html&quot;
## [1] &quot;  accomplishing&lt;/em&gt;. â\200”Researcher/physician John Ioannidis, quoted in an Atlantic &quot;
## [1] &quot;  accomplishing&lt;/em&gt;. â\200\&quot;Researcher/physician John Ioannidis, quoted in an Atlantic &quot;
## c:/web/p1-clean/201106.html  [1] &quot;c:/web/p1/201106.html&quot;
## c:/web/p1-clean/201107.html  [1] &quot;c:/web/p1/201107.html&quot;
## c:/web/p1-clean/201108.html  [1] &quot;c:/web/p1/201108.html&quot;
## c:/web/p1-clean/201109.html  [1] &quot;c:/web/p1/201109.html&quot;
## c:/web/p1-clean/201110.html  [1] &quot;c:/web/p1/201110.html&quot;
## c:/web/p1-clean/201111.html  [1] &quot;c:/web/p1/201111.html&quot;
## c:/web/p1-clean/201112.html  [1] &quot;c:/web/p1/201112.html&quot;
## [1] &quot;&lt;p&gt; One formula in algebra that most people can recall is the formula for a straight line. Actually, there are several different formulas, but the one that most people cite is     Y = m X + b where m represents the slope, and b represents the y-intercept (we&#39;ll call it just the intercept here). They can also sometimes remember the formula for the slope:     m = Î”y / Î”x. Note that the Greek symbol, delta (Î”), may not appear on your screen or your printout or it may look like a totally different letter or symbol.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt; One formula in algebra that most people can recall is the formula for a straight line. Actually, there are several different formulas, but the one that most people cite is     Y = m X + b where m represents the slope, and b represents the y-intercept (we&#39;ll call it just the intercept here). They can also sometimes remember the formula for the slope:     m = Î\&quot;y / Î\&quot;x. Note that the Greek symbol, delta (Î\&quot;), may not appear on your screen or your printout or it may look like a totally different letter or symbol.&lt;/p&gt;&quot;
## c:/web/p1-clean/201201.html  [1] &quot;c:/web/p1/201201.html&quot;
## c:/web/p1-clean/201202.html  [1] &quot;c:/web/p1/201202.html&quot;
## c:/web/p1-clean/201203.html  [1] &quot;c:/web/p1/201203.html&quot;
## [1] &quot;&lt;p&gt; &lt;strong&gt;Examples&lt;/strong&gt;: In a study of Parkinson&#39;s disease (Kaasinen 2001),Â a group of 61 unmedicated Parkinson&#39;s disease patients and 45 healthy controls were compared on 22 separate personality scales. The was prior data to suggest that novelty seeking would be lower in patients with Parkinson&#39;s, so this comparison was made without any Bonferroni adjustments. The remaining personality scores, however, had no such prior information and a Bonferroni adjustment was used for these remaining scales. An additional analysis looked PET scans for a subset of 47 Parkinson&#39;s patients. The 18F-dopa uptake in 10 regions of the brain were correlated with the 22 personality traits. The correlations involving novelty seeking were not adjusted, but the remaining correlations were adjusted to account for the fact that 210 (10x21) correlations were being analyzed. A significant correlation was observed between harm avoidance and 18F-dopa uptake in the right caudate nucleus (r=0.53, corrected P = 0.04). Interestingly, there was not a statistically significant correlation in the left caudate nucleus (r=0.43, corrected P=0.88) even though the uncorrected p-value was less than 0.01.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt; &lt;strong&gt;Examples&lt;/strong&gt;: In a study of Parkinson&#39;s disease (Kaasinen 2001),  a group of 61 unmedicated Parkinson&#39;s disease patients and 45 healthy controls were compared on 22 separate personality scales. The was prior data to suggest that novelty seeking would be lower in patients with Parkinson&#39;s, so this comparison was made without any Bonferroni adjustments. The remaining personality scores, however, had no such prior information and a Bonferroni adjustment was used for these remaining scales. An additional analysis looked PET scans for a subset of 47 Parkinson&#39;s patients. The 18F-dopa uptake in 10 regions of the brain were correlated with the 22 personality traits. The correlations involving novelty seeking were not adjusted, but the remaining correlations were adjusted to account for the fact that 210 (10x21) correlations were being analyzed. A significant correlation was observed between harm avoidance and 18F-dopa uptake in the right caudate nucleus (r=0.53, corrected P = 0.04). Interestingly, there was not a statistically significant correlation in the left caudate nucleus (r=0.43, corrected P=0.88) even though the uncorrected p-value was less than 0.01.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt; V Kaasinen, E Nurmi, J Bergman, O Eskola, O Solin, P Sonninen, J O Rinne. &lt;b&gt;Personality traits and brain dopaminergic function in Parkinson&#39;s disease&lt;/b&gt; Proc. Natl. Acad. Sci. U.S.A. 2001;98(23):13272â\200“13277.&lt;i&gt; &lt;/i&gt;[Accessed on March 3, 2012]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/11687621\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/11687621&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt; V Kaasinen, E Nurmi, J Bergman, O Eskola, O Solin, P Sonninen, J O Rinne. &lt;b&gt;Personality traits and brain dopaminergic function in Parkinson&#39;s disease&lt;/b&gt; Proc. Natl. Acad. Sci. U.S.A. 2001;98(23):13272â\200\&quot;13277.&lt;i&gt; &lt;/i&gt;[Accessed on March 3, 2012]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/11687621\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/11687621&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/201204.html  [1] &quot;c:/web/p1/201204.html&quot;
## c:/web/p1-clean/201205.html  [1] &quot;c:/web/p1/201205.html&quot;
## [1] &quot;&lt;p&gt;&lt;b&gt;&lt;strong&gt;--&amp;gt;&lt;/strong&gt;&lt;a name=\&quot;video\&quot;&gt;&amp;nbsp;&lt;/a&gt;Monthly Mean Video:&lt;/b&gt; TEDxSwarthmore - Steve Wang - 180 Degrees.  15 minutes, 7 seconds. Excerpt: &amp;quot;Sometimes you&#39;re wrong. Sometimes you think you&#39;re right, but it turns   out that you&#39;re wrong. Sometimes you&#39;re sure you&#39;re right because the   answer is obvious, and yet you&#39;re still wrong anywayâ\200”maybe even dead   wrong, 180 degrees wrong. This talk is about the last situation.&amp;quot; Description: Steve Wang is a statistician who illustrates the problem of selection bias and failure to account properly for missing data with three amusing examples. &lt;a href=\&quot;http://www.youtube.com/watch?v=lRHa82vMPhU\&quot;&gt;http://www.youtube.com/watch?v=lRHa82vMPhU&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;b&gt;&lt;strong&gt;--&amp;gt;&lt;/strong&gt;&lt;a name=\&quot;video\&quot;&gt;&amp;nbsp;&lt;/a&gt;Monthly Mean Video:&lt;/b&gt; TEDxSwarthmore - Steve Wang - 180 Degrees.  15 minutes, 7 seconds. Excerpt: &amp;quot;Sometimes you&#39;re wrong. Sometimes you think you&#39;re right, but it turns   out that you&#39;re wrong. Sometimes you&#39;re sure you&#39;re right because the   answer is obvious, and yet you&#39;re still wrong anywayâ\200\&quot;maybe even dead   wrong, 180 degrees wrong. This talk is about the last situation.&amp;quot; Description: Steve Wang is a statistician who illustrates the problem of selection bias and failure to account properly for missing data with three amusing examples. &lt;a href=\&quot;http://www.youtube.com/watch?v=lRHa82vMPhU\&quot;&gt;http://www.youtube.com/watch?v=lRHa82vMPhU&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/201206.html  [1] &quot;c:/web/p1/201206.html&quot;
## c:/web/p1-clean/201207.html  [1] &quot;c:/web/p1/201207.html&quot;
## [1] &quot;  --&amp;gt; L Leibovici. &lt;b&gt;Effects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infection: randomised controlled trial&lt;/b&gt;. BMJ 2001;323(7327):1450â\200“1451. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/11751349\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/11751349&lt;/a&gt;. &lt;/p&gt;&quot;
## [1] &quot;  --&amp;gt; L Leibovici. &lt;b&gt;Effects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infection: randomised controlled trial&lt;/b&gt;. BMJ 2001;323(7327):1450â\200\&quot;1451. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/11751349\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/11751349&lt;/a&gt;. &lt;/p&gt;&quot;
## [1] &quot;  --&amp;gt; Brian Olshansky, Larry Dossey. &lt;b&gt;Retroactive prayer: a preposterous hypothesis?&lt;/b&gt; BMJ. 2003;327(7429):1465â\200“1468. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/14684651\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/14684651&lt;/a&gt;. &lt;/p&gt;&quot;
## [1] &quot;  --&amp;gt; Brian Olshansky, Larry Dossey. &lt;b&gt;Retroactive prayer: a preposterous hypothesis?&lt;/b&gt; BMJ. 2003;327(7429):1465â\200\&quot;1468. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/14684651\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/14684651&lt;/a&gt;. &lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;b&gt;&lt;strong&gt;--&amp;gt;&lt;/strong&gt;&lt;a name=\&quot;journal\&quot;&gt;&amp;nbsp;&lt;/a&gt;Monthly Mean Article (peer reviewed):&lt;/b&gt; Benjamin Kasenda, Erik B von Elm, John You, Anette BlÃ¼mle, Yuki Tomonaga, Ramon Saccilotto, Alain Amstutz, Theresa Bengough, Joerg Meerpohl, Mihaela Stegert, Kari AO Tikkinen, Ignacio Neumann, Alonso Carrasco-Labra, Markus Faulhaber, Sohail Mulla, Dominik Mertz, Elie A Akl, Dirk Bassler, Jason Busse, Ignacio Ferreira-GonzÃ¡lez, Francois Lamontagne, Alain Nordmann, Rachel Rosenthal, Stefan Schandelmaier, Xin Sun, Per O Vandvik, Bradley C Johnston, Martin A Walter, Bernard Burnand, Matthias Schwenkglenks, Heiner C Bucher, Gordon H Guyatt and Matthias Briel. &lt;strong&gt;Learning from Failure - Rationale and Design for a Study about Discontinuation of Randomized Trials (DISCO study)&lt;/strong&gt;. BMC Medical Research Methodology 2012, 12:131 doi:10.1186/1471-2288-12-131. &lt;em&gt;Abstract (provisional): Background: Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility. Other RCTs are discontinued early because of insufficient recruitment. Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committees (RECs) spend considerable effort reviewing study protocols, and limited resources for conducting research are wasted. Currently, little is known regarding the frequency and characteristics of discontinued RCTs. Methods: Our aims are, first, to determine the prevalence of RCT discontinuation for any reason; second, to determine whether the risk of RCT discontinuation for specific reasons differs between investigator- and industry-initiated RCTs; third, to identify risk factors for RCT discontinuation due to insufficient recruitment; fourth, to determine at what stage RCTs are discontinued; and fifth, to examine the publication history of discontinued RCTs. We are currently assembling a multicenter cohort of RCTs based on protocols approved between 2000 and 2002/3 by 6 RECs in Switzerland, Germany, and Canada. We are extracting data on RCT characteristics and planned recruitment for all included protocols. Completion and publication status is determined using information from correspondence between investigators and RECs, publications identified through literature searches, or by contacting the investigators. We will use multivariable regression models to identify risk factors for trial discontinuation due to insufficient recruitment. We aim to include over 1000 RCTs of which an anticipated 150 will have been discontinued due to insufficient recruitment. Discussion: Our study will provide insights into the prevalence and characteristics of RCTs that were discontinued. Effective recruitment strategies and the anticipation of problems are key issues in the planning and evaluation of trials by investigators, Clinical Trial Units, RECs and funding agencies. Identification and modification of barriers to successful study completion at an early stage could help to reduce the risk of trial discontinuation, save limited resources, and enable RCTs to better meet their ethical requirements.&lt;/em&gt; Available at &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/12/131/abstract\&quot;&gt;http://www.biomedcentral.com/1471-2288/12/131/abstract&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;b&gt;&lt;strong&gt;--&amp;gt;&lt;/strong&gt;&lt;a name=\&quot;journal\&quot;&gt;&amp;nbsp;&lt;/a&gt;Monthly Mean Article (peer reviewed):&lt;/b&gt; Benjamin Kasenda, Erik B von Elm, John You, Anette BlÃ1/4mle, Yuki Tomonaga, Ramon Saccilotto, Alain Amstutz, Theresa Bengough, Joerg Meerpohl, Mihaela Stegert, Kari AO Tikkinen, Ignacio Neumann, Alonso Carrasco-Labra, Markus Faulhaber, Sohail Mulla, Dominik Mertz, Elie A Akl, Dirk Bassler, Jason Busse, Ignacio Ferreira-GonzÃ¡lez, Francois Lamontagne, Alain Nordmann, Rachel Rosenthal, Stefan Schandelmaier, Xin Sun, Per O Vandvik, Bradley C Johnston, Martin A Walter, Bernard Burnand, Matthias Schwenkglenks, Heiner C Bucher, Gordon H Guyatt and Matthias Briel. &lt;strong&gt;Learning from Failure - Rationale and Design for a Study about Discontinuation of Randomized Trials (DISCO study)&lt;/strong&gt;. BMC Medical Research Methodology 2012, 12:131 doi:10.1186/1471-2288-12-131. &lt;em&gt;Abstract (provisional): Background: Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility. Other RCTs are discontinued early because of insufficient recruitment. Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committees (RECs) spend considerable effort reviewing study protocols, and limited resources for conducting research are wasted. Currently, little is known regarding the frequency and characteristics of discontinued RCTs. Methods: Our aims are, first, to determine the prevalence of RCT discontinuation for any reason; second, to determine whether the risk of RCT discontinuation for specific reasons differs between investigator- and industry-initiated RCTs; third, to identify risk factors for RCT discontinuation due to insufficient recruitment; fourth, to determine at what stage RCTs are discontinued; and fifth, to examine the publication history of discontinued RCTs. We are currently assembling a multicenter cohort of RCTs based on protocols approved between 2000 and 2002/3 by 6 RECs in Switzerland, Germany, and Canada. We are extracting data on RCT characteristics and planned recruitment for all included protocols. Completion and publication status is determined using information from correspondence between investigators and RECs, publications identified through literature searches, or by contacting the investigators. We will use multivariable regression models to identify risk factors for trial discontinuation due to insufficient recruitment. We aim to include over 1000 RCTs of which an anticipated 150 will have been discontinued due to insufficient recruitment. Discussion: Our study will provide insights into the prevalence and characteristics of RCTs that were discontinued. Effective recruitment strategies and the anticipation of problems are key issues in the planning and evaluation of trials by investigators, Clinical Trial Units, RECs and funding agencies. Identification and modification of barriers to successful study completion at an early stage could help to reduce the risk of trial discontinuation, save limited resources, and enable RCTs to better meet their ethical requirements.&lt;/em&gt; Available at &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/12/131/abstract\&quot;&gt;http://www.biomedcentral.com/1471-2288/12/131/abstract&lt;/a&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/201208.html  [1] &quot;c:/web/p1/201208.html&quot;
## c:/web/p1-clean/201209.html  [1] &quot;c:/web/p1/201209.html&quot;
## c:/web/p1-clean/201210.html  [1] &quot;c:/web/p1/201210.html&quot;
## c:/web/p1-clean/201211.html  [1] &quot;c:/web/p1/201211.html&quot;
## [1] &quot;&lt;p&gt;David McArthur provided a spirited defense of data as plural, and I can&#39;t paraphrase his comments and still do them justice. He said &amp;quot;&lt;em&gt;Your \&quot;data is\&quot; article prompts me to retort with \&quot;darn  tootin them&#39;s plural\&quot; for the following specific reasons:Â  1) While a  dataset or dataframe or matrix or list is a container of information  (and it is indeed correct to think of a given dataset in the singular),  to consider the contents inside that container in any statistical sense  demands that we think seriously about the shape of the data inside, and  \&quot;shape\&quot; comes explicitly from considering plural pieces of  information.Â  Some students seem to conceive \&quot;data\&quot; in a stubborn,  singular, monolithic sense that indeed makes it harder for them to  drill into the utility of 5-point or 12-point or 16-point descriptive  summaries, but when faced with the notion that the dataset can be  parsed in multiple ways exactly because data are multiple in form,  things start to brighten up.Â  2) Any robust approach to statistical  analysis is premised on the reality that data elements even within the  same single variable have varying contributions to the overall story  (see issues like leverage or downweighting) and that mentally  singularizing those elements -- as if they all mean the same -- does a  major injustice to the whole.Â  And 3) the famous rubber ruler approach  to designing instruments and making measurements reinforces the  underlying notion that data must be plural to make sense (that is, you  are free to use my magic rubber ruler to your heart&#39;s delight to make  everyone in the room the identical height, though you&#39;ll surely end up  with singular data with no real meaning).Â  \&quot;Data\&quot; are plural.&lt;/em&gt;&amp;quot; He also followed up with the well known quote about anecdotes and data &amp;quot;&lt;em&gt;The plural of  anecdote is not data.&lt;/em&gt;&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;David McArthur provided a spirited defense of data as plural, and I can&#39;t paraphrase his comments and still do them justice. He said &amp;quot;&lt;em&gt;Your \&quot;data is\&quot; article prompts me to retort with \&quot;darn  tootin them&#39;s plural\&quot; for the following specific reasons:   1) While a  dataset or dataframe or matrix or list is a container of information  (and it is indeed correct to think of a given dataset in the singular),  to consider the contents inside that container in any statistical sense  demands that we think seriously about the shape of the data inside, and  \&quot;shape\&quot; comes explicitly from considering plural pieces of  information.   Some students seem to conceive \&quot;data\&quot; in a stubborn,  singular, monolithic sense that indeed makes it harder for them to  drill into the utility of 5-point or 12-point or 16-point descriptive  summaries, but when faced with the notion that the dataset can be  parsed in multiple ways exactly because data are multiple in form,  things start to brighten up.   2) Any robust approach to statistical  analysis is premised on the reality that data elements even within the  same single variable have varying contributions to the overall story  (see issues like leverage or downweighting) and that mentally  singularizing those elements -- as if they all mean the same -- does a  major injustice to the whole.   And 3) the famous rubber ruler approach  to designing instruments and making measurements reinforces the  underlying notion that data must be plural to make sense (that is, you  are free to use my magic rubber ruler to your heart&#39;s delight to make  everyone in the room the identical height, though you&#39;ll surely end up  with singular data with no real meaning).   \&quot;Data\&quot; are plural.&lt;/em&gt;&amp;quot; He also followed up with the well known quote about anecdotes and data &amp;quot;&lt;em&gt;The plural of  anecdote is not data.&lt;/em&gt;&amp;quot;&lt;/p&gt;&quot;
## c:/web/p1-clean/201212.html  [1] &quot;c:/web/p1/201212.html&quot;
## c:/web/p1-clean/201301.html  [1] &quot;c:/web/p1/201301.html&quot;
## [1] &quot;  &lt;a href=\&quot;#trivia\&quot;&gt;--&gt;Â Monthly Mean Trivia Question: What Beatles song...&lt;br&gt;&quot;
## [1] &quot;  &lt;a href=\&quot;#trivia\&quot;&gt;--&gt;  Monthly Mean Trivia Question: What Beatles song...&lt;br&gt;&quot;
## c:/web/p1-clean/201302.html  [1] &quot;c:/web/p1/201302.html&quot;
## [1] &quot;  &lt;a href=\&quot;#trivia\&quot;&gt;--&gt;Â Monthly Mean Trivia Question: Most movie sequels include ...&lt;/a&gt;&lt;br&gt;&quot;
## [1] &quot;  &lt;a href=\&quot;#trivia\&quot;&gt;--&gt;  Monthly Mean Trivia Question: Most movie sequels include ...&lt;/a&gt;&lt;br&gt;&quot;
## [1] &quot;&lt;p&gt;--&amp;gt;&lt;a name=\&quot;book\&quot;&gt;&lt;/a&gt; &lt;strong&gt;Monthly Mean Book&lt;/strong&gt;. Stef van Buuren. &lt;strong&gt;Flexible Imputation of Missing Data&lt;/strong&gt;. Chapman &amp;amp; Hall. ISBN-13: 978-1439868249. Here&#39;s the blurb from the back cover. &amp;quot;Missing data form a problem in every scientific discipline, yet the techniques required to handle them are complicated and often lacking. One of the great ideas in statistical scienceâ\200”multiple imputationâ\200”fills gaps in the data with plausible values, the uncertainty of which is coded in the data itself. It also solves other problems, many of which are missing data problems in disguise. Flexible Imputation of Missing Data is supported by many examples using real data taken from the author&#39;s vast experience of collaborative research, and presents a practical guide for handling missing data under the framework of multiple imputation. Furthermore, detailed guidance of implementation in R using the author&#39;s package MICE is included throughout the book. Assuming familiarity with basic statistical concepts and multivariate methods, Flexible Imputation of Missing Data is intended for two audiences:     (Bio)statisticians, epidemiologists, and methodologists in the social and health sciences, and    substantive researchers who do not call themselves statisticians, but who possess the necessary skills to understand the principles and to follow the recipes. This graduate-tested book avoids mathematical and technical details as much as possible: formulas are accompanied by a verbal statement that explains the formula in layperson terms. Readers less concerned with the theoretical underpinnings will be able to pick up the general idea, and technical material is available for those who desire deeper understanding. The analyses can be replicated in R using a dedicated package developed by the author.&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;--&amp;gt;&lt;a name=\&quot;book\&quot;&gt;&lt;/a&gt; &lt;strong&gt;Monthly Mean Book&lt;/strong&gt;. Stef van Buuren. &lt;strong&gt;Flexible Imputation of Missing Data&lt;/strong&gt;. Chapman &amp;amp; Hall. ISBN-13: 978-1439868249. Here&#39;s the blurb from the back cover. &amp;quot;Missing data form a problem in every scientific discipline, yet the techniques required to handle them are complicated and often lacking. One of the great ideas in statistical scienceâ\200\&quot;multiple imputationâ\200\&quot;fills gaps in the data with plausible values, the uncertainty of which is coded in the data itself. It also solves other problems, many of which are missing data problems in disguise. Flexible Imputation of Missing Data is supported by many examples using real data taken from the author&#39;s vast experience of collaborative research, and presents a practical guide for handling missing data under the framework of multiple imputation. Furthermore, detailed guidance of implementation in R using the author&#39;s package MICE is included throughout the book. Assuming familiarity with basic statistical concepts and multivariate methods, Flexible Imputation of Missing Data is intended for two audiences:     (Bio)statisticians, epidemiologists, and methodologists in the social and health sciences, and    substantive researchers who do not call themselves statisticians, but who possess the necessary skills to understand the principles and to follow the recipes. This graduate-tested book avoids mathematical and technical details as much as possible: formulas are accompanied by a verbal statement that explains the formula in layperson terms. Readers less concerned with the theoretical underpinnings will be able to pick up the general idea, and technical material is available for those who desire deeper understanding. The analyses can be replicated in R using a dedicated package developed by the author.&amp;quot;&lt;/p&gt;&quot;
## c:/web/p1-clean/201303.html  [1] &quot;c:/web/p1/201303.html&quot;
## c:/web/p1-clean/201304.html  [1] &quot;c:/web/p1/201304.html&quot;
## c:/web/p1-clean/201305.html  [1] &quot;c:/web/p1/201305.html&quot;
## [1] &quot;&lt;p&gt;&lt;a href=\&quot;#book\&quot;&gt;--&gt; Book: The Signal and the Noise: Why So Many Predictions Fail â\200” but Some Don&#39;t.&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;a href=\&quot;#book\&quot;&gt;--&gt; Book: The Signal and the Noise: Why So Many Predictions Fail â\200\&quot; but Some Don&#39;t.&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;strong&gt;--&amp;gt; Book:&lt;/strong&gt;&lt;a name=\&quot;book\&quot;&gt;&lt;/a&gt; Nate Silver. &lt;strong&gt;The Signal and the Noise: Why So Many Predictions Fail â\200” but Some Don&#39;t.&lt;/strong&gt; From the back cover: &lt;em&gt;Nate Silver built an innovative system for predicting baseball performance, predicted the 2008 election within a hair&#39;s breadth, and became a national sensation as a bloggerâ\200”all by the time he was thirty. The New York Times now publishes FiveThirtyEight.com, where Silver is one of the nation&#39;s most influential political forecasters. Drawing on his own groundbreaking work, Silver examines the world of prediction, investigating how we can distinguish a true signal from a universe of noisy data. Most predictions fail, often at great cost to society, because most of us have a poor understanding of probability and uncertainty. Both experts and laypeople mistake more confident predictions for more accurate ones. But overconfidence is often the reason for failure. If our appreciation of uncertainty improves, our predictions can get better too. This is the &amp;quot;prediction paradox&amp;quot;: The more humility we have about our ability to make predictions, the more successful we can be in planning for the future. In keeping with his own aim to seek truth from data, Silver visits the most successful forecasters in a range of areas, from hurricanes to baseball, from the poker table to the stock market, from Capitol Hill to the NBA. He explains and evaluates how these forecasters think and what bonds they share. What lies behind their success? Are they goodâ\200”or just lucky? What patterns have they unraveled? And are their forecasts really right? He explores unanticipated commonalities and exposes unexpected juxtapositions. And sometimes, it is not so much how good a prediction is in an absolute sense that matters but how good it is relative to the competition. In other cases, prediction is still a very rudimentaryâ\200”and dangerousâ\200”science. Silver observes that the most accurate forecasters tend to have a superior command of probability, and they tend to be both humble and hardworking. They distinguish the predictable from the unpredictable, and they notice a thousand little details that lead them closer to the truth. Because of their appreciation of probability, they can distinguish the signal from the noise. With everything from the health of the global economy to our ability to fight terrorism dependent on the quality of our predictions, Nate Silver&#39;s insights are an essential read.&lt;/em&gt;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;&lt;strong&gt;--&amp;gt; Book:&lt;/strong&gt;&lt;a name=\&quot;book\&quot;&gt;&lt;/a&gt; Nate Silver. &lt;strong&gt;The Signal and the Noise: Why So Many Predictions Fail â\200\&quot; but Some Don&#39;t.&lt;/strong&gt; From the back cover: &lt;em&gt;Nate Silver built an innovative system for predicting baseball performance, predicted the 2008 election within a hair&#39;s breadth, and became a national sensation as a bloggerâ\200\&quot;all by the time he was thirty. The New York Times now publishes FiveThirtyEight.com, where Silver is one of the nation&#39;s most influential political forecasters. Drawing on his own groundbreaking work, Silver examines the world of prediction, investigating how we can distinguish a true signal from a universe of noisy data. Most predictions fail, often at great cost to society, because most of us have a poor understanding of probability and uncertainty. Both experts and laypeople mistake more confident predictions for more accurate ones. But overconfidence is often the reason for failure. If our appreciation of uncertainty improves, our predictions can get better too. This is the &amp;quot;prediction paradox&amp;quot;: The more humility we have about our ability to make predictions, the more successful we can be in planning for the future. In keeping with his own aim to seek truth from data, Silver visits the most successful forecasters in a range of areas, from hurricanes to baseball, from the poker table to the stock market, from Capitol Hill to the NBA. He explains and evaluates how these forecasters think and what bonds they share. What lies behind their success? Are they goodâ\200\&quot;or just lucky? What patterns have they unraveled? And are their forecasts really right? He explores unanticipated commonalities and exposes unexpected juxtapositions. And sometimes, it is not so much how good a prediction is in an absolute sense that matters but how good it is relative to the competition. In other cases, prediction is still a very rudimentaryâ\200\&quot;and dangerousâ\200\&quot;science. Silver observes that the most accurate forecasters tend to have a superior command of probability, and they tend to be both humble and hardworking. They distinguish the predictable from the unpredictable, and they notice a thousand little details that lead them closer to the truth. Because of their appreciation of probability, they can distinguish the signal from the noise. With everything from the health of the global economy to our ability to fight terrorism dependent on the quality of our predictions, Nate Silver&#39;s insights are an essential read.&lt;/em&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/201306.html  [1] &quot;c:/web/p1/201306.html&quot;
## c:/web/p1-clean/201307.html  [1] &quot;c:/web/p1/201307.html&quot;
## c:/web/p1-clean/201308.html  [1] &quot;c:/web/p1/201308.html&quot;
## c:/web/p1-clean/201309.html  [1] &quot;c:/web/p1/201309.html&quot;
## c:/web/p1-clean/201310.html  [1] &quot;c:/web/p1/201310.html&quot;
## c:/web/p1-clean/201311.html  [1] &quot;c:/web/p1/201311.html&quot;
## c:/web/p1-clean/201312.html  [1] &quot;c:/web/p1/201312.html&quot;
## c:/web/p1-clean/aa.html  [1] &quot;c:/web/p1/aa.html&quot;
## c:/web/p1-clean/AbandonFrontPage.html  [1] &quot;c:/web/p1/AbandonFrontPage.html&quot;
## c:/web/p1-clean/AbsoluteRisk.html  [1] &quot;c:/web/p1/AbsoluteRisk.html&quot;
## c:/web/p1-clean/AbstainerErrors.html  [1] &quot;c:/web/p1/AbstainerErrors.html&quot;
## c:/web/p1-clean/abstracts.html  [1] &quot;c:/web/p1/abstracts.html&quot;
## [1] &quot;  &lt;p&gt;&lt;strong&gt;This abstract appears on slide #16. &lt;/strong&gt;Journal article: Bengt Winblad, Jeffrey Cummings, Niels Andreasen, George Grossberg, Marco Onofrj, Carl Sadowsky, Stefanie Zechner, Jennifer Nagel, Roger Lane. &lt;b&gt;A sixâ\200\220month doubleâ\200\220blind, randomized, placeboâ\200\220controlled study of a transdermal patch in Alzheimer&#39;s diseaseâ\200“â\200“ rivastigmine patch versus capsule&lt;/b&gt; International Journal of Geriatric Psychiatry. 2007;22(5):456-467. &lt;i&gt;Abstract: \&quot;Objectives: To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in patients with Alzheimer&#39;s disease (AD). Methods: In this 24-week, multicenter, double-blind, double-dummy, placebo- and active-controlled trial, patients with probable AD were randomized to one of four treatment groups: 12 mg/day rivastigmine capsules; 10 cm2 (9.5 mg/24 h) rivastigmine patch; 20 cm2 (17.4 mg/24 h) rivastigmine patch; or placebo. Primary efficacy measures were the Alzheimer&#39;s Disease Assessment Scaleâ\200”Cognitive subscale (ADAS-Cog) and Alzheimer&#39;s Disease Cooperative Studyâ\200“â\200“Clinical Global Impression of Change (ADCS-CGIC). Results: One thousand one hundred and ninety five AD patients from 21 countries participated in the study. Treatment differences (vs placebo) on the ADAS-Cog at Week 24 in 10 cm2 patch, 20 cm2 patch and capsule groups were 1.6 (p = 0.005), 2.6 (p &amp;lt; 0.001) and 1.6 (p = 0.003). Treatment differences on the ADCS-CGIC were 0.3 (p = 0.01), 0.2 (p = 0.054) and 0.3 (p = 0.009). Comparison between the 10 cm2 patch and the capsule revealed non-inferiority. Rates of nausea in the 10 cm2 patch and capsule groups were 7.2% and 23.1%, respectively; rates of vomiting were 6.2% and 17.0%, respectively. Moderate or severe skin irritation occurred in &amp;lt;= 10% patients across the four patch sizes (5, 10, 15 and 20 cm2). Conclusions: The target dose of 10 cm2 rivastigmine patch provides efficacy similar to the highest doses of capsules with a superior tolerability profile. The transdermal patch with rivastigmine may offer convenience important to many caregivers and patients. Keywords: Alzheimer&#39;s disease; patch;   rivastigmine; transdermal\&quot;&lt;/i&gt; [Accessed on December 8, 2011]. &lt;a href=\&quot;http://onlinelibrary.wiley.com/doi/10.1002/gps.1788/abstract\&quot;&gt;http://onlinelibrary.wiley.com/doi/10.1002/gps.1788/abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;strong&gt;This abstract appears on slide #16. &lt;/strong&gt;Journal article: Bengt Winblad, Jeffrey Cummings, Niels Andreasen, George Grossberg, Marco Onofrj, Carl Sadowsky, Stefanie Zechner, Jennifer Nagel, Roger Lane. &lt;b&gt;A sixâ\200\220month doubleâ\200\220blind, randomized, placeboâ\200\220controlled study of a transdermal patch in Alzheimer&#39;s diseaseâ\200\&quot;â\200\&quot; rivastigmine patch versus capsule&lt;/b&gt; International Journal of Geriatric Psychiatry. 2007;22(5):456-467. &lt;i&gt;Abstract: \&quot;Objectives: To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in patients with Alzheimer&#39;s disease (AD). Methods: In this 24-week, multicenter, double-blind, double-dummy, placebo- and active-controlled trial, patients with probable AD were randomized to one of four treatment groups: 12 mg/day rivastigmine capsules; 10 cm2 (9.5 mg/24 h) rivastigmine patch; 20 cm2 (17.4 mg/24 h) rivastigmine patch; or placebo. Primary efficacy measures were the Alzheimer&#39;s Disease Assessment Scaleâ\200\&quot;Cognitive subscale (ADAS-Cog) and Alzheimer&#39;s Disease Cooperative Studyâ\200\&quot;â\200\&quot;Clinical Global Impression of Change (ADCS-CGIC). Results: One thousand one hundred and ninety five AD patients from 21 countries participated in the study. Treatment differences (vs placebo) on the ADAS-Cog at Week 24 in 10 cm2 patch, 20 cm2 patch and capsule groups were 1.6 (p = 0.005), 2.6 (p &amp;lt; 0.001) and 1.6 (p = 0.003). Treatment differences on the ADCS-CGIC were 0.3 (p = 0.01), 0.2 (p = 0.054) and 0.3 (p = 0.009). Comparison between the 10 cm2 patch and the capsule revealed non-inferiority. Rates of nausea in the 10 cm2 patch and capsule groups were 7.2% and 23.1%, respectively; rates of vomiting were 6.2% and 17.0%, respectively. Moderate or severe skin irritation occurred in &amp;lt;= 10% patients across the four patch sizes (5, 10, 15 and 20 cm2). Conclusions: The target dose of 10 cm2 rivastigmine patch provides efficacy similar to the highest doses of capsules with a superior tolerability profile. The transdermal patch with rivastigmine may offer convenience important to many caregivers and patients. Keywords: Alzheimer&#39;s disease; patch;   rivastigmine; transdermal\&quot;&lt;/i&gt; [Accessed on December 8, 2011]. &lt;a href=\&quot;http://onlinelibrary.wiley.com/doi/10.1002/gps.1788/abstract\&quot;&gt;http://onlinelibrary.wiley.com/doi/10.1002/gps.1788/abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Susanne Ostrowitzki, Dennis Deptula, Lennart Thurfjell, Frederik Barkhof, Bernd Bohrmann, David J Brooks, William E Klunk, Elizabeth Ashford, Kisook Yoo, et al. &lt;b&gt;Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab&lt;/b&gt; Archives of Neurology. 2011. &lt;i&gt;Abstract: \&quot;BACKGROUND: Gantenerumab is a fully human anti-AÎ² monoclonal antibody in clinical development for the treatment of Alzheimer disease (AD).  OBJECTIVES: To investigate whether treatment with gantenerumab leads to a measurable reduction in the level of AÎ² amyloid in the brain and to elucidate the mechanism of amyloid reduction.  DESIGN: A multicenter, randomized, double-blind, placebo-controlled, ascending-dose positron emission tomographic study. Additionally, ex vivo studies of human brain slices from an independent sample of patients who had AD were performed.  SETTING: Three university medical centers. PatientsÂ  Patients with mild-to-moderate AD. InterventionÂ  Two consecutive cohorts of patients received 2 to 7 infusions of intravenous gantenerumab (60 or 200 mg) or placebo every 4 weeks. Brain slices from patients who had AD were coincubated with gantenerumab at increasing concentrations and with human microglial cells.  MAIN OUTCOME MEASURES: Percent change in the ratio of regional carbon 11-labeled Pittsburgh Compound B retention in vivo and semiquantitative assessment of gantenerumab-induced phagocytosis ex vivo.  RESULTS: Sixteen patients with end-of-treatment positron emission tomographic scans were included in the analysis. The mean (95% CI) percent change from baseline difference relative to placebo (nÂ =Â 4) in cortical brain amyloid level was -15.6% (95% CI, -42.7 to 11.6) for the 60-mg group (nÂ =Â 6) and -35.7% (95% CI, -63.5 to -7.9) for the 200-mg group (nÂ =Â 6). Two patients in the 200-mg group showed transient and focal areas of inflammation or vasogenic edema on magnetic resonance imaging scans at sites with the highest level of amyloid reduction. Gantenerumab induced phagocytosis of human amyloid in a dose-dependent manner ex vivo.  CONCLUSION: Gantenerumab treatment resulted in a dose-dependent reduction in brain amyloid level, possibly through an effector cell-mediated mechanism of action.\&quot;&lt;/i&gt; [Accessed on December 8, 2011]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/21987394\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/21987394&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Susanne Ostrowitzki, Dennis Deptula, Lennart Thurfjell, Frederik Barkhof, Bernd Bohrmann, David J Brooks, William E Klunk, Elizabeth Ashford, Kisook Yoo, et al. &lt;b&gt;Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab&lt;/b&gt; Archives of Neurology. 2011. &lt;i&gt;Abstract: \&quot;BACKGROUND: Gantenerumab is a fully human anti-AÎ² monoclonal antibody in clinical development for the treatment of Alzheimer disease (AD).  OBJECTIVES: To investigate whether treatment with gantenerumab leads to a measurable reduction in the level of AÎ² amyloid in the brain and to elucidate the mechanism of amyloid reduction.  DESIGN: A multicenter, randomized, double-blind, placebo-controlled, ascending-dose positron emission tomographic study. Additionally, ex vivo studies of human brain slices from an independent sample of patients who had AD were performed.  SETTING: Three university medical centers. Patients   Patients with mild-to-moderate AD. Intervention   Two consecutive cohorts of patients received 2 to 7 infusions of intravenous gantenerumab (60 or 200 mg) or placebo every 4 weeks. Brain slices from patients who had AD were coincubated with gantenerumab at increasing concentrations and with human microglial cells.  MAIN OUTCOME MEASURES: Percent change in the ratio of regional carbon 11-labeled Pittsburgh Compound B retention in vivo and semiquantitative assessment of gantenerumab-induced phagocytosis ex vivo.  RESULTS: Sixteen patients with end-of-treatment positron emission tomographic scans were included in the analysis. The mean (95% CI) percent change from baseline difference relative to placebo (n  =  4) in cortical brain amyloid level was -15.6% (95% CI, -42.7 to 11.6) for the 60-mg group (n  =  6) and -35.7% (95% CI, -63.5 to -7.9) for the 200-mg group (n  =  6). Two patients in the 200-mg group showed transient and focal areas of inflammation or vasogenic edema on magnetic resonance imaging scans at sites with the highest level of amyloid reduction. Gantenerumab induced phagocytosis of human amyloid in a dose-dependent manner ex vivo.  CONCLUSION: Gantenerumab treatment resulted in a dose-dependent reduction in brain amyloid level, possibly through an effector cell-mediated mechanism of action.\&quot;&lt;/i&gt; [Accessed on December 8, 2011]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/21987394\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/21987394&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/abstracts01.html  [1] &quot;c:/web/p1/abstracts01.html&quot;
## [1] &quot;  and for average childhood (ages 5ï¿½10 years) and adolescent (ages 10ï¿½20 years) &quot;
## [1] &quot;  and for average childhood (ages 5i¿1/210 years) and adolescent (ages 10i¿1/220 years) &quot;
## [1] &quot;  0.35ï¿½0.55) and 0.57 (95% CI 0.39ï¿½0.83) for the most overweight compared with &quot;
## [1] &quot;  0.35i¿1/20.55) and 0.57 (95% CI 0.39i¿1/20.83) for the most overweight compared with &quot;
## [1] &quot;  CI 0.38ï¿½0.71) for the most overweight compared with the most lean (P for trend &quot;
## [1] &quot;  CI 0.38i¿1/20.71) for the most overweight compared with the most lean (P for trend &quot;
## [1] &quot;  Jean-Marie Tonnelier, Gwenaï¿½l Prat, Grï¿½goire Le Gal, Christophe Gut-Gobert, &quot;
## [1] &quot;  Jean-Marie Tonnelier, Gwenai¿1/2l Prat, Gri¿1/2goire Le Gal, Christophe Gut-Gobert, &quot;
## [1] &quot;  Results The duration of mechanical ventilation (16.6 ï¿½ 13 days versus 22.5 ï¿½ &quot;
## [1] &quot;  Results The duration of mechanical ventilation (16.6 i¿1/2 13 days versus 22.5 i¿1/2 &quot;
## [1] &quot;  21 days; P = 0.02) and ICU length of stay (21.6 ï¿½ 14.3 days versus 27.6 ï¿½ 21.7 &quot;
## [1] &quot;  21 days; P = 0.02) and ICU length of stay (21.6 i¿1/2 14.3 days versus 27.6 i¿1/2 21.7 &quot;
## [1] &quot;  oxygen ratio 230.7 ï¿½ 36.1 mmHg versus 341.2 ï¿½ 92.8 mmHg; P &amp;lt; 0.001). Four out &quot;
## [1] &quot;  oxygen ratio 230.7 i¿1/2 36.1 mmHg versus 341.2 i¿1/2 92.8 mmHg; P &amp;lt; 0.001). Four out &quot;
## [1] &quot;  Surveillance Study conducted in San Franciscoï¿½Oakland, in Seattleï¿½Puget Sound, &quot;
## [1] &quot;  Surveillance Study conducted in San Franciscoi¿1/2Oakland, in Seattlei¿1/2Puget Sound, &quot;
## [1] &quot;  0.43ï¿½0.67) and nonbreast cancer mortality (hazard ratio, 0.59; 95% confidence &quot;
## [1] &quot;  0.43i¿1/20.67) and nonbreast cancer mortality (hazard ratio, 0.59; 95% confidence &quot;
## [1] &quot;  interval, 0.41ï¿½0.85) were lower in patients with implants than in those &quot;
## [1] &quot;  interval, 0.41i¿1/20.85) were lower in patients with implants than in those &quot;
## c:/web/p1-clean/AcademicFreedomIRB.html  [1] &quot;c:/web/p1/AcademicFreedomIRB.html&quot;
## [1] &quot;     required is limited to approval by the researcher’s department or other &quot;
## [1] &quot;     required is limited to approval by the researcher&#39;s department or other &quot;
## [1] &quot;     research—students do a considerable amount of the social science research &quot;
## [1] &quot;     research-students do a considerable amount of the social science research &quot;
## c:/web/p1-clean/access.html  [1] &quot;c:/web/p1/access.html&quot;
## c:/web/p1-clean/AccountForDropouts.html  [1] &quot;c:/web/p1/AccountForDropouts.html&quot;
## c:/web/p1-clean/AccountingForClusters.html  [1] &quot;c:/web/p1/AccountingForClusters.html&quot;
## c:/web/p1-clean/AccrualGrantRound3.html  [1] &quot;c:/web/p1/AccrualGrantRound3.html&quot;
## c:/web/p1-clean/AccrualHelp.html  [1] &quot;c:/web/p1/AccrualHelp.html&quot;
## c:/web/p1-clean/AccrualProblems-06.html  [1] &quot;c:/web/p1/AccrualProblems-06.html&quot;
## c:/web/p1-clean/AccrualProblems-category.html  [1] &quot;c:/web/p1/AccrualProblems-category.html&quot;
## [1] &quot;    &lt;p&gt;Journal article: Frederick L. Brancati&lt;a name=\&quot;brancati\&quot;&gt;&lt;/a&gt;, Mary Evans, Curt D. Furberg, Nancy Geller, Steven Haffner, Steven E. Kahn, Peter G. Kaufmann, Cora E. Lewis, David M. Nathan, et al. &lt;b&gt;Midcourse Correction to a Clinical Trial When the Event Rate Is Underestimated: The Look AHEAD (Action for Health in Diabetes) Study.&lt;/b&gt; Clin Trials. 2012;9(1):113–124. &lt;i&gt;Abstract: \&quot;The Look AHEAD (Action for Health in Diabetes) Study is a long-term clinical trial that aims to determine the cardiovascular disease (CVD) benefits of an intensive lifestyle intervention (ILI) in obese adults with type 2 diabetes. The study was designed to have 90% statistical power to detect an 18% reduction in the CVD event rate in the ILI Group compared to the Diabetes Support and Education (DSE) Group over 10.5 years of follow-up. The original power calculations were based on an expected CVD rate of 3.125% per year in the DSE group; however, a much lower-than-expected rate in the first 2 years of follow-up prompted the Data and Safety Monitoring Board (DSMB) to recommend that the Steering Committee undertake a formal blinded evaluation of these design considerations. The Steering Committee created an Endpoint Working Group (EPWG) that consisted of individuals masked to study data to examine relevant issues. The EPWG considered two primary options: (1) expanding the definition of the primary endpoint and (2) extending follow-up of participants. Ultimately, the EPWG recommended that the Look AHEAD Steering Committee approve both strategies. The DSMB accepted these modifications, rather than recommending that the trial continue with inadequate statistical power. Trialists sometimes need to modify endpoints after launch. This decision should be well justified and should be made by individuals who are fully masked to interim results that could introduce bias. This article describes this process in the Look AHEAD study and places it in the context of recent articles on endpoint modification and recent trials that reported endpoint modification.\&quot;&lt;/i&gt; [Accessed on May 24, 2012]. &lt;a href=\&quot;http://ctj.sagepub.com/content/9/1/113\&quot;&gt;http://ctj.sagepub.com/content/9/1/113&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Journal article: Frederick L. Brancati&lt;a name=\&quot;brancati\&quot;&gt;&lt;/a&gt;, Mary Evans, Curt D. Furberg, Nancy Geller, Steven Haffner, Steven E. Kahn, Peter G. Kaufmann, Cora E. Lewis, David M. Nathan, et al. &lt;b&gt;Midcourse Correction to a Clinical Trial When the Event Rate Is Underestimated: The Look AHEAD (Action for Health in Diabetes) Study.&lt;/b&gt; Clin Trials. 2012;9(1):113-124. &lt;i&gt;Abstract: \&quot;The Look AHEAD (Action for Health in Diabetes) Study is a long-term clinical trial that aims to determine the cardiovascular disease (CVD) benefits of an intensive lifestyle intervention (ILI) in obese adults with type 2 diabetes. The study was designed to have 90% statistical power to detect an 18% reduction in the CVD event rate in the ILI Group compared to the Diabetes Support and Education (DSE) Group over 10.5 years of follow-up. The original power calculations were based on an expected CVD rate of 3.125% per year in the DSE group; however, a much lower-than-expected rate in the first 2 years of follow-up prompted the Data and Safety Monitoring Board (DSMB) to recommend that the Steering Committee undertake a formal blinded evaluation of these design considerations. The Steering Committee created an Endpoint Working Group (EPWG) that consisted of individuals masked to study data to examine relevant issues. The EPWG considered two primary options: (1) expanding the definition of the primary endpoint and (2) extending follow-up of participants. Ultimately, the EPWG recommended that the Look AHEAD Steering Committee approve both strategies. The DSMB accepted these modifications, rather than recommending that the trial continue with inadequate statistical power. Trialists sometimes need to modify endpoints after launch. This decision should be well justified and should be made by individuals who are fully masked to interim results that could introduce bias. This article describes this process in the Look AHEAD study and places it in the context of recent articles on endpoint modification and recent trials that reported endpoint modification.\&quot;&lt;/i&gt; [Accessed on May 24, 2012]. &lt;a href=\&quot;http://ctj.sagepub.com/content/9/1/113\&quot;&gt;http://ctj.sagepub.com/content/9/1/113&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;      different recruitment scenarios.&amp;quot; Copyright © 2007John Wiley &amp;amp; Sons, Ltd.&lt;/i&gt; &quot;
## [1] &quot;      different recruitment scenarios.&amp;quot; Copyright (c) 2007John Wiley &amp;amp; Sons, Ltd.&lt;/i&gt; &quot;
## [1] &quot;  &lt;p&gt;Journal article: Shaun Treweek, Elizabeth Mitchell, Marie Pitkethly, Jonathan Cook, Monica Kjeldstrøm, Marit Johansen, Taina K Taskila, Frank Sullivan, Sue Wilson, et al. &lt;b&gt;Strategies to improve recruitment to randomised controlled trials&lt;/b&gt; Cochrane Database of Systematic Reviews. 2010. &lt;i&gt;Abstract: \&quot;Background: Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research. Objectives: To quantify the effects of strategies to improve recruitment of participants to randomised controlled trials. Search strategy: We searched the Cochrane Methodology Review Group Specialised Register (CMR) 2010, Issue 2, part of The Cochrane Library (online) www.thecochranelibrary.com (searched 16 April 2010); MEDLINE, Ovid (1950 to March Week 5 2010) (searched 14 April 2010); EMBASE, Ovid (1980 to 2010 Week 14) (searched 14 April 2010); ERIC, CSA (1966 to 14 April 2010); Science Citation Index Expanded, ISI Web of Science (1975 to 14 April 2010); Social Sciences Citation Index, ISI Web of Science (1975 to 14 April 2010); National Research Register (online) (Issue 3 2007) (searched 3 September 2007); C2-SPECTR (searched 9 April 2008) and PubMed &#39;Related citations&#39; (searched 4 June 2010). Selection criteria: Randomised and quasi-randomised controlled trials of methods to increase recruitment to randomised controlled trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to questionnaires or trial retention, or which evaluated incentives and disincentives for clinicians to recruit patients. Data collection and analysis: We extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used a risk or odds ratio and their 95% confidence interval (CI) to describe the effect in individual trials. We assessed heterogeneity between trial results. Main results: We identified 45 eligible trials (18 new to this update) with more than 41,239 participants. There were 40 studies involving interventions aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health care. Some interventions were effective in increasing recruitment: telephone reminders to non-respondents (odds ratio (OR) 1.95, 95% CI 1.04 to 3.66; two trials, 1058 participants), use of opt-out, rather than opt-in, procedures for contacting potential trial participants (RR 1.39, 95% CI 1.06 to 1.84; one study, 152 participants) and open designs where participants know which treatment they are receiving in the trial (RR 1.22, 95% CI 1.09 to 1.36; two studies, 4833 participants). However, some of these strategies have disadvantages, which may limit their widespread use. For example, opt-out procedures are controversial and open designs are by definition unblinded. The effects of many other recruitment strategies are unclear; examples include the use of video to provide trial information to potential participants and modifying the training of recruiters. Many studies looked at recruitment to hypothetical trials and it is unclear how applicable these results are to real trials. Authors&#39; conclusions: There are promising strategies for increasing recruitment to trials: telephone reminders; requiring potential participants to opt-out of being contacted by the trial team regarding taking part in a trial, rather than them having to opt-in, and open designs. Some strategies (e.g. open trial designs) need to be considered carefully before use because they also have disadvantages. For example, opt-out procedures are controversial and open designs are by definition unblinded.\&quot;&lt;/i&gt; [Accessed on January 20, 2012]. &lt;a href=\&quot;http://summaries.cochrane.org/MR000013/strategies-to-recruit-participants-to-randomised-trials\&quot;&gt;http://summaries.cochrane.org/MR000013/strategies-to-recruit-participants-to-randomised-trials&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Shaun Treweek, Elizabeth Mitchell, Marie Pitkethly, Jonathan Cook, Monica Kjeldstrom, Marit Johansen, Taina K Taskila, Frank Sullivan, Sue Wilson, et al. &lt;b&gt;Strategies to improve recruitment to randomised controlled trials&lt;/b&gt; Cochrane Database of Systematic Reviews. 2010. &lt;i&gt;Abstract: \&quot;Background: Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research. Objectives: To quantify the effects of strategies to improve recruitment of participants to randomised controlled trials. Search strategy: We searched the Cochrane Methodology Review Group Specialised Register (CMR) 2010, Issue 2, part of The Cochrane Library (online) www.thecochranelibrary.com (searched 16 April 2010); MEDLINE, Ovid (1950 to March Week 5 2010) (searched 14 April 2010); EMBASE, Ovid (1980 to 2010 Week 14) (searched 14 April 2010); ERIC, CSA (1966 to 14 April 2010); Science Citation Index Expanded, ISI Web of Science (1975 to 14 April 2010); Social Sciences Citation Index, ISI Web of Science (1975 to 14 April 2010); National Research Register (online) (Issue 3 2007) (searched 3 September 2007); C2-SPECTR (searched 9 April 2008) and PubMed &#39;Related citations&#39; (searched 4 June 2010). Selection criteria: Randomised and quasi-randomised controlled trials of methods to increase recruitment to randomised controlled trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to questionnaires or trial retention, or which evaluated incentives and disincentives for clinicians to recruit patients. Data collection and analysis: We extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used a risk or odds ratio and their 95% confidence interval (CI) to describe the effect in individual trials. We assessed heterogeneity between trial results. Main results: We identified 45 eligible trials (18 new to this update) with more than 41,239 participants. There were 40 studies involving interventions aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health care. Some interventions were effective in increasing recruitment: telephone reminders to non-respondents (odds ratio (OR) 1.95, 95% CI 1.04 to 3.66; two trials, 1058 participants), use of opt-out, rather than opt-in, procedures for contacting potential trial participants (RR 1.39, 95% CI 1.06 to 1.84; one study, 152 participants) and open designs where participants know which treatment they are receiving in the trial (RR 1.22, 95% CI 1.09 to 1.36; two studies, 4833 participants). However, some of these strategies have disadvantages, which may limit their widespread use. For example, opt-out procedures are controversial and open designs are by definition unblinded. The effects of many other recruitment strategies are unclear; examples include the use of video to provide trial information to potential participants and modifying the training of recruiters. Many studies looked at recruitment to hypothetical trials and it is unclear how applicable these results are to real trials. Authors&#39; conclusions: There are promising strategies for increasing recruitment to trials: telephone reminders; requiring potential participants to opt-out of being contacted by the trial team regarding taking part in a trial, rather than them having to opt-in, and open designs. Some strategies (e.g. open trial designs) need to be considered carefully before use because they also have disadvantages. For example, opt-out procedures are controversial and open designs are by definition unblinded.\&quot;&lt;/i&gt; [Accessed on January 20, 2012]. &lt;a href=\&quot;http://summaries.cochrane.org/MR000013/strategies-to-recruit-participants-to-randomised-trials\&quot;&gt;http://summaries.cochrane.org/MR000013/strategies-to-recruit-participants-to-randomised-trials&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/AccrualProblems1.html  [1] &quot;c:/web/p1/AccrualProblems1.html&quot;
## [1] &quot;        recruitment problem is extremely costly for drug companies, contributing to 85–95 per cent &quot;
## [1] &quot;        recruitment problem is extremely costly for drug companies, contributing to 85-95 per cent &quot;
## c:/web/p1-clean/accuracy.html  [1] &quot;c:/web/p1/accuracy.html&quot;
## c:/web/p1-clean/ack.html  [1] &quot;c:/web/p1/ack.html&quot;
## c:/web/p1-clean/AcknowledgingContributions.html  [1] &quot;c:/web/p1/AcknowledgingContributions.html&quot;
## c:/web/p1-clean/Acknowledgments.html  [1] &quot;c:/web/p1/Acknowledgments.html&quot;
## c:/web/p1-clean/acuity.html  [1] &quot;c:/web/p1/acuity.html&quot;
## c:/web/p1-clean/adaptive-04.html  [1] &quot;c:/web/p1/adaptive-04.html&quot;
## c:/web/p1-clean/adaptive-12.html  [1] &quot;c:/web/p1/adaptive-12.html&quot;
## c:/web/p1-clean/AdditionsImprovements.html  [1] &quot;c:/web/p1/AdditionsImprovements.html&quot;
## c:/web/p1-clean/adjusted.html  [1] &quot;c:/web/p1/adjusted.html&quot;
## c:/web/p1-clean/AdjustedHazardRatio.html  [1] &quot;c:/web/p1/AdjustedHazardRatio.html&quot;
## c:/web/p1-clean/AdjustedOR.html  [1] &quot;c:/web/p1/AdjustedOR.html&quot;
## c:/web/p1-clean/AdjustingForAgeAndSex.html  [1] &quot;c:/web/p1/AdjustingForAgeAndSex.html&quot;
## c:/web/p1-clean/AdmissionInstructions.html  [1] &quot;c:/web/p1/AdmissionInstructions.html&quot;
## c:/web/p1-clean/adoption.html  [1] &quot;c:/web/p1/adoption.html&quot;
## c:/web/p1-clean/AdverseEvents-05.html  [1] &quot;c:/web/p1/AdverseEvents-05.html&quot;
## c:/web/p1-clean/AdverseEvents-06.html  [1] &quot;c:/web/p1/AdverseEvents-06.html&quot;
## c:/web/p1-clean/AdverseEvents-category.html  [1] &quot;c:/web/p1/AdverseEvents-category.html&quot;
## c:/web/p1-clean/AdverseEvents1.html  [1] &quot;c:/web/p1/AdverseEvents1.html&quot;
## c:/web/p1-clean/Advice.html  [1] &quot;c:/web/p1/Advice.html&quot;
## c:/web/p1-clean/AdviceSearching.html  [1] &quot;c:/web/p1/AdviceSearching.html&quot;
## c:/web/p1-clean/agate.html  [1] &quot;c:/web/p1/agate.html&quot;
## c:/web/p1-clean/AgreementWithConsensus.html  [1] &quot;c:/web/p1/AgreementWithConsensus.html&quot;
## c:/web/p1-clean/aipe.html  [1] &quot;c:/web/p1/aipe.html&quot;
## c:/web/p1-clean/aliasing.html  [1] &quot;c:/web/p1/aliasing.html&quot;
## c:/web/p1-clean/all.html  [1] &quot;c:/web/p1/all.html&quot;
## c:/web/p1-clean/AllModelsAre.html  [1] &quot;c:/web/p1/AllModelsAre.html&quot;
## c:/web/p1-clean/AllScientificWork.html  [1] &quot;c:/web/p1/AllScientificWork.html&quot;
## [1] &quot;       &lt;p&gt;&lt;i&gt;All scientific work is incomplete—whether it be observational or experimental. All &quot;
## [1] &quot;       &lt;p&gt;&lt;i&gt;All scientific work is incomplete-whether it be observational or experimental. All &quot;
## c:/web/p1-clean/AlphabeticalBookmarkList.html  [1] &quot;c:/web/p1/AlphabeticalBookmarkList.html&quot;
## c:/web/p1-clean/alternate.html  [1] &quot;c:/web/p1/alternate.html&quot;
## c:/web/p1-clean/AlternateAccrual.html  [1] &quot;c:/web/p1/AlternateAccrual.html&quot;
## c:/web/p1-clean/AlternativeMedicine.html  [1] &quot;c:/web/p1/AlternativeMedicine.html&quot;
## [1] &quot;    straightforward and easily definable - and therefore reproducible: “This &quot;
## [1] &quot;    straightforward and easily definable - and therefore reproducible: \&quot;This &quot;
## [1] &quot;    the following changes at the following stages”. However, the &quot;
## [1] &quot;    the following changes at the following stages\&quot;. However, the &quot;
## c:/web/p1-clean/AlternativePvalue-08.html  [1] &quot;c:/web/p1/AlternativePvalue-08.html&quot;
## c:/web/p1-clean/AlternativePvalue-08a.html  [1] &quot;c:/web/p1/AlternativePvalue-08a.html&quot;
## c:/web/p1-clean/AlwaysAskWhy.html  [1] &quot;c:/web/p1/AlwaysAskWhy.html&quot;
## c:/web/p1-clean/amateur.html  [1] &quot;c:/web/p1/amateur.html&quot;
## c:/web/p1-clean/AMathematicianIs.html  [1] &quot;c:/web/p1/AMathematicianIs.html&quot;
## c:/web/p1-clean/AmbiguousData.html  [1] &quot;c:/web/p1/AmbiguousData.html&quot;
## c:/web/p1-clean/AmbiguousDefinition.html  [1] &quot;c:/web/p1/AmbiguousDefinition.html&quot;
## c:/web/p1-clean/AmusingCorrelation.html  [1] &quot;c:/web/p1/AmusingCorrelation.html&quot;
## c:/web/p1-clean/AnalysisOfMeans-06.html  [1] &quot;c:/web/p1/AnalysisOfMeans-06.html&quot;
## c:/web/p1-clean/AnalysisOfMeans-category.html  [1] &quot;c:/web/p1/AnalysisOfMeans-category.html&quot;
## c:/web/p1-clean/AnalysisOfSubgroupResults.html  [1] &quot;c:/web/p1/AnalysisOfSubgroupResults.html&quot;
## c:/web/p1-clean/AnalysisOfVariance.html  [1] &quot;c:/web/p1/AnalysisOfVariance.html&quot;
## c:/web/p1-clean/AnalyzeSafety-08.html  [1] &quot;c:/web/p1/AnalyzeSafety-08.html&quot;
## c:/web/p1-clean/AnalyzeSafety-08a.html  [1] &quot;c:/web/p1/AnalyzeSafety-08a.html&quot;
## c:/web/p1-clean/AnalyzingItt.html  [1] &quot;c:/web/p1/AnalyzingItt.html&quot;
## [1] &quot;  everybody. Don’t let any patients be excluded from the analysis because they &quot;
## [1] &quot;  everybody. Don&#39;t let any patients be excluded from the analysis because they &quot;
## c:/web/p1-clean/AnecdotalEvidence.html  [1] &quot;c:/web/p1/AnecdotalEvidence.html&quot;
## c:/web/p1-clean/AnecdotalInformation.html  [1] &quot;c:/web/p1/AnecdotalInformation.html&quot;
## c:/web/p1-clean/animal.html  [1] &quot;c:/web/p1/animal.html&quot;
## c:/web/p1-clean/animations.html  [1] &quot;c:/web/p1/animations.html&quot;
## c:/web/p1-clean/AnomAnswers.html  [1] &quot;c:/web/p1/AnomAnswers.html&quot;
## c:/web/p1-clean/AnomCalculations.html  [1] &quot;c:/web/p1/AnomCalculations.html&quot;
## c:/web/p1-clean/AnomCalculations1.html  [1] &quot;c:/web/p1/AnomCalculations1.html&quot;
## c:/web/p1-clean/AnomExample.html  [1] &quot;c:/web/p1/AnomExample.html&quot;
## c:/web/p1-clean/AnomTable05Part1.html  [1] &quot;c:/web/p1/AnomTable05Part1.html&quot;
## c:/web/p1-clean/AnomTable05Part2.html  [1] &quot;c:/web/p1/AnomTable05Part2.html&quot;
## c:/web/p1-clean/AnotherPersonsGrant.html  [1] &quot;c:/web/p1/AnotherPersonsGrant.html&quot;
## c:/web/p1-clean/anova.html  [1] &quot;c:/web/p1/anova.html&quot;
## c:/web/p1-clean/AnovaPower.html  [1] &quot;c:/web/p1/AnovaPower.html&quot;
## [1] &quot;  &lt;font face=\&quot;Times New Roman\&quot;&gt;ï¿½&lt;sub&gt;i&lt;/sub&gt; and standard deviation &amp;#963;. The &quot;
## [1] &quot;  &lt;font face=\&quot;Times New Roman\&quot;&gt;i¿1/2&lt;sub&gt;i&lt;/sub&gt; and standard deviation &amp;#963;. The &quot;
## [1] &quot;  parameter ï¿½ represents the overall population mean across all subjects. The &quot;
## [1] &quot;  parameter i¿1/2 represents the overall population mean across all subjects. The &quot;
## c:/web/p1-clean/answers.html  [1] &quot;c:/web/p1/answers.html&quot;
## [1] &quot; fatness at each age and for average childhood (ages 5–10 years) and adolescent &quot;
## [1] &quot; fatness at each age and for average childhood (ages 5-10 years) and adolescent &quot;
## [1] &quot; (ages 10–20 years) fatness. &lt;b&gt;Results&lt;/b&gt;: Body fatness at each age was &quot;
## [1] &quot; (ages 10-20 years) fatness. &lt;b&gt;Results&lt;/b&gt;: Body fatness at each age was &quot;
## [1] &quot; multivariate RRs were 0.48 (95% CI 0.35–0.55) and 0.57 (95% CI 0.39–0.83) for &quot;
## [1] &quot; multivariate RRs were 0.48 (95% CI 0.35-0.55) and 0.57 (95% CI 0.39-0.83) for &quot;
## [1] &quot; multivariate RR of 0.52 (95% CI 0.38–0.71) for the most overweight compared &quot;
## [1] &quot; multivariate RR of 0.52 (95% CI 0.38-0.71) for the most overweight compared &quot;
## [1] &quot; Jean-Marie Tonnelier, Gwenaël Prat, Grégoire Le Gal, Christophe Gut-Gobert, &quot;
## [1] &quot; Jean-Marie Tonnelier, Gwenael Prat, Gregoire Le Gal, Christophe Gut-Gobert, &quot;
## [1] &quot; Results&lt;/b&gt;: The duration of mechanical ventilation (16.6 ± 13 days versus 22.5 &quot;
## [1] &quot; Results&lt;/b&gt;: The duration of mechanical ventilation (16.6 +/- 13 days versus 22.5 &quot;
## [1] &quot; ± 21 days; P = 0.02) and ICU length of stay (21.6 ± 14.3 days versus 27.6 ± &quot;
## [1] &quot; +/- 21 days; P = 0.02) and ICU length of stay (21.6 +/- 14.3 days versus 27.6 +/- &quot;
## [1] &quot; tension/fractional inspired oxygen ratio 230.7 ± 36.1 mmHg versus 341.2 ± 92.8 &quot;
## [1] &quot; tension/fractional inspired oxygen ratio 230.7 +/- 36.1 mmHg versus 341.2 +/- 92.8 &quot;
## [1] &quot; Implant Surveillance Study conducted in San Francisco–Oakland, in Seattle–Puget &quot;
## [1] &quot; Implant Surveillance Study conducted in San Francisco-Oakland, in Seattle-Puget &quot;
## [1] &quot; 0.43–0.67) and nonbreast cancer mortality (hazard ratio, 0.59; 95% confidence &quot;
## [1] &quot; 0.43-0.67) and nonbreast cancer mortality (hazard ratio, 0.59; 95% confidence &quot;
## [1] &quot; interval, 0.41–0.85) were lower in patients with implants than in those &quot;
## [1] &quot; interval, 0.41-0.85) were lower in patients with implants than in those &quot;
## [1] &quot; between 1954–1963 in Helsinki, Finland, 2,089 of which were eligible for the &quot;
## [1] &quot; between 1954-1963 in Helsinki, Finland, 2,089 of which were eligible for the &quot;
## [1] &quot; 35 – 74). A sample of 979 women (123 cases, 856 controls) from the cohort was &quot;
## [1] &quot; 35 - 74). A sample of 979 women (123 cases, 856 controls) from the cohort was &quot;
## [1] &quot; weight gain (&amp;gt;15 kg) had a 1.62-fold (95% CI 1.03–2.53) higher breast cancer &quot;
## [1] &quot; weight gain (&amp;gt;15 kg) had a 1.62-fold (95% CI 1.03-2.53) higher breast cancer &quot;
## [1] &quot; 12.9 kg, range 11–15 kg), after adjusting for mother&#39;s age at menarche, age at &quot;
## [1] &quot; 12.9 kg, range 11-15 kg), after adjusting for mother&#39;s age at menarche, age at &quot;
## [1] &quot; confidence interval 0.6, 0.4–0.97), but were as likely as whites to have blood &quot;
## [1] &quot; confidence interval 0.6, 0.4-0.97), but were as likely as whites to have blood &quot;
## [1] &quot; cultures obtained prior to receiving antibiotics (0.7, 0.3–1.5), to have &quot;
## [1] &quot; cultures obtained prior to receiving antibiotics (0.7, 0.3-1.5), to have &quot;
## [1] &quot; oxygenation assessed within 24 hours of presentation (1.6, 0.9–3.0), and to &quot;
## [1] &quot; oxygenation assessed within 24 hours of presentation (1.6, 0.9-3.0), and to &quot;
## [1] &quot; receive guideline concordant antibiotics (OR 0.9, 0.6–1.7). Black patients had &quot;
## [1] &quot; receive guideline concordant antibiotics (OR 0.9, 0.6-1.7). Black patients had &quot;
## c:/web/p1-clean/AnswersChapter6.html  [1] &quot;c:/web/p1/AnswersChapter6.html&quot;
## [1] &quot;  J.D., and Fuchs, B. D. Critical Care 2004, 8:R322–R327. Introduction: &quot;
## [1] &quot;  J.D., and Fuchs, B. D. Critical Care 2004, 8:R322-R327. Introduction: &quot;
## [1] &quot;  ventilation within 72 hours (n ¼ 60), and the control cohort included patients &quot;
## [1] &quot;  ventilation within 72 hours (n 1/4 60), and the control cohort included patients &quot;
## [1] &quot;  who were successfully extubated at 72 hours (n ¼ 93). Results: The primary &quot;
## [1] &quot;  who were successfully extubated at 72 hours (n 1/4 93). Results: The primary &quot;
## [1] &quot;  extubation (odds ratio ¼ 12.2, 95% confidence interval [CI] ¼ 1.5–101; p &amp;lt; &quot;
## [1] &quot;  extubation (odds ratio 1/4 12.2, 95% confidence interval [CI] 1/4 1.5-101; p &amp;lt; &quot;
## [1] &quot;  ratio ¼ 2.1, 95% CI ¼ 0.8–5.4; p &amp;lt; 0.15). Total hospital costs (estimated from &quot;
## [1] &quot;  ratio 1/4 2.1, 95% CI 1/4 0.8-5.4; p &amp;lt; 0.15). Total hospital costs (estimated from &quot;
## [1] &quot;  US$33,926 (95% CI ¼ US$22,573–45,280; p &amp;lt; 0.01). Conclusion: Extubation &quot;
## [1] &quot;  US$33,926 (95% CI 1/4 US$22,573-45,280; p &amp;lt; 0.01). Conclusion: Extubation &quot;
## [1] &quot;  treatment (95% CI, 0.0– 0.68C). Acetaminophen had no significant effect on &quot;
## [1] &quot;  treatment (95% CI, 0.0- 0.68C). Acetaminophen had no significant effect on &quot;
## [1] &quot;  was associated with an increased C-reactive protein (r ¼ 0.23, p &amp;lt; 0.001) and &quot;
## [1] &quot;  was associated with an increased C-reactive protein (r 1/4 0.23, p &amp;lt; 0.001) and &quot;
## [1] &quot;  C-reactive protein (r ¼ 0.42, p &amp;lt; 0.0001). IL1RN and IL6 genotypes had no &quot;
## [1] &quot;  C-reactive protein (r 1/4 0.42, p &amp;lt; 0.0001). IL1RN and IL6 genotypes had no &quot;
## [1] &quot;  significantly affected by an interaction between WBC and the IL1 (p ¼ 0.61) or &quot;
## [1] &quot;  significantly affected by an interaction between WBC and the IL1 (p 1/4 0.61) or &quot;
## [1] &quot;  IL6 (p ¼ 0.48) SIMON: Statistical Evidence in Medical Trials 06-simon-chap06 &quot;
## [1] &quot;  IL6 (p 1/4 0.48) SIMON: Statistical Evidence in Medical Trials 06-simon-chap06 &quot;
## [1] &quot;  standard quality paper (relative rate of response 0.75, 95% CI, 0.33–1.05, p ¼ &quot;
## [1] &quot;  standard quality paper (relative rate of response 0.75, 95% CI, 0.33-1.05, p 1/4 &quot;
## [1] &quot;  score difference between these EQ-5D versions was\003\001 0.14 to þ0.03 points for utility scores and\003\001 &quot;
## [1] &quot;  score difference between these EQ-5D versions was\003\001 0.14 to p0.03 points for utility scores and\003\001 &quot;
## [1] &quot;  11.6 to þ3.3 points for EQ-VAS scores (equivalence margins of\003\001 0.05 to þ0.05 &quot;
## [1] &quot;  11.6 to p3.3 points for EQ-VAS scores (equivalence margins of\003\001 0.05 to p0.05 &quot;
## [1] &quot;  and\003\001 5.0 to þ5.0 respectively). Conclusion: These data provide promising &quot;
## [1] &quot;  and\003\001 5.0 to p5.0 respectively). Conclusion: These data provide promising &quot;
## [1] &quot;  cryotherapy (relative risk [DELETED], 95% CI, 0.00– 0.80, p ¼ 0.041). &quot;
## [1] &quot;  cryotherapy (relative risk [DELETED], 95% CI, 0.00- 0.80, p 1/4 0.041). &quot;
## [1] &quot;  from a special ‘Postpartum Haemorrhage Trolley’. In addition, participants who &quot;
## [1] &quot;  from a special &#39;Postpartum Haemorrhage Trolley&#39;. In addition, participants who &quot;
## [1] &quot;  after enrolment measured in a flat plastic ‘fracture bedpan’, the primary &quot;
## [1] &quot;  after enrolment measured in a flat plastic &#39;fracture bedpan&#39;, the primary &quot;
## [1] &quot;  0.21–1.46). There was no difference in mean blood loss or haemoglobin level on &quot;
## [1] &quot;  0.21-1.46). There was no difference in mean blood loss or haemoglobin level on &quot;
## [1] &quot;  namely shivering (63/116 vs. 30/118; [DELETED], 1.50–3.04) and pyrexia &amp;gt; 38.5 &quot;
## [1] &quot;  namely shivering (63/116 vs. 30/118; [DELETED], 1.50-3.04) and pyrexia &amp;gt; 38.5 &quot;
## [1] &quot;  degrees C (11/114 vs. 2/118; [DELETED], 1.29–25). In the misoprostol group &quot;
## [1] &quot;  degrees C (11/114 vs. 2/118; [DELETED], 1.29-25). In the misoprostol group &quot;
## [1] &quot;  index was created based on partner’s education, public assistance receipt, and &quot;
## [1] &quot;  index was created based on partner&#39;s education, public assistance receipt, and &quot;
## [1] &quot;  associated with past-year IPV (OR ¼ 0.9). Pastyear IPV prevalence was 42.8% &quot;
## [1] &quot;  associated with past-year IPV (OR 1/4 0.9). Pastyear IPV prevalence was 42.8% &quot;
## [1] &quot;  past-year IPV (OR ¼ 5.0; 95% CI, 2.4, 10.7). Conclusions: Native American &quot;
## [1] &quot;  past-year IPV (OR 1/4 5.0; 95% CI, 2.4, 10.7). Conclusions: Native American &quot;
## [1] &quot;  (n ¼ 66, 33%) than the control group (n ¼ 19, 9.5%) [OR: [DELETED]; 95% CI, &quot;
## [1] &quot;  (n 1/4 66, 33%) than the control group (n 1/4 19, 9.5%) [OR: [DELETED]; 95% CI, &quot;
## [1] &quot;  2.61–8.52] (p-value &amp;lt; 0.0001). BMG, too, was significantly more frequent in &quot;
## [1] &quot;  2.61-8.52] (p-value &amp;lt; 0.0001). BMG, too, was significantly more frequent in &quot;
## [1] &quot;  [DELETED]; 95% CI, 1.20–5.50) (p-value &amp;lt; 0.012). In 11 patients (5.5%), FT and &quot;
## [1] &quot;  [DELETED]; 95% CI, 1.20-5.50) (p-value &amp;lt; 0.012). In 11 patients (5.5%), FT and &quot;
## [1] &quot;  Mother–infant dyads were systematically selected from three District of &quot;
## [1] &quot;  Mother-infant dyads were systematically selected from three District of &quot;
## [1] &quot;  Interviews were conducted at 3–7 months postpartum and again at 7–12 months &quot;
## [1] &quot;  Interviews were conducted at 3-7 months postpartum and again at 7-12 months &quot;
## [1] &quot;  interval [CI], 0.08– 0.47), and mother foreign-born (AOR, 4.90; 95% CI, &quot;
## [1] &quot;  interval [CI], 0.08- 0.47), and mother foreign-born (AOR, 4.90; 95% CI, &quot;
## [1] &quot;  2.38–10.10). Twenty-five percent of study participants who did not initiate &quot;
## [1] &quot;  2.38-10.10). Twenty-five percent of study participants who did not initiate &quot;
## [1] &quot;  CI, 0.39–0.77) increasing maternal age (HR for 5-year increments, 0.80; 95% &quot;
## [1] &quot;  CI, 0.39-0.77) increasing maternal age (HR for 5-year increments, 0.80; 95% &quot;
## [1] &quot;  CI, 0.69–0.92), and infant birth weight &amp;gt; or ¼ 2500 grams (HR, 0.45; 95% CI, &quot;
## [1] &quot;  CI, 0.69-0.92), and infant birth weight &amp;gt; or 1/4 2500 grams (HR, 0.45; 95% CI, &quot;
## [1] &quot;  0.26–0.80). Conclusions: Breastfeeding initiation rates and duration were &quot;
## [1] &quot;  0.26-0.80). Conclusions: Breastfeeding initiation rates and duration were &quot;
## [1] &quot;  [DELETED] (95% confidence interval 2.3–3.3). For global improvement in &quot;
## [1] &quot;  [DELETED] (95% confidence interval 2.3-3.3). For global improvement in &quot;
## [1] &quot;  erections the NNT was 1.7 (1.6–1.9). Treatment related adverse events occurred &quot;
## [1] &quot;  erections the NNT was 1.7 (1.6-1.9). Treatment related adverse events occurred &quot;
## [1] &quot;  NNH was [DELETED] (4.3–7.3). All cause discontinuations were less frequent &quot;
## [1] &quot;  NNH was [DELETED] (4.3-7.3). All cause discontinuations were less frequent &quot;
## c:/web/p1-clean/AnswersChapter7.html  [1] &quot;c:/web/p1/AnswersChapter7.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;5. Perform a web search on the phrase ï¿½Reiki Therapyï¿½ or ï¿½Cognitive &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;5. Perform a web search on the phrase i¿1/2Reiki Therapyi¿1/2 or i¿1/2Cognitive &quot;
## [1] &quot;  Behavioral Therapyï¿½ and examine the first ten sites that appear. How many of &quot;
## [1] &quot;  Behavioral Therapyi¿1/2 and examine the first ten sites that appear. How many of &quot;
## c:/web/p1-clean/AntiIntellectualism.html  [1] &quot;c:/web/p1/AntiIntellectualism.html&quot;
## [1] &quot;  &lt;p&gt;&amp;quot;&lt;i&gt;Mr. Bush is the triumph of the seemingly average American man. He’s not &quot;
## [1] &quot;  &lt;p&gt;&amp;quot;&lt;i&gt;Mr. Bush is the triumph of the seemingly average American man. He&#39;s not &quot;
## c:/web/p1-clean/AntiIntellectualismPart2.html  [1] &quot;c:/web/p1/AntiIntellectualismPart2.html&quot;
## [1] &quot;  &amp;quot;Mr. Bush is the triumph of the seemingly average American man. He’s not an &quot;
## [1] &quot;  &amp;quot;Mr. Bush is the triumph of the seemingly average American man. He&#39;s not an &quot;
## c:/web/p1-clean/AnySize.html  [1] &quot;c:/web/p1/AnySize.html&quot;
## c:/web/p1-clean/ApplyingLikelihoodRatios.html  [1] &quot;c:/web/p1/ApplyingLikelihoodRatios.html&quot;
## c:/web/p1-clean/AppropriateSampleSize.html  [1] &quot;c:/web/p1/AppropriateSampleSize.html&quot;
## c:/web/p1-clean/APRDRGs.html  [1] &quot;c:/web/p1/APRDRGs.html&quot;
## c:/web/p1-clean/arachnologist.html  [1] &quot;c:/web/p1/arachnologist.html&quot;
## c:/web/p1-clean/archive-webinars.html  [1] &quot;c:/web/p1/archive-webinars.html&quot;
## [1] &quot;  turns ï¿½foodï¿½ into a ï¿½delicious dishï¿½. However, meta-analyses are like &quot;
## [1] &quot;  turns i¿1/2foodi¿1/2 into a i¿1/2delicious dishi¿1/2. However, meta-analyses are like &quot;
## [1] &quot;  ï¿½combining data from multiple studies into single estimates of treatment &quot;
## [1] &quot;  i¿1/2combining data from multiple studies into single estimates of treatment &quot;
## [1] &quot;  &lt;p&gt;&lt;b&gt;Reading #1&lt;/b&gt;: von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gï¿½tzsche, P. C., &amp;amp; &quot;
## [1] &quot;  &lt;p&gt;&lt;b&gt;Reading #1&lt;/b&gt;: von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gi¿1/2tzsche, P. C., &amp;amp; &quot;
## [1] &quot;  control group, you need to assess whether the comparison is a fair comparisonï¿½ &quot;
## [1] &quot;  control group, you need to assess whether the comparison is a fair comparisoni¿1/2 &quot;
## c:/web/p1-clean/archive-weblog.html  [1] &quot;c:/web/p1/archive-weblog.html&quot;
## c:/web/p1-clean/Archive.html  [1] &quot;c:/web/p1/Archive.html&quot;
## [1] &quot;  &lt;li&gt; &lt;a href=\&quot;2009-09.html#5\&quot;&gt;Don’t Blame Flu Shots for All Ills, Officials &quot;
## [1] &quot;  &lt;li&gt; &lt;a href=\&quot;2009-09.html#5\&quot;&gt;Don&#39;t Blame Flu Shots for All Ills, Officials &quot;
## c:/web/p1-clean/Archive00.html  [1] &quot;c:/web/p1/Archive00.html&quot;
## c:/web/p1-clean/Archive01.html  [1] &quot;c:/web/p1/Archive01.html&quot;
## c:/web/p1-clean/Archive02.html  [1] &quot;c:/web/p1/Archive02.html&quot;
## c:/web/p1-clean/Archive03.html  [1] &quot;c:/web/p1/Archive03.html&quot;
## c:/web/p1-clean/Archive04.html  [1] &quot;c:/web/p1/Archive04.html&quot;
## c:/web/p1-clean/Archive05.html  [1] &quot;c:/web/p1/Archive05.html&quot;
## c:/web/p1-clean/Archive06.html  [1] &quot;c:/web/p1/Archive06.html&quot;
## c:/web/p1-clean/Archive07.html  [1] &quot;c:/web/p1/Archive07.html&quot;
## [1] &quot;  misconduct: can Australia learn from the UK’s stuttering system? (July 9, &quot;
## [1] &quot;  misconduct: can Australia learn from the UK&#39;s stuttering system? (July 9, &quot;
## c:/web/p1-clean/Archive08.html  [1] &quot;c:/web/p1/Archive08.html&quot;
## [1] &quot;  also have a sort of “model experiment” which contains the values in which I am &quot;
## [1] &quot;  also have a sort of \&quot;model experiment\&quot; which contains the values in which I am &quot;
## [1] &quot;  statistically different from the “model experiment” value.&lt;br&gt;&quot;
## [1] &quot;  statistically different from the \&quot;model experiment\&quot; value.&lt;br&gt;&quot;
## [1] &quot;  measures designs (created 2008-09-25)&lt;/a&gt;. &lt;i&gt;I’ve been struggling with a &quot;
## [1] &quot;  measures designs (created 2008-09-25)&lt;/a&gt;. &lt;i&gt;I&#39;ve been struggling with a &quot;
## [1] &quot;  efforts in helping those of us attempting to learn biostatistics. I’ve been &quot;
## [1] &quot;  efforts in helping those of us attempting to learn biostatistics. I&#39;ve been &quot;
## [1] &quot;  and power analysis. I’m not sure if you are currently accepting questions of &quot;
## [1] &quot;  and power analysis. I&#39;m not sure if you are currently accepting questions of &quot;
## c:/web/p1-clean/Archive09.html  [1] &quot;c:/web/p1/Archive09.html&quot;
## c:/web/p1-clean/Archive10.html  [1] &quot;c:/web/p1/Archive10.html&quot;
## [1] &quot;   12.2, 95% confidence interval [CI] = 1.5ï¿½101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;   12.2, 95% confidence interval [CI] = 1.5i¿1/2101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;   0.8ï¿½5.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;   0.8i¿1/25.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;   US$22,573ï¿½45,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## [1] &quot;   US$22,573i¿1/245,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## c:/web/p1-clean/Archive1999.html  [1] &quot;c:/web/p1/Archive1999.html&quot;
## [1] &quot;  &lt;p&gt;14. &lt;a href=\&quot;pilot.html\&quot;&gt;P.Mean:Â Pilot study (created 1999-09-03, updated 2010-07-08)&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;14. &lt;a href=\&quot;pilot.html\&quot;&gt;P.Mean:  Pilot study (created 1999-09-03, updated 2010-07-08)&lt;/a&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/Archive2000.html  [1] &quot;c:/web/p1/Archive2000.html&quot;
## c:/web/p1-clean/Archive2001.html  [1] &quot;c:/web/p1/Archive2001.html&quot;
## c:/web/p1-clean/Archive2002.html  [1] &quot;c:/web/p1/Archive2002.html&quot;
## c:/web/p1-clean/Archive2003.html  [1] &quot;c:/web/p1/Archive2003.html&quot;
## c:/web/p1-clean/Archive2004.html  [1] &quot;c:/web/p1/Archive2004.html&quot;
## c:/web/p1-clean/Archive2005.html  [1] &quot;c:/web/p1/Archive2005.html&quot;
## c:/web/p1-clean/Archive2006.html  [1] &quot;c:/web/p1/Archive2006.html&quot;
## c:/web/p1-clean/Archive2007.html  [1] &quot;c:/web/p1/Archive2007.html&quot;
## [1] &quot;  misconduct: can Australia learn from the UK’s stuttering system? (July 9, &quot;
## [1] &quot;  misconduct: can Australia learn from the UK&#39;s stuttering system? (July 9, &quot;
## c:/web/p1-clean/Archive2008.html  [1] &quot;c:/web/p1/Archive2008.html&quot;
## [1] &quot;  also have a sort of “model experiment” which contains the values in which I am &quot;
## [1] &quot;  also have a sort of \&quot;model experiment\&quot; which contains the values in which I am &quot;
## [1] &quot;  statistically different from the “model experiment” value.&lt;br&gt;&quot;
## [1] &quot;  statistically different from the \&quot;model experiment\&quot; value.&lt;br&gt;&quot;
## [1] &quot;  measures designs (created 2008-09-25)&lt;/a&gt;. &lt;i&gt;I’ve been struggling with a &quot;
## [1] &quot;  measures designs (created 2008-09-25)&lt;/a&gt;. &lt;i&gt;I&#39;ve been struggling with a &quot;
## [1] &quot;  efforts in helping those of us attempting to learn biostatistics. I’ve been &quot;
## [1] &quot;  efforts in helping those of us attempting to learn biostatistics. I&#39;ve been &quot;
## [1] &quot;  and power analysis. I’m not sure if you are currently accepting questions of &quot;
## [1] &quot;  and power analysis. I&#39;m not sure if you are currently accepting questions of &quot;
## c:/web/p1-clean/Archive2009.html  [1] &quot;c:/web/p1/Archive2009.html&quot;
## c:/web/p1-clean/Archive2010.html  [1] &quot;c:/web/p1/Archive2010.html&quot;
## [1] &quot;   12.2, 95% confidence interval [CI] = 1.5–101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;   12.2, 95% confidence interval [CI] = 1.5-101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;   0.8–5.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;   0.8-5.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;   US$22,573–45,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## [1] &quot;   US$22,573-45,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## c:/web/p1-clean/Archive2011.html  [1] &quot;c:/web/p1/Archive2011.html&quot;
## c:/web/p1-clean/Archive99.html  [1] &quot;c:/web/p1/Archive99.html&quot;
## [1] &quot;  &lt;p&gt;14. &lt;a href=\&quot;pilot.html\&quot;&gt;P.Mean:Â Pilot study (created 1999-09-03, updated 2010-07-08)&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;14. &lt;a href=\&quot;pilot.html\&quot;&gt;P.Mean:  Pilot study (created 1999-09-03, updated 2010-07-08)&lt;/a&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/arguing.html  [1] &quot;c:/web/p1/arguing.html&quot;
## c:/web/p1-clean/array.html  [1] &quot;c:/web/p1/array.html&quot;
## c:/web/p1-clean/ArrayAnalyzer.html  [1] &quot;c:/web/p1/ArrayAnalyzer.html&quot;
## c:/web/p1-clean/artist.html  [1] &quot;c:/web/p1/artist.html&quot;
## c:/web/p1-clean/Asia.html  [1] &quot;c:/web/p1/Asia.html&quot;
## c:/web/p1-clean/AskProfessorMean.html  [1] &quot;c:/web/p1/AskProfessorMean.html&quot;
## c:/web/p1-clean/AssessingExponential-08.html  [1] &quot;c:/web/p1/AssessingExponential-08.html&quot;
## c:/web/p1-clean/AssessingExponential-08a.html  [1] &quot;c:/web/p1/AssessingExponential-08a.html&quot;
## c:/web/p1-clean/asymmetric.html  [1] &quot;c:/web/p1/asymmetric.html&quot;
## c:/web/p1-clean/auc.html  [1] &quot;c:/web/p1/auc.html&quot;
## c:/web/p1-clean/AuthorPays.html  [1] &quot;c:/web/p1/AuthorPays.html&quot;
## [1] &quot;&lt;title&gt;P.Mean:Â Author pays model (created 2011-12-31)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean:  Author pays model (created 2011-12-31)&lt;/title&gt;&quot;
## c:/web/p1-clean/AutomatingAnalyses.html  [1] &quot;c:/web/p1/AutomatingAnalyses.html&quot;
## c:/web/p1-clean/axis.html  [1] &quot;c:/web/p1/axis.html&quot;
## c:/web/p1-clean/backup.html  [1] &quot;c:/web/p1/backup.html&quot;
## c:/web/p1-clean/BadAnalysis-08.html  [1] &quot;c:/web/p1/BadAnalysis-08.html&quot;
## c:/web/p1-clean/BadAnalysis-08a.html  [1] &quot;c:/web/p1/BadAnalysis-08a.html&quot;
## c:/web/p1-clean/BadCalculation.html  [1] &quot;c:/web/p1/BadCalculation.html&quot;
## c:/web/p1-clean/BadControlGroups.html  [1] &quot;c:/web/p1/BadControlGroups.html&quot;
## c:/web/p1-clean/BadData.html  [1] &quot;c:/web/p1/BadData.html&quot;
## c:/web/p1-clean/BadExamples-08.html  [1] &quot;c:/web/p1/BadExamples-08.html&quot;
## c:/web/p1-clean/BadExamples-08a.html  [1] &quot;c:/web/p1/BadExamples-08a.html&quot;
## [1] &quot;  while—pretty much for the entire century so far.&lt;/p&gt;&quot;
## [1] &quot;  while-pretty much for the entire century so far.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;For what it’s worth, I do have a pedagogical bone to pick. I believe it is &quot;
## [1] &quot;  &lt;p&gt;For what it&#39;s worth, I do have a pedagogical bone to pick. I believe it is &quot;
## [1] &quot;  not a good idea to find a “bad” publication and tear it apart. It encourages &quot;
## [1] &quot;  not a good idea to find a \&quot;bad\&quot; publication and tear it apart. It encourages &quot;
## [1] &quot;  “checklist” mentality that seems to be rampant in Evidence Based Medicine. &quot;
## [1] &quot;  \&quot;checklist\&quot; mentality that seems to be rampant in Evidence Based Medicine. &quot;
## c:/web/p1-clean/BadExamples1.html  [1] &quot;c:/web/p1/BadExamples1.html&quot;
## [1] &quot;  while—pretty much for the entire century so far.&lt;/p&gt;&quot;
## [1] &quot;  while-pretty much for the entire century so far.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;For what it’s worth, I do have a pedagogical bone to pick. I believe it is &quot;
## [1] &quot;&lt;p&gt;For what it&#39;s worth, I do have a pedagogical bone to pick. I believe it is &quot;
## [1] &quot;  not a good idea to find a “bad” publication and tear it apart. It encourages &quot;
## [1] &quot;  not a good idea to find a \&quot;bad\&quot; publication and tear it apart. It encourages &quot;
## [1] &quot;  “checklist” mentality that seems to be rampant in Evidence Based Medicine. &quot;
## [1] &quot;  \&quot;checklist\&quot; mentality that seems to be rampant in Evidence Based Medicine. &quot;
## c:/web/p1-clean/badroc.html  [1] &quot;c:/web/p1/badroc.html&quot;
## c:/web/p1-clean/BadSurvey.html  [1] &quot;c:/web/p1/BadSurvey.html&quot;
## c:/web/p1-clean/BalestracciSeminar.html  [1] &quot;c:/web/p1/BalestracciSeminar.html&quot;
## c:/web/p1-clean/barpie.html  [1] &quot;c:/web/p1/barpie.html&quot;
## c:/web/p1-clean/baseline.html  [1] &quot;c:/web/p1/baseline.html&quot;
## c:/web/p1-clean/BaselineAdjustment.html  [1] &quot;c:/web/p1/BaselineAdjustment.html&quot;
## c:/web/p1-clean/BaselineImbalance.html  [1] &quot;c:/web/p1/BaselineImbalance.html&quot;
## c:/web/p1-clean/BasicScientists-08.html  [1] &quot;c:/web/p1/BasicScientists-08.html&quot;
## c:/web/p1-clean/BasicScientists-08a.html  [1] &quot;c:/web/p1/BasicScientists-08a.html&quot;
## c:/web/p1-clean/battles.html  [1] &quot;c:/web/p1/battles.html&quot;
## c:/web/p1-clean/bayesian.html  [1] &quot;c:/web/p1/bayesian.html&quot;
## c:/web/p1-clean/BayesianAccrualModel.html  [1] &quot;c:/web/p1/BayesianAccrualModel.html&quot;
## c:/web/p1-clean/BayesianAnalysis.html  [1] &quot;c:/web/p1/BayesianAnalysis.html&quot;
## c:/web/p1-clean/BayesianStatistics.html  [1] &quot;c:/web/p1/BayesianStatistics.html&quot;
## [1] &quot;      principles. * Provides exercises designed to help reinforce the reader’s &quot;
## [1] &quot;      principles. * Provides exercises designed to help reinforce the reader&#39;s &quot;
## [1] &quot;      additional evidence—for example, of biological plausibility or of biases in &quot;
## [1] &quot;      additional evidence-for example, of biological plausibility or of biases in &quot;
## [1] &quot;      analysis starts with a “prior” probability distribution for the value of &quot;
## [1] &quot;      analysis starts with a \&quot;prior\&quot; probability distribution for the value of &quot;
## [1] &quot;      interest (for example, a true relative risk)—based on previous knowledge—and &quot;
## [1] &quot;      interest (for example, a true relative risk)-based on previous knowledge-and &quot;
## [1] &quot;      adds the new evidence (via a model) to produce a “posterior” probability &quot;
## [1] &quot;      adds the new evidence (via a model) to produce a \&quot;posterior\&quot; probability &quot;
## [1] &quot;      been included for further discussion of specific topics. FDA’s guidance &quot;
## [1] &quot;      been included for further discussion of specific topics. FDA&#39;s guidance &quot;
## [1] &quot;      responsibilities. Instead, guidances describe the Agency’s current thinking on &quot;
## [1] &quot;      responsibilities. Instead, guidances describe the Agency&#39;s current thinking on &quot;
## c:/web/p1-clean/BayesSmallSample.html  [1] &quot;c:/web/p1/BayesSmallSample.html&quot;
## [1] &quot;&lt;title&gt;P.Mean: Can Bayesian methods help with small sample sizes?Â (created 2011-04-20)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean: Can Bayesian methods help with small sample sizes?  (created 2011-04-20)&lt;/title&gt;&quot;
## c:/web/p1-clean/beaches.html  [1] &quot;c:/web/p1/beaches.html&quot;
## c:/web/p1-clean/bed.html  [1] &quot;c:/web/p1/bed.html&quot;
## c:/web/p1-clean/BestEBM.html  [1] &quot;c:/web/p1/BestEBM.html&quot;
## [1] &quot;  &lt;li&gt;John Gabbay, Andrée le May evidence-based guidelines or collectively &quot;
## [1] &quot;  &lt;li&gt;John Gabbay, Andree le May evidence-based guidelines or collectively &quot;
## c:/web/p1-clean/bestfit.html  [1] &quot;c:/web/p1/bestfit.html&quot;
## c:/web/p1-clean/BestModel.html  [1] &quot;c:/web/p1/BestModel.html&quot;
## c:/web/p1-clean/BetaCoefficient.html  [1] &quot;c:/web/p1/BetaCoefficient.html&quot;
## c:/web/p1-clean/bimodality.html  [1] &quot;c:/web/p1/bimodality.html&quot;
## c:/web/p1-clean/binary.html  [1] &quot;c:/web/p1/binary.html&quot;
## c:/web/p1-clean/BinaryCoding.html  [1] &quot;c:/web/p1/BinaryCoding.html&quot;
## c:/web/p1-clean/BindingImage.html  [1] &quot;c:/web/p1/BindingImage.html&quot;
## c:/web/p1-clean/binomial.html  [1] &quot;c:/web/p1/binomial.html&quot;
## c:/web/p1-clean/biography.html  [1] &quot;c:/web/p1/biography.html&quot;
## c:/web/p1-clean/BioinformaticsDegree.html  [1] &quot;c:/web/p1/BioinformaticsDegree.html&quot;
## c:/web/p1-clean/BiostatisticsPrograms.html  [1] &quot;c:/web/p1/BiostatisticsPrograms.html&quot;
## c:/web/p1-clean/BiplotFunction.html  [1] &quot;c:/web/p1/BiplotFunction.html&quot;
## c:/web/p1-clean/BiplotResources.html  [1] &quot;c:/web/p1/BiplotResources.html&quot;
## c:/web/p1-clean/blank.html  [1] &quot;c:/web/p1/blank.html&quot;
## c:/web/p1-clean/blind.html  [1] &quot;c:/web/p1/blind.html&quot;
## c:/web/p1-clean/BlindingInResearch.html  [1] &quot;c:/web/p1/BlindingInResearch.html&quot;
## c:/web/p1-clean/BlockRandomization.html  [1] &quot;c:/web/p1/BlockRandomization.html&quot;
## c:/web/p1-clean/bonferroni.html  [1] &quot;c:/web/p1/bonferroni.html&quot;
## c:/web/p1-clean/BookSales.html  [1] &quot;c:/web/p1/BookSales.html&quot;
## c:/web/p1-clean/BookSpss.html  [1] &quot;c:/web/p1/BookSpss.html&quot;
## c:/web/p1-clean/BookTitle.html  [1] &quot;c:/web/p1/BookTitle.html&quot;
## [1] &quot;&lt;title&gt;P.Mean: Thinking about the title for my second bookÂ (created 2011-04-11)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean: Thinking about the title for my second book  (created 2011-04-11)&lt;/title&gt;&quot;
## c:/web/p1-clean/BookUpdate.html  [1] &quot;c:/web/p1/BookUpdate.html&quot;
## c:/web/p1-clean/bootstrap.html  [1] &quot;c:/web/p1/bootstrap.html&quot;
## c:/web/p1-clean/BootstrapStandardError-08.html  [1] &quot;c:/web/p1/BootstrapStandardError-08.html&quot;
## c:/web/p1-clean/BootstrapStandardError-08a.html  [1] &quot;c:/web/p1/BootstrapStandardError-08a.html&quot;
## c:/web/p1-clean/borderline.html  [1] &quot;c:/web/p1/borderline.html&quot;
## c:/web/p1-clean/BoxQuote.html  [1] &quot;c:/web/p1/BoxQuote.html&quot;
## c:/web/p1-clean/branson.html  [1] &quot;c:/web/p1/branson.html&quot;
## c:/web/p1-clean/briefbio.html  [1] &quot;c:/web/p1/briefbio.html&quot;
## c:/web/p1-clean/BugsBetaBinomial.html  [1] &quot;c:/web/p1/BugsBetaBinomial.html&quot;
## c:/web/p1-clean/BugsVersions.html  [1] &quot;c:/web/p1/BugsVersions.html&quot;
## c:/web/p1-clean/BusinessAspects.html  [1] &quot;c:/web/p1/BusinessAspects.html&quot;
## c:/web/p1-clean/BusinessCard.html  [1] &quot;c:/web/p1/BusinessCard.html&quot;
## c:/web/p1-clean/CalculatingNnt-08.html  [1] &quot;c:/web/p1/CalculatingNnt-08.html&quot;
## c:/web/p1-clean/CalculatingNnt-08a.html  [1] &quot;c:/web/p1/CalculatingNnt-08a.html&quot;
## c:/web/p1-clean/CalculatingRates.html  [1] &quot;c:/web/p1/CalculatingRates.html&quot;
## c:/web/p1-clean/CalculatingWeights.html  [1] &quot;c:/web/p1/CalculatingWeights.html&quot;
## c:/web/p1-clean/CalculationsDiagnosticTest.html  [1] &quot;c:/web/p1/CalculationsDiagnosticTest.html&quot;
## c:/web/p1-clean/calendar.html  [1] &quot;c:/web/p1/calendar.html&quot;
## c:/web/p1-clean/CanIAsk.html  [1] &quot;c:/web/p1/CanIAsk.html&quot;
## [1] &quot;  attempting to learn biostatistics. I’ve been struggling with a design/analysis &quot;
## [1] &quot;  attempting to learn biostatistics. I&#39;ve been struggling with a design/analysis &quot;
## [1] &quot;  question related to repeated measures design and power analysis. I’m not sure &quot;
## [1] &quot;  question related to repeated measures design and power analysis. I&#39;m not sure &quot;
## c:/web/p1-clean/CanIRun-08.html  [1] &quot;c:/web/p1/CanIRun-08.html&quot;
## c:/web/p1-clean/CanIRun-08a.html  [1] &quot;c:/web/p1/CanIRun-08a.html&quot;
## c:/web/p1-clean/CanIStop.html  [1] &quot;c:/web/p1/CanIStop.html&quot;
## c:/web/p1-clean/CanIUseYou.html  [1] &quot;c:/web/p1/CanIUseYou.html&quot;
## c:/web/p1-clean/cardiology.html  [1] &quot;c:/web/p1/cardiology.html&quot;
## c:/web/p1-clean/Career.html  [1] &quot;c:/web/p1/Career.html&quot;
## c:/web/p1-clean/CaseCohort.html  [1] &quot;c:/web/p1/CaseCohort.html&quot;
## c:/web/p1-clean/CaseControl.html  [1] &quot;c:/web/p1/CaseControl.html&quot;
## c:/web/p1-clean/CaseStudies-08.html  [1] &quot;c:/web/p1/CaseStudies-08.html&quot;
## c:/web/p1-clean/CaseStudies-08a.html  [1] &quot;c:/web/p1/CaseStudies-08a.html&quot;
## c:/web/p1-clean/CaseStudiesChildren.html  [1] &quot;c:/web/p1/CaseStudiesChildren.html&quot;
## c:/web/p1-clean/CaseStudyOfAccrual.html  [1] &quot;c:/web/p1/CaseStudyOfAccrual.html&quot;
## c:/web/p1-clean/CaseStudyOfAccrualPart2.html  [1] &quot;c:/web/p1/CaseStudyOfAccrualPart2.html&quot;
## c:/web/p1-clean/categorical.html  [1] &quot;c:/web/p1/categorical.html&quot;
## c:/web/p1-clean/CategorizingEntropy.html  [1] &quot;c:/web/p1/CategorizingEntropy.html&quot;
## c:/web/p1-clean/CategorizingWeblog.html  [1] &quot;c:/web/p1/CategorizingWeblog.html&quot;
## c:/web/p1-clean/causation.html  [1] &quot;c:/web/p1/causation.html&quot;
## c:/web/p1-clean/CensoredValues.html  [1] &quot;c:/web/p1/CensoredValues.html&quot;
## c:/web/p1-clean/CenteringData.html  [1] &quot;c:/web/p1/CenteringData.html&quot;
## c:/web/p1-clean/CentralLineInfections.html  [1] &quot;c:/web/p1/CentralLineInfections.html&quot;
## c:/web/p1-clean/centroids.html  [1] &quot;c:/web/p1/centroids.html&quot;
## c:/web/p1-clean/cer.html  [1] &quot;c:/web/p1/cer.html&quot;
## [1] &quot;&lt;title&gt;P.Mean: Resources for Comparative Effectiveness ResearchÂ (created 2011-04-13)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean: Resources for Comparative Effectiveness Research  (created 2011-04-13)&lt;/title&gt;&quot;
## c:/web/p1-clean/ChanceNews.html  [1] &quot;c:/web/p1/ChanceNews.html&quot;
## c:/web/p1-clean/ChanceNews1.html  [1] &quot;c:/web/p1/ChanceNews1.html&quot;
## c:/web/p1-clean/ChanceWiki.html  [1] &quot;c:/web/p1/ChanceWiki.html&quot;
## c:/web/p1-clean/ChanceWikiA.html  [1] &quot;c:/web/p1/ChanceWikiA.html&quot;
## c:/web/p1-clean/ChandraCasestudy.html  [1] &quot;c:/web/p1/ChandraCasestudy.html&quot;
## c:/web/p1-clean/change.html  [1] &quot;c:/web/p1/change.html&quot;
## c:/web/p1-clean/ChangedYourMind-08.html  [1] &quot;c:/web/p1/ChangedYourMind-08.html&quot;
## c:/web/p1-clean/ChangedYourMind-08a.html  [1] &quot;c:/web/p1/ChangedYourMind-08a.html&quot;
## c:/web/p1-clean/ChangesStatL.html  [1] &quot;c:/web/p1/ChangesStatL.html&quot;
## c:/web/p1-clean/Chapter01.html  [1] &quot;c:/web/p1/Chapter01.html&quot;
## c:/web/p1-clean/Chapter01a.html  [1] &quot;c:/web/p1/Chapter01a.html&quot;
## [1] &quot;   ‘treatment’ in this book, feel free to substitute the word ‘‘exposure’’ and &quot;
## [1] &quot;   &#39;treatment&#39; in this book, feel free to substitute the word &#39;&#39;exposure&#39;&#39; and &quot;
## c:/web/p1-clean/Chapter01b.html  [1] &quot;c:/web/p1/Chapter01b.html&quot;
## [1] &quot;   stiffness, Lequesne’s functional index, time for climbing up ten steps, as &quot;
## [1] &quot;   stiffness, Lequesne&#39;s functional index, time for climbing up ten steps, as &quot;
## [1] &quot;   well as physician’s and patients’ overall opinions on improvement.&lt;/p&gt;&quot;
## [1] &quot;   well as physician&#39;s and patients&#39; overall opinions on improvement.&lt;/p&gt;&quot;
## [1] &quot;   such a serious imbalance, and a total of 20–40 subjects would be acceptable &quot;
## [1] &quot;   such a serious imbalance, and a total of 20-40 subjects would be acceptable &quot;
## [1] &quot;   order. Attach a random number to each patient’s name. Then sort the patient &quot;
## [1] &quot;   order. Attach a random number to each patient&#39;s name. Then sort the patient &quot;
## [1] &quot;   ‘desirable’ group. Unblinded allocation schemes tend, on average to overstate &quot;
## [1] &quot;   &#39;desirable&#39; group. Unblinded allocation schemes tend, on average to overstate &quot;
## [1] &quot;   the effectiveness of the new therapy by 30–40% (Schulz 1996).&lt;/p&gt;&quot;
## [1] &quot;   the effectiveness of the new therapy by 30-40% (Schulz 1996).&lt;/p&gt;&quot;
## [1] &quot;   Genetic conditions like Down’s syndrome cannot be randomly assigned to half &quot;
## [1] &quot;   Genetic conditions like Down&#39;s syndrome cannot be randomly assigned to half &quot;
## [1] &quot;   faster at first. It will extend into the neighboring cabbage’s territory, &quot;
## [1] &quot;   faster at first. It will extend into the neighboring cabbage&#39;s territory, &quot;
## c:/web/p1-clean/Chapter01c.html  [1] &quot;c:/web/p1/Chapter01c.html&quot;
## [1] &quot;   (Henquet 2005), a sample of young adults aged 14–24 years were divided into a &quot;
## [1] &quot;   (Henquet 2005), a sample of young adults aged 14-24 years were divided into a &quot;
## [1] &quot;   extremely large. As a rough rule of thumb, you need to observe 25–50 outcomes &quot;
## [1] &quot;   extremely large. As a rough rule of thumb, you need to observe 25-50 outcomes &quot;
## [1] &quot;  &lt;p&gt;You want to avoid ‘leaky groups’ in a cohort design. If the exposure group &quot;
## [1] &quot;  &lt;p&gt;You want to avoid &#39;leaky groups&#39; in a cohort design. If the exposure group &quot;
## [1] &quot;   example, within the same family, males (especially boys aged 11–17 years) &quot;
## [1] &quot;   example, within the same family, males (especially boys aged 11-17 years) &quot;
## [1] &quot;  &lt;p&gt;If you have ‘leaky groups’ in a case-control design, this can cause &quot;
## [1] &quot;  &lt;p&gt;If you have &#39;leaky groups&#39; in a case-control design, this can cause &quot;
## [1] &quot;  &lt;p&gt;Patients with milder forms of Alzheimer’s disease may not bother to seek &quot;
## [1] &quot;  &lt;p&gt;Patients with milder forms of Alzheimer&#39;s disease may not bother to seek &quot;
## [1] &quot;   patients’ ability to live and function independently will you encounter such &quot;
## [1] &quot;   patients&#39; ability to live and function independently will you encounter such &quot;
## [1] &quot;   Don’t let this bother you too much, though. The mathematics that justify the &quot;
## [1] &quot;   Don&#39;t let this bother you too much, though. The mathematics that justify the &quot;
## [1] &quot;   cause of Reye’s syndrome (Monto 1999). It is hard to imagine how a randomized &quot;
## [1] &quot;   cause of Reye&#39;s syndrome (Monto 1999). It is hard to imagine how a randomized &quot;
## [1] &quot;   trial for Reye’s syndrome could have been done, because you would have to &quot;
## [1] &quot;   trial for Reye&#39;s syndrome could have been done, because you would have to &quot;
## c:/web/p1-clean/Chapter01d.html  [1] &quot;c:/web/p1/Chapter01d.html&quot;
## c:/web/p1-clean/Chapter02.html  [1] &quot;c:/web/p1/Chapter02.html&quot;
## c:/web/p1-clean/Chapter03.html  [1] &quot;c:/web/p1/Chapter03.html&quot;
## c:/web/p1-clean/Chapter04.html  [1] &quot;c:/web/p1/Chapter04.html&quot;
## c:/web/p1-clean/Chapter05.html  [1] &quot;c:/web/p1/Chapter05.html&quot;
## c:/web/p1-clean/Chapter06.html  [1] &quot;c:/web/p1/Chapter06.html&quot;
## c:/web/p1-clean/Chapter07.html  [1] &quot;c:/web/p1/Chapter07.html&quot;
## c:/web/p1-clean/CheckingChisquare.html  [1] &quot;c:/web/p1/CheckingChisquare.html&quot;
## c:/web/p1-clean/CheckMetadata.html  [1] &quot;c:/web/p1/CheckMetadata.html&quot;
## c:/web/p1-clean/CherryPicking.html  [1] &quot;c:/web/p1/CherryPicking.html&quot;
## c:/web/p1-clean/ChildrenInResearch.html  [1] &quot;c:/web/p1/ChildrenInResearch.html&quot;
## c:/web/p1-clean/china_pictures.html  [1] &quot;c:/web/p1/china_pictures.html&quot;
## c:/web/p1-clean/chisquared.html  [1] &quot;c:/web/p1/chisquared.html&quot;
## c:/web/p1-clean/Chores.html  [1] &quot;c:/web/p1/Chores.html&quot;
## c:/web/p1-clean/CIforP.html  [1] &quot;c:/web/p1/CIforP.html&quot;
## [1] &quot;  &lt;p&gt;H M Hung, R T O&#39;Neill, P Bauer, K Kï¿½hne. &lt;b&gt;The behavior of the P-value &quot;
## [1] &quot;  &lt;p&gt;H M Hung, R T O&#39;Neill, P Bauer, K Ki¿1/2hne. &lt;b&gt;The behavior of the P-value &quot;
## c:/web/p1-clean/circle2.html  [1] &quot;c:/web/p1/circle2.html&quot;
## c:/web/p1-clean/circular.html  [1] &quot;c:/web/p1/circular.html&quot;
## c:/web/p1-clean/CisSearch.html  [1] &quot;c:/web/p1/CisSearch.html&quot;
## [1] &quot;      Gönen, Mithat, Johnson, Wesley O., Lu, Yonggang and Westfall, Peter H. (2005). The &quot;
## [1] &quot;      Gonen, Mithat, Johnson, Wesley O., Lu, Yonggang and Westfall, Peter H. (2005). The &quot;
## [1] &quot;      and Balakrishnan, N. (ed.). Birkh?¤user Verlag (Basel; Cambridge, MA). Keywords: &quot;
## [1] &quot;      and Balakrishnan, N. (ed.). Birkh?*user Verlag (Basel; Cambridge, MA). Keywords: &quot;
## [1] &quot;      Conference, 209-222. Råde, Lennart (ed.) and Rade, Lennart (ed.). Almquist &amp;amp; Wiksell &quot;
## [1] &quot;      Conference, 209-222. Rade, Lennart (ed.) and Rade, Lennart (ed.). Almquist &amp;amp; Wiksell &quot;
## c:/web/p1-clean/citation.html  [1] &quot;c:/web/p1/citation.html&quot;
## c:/web/p1-clean/CitingSoftware.html  [1] &quot;c:/web/p1/CitingSoftware.html&quot;
## c:/web/p1-clean/ClassicReferences.html  [1] &quot;c:/web/p1/ClassicReferences.html&quot;
## [1] &quot;Assn. 53:457ï¿½481, 1958. This paper started a major branch of Statistics, &quot;
## [1] &quot;Assn. 53:457i¿1/2481, 1958. This paper started a major branch of Statistics, &quot;
## [1] &quot;cervix. J Natl Cancer Inst 11: 1269ï¿½1275. This paper demonstrated that the odds &quot;
## [1] &quot;cervix. J Natl Cancer Inst 11: 1269i¿1/21275. This paper demonstrated that the odds &quot;
## [1] &quot;(1982) &amp;quot;Random-Effects Models for Longitudinal Data&amp;quot;, Biometrics, 38, 963ï¿½974. &quot;
## [1] &quot;(1982) &amp;quot;Random-Effects Models for Longitudinal Data&amp;quot;, Biometrics, 38, 963i¿1/2974. &quot;
## [1] &quot;measurement&amp;quot;. Lancet 1 (8476): 307ï¿½10. This paper showed a simple graphical &quot;
## [1] &quot;measurement&amp;quot;. Lancet 1 (8476): 307i¿1/210. This paper showed a simple graphical &quot;
## c:/web/p1-clean/ClassicReferencesForEbm.html  [1] &quot;c:/web/p1/ClassicReferencesForEbm.html&quot;
## c:/web/p1-clean/classroom.html  [1] &quot;c:/web/p1/classroom.html&quot;
## c:/web/p1-clean/ClinicalImportance-05.html  [1] &quot;c:/web/p1/ClinicalImportance-05.html&quot;
## c:/web/p1-clean/ClinicalImportance-category.html  [1] &quot;c:/web/p1/ClinicalImportance-category.html&quot;
## [1] &quot;  &lt;p name=\&quot;Moynihan\&quot;&gt;&lt;a name=\&quot;Moynihan\&quot;&gt;&lt;/a&gt;Journal article: Ray Moynihan. &lt;b&gt;Surrogates under scrutiny: fallible correlations, fatal consequences&lt;/b&gt; BMJ. 2011;343:d5160. &lt;i&gt;Excerpt: \&quot;We live in a time when much disease is measured not by symptoms but by numbers, determined by biomarkers in our blood or bone.  Transforming a healthy person&#39;s risk of disease into a chronic condition has been a key characteristic of modern medicine, creating vast new markets for &#39;preventive&#39; pills designed to reduce suffering and extend life. The annual global spend on cholesterol lowering drugs alone has exceeded Â£10bn (â‚¬11bn; $16bn), while more generally widening definitions and lowering thresholds continue to expand the patient pool.  Well funded campaigns urge the public to know their numbers, and professionals are rewarded for treating to target. Yet the grand assumption underpinning this approachâ\200”that helping a person&#39;s numbers will automatically improve their healthâ\200”is a delusion as dangerous as it is seductive.\&quot;&lt;/i&gt; [Accessed on August 22, 2011]. &lt;a href=\&quot;http://www.bmj.com/content/343/bmj.d5160.extract\&quot;&gt;http://www.bmj.com/content/343/bmj.d5160.extract&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p name=\&quot;Moynihan\&quot;&gt;&lt;a name=\&quot;Moynihan\&quot;&gt;&lt;/a&gt;Journal article: Ray Moynihan. &lt;b&gt;Surrogates under scrutiny: fallible correlations, fatal consequences&lt;/b&gt; BMJ. 2011;343:d5160. &lt;i&gt;Excerpt: \&quot;We live in a time when much disease is measured not by symptoms but by numbers, determined by biomarkers in our blood or bone.  Transforming a healthy person&#39;s risk of disease into a chronic condition has been a key characteristic of modern medicine, creating vast new markets for &#39;preventive&#39; pills designed to reduce suffering and extend life. The annual global spend on cholesterol lowering drugs alone has exceeded  lb10bn (â‚¬11bn; $16bn), while more generally widening definitions and lowering thresholds continue to expand the patient pool.  Well funded campaigns urge the public to know their numbers, and professionals are rewarded for treating to target. Yet the grand assumption underpinning this approachâ\200\&quot;that helping a person&#39;s numbers will automatically improve their healthâ\200\&quot;is a delusion as dangerous as it is seductive.\&quot;&lt;/i&gt; [Accessed on August 22, 2011]. &lt;a href=\&quot;http://www.bmj.com/content/343/bmj.d5160.extract\&quot;&gt;http://www.bmj.com/content/343/bmj.d5160.extract&lt;/a&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/ClinicalImportanceA.html  [1] &quot;c:/web/p1/ClinicalImportanceA.html&quot;
## c:/web/p1-clean/ClinicallyTrivial.html  [1] &quot;c:/web/p1/ClinicallyTrivial.html&quot;
## c:/web/p1-clean/ClinicalResearchTrack.html  [1] &quot;c:/web/p1/ClinicalResearchTrack.html&quot;
## [1] &quot;ï»¿&lt;html&gt;&quot;
## [1] &quot;i»¿&lt;html&gt;&quot;
## c:/web/p1-clean/Cloggers.html  [1] &quot;c:/web/p1/Cloggers.html&quot;
## c:/web/p1-clean/ClopperPearson.html  [1] &quot;c:/web/p1/ClopperPearson.html&quot;
## c:/web/p1-clean/ClosedForm.html  [1] &quot;c:/web/p1/ClosedForm.html&quot;
## c:/web/p1-clean/clt-04.html  [1] &quot;c:/web/p1/clt-04.html&quot;
## c:/web/p1-clean/clt-13.html  [1] &quot;c:/web/p1/clt-13.html&quot;
## c:/web/p1-clean/ClumsyAnonymization.html  [1] &quot;c:/web/p1/ClumsyAnonymization.html&quot;
## [1] &quot;   was shocked to hear that AOL had saved and published three months’ worth of &quot;
## [1] &quot;   was shocked to hear that AOL had saved and published three months&#39; worth of &quot;
## [1] &quot;   them. “My goodness, it’s my whole personal life,” she said. “I had no idea &quot;
## [1] &quot;   them. \&quot;My goodness, it&#39;s my whole personal life,\&quot; she said. \&quot;I had no idea &quot;
## [1] &quot;   somebody was looking over my shoulder.”&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;   somebody was looking over my shoulder.\&quot;&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;  Data Encryption Tutorial — Lesson 1&lt;/a&gt;&lt;/strong&gt;. Julie Meloni. Accessed on &quot;
## [1] &quot;  Data Encryption Tutorial - Lesson 1&lt;/a&gt;&lt;/strong&gt;. Julie Meloni. Accessed on &quot;
## c:/web/p1-clean/cluster-03.html  [1] &quot;c:/web/p1/cluster-03.html&quot;
## c:/web/p1-clean/cluster-04.html  [1] &quot;c:/web/p1/cluster-04.html&quot;
## c:/web/p1-clean/ClusteringAlgorithms.html  [1] &quot;c:/web/p1/ClusteringAlgorithms.html&quot;
## c:/web/p1-clean/ClusterSize.html  [1] &quot;c:/web/p1/ClusterSize.html&quot;
## c:/web/p1-clean/Coauthorship.html  [1] &quot;c:/web/p1/Coauthorship.html&quot;
## c:/web/p1-clean/CodeForNewSlideRule.html  [1] &quot;c:/web/p1/CodeForNewSlideRule.html&quot;
## c:/web/p1-clean/CoefficientDetermination.html  [1] &quot;c:/web/p1/CoefficientDetermination.html&quot;
## c:/web/p1-clean/Collage.html  [1] &quot;c:/web/p1/Collage.html&quot;
## c:/web/p1-clean/CollectionStudies.html  [1] &quot;c:/web/p1/CollectionStudies.html&quot;
## c:/web/p1-clean/collinearity.html  [1] &quot;c:/web/p1/collinearity.html&quot;
## c:/web/p1-clean/ColloquialTone.html  [1] &quot;c:/web/p1/ColloquialTone.html&quot;
## c:/web/p1-clean/ColorsForR.html  [1] &quot;c:/web/p1/ColorsForR.html&quot;
## c:/web/p1-clean/ComingSoon.html  [1] &quot;c:/web/p1/ComingSoon.html&quot;
## c:/web/p1-clean/CompetingBooks.html  [1] &quot;c:/web/p1/CompetingBooks.html&quot;
## c:/web/p1-clean/complex-03.html  [1] &quot;c:/web/p1/complex-03.html&quot;
## c:/web/p1-clean/complex-16.html  [1] &quot;c:/web/p1/complex-16.html&quot;
## c:/web/p1-clean/ComplexDesigns.html  [1] &quot;c:/web/p1/ComplexDesigns.html&quot;
## c:/web/p1-clean/compliments.html  [1] &quot;c:/web/p1/compliments.html&quot;
## [1] &quot;  &lt;p&gt;&lt;b&gt;July 20, 2007&lt;/b&gt;. I also want to thank you for your “Ask Professor &quot;
## [1] &quot;  &lt;p&gt;&lt;b&gt;July 20, 2007&lt;/b&gt;. I also want to thank you for your \&quot;Ask Professor &quot;
## [1] &quot;   Mean” website; it is like having a life-line when drowning in a sea of &quot;
## [1] &quot;   Mean\&quot; website; it is like having a life-line when drowning in a sea of &quot;
## c:/web/p1-clean/composite.html  [1] &quot;c:/web/p1/composite.html&quot;
## c:/web/p1-clean/CompoundInterest.html  [1] &quot;c:/web/p1/CompoundInterest.html&quot;
## c:/web/p1-clean/ComputationalTrack.html  [1] &quot;c:/web/p1/ComputationalTrack.html&quot;
## c:/web/p1-clean/ComputingDifference.html  [1] &quot;c:/web/p1/ComputingDifference.html&quot;
## c:/web/p1-clean/ComputingPercentiles-08.html  [1] &quot;c:/web/p1/ComputingPercentiles-08.html&quot;
## c:/web/p1-clean/ComputingPercentiles-08a.html  [1] &quot;c:/web/p1/ComputingPercentiles-08a.html&quot;
## c:/web/p1-clean/Conference.html  [1] &quot;c:/web/p1/Conference.html&quot;
## c:/web/p1-clean/ConferenceMaterials.html  [1] &quot;c:/web/p1/ConferenceMaterials.html&quot;
## c:/web/p1-clean/confid.html  [1] &quot;c:/web/p1/confid.html&quot;
## c:/web/p1-clean/confidence-04.html  [1] &quot;c:/web/p1/confidence-04.html&quot;
## c:/web/p1-clean/confidence-99.html  [1] &quot;c:/web/p1/confidence-99.html&quot;
## c:/web/p1-clean/ConfidenceInterval-05.html  [1] &quot;c:/web/p1/ConfidenceInterval-05.html&quot;
## c:/web/p1-clean/ConfidenceInterval-08.html  [1] &quot;c:/web/p1/ConfidenceInterval-08.html&quot;
## c:/web/p1-clean/ConfidenceIntervalA.html  [1] &quot;c:/web/p1/ConfidenceIntervalA.html&quot;
## c:/web/p1-clean/ConfidenceIntervalB.html  [1] &quot;c:/web/p1/ConfidenceIntervalB.html&quot;
## [1] &quot;    at 3–7 months postpartum and again at 7–12 months postpartum to determine &quot;
## [1] &quot;    at 3-7 months postpartum and again at 7-12 months postpartum to determine &quot;
## [1] &quot;    confidence interval [CI], 0.08–0.47), and mother foreign-born (AOR, 4.90; &quot;
## [1] &quot;    confidence interval [CI], 0.08-0.47), and mother foreign-born (AOR, 4.90; &quot;
## [1] &quot;    95% CI, 2.38–10.10). Twenty-five percent of study participants who did not &quot;
## [1] &quot;    95% CI, 2.38-10.10). Twenty-five percent of study participants who did not &quot;
## [1] &quot;    ratio [HR], 0.55; 95% CI 0.39–0.77) increasing maternal age (HR for 5-year &quot;
## [1] &quot;    ratio [HR], 0.55; 95% CI 0.39-0.77) increasing maternal age (HR for 5-year &quot;
## [1] &quot;    increments, 0.80; 95% CI, 0.69–0.92), and infant birth weight &amp;#8805; 2500 grams &quot;
## [1] &quot;    increments, 0.80; 95% CI, 0.69-0.92), and infant birth weight &amp;#8805; 2500 grams &quot;
## [1] &quot;    (HR, 0.45; 95% CI, 0.26–0.80). &lt;b&gt;Conclusions:&lt;/b&gt; Breastfeeding initiation &quot;
## [1] &quot;    (HR, 0.45; 95% CI, 0.26-0.80). &lt;b&gt;Conclusions:&lt;/b&gt; Breastfeeding initiation &quot;
## [1] &quot;    Jamtvedt G., Bjørndal A. &lt;i&gt;BMC Medical Education 2003&lt;/i&gt;, 3:2 (13 March &quot;
## [1] &quot;    Jamtvedt G., Bjorndal A. &lt;i&gt;BMC Medical Education 2003&lt;/i&gt;, 3:2 (13 March &quot;
## [1] &quot;    Mean difference of 0.4 (95% CI: 0.2–0.6) in the score for knowledge about &quot;
## [1] &quot;    Mean difference of 0.4 (95% CI: 0.2-0.6) in the score for knowledge about &quot;
## [1] &quot;    EBM-resources and mean difference of 0.2 (95% CI: 0.0–0.3) in the score for &quot;
## [1] &quot;    EBM-resources and mean difference of 0.2 (95% CI: 0.0-0.3) in the score for &quot;
## [1] &quot;    BMI as normal weight (18.5–&amp;lt;25), overweight (25–&amp;lt;30), obesity class I &quot;
## [1] &quot;    BMI as normal weight (18.5-&amp;lt;25), overweight (25-&amp;lt;30), obesity class I &quot;
## [1] &quot;    (30–&amp;lt;35), obesity class II (35–&amp;lt;40), and obesity class III (&amp;#8805; 40). Interval &quot;
## [1] &quot;    (30-&amp;lt;35), obesity class II (35-&amp;lt;40), and obesity class III (&amp;#8805; 40). Interval &quot;
## [1] &quot;    overweight (odds ratio [OR] 1.25, 95% CI = 1.05–1.51) and obesity class I &quot;
## [1] &quot;    overweight (odds ratio [OR] 1.25, 95% CI = 1.05-1.51) and obesity class I &quot;
## [1] &quot;    (OR = 1.21, 95% CI = 1.03–1.75) categories were more likely to have &quot;
## [1] &quot;    (OR = 1.21, 95% CI = 1.03-1.75) categories were more likely to have &quot;
## [1] &quot;    obesity class I (OR = 0.86, 95%CI = 0.78–0.94) and II (OR = 0.88, 95%CI = &quot;
## [1] &quot;    obesity class I (OR = 0.86, 95%CI = 0.78-0.94) and II (OR = 0.88, 95%CI = &quot;
## [1] &quot;    0.79–0.99) categories were less likely to have obtained a screening SIG &quot;
## [1] &quot;    0.79-0.99) categories were less likely to have obtained a screening SIG &quot;
## [1] &quot;    colitis (95% CI for the difference: 8.9% – 15%). In patients with Crohn&#39;s &quot;
## [1] &quot;    colitis (95% CI for the difference: 8.9% - 15%). In patients with Crohn&#39;s &quot;
## [1] &quot;    1.04, 95% CI 0.96 – 1.13) &lt;b&gt;Conclusion:&lt;/b&gt; The offer of a prize draw &quot;
## [1] &quot;    1.04, 95% CI 0.96 - 1.13) &lt;b&gt;Conclusion:&lt;/b&gt; The offer of a prize draw &quot;
## [1] &quot;    points (95% CI 0.65, 2.00) on a scale from 0–23. Subsequent item analysis &quot;
## [1] &quot;    points (95% CI 0.65, 2.00) on a scale from 0-23. Subsequent item analysis &quot;
## [1] &quot;    extubation (odds ratio = 12.2, 95% confidence interval [CI] = 1.5–101; P &amp;lt; &quot;
## [1] &quot;    extubation (odds ratio = 12.2, 95% confidence interval [CI] = 1.5-101; P &amp;lt; &quot;
## [1] &quot;    ratio = 2.1, 95% CI = 0.8–5.4; P &amp;lt; 0.15). Total hospital costs (estimated &quot;
## [1] &quot;    ratio = 2.1, 95% CI = 0.8-5.4; P &amp;lt; 0.15). Total hospital costs (estimated &quot;
## [1] &quot;    US$33,926 (95% CI = US$22,573–45,280; P &amp;lt; 0.01). &lt;b&gt;Conclusion:&lt;/b&gt; &quot;
## [1] &quot;    US$33,926 (95% CI = US$22,573-45,280; P &amp;lt; 0.01). &lt;b&gt;Conclusion:&lt;/b&gt; &quot;
## c:/web/p1-clean/ConfidenceIntervalForRate.html  [1] &quot;c:/web/p1/ConfidenceIntervalForRate.html&quot;
## c:/web/p1-clean/ConfidenceIntervals-04.html  [1] &quot;c:/web/p1/ConfidenceIntervals-04.html&quot;
## c:/web/p1-clean/ConfidenceIntervals-category.html  [1] &quot;c:/web/p1/ConfidenceIntervals-category.html&quot;
## [1] &quot;      are ;linear combinations of unknown parameters &amp;#946;1,&amp;#946;2,ï¿½,&amp;#946;pand that the joint &quot;
## [1] &quot;      are ;linear combinations of unknown parameters &amp;#946;1,&amp;#946;2,i¿1/2,&amp;#946;pand that the joint &quot;
## c:/web/p1-clean/conflict.html  [1] &quot;c:/web/p1/conflict.html&quot;
## c:/web/p1-clean/conflict1.html  [1] &quot;c:/web/p1/conflict1.html&quot;
## c:/web/p1-clean/ConflictingAnalyses.html  [1] &quot;c:/web/p1/ConflictingAnalyses.html&quot;
## c:/web/p1-clean/ConflictInterest.html  [1] &quot;c:/web/p1/ConflictInterest.html&quot;
## [1] &quot;    “Normally grants are given to study what [agent] looks most promising,” &quot;
## [1] &quot;    \&quot;Normally grants are given to study what [agent] looks most promising,\&quot; &quot;
## [1] &quot;    Quackwatch.org Web site. “There is very little discrimination, none by this &quot;
## [1] &quot;    Quackwatch.org Web site. \&quot;There is very little discrimination, none by this &quot;
## [1] &quot;    ought to be assigned on the basis of promise.” Barrett also raised &quot;
## [1] &quot;    ought to be assigned on the basis of promise.\&quot; Barrett also raised &quot;
## [1] &quot;    Alternative Medicine, a cosponsor of the report. “It&#39;s extremely important &quot;
## [1] &quot;    Alternative Medicine, a cosponsor of the report. \&quot;It&#39;s extremely important &quot;
## [1] &quot;    to look at the composition of this committee,” he said.&lt;/i&gt; Rebecca Voelker,&quot;
## [1] &quot;    to look at the composition of this committee,\&quot; he said.&lt;/i&gt; Rebecca Voelker,&quot;
## [1] &quot;    EPA’s implementation of the Clean Air or Water Acts or the Superfund &quot;
## [1] &quot;    EPA&#39;s implementation of the Clean Air or Water Acts or the Superfund &quot;
## c:/web/p1-clean/ConflictInterestA.html  [1] &quot;c:/web/p1/ConflictInterestA.html&quot;
## c:/web/p1-clean/ConflictOfInterest-06.html  [1] &quot;c:/web/p1/ConflictOfInterest-06.html&quot;
## c:/web/p1-clean/ConflictOfInterest-category.html  [1] &quot;c:/web/p1/ConflictOfInterest-category.html&quot;
## [1] &quot;  &lt;p&gt;Journal article: Elizabeth A. &lt;a name=\&quot;Boyd\&quot;&gt;&lt;/a&gt;Boyd, Lisa A. Bero. &lt;b&gt;Assessing Faculty Financial Relationships With Industry&lt;/b&gt; JAMA: The Journal of the American Medical Association. 2000;284(17):2209 -2214. &lt;i&gt;Description: This article summarizes the financial relationships that faculty members at the University of California, San Francisco have with external sponsors of clinical research. This occurs about 8% of the time. The finncial relationships typically involve paid speaking engagements and consulting agreements. A smaller proportion involved equity holding or participation on an advisory board. Abstract \&quot;Context: A growing number of academic researchers receive industry funding for clinical and basic research, but little is known about the personal financial relationships of researchers with their industry sponsors. Objectives: To assess the extent to which faculty researchers have personal financial relationships with the sponsors of their research, the nature of those financial relationships, and efforts made at the institutional level to address disclosed financial relationships and perceived conflicts of interest. Design and Setting: Case study of the University of California, San Francisco (UCSF). Data sources included disclosure forms and official documents maintained by the UCSF Office of Research Administration from December 1980 to October 1999, including decisions made by the UCSF Chancellor&#39;s Advisory Panel on Relations with Industry. Main Outcome Measures: Number and types of personal financial relationships with external sponsors (positive financial disclosures from all clinical, basic, or social science faculty who were principal investigators), amount of annual income received from sponsors, and decisions and management strategies used by the advisory panel. Results: By 1999, almost 7.6% of faculty investigators reported personal financial ties with sponsors of their research. Throughout the study period, 34% of disclosed relationships involved paid speaking engagements (range, $250ï¿½$20,000 per year), 33% involved consulting agreements between researcher and sponsor (range, &amp;lt;$1000ï¿½$120,000 per year), and 32% involved the investigator holding a position on a scientific advisory board or board of directors. Fourteen percent involved equity ownership, and 12% involved multiple relationships. The advisory panel recommended managing perceived conflicts of interest in 26% of the cases, including recommending the sale of stock, refusing additional payment for talks, resigning from a management position, or naming a new principal investigator for a project. Conclusions: Faculty researchers are increasingly involved in financial relationships with their research sponsors. Guidelines for what constitutes a conflict and how the conflict should be managed are needed if researchers are to have consistent standards of behavior among institutions.\&quot;&lt;/i&gt; [Accessed on August 16, 2011]. &lt;a href=\&quot;http://jama.ama-assn.org/content/284/17/2209.abstract\&quot;&gt;http://jama.ama-assn.org/content/284/17/2209.abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Elizabeth A. &lt;a name=\&quot;Boyd\&quot;&gt;&lt;/a&gt;Boyd, Lisa A. Bero. &lt;b&gt;Assessing Faculty Financial Relationships With Industry&lt;/b&gt; JAMA: The Journal of the American Medical Association. 2000;284(17):2209 -2214. &lt;i&gt;Description: This article summarizes the financial relationships that faculty members at the University of California, San Francisco have with external sponsors of clinical research. This occurs about 8% of the time. The finncial relationships typically involve paid speaking engagements and consulting agreements. A smaller proportion involved equity holding or participation on an advisory board. Abstract \&quot;Context: A growing number of academic researchers receive industry funding for clinical and basic research, but little is known about the personal financial relationships of researchers with their industry sponsors. Objectives: To assess the extent to which faculty researchers have personal financial relationships with the sponsors of their research, the nature of those financial relationships, and efforts made at the institutional level to address disclosed financial relationships and perceived conflicts of interest. Design and Setting: Case study of the University of California, San Francisco (UCSF). Data sources included disclosure forms and official documents maintained by the UCSF Office of Research Administration from December 1980 to October 1999, including decisions made by the UCSF Chancellor&#39;s Advisory Panel on Relations with Industry. Main Outcome Measures: Number and types of personal financial relationships with external sponsors (positive financial disclosures from all clinical, basic, or social science faculty who were principal investigators), amount of annual income received from sponsors, and decisions and management strategies used by the advisory panel. Results: By 1999, almost 7.6% of faculty investigators reported personal financial ties with sponsors of their research. Throughout the study period, 34% of disclosed relationships involved paid speaking engagements (range, $250i¿1/2$20,000 per year), 33% involved consulting agreements between researcher and sponsor (range, &amp;lt;$1000i¿1/2$120,000 per year), and 32% involved the investigator holding a position on a scientific advisory board or board of directors. Fourteen percent involved equity ownership, and 12% involved multiple relationships. The advisory panel recommended managing perceived conflicts of interest in 26% of the cases, including recommending the sale of stock, refusing additional payment for talks, resigning from a management position, or naming a new principal investigator for a project. Conclusions: Faculty researchers are increasingly involved in financial relationships with their research sponsors. Guidelines for what constitutes a conflict and how the conflict should be managed are needed if researchers are to have consistent standards of behavior among institutions.\&quot;&lt;/i&gt; [Accessed on August 16, 2011]. &lt;a href=\&quot;http://jama.ama-assn.org/content/284/17/2209.abstract\&quot;&gt;http://jama.ama-assn.org/content/284/17/2209.abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Mohit &lt;a name=\&quot;Bhandari\&quot;&gt;&lt;/a&gt;Bhandari, Jason W. Busse, Dianne Jackowski, Victor M. Montori, Holger Schï¿½nemann, Sheila Sprague, Derek Mears, Emil H. Schemitsch, Dianne Heels-Ansdell, et al. &lt;b&gt;Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials&lt;/b&gt; Canadian Medical Association Journal. 2004;170(4):477 -480. &lt;i&gt;Description: This article provides evidence that randomized trials sponsored by industry are more likely to report results favorable to the sponsoring company and compares these results to other studies looking at this issue. Abstract: \&quot;Background: Conflicting reports exist in the medical literature regarding the association between industry funding and published research findings. In this study, we examine the association between industry funding and the statistical significance of results in recently published medical and surgical trials.Methods: We examined a consecutive series of 332 randomized trials published between January 1999 and June 2001 in 8 leading surgical journals and 5 medical journals. Each eligible study was independently reviewed for methodological quality using a 21-point index with 5 domains: randomization, outcomes, eligibility criteria, interventions and statistical issues. Our primary analysis included studies that explicitly identified the primary outcome and reported it as statistically significant. For studies that did not explicitly identify a primary outcome, we defined a &#39;positive&#39; study as one with at least 1 statistically significant outcome measure. We used multivariable regression analysis to determine whether there was an association between reported industry funding and trial results, while controlling for study quality and sample size.Results: Among the 332 randomized trials, there were 158 drug trials, 87 surgical trials and 87 trials of other therapies. In 122 (37%) of the trials, authors declared industry funding. An unadjusted analysis of this sample of trials revealed that industry funding was associated with a statistically significant result in favour of the new industry product (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.3ï¿½3.5). The association remained significant after adjustment for study quality and sample size (adjusted OR 1.8, 95% CI 1.1ï¿½3.0). There was a nonsignificant difference between surgical trials (OR 8.0, 95% CI 1.1ï¿½53.2) and drug trials (OR 1.6, 95% CI 1.1ï¿½2.8), both of which were likely to have a pro-industry result (relative OR 5.0, 95% CI 0.7ï¿½37.5, p = 0.14).Interpretation: Industry-funded trials are more likely to be associated with statistically significant pro-industry findings, both in medical trials and surgical interventions.\&quot;&lt;/i&gt; [Accessed on August 16, 2011]. &lt;a href=\&quot;http://www.cmaj.ca/content/170/4/477.abstract\&quot;&gt;http://www.cmaj.ca/content/170/4/477.abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Mohit &lt;a name=\&quot;Bhandari\&quot;&gt;&lt;/a&gt;Bhandari, Jason W. Busse, Dianne Jackowski, Victor M. Montori, Holger Schi¿1/2nemann, Sheila Sprague, Derek Mears, Emil H. Schemitsch, Dianne Heels-Ansdell, et al. &lt;b&gt;Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials&lt;/b&gt; Canadian Medical Association Journal. 2004;170(4):477 -480. &lt;i&gt;Description: This article provides evidence that randomized trials sponsored by industry are more likely to report results favorable to the sponsoring company and compares these results to other studies looking at this issue. Abstract: \&quot;Background: Conflicting reports exist in the medical literature regarding the association between industry funding and published research findings. In this study, we examine the association between industry funding and the statistical significance of results in recently published medical and surgical trials.Methods: We examined a consecutive series of 332 randomized trials published between January 1999 and June 2001 in 8 leading surgical journals and 5 medical journals. Each eligible study was independently reviewed for methodological quality using a 21-point index with 5 domains: randomization, outcomes, eligibility criteria, interventions and statistical issues. Our primary analysis included studies that explicitly identified the primary outcome and reported it as statistically significant. For studies that did not explicitly identify a primary outcome, we defined a &#39;positive&#39; study as one with at least 1 statistically significant outcome measure. We used multivariable regression analysis to determine whether there was an association between reported industry funding and trial results, while controlling for study quality and sample size.Results: Among the 332 randomized trials, there were 158 drug trials, 87 surgical trials and 87 trials of other therapies. In 122 (37%) of the trials, authors declared industry funding. An unadjusted analysis of this sample of trials revealed that industry funding was associated with a statistically significant result in favour of the new industry product (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.3i¿1/23.5). The association remained significant after adjustment for study quality and sample size (adjusted OR 1.8, 95% CI 1.1i¿1/23.0). There was a nonsignificant difference between surgical trials (OR 8.0, 95% CI 1.1i¿1/253.2) and drug trials (OR 1.6, 95% CI 1.1i¿1/22.8), both of which were likely to have a pro-industry result (relative OR 5.0, 95% CI 0.7i¿1/237.5, p = 0.14).Interpretation: Industry-funded trials are more likely to be associated with statistically significant pro-industry findings, both in medical trials and surgical interventions.\&quot;&lt;/i&gt; [Accessed on August 16, 2011]. &lt;a href=\&quot;http://www.cmaj.ca/content/170/4/477.abstract\&quot;&gt;http://www.cmaj.ca/content/170/4/477.abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;      disclosure of conflictsï¿½both financial and otherwise. In my view, these events &quot;
## [1] &quot;      disclosure of conflictsi¿1/2both financial and otherwise. In my view, these events &quot;
## [1] &quot;  &lt;p&gt;Journal article: Richard Smith. &lt;b&gt;Conflicts of interest: how money clouds objectivity&lt;/b&gt; J R Soc Med. 2006;99(6):292-297. &lt;i&gt;Excerpt: \&quot;I want to begin this article with a fantasy, one that has a powerful hold in the minds of many. Doctors treat patients using simply the best evidence and their experience. They are not influenced by money or self interest. Similarly, researchers try to answer the important questions in medicine; specialist societies are concerned only with what is best for a population of patients; and editors of journals publish only what is true and important for medicine. Unlike people who work in the venal worlds of commerce, politics, or journalism we in healthcare are untainted by money and `the pursuit&#39;, in the words of Sigmund Freud, `... of fame and the love of beautiful women (or perhaps men)&#39;. This is, of course, nonsense. Those who work in healthcare are human beings and just as prone as any other humans to acting in their own interest; responding to economic incentives, and stumbling into frank fraud and corruption. Anybody who has knocked around in the world and read Dante, Juvenal, Balzac and Dickens knows that this is how human beings behave. Yet somehow in medicine we have fallen prey to the fantasy that we are superhuman. We are not. We are exposed to conflicts of interest, like everybody else. Our response should not be to pretend that they do not exist, but rather to acknowledge and disclose them alwaysï¿½and sometimes to accept that they are so extreme that the doctor should not treat a particular patient or an author write an editorial in a medical journal.\&quot;&lt;/i&gt; [Accessed on November 16, 2011]. Available at &quot;
## [1] &quot;  &lt;p&gt;Journal article: Richard Smith. &lt;b&gt;Conflicts of interest: how money clouds objectivity&lt;/b&gt; J R Soc Med. 2006;99(6):292-297. &lt;i&gt;Excerpt: \&quot;I want to begin this article with a fantasy, one that has a powerful hold in the minds of many. Doctors treat patients using simply the best evidence and their experience. They are not influenced by money or self interest. Similarly, researchers try to answer the important questions in medicine; specialist societies are concerned only with what is best for a population of patients; and editors of journals publish only what is true and important for medicine. Unlike people who work in the venal worlds of commerce, politics, or journalism we in healthcare are untainted by money and `the pursuit&#39;, in the words of Sigmund Freud, `... of fame and the love of beautiful women (or perhaps men)&#39;. This is, of course, nonsense. Those who work in healthcare are human beings and just as prone as any other humans to acting in their own interest; responding to economic incentives, and stumbling into frank fraud and corruption. Anybody who has knocked around in the world and read Dante, Juvenal, Balzac and Dickens knows that this is how human beings behave. Yet somehow in medicine we have fallen prey to the fantasy that we are superhuman. We are not. We are exposed to conflicts of interest, like everybody else. Our response should not be to pretend that they do not exist, but rather to acknowledge and disclose them alwaysi¿1/2and sometimes to accept that they are so extreme that the doctor should not treat a particular patient or an author write an editorial in a medical journal.\&quot;&lt;/i&gt; [Accessed on November 16, 2011]. Available at &quot;
## c:/web/p1-clean/ConflictOfInterestList.html  [1] &quot;c:/web/p1/ConflictOfInterestList.html&quot;
## c:/web/p1-clean/ConflictOfInterestPolicy.html  [1] &quot;c:/web/p1/ConflictOfInterestPolicy.html&quot;
## c:/web/p1-clean/confusion.html  [1] &quot;c:/web/p1/confusion.html&quot;
## c:/web/p1-clean/ConfusionPvalues.html  [1] &quot;c:/web/p1/ConfusionPvalues.html&quot;
## c:/web/p1-clean/ConsecutiveDates.html  [1] &quot;c:/web/p1/ConsecutiveDates.html&quot;
## c:/web/p1-clean/consent.html  [1] &quot;c:/web/p1/consent.html&quot;
## [1] &quot;   research to which patients have not given fully informed consent–with three &quot;
## [1] &quot;   research to which patients have not given fully informed consent-with three &quot;
## c:/web/p1-clean/constraints.html  [1] &quot;c:/web/p1/constraints.html&quot;
## c:/web/p1-clean/ConstructValidity.html  [1] &quot;c:/web/p1/ConstructValidity.html&quot;
## c:/web/p1-clean/consulting-03.html  [1] &quot;c:/web/p1/consulting-03.html&quot;
## c:/web/p1-clean/consulting-04.html  [1] &quot;c:/web/p1/consulting-04.html&quot;
## c:/web/p1-clean/ConsultingDifferences.html  [1] &quot;c:/web/p1/ConsultingDifferences.html&quot;
## c:/web/p1-clean/ConsultingRemotely.html  [1] &quot;c:/web/p1/ConsultingRemotely.html&quot;
## c:/web/p1-clean/ConsultingResources.html  [1] &quot;c:/web/p1/ConsultingResources.html&quot;
## [1] &quot;  consultant. These difficulties include • an initial lack of confidence in &quot;
## [1] &quot;  consultant. These difficulties include . an initial lack of confidence in &quot;
## [1] &quot;  statistical knowledge and abilities; • unrealistic expectations from their &quot;
## [1] &quot;  statistical knowledge and abilities; . unrealistic expectations from their &quot;
## [1] &quot;  clients; and • knowing how to deal with clients who have minimal statistical &quot;
## [1] &quot;  clients; and . knowing how to deal with clients who have minimal statistical &quot;
## c:/web/p1-clean/ConsultingSop.html  [1] &quot;c:/web/p1/ConsultingSop.html&quot;
## [1] &quot;  Statistical Sciences Core&lt;/b&gt;. &lt;i&gt;Excerpt: &amp;quot;Members of the CCIï¿½s Statistical &quot;
## [1] &quot;  Statistical Sciences Core&lt;/b&gt;. &lt;i&gt;Excerpt: &amp;quot;Members of the CCIi¿1/2s Statistical &quot;
## c:/web/p1-clean/ConsultService.html  [1] &quot;c:/web/p1/ConsultService.html&quot;
## c:/web/p1-clean/contact.html  [1] &quot;c:/web/p1/contact.html&quot;
## c:/web/p1-clean/Contents.html  [1] &quot;c:/web/p1/Contents.html&quot;
## c:/web/p1-clean/contest-11.html  [1] &quot;c:/web/p1/contest-11.html&quot;
## c:/web/p1-clean/contest-12.html  [1] &quot;c:/web/p1/contest-12.html&quot;
## c:/web/p1-clean/ContinuingEducationQuestions.html  [1] &quot;c:/web/p1/ContinuingEducationQuestions.html&quot;
## c:/web/p1-clean/ContinuityCorrection.html  [1] &quot;c:/web/p1/ContinuityCorrection.html&quot;
## c:/web/p1-clean/ContinuousMonitoringNNH.html  [1] &quot;c:/web/p1/ContinuousMonitoringNNH.html&quot;
## c:/web/p1-clean/ContinuousVariables.html  [1] &quot;c:/web/p1/ContinuousVariables.html&quot;
## c:/web/p1-clean/ContradictoryResearch.html  [1] &quot;c:/web/p1/ContradictoryResearch.html&quot;
## c:/web/p1-clean/ControlChartAdvice.html  [1] &quot;c:/web/p1/ControlChartAdvice.html&quot;
## c:/web/p1-clean/ControlCharts-05.html  [1] &quot;c:/web/p1/ControlCharts-05.html&quot;
## c:/web/p1-clean/ControlCharts-06.html  [1] &quot;c:/web/p1/ControlCharts-06.html&quot;
## c:/web/p1-clean/ControlCharts-category.html  [1] &quot;c:/web/p1/ControlCharts-category.html&quot;
## c:/web/p1-clean/ControlChartsA.html  [1] &quot;c:/web/p1/ControlChartsA.html&quot;
## c:/web/p1-clean/ControversialArea.html  [1] &quot;c:/web/p1/ControversialArea.html&quot;
## c:/web/p1-clean/ControversialMetaanalysis.html  [1] &quot;c:/web/p1/ControversialMetaanalysis.html&quot;
## [1] &quot;      be based on “immaterial” interactions, if any (something like the “vital force” in &quot;
## [1] &quot;      be based on \&quot;immaterial\&quot; interactions, if any (something like the \&quot;vital force\&quot; in &quot;
## [1] &quot;    &lt;li&gt;&lt;i&gt;“immaterial”, and hence non-measurable, interactions are commonly discarded as &quot;
## [1] &quot;    &lt;li&gt;&lt;i&gt;\&quot;immaterial\&quot;, and hence non-measurable, interactions are commonly discarded as &quot;
## [1] &quot;    &lt;li&gt;&lt;i&gt;nevertheless, conventional medicine looks at the placebo effect as something “real”. &quot;
## [1] &quot;    &lt;li&gt;&lt;i&gt;nevertheless, conventional medicine looks at the placebo effect as something \&quot;real\&quot;. &quot;
## [1] &quot;    “control” group of patients to be treated with “sugar pills” and therefore the placebo &quot;
## [1] &quot;    \&quot;control\&quot; group of patients to be treated with \&quot;sugar pills\&quot; and therefore the placebo &quot;
## [1] &quot;      people cured by the administration of a “sugar pill” instead of an active drug.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      people cured by the administration of a \&quot;sugar pill\&quot; instead of an active drug.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      In 1991, Dr. Harris L. Coulter [10], in his book “The Controlled Clinical Trial: An &quot;
## [1] &quot;      In 1991, Dr. Harris L. Coulter [10], in his book \&quot;The Controlled Clinical Trial: An &quot;
## [1] &quot;      Analysis”, reported that “CCT cannot guarantee drug safety and efficacy because the &quot;
## [1] &quot;      Analysis\&quot;, reported that \&quot;CCT cannot guarantee drug safety and efficacy because the &quot;
## [1] &quot;      theoretical requirements of CCT are both unrealistic and unscientific”. This point of &quot;
## [1] &quot;      theoretical requirements of CCT are both unrealistic and unscientific\&quot;. This point of &quot;
## [1] &quot;      of the new drug “ASA” (acetylsalicylic acid) in the treatment of fever. According to CCT &quot;
## [1] &quot;      of the new drug \&quot;ASA\&quot; (acetylsalicylic acid) in the treatment of fever. According to CCT &quot;
## [1] &quot;      through the process of “randomization”, to either the active drug (ASA) or a placebo &quot;
## [1] &quot;      through the process of \&quot;randomization\&quot;, to either the active drug (ASA) or a placebo &quot;
## [1] &quot;      treatment, and look for differences in response. Hence: one disease (or symptom) – one &quot;
## [1] &quot;      treatment, and look for differences in response. Hence: one disease (or symptom) - one &quot;
## c:/web/p1-clean/ConvertOddsRatio.html  [1] &quot;c:/web/p1/ConvertOddsRatio.html&quot;
## c:/web/p1-clean/copyright.html  [1] &quot;c:/web/p1/copyright.html&quot;
## c:/web/p1-clean/CorrelatedNormalProbabilities.html  [1] &quot;c:/web/p1/CorrelatedNormalProbabilities.html&quot;
## c:/web/p1-clean/correlation.html  [1] &quot;c:/web/p1/correlation.html&quot;
## c:/web/p1-clean/CorrelationCoefficient-05.html  [1] &quot;c:/web/p1/CorrelationCoefficient-05.html&quot;
## c:/web/p1-clean/CorrelationCoefficient-07.html  [1] &quot;c:/web/p1/CorrelationCoefficient-07.html&quot;
## c:/web/p1-clean/correlations.html  [1] &quot;c:/web/p1/correlations.html&quot;
## c:/web/p1-clean/CorroboratingEvidence.html  [1] &quot;c:/web/p1/CorroboratingEvidence.html&quot;
## c:/web/p1-clean/CountData-07.html  [1] &quot;c:/web/p1/CountData-07.html&quot;
## c:/web/p1-clean/CountData-08.html  [1] &quot;c:/web/p1/CountData-08.html&quot;
## c:/web/p1-clean/Counterintuitive.html  [1] &quot;c:/web/p1/Counterintuitive.html&quot;
## [1] &quot;  expositor and philosopher who died May 22 at age 95. Fosheeï¿½s riddle is a &quot;
## [1] &quot;  expositor and philosopher who died May 22 at age 95. Fosheei¿1/2s riddle is a &quot;
## c:/web/p1-clean/counting-12.html  [1] &quot;c:/web/p1/counting-12.html&quot;
## c:/web/p1-clean/counting-13.html  [1] &quot;c:/web/p1/counting-13.html&quot;
## c:/web/p1-clean/CovariateAdjustment.html  [1] &quot;c:/web/p1/CovariateAdjustment.html&quot;
## c:/web/p1-clean/CovariateImbalance.html  [1] &quot;c:/web/p1/CovariateImbalance.html&quot;
## c:/web/p1-clean/Craniosacral.html  [1] &quot;c:/web/p1/Craniosacral.html&quot;
## [1] &quot;    of all kinds — birth, falls, accidents and other injuries, physical, sexual &quot;
## [1] &quot;    of all kinds - birth, falls, accidents and other injuries, physical, sexual &quot;
## [1] &quot;    or emotional abuse, PTSD, loss/grief, surgery, anesthesia — all are good &quot;
## [1] &quot;    or emotional abuse, PTSD, loss/grief, surgery, anesthesia - all are good &quot;
## c:/web/p1-clean/crayola.html  [1] &quot;c:/web/p1/crayola.html&quot;
## c:/web/p1-clean/CriticalAppraisal.html  [1] &quot;c:/web/p1/CriticalAppraisal.html&quot;
## [1] &quot;      have always been sharedï¿½among physicians as well as among patients and their &quot;
## [1] &quot;      have always been sharedi¿1/2among physicians as well as among patients and their &quot;
## [1] &quot;      relatives. With the evolution of ï¿½modernï¿½ medicine, narratives were &quot;
## [1] &quot;      relatives. With the evolution of i¿1/2moderni¿1/2 medicine, narratives were &quot;
## [1] &quot;      increasingly neglected in favor of ï¿½facts and findings,ï¿½ which were regarded &quot;
## [1] &quot;      increasingly neglected in favor of i¿1/2facts and findings,i¿1/2 which were regarded &quot;
## [1] &quot;      changingï¿½from the stories about patients and their illnesses, patient &quot;
## [1] &quot;      changingi¿1/2from the stories about patients and their illnesses, patient &quot;
## [1] &quot;  &lt;p&gt;Journal article: Zachary F. &lt;a name=\&quot;Meisel\&quot;&gt;&lt;/a&gt;Meisel, Jason Karlawish. &lt;b&gt;Narrative vs Evidence-Based Medicineï¿½And, Not Or&lt;/b&gt; JAMA: The Journal of the American Medical Association. 2011;306(18):2022 -2023. &lt;i&gt;Excerpt: \&quot;The week before the US Preventive Services Task Force (USPSTF) released its recommendations against routine prostate screening for healthy men, celebrity patients including Joe Torre and Rudy Giuliani had already lined up to challenge the population-based recommendations. To promote their position that screening for prostate-specific antigen is lifesaving, these individuals relied on a powerful tool: their own personal narratives. However, the experts whose goal is to disseminate and translate population-based evidence will, in the name of science, shun individual stories. This one-sided use of narrative has played out repeatedly, from the USPSTF recommendations on screening mammography to the US Food and Drug Administration (FDA) labeling hearings on bevacizumab for advanced breast cancer.1,2 Each time, those who espouse only evidenceï¿½without narratives about real peopleï¿½struggle to control the debate. Typically, they lose.\&quot;&lt;/i&gt; [Accessed on November 9, 2011].&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Zachary F. &lt;a name=\&quot;Meisel\&quot;&gt;&lt;/a&gt;Meisel, Jason Karlawish. &lt;b&gt;Narrative vs Evidence-Based Medicinei¿1/2And, Not Or&lt;/b&gt; JAMA: The Journal of the American Medical Association. 2011;306(18):2022 -2023. &lt;i&gt;Excerpt: \&quot;The week before the US Preventive Services Task Force (USPSTF) released its recommendations against routine prostate screening for healthy men, celebrity patients including Joe Torre and Rudy Giuliani had already lined up to challenge the population-based recommendations. To promote their position that screening for prostate-specific antigen is lifesaving, these individuals relied on a powerful tool: their own personal narratives. However, the experts whose goal is to disseminate and translate population-based evidence will, in the name of science, shun individual stories. This one-sided use of narrative has played out repeatedly, from the USPSTF recommendations on screening mammography to the US Food and Drug Administration (FDA) labeling hearings on bevacizumab for advanced breast cancer.1,2 Each time, those who espouse only evidencei¿1/2without narratives about real peoplei¿1/2struggle to control the debate. Typically, they lose.\&quot;&lt;/i&gt; [Accessed on November 9, 2011].&lt;/p&gt;&quot;
## [1] &quot;      pressures and the Centerï¿½s charter would seem to make this inevitable. Ethics &quot;
## [1] &quot;      pressures and the Centeri¿1/2s charter would seem to make this inevitable. Ethics &quot;
## [1] &quot;    &lt;i&gt;Excerpt: &amp;quot;For may years, versions of a claim that students remember ï¿½10% of &quot;
## [1] &quot;    &lt;i&gt;Excerpt: &amp;quot;For may years, versions of a claim that students remember i¿1/210% of &quot;
## [1] &quot;      see and hear, and 90% of what they doï¿½ have been widely circulated among &quot;
## [1] &quot;      see and hear, and 90% of what they doi¿1/2 have been widely circulated among &quot;
## [1] &quot;    G, Kasper J, Mï¿½hlhauser I. &lt;strong&gt;Training of patient and consumer representatives in the basic competencies of &quot;
## [1] &quot;    G, Kasper J, Mi¿1/2hlhauser I. &lt;strong&gt;Training of patient and consumer representatives in the basic competencies of &quot;
## c:/web/p1-clean/CriticalThinking.html  [1] &quot;c:/web/p1/CriticalThinking.html&quot;
## c:/web/p1-clean/CriticalValue-08.html  [1] &quot;c:/web/p1/CriticalValue-08.html&quot;
## c:/web/p1-clean/CriticalValue-08a.html  [1] &quot;c:/web/p1/CriticalValue-08a.html&quot;
## c:/web/p1-clean/Criticism.html  [1] &quot;c:/web/p1/Criticism.html&quot;
## c:/web/p1-clean/criticisms.html  [1] &quot;c:/web/p1/criticisms.html&quot;
## [1] &quot;      definable - and therefore reproducible: “This series of exercise in this order with this &quot;
## [1] &quot;      definable - and therefore reproducible: \&quot;This series of exercise in this order with this &quot;
## [1] &quot;      frequency for this long, with the following changes at the following stages”. However, &quot;
## [1] &quot;      frequency for this long, with the following changes at the following stages\&quot;. However, &quot;
## c:/web/p1-clean/CronbachAlpha.html  [1] &quot;c:/web/p1/CronbachAlpha.html&quot;
## [1] &quot;    “label” (i.e., fair, poor, etc.)? &lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;    \&quot;label\&quot; (i.e., fair, poor, etc.)? &lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/CronbachsAlpha.html  [1] &quot;c:/web/p1/CronbachsAlpha.html&quot;
## c:/web/p1-clean/CumulativeEntropy.html  [1] &quot;c:/web/p1/CumulativeEntropy.html&quot;
## c:/web/p1-clean/CumulativeMetaanalysis.html  [1] &quot;c:/web/p1/CumulativeMetaanalysis.html&quot;
## c:/web/p1-clean/CumulativeProbabilities.html  [1] &quot;c:/web/p1/CumulativeProbabilities.html&quot;
## c:/web/p1-clean/cupcakes.html  [1] &quot;c:/web/p1/cupcakes.html&quot;
## c:/web/p1-clean/curve.html  [1] &quot;c:/web/p1/curve.html&quot;
## c:/web/p1-clean/CusumChart.html  [1] &quot;c:/web/p1/CusumChart.html&quot;
## c:/web/p1-clean/CuttingCode.html  [1] &quot;c:/web/p1/CuttingCode.html&quot;
## c:/web/p1-clean/CyclicalTrends.html  [1] &quot;c:/web/p1/CyclicalTrends.html&quot;
## c:/web/p1-clean/CytelAccrual.html  [1] &quot;c:/web/p1/CytelAccrual.html&quot;
## c:/web/p1-clean/DadsDay.html  [1] &quot;c:/web/p1/DadsDay.html&quot;
## c:/web/p1-clean/DallasPostlude.html  [1] &quot;c:/web/p1/DallasPostlude.html&quot;
## c:/web/p1-clean/DangerUsingHumor.html  [1] &quot;c:/web/p1/DangerUsingHumor.html&quot;
## c:/web/p1-clean/data_is.html  [1] &quot;c:/web/p1/data_is.html&quot;
## c:/web/p1-clean/DataEntryErrors.html  [1] &quot;c:/web/p1/DataEntryErrors.html&quot;
## c:/web/p1-clean/DataIrbs.html  [1] &quot;c:/web/p1/DataIrbs.html&quot;
## c:/web/p1-clean/DataManagement.html  [1] &quot;c:/web/p1/DataManagement.html&quot;
## [1] &quot;&lt;p&gt;30. &lt;a href=\&quot;../news/201104.html#3\&quot;&gt;The Monthly Mean:  A binary coding trick that you can learn from Car Talk&lt;/a&gt;. (March/April 2011) and &lt;a href=\&quot;../11/BinaryCoding.html\&quot;&gt;P.Mean:Â Using a binary coding trick illustrated by a Car Talk puzzler (created 2011-05-21)&lt;/a&gt;. I often need to see how often certain variables and combinations of those variables appear in a data set. If the variable is binary, there is a trick for doing this that is illustrated by a Car Talk puzzler.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;30. &lt;a href=\&quot;../news/201104.html#3\&quot;&gt;The Monthly Mean:  A binary coding trick that you can learn from Car Talk&lt;/a&gt;. (March/April 2011) and &lt;a href=\&quot;../11/BinaryCoding.html\&quot;&gt;P.Mean:  Using a binary coding trick illustrated by a Car Talk puzzler (created 2011-05-21)&lt;/a&gt;. I often need to see how often certain variables and combinations of those variables appear in a data set. If the variable is binary, there is a trick for doing this that is illustrated by a Car Talk puzzler.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;10. &lt;a href=\&quot;../05/ValueLabels.html\&quot;&gt;StATS: Importing value labels from Access into SPSS (May 24, 2005)&lt;/a&gt;. Someone asked about importing data from Access into SPSS. The Access file has value labels (e.g., 1=Male, 2=Female, 3=Missing) and wanted to know if there was anyÂ way to get this information into SPSS.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;10. &lt;a href=\&quot;../05/ValueLabels.html\&quot;&gt;StATS: Importing value labels from Access into SPSS (May 24, 2005)&lt;/a&gt;. Someone asked about importing data from Access into SPSS. The Access file has value labels (e.g., 1=Male, 2=Female, 3=Missing) and wanted to know if there was any  way to get this information into SPSS.&lt;/p&gt;&quot;
## c:/web/p1-clean/datamining-03.html  [1] &quot;c:/web/p1/datamining-03.html&quot;
## c:/web/p1-clean/datamining-04.html  [1] &quot;c:/web/p1/datamining-04.html&quot;
## c:/web/p1-clean/DataMining-05.html  [1] &quot;c:/web/p1/DataMining-05.html&quot;
## c:/web/p1-clean/DataMining-06.html  [1] &quot;c:/web/p1/DataMining-06.html&quot;
## c:/web/p1-clean/DataMining-category.html  [1] &quot;c:/web/p1/DataMining-category.html&quot;
## [1] &quot;      also have a sort of ï¿½model experimentï¿½ which contains the values in which I am &quot;
## [1] &quot;      also have a sort of i¿1/2model experimenti¿1/2 which contains the values in which I am &quot;
## [1] &quot;  statistically different from the ï¿½model experimentï¿½ value.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;  statistically different from the i¿1/2model experimenti¿1/2 value.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Torsten Hothorn, Berthold Lausen, Axel Benner, Martin Radespiel-Trï¿½ger. &lt;b&gt;Bagging survival trees&lt;/b&gt;. Stat Med. 2004;23(1):77-91. &lt;i&gt;Abstract: \&quot;Predicted survival probability functions of censored event free survival are improved by bagging survival trees. We suggest a new method to aggregate survival trees in order to obtain better predictions for breast cancer and lymphoma patients. A set of survival trees based on B bootstrap samples is computed. We define the aggregated Kaplan-Meier curve of a new observation by the Kaplan-Meier curve of all observations identified by the B leaves containing the new observation. The integrated Brier score is used for the evaluation of predictive models. We analyse data of a large trial on node positive breast cancer patients conducted by the German Breast Cancer Study Group and a smaller &#39;pilot&#39; study on diffuse large B-cell lymphoma, where prognostic factors are derived from microarray expression values. In addition, simulation experiments underline the predictive power of our proposal.\&quot;&lt;/i&gt; [Accessed February 22, 2011]. Available at: &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/14695641\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/14695641&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Torsten Hothorn, Berthold Lausen, Axel Benner, Martin Radespiel-Tri¿1/2ger. &lt;b&gt;Bagging survival trees&lt;/b&gt;. Stat Med. 2004;23(1):77-91. &lt;i&gt;Abstract: \&quot;Predicted survival probability functions of censored event free survival are improved by bagging survival trees. We suggest a new method to aggregate survival trees in order to obtain better predictions for breast cancer and lymphoma patients. A set of survival trees based on B bootstrap samples is computed. We define the aggregated Kaplan-Meier curve of a new observation by the Kaplan-Meier curve of all observations identified by the B leaves containing the new observation. The integrated Brier score is used for the evaluation of predictive models. We analyse data of a large trial on node positive breast cancer patients conducted by the German Breast Cancer Study Group and a smaller &#39;pilot&#39; study on diffuse large B-cell lymphoma, where prognostic factors are derived from microarray expression values. In addition, simulation experiments underline the predictive power of our proposal.\&quot;&lt;/i&gt; [Accessed February 22, 2011]. Available at: &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/14695641\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/14695641&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/dates.html  [1] &quot;c:/web/p1/dates.html&quot;
## c:/web/p1-clean/DatesInR.html  [1] &quot;c:/web/p1/DatesInR.html&quot;
## c:/web/p1-clean/DeafChairs.html  [1] &quot;c:/web/p1/DeafChairs.html&quot;
## c:/web/p1-clean/DebateHistoricalControls.html  [1] &quot;c:/web/p1/DebateHistoricalControls.html&quot;
## c:/web/p1-clean/DecliningCount-08.html  [1] &quot;c:/web/p1/DecliningCount-08.html&quot;
## c:/web/p1-clean/DecliningCount-08a.html  [1] &quot;c:/web/p1/DecliningCount-08a.html&quot;
## c:/web/p1-clean/DefendingBonferroni.html  [1] &quot;c:/web/p1/DefendingBonferroni.html&quot;
## c:/web/p1-clean/Definitions.html  [1] &quot;c:/web/p1/Definitions.html&quot;
## c:/web/p1-clean/DegreesFreedom.html  [1] &quot;c:/web/p1/DegreesFreedom.html&quot;
## c:/web/p1-clean/des_spss.html  [1] &quot;c:/web/p1/des_spss.html&quot;
## c:/web/p1-clean/DescribeWorkStatistician.html  [1] &quot;c:/web/p1/DescribeWorkStatistician.html&quot;
## c:/web/p1-clean/descriptive-01.html  [1] &quot;c:/web/p1/descriptive-01.html&quot;
## c:/web/p1-clean/descriptive-13.html  [1] &quot;c:/web/p1/descriptive-13.html&quot;
## c:/web/p1-clean/DescriptiveAnalysis.html  [1] &quot;c:/web/p1/DescriptiveAnalysis.html&quot;
## c:/web/p1-clean/DescriptiveStatistics.html  [1] &quot;c:/web/p1/DescriptiveStatistics.html&quot;
## [1] &quot;  &lt;p&gt;27. &lt;a href=\&quot;../11/SmallStdDev.html\&quot;&gt;P.Mean:Â Why is my standard deviation so small? (created 2011-05-02)&lt;/a&gt;. I am helping someone with a projec that involves (among other things), computing averages of many Likert scale items. A Likert scale has different interpretations, but I use the term to mean a scale that has five items with a logical ordering. So the scale 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, and 5=Strongly agree is a Likert scale. This person ran some descriptive statistics on the individual items and on the mean of those items. The results are shown below with generic names for the individual items. I was asked why the average had a standard deviation that was so much smaller than the standard deviations of the individual items.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;27. &lt;a href=\&quot;../11/SmallStdDev.html\&quot;&gt;P.Mean:  Why is my standard deviation so small? (created 2011-05-02)&lt;/a&gt;. I am helping someone with a projec that involves (among other things), computing averages of many Likert scale items. A Likert scale has different interpretations, but I use the term to mean a scale that has five items with a logical ordering. So the scale 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, and 5=Strongly agree is a Likert scale. This person ran some descriptive statistics on the individual items and on the mean of those items. The results are shown below with generic names for the individual items. I was asked why the average had a standard deviation that was so much smaller than the standard deviations of the individual items.&lt;/p&gt;&quot;
## c:/web/p1-clean/DesigningQuestionnaire.html  [1] &quot;c:/web/p1/DesigningQuestionnaire.html&quot;
## c:/web/p1-clean/df.html  [1] &quot;c:/web/p1/df.html&quot;
## c:/web/p1-clean/diag.html  [1] &quot;c:/web/p1/diag.html&quot;
## c:/web/p1-clean/diagnostic-03.html  [1] &quot;c:/web/p1/diagnostic-03.html&quot;
## c:/web/p1-clean/diagnostic-04.html  [1] &quot;c:/web/p1/diagnostic-04.html&quot;
## c:/web/p1-clean/diagnostic-99.html  [1] &quot;c:/web/p1/diagnostic-99.html&quot;
## c:/web/p1-clean/DiagnosticExercises.html  [1] &quot;c:/web/p1/DiagnosticExercises.html&quot;
## [1] &quot;      Primary Care practices in the Vermont Diabetes Information System June 2003 – December &quot;
## [1] &quot;      Primary Care practices in the Vermont Diabetes Information System June 2003 - December &quot;
## [1] &quot;      (CI95% = 85–99) and &lt;b&gt;&lt;code&gt;[[CALCULATE THIS VALUE]]&lt;/code&gt;&lt;/b&gt; (CI95% = 36–99), &quot;
## [1] &quot;      (CI95% = 85-99) and &lt;b&gt;&lt;code&gt;[[CALCULATE THIS VALUE]]&lt;/code&gt;&lt;/b&gt; (CI95% = 36-99), &quot;
## c:/web/p1-clean/DiagnosticHandout.html  [1] &quot;c:/web/p1/DiagnosticHandout.html&quot;
## c:/web/p1-clean/DiagnosticMetaanalysis.html  [1] &quot;c:/web/p1/DiagnosticMetaanalysis.html&quot;
## c:/web/p1-clean/DiagnosticTalk.html  [1] &quot;c:/web/p1/DiagnosticTalk.html&quot;
## c:/web/p1-clean/DiagnosticTesting.html  [1] &quot;c:/web/p1/DiagnosticTesting.html&quot;
## [1] &quot;  &lt;p&gt;K J Hamberg, B Carstensen, T I Sï¿½rensen, K Eghï¿½je. &lt;b&gt;Accuracy of clinical &quot;
## [1] &quot;  &lt;p&gt;K J Hamberg, B Carstensen, T I Si¿1/2rensen, K Eghi¿1/2je. &lt;b&gt;Accuracy of clinical &quot;
## [1] &quot;      breast cancer metastasis. Copyright ï¿½ 2006 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; &quot;
## [1] &quot;      breast cancer metastasis. Copyright i¿1/2 2006 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; &quot;
## [1] &quot;      Copyright ï¿½ 2010 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed June 16, 2010]. &quot;
## [1] &quot;      Copyright i¿1/2 2010 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed June 16, 2010]. &quot;
## c:/web/p1-clean/DifferenceInExponentials.html  [1] &quot;c:/web/p1/DifferenceInExponentials.html&quot;
## c:/web/p1-clean/DifferencesBetweenTests.html  [1] &quot;c:/web/p1/DifferencesBetweenTests.html&quot;
## c:/web/p1-clean/DifferencesInChildren.html  [1] &quot;c:/web/p1/DifferencesInChildren.html&quot;
## c:/web/p1-clean/DigitalObjectIdentifier.html  [1] &quot;c:/web/p1/DigitalObjectIdentifier.html&quot;
## c:/web/p1-clean/DigitizingGraph.html  [1] &quot;c:/web/p1/DigitizingGraph.html&quot;
## c:/web/p1-clean/DimensionReduction.html  [1] &quot;c:/web/p1/DimensionReduction.html&quot;
## c:/web/p1-clean/DisasterAverted.html  [1] &quot;c:/web/p1/DisasterAverted.html&quot;
## c:/web/p1-clean/DisasterAvertedA.html  [1] &quot;c:/web/p1/DisasterAvertedA.html&quot;
## c:/web/p1-clean/disclaimer.html  [1] &quot;c:/web/p1/disclaimer.html&quot;
## c:/web/p1-clean/discrepancy.html  [1] &quot;c:/web/p1/discrepancy.html&quot;
## c:/web/p1-clean/DishonestyResearch.html  [1] &quot;c:/web/p1/DishonestyResearch.html&quot;
## c:/web/p1-clean/DissertationConsulting.html  [1] &quot;c:/web/p1/DissertationConsulting.html&quot;
## c:/web/p1-clean/DistinctGroups.html  [1] &quot;c:/web/p1/DistinctGroups.html&quot;
## c:/web/p1-clean/distributions.html  [1] &quot;c:/web/p1/distributions.html&quot;
## c:/web/p1-clean/DistrustBayesian.html  [1] &quot;c:/web/p1/DistrustBayesian.html&quot;
## c:/web/p1-clean/document.html  [1] &quot;c:/web/p1/document.html&quot;
## c:/web/p1-clean/DontWantToRandomize.html  [1] &quot;c:/web/p1/DontWantToRandomize.html&quot;
## c:/web/p1-clean/DoYourOwnPower.html  [1] &quot;c:/web/p1/DoYourOwnPower.html&quot;
## c:/web/p1-clean/DraftGrant.html  [1] &quot;c:/web/p1/DraftGrant.html&quot;
## [1] &quot;&lt;p&gt;Lenth, R. V.  (2006).Â  Java Applets  for Power and Sample Size [Computer software].Â  Retrieved September 28, 2011, from  http://www.stat.uiowa.edu/~rlenth/Power&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Lenth, R. V.  (2006).   Java Applets  for Power and Sample Size [Computer software].   Retrieved September 28, 2011, from  http://www.stat.uiowa.edu/~rlenth/Power&lt;/p&gt;&quot;
## c:/web/p1-clean/dropouts.html  [1] &quot;c:/web/p1/dropouts.html&quot;
## c:/web/p1-clean/DumpingData.html  [1] &quot;c:/web/p1/DumpingData.html&quot;
## c:/web/p1-clean/DuplicateRecords.html  [1] &quot;c:/web/p1/DuplicateRecords.html&quot;
## c:/web/p1-clean/duration.html  [1] &quot;c:/web/p1/duration.html&quot;
## c:/web/p1-clean/Early Stopping1.html  [1] &quot;c:/web/p1/Early Stopping1.html&quot;
## [1] &quot;            also chair of a Data Safety and Monitoring Board – he was surprised that we didn’t &quot;
## [1] &quot;            also chair of a Data Safety and Monitoring Board - he was surprised that we didn&#39;t &quot;
## [1] &quot;            &lt;p&gt;&lt;i&gt;He had a hard time arguing the statistics but asked how we didn’t know that the &quot;
## [1] &quot;            &lt;p&gt;&lt;i&gt;He had a hard time arguing the statistics but asked how we didn&#39;t know that the &quot;
## [1] &quot;            next 20 patients wouldn’t have shown the opposite results. I think most people are &quot;
## [1] &quot;            next 20 patients wouldn&#39;t have shown the opposite results. I think most people are &quot;
## [1] &quot;            the fact that we didn’t control for an important confounding variable, and the fact that &quot;
## [1] &quot;            the fact that we didn&#39;t control for an important confounding variable, and the fact that &quot;
## [1] &quot;            medical settings. It’s also unfortunate that [an important covariate] was worse for the &quot;
## [1] &quot;            medical settings. It&#39;s also unfortunate that [an important covariate] was worse for the &quot;
## c:/web/p1-clean/EarlyDraft.html  [1] &quot;c:/web/p1/EarlyDraft.html&quot;
## c:/web/p1-clean/EarlyStopping-04.html  [1] &quot;c:/web/p1/EarlyStopping-04.html&quot;
## c:/web/p1-clean/EarlyStopping-category.html  [1] &quot;c:/web/p1/EarlyStopping-category.html&quot;
## c:/web/p1-clean/EarlyStopping1.html  [1] &quot;c:/web/p1/EarlyStopping1.html&quot;
## [1] &quot;            also chair of a Data Safety and Monitoring Board – he was surprised that we didn’t &quot;
## [1] &quot;            also chair of a Data Safety and Monitoring Board - he was surprised that we didn&#39;t &quot;
## [1] &quot;            &lt;p&gt;&lt;i&gt;He had a hard time arguing the statistics but asked how we didn’t know that the &quot;
## [1] &quot;            &lt;p&gt;&lt;i&gt;He had a hard time arguing the statistics but asked how we didn&#39;t know that the &quot;
## [1] &quot;            next 20 patients wouldn’t have shown the opposite results. I think most people are &quot;
## [1] &quot;            next 20 patients wouldn&#39;t have shown the opposite results. I think most people are &quot;
## [1] &quot;            the fact that we didn’t control for an important confounding variable, and the fact that &quot;
## [1] &quot;            the fact that we didn&#39;t control for an important confounding variable, and the fact that &quot;
## [1] &quot;            medical settings. It’s also unfortunate that [an important covariate] was worse for the &quot;
## [1] &quot;            medical settings. It&#39;s also unfortunate that [an important covariate] was worse for the &quot;
## c:/web/p1-clean/EarlyStoppingAnimal.html  [1] &quot;c:/web/p1/EarlyStoppingAnimal.html&quot;
## c:/web/p1-clean/EarlyStoppingControversy.html  [1] &quot;c:/web/p1/EarlyStoppingControversy.html&quot;
## [1] &quot;     Monitoring Board – he was surprised that we didn’t enroll at least a third &quot;
## [1] &quot;     Monitoring Board - he was surprised that we didn&#39;t enroll at least a third &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;He had a hard time arguing the statistics but asked how we didn’t know &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;He had a hard time arguing the statistics but asked how we didn&#39;t know &quot;
## [1] &quot;     that the next 20 patients wouldn’t have shown the opposite results. I think &quot;
## [1] &quot;     that the next 20 patients wouldn&#39;t have shown the opposite results. I think &quot;
## [1] &quot;     enrollment of only 20 patients, the fact that we didn’t control for an &quot;
## [1] &quot;     enrollment of only 20 patients, the fact that we didn&#39;t control for an &quot;
## [1] &quot;     settings. It’s also unfortunate that [an important covariate] was worse for &quot;
## [1] &quot;     settings. It&#39;s also unfortunate that [an important covariate] was worse for &quot;
## c:/web/p1-clean/ebcam.html  [1] &quot;c:/web/p1/ebcam.html&quot;
## c:/web/p1-clean/EbmArticles2005.html  [1] &quot;c:/web/p1/EbmArticles2005.html&quot;
## c:/web/p1-clean/EbmForPatients-08.html  [1] &quot;c:/web/p1/EbmForPatients-08.html&quot;
## c:/web/p1-clean/EbmForPatients-08a.html  [1] &quot;c:/web/p1/EbmForPatients-08a.html&quot;
## c:/web/p1-clean/EbmTooRigid.html  [1] &quot;c:/web/p1/EbmTooRigid.html&quot;
## c:/web/p1-clean/EconomicEvaluations.html  [1] &quot;c:/web/p1/EconomicEvaluations.html&quot;
## [1] &quot;      1.5%­2%.5 An important reason for discounting future costs and benefits is “time &quot;
## [1] &quot;      1.5%­2%.5 An important reason for discounting future costs and benefits is \&quot;time &quot;
## [1] &quot;      preference,” which refers to the desire to enjoy benefits in the present while deferring &quot;
## [1] &quot;      preference,\&quot; which refers to the desire to enjoy benefits in the present while deferring &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Two methods of costing illness exist—the prevalence and incidence approaches. The &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Two methods of costing illness exist-the prevalence and incidence approaches. The &quot;
## c:/web/p1-clean/Editorials.html  [1] &quot;c:/web/p1/Editorials.html&quot;
## c:/web/p1-clean/educational.html  [1] &quot;c:/web/p1/educational.html&quot;
## c:/web/p1-clean/EducationalOpportunities.html  [1] &quot;c:/web/p1/EducationalOpportunities.html&quot;
## c:/web/p1-clean/EffectiveGraphs.html  [1] &quot;c:/web/p1/EffectiveGraphs.html&quot;
## c:/web/p1-clean/egg.html  [1] &quot;c:/web/p1/egg.html&quot;
## c:/web/p1-clean/elbow.html  [1] &quot;c:/web/p1/elbow.html&quot;
## c:/web/p1-clean/ElicitingPrior-08.html  [1] &quot;c:/web/p1/ElicitingPrior-08.html&quot;
## c:/web/p1-clean/ElicitingPrior-08a.html  [1] &quot;c:/web/p1/ElicitingPrior-08a.html&quot;
## c:/web/p1-clean/em.html  [1] &quot;c:/web/p1/em.html&quot;
## c:/web/p1-clean/EmailAccounts.html  [1] &quot;c:/web/p1/EmailAccounts.html&quot;
## c:/web/p1-clean/EmailDiscussionGroup.html  [1] &quot;c:/web/p1/EmailDiscussionGroup.html&quot;
## c:/web/p1-clean/EmailLists.html  [1] &quot;c:/web/p1/EmailLists.html&quot;
## [1] &quot;     sending ‘subscribe’ (or ‘unsubscribe’) in the body of the message (not in &quot;
## [1] &quot;     sending &#39;subscribe&#39; (or &#39;unsubscribe&#39;) in the body of the message (not in &quot;
## [1] &quot;     done analogously, with ‘R-help’ replaced by ‘R-announce’, ‘R-packages’, and &quot;
## [1] &quot;     done analogously, with &#39;R-help&#39; replaced by &#39;R-announce&#39;, &#39;R-packages&#39;, and &quot;
## [1] &quot;     ‘R-devel’, respectively. Note that the R-announce and R-packages lists are &quot;
## [1] &quot;     &#39;R-devel&#39;, respectively. Note that the R-announce and R-packages lists are &quot;
## c:/web/p1-clean/EmilyRosaExperiment.html  [1] &quot;c:/web/p1/EmilyRosaExperiment.html&quot;
## c:/web/p1-clean/EndOfResearch.html  [1] &quot;c:/web/p1/EndOfResearch.html&quot;
## c:/web/p1-clean/EndSpam.html  [1] &quot;c:/web/p1/EndSpam.html&quot;
## c:/web/p1-clean/enotation.html  [1] &quot;c:/web/p1/enotation.html&quot;
## c:/web/p1-clean/EnoughData.html  [1] &quot;c:/web/p1/EnoughData.html&quot;
## c:/web/p1-clean/EnsemblSearch.html  [1] &quot;c:/web/p1/EnsemblSearch.html&quot;
## c:/web/p1-clean/EntirePopulation.html  [1] &quot;c:/web/p1/EntirePopulation.html&quot;
## c:/web/p1-clean/EntrenchedBeliefs.html  [1] &quot;c:/web/p1/EntrenchedBeliefs.html&quot;
## c:/web/p1-clean/entry.html  [1] &quot;c:/web/p1/entry.html&quot;
## c:/web/p1-clean/enumerative.html  [1] &quot;c:/web/p1/enumerative.html&quot;
## c:/web/p1-clean/Epidemiology.html  [1] &quot;c:/web/p1/Epidemiology.html&quot;
## [1] &quot;  30(5); 1146-55.&lt;em&gt; Excerpt: &amp;quot;In 1948â\200”and now as a civilianâ\200”Jerry Morris became Director of the Medical Research Council Social Medicine Research Unit. This unit contributed importantly to the development of the methodology and practice of the epidemiology of chronic disease and in 1955 the Director published an article entitled &#39;Uses of Epidemiology&#39; in the British Medical Journal. This article was expanded into a book which, on publication in 1957, became one of the pioneering texts of 20th century epidemiology.&amp;quot;&lt;/em&gt; Available at &lt;a href=\&quot;http://ije.oxfordjournals.org/content/30/5/1146.short\&quot;&gt;http://ije.oxfordjournals.org/content/30/5/1146.short&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  30(5); 1146-55.&lt;em&gt; Excerpt: &amp;quot;In 1948â\200\&quot;and now as a civilianâ\200\&quot;Jerry Morris became Director of the Medical Research Council Social Medicine Research Unit. This unit contributed importantly to the development of the methodology and practice of the epidemiology of chronic disease and in 1955 the Director published an article entitled &#39;Uses of Epidemiology&#39; in the British Medical Journal. This article was expanded into a book which, on publication in 1957, became one of the pioneering texts of 20th century epidemiology.&amp;quot;&lt;/em&gt; Available at &lt;a href=\&quot;http://ije.oxfordjournals.org/content/30/5/1146.short\&quot;&gt;http://ije.oxfordjournals.org/content/30/5/1146.short&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/Equipoise.html  [1] &quot;c:/web/p1/Equipoise.html&quot;
## c:/web/p1-clean/EquipoiseA.html  [1] &quot;c:/web/p1/EquipoiseA.html&quot;
## c:/web/p1-clean/EquipoiseAlternatives.html  [1] &quot;c:/web/p1/EquipoiseAlternatives.html&quot;
## c:/web/p1-clean/EquipoiseInResearch.html  [1] &quot;c:/web/p1/EquipoiseInResearch.html&quot;
## [1] &quot;    trials have for decades been considered essential for proving a drugï¿½s value &quot;
## [1] &quot;    trials have for decades been considered essential for proving a drugi¿1/2s value &quot;
## [1] &quot;    controlled trial that measures a drugï¿½s impact on extending life is still &quot;
## [1] &quot;    controlled trial that measures a drugi¿1/2s impact on extending life is still &quot;
## c:/web/p1-clean/equivalence.html  [1] &quot;c:/web/p1/equivalence.html&quot;
## c:/web/p1-clean/EthicalConcernsChildren.html  [1] &quot;c:/web/p1/EthicalConcernsChildren.html&quot;
## c:/web/p1-clean/ethics.html  [1] &quot;c:/web/p1/ethics.html&quot;
## c:/web/p1-clean/EthicsCAM.html  [1] &quot;c:/web/p1/EthicsCAM.html&quot;
## [1] &quot;     not meet any one particular criterion—say, biological plausibility. &quot;
## [1] &quot;     not meet any one particular criterion-say, biological plausibility. &quot;
## [1] &quot;     “established,” will both increase under such circumstances.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;     \&quot;established,\&quot; will both increase under such circumstances.&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/EthicsInResearch.html  [1] &quot;c:/web/p1/EthicsInResearch.html&quot;
## [1] &quot;      Emanuel, eds. Oxford University Press, 2007. Pp 400. ï¿½32ï¿½99. ISBN &quot;
## [1] &quot;      Emanuel, eds. Oxford University Press, 2007. Pp 400. i¿1/232i¿1/299. ISBN &quot;
## [1] &quot;&lt;p&gt;Journal article: Gardiner &lt;a name=\&quot;Harris\&quot;&gt;&lt;/a&gt;Harris. &lt;b&gt;The Public&#39;s Quiet Savior From Harmful Medicines&lt;/b&gt; The New York Times. 2010. &lt;i&gt;Excerpt: \&quot;Dr. Frances Oldham Kelsey is 96 now, nearly deaf and barely mobile, as modest as her faded house in this Washington suburb. And though her story is nearly forgotten, she was once America&#39;s most admired civil servant ï¿½ celebrated for her dual role in saving thousands of newborns from the perils of the drug thalidomide and in serving as midwife to modern pharmaceutical regulation. \&quot;&lt;/i&gt; [Accessed on January 4, 2012]. &lt;a href=\&quot;http://www.nytimes.com/2010/09/14/health/14kelsey.html\&quot;&gt;http://www.nytimes.com/2010/09/14/health/14kelsey.html&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Journal article: Gardiner &lt;a name=\&quot;Harris\&quot;&gt;&lt;/a&gt;Harris. &lt;b&gt;The Public&#39;s Quiet Savior From Harmful Medicines&lt;/b&gt; The New York Times. 2010. &lt;i&gt;Excerpt: \&quot;Dr. Frances Oldham Kelsey is 96 now, nearly deaf and barely mobile, as modest as her faded house in this Washington suburb. And though her story is nearly forgotten, she was once America&#39;s most admired civil servant i¿1/2 celebrated for her dual role in saving thousands of newborns from the perils of the drug thalidomide and in serving as midwife to modern pharmaceutical regulation. \&quot;&lt;/i&gt; [Accessed on January 4, 2012]. &lt;a href=\&quot;http://www.nytimes.com/2010/09/14/health/14kelsey.html\&quot;&gt;http://www.nytimes.com/2010/09/14/health/14kelsey.html&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  to have committed another alleged war crimeï¿½illegal experimentation on &quot;
## [1] &quot;  to have committed another alleged war crimei¿1/2illegal experimentation on &quot;
## c:/web/p1-clean/EthicsRandomization.html  [1] &quot;c:/web/p1/EthicsRandomization.html&quot;
## [1] &quot;            accommodate—one, 20, or an infinite number?&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;            accommodate-one, 20, or an infinite number?&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/evidence-08.html  [1] &quot;c:/web/p1/evidence-08.html&quot;
## c:/web/p1-clean/evidence-08a.html  [1] &quot;c:/web/p1/evidence-08a.html&quot;
## c:/web/p1-clean/EvidenceBasedMedicine.html  [1] &quot;c:/web/p1/EvidenceBasedMedicine.html&quot;
## c:/web/p1-clean/excel.html  [1] &quot;c:/web/p1/excel.html&quot;
## c:/web/p1-clean/ExcelMultinomial.html  [1] &quot;c:/web/p1/ExcelMultinomial.html&quot;
## c:/web/p1-clean/exclusions.html  [1] &quot;c:/web/p1/exclusions.html&quot;
## c:/web/p1-clean/ExclusionsInResearch.html  [1] &quot;c:/web/p1/ExclusionsInResearch.html&quot;
## [1] &quot;      &lt;p&gt;Journal article: Elke &lt;a name=\&quot;Vervolgyi\&quot;&gt;&lt;/a&gt;VervÃ¶lgyi, Mandy Kromp, Guido Skipka, Ralf Bender, Thomas Kaiser. &lt;b&gt;Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey&lt;/b&gt; BMC Med Res Methodol. 2011;11:130. &lt;i&gt;Abstract: \&quot;BACKGROUND: To assess the reporting of loss to follow-up (LTFU) information in articles on randomised controlled trials (RCTs) with time-to-event outcomes, and to assess whether discrepancies affect the validity of study results. METHODS: Literature survey of all issues of the BMJ, Lancet, JAMA, and New England Journal of Medicine published between 2003 and 2005. Eligible articles were reports of RCTs including at least one Kaplan-Meier plot. Articles were classified as \&quot;assessable\&quot; if sufficient information was available to assess LTFU. In these articles, LTFU information was derived from Kaplan-Meier plots, extracted from the text, and compared. Articles were then classified as \&quot;consistent\&quot; or \&quot;not consistent\&quot;. Sensitivity analyses were performed to assess the validity of study results. RESULTS: 319 eligible articles were identified. 187 (59%) were classified as \&quot;assessable\&quot;, as they included sufficient information for evaluation; 140 of 319 (44%) presented consistent LTFU information between the Kaplan-Meier plot and text. 47 of 319 (15%) were classified as \&quot;not consistent\&quot;. These 47 articles were included in sensitivity analyses. When various imputation methods were used, the results of a chi2-test applied to the corresponding 2 Ã— 2 table changed and hence were not robust in about half of the studies. CONCLUSIONS: Less than half of the articles on RCTs using Kaplan-Meier plots provide assessable and consistent LTFU information, thus questioning the validity of the results and conclusions of many studies presenting survival analyses. Authors should improve the presentation of both Kaplan-Meier plots and LTFU information, and reviewers of study publications and journal editors should critically appraise the validity of the information provided.\&quot;&lt;/i&gt; [Accessed on December 26, 2011]. &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/11/130\&quot;&gt;http://www.biomedcentral.com/1471-2288/11/130&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;      &lt;p&gt;Journal article: Elke &lt;a name=\&quot;Vervolgyi\&quot;&gt;&lt;/a&gt;VervÃ¶lgyi, Mandy Kromp, Guido Skipka, Ralf Bender, Thomas Kaiser. &lt;b&gt;Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey&lt;/b&gt; BMC Med Res Methodol. 2011;11:130. &lt;i&gt;Abstract: \&quot;BACKGROUND: To assess the reporting of loss to follow-up (LTFU) information in articles on randomised controlled trials (RCTs) with time-to-event outcomes, and to assess whether discrepancies affect the validity of study results. METHODS: Literature survey of all issues of the BMJ, Lancet, JAMA, and New England Journal of Medicine published between 2003 and 2005. Eligible articles were reports of RCTs including at least one Kaplan-Meier plot. Articles were classified as \&quot;assessable\&quot; if sufficient information was available to assess LTFU. In these articles, LTFU information was derived from Kaplan-Meier plots, extracted from the text, and compared. Articles were then classified as \&quot;consistent\&quot; or \&quot;not consistent\&quot;. Sensitivity analyses were performed to assess the validity of study results. RESULTS: 319 eligible articles were identified. 187 (59%) were classified as \&quot;assessable\&quot;, as they included sufficient information for evaluation; 140 of 319 (44%) presented consistent LTFU information between the Kaplan-Meier plot and text. 47 of 319 (15%) were classified as \&quot;not consistent\&quot;. These 47 articles were included in sensitivity analyses. When various imputation methods were used, the results of a chi2-test applied to the corresponding 2 Ã- 2 table changed and hence were not robust in about half of the studies. CONCLUSIONS: Less than half of the articles on RCTs using Kaplan-Meier plots provide assessable and consistent LTFU information, thus questioning the validity of the results and conclusions of many studies presenting survival analyses. Authors should improve the presentation of both Kaplan-Meier plots and LTFU information, and reviewers of study publications and journal editors should critically appraise the validity of the information provided.\&quot;&lt;/i&gt; [Accessed on December 26, 2011]. &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/11/130\&quot;&gt;http://www.biomedcentral.com/1471-2288/11/130&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/Expectations.html  [1] &quot;c:/web/p1/Expectations.html&quot;
## c:/web/p1-clean/ExpertTestimony.html  [1] &quot;c:/web/p1/ExpertTestimony.html&quot;
## c:/web/p1-clean/ExplainingCart.html  [1] &quot;c:/web/p1/ExplainingCart.html&quot;
## [1] &quot;    &lt;li&gt;&lt;b&gt;Explicit criteria for prioritization of cataract surgery&lt;/b&gt;. José M &quot;
## [1] &quot;    &lt;li&gt;&lt;b&gt;Explicit criteria for prioritization of cataract surgery&lt;/b&gt;. Jose M &quot;
## c:/web/p1-clean/ExponentialAccrual-08.html  [1] &quot;c:/web/p1/ExponentialAccrual-08.html&quot;
## [1] &quot;    (2007); 26: 4958–4975. DOI: 10.1002/sim.2956&quot;
## [1] &quot;    (2007); 26: 4958-4975. DOI: 10.1002/sim.2956&quot;
## [1] &quot;   study started and let t&lt;sub&gt;1&lt;/sub&gt;, t&lt;sub&gt;2&lt;/sub&gt;, …, t&lt;sub&gt;m&lt;/sub&gt; &quot;
## [1] &quot;   study started and let t&lt;sub&gt;1&lt;/sub&gt;, t&lt;sub&gt;2&lt;/sub&gt;, ..., t&lt;sub&gt;m&lt;/sub&gt; &quot;
## [1] &quot;  &lt;p&gt;We are interested in predicting the next n-m waiting times W&lt;sub&gt;m+1&lt;/sub&gt;,…,W&lt;sub&gt;n&lt;/sub&gt;. &quot;
## [1] &quot;  &lt;p&gt;We are interested in predicting the next n-m waiting times W&lt;sub&gt;m+1&lt;/sub&gt;,...,W&lt;sub&gt;n&lt;/sub&gt;. &quot;
## [1] &quot;   random variables from W&lt;sub&gt;m+1,1&lt;/sub&gt; ,…,W&lt;sub&gt;n,1&lt;/sub&gt; from an &quot;
## [1] &quot;   random variables from W&lt;sub&gt;m+1,1&lt;/sub&gt; ,...,W&lt;sub&gt;n,1&lt;/sub&gt; from an &quot;
## [1] &quot;   for &amp;#952;&lt;sub&gt;2&lt;/sub&gt;, &amp;#952;&lt;sub&gt;3&lt;/sub&gt;,…,&amp;#952;&lt;sub&gt;b&lt;/sub&gt;, where b is a large number &quot;
## [1] &quot;   for &amp;#952;&lt;sub&gt;2&lt;/sub&gt;, &amp;#952;&lt;sub&gt;3&lt;/sub&gt;,...,&amp;#952;&lt;sub&gt;b&lt;/sub&gt;, where b is a large number &quot;
## [1] &quot;   = w&lt;sub&gt;1&lt;/sub&gt; + w&lt;sub&gt;2&lt;/sub&gt; + … + w&lt;sub&gt;m&lt;/sub&gt; + W&lt;sub&gt;m+1,b&lt;/sub&gt; + … + &quot;
## [1] &quot;   = w&lt;sub&gt;1&lt;/sub&gt; + w&lt;sub&gt;2&lt;/sub&gt; + ... + w&lt;sub&gt;m&lt;/sub&gt; + W&lt;sub&gt;m+1,b&lt;/sub&gt; + ... + &quot;
## c:/web/p1-clean/ExponentialAccrual-08a.html  [1] &quot;c:/web/p1/ExponentialAccrual-08a.html&quot;
## [1] &quot;    (2007); 26: 4958–4975. DOI: 10.1002/sim.2956&quot;
## [1] &quot;    (2007); 26: 4958-4975. DOI: 10.1002/sim.2956&quot;
## [1] &quot;   study started and let t&lt;sub&gt;1&lt;/sub&gt;, t&lt;sub&gt;2&lt;/sub&gt;, …, t&lt;sub&gt;m&lt;/sub&gt; &quot;
## [1] &quot;   study started and let t&lt;sub&gt;1&lt;/sub&gt;, t&lt;sub&gt;2&lt;/sub&gt;, ..., t&lt;sub&gt;m&lt;/sub&gt; &quot;
## [1] &quot;  &lt;p&gt;We are interested in predicting the next n-m waiting times W&lt;sub&gt;m+1&lt;/sub&gt;,…,W&lt;sub&gt;n&lt;/sub&gt;. &quot;
## [1] &quot;  &lt;p&gt;We are interested in predicting the next n-m waiting times W&lt;sub&gt;m+1&lt;/sub&gt;,...,W&lt;sub&gt;n&lt;/sub&gt;. &quot;
## [1] &quot;   random variables from W&lt;sub&gt;m+1,1&lt;/sub&gt; ,…,W&lt;sub&gt;n,1&lt;/sub&gt; from an &quot;
## [1] &quot;   random variables from W&lt;sub&gt;m+1,1&lt;/sub&gt; ,...,W&lt;sub&gt;n,1&lt;/sub&gt; from an &quot;
## [1] &quot;   for &amp;#952;&lt;sub&gt;2&lt;/sub&gt;, &amp;#952;&lt;sub&gt;3&lt;/sub&gt;,…,&amp;#952;&lt;sub&gt;b&lt;/sub&gt;, where b is a large number &quot;
## [1] &quot;   for &amp;#952;&lt;sub&gt;2&lt;/sub&gt;, &amp;#952;&lt;sub&gt;3&lt;/sub&gt;,...,&amp;#952;&lt;sub&gt;b&lt;/sub&gt;, where b is a large number &quot;
## [1] &quot;   = w&lt;sub&gt;1&lt;/sub&gt; + w&lt;sub&gt;2&lt;/sub&gt; + … + w&lt;sub&gt;m&lt;/sub&gt; + W&lt;sub&gt;m+1,b&lt;/sub&gt; + … + &quot;
## [1] &quot;   = w&lt;sub&gt;1&lt;/sub&gt; + w&lt;sub&gt;2&lt;/sub&gt; + ... + w&lt;sub&gt;m&lt;/sub&gt; + W&lt;sub&gt;m+1,b&lt;/sub&gt; + ... + &quot;
## c:/web/p1-clean/ExponentialAmbiguity.html  [1] &quot;c:/web/p1/ExponentialAmbiguity.html&quot;
## [1] &quot;  &lt;p&gt;Here &lt;font face=\&quot;Times New Roman\&quot;&gt;ï¿½&lt;/font&gt; is a rate and corresponds to&quot;
## [1] &quot;  &lt;p&gt;Here &lt;font face=\&quot;Times New Roman\&quot;&gt;i¿1/2&lt;/font&gt; is a rate and corresponds to&quot;
## c:/web/p1-clean/ExponentialInterpolation.html  [1] &quot;c:/web/p1/ExponentialInterpolation.html&quot;
## c:/web/p1-clean/export.html  [1] &quot;c:/web/p1/export.html&quot;
## c:/web/p1-clean/ExtendingSPSS.html  [1] &quot;c:/web/p1/ExtendingSPSS.html&quot;
## [1] &quot;      jobs through conditional execution control statements (such as “If/Then/Else”) and &quot;
## [1] &quot;      jobs through conditional execution control statements (such as \&quot;If/Then/Else\&quot;) and &quot;
## [1] &quot;      looping control statements (such as “For” and “While”). These types of statements are &quot;
## [1] &quot;      looping control statements (such as \&quot;For\&quot; and \&quot;While\&quot;). These types of statements are &quot;
## c:/web/p1-clean/ExternalScholars.html  [1] &quot;c:/web/p1/ExternalScholars.html&quot;
## [1] &quot;      credible experts in the candidate’s specialty area who can judge the &quot;
## [1] &quot;      credible experts in the candidate&#39;s specialty area who can judge the &quot;
## [1] &quot;      candidate’s contributions and activities in relation to his/her field &quot;
## [1] &quot;      candidate&#39;s contributions and activities in relation to his/her field &quot;
## [1] &quot;      supervisors/mentors from the candidate’s postgraduate institution(s) &quot;
## [1] &quot;      supervisors/mentors from the candidate&#39;s postgraduate institution(s) &quot;
## [1] &quot;      initial acceptance to review the candidate’s credentials for a faculty &quot;
## [1] &quot;      initial acceptance to review the candidate&#39;s credentials for a faculty &quot;
## [1] &quot;      name to the External Scholars’ List. &lt;/p&gt;&quot;
## [1] &quot;      name to the External Scholars&#39; List. &lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;It will be necessary for the candidate’s Department Promotions &quot;
## [1] &quot;    &lt;p&gt;It will be necessary for the candidate&#39;s Department Promotions &quot;
## [1] &quot;      Committee (if one exists), the head of applicant’s unit, the &quot;
## [1] &quot;      Committee (if one exists), the head of applicant&#39;s unit, the &quot;
## [1] &quot;      Institution’s Associate Dean if applicable, and SOM Faculty Coordinator &quot;
## [1] &quot;      Institution&#39;s Associate Dean if applicable, and SOM Faculty Coordinator &quot;
## [1] &quot;      to review the candidate’s List of Five (5) External Scholars to make sure &quot;
## [1] &quot;      to review the candidate&#39;s List of Five (5) External Scholars to make sure &quot;
## [1] &quot;      candidate’s credentials to the reviewers. The requirement of external &quot;
## [1] &quot;      candidate&#39;s credentials to the reviewers. The requirement of external &quot;
## [1] &quot;      vital documents in judging the candidate’s credentials.&lt;/p&gt;&quot;
## [1] &quot;      vital documents in judging the candidate&#39;s credentials.&lt;/p&gt;&quot;
## [1] &quot;      further enhances the candidate’s activities and performance. The &quot;
## [1] &quot;      further enhances the candidate&#39;s activities and performance. The &quot;
## [1] &quot;      candidate’s credentials to the SOM Faculty Promotions Committee for a &quot;
## [1] &quot;      candidate&#39;s credentials to the SOM Faculty Promotions Committee for a &quot;
## [1] &quot;      evaluations for the SOM’s review process.&lt;/p&gt;&quot;
## [1] &quot;      evaluations for the SOM&#39;s review process.&lt;/p&gt;&quot;
## [1] &quot;      I am a biostatistician at a Children’s Mercy Hospital in Kansas City who &quot;
## [1] &quot;      I am a biostatistician at a Children&#39;s Mercy Hospital in Kansas City who &quot;
## [1] &quot;      evaluators “must hold full-time faculty titles at the same or higher &quot;
## [1] &quot;      evaluators \&quot;must hold full-time faculty titles at the same or higher &quot;
## [1] &quot;      must be from an AAMC accredited school.” I can’t choose personal friends, &quot;
## [1] &quot;      must be from an AAMC accredited school.\&quot; I can&#39;t choose personal friends, &quot;
## [1] &quot;      I’m at a loss as to who to identify in these roles, and was hoping you &quot;
## [1] &quot;      I&#39;m at a loss as to who to identify in these roles, and was hoping you &quot;
## c:/web/p1-clean/ExtrapolationsInResearch.html  [1] &quot;c:/web/p1/ExtrapolationsInResearch.html&quot;
## c:/web/p1-clean/ExtremeValue.html  [1] &quot;c:/web/p1/ExtremeValue.html&quot;
## c:/web/p1-clean/Facebook.html  [1] &quot;c:/web/p1/Facebook.html&quot;
## c:/web/p1-clean/FacultyPage.html  [1] &quot;c:/web/p1/FacultyPage.html&quot;
## c:/web/p1-clean/FacultyPromotion.html  [1] &quot;c:/web/p1/FacultyPromotion.html&quot;
## c:/web/p1-clean/FailureOption.html  [1] &quot;c:/web/p1/FailureOption.html&quot;
## c:/web/p1-clean/FairUse.html  [1] &quot;c:/web/p1/FairUse.html&quot;
## c:/web/p1-clean/FalseFrugality.html  [1] &quot;c:/web/p1/FalseFrugality.html&quot;
## c:/web/p1-clean/FalsePositive.html  [1] &quot;c:/web/p1/FalsePositive.html&quot;
## c:/web/p1-clean/FanPage.html  [1] &quot;c:/web/p1/FanPage.html&quot;
## c:/web/p1-clean/FavoriteBooks08.html  [1] &quot;c:/web/p1/FavoriteBooks08.html&quot;
## [1] &quot;       &lt;p&gt;A review by Ivan Krešimir Lukiæ (my apologies if this name gets mangled by my web &quot;
## [1] &quot;       &lt;p&gt;A review by Ivan Kresimir Lukiae (my apologies if this name gets mangled by my web &quot;
## [1] &quot;            their reports a really “professional” look, to avoid the most common “traps”, and to &quot;
## [1] &quot;            their reports a really \&quot;professional\&quot; look, to avoid the most common \&quot;traps\&quot;, and to &quot;
## c:/web/p1-clean/FavoriteBooks09.html  [1] &quot;c:/web/p1/FavoriteBooks09.html&quot;
## [1] &quot;        consistent with overall targets. This process, sometimes called a “roll-up,” reflects the &quot;
## [1] &quot;        consistent with overall targets. This process, sometimes called a \&quot;roll-up,\&quot; reflects the &quot;
## c:/web/p1-clean/FavoriteBooks10.html  [1] &quot;c:/web/p1/FavoriteBooks10.html&quot;
## c:/web/p1-clean/FdaOnBayes.html  [1] &quot;c:/web/p1/FdaOnBayes.html&quot;
## [1] &quot;  analyst refers to this approach as “borrowing strength.” For device trials, &quot;
## [1] &quot;  analyst refers to this approach as \&quot;borrowing strength.\&quot; For device trials, &quot;
## [1] &quot;  or even potentially “borrow negatively”. In a regulatory setting, hierarchical &quot;
## [1] &quot;  or even potentially \&quot;borrow negatively\&quot;. In a regulatory setting, hierarchical &quot;
## [1] &quot;  purposes. The key concept: “Today’s posterior is tomorrow’s prior” allows you &quot;
## [1] &quot;  purposes. The key concept: \&quot;Today&#39;s posterior is tomorrow&#39;s prior\&quot; allows you &quot;
## [1] &quot;  with post-market data via Bayes’ theorem if you can justify exchangeability &quot;
## [1] &quot;  with post-market data via Bayes&#39; theorem if you can justify exchangeability &quot;
## [1] &quot;  information via Bayes’ theorem as more data are gathered. You may also use &quot;
## [1] &quot;  information via Bayes&#39; theorem as more data are gathered. You may also use &quot;
## c:/web/p1-clean/feedback.html  [1] &quot;c:/web/p1/feedback.html&quot;
## c:/web/p1-clean/FewerThanTen.html  [1] &quot;c:/web/p1/FewerThanTen.html&quot;
## c:/web/p1-clean/FiduciaryObligation.html  [1] &quot;c:/web/p1/FiduciaryObligation.html&quot;
## [1] &quot;     physicians. Though some may see medicine as “just a business,” clearly—at &quot;
## [1] &quot;     physicians. Though some may see medicine as \&quot;just a business,\&quot; clearly-at &quot;
## [1] &quot;     the present time at least—patients, and society do not see it this way: &quot;
## [1] &quot;     the present time at least-patients, and society do not see it this way: &quot;
## [1] &quot;     Patients rightly expect their physician to act in their (the patient’s) &quot;
## [1] &quot;     Patients rightly expect their physician to act in their (the patient&#39;s) &quot;
## c:/web/p1-clean/filler.html  [1] &quot;c:/web/p1/filler.html&quot;
## [1] &quot;  &lt;p&gt;&lt;b&gt;In the City’s Vital Statistics, So Many Ways to Die by Accident&lt;/b&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;b&gt;In the City&#39;s Vital Statistics, So Many Ways to Die by Accident&lt;/b&gt;&quot;
## [1] &quot;  who don&#39;t to be more open-minded. music © QualiaSoup . A note on spelling: A &quot;
## [1] &quot;  who don&#39;t to be more open-minded. music (c) QualiaSoup . A note on spelling: A &quot;
## c:/web/p1-clean/FindingGenes.html  [1] &quot;c:/web/p1/FindingGenes.html&quot;
## c:/web/p1-clean/FindingGenesB.html  [1] &quot;c:/web/p1/FindingGenesB.html&quot;
## c:/web/p1-clean/FirstMetaAnalysis.html  [1] &quot;c:/web/p1/FirstMetaAnalysis.html&quot;
## c:/web/p1-clean/FirstPeek.html  [1] &quot;c:/web/p1/FirstPeek.html&quot;
## c:/web/p1-clean/FirstSession.html  [1] &quot;c:/web/p1/FirstSession.html&quot;
## c:/web/p1-clean/fish.html  [1] &quot;c:/web/p1/fish.html&quot;
## c:/web/p1-clean/Fishbone.html  [1] &quot;c:/web/p1/Fishbone.html&quot;
## c:/web/p1-clean/FishboneDiagram-06.html  [1] &quot;c:/web/p1/FishboneDiagram-06.html&quot;
## c:/web/p1-clean/FishboneDiagram-07.html  [1] &quot;c:/web/p1/FishboneDiagram-07.html&quot;
## c:/web/p1-clean/fishers-00.html  [1] &quot;c:/web/p1/fishers-00.html&quot;
## c:/web/p1-clean/fishers-12.html  [1] &quot;c:/web/p1/fishers-12.html&quot;
## c:/web/p1-clean/Fishers.html  [1] &quot;c:/web/p1/Fishers.html&quot;
## c:/web/p1-clean/FishersExact.html  [1] &quot;c:/web/p1/FishersExact.html&quot;
## c:/web/p1-clean/fishmonger.html  [1] &quot;c:/web/p1/fishmonger.html&quot;
## c:/web/p1-clean/fishy.html  [1] &quot;c:/web/p1/fishy.html&quot;
## c:/web/p1-clean/flaws-00.html  [1] &quot;c:/web/p1/flaws-00.html&quot;
## c:/web/p1-clean/flaws-04.html  [1] &quot;c:/web/p1/flaws-04.html&quot;
## c:/web/p1-clean/FmriAnalysis.html  [1] &quot;c:/web/p1/FmriAnalysis.html&quot;
## c:/web/p1-clean/FocusGroups-04.html  [1] &quot;c:/web/p1/FocusGroups-04.html&quot;
## c:/web/p1-clean/FocusGroups-06.html  [1] &quot;c:/web/p1/FocusGroups-06.html&quot;
## c:/web/p1-clean/ForestPlots.html  [1] &quot;c:/web/p1/ForestPlots.html&quot;
## c:/web/p1-clean/FormatCodes.html  [1] &quot;c:/web/p1/FormatCodes.html&quot;
## c:/web/p1-clean/FrailtyModel.html  [1] &quot;c:/web/p1/FrailtyModel.html&quot;
## c:/web/p1-clean/FraudInResearch.html  [1] &quot;c:/web/p1/FraudInResearch.html&quot;
## c:/web/p1-clean/FraudulentImages.html  [1] &quot;c:/web/p1/FraudulentImages.html&quot;
## c:/web/p1-clean/free.html  [1] &quot;c:/web/p1/free.html&quot;
## c:/web/p1-clean/FreeBooks.html  [1] &quot;c:/web/p1/FreeBooks.html&quot;
## c:/web/p1-clean/frisbee.html  [1] &quot;c:/web/p1/frisbee.html&quot;
## c:/web/p1-clean/FromMyAssociations.html  [1] &quot;c:/web/p1/FromMyAssociations.html&quot;
## c:/web/p1-clean/frontiers.html  [1] &quot;c:/web/p1/frontiers.html&quot;
## c:/web/p1-clean/Frosty.html  [1] &quot;c:/web/p1/Frosty.html&quot;
## c:/web/p1-clean/FullBodyScan.html  [1] &quot;c:/web/p1/FullBodyScan.html&quot;
## c:/web/p1-clean/FullText.html  [1] &quot;c:/web/p1/FullText.html&quot;
## c:/web/p1-clean/FundingSources.html  [1] &quot;c:/web/p1/FundingSources.html&quot;
## c:/web/p1-clean/FunnyFractions.html  [1] &quot;c:/web/p1/FunnyFractions.html&quot;
## c:/web/p1-clean/Futility.html  [1] &quot;c:/web/p1/Futility.html&quot;
## c:/web/p1-clean/future.html  [1] &quot;c:/web/p1/future.html&quot;
## c:/web/p1-clean/gee.html  [1] &quot;c:/web/p1/gee.html&quot;
## c:/web/p1-clean/GeneExpression.html  [1] &quot;c:/web/p1/GeneExpression.html&quot;
## c:/web/p1-clean/GeneralizingResearch.html  [1] &quot;c:/web/p1/GeneralizingResearch.html&quot;
## c:/web/p1-clean/GenomicsTrack.html  [1] &quot;c:/web/p1/GenomicsTrack.html&quot;
## c:/web/p1-clean/Geometric.html  [1] &quot;c:/web/p1/Geometric.html&quot;
## [1] &quot;&lt;title&gt;P.Mean: Bayesian inference on the geometric distributionÂ (created 2011-05-22)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean: Bayesian inference on the geometric distribution  (created 2011-05-22)&lt;/title&gt;&quot;
## c:/web/p1-clean/GeometricDistribution.html  [1] &quot;c:/web/p1/GeometricDistribution.html&quot;
## c:/web/p1-clean/GivingCredit.html  [1] &quot;c:/web/p1/GivingCredit.html&quot;
## c:/web/p1-clean/Glossary.html  [1] &quot;c:/web/p1/Glossary.html&quot;
## c:/web/p1-clean/GodwinsLaw.html  [1] &quot;c:/web/p1/GodwinsLaw.html&quot;
## c:/web/p1-clean/GoldStandard.html  [1] &quot;c:/web/p1/GoldStandard.html&quot;
## [1] &quot;      definable - and therefore reproducible: “This series of exercise in this order with this &quot;
## [1] &quot;      definable - and therefore reproducible: \&quot;This series of exercise in this order with this &quot;
## [1] &quot;      frequency for this long, with the following changes at the following stages”. However, &quot;
## [1] &quot;      frequency for this long, with the following changes at the following stages\&quot;. However, &quot;
## c:/web/p1-clean/good.html  [1] &quot;c:/web/p1/good.html&quot;
## [1] &quot;  &lt;p&gt;&lt;strong&gt;Inquisitive&lt;/strong&gt;. &amp;quot;&lt;em&gt;The statistician who supposes that his main contribution to the planning of an experiment will involve statistical theory, finds repeatedly that he makes his most valuable contribution simply by persuading the investigator to explain why he wishes to do the experiment, by persuading him to justify the experimental treatments, and to explain why it is that the experiment, when completed, will assist him in his research.&lt;/em&gt;&amp;quot;Â -- Gertrude M. Cox. Be prepared for a lot of questions. It&#39;s not an attack on your research concept, but a probing to make sure that whatever you do is well justified. &lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;strong&gt;Inquisitive&lt;/strong&gt;. &amp;quot;&lt;em&gt;The statistician who supposes that his main contribution to the planning of an experiment will involve statistical theory, finds repeatedly that he makes his most valuable contribution simply by persuading the investigator to explain why he wishes to do the experiment, by persuading him to justify the experimental treatments, and to explain why it is that the experiment, when completed, will assist him in his research.&lt;/em&gt;&amp;quot;  -- Gertrude M. Cox. Be prepared for a lot of questions. It&#39;s not an attack on your research concept, but a probing to make sure that whatever you do is well justified. &lt;/p&gt;&quot;
## c:/web/p1-clean/GoodBook-04.html  [1] &quot;c:/web/p1/GoodBook-04.html&quot;
## [1] &quot;       American Statistical Association&lt;/a&gt;. The review was written by Daniel W. Byrne. Here&#39;s the opening paragraph of the review. &lt;i&gt;Those who teach statistics in the health sciences are often asked to recommend “a &quot;
## [1] &quot;       American Statistical Association&lt;/a&gt;. The review was written by Daniel W. Byrne. Here&#39;s the opening paragraph of the review. &lt;i&gt;Those who teach statistics in the health sciences are often asked to recommend \&quot;a &quot;
## [1] &quot;            good introductory statistics book”. This request is frequently made by &quot;
## [1] &quot;            good introductory statistics book\&quot;. This request is frequently made by &quot;
## [1] &quot;            that combines the two. In my opinion, Marija Norusis’ book “SPSS® 12.0 Guide to Data &quot;
## [1] &quot;            that combines the two. In my opinion, Marija Norusis&#39; book \&quot;SPSS* 12.0 Guide to Data &quot;
## [1] &quot;            Analysis” fills this niche better than any of the competing books. For the past 15 &quot;
## [1] &quot;            Analysis\&quot; fills this niche better than any of the competing books. For the past 15 &quot;
## c:/web/p1-clean/GoodBook-06.html  [1] &quot;c:/web/p1/GoodBook-06.html&quot;
## c:/web/p1-clean/GoodConsultant.html  [1] &quot;c:/web/p1/GoodConsultant.html&quot;
## c:/web/p1-clean/GoodDiagnosticTest.html  [1] &quot;c:/web/p1/GoodDiagnosticTest.html&quot;
## c:/web/p1-clean/GoodEvidence.html  [1] &quot;c:/web/p1/GoodEvidence.html&quot;
## c:/web/p1-clean/goodness.html  [1] &quot;c:/web/p1/goodness.html&quot;
## c:/web/p1-clean/GoodNews.html  [1] &quot;c:/web/p1/GoodNews.html&quot;
## c:/web/p1-clean/GoodWebsite.html  [1] &quot;c:/web/p1/GoodWebsite.html&quot;
## c:/web/p1-clean/GoogleDiagnosis.html  [1] &quot;c:/web/p1/GoogleDiagnosis.html&quot;
## [1] &quot;        &lt;b&gt;Googling for a diagnosis—use of Google as a diagnostic aid: internet based study.&lt;/b&gt; &quot;
## [1] &quot;        &lt;b&gt;Googling for a diagnosis-use of Google as a diagnostic aid: internet based study.&lt;/b&gt; &quot;
## c:/web/p1-clean/GoogleScholar.html  [1] &quot;c:/web/p1/GoogleScholar.html&quot;
## c:/web/p1-clean/GraduateCertificate.html  [1] &quot;c:/web/p1/GraduateCertificate.html&quot;
## c:/web/p1-clean/grants.html  [1] &quot;c:/web/p1/grants.html&quot;
## c:/web/p1-clean/GrantWriting.html  [1] &quot;c:/web/p1/GrantWriting.html&quot;
## [1] &quot;  &lt;p&gt;10. &lt;a href=\&quot;../11/AnotherPersonsGrant.html\&quot;&gt;P.Mean:Â When you&#39;re stuck writing major sections of another person&#39;s grant (created 2011-06-02)&lt;/a&gt;. I was helping someone write a grant when I got that request that I always dread, &amp;quot;Can you write this section of the grant.&amp;quot; I hate those requests for a personal reason--I&#39;d much rather tell someone else what to do than to actually do it myself. One of the great joys of consulting is being able to boss other people around. But there&#39;s a serious reason why I dislike this. I believe that a grant should be written by one person, with guidance of course by other experts. But one person needs to have at least a passing level of familiarity with each and every aspect of the grant; enough familiarity that they can write the entire grant. It also assures consistency of tone and language. But there are often reasons why this can&#39;t be done, and if you&#39;re stuck writing major sections of someone else&#39;s grant, you need to write your section of the grant so that it fits in well with the rest of the grant. There&#39;s a famous saying that a camel is a horse designed by a committee. You want to make sure that the completed protocol does not come out looking like a camel. If certain sections have abrupt transitions, use different terms for the same thing, and have radical changes in writing style, you&#39;ve got problems. You won&#39;t get things perfect, and I certainly didn&#39;t with this project. But the closer you get, the better the grant will be.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;10. &lt;a href=\&quot;../11/AnotherPersonsGrant.html\&quot;&gt;P.Mean:  When you&#39;re stuck writing major sections of another person&#39;s grant (created 2011-06-02)&lt;/a&gt;. I was helping someone write a grant when I got that request that I always dread, &amp;quot;Can you write this section of the grant.&amp;quot; I hate those requests for a personal reason--I&#39;d much rather tell someone else what to do than to actually do it myself. One of the great joys of consulting is being able to boss other people around. But there&#39;s a serious reason why I dislike this. I believe that a grant should be written by one person, with guidance of course by other experts. But one person needs to have at least a passing level of familiarity with each and every aspect of the grant; enough familiarity that they can write the entire grant. It also assures consistency of tone and language. But there are often reasons why this can&#39;t be done, and if you&#39;re stuck writing major sections of someone else&#39;s grant, you need to write your section of the grant so that it fits in well with the rest of the grant. There&#39;s a famous saying that a camel is a horse designed by a committee. You want to make sure that the completed protocol does not come out looking like a camel. If certain sections have abrupt transitions, use different terms for the same thing, and have radical changes in writing style, you&#39;ve got problems. You won&#39;t get things perfect, and I certainly didn&#39;t with this project. But the closer you get, the better the grant will be.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;8. &lt;a href=\&quot;../01/methods.html\&quot;&gt;P.&lt;/a&gt;&lt;a href=\&quot;../01/methods.html\&quot;&gt;Mean:Â Writing the methods section of your grant (created 2001-01-15, revised 2011-04-26)&lt;/a&gt;. &lt;em&gt;Dear Professor Mean, I&#39;m starting to write the methods section for a &quot;
## [1] &quot;  &lt;p&gt;8. &lt;a href=\&quot;../01/methods.html\&quot;&gt;P.&lt;/a&gt;&lt;a href=\&quot;../01/methods.html\&quot;&gt;Mean:  Writing the methods section of your grant (created 2001-01-15, revised 2011-04-26)&lt;/a&gt;. &lt;em&gt;Dear Professor Mean, I&#39;m starting to write the methods section for a &quot;
## [1] &quot;  &lt;p&gt;7. &lt;a href=\&quot;../11/cer.html\&quot;&gt;P.Mean: Resources for Comparative Effectiveness ResearchÂ (created 2011-04-13)&lt;/a&gt;. I attended an interesting webinar on Comparative Effectiveness Research (CER). I always try to take notes during presentations like this, but my notes are often a poor amagalm of random thoughts and realizations. What I did find, though, during this webinar, were links to two important resources for CER.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;7. &lt;a href=\&quot;../11/cer.html\&quot;&gt;P.Mean: Resources for Comparative Effectiveness Research  (created 2011-04-13)&lt;/a&gt;. I attended an interesting webinar on Comparative Effectiveness Research (CER). I always try to take notes during presentations like this, but my notes are often a poor amagalm of random thoughts and realizations. What I did find, though, during this webinar, were links to two important resources for CER.&lt;/p&gt;&quot;
## c:/web/p1-clean/GraphicalDisplay.html  [1] &quot;c:/web/p1/GraphicalDisplay.html&quot;
## [1] &quot;  &lt;p&gt;Webpage: Ben &lt;a name=\&quot;Greenman\&quot;&gt;&lt;/a&gt;Greenman. &lt;b&gt;I Love Charts â\200“ Ben Greenman&#39;s Museum of Silly Charts&lt;/b&gt; &lt;i&gt;Excerpt: \&quot;My interest in charts springs primarily from my disinterest in charts. Reality is so messy. Nothing that passes for a fact ever really is one. When I was a kid, infographics were intoxicating because they promised a world of order, and it&#39;s specifically this promise that has come, over time, to seem like a cruel deception. You&#39;ll never really get an elegant presentation of so-called facts that accurately and meaningfully represents reality. So, as much as I&#39;m drawn to those charts, I&#39;m also drawn to charts that obfuscate, or thwart, or somehow sharpen our sense of the absurdity of trying to accurately present and analyze information.\&quot;&lt;/i&gt; [Accessed on May 11, 2011]. &lt;a href=\&quot;http://ilovecharts.tumblr.com/BenGreenman\&quot;&gt;http://ilovecharts.tumblr.com/BenGreenman&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Webpage: Ben &lt;a name=\&quot;Greenman\&quot;&gt;&lt;/a&gt;Greenman. &lt;b&gt;I Love Charts â\200\&quot; Ben Greenman&#39;s Museum of Silly Charts&lt;/b&gt; &lt;i&gt;Excerpt: \&quot;My interest in charts springs primarily from my disinterest in charts. Reality is so messy. Nothing that passes for a fact ever really is one. When I was a kid, infographics were intoxicating because they promised a world of order, and it&#39;s specifically this promise that has come, over time, to seem like a cruel deception. You&#39;ll never really get an elegant presentation of so-called facts that accurately and meaningfully represents reality. So, as much as I&#39;m drawn to those charts, I&#39;m also drawn to charts that obfuscate, or thwart, or somehow sharpen our sense of the absurdity of trying to accurately present and analyze information.\&quot;&lt;/i&gt; [Accessed on May 11, 2011]. &lt;a href=\&quot;http://ilovecharts.tumblr.com/BenGreenman\&quot;&gt;http://ilovecharts.tumblr.com/BenGreenman&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/GraphicsOptionsR.html  [1] &quot;c:/web/p1/GraphicsOptionsR.html&quot;
## c:/web/p1-clean/GraphModifications.html  [1] &quot;c:/web/p1/GraphModifications.html&quot;
## c:/web/p1-clean/gravity.html  [1] &quot;c:/web/p1/gravity.html&quot;
## c:/web/p1-clean/GroupSequential-05.html  [1] &quot;c:/web/p1/GroupSequential-05.html&quot;
## c:/web/p1-clean/GroupSequential-11.html  [1] &quot;c:/web/p1/GroupSequential-11.html&quot;
## c:/web/p1-clean/GrowthCurves.html  [1] &quot;c:/web/p1/GrowthCurves.html&quot;
## c:/web/p1-clean/GrowUp.html  [1] &quot;c:/web/p1/GrowUp.html&quot;
## c:/web/p1-clean/hand17.html  [1] &quot;c:/web/p1/hand17.html&quot;
## c:/web/p1-clean/hand17d.html  [1] &quot;c:/web/p1/hand17d.html&quot;
## c:/web/p1-clean/hand18.html  [1] &quot;c:/web/p1/hand18.html&quot;
## c:/web/p1-clean/hand18condensed.html  [1] &quot;c:/web/p1/hand18condensed.html&quot;
## c:/web/p1-clean/hand44.html  [1] &quot;c:/web/p1/hand44.html&quot;
## c:/web/p1-clean/hand52.html  [1] &quot;c:/web/p1/hand52.html&quot;
## c:/web/p1-clean/HandlingDropouts.html  [1] &quot;c:/web/p1/HandlingDropouts.html&quot;
## c:/web/p1-clean/HaplotypeAnalysis.html  [1] &quot;c:/web/p1/HaplotypeAnalysis.html&quot;
## [1] &quot;            “genotypes,” we shall refer to them as “marker phenotypes,” reserving the term &quot;
## [1] &quot;            \&quot;genotypes,\&quot; we shall refer to them as \&quot;marker phenotypes,\&quot; reserving the term &quot;
## [1] &quot;            “genotype” for when linkage phase is known. The traditional method to determine &quot;
## [1] &quot;            \&quot;genotype\&quot; for when linkage phase is known. The traditional method to determine &quot;
## [1] &quot;            among unrelated subjects, several algorithms—including a parsimony algorithm (Clark &quot;
## [1] &quot;            among unrelated subjects, several algorithms-including a parsimony algorithm (Clark &quot;
## [1] &quot;            and Slatkin 1995; Hawley and Kidd 1995; Long et al. 1995)—have been proposed. An &quot;
## [1] &quot;            and Slatkin 1995; Hawley and Kidd 1995; Long et al. 1995)-have been proposed. An &quot;
## c:/web/p1-clean/HaplotypeAnalysis1.html  [1] &quot;c:/web/p1/HaplotypeAnalysis1.html&quot;
## c:/web/p1-clean/HapMap.html  [1] &quot;c:/web/p1/HapMap.html&quot;
## c:/web/p1-clean/HardLessons.html  [1] &quot;c:/web/p1/HardLessons.html&quot;
## c:/web/p1-clean/HardwareRequirements.html  [1] &quot;c:/web/p1/HardwareRequirements.html&quot;
## c:/web/p1-clean/HarmonicMean.html  [1] &quot;c:/web/p1/HarmonicMean.html&quot;
## c:/web/p1-clean/HarrellPhilosophy.html  [1] &quot;c:/web/p1/HarrellPhilosophy.html&quot;
## c:/web/p1-clean/HarrellReferences.html  [1] &quot;c:/web/p1/HarrellReferences.html&quot;
## [1] &quot;&lt;title&gt;P.Mean: Quotes and references from Dr. HarrellÂ (created 2011-04-07)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean: Quotes and references from Dr. Harrell  (created 2011-04-07)&lt;/title&gt;&quot;
## c:/web/p1-clean/HarshSanctions.html  [1] &quot;c:/web/p1/HarshSanctions.html&quot;
## c:/web/p1-clean/HcupSeminar.html  [1] &quot;c:/web/p1/HcupSeminar.html&quot;
## c:/web/p1-clean/HealyViewpoint.html  [1] &quot;c:/web/p1/HealyViewpoint.html&quot;
## c:/web/p1-clean/hedge.html  [1] &quot;c:/web/p1/hedge.html&quot;
## c:/web/p1-clean/HedgesG.html  [1] &quot;c:/web/p1/HedgesG.html&quot;
## c:/web/p1-clean/HeiserWebpages.html  [1] &quot;c:/web/p1/HeiserWebpages.html&quot;
## c:/web/p1-clean/HelpForStatistics.html  [1] &quot;c:/web/p1/HelpForStatistics.html&quot;
## c:/web/p1-clean/HelpMyIrb.html  [1] &quot;c:/web/p1/HelpMyIrb.html&quot;
## c:/web/p1-clean/Heterogeneity.html  [1] &quot;c:/web/p1/Heterogeneity.html&quot;
## c:/web/p1-clean/HeterogeneityInAnova-08.html  [1] &quot;c:/web/p1/HeterogeneityInAnova-08.html&quot;
## c:/web/p1-clean/HeterogeneityInAnova-08a.html  [1] &quot;c:/web/p1/HeterogeneityInAnova-08a.html&quot;
## c:/web/p1-clean/HeteroscedasticTtest.html  [1] &quot;c:/web/p1/HeteroscedasticTtest.html&quot;
## c:/web/p1-clean/HicklinOffice.html  [1] &quot;c:/web/p1/HicklinOffice.html&quot;
## c:/web/p1-clean/Hierarchical.html  [1] &quot;c:/web/p1/Hierarchical.html&quot;
## c:/web/p1-clean/HighAltitude-08.html  [1] &quot;c:/web/p1/HighAltitude-08.html&quot;
## [1] &quot;    &lt;p&gt;football’s governing body, the Federation of International Football &quot;
## [1] &quot;    &lt;p&gt;football&#39;s governing body, the Federation of International Football &quot;
## c:/web/p1-clean/HighAltitude-08a.html  [1] &quot;c:/web/p1/HighAltitude-08a.html&quot;
## [1] &quot;    &lt;p&gt;football’s governing body, the Federation of International Football &quot;
## [1] &quot;    &lt;p&gt;football&#39;s governing body, the Federation of International Football &quot;
## c:/web/p1-clean/HighLevel.html  [1] &quot;c:/web/p1/HighLevel.html&quot;
## c:/web/p1-clean/HighQuality.html  [1] &quot;c:/web/p1/HighQuality.html&quot;
## [1] &quot;  &lt;p&gt;Schulz 95, Moher 98, Juni 99,Â  Lachin 00, Juni 01, Kjaergard 01, Tierney 04, Poolman 07, Wood 08 &lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Schulz 95, Moher 98, Juni 99,   Lachin 00, Juni 01, Kjaergard 01, Tierney 04, Poolman 07, Wood 08 &lt;/p&gt;&quot;
## c:/web/p1-clean/HistogramPatterns.html  [1] &quot;c:/web/p1/HistogramPatterns.html&quot;
## c:/web/p1-clean/hobbies.html  [1] &quot;c:/web/p1/hobbies.html&quot;
## c:/web/p1-clean/homogenous.html  [1] &quot;c:/web/p1/homogenous.html&quot;
## c:/web/p1-clean/Hoop.html  [1] &quot;c:/web/p1/Hoop.html&quot;
## c:/web/p1-clean/HowGood.html  [1] &quot;c:/web/p1/HowGood.html&quot;
## c:/web/p1-clean/HowManyCharts.html  [1] &quot;c:/web/p1/HowManyCharts.html&quot;
## c:/web/p1-clean/HowManyFiles.html  [1] &quot;c:/web/p1/HowManyFiles.html&quot;
## c:/web/p1-clean/HowManyWebpages.html  [1] &quot;c:/web/p1/HowManyWebpages.html&quot;
## c:/web/p1-clean/howto.html  [1] &quot;c:/web/p1/howto.html&quot;
## c:/web/p1-clean/HowWide-08.html  [1] &quot;c:/web/p1/HowWide-08.html&quot;
## c:/web/p1-clean/HowWide-08a.html  [1] &quot;c:/web/p1/HowWide-08a.html&quot;
## c:/web/p1-clean/HtmlDebris.html  [1] &quot;c:/web/p1/HtmlDebris.html&quot;
## c:/web/p1-clean/HumanFace.html  [1] &quot;c:/web/p1/HumanFace.html&quot;
## c:/web/p1-clean/HumanSideStatistics.html  [1] &quot;c:/web/p1/HumanSideStatistics.html&quot;
## [1] &quot;  &lt;p&gt;34. &lt;a href=\&quot;../11/web20.html\&quot;&gt;Promoting your consulting career in the era of Web 2.0Â (created 2011-05-20)&lt;/a&gt;. I was approached by a member of the planning committee for the American Statistical Association Conference on Statistical Practice about giving a talk at that conference. The talk would be an extension of a roundtable discussion I am giving at the Joint Statistical Meetings in 2011, Using Email Newsletters, Webinars, Blogs, And Social Media To Promote Your Consulting Career. After a telephone call this morning, I offered to prepare an abstract of a talk that I might give at this conference. I&#39;m very flexible on the content of this talk, but I thought it would be a good idea to put my thoughts down in writing.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;34. &lt;a href=\&quot;../11/web20.html\&quot;&gt;Promoting your consulting career in the era of Web 2.0  (created 2011-05-20)&lt;/a&gt;. I was approached by a member of the planning committee for the American Statistical Association Conference on Statistical Practice about giving a talk at that conference. The talk would be an extension of a roundtable discussion I am giving at the Joint Statistical Meetings in 2011, Using Email Newsletters, Webinars, Blogs, And Social Media To Promote Your Consulting Career. After a telephone call this morning, I offered to prepare an abstract of a talk that I might give at this conference. I&#39;m very flexible on the content of this talk, but I thought it would be a good idea to put my thoughts down in writing.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Shari &lt;a name=\&quot;Messinger\&quot;&gt;&lt;/a&gt;Messinger. &lt;b&gt;No shortcuts when collaborating&lt;/b&gt; Amstat News. August 1, 2011. &lt;i&gt;Excerpt: \&quot;As a collaborating statistician, I am often asked by researchers to &#39;run their data&#39; so they can get the answers they seek corresponding to a particular investigation. What they are really requesting (usually) is that I perform data analysis to address their research questionsâ\200”some of them quite vagueâ\200”and that I first need to determine an appropriate analytic approach based on the nature of the investigation, study design, distributional properties of the data, and particular research objectives. Although I know this is really what they are requesting, I am not sure if they are really aware of what is involved.\&quot;&lt;/i&gt; [Accessed on August 17, 2011]. &lt;a href=\&quot;http://magazine.amstat.org/blog/2011/08/01/statscienceaug11/\&quot;&gt;http://magazine.amstat.org/blog/2011/08/01/statscienceaug11/&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Journal article: Shari &lt;a name=\&quot;Messinger\&quot;&gt;&lt;/a&gt;Messinger. &lt;b&gt;No shortcuts when collaborating&lt;/b&gt; Amstat News. August 1, 2011. &lt;i&gt;Excerpt: \&quot;As a collaborating statistician, I am often asked by researchers to &#39;run their data&#39; so they can get the answers they seek corresponding to a particular investigation. What they are really requesting (usually) is that I perform data analysis to address their research questionsâ\200\&quot;some of them quite vagueâ\200\&quot;and that I first need to determine an appropriate analytic approach based on the nature of the investigation, study design, distributional properties of the data, and particular research objectives. Although I know this is really what they are requesting, I am not sure if they are really aware of what is involved.\&quot;&lt;/i&gt; [Accessed on August 17, 2011]. &lt;a href=\&quot;http://magazine.amstat.org/blog/2011/08/01/statscienceaug11/\&quot;&gt;http://magazine.amstat.org/blog/2011/08/01/statscienceaug11/&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/HumilityInResearch.html  [1] &quot;c:/web/p1/HumilityInResearch.html&quot;
## c:/web/p1-clean/HundredWords.html  [1] &quot;c:/web/p1/HundredWords.html&quot;
## c:/web/p1-clean/hypo.html  [1] &quot;c:/web/p1/hypo.html&quot;
## c:/web/p1-clean/HypothesisTesting.html  [1] &quot;c:/web/p1/HypothesisTesting.html&quot;
## [1] &quot;        non-inferiority trials. The term ï¿½non-inferiorityï¿½ is now well established, &quot;
## [1] &quot;        non-inferiority trials. The term i¿1/2non-inferiorityi¿1/2 is now well established, &quot;
## c:/web/p1-clean/IbmPuzzle.html  [1] &quot;c:/web/p1/IbmPuzzle.html&quot;
## c:/web/p1-clean/iceskater.html  [1] &quot;c:/web/p1/iceskater.html&quot;
## c:/web/p1-clean/icf.html  [1] &quot;c:/web/p1/icf.html&quot;
## c:/web/p1-clean/ideas.html  [1] &quot;c:/web/p1/ideas.html&quot;
## c:/web/p1-clean/IllustratedCaseStudies.html  [1] &quot;c:/web/p1/IllustratedCaseStudies.html&quot;
## c:/web/p1-clean/IllustrationsForTgn1412.html  [1] &quot;c:/web/p1/IllustrationsForTgn1412.html&quot;
## [1] &quot;  from Parexel International -&amp;quot;healthy males needed for a drug trial&amp;quot;for £2,000 &quot;
## [1] &quot;  from Parexel International -&amp;quot;healthy males needed for a drug trial&amp;quot;for lb2,000 &quot;
## c:/web/p1-clean/IllustrativeExamples.html  [1] &quot;c:/web/p1/IllustrativeExamples.html&quot;
## c:/web/p1-clean/ImportantStudies-08.html  [1] &quot;c:/web/p1/ImportantStudies-08.html&quot;
## c:/web/p1-clean/ImportantStudies-08a.html  [1] &quot;c:/web/p1/ImportantStudies-08a.html&quot;
## c:/web/p1-clean/ImpossibleResume-08.html  [1] &quot;c:/web/p1/ImpossibleResume-08.html&quot;
## c:/web/p1-clean/ImpossibleResume-08a.html  [1] &quot;c:/web/p1/ImpossibleResume-08a.html&quot;
## c:/web/p1-clean/ImprovementsWeblogCategories.html  [1] &quot;c:/web/p1/ImprovementsWeblogCategories.html&quot;
## c:/web/p1-clean/ImputationFormula.html  [1] &quot;c:/web/p1/ImputationFormula.html&quot;
## c:/web/p1-clean/IncidenceDensity.html  [1] &quot;c:/web/p1/IncidenceDensity.html&quot;
## c:/web/p1-clean/IncompletePages.html  [1] &quot;c:/web/p1/IncompletePages.html&quot;
## c:/web/p1-clean/IncreasingTrend.html  [1] &quot;c:/web/p1/IncreasingTrend.html&quot;
## c:/web/p1-clean/index-cases.html  [1] &quot;c:/web/p1/index-cases.html&quot;
## c:/web/p1-clean/index-informatics.html  [1] &quot;c:/web/p1/index-informatics.html&quot;
## c:/web/p1-clean/index-news.html  [1] &quot;c:/web/p1/index-news.html&quot;
## c:/web/p1-clean/index-personal.html  [1] &quot;c:/web/p1/index-personal.html&quot;
## [1] &quot;question. &amp;quot;&lt;i&gt;This was sent in by Norm Loveless. Imagine youï¿½re at home in a &quot;
## [1] &quot;question. &amp;quot;&lt;i&gt;This was sent in by Norm Loveless. Imagine youi¿1/2re at home in a &quot;
## [1] &quot;and soon are stupefied to find a sign saying, ï¿½Welcome to State Xï¿½! There is &quot;
## [1] &quot;and soon are stupefied to find a sign saying, i¿1/2Welcome to State Xi¿1/2! There is &quot;
## c:/web/p1-clean/index-training.html  [1] &quot;c:/web/p1/index-training.html&quot;
## c:/web/p1-clean/index-webinars.html  [1] &quot;c:/web/p1/index-webinars.html&quot;
## c:/web/p1-clean/IneligiblePatients.html  [1] &quot;c:/web/p1/IneligiblePatients.html&quot;
## c:/web/p1-clean/InferentialDescriptive.html  [1] &quot;c:/web/p1/InferentialDescriptive.html&quot;
## c:/web/p1-clean/InformaticsVision.html  [1] &quot;c:/web/p1/InformaticsVision.html&quot;
## [1] &quot;&lt;p&gt;According to the World Health Organization “health is not only the absence of &quot;
## [1] &quot;&lt;p&gt;According to the World Health Organization \&quot;health is not only the absence of &quot;
## [1] &quot;well-being.” Personalized health programs identify issues that can improve an &quot;
## [1] &quot;well-being.\&quot; Personalized health programs identify issues that can improve an &quot;
## [1] &quot;individual’s well-being and incorporate these features into the health care and &quot;
## [1] &quot;individual&#39;s well-being and incorporate these features into the health care and &quot;
## [1] &quot;care and a person’s genetic endowment. A useful pictorial for how these factors &quot;
## [1] &quot;care and a person&#39;s genetic endowment. A useful pictorial for how these factors &quot;
## [1] &quot;environmental toxins. Although an individual’s genetic makeup can certainly &quot;
## [1] &quot;environmental toxins. Although an individual&#39;s genetic makeup can certainly &quot;
## [1] &quot;individual’s physical and social needs. A diagram of the mismatch between &quot;
## [1] &quot;individual&#39;s physical and social needs. A diagram of the mismatch between &quot;
## c:/web/p1-clean/information-04.html  [1] &quot;c:/web/p1/information-04.html&quot;
## c:/web/p1-clean/information-99.html  [1] &quot;c:/web/p1/information-99.html&quot;
## c:/web/p1-clean/information1.html  [1] &quot;c:/web/p1/information1.html&quot;
## c:/web/p1-clean/InformationCalibration.html  [1] &quot;c:/web/p1/InformationCalibration.html&quot;
## c:/web/p1-clean/InformationSearching.html  [1] &quot;c:/web/p1/InformationSearching.html&quot;
## [1] &quot;    to research the following question: &lt;i&gt;In a patient (2 months ï¿½ 2 years of &quot;
## [1] &quot;    to research the following question: &lt;i&gt;In a patient (2 months i¿1/2 2 years of &quot;
## c:/web/p1-clean/InformationSource.html  [1] &quot;c:/web/p1/InformationSource.html&quot;
## c:/web/p1-clean/InformationTheory-05.html  [1] &quot;c:/web/p1/InformationTheory-05.html&quot;
## c:/web/p1-clean/InformationTheory-category.html  [1] &quot;c:/web/p1/InformationTheory-category.html&quot;
## c:/web/p1-clean/InformationTheoryA.html  [1] &quot;c:/web/p1/InformationTheoryA.html&quot;
## c:/web/p1-clean/InformationTheoryB.html  [1] &quot;c:/web/p1/InformationTheoryB.html&quot;
## c:/web/p1-clean/injury.html  [1] &quot;c:/web/p1/injury.html&quot;
## c:/web/p1-clean/Instructions.html  [1] &quot;c:/web/p1/Instructions.html&quot;
## c:/web/p1-clean/InstrumentalVariables-08.html  [1] &quot;c:/web/p1/InstrumentalVariables-08.html&quot;
## c:/web/p1-clean/InstrumentalVariables-08a.html  [1] &quot;c:/web/p1/InstrumentalVariables-08a.html&quot;
## c:/web/p1-clean/InstrumentalVariables-10.html  [1] &quot;c:/web/p1/InstrumentalVariables-10.html&quot;
## c:/web/p1-clean/InsufficientData.html  [1] &quot;c:/web/p1/InsufficientData.html&quot;
## c:/web/p1-clean/IntegratingEvidence.html  [1] &quot;c:/web/p1/IntegratingEvidence.html&quot;
## c:/web/p1-clean/IntellectualCOI.html  [1] &quot;c:/web/p1/IntellectualCOI.html&quot;
## c:/web/p1-clean/IntelligentBackup.html  [1] &quot;c:/web/p1/IntelligentBackup.html&quot;
## c:/web/p1-clean/intention.html  [1] &quot;c:/web/p1/intention.html&quot;
## c:/web/p1-clean/Interaction.html  [1] &quot;c:/web/p1/Interaction.html&quot;
## c:/web/p1-clean/interactions.html  [1] &quot;c:/web/p1/interactions.html&quot;
## c:/web/p1-clean/Interesting2008.html  [1] &quot;c:/web/p1/Interesting2008.html&quot;
## [1] &quot;  of older reference manager software (like EndNote)—the ability to store &quot;
## [1] &quot;  of older reference manager software (like EndNote)-the ability to store &quot;
## [1] &quot;  formatted references—and the best parts of modern software and web &quot;
## [1] &quot;  formatted references-and the best parts of modern software and web &quot;
## [1] &quot;  object on the web, and—on many major research and library sites—find and &quot;
## [1] &quot;  object on the web, and-on many major research and library sites-find and &quot;
## [1] &quot;  applications; since it runs on one’s personal computer, it can also &quot;
## [1] &quot;  applications; since it runs on one&#39;s personal computer, it can also &quot;
## c:/web/p1-clean/Interesting2009.html  [1] &quot;c:/web/p1/Interesting2009.html&quot;
## [1] &quot;  Copyright ï¿½ 2002 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed December 18, 2009]. &quot;
## [1] &quot;  Copyright i¿1/2 2002 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed December 18, 2009]. &quot;
## [1] &quot;  breast cancer metastasis. Copyright ï¿½ 2006 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; &quot;
## [1] &quot;  breast cancer metastasis. Copyright i¿1/2 2006 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; &quot;
## [1] &quot;  one of the many products stemming from ORIï¿½s educational initiatives in the &quot;
## [1] &quot;  one of the many products stemming from ORIi¿1/2s educational initiatives in the &quot;
## [1] &quot;  have always been sharedï¿½among physicians as well as among patients and their &quot;
## [1] &quot;  have always been sharedi¿1/2among physicians as well as among patients and their &quot;
## [1] &quot;  relatives. With the evolution of ï¿½modernï¿½ medicine, narratives were &quot;
## [1] &quot;  relatives. With the evolution of i¿1/2moderni¿1/2 medicine, narratives were &quot;
## [1] &quot;  increasingly neglected in favor of ï¿½facts and findings,ï¿½ which were regarded &quot;
## [1] &quot;  increasingly neglected in favor of i¿1/2facts and findings,i¿1/2 which were regarded &quot;
## [1] &quot;  changingï¿½from the stories about patients and their illnesses, patient &quot;
## [1] &quot;  changingi¿1/2from the stories about patients and their illnesses, patient &quot;
## [1] &quot;  hand, it was written to accompany a set of Windowsï¿½ programs that I have &quot;
## [1] &quot;  hand, it was written to accompany a set of Windowsi¿1/2 programs that I have &quot;
## [1] &quot;  a testï¿½s sensitivity or specificity. Results: The nomograms could be easily &quot;
## [1] &quot;  a testi¿1/2s sensitivity or specificity. Results: The nomograms could be easily &quot;
## [1] &quot;  been included for further discussion of specific topics. FDAï¿½s guidance &quot;
## [1] &quot;  been included for further discussion of specific topics. FDAi¿1/2s guidance &quot;
## [1] &quot;  responsibilities. Instead, guidances describe the Agencyï¿½s current thinking on &quot;
## [1] &quot;  responsibilities. Instead, guidances describe the Agencyi¿1/2s current thinking on &quot;
## [1] &quot;  disclosure of conflictsï¿½both financial and otherwise. In my view, these events &quot;
## [1] &quot;  disclosure of conflictsi¿1/2both financial and otherwise. In my view, these events &quot;
## [1] &quot;  contour enhanced funnel plots, a regression based adjustment method, Eggerï¿½s &quot;
## [1] &quot;  contour enhanced funnel plots, a regression based adjustment method, Eggeri¿1/2s &quot;
## [1] &quot;    &lt;li&gt;Neal R. &lt;b&gt;Radford Nealï¿½s blog.&lt;/b&gt; Available at:&lt;a href=\&quot;http://radfordneal.wordpress.com/\&quot;&gt; &quot;
## [1] &quot;    &lt;li&gt;Neal R. &lt;b&gt;Radford Neali¿1/2s blog.&lt;/b&gt; Available at:&lt;a href=\&quot;http://radfordneal.wordpress.com/\&quot;&gt; &quot;
## [1] &quot;  &lt;li&gt;Vance A. &lt;b&gt;Data Analysts Captivated by Rï¿½s Power&lt;/b&gt;. The New York Times. &quot;
## [1] &quot;  &lt;li&gt;Vance A. &lt;b&gt;Data Analysts Captivated by Ri¿1/2s Power&lt;/b&gt;. The New York Times. &quot;
## [1] &quot;  letter of the alphabet. To others, itï¿½s the rating on racy movies, a measure &quot;
## [1] &quot;  letter of the alphabet. To others, iti¿1/2s the rating on racy movies, a measure &quot;
## [1] &quot;  of an atticï¿½s insulation or what pirates in movies say. R is also the name of &quot;
## [1] &quot;  of an attici¿1/2s insulation or what pirates in movies say. R is also the name of &quot;
## c:/web/p1-clean/Interesting2010.html  [1] &quot;c:/web/p1/Interesting2010.html&quot;
## [1] &quot;  exercises designed to help reinforce the readerï¿½s knowledge and a &quot;
## [1] &quot;  exercises designed to help reinforce the readeri¿1/2s knowledge and a &quot;
## [1] &quot;  decision makers to take explicit account of additional evidenceï¿½for example, &quot;
## [1] &quot;  decision makers to take explicit account of additional evidencei¿1/2for example, &quot;
## [1] &quot;  overcomes both these problems. A Bayesian analysis starts with a ï¿½priorï¿½ &quot;
## [1] &quot;  overcomes both these problems. A Bayesian analysis starts with a i¿1/2priori¿1/2 &quot;
## [1] &quot;  relative risk)ï¿½based on previous knowledgeï¿½and adds the new evidence (via a &quot;
## [1] &quot;  relative risk)i¿1/2based on previous knowledgei¿1/2and adds the new evidence (via a &quot;
## [1] &quot;  model) to produce a ï¿½posteriorï¿½ probability distribution. Because different &quot;
## [1] &quot;  model) to produce a i¿1/2posteriori¿1/2 probability distribution. Because different &quot;
## [1] &quot;  (IRBs). It describes the Food and Drug Administrationï¿½s (FDA) longstanding &quot;
## [1] &quot;  (IRBs). It describes the Food and Drug Administrationi¿1/2s (FDA) longstanding &quot;
## [1] &quot;  records, safeguarding the privacy and confidentiality of the subjectï¿½s &quot;
## [1] &quot;  records, safeguarding the privacy and confidentiality of the subjecti¿1/2s &quot;
## [1] &quot;  research study, or when an investigator terminates a subjectï¿½s participation &quot;
## [1] &quot;  research study, or when an investigator terminates a subjecti¿1/2s participation &quot;
## [1] &quot;  in such a research study without regard to the subjectï¿½s consent, the &quot;
## [1] &quot;  in such a research study without regard to the subjecti¿1/2s consent, the &quot;
## [1] &quot;  and Drug Administration (FDA), FDAï¿½s guidance on this issue also should be &quot;
## [1] &quot;  and Drug Administration (FDA), FDAi¿1/2s guidance on this issue also should be &quot;
## [1] &quot;  Journal of Systems and Software. 2000;54(1):1. &lt;i&gt;Excerpt: &amp;quot;Editorï¿½s Note: It &quot;
## [1] &quot;  Journal of Systems and Software. 2000;54(1):1. &lt;i&gt;Excerpt: &amp;quot;Editori¿1/2s Note: It &quot;
## [1] &quot;  considered essential for proving a drugï¿½s value before it can go to market. &quot;
## [1] &quot;  considered essential for proving a drugi¿1/2s value before it can go to market. &quot;
## [1] &quot;  measures a drugï¿½s impact on extending life is still the best method for &quot;
## [1] &quot;  measures a drugi¿1/2s impact on extending life is still the best method for &quot;
## [1] &quot;  trials. The term ï¿½non-inferiorityï¿½ is now well established, but if taken &quot;
## [1] &quot;  trials. The term i¿1/2non-inferiorityi¿1/2 is now well established, but if taken &quot;
## [1] &quot;  &lt;li&gt;Iain Hrynaszkiewicz. &lt;b&gt;BMC Research Notes ï¿½ adding value to your data&lt;/b&gt;.&quot;
## [1] &quot;  &lt;li&gt;Iain Hrynaszkiewicz. &lt;b&gt;BMC Research Notes i¿1/2 adding value to your data&lt;/b&gt;.&quot;
## [1] &quot;  2010, so rather than ï¿½why share data?ï¿½ the question now is ï¿½how?ï¿½. Making data &quot;
## [1] &quot;  2010, so rather than i¿1/2why share data?i¿1/2 the question now is i¿1/2how?i¿1/2. Making data &quot;
## [1] &quot;  (Case Reports and Technical Notes), 5ï¿½10 authors (retrospective full-length &quot;
## [1] &quot;  (Case Reports and Technical Notes), 5i¿1/210 authors (retrospective full-length &quot;
## [1] &quot;  articles), 10ï¿½15 (prospective, often grant-funded articles), more than 15 &quot;
## [1] &quot;  articles), 10i¿1/215 (prospective, often grant-funded articles), more than 15 &quot;
## [1] &quot;  commonly used for adjustment ï¿½ the process of correcting the main effect for &quot;
## [1] &quot;  commonly used for adjustment i¿1/2 the process of correcting the main effect for &quot;
## [1] &quot;  &lt;li&gt;Steve Miller. &lt;b&gt;Biostatistics, Open Source and BI ï¿½ an Interview with &quot;
## [1] &quot;  &lt;li&gt;Steve Miller. &lt;b&gt;Biostatistics, Open Source and BI i¿1/2 an Interview with &quot;
## [1] &quot;  will learn as much from Frankï¿½s responses as I did.&amp;quot;&lt;/i&gt; [Accessed July 19, &quot;
## [1] &quot;  will learn as much from Franki¿1/2s responses as I did.&amp;quot;&lt;/i&gt; [Accessed July 19, &quot;
## [1] &quot;  Times. 2010. &lt;i&gt;Excerpt: &amp;quot;The program, called ï¿½continuous performance &quot;
## [1] &quot;  Times. 2010. &lt;i&gt;Excerpt: &amp;quot;The program, called i¿1/2continuous performance &quot;
## [1] &quot;  improvement,ï¿½ or C.P.I., examines every aspect of patientsï¿½ stays at the &quot;
## [1] &quot;  improvement,i¿1/2 or C.P.I., examines every aspect of patientsi¿1/2 stays at the &quot;
## [1] &quot;  Childrenï¿½s costs per patient by 3.7 percent, for a total savings of $23 &quot;
## [1] &quot;  Childreni¿1/2s costs per patient by 3.7 percent, for a total savings of $23 &quot;
## [1] &quot;  large trials (2ï¿½4). Heretofore, the defenders of smaller trials have &quot;
## [1] &quot;  large trials (2i¿1/24). Heretofore, the defenders of smaller trials have &quot;
## [1] &quot;  and participantsï¿½ altruistic satisfaction.&amp;quot;&lt;/i&gt; [Accessed July 7, 2010]. &quot;
## [1] &quot;  and participantsi¿1/2 altruistic satisfaction.&amp;quot;&lt;/i&gt; [Accessed July 7, 2010]. &quot;
## [1] &quot;  provided to supplement the primary analysis. Copyright ï¿½ 2009 John Wiley &amp;amp; &quot;
## [1] &quot;  provided to supplement the primary analysis. Copyright i¿1/2 2009 John Wiley &amp;amp; &quot;
## [1] &quot;  Copyright ï¿½ 2010 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed June 16, 2010]. &quot;
## [1] &quot;  Copyright i¿1/2 2010 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed June 16, 2010]. &quot;
## [1] &quot;  to have committed another alleged war crimeï¿½illegal experimentation on &quot;
## [1] &quot;  to have committed another alleged war crimei¿1/2illegal experimentation on &quot;
## [1] &quot;  turns ï¿½foodï¿½ into a ï¿½delicious dishï¿½. However, meta-analyses are like &quot;
## [1] &quot;  turns i¿1/2foodi¿1/2 into a i¿1/2delicious dishi¿1/2. However, meta-analyses are like &quot;
## [1] &quot;  subject (n-of-1) designs, sequential designs, ï¿½within-subjectï¿½ designs, &quot;
## [1] &quot;  subject (n-of-1) designs, sequential designs, i¿1/2within-subjecti¿1/2 designs, &quot;
## [1] &quot;  ï¿½combining data from multiple studies into single estimates of treatment &quot;
## [1] &quot;  i¿1/2combining data from multiple studies into single estimates of treatment &quot;
## [1] &quot;  intervention could compromise the trialsï¿½ generalisability. We investigated &quot;
## [1] &quot;  intervention could compromise the trialsi¿1/2 generalisability. We investigated &quot;
## [1] &quot;  ï¿½check inï¿½ at every locale, automatically building a detailed diary of &quot;
## [1] &quot;  i¿1/2check ini¿1/2 at every locale, automatically building a detailed diary of &quot;
## [1] &quot;  movements and habits; many users publish these data widely. Nintendoï¿½s Wii &quot;
## [1] &quot;  movements and habits; many users publish these data widely. Nintendoi¿1/2s Wii &quot;
## [1] &quot;  &lt;i&gt;Excerpt: &amp;quot;For may years, versions of a claim that students remember ï¿½10% of &quot;
## [1] &quot;  &lt;i&gt;Excerpt: &amp;quot;For may years, versions of a claim that students remember i¿1/210% of &quot;
## [1] &quot;  see and hear, and 90% of what they doï¿½ have been widely circulated among &quot;
## [1] &quot;  see and hear, and 90% of what they doi¿1/2 have been widely circulated among &quot;
## [1] &quot;  accessible to medical researchers. However, multiple imputationï¿½a relatively &quot;
## [1] &quot;  accessible to medical researchers. However, multiple imputationi¿1/2a relatively &quot;
## [1] &quot;  flexible, general purpose approach to dealing with missing dataï¿½is now &quot;
## [1] &quot;  flexible, general purpose approach to dealing with missing datai¿1/2is now &quot;
## c:/web/p1-clean/Interesting2011.html  [1] &quot;c:/web/p1/Interesting2011.html&quot;
## c:/web/p1-clean/InterestingApril.html  [1] &quot;c:/web/p1/InterestingApril.html&quot;
## c:/web/p1-clean/InterestingArticles.html  [1] &quot;c:/web/p1/InterestingArticles.html&quot;
## [1] &quot;  &lt;li&gt;&lt;a name=\&quot;ArRaAm\&quot;&gt;&lt;/a&gt;&lt;b&gt;The ï¿½Arms Raceï¿½ on American Roads: The Effect of &quot;
## [1] &quot;  &lt;li&gt;&lt;a name=\&quot;ArRaAm\&quot;&gt;&lt;/a&gt;&lt;b&gt;The i¿1/2Arms Racei¿1/2 on American Roads: The Effect of &quot;
## [1] &quot;  SUVï¿½s and Pickup Trucks on Traffic Safety [pdf].&lt;/b&gt; Michelle J. White. 2004: &quot;
## [1] &quot;  SUVi¿1/2s and Pickup Trucks on Traffic Safety [pdf].&lt;/b&gt; Michelle J. White. 2004: &quot;
## [1] &quot;  Hï¿½bert, Sheldon Kotzin, Ana Marusic, Peush Sahni, Torben V Schroeder, Harold C &quot;
## [1] &quot;  Hi¿1/2bert, Sheldon Kotzin, Ana Marusic, Peush Sahni, Torben V Schroeder, Harold C &quot;
## [1] &quot;  University Press, 2007. Pp 400. ï¿½32ï¿½99. ISBN 0-19-517922-4. This book contains &quot;
## [1] &quot;  University Press, 2007. Pp 400. i¿1/232i¿1/299. ISBN 0-19-517922-4. This book contains &quot;
## [1] &quot;  &lt;li&gt;&lt;a name=\&quot;dadtta\&quot;&gt;&lt;/a&gt;&lt;b&gt;Donï¿½t Ask, Donï¿½t Tell? Transfer and Sale of &quot;
## [1] &quot;  &lt;li&gt;&lt;a name=\&quot;dadtta\&quot;&gt;&lt;/a&gt;&lt;b&gt;Doni¿1/2t Ask, Doni¿1/2t Tell? Transfer and Sale of &quot;
## [1] &quot;  study.&lt;/b&gt; Egger M, Jï¿½ni P, Bartlett C, Holenstein F, Sterne J. Health &quot;
## [1] &quot;  study.&lt;/b&gt; Egger M, Ji¿1/2ni P, Bartlett C, Holenstein F, Sterne J. Health &quot;
## [1] &quot;  he UKï¿½s stuttering system? &lt;/b&gt;Peter T Wilmshurst. MJA 2007; 186 (12): &quot;
## [1] &quot;  he UKi¿1/2s stuttering system? &lt;/b&gt;Peter T Wilmshurst. MJA 2007; 186 (12): &quot;
## [1] &quot;  and publication of results.&lt;/b&gt; Pich J, Carnï¿½ X, Arnaiz J-A, Gï¿½mez B, Trilla &quot;
## [1] &quot;  and publication of results.&lt;/b&gt; Pich J, Carni¿1/2 X, Arnaiz J-A, Gi¿1/2mez B, Trilla &quot;
## [1] &quot;  A, Rodï¿½s J. The Lancet 2003: 361(9362);&quot;
## [1] &quot;  A, Rodi¿1/2s J. The Lancet 2003: 361(9362);&quot;
## [1] &quot;  systematic reviews? Empirical study&lt;/a&gt;&lt;/strong&gt;. Egger M, Jï¿½ni P, Bartlett C, &quot;
## [1] &quot;  systematic reviews? Empirical study&lt;/a&gt;&lt;/strong&gt;. Egger M, Ji¿1/2ni P, Bartlett C, &quot;
## [1] &quot;  to share his or her insight, experience and opinionsï¿½and earn money. If this &quot;
## [1] &quot;  to share his or her insight, experience and opinionsi¿1/2and earn money. If this &quot;
## [1] &quot;  can leave readers confused and wary; they &amp;quot;tune out&amp;quot;ï¿½and you lose your &quot;
## [1] &quot;  can leave readers confused and wary; they &amp;quot;tune out&amp;quot;i¿1/2and you lose your &quot;
## [1] &quot;  do you attract the new ï¿½Net denizens to your e-store and entice them to hit &quot;
## [1] &quot;  do you attract the new i¿1/2Net denizens to your e-store and entice them to hit &quot;
## [1] &quot;  the ï¿½Submit Orderï¿½ button? Experts say the answer depends on the content you &quot;
## [1] &quot;  the i¿1/2Submit Orderi¿1/2 button? Experts say the answer depends on the content you &quot;
## [1] &quot;  and others who create content for online media ï¿½ Web sites, e-mail &quot;
## [1] &quot;  and others who create content for online media i¿1/2 Web sites, e-mail &quot;
## [1] &quot;  &lt;font color=\&quot;#FF0000\&quot;&gt;&amp;quot;The Digital Object Identifier (DOIï¿½) is a system for &quot;
## [1] &quot;  &lt;font color=\&quot;#FF0000\&quot;&gt;&amp;quot;The Digital Object Identifier (DOIi¿1/2) is a system for &quot;
## [1] &quot;  ForecastXï¿½ supply chain solutions and capabilities to leverage IT investments, &quot;
## [1] &quot;  ForecastXi¿1/2 supply chain solutions and capabilities to leverage IT investments, &quot;
## [1] &quot;  Thomas Lumley, Martin Mï¿½chler, Guido Masarotto, Paul Murrell, Balasubramanian &quot;
## [1] &quot;  Thomas Lumley, Martin Mi¿1/2chler, Guido Masarotto, Paul Murrell, Balasubramanian &quot;
## [1] &quot;  Narasimhan, Brian Ripley, Gï¿½nther Sawitzki, Duncan Temple Lang, Luke Tierney, &quot;
## [1] &quot;  Narasimhan, Brian Ripley, Gi¿1/2nther Sawitzki, Duncan Temple Lang, Luke Tierney, &quot;
## c:/web/p1-clean/InterestingBooks.html  [1] &quot;c:/web/p1/InterestingBooks.html&quot;
## [1] &quot;  recommend ï¿½a good introductory statistics bookï¿½. This request is frequently &quot;
## [1] &quot;  recommend i¿1/2a good introductory statistics booki¿1/2. This request is frequently &quot;
## [1] &quot;  opinion, Marija Norusisï¿½ book ï¿½SPSSï¿½ 12.0 Guide to Data Analysisï¿½ fills this &quot;
## [1] &quot;  opinion, Marija Norusisi¿1/2 book i¿1/2SPSSi¿1/2 12.0 Guide to Data Analysisi¿1/2 fills this &quot;
## c:/web/p1-clean/InterestingCaseStudies.html  [1] &quot;c:/web/p1/InterestingCaseStudies.html&quot;
## c:/web/p1-clean/InterestingMarch.html  [1] &quot;c:/web/p1/InterestingMarch.html&quot;
## [1] &quot;       these “experiments”, a two group study where 20S have been randomly assigned (n=10 to each &quot;
## [1] &quot;       these \&quot;experiments\&quot;, a two group study where 20S have been randomly assigned (n=10 to each &quot;
## [1] &quot;       specimens (hereafter referred to as “specimens”) that is conducted or supported by HHS. This &quot;
## [1] &quot;       specimens (hereafter referred to as \&quot;specimens\&quot;) that is conducted or supported by HHS. This &quot;
## c:/web/p1-clean/InterestingMay.html  [1] &quot;c:/web/p1/InterestingMay.html&quot;
## c:/web/p1-clean/InterestingQuotes.html  [1] &quot;c:/web/p1/InterestingQuotes.html&quot;
## c:/web/p1-clean/InterestingStuff.html  [1] &quot;c:/web/p1/InterestingStuff.html&quot;
## c:/web/p1-clean/InterestingWebsites.html  [1] &quot;c:/web/p1/InterestingWebsites.html&quot;
## [1] &quot;  Franï¿½ois-Xavier Micheloud. This website is cited in &lt;a href=\&quot;UnusualData.html\&quot;&gt;&quot;
## [1] &quot;  Frani¿1/2ois-Xavier Micheloud. This website is cited in &lt;a href=\&quot;UnusualData.html\&quot;&gt;&quot;
## [1] &quot;  Magrini, Susan Manley, Mercï¿½ Marzo, James Mason, Alison MacLeod, Philippa &quot;
## [1] &quot;  Magrini, Susan Manley, Merci¿1/2 Marzo, James Mason, Alison MacLeod, Philippa &quot;
## [1] &quot;  Middleton, Andrew Mitchell, Victor M. Montori, Susan L. Norris, Gï¿½nter &quot;
## [1] &quot;  Middleton, Andrew Mitchell, Victor M. Montori, Susan L. Norris, Gi¿1/2nter &quot;
## [1] &quot;  Ollenschlï¿½ger, Wytze Oosterhuis, Jacek Mrukowicz, Andrew David Oxman, Bob &quot;
## [1] &quot;  Ollenschli¿1/2ger, Wytze Oosterhuis, Jacek Mrukowicz, Andrew David Oxman, Bob &quot;
## [1] &quot;  Phillips, David M Rind, Vivian Robinson, Arturo Salazar, Holger J Schï¿½nemann, &quot;
## [1] &quot;  Phillips, David M Rind, Vivian Robinson, Arturo Salazar, Holger J Schi¿1/2nemann, &quot;
## [1] &quot;  placebo (Latin for ï¿½I shall pleaseï¿½) is a medication or treatment believed by &quot;
## [1] &quot;  placebo (Latin for i¿1/2I shall pleasei¿1/2) is a medication or treatment believed by &quot;
## [1] &quot;  sugar pills or starch pills. Even ï¿½fakeï¿½ surgery and ï¿½fakeï¿½ psychotherapy are &quot;
## [1] &quot;  sugar pills or starch pills. Even i¿1/2fakei¿1/2 surgery and i¿1/2fakei¿1/2 psychotherapy are &quot;
## [1] &quot;  prevention and diagnostic screening methods. Todayï¿½s most effective prevention &quot;
## [1] &quot;  prevention and diagnostic screening methods. Todayi¿1/2s most effective prevention &quot;
## [1] &quot;  implementation of having hospitals set payment rates based on the 3Mï¿½ APR-DRGï¿½ &quot;
## [1] &quot;  implementation of having hospitals set payment rates based on the 3Mi¿1/2 APR-DRGi¿1/2 &quot;
## [1] &quot;  Classification Systemï¿½s severity scoring, hospitals might feel overwhelmed &quot;
## [1] &quot;  Classification Systemi¿1/2s severity scoring, hospitals might feel overwhelmed &quot;
## [1] &quot;  with the requirements for change. But, this change doesnï¿½t have to be complex. &quot;
## [1] &quot;  with the requirements for change. But, this change doesni¿1/2t have to be complex. &quot;
## [1] &quot;   presidential race by simply asking, ï¿½Whoï¿½s your pick?ï¿½ But that question &quot;
## [1] &quot;   presidential race by simply asking, i¿1/2Whoi¿1/2s your pick?i¿1/2 But that question &quot;
## [1] &quot;   Stats&lt;/a&gt;&lt;/strong&gt;. R Lowry. Accessed on 2001-11-15. &amp;quot;Welcome to ï¿½Concepts &quot;
## [1] &quot;   Stats&lt;/a&gt;&lt;/strong&gt;. R Lowry. Accessed on 2001-11-15. &amp;quot;Welcome to i¿1/2Concepts &quot;
## [1] &quot;   and Applications of Inferential Statisticsï¿½, which is a free, full-length, &quot;
## [1] &quot;   and Applications of Inferential Statisticsi¿1/2, which is a free, full-length, &quot;
## c:/web/p1-clean/interim.html  [1] &quot;c:/web/p1/interim.html&quot;
## c:/web/p1-clean/InterpretationOddsRatio.html  [1] &quot;c:/web/p1/InterpretationOddsRatio.html&quot;
## c:/web/p1-clean/InterpretCorrelation.html  [1] &quot;c:/web/p1/InterpretCorrelation.html&quot;
## c:/web/p1-clean/InterpretingPart1.html  [1] &quot;c:/web/p1/InterpretingPart1.html&quot;
## [1] &quot;  95% confidence interval [CI] = 1.5ï¿½101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;  95% confidence interval [CI] = 1.5i¿1/2101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;  0.8ï¿½5.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;  0.8i¿1/25.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;  US$22,573ï¿½45,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## [1] &quot;  US$22,573i¿1/245,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## c:/web/p1-clean/IntervalTooWide.html  [1] &quot;c:/web/p1/IntervalTooWide.html&quot;
## c:/web/p1-clean/InterveningVariable.html  [1] &quot;c:/web/p1/InterveningVariable.html&quot;
## c:/web/p1-clean/InTheEnd.html  [1] &quot;c:/web/p1/InTheEnd.html&quot;
## [1] &quot;       Jan P Vandenbroucke, &lt;b&gt;Experts’ views are still needed&lt;/b&gt;, BMJ 1998;316:469 (7 February)&quot;
## [1] &quot;       Jan P Vandenbroucke, &lt;b&gt;Experts&#39; views are still needed&lt;/b&gt;, BMJ 1998;316:469 (7 February)&quot;
## c:/web/p1-clean/Introduction-evidence.html  [1] &quot;c:/web/p1/Introduction-evidence.html&quot;
## [1] &quot;     dimension to the level of confidence — or lack thereof — that chance &quot;
## [1] &quot;     dimension to the level of confidence - or lack thereof - that chance &quot;
## [1] &quot;     relation—which, in the final analysis, is the bedrock on which good medical &quot;
## [1] &quot;     relation-which, in the final analysis, is the bedrock on which good medical &quot;
## c:/web/p1-clean/Introduction-webinars.html  [1] &quot;c:/web/p1/Introduction-webinars.html&quot;
## c:/web/p1-clean/Intuition-05.html  [1] &quot;c:/web/p1/Intuition-05.html&quot;
## c:/web/p1-clean/Intuition-10.html  [1] &quot;c:/web/p1/Intuition-10.html&quot;
## c:/web/p1-clean/inVitro.html  [1] &quot;c:/web/p1/inVitro.html&quot;
## [1] &quot;      CP, Vacek JL, Jones PG, Forker A, O’Keefe JH, McCallister BD. Archives of Internal Medicine &quot;
## [1] &quot;      CP, Vacek JL, Jones PG, Forker A, O&#39;Keefe JH, McCallister BD. Archives of Internal Medicine &quot;
## c:/web/p1-clean/IomReport.html  [1] &quot;c:/web/p1/IomReport.html&quot;
## c:/web/p1-clean/IowaTalk.html  [1] &quot;c:/web/p1/IowaTalk.html&quot;
## c:/web/p1-clean/irb-02.html  [1] &quot;c:/web/p1/irb-02.html&quot;
## c:/web/p1-clean/irb-04.html  [1] &quot;c:/web/p1/irb-04.html&quot;
## [1] &quot;    whether intended as a “pilot” vs “definitive” study. Include plan for &quot;
## [1] &quot;    whether intended as a \&quot;pilot\&quot; vs \&quot;definitive\&quot; study. Include plan for &quot;
## [1] &quot;    Sponsor’s assessment of risk: [ ] Non-significant risk device: [ ] &quot;
## [1] &quot;    Sponsor&#39;s assessment of risk: [ ] Non-significant risk device: [ ] &quot;
## [1] &quot;    Investigator’s opinion of risk: [ ] Non-significant risk device: [ ] &quot;
## [1] &quot;    Investigator&#39;s opinion of risk: [ ] Non-significant risk device: [ ] &quot;
## [1] &quot;    3. Investigator’s Assessment of Risk: (according to 45 CFR Part 46 Subpart &quot;
## [1] &quot;    3. Investigator&#39;s Assessment of Risk: (according to 45 CFR Part 46 Subpart &quot;
## [1] &quot;    generalizable knowledge about the subject’s disorder or condition.&lt;br&gt;&quot;
## [1] &quot;    generalizable knowledge about the subject&#39;s disorder or condition.&lt;br&gt;&quot;
## c:/web/p1-clean/IrbReviewPilot.html  [1] &quot;c:/web/p1/IrbReviewPilot.html&quot;
## c:/web/p1-clean/IrbStatistician.html  [1] &quot;c:/web/p1/IrbStatistician.html&quot;
## c:/web/p1-clean/ironwoods.html  [1] &quot;c:/web/p1/ironwoods.html&quot;
## c:/web/p1-clean/ItemResponseTheory.html  [1] &quot;c:/web/p1/ItemResponseTheory.html&quot;
## c:/web/p1-clean/ItSeemsToMeReasonable.html  [1] &quot;c:/web/p1/ItSeemsToMeReasonable.html&quot;
## c:/web/p1-clean/JackknifeEntropy.html  [1] &quot;c:/web/p1/JackknifeEntropy.html&quot;
## c:/web/p1-clean/jags.html  [1] &quot;c:/web/p1/jags.html&quot;
## c:/web/p1-clean/jargon.html  [1] &quot;c:/web/p1/jargon.html&quot;
## c:/web/p1-clean/jayhawker.html  [1] &quot;c:/web/p1/jayhawker.html&quot;
## c:/web/p1-clean/JointEntropy.html  [1] &quot;c:/web/p1/JointEntropy.html&quot;
## c:/web/p1-clean/JournalClub.html  [1] &quot;c:/web/p1/JournalClub.html&quot;
## c:/web/p1-clean/JumpStart.html  [1] &quot;c:/web/p1/JumpStart.html&quot;
## c:/web/p1-clean/kaplan.html  [1] &quot;c:/web/p1/kaplan.html&quot;
## c:/web/p1-clean/KcalsiGrant.html  [1] &quot;c:/web/p1/KcalsiGrant.html&quot;
## [1] &quot;       &lt;p&gt;&lt;b&gt;Biographical Sketch&lt;/b&gt; – Principal Investigator/Program Director (Not to exceed four &quot;
## [1] &quot;       &lt;p&gt;&lt;b&gt;Biographical Sketch&lt;/b&gt; - Principal Investigator/Program Director (Not to exceed four &quot;
## [1] &quot;       Other Biographical Sketches (Not to exceed four pages for each – See instructions) The RFP &quot;
## [1] &quot;       Other Biographical Sketches (Not to exceed four pages for each - See instructions) The RFP &quot;
## c:/web/p1-clean/KCStar.html  [1] &quot;c:/web/p1/KCStar.html&quot;
## c:/web/p1-clean/KickAround.html  [1] &quot;c:/web/p1/KickAround.html&quot;
## c:/web/p1-clean/KidneyBiopsy.html  [1] &quot;c:/web/p1/KidneyBiopsy.html&quot;
## c:/web/p1-clean/km.html  [1] &quot;c:/web/p1/km.html&quot;
## c:/web/p1-clean/km1a.html  [1] &quot;c:/web/p1/km1a.html&quot;
## c:/web/p1-clean/km1b.html  [1] &quot;c:/web/p1/km1b.html&quot;
## c:/web/p1-clean/km2a.html  [1] &quot;c:/web/p1/km2a.html&quot;
## c:/web/p1-clean/km2b.html  [1] &quot;c:/web/p1/km2b.html&quot;
## c:/web/p1-clean/km3a.html  [1] &quot;c:/web/p1/km3a.html&quot;
## c:/web/p1-clean/km3b.html  [1] &quot;c:/web/p1/km3b.html&quot;
## c:/web/p1-clean/km4a.html  [1] &quot;c:/web/p1/km4a.html&quot;
## c:/web/p1-clean/km4b.html  [1] &quot;c:/web/p1/km4b.html&quot;
## c:/web/p1-clean/km5a.html  [1] &quot;c:/web/p1/km5a.html&quot;
## c:/web/p1-clean/km5b.html  [1] &quot;c:/web/p1/km5b.html&quot;
## c:/web/p1-clean/km6a.html  [1] &quot;c:/web/p1/km6a.html&quot;
## c:/web/p1-clean/km6b.html  [1] &quot;c:/web/p1/km6b.html&quot;
## c:/web/p1-clean/KnockKnock.html  [1] &quot;c:/web/p1/KnockKnock.html&quot;
## c:/web/p1-clean/Koan04.html  [1] &quot;c:/web/p1/Koan04.html&quot;
## c:/web/p1-clean/Koan05.html  [1] &quot;c:/web/p1/Koan05.html&quot;
## c:/web/p1-clean/KoanPage.html  [1] &quot;c:/web/p1/KoanPage.html&quot;
## c:/web/p1-clean/koans-08.html  [1] &quot;c:/web/p1/koans-08.html&quot;
## c:/web/p1-clean/koans-08a.html  [1] &quot;c:/web/p1/koans-08a.html&quot;
## c:/web/p1-clean/Krauthammer.html  [1] &quot;c:/web/p1/Krauthammer.html&quot;
## c:/web/p1-clean/KreamerAward-08.html  [1] &quot;c:/web/p1/KreamerAward-08.html&quot;
## [1] &quot;    or research staff of Children’s Mercy Hospital for a minimum of 5 years;&lt;/li&gt;&quot;
## [1] &quot;    or research staff of Children&#39;s Mercy Hospital for a minimum of 5 years;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;The nominee’s research should have an impact on improving health care of &quot;
## [1] &quot;  &lt;li&gt;The nominee&#39;s research should have an impact on improving health care of &quot;
## c:/web/p1-clean/KreamerAward-08a.html  [1] &quot;c:/web/p1/KreamerAward-08a.html&quot;
## [1] &quot;    or research staff of Children’s Mercy Hospital for a minimum of 5 years;&lt;/li&gt;&quot;
## [1] &quot;    or research staff of Children&#39;s Mercy Hospital for a minimum of 5 years;&lt;/li&gt;&quot;
## [1] &quot;    &lt;li&gt;The nominee’s research should have an impact on improving health care of &quot;
## [1] &quot;    &lt;li&gt;The nominee&#39;s research should have an impact on improving health care of &quot;
## c:/web/p1-clean/labor.html  [1] &quot;c:/web/p1/labor.html&quot;
## c:/web/p1-clean/LanDeMets.html  [1] &quot;c:/web/p1/LanDeMets.html&quot;
## c:/web/p1-clean/LanguageResources.html  [1] &quot;c:/web/p1/LanguageResources.html&quot;
## c:/web/p1-clean/LargeFile.html  [1] &quot;c:/web/p1/LargeFile.html&quot;
## c:/web/p1-clean/lasagna.html  [1] &quot;c:/web/p1/lasagna.html&quot;
## [1] &quot;  &lt;p&gt;A variant, called MÃ¼nch&#39;s law (note the umlaut, and be sure to also search for Munch&#39;s law or  Muench&#39;s law)  uses the previously cited ten fold discrepancy&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;A variant, called MÃ1/4nch&#39;s law (note the umlaut, and be sure to also search for Munch&#39;s law or  Muench&#39;s law)  uses the previously cited ten fold discrepancy&lt;/p&gt;&quot;
## c:/web/p1-clean/lasso-12.html  [1] &quot;c:/web/p1/lasso-12.html&quot;
## c:/web/p1-clean/lasso-16.html  [1] &quot;c:/web/p1/lasso-16.html&quot;
## c:/web/p1-clean/lassof1.html  [1] &quot;c:/web/p1/lassof1.html&quot;
## c:/web/p1-clean/lassof2.html  [1] &quot;c:/web/p1/lassof2.html&quot;
## c:/web/p1-clean/lassof3.html  [1] &quot;c:/web/p1/lassof3.html&quot;
## c:/web/p1-clean/lassof4.html  [1] &quot;c:/web/p1/lassof4.html&quot;
## c:/web/p1-clean/lassof5.html  [1] &quot;c:/web/p1/lassof5.html&quot;
## c:/web/p1-clean/lassof6.html  [1] &quot;c:/web/p1/lassof6.html&quot;
## c:/web/p1-clean/LatentGrowth.html  [1] &quot;c:/web/p1/LatentGrowth.html&quot;
## c:/web/p1-clean/LaTeX.html  [1] &quot;c:/web/p1/LaTeX.html&quot;
## c:/web/p1-clean/LearnMore.html  [1] &quot;c:/web/p1/LearnMore.html&quot;
## c:/web/p1-clean/LeastSquares.html  [1] &quot;c:/web/p1/LeastSquares.html&quot;
## c:/web/p1-clean/legal.html  [1] &quot;c:/web/p1/legal.html&quot;
## c:/web/p1-clean/Lessons.html  [1] &quot;c:/web/p1/Lessons.html&quot;
## c:/web/p1-clean/LessonsLearned.html  [1] &quot;c:/web/p1/LessonsLearned.html&quot;
## c:/web/p1-clean/letter.html  [1] &quot;c:/web/p1/letter.html&quot;
## c:/web/p1-clean/LetterCensus.html  [1] &quot;c:/web/p1/LetterCensus.html&quot;
## c:/web/p1-clean/Letters.html  [1] &quot;c:/web/p1/Letters.html&quot;
## [1] &quot;  Bush (Will Bushï¿½s presidency rebound in history like Trumanï¿½s?). Truman &quot;
## [1] &quot;  Bush (Will Bushi¿1/2s presidency rebound in history like Trumani¿1/2s?). Truman &quot;
## [1] &quot;  November 14, 2008). He says weï¿½ll see negative job growth, large federal &quot;
## [1] &quot;  November 14, 2008). He says wei¿1/2ll see negative job growth, large federal &quot;
## [1] &quot;  sounds a lot like what weï¿½re seeing today. The Post Office is awfully slow. &quot;
## [1] &quot;  sounds a lot like what wei¿1/2re seeing today. The Post Office is awfully slow. &quot;
## [1] &quot;  Are you sure that letter wasnï¿½t written in 2000 and was really referring to &quot;
## [1] &quot;  Are you sure that letter wasni¿1/2t written in 2000 and was really referring to &quot;
## [1] &quot;  Heï¿½s not an intellectual. Intellectuals start all the trouble in the world.&amp;quot;&quot;
## [1] &quot;  Hei¿1/2s not an intellectual. Intellectuals start all the trouble in the world.&amp;quot;&quot;
## [1] &quot;  belong to a single party (Letters, November 14, 2008). He says weï¿½ll see &quot;
## [1] &quot;  belong to a single party (Letters, November 14, 2008). He says wei¿1/2ll see &quot;
## [1] &quot;  dependence on foreign oil. Gee, that sounds a lot like what weï¿½re seeing &quot;
## [1] &quot;  dependence on foreign oil. Gee, that sounds a lot like what wei¿1/2re seeing &quot;
## [1] &quot;  today. The Post Office is awfully slow. Are you sure that letter wasnï¿½t &quot;
## [1] &quot;  today. The Post Office is awfully slow. Are you sure that letter wasni¿1/2t &quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;I think this got published&lt;/i&gt;. Letï¿½s stop talking about Sarah Palinï¿½s &quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;I think this got published&lt;/i&gt;. Leti¿1/2s stop talking about Sarah Palini¿1/2s &quot;
## [1] &quot;  Condoleezza Rice, or Joe Lieberman. He didnï¿½t because they all flunked the &quot;
## [1] &quot;  Condoleezza Rice, or Joe Lieberman. He didni¿1/2t because they all flunked the &quot;
## [1] &quot;  Barack Obamaï¿½s call for responsible fatherhood, she claims that problems with &quot;
## [1] &quot;  Barack Obamai¿1/2s call for responsible fatherhood, she claims that problems with &quot;
## [1] &quot;  collect overdue child support (Demonizing Men Doesnï¿½t Bring Home Absent Dads &quot;
## [1] &quot;  collect overdue child support (Demonizing Men Doesni¿1/2t Bring Home Absent Dads &quot;
## [1] &quot;  As a man, Iï¿½m all for ending the demonization of my gender. But letï¿½s not &quot;
## [1] &quot;  As a man, Ii¿1/2m all for ending the demonization of my gender. But leti¿1/2s not &quot;
## [1] &quot;  Toyota Prius, Mr. Diuguid (ï¿½To compete, Detroit needs to heed consumersï¿½ &quot;
## [1] &quot;  Toyota Prius, Mr. Diuguid (i¿1/2To compete, Detroit needs to heed consumersi¿1/2 &quot;
## [1] &quot;  it means Iï¿½m keeping another dollar from OPECï¿½s greedy clutches. And when I &quot;
## [1] &quot;  it means Ii¿1/2m keeping another dollar from OPECi¿1/2s greedy clutches. And when I &quot;
## [1] &quot;  brake for a jaywalking squirrel, Iï¿½m saving a life and saving the environment.&lt;br&gt;&quot;
## [1] &quot;  brake for a jaywalking squirrel, Ii¿1/2m saving a life and saving the environment.&lt;br&gt;&quot;
## [1] &quot;  my iPod. Iï¿½m in geek heaven.&lt;br&gt;&quot;
## [1] &quot;  my iPod. Ii¿1/2m in geek heaven.&lt;br&gt;&quot;
## [1] &quot;  cited some viewpoints in that debate. They didnï¿½t because framing it as a &quot;
## [1] &quot;  cited some viewpoints in that debate. They didni¿1/2t because framing it as a &quot;
## c:/web/p1-clean/LibrariesR.html  [1] &quot;c:/web/p1/LibrariesR.html&quot;
## c:/web/p1-clean/likelihood_extra.html  [1] &quot;c:/web/p1/likelihood_extra.html&quot;
## c:/web/p1-clean/LikelihoodSoftware.html  [1] &quot;c:/web/p1/LikelihoodSoftware.html&quot;
## c:/web/p1-clean/LikertAnova.html  [1] &quot;c:/web/p1/LikertAnova.html&quot;
## c:/web/p1-clean/LikertScale.html  [1] &quot;c:/web/p1/LikertScale.html&quot;
## [1] &quot;    3) to get a ‘mean’ response of 2.5 (what would it mean?).&lt;/i&gt; &quot;
## [1] &quot;    3) to get a &#39;mean&#39; response of 2.5 (what would it mean?).&lt;/i&gt; &quot;
## c:/web/p1-clean/LikertSum.html  [1] &quot;c:/web/p1/LikertSum.html&quot;
## c:/web/p1-clean/LimitingEnrollment.html  [1] &quot;c:/web/p1/LimitingEnrollment.html&quot;
## c:/web/p1-clean/lin_coef-02.html  [1] &quot;c:/web/p1/lin_coef-02.html&quot;
## c:/web/p1-clean/lin_coef-99.html  [1] &quot;c:/web/p1/lin_coef-99.html&quot;
## c:/web/p1-clean/lin_int.html  [1] &quot;c:/web/p1/lin_int.html&quot;
## c:/web/p1-clean/lin_spss.html  [1] &quot;c:/web/p1/lin_spss.html&quot;
## c:/web/p1-clean/linear.html  [1] &quot;c:/web/p1/linear.html&quot;
## c:/web/p1-clean/LinearRegression-category.html  [1] &quot;c:/web/p1/LinearRegression-category.html&quot;
## c:/web/p1-clean/LinearRegression-webinars.html  [1] &quot;c:/web/p1/LinearRegression-webinars.html&quot;
## c:/web/p1-clean/links.html  [1] &quot;c:/web/p1/links.html&quot;
## c:/web/p1-clean/LinksAndReferences.html  [1] &quot;c:/web/p1/LinksAndReferences.html&quot;
## c:/web/p1-clean/LocatingRoc.html  [1] &quot;c:/web/p1/LocatingRoc.html&quot;
## c:/web/p1-clean/log-02.html  [1] &quot;c:/web/p1/log-02.html&quot;
## c:/web/p1-clean/log-personal.html  [1] &quot;c:/web/p1/log-personal.html&quot;
## c:/web/p1-clean/log2011.html  [1] &quot;c:/web/p1/log2011.html&quot;
## c:/web/p1-clean/log2012.html  [1] &quot;c:/web/p1/log2012.html&quot;
## c:/web/p1-clean/log2012a.html  [1] &quot;c:/web/p1/log2012a.html&quot;
## c:/web/p1-clean/log2012z.html  [1] &quot;c:/web/p1/log2012z.html&quot;
## c:/web/p1-clean/logist_concepts.html  [1] &quot;c:/web/p1/logist_concepts.html&quot;
## c:/web/p1-clean/logist_spss.html  [1] &quot;c:/web/p1/logist_spss.html&quot;
## c:/web/p1-clean/logistic.html  [1] &quot;c:/web/p1/logistic.html&quot;
## c:/web/p1-clean/LogisticAssumptions.html  [1] &quot;c:/web/p1/LogisticAssumptions.html&quot;
## c:/web/p1-clean/LogisticRegression-category.html  [1] &quot;c:/web/p1/LogisticRegression-category.html&quot;
## c:/web/p1-clean/LogisticRegression-webinars.html  [1] &quot;c:/web/p1/LogisticRegression-webinars.html&quot;
## c:/web/p1-clean/longitudinal-02.html  [1] &quot;c:/web/p1/longitudinal-02.html&quot;
## c:/web/p1-clean/longitudinal-99.html  [1] &quot;c:/web/p1/longitudinal-99.html&quot;
## c:/web/p1-clean/LongitudinalPart1.html  [1] &quot;c:/web/p1/LongitudinalPart1.html&quot;
## c:/web/p1-clean/LongPageNames.html  [1] &quot;c:/web/p1/LongPageNames.html&quot;
## c:/web/p1-clean/LosingWebPages-08.html  [1] &quot;c:/web/p1/LosingWebPages-08.html&quot;
## c:/web/p1-clean/LosingWebPages-08a.html  [1] &quot;c:/web/p1/LosingWebPages-08a.html&quot;
## c:/web/p1-clean/LostFiles.html  [1] &quot;c:/web/p1/LostFiles.html&quot;
## c:/web/p1-clean/LoveToWrite.html  [1] &quot;c:/web/p1/LoveToWrite.html&quot;
## c:/web/p1-clean/LoweringPrevalence-08.html  [1] &quot;c:/web/p1/LoweringPrevalence-08.html&quot;
## [1] &quot;  &lt;p&gt;Do you know how to lower the prevalence of a disease? If so, there’s a job &quot;
## [1] &quot;  &lt;p&gt;Do you know how to lower the prevalence of a disease? If so, there&#39;s a job &quot;
## [1] &quot;  for you in the Public Health Service. Sorry, I couldn’t resist.&lt;/p&gt;&quot;
## [1] &quot;  for you in the Public Health Service. Sorry, I couldn&#39;t resist.&lt;/p&gt;&quot;
## [1] &quot;  get swamped by a bunch of false positives. That’s why we stop testing for &quot;
## [1] &quot;  get swamped by a bunch of false positives. That&#39;s why we stop testing for &quot;
## [1] &quot;  &lt;p&gt;There’s an unspoken assumption that sensitivity is unchanged by prevalence, &quot;
## [1] &quot;  &lt;p&gt;There&#39;s an unspoken assumption that sensitivity is unchanged by prevalence, &quot;
## [1] &quot;  &lt;p&gt;Now this is all speculative, of course, because we can’t take a child and &quot;
## [1] &quot;  &lt;p&gt;Now this is all speculative, of course, because we can&#39;t take a child and &quot;
## [1] &quot;  &lt;p&gt;We can’t disentangle these alternate explanations because we can’t &quot;
## [1] &quot;  &lt;p&gt;We can&#39;t disentangle these alternate explanations because we can&#39;t &quot;
## [1] &quot;  comment earlier. Because we can’t experimentally manipulate prevalence, &quot;
## [1] &quot;  comment earlier. Because we can&#39;t experimentally manipulate prevalence, &quot;
## [1] &quot;  &lt;p&gt;For what it’s worth, if sensitivity is affected by prevalence, it is &quot;
## [1] &quot;  &lt;p&gt;For what it&#39;s worth, if sensitivity is affected by prevalence, it is &quot;
## c:/web/p1-clean/LoweringPrevalence-08a.html  [1] &quot;c:/web/p1/LoweringPrevalence-08a.html&quot;
## [1] &quot;  &lt;p&gt;Do you know how to lower the prevalence of a disease? If so, there’s a job &quot;
## [1] &quot;  &lt;p&gt;Do you know how to lower the prevalence of a disease? If so, there&#39;s a job &quot;
## [1] &quot;  for you in the Public Health Service. Sorry, I couldn’t resist.&lt;/p&gt;&quot;
## [1] &quot;  for you in the Public Health Service. Sorry, I couldn&#39;t resist.&lt;/p&gt;&quot;
## [1] &quot;  get swamped by a bunch of false positives. That’s why we stop testing for &quot;
## [1] &quot;  get swamped by a bunch of false positives. That&#39;s why we stop testing for &quot;
## [1] &quot;  &lt;p&gt;There’s an unspoken assumption that sensitivity is unchanged by prevalence, &quot;
## [1] &quot;  &lt;p&gt;There&#39;s an unspoken assumption that sensitivity is unchanged by prevalence, &quot;
## [1] &quot;  &lt;p&gt;Now this is all speculative, of course, because we can’t take a child and &quot;
## [1] &quot;  &lt;p&gt;Now this is all speculative, of course, because we can&#39;t take a child and &quot;
## [1] &quot;  &lt;p&gt;We can’t disentangle these alternate explanations because we can’t &quot;
## [1] &quot;  &lt;p&gt;We can&#39;t disentangle these alternate explanations because we can&#39;t &quot;
## [1] &quot;  comment earlier. Because we can’t experimentally manipulate prevalence, &quot;
## [1] &quot;  comment earlier. Because we can&#39;t experimentally manipulate prevalence, &quot;
## [1] &quot;  &lt;p&gt;For what it’s worth, if sensitivity is affected by prevalence, it is &quot;
## [1] &quot;  &lt;p&gt;For what it&#39;s worth, if sensitivity is affected by prevalence, it is &quot;
## c:/web/p1-clean/MachineLearning.html  [1] &quot;c:/web/p1/MachineLearning.html&quot;
## c:/web/p1-clean/MailSoftware.html  [1] &quot;c:/web/p1/MailSoftware.html&quot;
## c:/web/p1-clean/MakingUpData.html  [1] &quot;c:/web/p1/MakingUpData.html&quot;
## [1] &quot;     Health — a crime subject to as many as five years in federal prison. Poehlman’s &quot;
## [1] &quot;     Health - a crime subject to as many as five years in federal prison. Poehlman&#39;s &quot;
## [1] &quot;     the blood change with age. DeNino’s task was to compare the levels of lipids, or fats, &quot;
## [1] &quot;     the blood change with age. DeNino&#39;s task was to compare the levels of lipids, or fats, &quot;
## [1] &quot;     down. Poehlman’s hypothesis was not controversial; the idea that lipid levels worsen &quot;
## [1] &quot;     down. Poehlman&#39;s hypothesis was not controversial; the idea that lipid levels worsen &quot;
## [1] &quot;     that hadn’t been changed were the ones that supported his hypothesis.&lt;/p&gt;&quot;
## [1] &quot;     that hadn&#39;t been changed were the ones that supported his hypothesis.&lt;/p&gt;&quot;
## [1] &quot;     scientist as prominent as Poehlman could end DeNino’s career before it even began.&lt;/p&gt;&quot;
## [1] &quot;     scientist as prominent as Poehlman could end DeNino&#39;s career before it even began.&lt;/p&gt;&quot;
## [1] &quot;   &lt;p&gt;If you’re going to do something, make sure you really have the evidence.&lt;/p&gt;&quot;
## [1] &quot;   &lt;p&gt;If you&#39;re going to do something, make sure you really have the evidence.&lt;/p&gt;&quot;
## [1] &quot;   &lt;p&gt;DeNino spent the next several evenings combing through hundreds of patients’ records &quot;
## [1] &quot;   &lt;p&gt;DeNino spent the next several evenings combing through hundreds of patients&#39; records &quot;
## [1] &quot;     in the lab and university hospital, trying to verify the data contained in Poehlman’s &quot;
## [1] &quot;     in the lab and university hospital, trying to verify the data contained in Poehlman&#39;s &quot;
## [1] &quot;     handling by multiple technicians and postdocs over the years. “I found that noncredible, &quot;
## [1] &quot;     handling by multiple technicians and postdocs over the years. \&quot;I found that noncredible, &quot;
## [1] &quot;     really, for an investigator of Eric’s experience,” Sobel later told the investigative &quot;
## [1] &quot;     really, for an investigator of Eric&#39;s experience,\&quot; Sobel later told the investigative &quot;
## [1] &quot;     panel. “There had to be a backup copy that was pure,” Sobel reasoned before the panel. &quot;
## [1] &quot;     panel. \&quot;There had to be a backup copy that was pure,\&quot; Sobel reasoned before the panel. &quot;
## [1] &quot;     “You would not have postdocs and lab techs in charge of discrepant data sets.” But &quot;
## [1] &quot;     \&quot;You would not have postdocs and lab techs in charge of discrepant data sets.\&quot; But &quot;
## [1] &quot;     he’d given DeNino, Poehlman laid out his most elaborate explanation yet. He had imputed &quot;
## [1] &quot;     he&#39;d given DeNino, Poehlman laid out his most elaborate explanation yet. He had imputed &quot;
## [1] &quot;     data — that is, he had derived predicted values for measurements using a complicated &quot;
## [1] &quot;     data - that is, he had derived predicted values for measurements using a complicated &quot;
## [1] &quot;     scientists can be a heavy burden for a university. “It’s your own faculty, and there’s &quot;
## [1] &quot;     scientists can be a heavy burden for a university. \&quot;It&#39;s your own faculty, and there&#39;s &quot;
## [1] &quot;     this idea of supporting and nurturing them,” says Ellen Hyman-Browne, a &quot;
## [1] &quot;     this idea of supporting and nurturing them,\&quot; says Ellen Hyman-Browne, a &quot;
## [1] &quot;     research-compliance officer at the Children’s Hospital of Philadelphia, a teaching &quot;
## [1] &quot;     research-compliance officer at the Children&#39;s Hospital of Philadelphia, a teaching &quot;
## [1] &quot;   &lt;p&gt;“There are conflicting influences on a university where they are the co-grantor and &quot;
## [1] &quot;   &lt;p&gt;\&quot;There are conflicting influences on a university where they are the co-grantor and &quot;
## [1] &quot;     responsible to other investigators,” says Stephen Kelly, the Justice Department attorney &quot;
## [1] &quot;     responsible to other investigators,\&quot; says Stephen Kelly, the Justice Department attorney &quot;
## [1] &quot;     who prosecuted Poehlman. “For the system to work, the university has to be very &quot;
## [1] &quot;     who prosecuted Poehlman. \&quot;For the system to work, the university has to be very &quot;
## [1] &quot;     ethical.”&lt;/p&gt;&quot;
## [1] &quot;     ethical.\&quot;&lt;/p&gt;&quot;
## [1] &quot;   &lt;p&gt;“When scientists use their skill and their intelligence and their sophistication and &quot;
## [1] &quot;   &lt;p&gt;\&quot;When scientists use their skill and their intelligence and their sophistication and &quot;
## [1] &quot;     extraordinarily serious,” the judge said. “In one way, this is a final lesson that you &quot;
## [1] &quot;     extraordinarily serious,\&quot; the judge said. \&quot;In one way, this is a final lesson that you &quot;
## [1] &quot;     are offering.”&lt;/p&gt;&quot;
## [1] &quot;     are offering.\&quot;&lt;/p&gt;&quot;
## c:/web/p1-clean/ManipulationPeerReview-06.html  [1] &quot;c:/web/p1/ManipulationPeerReview-06.html&quot;
## c:/web/p1-clean/ManipulationPeerReview-07.html  [1] &quot;c:/web/p1/ManipulationPeerReview-07.html&quot;
## [1] &quot;        On the take: How medicine’s complicity with big business can endanger your health. (2004 &quot;
## [1] &quot;        On the take: How medicine&#39;s complicity with big business can endanger your health. (2004 &quot;
## [1] &quot;        The dawn of McScience. (New York Rev Books 2004. 51(4): 7–9.)&lt;/ul&gt;&quot;
## [1] &quot;        The dawn of McScience. (New York Rev Books 2004. 51(4): 7-9.)&lt;/ul&gt;&quot;
## [1] &quot;            &lt;p&gt;&lt;i&gt;A large trial published in a major journal has the journal’s stamp of approval &quot;
## [1] &quot;            &lt;p&gt;&lt;i&gt;A large trial published in a major journal has the journal&#39;s stamp of approval &quot;
## [1] &quot;        &lt;i&gt;Present results that are most likely to impress—for example, reduction in relative rather &quot;
## [1] &quot;        &lt;i&gt;Present results that are most likely to impress-for example, reduction in relative rather &quot;
## c:/web/p1-clean/mann.html  [1] &quot;c:/web/p1/mann.html&quot;
## c:/web/p1-clean/maps.html  [1] &quot;c:/web/p1/maps.html&quot;
## c:/web/p1-clean/MathematicalGraphs.html  [1] &quot;c:/web/p1/MathematicalGraphs.html&quot;
## c:/web/p1-clean/MathematicaMatlab.html  [1] &quot;c:/web/p1/MathematicaMatlab.html&quot;
## c:/web/p1-clean/MathError-08.html  [1] &quot;c:/web/p1/MathError-08.html&quot;
## c:/web/p1-clean/MathError-08a.html  [1] &quot;c:/web/p1/MathError-08a.html&quot;
## c:/web/p1-clean/mcnemar.html  [1] &quot;c:/web/p1/mcnemar.html&quot;
## c:/web/p1-clean/mdac.html  [1] &quot;c:/web/p1/mdac.html&quot;
## c:/web/p1-clean/meanormedian-00.html  [1] &quot;c:/web/p1/meanormedian-00.html&quot;
## c:/web/p1-clean/meanormedian-03.html  [1] &quot;c:/web/p1/meanormedian-03.html&quot;
## c:/web/p1-clean/MeasuringAgreement-05.html  [1] &quot;c:/web/p1/MeasuringAgreement-05.html&quot;
## c:/web/p1-clean/MeasuringAgreement-category.html  [1] &quot;c:/web/p1/MeasuringAgreement-category.html&quot;
## [1] &quot;      Ed. 1999;81(1):F50ï¿½F55. Description: &lt;i&gt;This article provides an illustrative example of how to use &quot;
## [1] &quot;      Ed. 1999;81(1):F50i¿1/2F55. Description: &lt;i&gt;This article provides an illustrative example of how to use &quot;
## [1] &quot;        predictive interval of ï¿½ 27.5mm. CONCLUSIONS: KHL was less reproducible than &quot;
## [1] &quot;        predictive interval of i¿1/2 27.5mm. CONCLUSIONS: KHL was less reproducible than &quot;
## [1] &quot;      consider a Cronbach alpha of .60 to be in terms of ï¿½labelï¿½ (i.e., fair, poor, &quot;
## [1] &quot;      consider a Cronbach alpha of .60 to be in terms of i¿1/2labeli¿1/2 (i.e., fair, poor, &quot;
## c:/web/p1-clean/MeasuringBenefitRisk.html  [1] &quot;c:/web/p1/MeasuringBenefitRisk.html&quot;
## [1] &quot;      having hospitals set payment rates based on the 3Mï¿½ APR-DRGï¿½ Classification &quot;
## [1] &quot;      having hospitals set payment rates based on the 3Mi¿1/2 APR-DRGi¿1/2 Classification &quot;
## [1] &quot;      Systemï¿½s severity scoring, hospitals might feel overwhelmed with the &quot;
## [1] &quot;      Systemi¿1/2s severity scoring, hospitals might feel overwhelmed with the &quot;
## [1] &quot;      requirements for change. But, this change doesnï¿½t have to be complex. In fact, &quot;
## [1] &quot;      requirements for change. But, this change doesni¿1/2t have to be complex. In fact, &quot;
## [1] &quot;  &lt;p&gt;&lt;a href=\&quot;http://www.econ.ucsd.edu/~miwhite/suv-jle.pdf\&quot;&gt;The ï¿½Arms Raceï¿½ on American &quot;
## [1] &quot;  &lt;p&gt;&lt;a href=\&quot;http://www.econ.ucsd.edu/~miwhite/suv-jle.pdf\&quot;&gt;The i¿1/2Arms Racei¿1/2 on American &quot;
## [1] &quot;    Roads: The Effect of SUVï¿½s and Pickup Trucks on Traffic Safety [pdf]&lt;/a&gt; &quot;
## [1] &quot;    Roads: The Effect of SUVi¿1/2s and Pickup Trucks on Traffic Safety [pdf]&lt;/a&gt; &quot;
## c:/web/p1-clean/mechanism.html  [1] &quot;c:/web/p1/mechanism.html&quot;
## c:/web/p1-clean/medals.html  [1] &quot;c:/web/p1/medals.html&quot;
## c:/web/p1-clean/MediaInterviews.html  [1] &quot;c:/web/p1/MediaInterviews.html&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Don’t answer hypotheticals.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Don&#39;t answer hypotheticals.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Don’t be afraid to say you don’t know the answer to the question.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Don&#39;t be afraid to say you don&#39;t know the answer to the question.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Don’t be afraid to say you need to verify the facts and call back.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Don&#39;t be afraid to say you need to verify the facts and call back.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Speak in “sound bites” (concise, memorable explanations).&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;Speak in \&quot;sound bites\&quot; (concise, memorable explanations).&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;    reporter’s question. Instead, state the information in a positive manner &quot;
## [1] &quot;    reporter&#39;s question. Instead, state the information in a positive manner &quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;When you have answered well, stop speaking. Resist the urge to “fill &quot;
## [1] &quot;  &lt;li&gt;&lt;i&gt;When you have answered well, stop speaking. Resist the urge to \&quot;fill &quot;
## [1] &quot;    the silences.”&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;    the silences.\&quot;&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Be Prepared. Ask the reporter questions such as: What’s your deadline? &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Be Prepared. Ask the reporter questions such as: What&#39;s your deadline? &quot;
## [1] &quot;    What kind of story is it? What’s your angle? Who else has been or will be &quot;
## [1] &quot;    What kind of story is it? What&#39;s your angle? Who else has been or will be &quot;
## [1] &quot;    interviewed? Learn about the reporter’s style and media outlet.&lt;/i&gt; The &quot;
## [1] &quot;    interviewed? Learn about the reporter&#39;s style and media outlet.&lt;/i&gt; The &quot;
## c:/web/p1-clean/MedicalConcernsChildren.html  [1] &quot;c:/web/p1/MedicalConcernsChildren.html&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Patients’ perception of the risk and severity of side-effects may &quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Patients&#39; perception of the risk and severity of side-effects may &quot;
## c:/web/p1-clean/MedicalGuidelines.html  [1] &quot;c:/web/p1/MedicalGuidelines.html&quot;
## c:/web/p1-clean/MedlineVeryBusy.html  [1] &quot;c:/web/p1/MedlineVeryBusy.html&quot;
## c:/web/p1-clean/MedStats.html  [1] &quot;c:/web/p1/MedStats.html&quot;
## c:/web/p1-clean/Mendenhall.html  [1] &quot;c:/web/p1/Mendenhall.html&quot;
## c:/web/p1-clean/meps.html  [1] &quot;c:/web/p1/meps.html&quot;
## c:/web/p1-clean/merging.html  [1] &quot;c:/web/p1/merging.html&quot;
## c:/web/p1-clean/MergingInR.html  [1] &quot;c:/web/p1/MergingInR.html&quot;
## c:/web/p1-clean/metaanalysis.html  [1] &quot;c:/web/p1/metaanalysis.html&quot;
## c:/web/p1-clean/MetaanalysisArticles.html  [1] &quot;c:/web/p1/MetaanalysisArticles.html&quot;
## c:/web/p1-clean/MetaanalysisCritique.html  [1] &quot;c:/web/p1/MetaanalysisCritique.html&quot;
## c:/web/p1-clean/MetaAnalysisDiagnostic.html  [1] &quot;c:/web/p1/MetaAnalysisDiagnostic.html&quot;
## c:/web/p1-clean/MetaanalysisTalk.html  [1] &quot;c:/web/p1/MetaanalysisTalk.html&quot;
## c:/web/p1-clean/MethodologicalFlaws.html  [1] &quot;c:/web/p1/MethodologicalFlaws.html&quot;
## c:/web/p1-clean/MethodologyErrors.html  [1] &quot;c:/web/p1/MethodologyErrors.html&quot;
## c:/web/p1-clean/methods.html  [1] &quot;c:/web/p1/methods.html&quot;
## c:/web/p1-clean/MetropolisAlgorithm.html  [1] &quot;c:/web/p1/MetropolisAlgorithm.html&quot;
## c:/web/p1-clean/microarray.html  [1] &quot;c:/web/p1/microarray.html&quot;
## c:/web/p1-clean/MicroArrayA.html  [1] &quot;c:/web/p1/MicroArrayA.html&quot;
## c:/web/p1-clean/MicroArrayB.html  [1] &quot;c:/web/p1/MicroArrayB.html&quot;
## c:/web/p1-clean/MicroarrayC.html  [1] &quot;c:/web/p1/MicroarrayC.html&quot;
## c:/web/p1-clean/MicroArrayD.html  [1] &quot;c:/web/p1/MicroArrayD.html&quot;
## c:/web/p1-clean/MicroArrayE.html  [1] &quot;c:/web/p1/MicroArrayE.html&quot;
## [1] &quot;        Oskar Johannsson, Håkan Olsson, Benjamin Wilfond, Guido Sauter, Olli-P. Kallioniemi, Åke &quot;
## [1] &quot;        Oskar Johannsson, Hakan Olsson, Benjamin Wilfond, Guido Sauter, Olli-P. Kallioniemi, Ake &quot;
## c:/web/p1-clean/MicroArrayF.html  [1] &quot;c:/web/p1/MicroArrayF.html&quot;
## [1] &quot;        O’Connell,M. (2003) In Parmigiani, G., Garrett, E.S., Irizarry, R.A. and Zeger, S.L. (ed.), &quot;
## [1] &quot;        O&#39;Connell,M. (2003) In Parmigiani, G., Garrett, E.S., Irizarry, R.A. and Zeger, S.L. (ed.), &quot;
## c:/web/p1-clean/MicroarrayG.html  [1] &quot;c:/web/p1/MicroarrayG.html&quot;
## c:/web/p1-clean/Middle.html  [1] &quot;c:/web/p1/Middle.html&quot;
## c:/web/p1-clean/mind.html  [1] &quot;c:/web/p1/mind.html&quot;
## c:/web/p1-clean/MisleadingBargraph.html  [1] &quot;c:/web/p1/MisleadingBargraph.html&quot;
## c:/web/p1-clean/missing.html  [1] &quot;c:/web/p1/missing.html&quot;
## c:/web/p1-clean/MissingData.html  [1] &quot;c:/web/p1/MissingData.html&quot;
## c:/web/p1-clean/MissingValues.html  [1] &quot;c:/web/p1/MissingValues.html&quot;
## c:/web/p1-clean/MissingVerse.html  [1] &quot;c:/web/p1/MissingVerse.html&quot;
## c:/web/p1-clean/MissouriTechnology.html  [1] &quot;c:/web/p1/MissouriTechnology.html&quot;
## c:/web/p1-clean/MistakesEBM.html  [1] &quot;c:/web/p1/MistakesEBM.html&quot;
## c:/web/p1-clean/MixedLinearModels.html  [1] &quot;c:/web/p1/MixedLinearModels.html&quot;
## c:/web/p1-clean/MixedLogistic.html  [1] &quot;c:/web/p1/MixedLogistic.html&quot;
## c:/web/p1-clean/MixedModels.html  [1] &quot;c:/web/p1/MixedModels.html&quot;
## c:/web/p1-clean/MixedSeminar.html  [1] &quot;c:/web/p1/MixedSeminar.html&quot;
## c:/web/p1-clean/mixture.html  [1] &quot;c:/web/p1/mixture.html&quot;
## c:/web/p1-clean/mle.html  [1] &quot;c:/web/p1/mle.html&quot;
## c:/web/p1-clean/MMalgorithm.html  [1] &quot;c:/web/p1/MMalgorithm.html&quot;
## c:/web/p1-clean/ModelingIssues.html  [1] &quot;c:/web/p1/ModelingIssues.html&quot;
## [1] &quot;&lt;p&gt;Steve &lt;a name=\&quot;Miller\&quot;&gt;Miller&lt;/a&gt;. &lt;b&gt;Biostatistics, Open Source and BI ï¿½ an Interview with &quot;
## [1] &quot;&lt;p&gt;Steve &lt;a name=\&quot;Miller\&quot;&gt;Miller&lt;/a&gt;. &lt;b&gt;Biostatistics, Open Source and BI i¿1/2 an Interview with &quot;
## [1] &quot;        will learn as much from Frankï¿½s responses as I did.&amp;quot;&lt;/i&gt; [Accessed July 19, &quot;
## [1] &quot;        will learn as much from Franki¿1/2s responses as I did.&amp;quot;&lt;/i&gt; [Accessed July 19, &quot;
## [1] &quot;        research. It is most commonly used for adjustment ï¿½ the process of &quot;
## [1] &quot;        research. It is most commonly used for adjustment i¿1/2 the process of &quot;
## c:/web/p1-clean/ModelMicroarray.html  [1] &quot;c:/web/p1/ModelMicroarray.html&quot;
## [1] &quot;  and 107 experiments (columns).&amp;nbsp; In addition, I also have a sort of “model &quot;
## [1] &quot;  and 107 experiments (columns).&amp;nbsp; In addition, I also have a sort of \&quot;model &quot;
## [1] &quot;  experiment” which contains the values in which I am most interested. For each &quot;
## [1] &quot;  experiment\&quot; which contains the values in which I am most interested. For each &quot;
## [1] &quot;  from the “model experiment” value.&amp;nbsp; An example may make this clearer:&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;  from the \&quot;model experiment\&quot; value.&amp;nbsp; An example may make this clearer:&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;  value from from genes 1 and 3 from the “test” experiments are “not &quot;
## [1] &quot;  value from from genes 1 and 3 from the \&quot;test\&quot; experiments are \&quot;not &quot;
## [1] &quot;  significantly different” from the “Model” experiment.&amp;nbsp; However, I’m not sure &quot;
## [1] &quot;  significantly different\&quot; from the \&quot;Model\&quot; experiment.&amp;nbsp; However, I&#39;m not sure &quot;
## [1] &quot;  to test the hypothesis that the mean from the “test” experiments is not &quot;
## [1] &quot;  to test the hypothesis that the mean from the \&quot;test\&quot; experiments is not &quot;
## [1] &quot;  different from the “model” value, then only take those genes with the highest &quot;
## [1] &quot;  different from the \&quot;model\&quot; value, then only take those genes with the highest &quot;
## [1] &quot;  p-values, but this gives only a very small number of genes, and just doesn’t &quot;
## [1] &quot;  p-values, but this gives only a very small number of genes, and just doesn&#39;t &quot;
## c:/web/p1-clean/ModeratorVariable.html  [1] &quot;c:/web/p1/ModeratorVariable.html&quot;
## c:/web/p1-clean/modify.html  [1] &quot;c:/web/p1/modify.html&quot;
## c:/web/p1-clean/ModularArithmeticInR.html  [1] &quot;c:/web/p1/ModularArithmeticInR.html&quot;
## c:/web/p1-clean/MolassesMilk.html  [1] &quot;c:/web/p1/MolassesMilk.html&quot;
## [1] &quot;    infants, administer first in doctor’s office.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;    infants, administer first in doctor&#39;s office.&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/MolecularBiologists.html  [1] &quot;c:/web/p1/MolecularBiologists.html&quot;
## c:/web/p1-clean/Moments.html  [1] &quot;c:/web/p1/Moments.html&quot;
## c:/web/p1-clean/MonetaryIncentives.html  [1] &quot;c:/web/p1/MonetaryIncentives.html&quot;
## c:/web/p1-clean/montecarlo.html  [1] &quot;c:/web/p1/montecarlo.html&quot;
## c:/web/p1-clean/MontyHall.html  [1] &quot;c:/web/p1/MontyHall.html&quot;
## c:/web/p1-clean/MooseShirt.html  [1] &quot;c:/web/p1/MooseShirt.html&quot;
## c:/web/p1-clean/mortenson.html  [1] &quot;c:/web/p1/mortenson.html&quot;
## c:/web/p1-clean/MovieGroup.html  [1] &quot;c:/web/p1/MovieGroup.html&quot;
## c:/web/p1-clean/MovingContent-08.html  [1] &quot;c:/web/p1/MovingContent-08.html&quot;
## c:/web/p1-clean/MovingContent-08a.html  [1] &quot;c:/web/p1/MovingContent-08a.html&quot;
## c:/web/p1-clean/MovingRObjects.html  [1] &quot;c:/web/p1/MovingRObjects.html&quot;
## c:/web/p1-clean/MSorPHD.html  [1] &quot;c:/web/p1/MSorPHD.html&quot;
## c:/web/p1-clean/Multicollinearity.html  [1] &quot;c:/web/p1/Multicollinearity.html&quot;
## c:/web/p1-clean/MultinomialProportions.html  [1] &quot;c:/web/p1/MultinomialProportions.html&quot;
## c:/web/p1-clean/MultipleComparisons-05.html  [1] &quot;c:/web/p1/MultipleComparisons-05.html&quot;
## c:/web/p1-clean/MultipleComparisons-06.html  [1] &quot;c:/web/p1/MultipleComparisons-06.html&quot;
## c:/web/p1-clean/MultipleComparisons-category.html  [1] &quot;c:/web/p1/MultipleComparisons-category.html&quot;
## [1] &quot;    &lt;p&gt;N Stallard, P F Thall, J Whitehead. &lt;b&gt;Decision theoretic designs for phase II clinical trials with multiple outcomes&lt;/b&gt;. Biometrics. 1999;55(3):971-977. &lt;i&gt;Abstract: \&quot;In many phase II clinical trials, it is essential to assess both efficacy and safety. Although several phase II designs that accommodate multiple outcomes have been proposed recently, none are derived using decision theory. This paper describes a Bayesian decision theoretic strategy for constructing phase II designs based on both efficacy and adverse events. The gain function includes utilities assigned to patient outcomes, a reward for declaring the new treatment promising, and costs associated with the conduct of the phase II trial and future phase III testing. A method for eliciting gain function parameters from medical collaborators and for evaluating the designÊ¼s frequentist operating characteristics is described. The strategy is illustrated by application to a clinical trial of peripheral blood stem cell transplantation for multiple myeloma.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/11315037\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/11315037&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;N Stallard, P F Thall, J Whitehead. &lt;b&gt;Decision theoretic designs for phase II clinical trials with multiple outcomes&lt;/b&gt;. Biometrics. 1999;55(3):971-977. &lt;i&gt;Abstract: \&quot;In many phase II clinical trials, it is essential to assess both efficacy and safety. Although several phase II designs that accommodate multiple outcomes have been proposed recently, none are derived using decision theory. This paper describes a Bayesian decision theoretic strategy for constructing phase II designs based on both efficacy and adverse events. The gain function includes utilities assigned to patient outcomes, a reward for declaring the new treatment promising, and costs associated with the conduct of the phase II trial and future phase III testing. A method for eliciting gain function parameters from medical collaborators and for evaluating the designÊ1/4s frequentist operating characteristics is described. The strategy is illustrated by application to a clinical trial of peripheral blood stem cell transplantation for multiple myeloma.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/11315037\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/11315037&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Ronald Feise. &lt;b&gt;Do multiple outcome measures require p-value adjustment?&lt;/b&gt;. BMC Medical Research Methodology. 2002;2(1):8. &lt;i&gt;Abstract: \&quot;BACKGROUND: Readers may question the interpretation of findings in clinical trials when multiple outcome measures are used without adjustment of the p-value. This question arises because of the increased risk of Type I errors (findings of false \&quot;significance\&quot;) when multiple simultaneous hypotheses are tested at set p-values. The primary aim of this study was to estimate the need to make appropriate p-value adjustments in clinical trials to compensate for a possible increased risk in committing Type I errors when multiple outcome measures are used. DISCUSSION: The classicists believe that the chance of finding at least one test statistically significant due to chance and incorrectly declaring a difference increases as the number of comparisons increases. The rationalists have the following objections to that theory: 1) P-value adjustments are calculated based on how many tests are to be considered, and that number has been defined arbitrarily and variably; 2) P-value adjustments reduce the chance of making type I errors, but they increase the chance of making type II errors or needing to increase the sample size.SUMMARY:Readers should balance a studyÊ¼s statistical significance with the magnitude of effect, the quality of the study and with findings from other studies. Researchers facing multiple outcome measures might want to either select a primary outcome measure or use a global assessment measure, rather than adjusting the p-value.&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/2/8\&quot;&gt;http://www.biomedcentral.com/1471-2288/2/8&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Ronald Feise. &lt;b&gt;Do multiple outcome measures require p-value adjustment?&lt;/b&gt;. BMC Medical Research Methodology. 2002;2(1):8. &lt;i&gt;Abstract: \&quot;BACKGROUND: Readers may question the interpretation of findings in clinical trials when multiple outcome measures are used without adjustment of the p-value. This question arises because of the increased risk of Type I errors (findings of false \&quot;significance\&quot;) when multiple simultaneous hypotheses are tested at set p-values. The primary aim of this study was to estimate the need to make appropriate p-value adjustments in clinical trials to compensate for a possible increased risk in committing Type I errors when multiple outcome measures are used. DISCUSSION: The classicists believe that the chance of finding at least one test statistically significant due to chance and incorrectly declaring a difference increases as the number of comparisons increases. The rationalists have the following objections to that theory: 1) P-value adjustments are calculated based on how many tests are to be considered, and that number has been defined arbitrarily and variably; 2) P-value adjustments reduce the chance of making type I errors, but they increase the chance of making type II errors or needing to increase the sample size.SUMMARY:Readers should balance a studyÊ1/4s statistical significance with the magnitude of effect, the quality of the study and with findings from other studies. Researchers facing multiple outcome measures might want to either select a primary outcome measure or use a global assessment measure, rather than adjusting the p-value.&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/2/8\&quot;&gt;http://www.biomedcentral.com/1471-2288/2/8&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Journal article: X. &lt;a name=\&quot;Sun\&quot;&gt;&lt;/a&gt;Sun, M. Briel, S. D. Walter, G. H. Guyatt. &lt;b&gt;Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses&lt;/b&gt; BMJ. 2010;340(mar30 3):c117-c117. &lt;i&gt;Excerpt: \&quot;Subgroup analyses in randomised controlled trials (RCTs) or in meta-analyses of RCTs examine whether treatment effects vary according to patient group, way of giving an intervention, or approach to measuring an outcome. Subgroup analyses are common and often associated with claims of difference of treatment effects between subgroupsâ\200”termed &#39;subgroup effect&#39;, &#39;effect modification&#39;, or &#39;interaction between a subgroup variable and treatment&#39;. A difference in effect between subgroups, if true, is likely to have important implications for clinical practice and policy making. Many subgroup claims are, however, subsequently shown to be false. Thus, investigators, clinicians, and policy makers face the challenge of whether or not to believe apparent differences in effect. \&quot;&lt;/i&gt; [Accessed on April 4, 2011]. &lt;a href=\&quot;http://www.bmj.com/cgi/doi/10.1136/bmj.c117\&quot;&gt;http://www.bmj.com/cgi/doi/10.1136/bmj.c117&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Journal article: X. &lt;a name=\&quot;Sun\&quot;&gt;&lt;/a&gt;Sun, M. Briel, S. D. Walter, G. H. Guyatt. &lt;b&gt;Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses&lt;/b&gt; BMJ. 2010;340(mar30 3):c117-c117. &lt;i&gt;Excerpt: \&quot;Subgroup analyses in randomised controlled trials (RCTs) or in meta-analyses of RCTs examine whether treatment effects vary according to patient group, way of giving an intervention, or approach to measuring an outcome. Subgroup analyses are common and often associated with claims of difference of treatment effects between subgroupsâ\200\&quot;termed &#39;subgroup effect&#39;, &#39;effect modification&#39;, or &#39;interaction between a subgroup variable and treatment&#39;. A difference in effect between subgroups, if true, is likely to have important implications for clinical practice and policy making. Many subgroup claims are, however, subsequently shown to be false. Thus, investigators, clinicians, and policy makers face the challenge of whether or not to believe apparent differences in effect. \&quot;&lt;/i&gt; [Accessed on April 4, 2011]. &lt;a href=\&quot;http://www.bmj.com/cgi/doi/10.1136/bmj.c117\&quot;&gt;http://www.bmj.com/cgi/doi/10.1136/bmj.c117&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Carl E Counsell, Mike J Clarke, Jim Slattery, Peter A G Sandercock. &lt;b&gt;The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?&lt;/b&gt;. BMJ. 1994;309(6970):1677 -1681. &lt;i&gt;Abstract: \&quot;Objective: To determine whether inappropriate subgroup analysis together with chance could change the conclusion of a systematic review of several randomised trials of an ineffective treatment.Design: 44 randomised controlled trials of DICE therapy for stroke were performed (simulated by rolling different coloured dice; two trials per investigator). Each roll of the dice yielded the outcome (death or survival) for that &#39;patient.&#39; Publication bias was also simulated. The results were combined in a systematic review.Setting: Edinburgh. Main outcome measureâ\200”Mortality.Results: The &#39;hypothesis generating&#39; trial suggested that DICE therapy provided complete protection against death from acute stroke. However, analysis of all the trials suggested a reduction of only 11% (SD 11) in the odds of death. A predefined subgroup analysis by colour of dice suggested that red dice therapy increased the odds by 9% (22). If the analysis excluded red dice trials and those of poor methodological quality the odds decreased by 22% (13, 2P=0.09). Analysis of &#39;published&#39; trials showed a decrease of 23% (13, 2P=0.07) while analysis of only those in which the trialist had become familiar with the intervention showed a decrease of 39% (17, 2P=0.02).Conclusion: The early benefits of DICE therapy were not confirmed by subsequent trials. A plausible (but inappropriate) subset analysis of the effects of treatment led to the qualitatively different conclusion that DICE therapy reduced mortality, whereas in truth it was ineffective. Chance influences the outcome of clinical trials and systematic reviews of trials much more than many investigators realise, and its effects may lead to incorrect conclusions about the benefits of treatment.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.bmj.com/content/309/6970/1677.abstract\&quot;&gt;http://www.bmj.com/content/309/6970/1677.abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Carl E Counsell, Mike J Clarke, Jim Slattery, Peter A G Sandercock. &lt;b&gt;The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?&lt;/b&gt;. BMJ. 1994;309(6970):1677 -1681. &lt;i&gt;Abstract: \&quot;Objective: To determine whether inappropriate subgroup analysis together with chance could change the conclusion of a systematic review of several randomised trials of an ineffective treatment.Design: 44 randomised controlled trials of DICE therapy for stroke were performed (simulated by rolling different coloured dice; two trials per investigator). Each roll of the dice yielded the outcome (death or survival) for that &#39;patient.&#39; Publication bias was also simulated. The results were combined in a systematic review.Setting: Edinburgh. Main outcome measureâ\200\&quot;Mortality.Results: The &#39;hypothesis generating&#39; trial suggested that DICE therapy provided complete protection against death from acute stroke. However, analysis of all the trials suggested a reduction of only 11% (SD 11) in the odds of death. A predefined subgroup analysis by colour of dice suggested that red dice therapy increased the odds by 9% (22). If the analysis excluded red dice trials and those of poor methodological quality the odds decreased by 22% (13, 2P=0.09). Analysis of &#39;published&#39; trials showed a decrease of 23% (13, 2P=0.07) while analysis of only those in which the trialist had become familiar with the intervention showed a decrease of 39% (17, 2P=0.02).Conclusion: The early benefits of DICE therapy were not confirmed by subsequent trials. A plausible (but inappropriate) subset analysis of the effects of treatment led to the qualitatively different conclusion that DICE therapy reduced mortality, whereas in truth it was ineffective. Chance influences the outcome of clinical trials and systematic reviews of trials much more than many investigators realise, and its effects may lead to incorrect conclusions about the benefits of treatment.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.bmj.com/content/309/6970/1677.abstract\&quot;&gt;http://www.bmj.com/content/309/6970/1677.abstract&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Martin Bland. &lt;b&gt;Multiple significance tests and the Bonferroni correction&lt;/b&gt;. &lt;i&gt;Excerpt: \&quot;f we test a null hypothesis which is in fact true, using 0.05 as the critical significance level, we have a probability of 0.95 of coming to a `not significantÊ¼ (i.e. correct) conclusion. If we test two independent true null hypotheses, the probability that neither test will be significant is 0.95 times 0.95 = 0.90 (Section 6.2). If we test twenty such hypotheses the probability that none will be significant is 0.9520 = 0.36. This gives a probability of 1 - 0.36 = 0.64 of getting at least one significant result; we are more likely to get one than not. The expected number of spurious significant results is 20 times 0.05 = 1. Many medical research studies are published with large numbers of significance tests. These are not usually independent, being carried out on the same set of subjects, so the above calculations do not apply exactly. However, it is clear that if we go on testing long enough we will find something which is `significant&#39;. We must beware of attaching too much importance to a lone significant result among a mass of non-significant ones. It may be the one in twenty which we should get by chance alone. \&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www-users.york.ac.uk/~mb55/intro/bonf.htm\&quot;&gt;http://www-users.york.ac.uk/~mb55/intro/bonf.htm&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Martin Bland. &lt;b&gt;Multiple significance tests and the Bonferroni correction&lt;/b&gt;. &lt;i&gt;Excerpt: \&quot;f we test a null hypothesis which is in fact true, using 0.05 as the critical significance level, we have a probability of 0.95 of coming to a `not significantÊ1/4 (i.e. correct) conclusion. If we test two independent true null hypotheses, the probability that neither test will be significant is 0.95 times 0.95 = 0.90 (Section 6.2). If we test twenty such hypotheses the probability that none will be significant is 0.9520 = 0.36. This gives a probability of 1 - 0.36 = 0.64 of getting at least one significant result; we are more likely to get one than not. The expected number of spurious significant results is 20 times 0.05 = 1. Many medical research studies are published with large numbers of significance tests. These are not usually independent, being carried out on the same set of subjects, so the above calculations do not apply exactly. However, it is clear that if we go on testing long enough we will find something which is `significant&#39;. We must beware of attaching too much importance to a lone significant result among a mass of non-significant ones. It may be the one in twenty which we should get by chance alone. \&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www-users.york.ac.uk/~mb55/intro/bonf.htm\&quot;&gt;http://www-users.york.ac.uk/~mb55/intro/bonf.htm&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Rodney &lt;a name=\&quot;Hayward\&quot;&gt;&lt;/a&gt;Hayward, David Kent, Sandeep Vijan, Timothy Hofer. &lt;b&gt;Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis&lt;/b&gt;. BMC Medical Research Methodology. 2006;6(1):18. &lt;i&gt;Abstract: \&quot;BACKGROUND: When subgroup analyses of a positive clinical trial are unrevealing, such findings are commonly used to argue that the treatmentÊ¼s benefits apply to the entire study population; however, such analyses are often limited by poor statistical power. Multivariable risk-stratified analysis has been proposed as an important advance in investigating heterogeneity in treatment benefits, yet no one has conducted a systematic statistical examination of circumstances influencing the relative merits of this approach vs. conventional subgroup analysis. METHODS: Using simulated clinical trials in which the probability of outcomes in individual patients was stochastically determined by the presence of risk factors and the effects of treatment, we examined the relative merits of a conventional vs. a \&quot;risk-stratified\&quot; subgroup analysis under a variety of circumstances in which there is a small amount of uniformly distributed treatment-related harm. The statistical power to detect treatment-effect heterogeneity was calculated for risk-stratified and conventional subgroup analysis while varying: 1) the number, prevalence and odds ratios of individual risk factors for risk in the absence of treatment, 2) the predictiveness of the multivariable risk model (including the accuracy of its weights), 3) the degree of treatment-related harm, and 5) the average untreated risk of the study population. RESULTS: Conventional subgroup analysis (in which single patient attributes are evaluated \&quot;one-at-a-time\&quot;) had at best moderate statistical power (30% to 45%) to detect variation in a treatmentÊ¼s net relative risk reduction resulting from treatment-related harm, even under optimal circumstances (overall statistical power of the study was good and treatment-effect heterogeneity was evaluated across a major risk factor [OR = 3]). In some instances a multi-variable risk-stratified approach also had low to moderate statistical power (especially when the multivariable risk prediction tool had low discrimination). However, a multivariable risk-stratified approach can have excellent statistical power to detect heterogeneity in net treatment benefit under a wide variety of circumstances, instances under which conventional subgroup analysis has poor statistical power. CONCLUSION: These results suggest that under many likely scenarios, a multivariable risk-stratified approach will have substantially greater statistical power than conventional subgroup analysis for detecting heterogeneity in treatment benefits and safety related to previously unidentified treatment-related harm. Subgroup analyses must always be well-justified and interpreted with care, and conventional subgroup analyses can be useful under some circumstances; however, clinical trial reporting should include a multivariable risk-stratified analysis when an adequate externally-developed risk prediction tool is available.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/6/18\&quot;&gt;http://www.biomedcentral.com/1471-2288/6/18&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Rodney &lt;a name=\&quot;Hayward\&quot;&gt;&lt;/a&gt;Hayward, David Kent, Sandeep Vijan, Timothy Hofer. &lt;b&gt;Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis&lt;/b&gt;. BMC Medical Research Methodology. 2006;6(1):18. &lt;i&gt;Abstract: \&quot;BACKGROUND: When subgroup analyses of a positive clinical trial are unrevealing, such findings are commonly used to argue that the treatmentÊ1/4s benefits apply to the entire study population; however, such analyses are often limited by poor statistical power. Multivariable risk-stratified analysis has been proposed as an important advance in investigating heterogeneity in treatment benefits, yet no one has conducted a systematic statistical examination of circumstances influencing the relative merits of this approach vs. conventional subgroup analysis. METHODS: Using simulated clinical trials in which the probability of outcomes in individual patients was stochastically determined by the presence of risk factors and the effects of treatment, we examined the relative merits of a conventional vs. a \&quot;risk-stratified\&quot; subgroup analysis under a variety of circumstances in which there is a small amount of uniformly distributed treatment-related harm. The statistical power to detect treatment-effect heterogeneity was calculated for risk-stratified and conventional subgroup analysis while varying: 1) the number, prevalence and odds ratios of individual risk factors for risk in the absence of treatment, 2) the predictiveness of the multivariable risk model (including the accuracy of its weights), 3) the degree of treatment-related harm, and 5) the average untreated risk of the study population. RESULTS: Conventional subgroup analysis (in which single patient attributes are evaluated \&quot;one-at-a-time\&quot;) had at best moderate statistical power (30% to 45%) to detect variation in a treatmentÊ1/4s net relative risk reduction resulting from treatment-related harm, even under optimal circumstances (overall statistical power of the study was good and treatment-effect heterogeneity was evaluated across a major risk factor [OR = 3]). In some instances a multi-variable risk-stratified approach also had low to moderate statistical power (especially when the multivariable risk prediction tool had low discrimination). However, a multivariable risk-stratified approach can have excellent statistical power to detect heterogeneity in net treatment benefit under a wide variety of circumstances, instances under which conventional subgroup analysis has poor statistical power. CONCLUSION: These results suggest that under many likely scenarios, a multivariable risk-stratified approach will have substantially greater statistical power than conventional subgroup analysis for detecting heterogeneity in treatment benefits and safety related to previously unidentified treatment-related harm. Subgroup analyses must always be well-justified and interpreted with care, and conventional subgroup analyses can be useful under some circumstances; however, clinical trial reporting should include a multivariable risk-stratified analysis when an adequate externally-developed risk prediction tool is available.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.biomedcentral.com/1471-2288/6/18\&quot;&gt;http://www.biomedcentral.com/1471-2288/6/18&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;E D &lt;a name=\&quot;Moreira\&quot;&gt;&lt;/a&gt;Moreira Jr, Z Stein, E Susser. &lt;b&gt;Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals&lt;/b&gt;. Braz. J. Med. Biol. Res. 2001;34(11):1441-1446. &lt;i&gt;Abstract: \&quot;Results of subgroup analysis (SA) reported in randomized clinical trials (RCT) cannot be adequately interpreted without information about the methods used in the study design and the data analysis. Our aim was to show how often inaccurate or incomplete reports occur. First, we selected eight methodological aspects of SA on the basis of their importance to a reader in determining the confidence that should be placed in the authorÊ¼s conclusions regarding such analysis. Then, we reviewed the current practice of reporting these methodological aspects of SA in clinical trials in four leading journals, i.e., the New England Journal of Medicine, the Journal of the American Medical Association, the Lancet, and the American Journal of Public Health. Eight consecutive reports from each journal published after July 1, 1998 were included. Of the 32 trials surveyed, 17 (53%) had at least one SA. Overall, the proportion of RCT reporting a particular methodological aspect ranged from 23 to 94%. Information on whether the SA preceded/followed the analysis was reported in only 7 (41%) of the studies. Of the total possible number of items to be reported, NEJM, JAMA, Lancet and AJPH clearly mentioned 59, 67, 58 and 72%, respectively. We conclude that current reporting of SA in RCT is incomplete and inaccurate. The results of such SA may have harmful effects on treatment recommendations if accepted without judicious scrutiny. We recommend that editors improve the reporting of SA in RCT by giving authors a list of the important items to be reported.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.scielo.br/pdf/bjmbr/v34n11/4111.pdf\&quot;&gt;http://www.scielo.br/pdf/bjmbr/v34n11/4111.pdf&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;E D &lt;a name=\&quot;Moreira\&quot;&gt;&lt;/a&gt;Moreira Jr, Z Stein, E Susser. &lt;b&gt;Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals&lt;/b&gt;. Braz. J. Med. Biol. Res. 2001;34(11):1441-1446. &lt;i&gt;Abstract: \&quot;Results of subgroup analysis (SA) reported in randomized clinical trials (RCT) cannot be adequately interpreted without information about the methods used in the study design and the data analysis. Our aim was to show how often inaccurate or incomplete reports occur. First, we selected eight methodological aspects of SA on the basis of their importance to a reader in determining the confidence that should be placed in the authorÊ1/4s conclusions regarding such analysis. Then, we reviewed the current practice of reporting these methodological aspects of SA in clinical trials in four leading journals, i.e., the New England Journal of Medicine, the Journal of the American Medical Association, the Lancet, and the American Journal of Public Health. Eight consecutive reports from each journal published after July 1, 1998 were included. Of the 32 trials surveyed, 17 (53%) had at least one SA. Overall, the proportion of RCT reporting a particular methodological aspect ranged from 23 to 94%. Information on whether the SA preceded/followed the analysis was reported in only 7 (41%) of the studies. Of the total possible number of items to be reported, NEJM, JAMA, Lancet and AJPH clearly mentioned 59, 67, 58 and 72%, respectively. We conclude that current reporting of SA in RCT is incomplete and inaccurate. The results of such SA may have harmful effects on treatment recommendations if accepted without judicious scrutiny. We recommend that editors improve the reporting of SA in RCT by giving authors a list of the important items to be reported.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.scielo.br/pdf/bjmbr/v34n11/4111.pdf\&quot;&gt;http://www.scielo.br/pdf/bjmbr/v34n11/4111.pdf&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Xin Sun, Matthias Briel, Jason Busse, et al. &lt;b&gt;Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials&lt;/b&gt;. Trials. 2009;10(1):101. &lt;i&gt;Abstract: \&quot;BACKGROUND: Subgroup analyses in randomized trials examine whether effects of interventions differ between subgroups of study populations according to characteristics of patients or interventions. However, findings from subgroup analyses may be misleading, potentially resulting in suboptimal clinical and health decision making. Few studies have investigated the reporting and conduct of subgroup analyses and a number of important questions remain unanswered. The objectives of this study are: 1) to describe the reporting of subgroup analyses and claims of subgroup effects in randomized controlled trials, 2) to assess study characteristics associated with reporting of subgroup analyses and with claims of subgroup effects, and 3) to examine the analysis, and interpretation of subgroup effects for each studyÊ¼s primary outcome. METHODS: We will conduct a systematic review of 464 randomized controlled human trials published in 2007 in the 118 Core Clinical Journals defined by the National Library of Medicine. We will randomly select journal articles, stratified in a 1:1 ratio by higher impact versus lower impact journals. According to 2007 ISI total citations, we consider the New England Journal of Medicine, JAMA, Lancet, Annals of Internal Medicine, and BMJ as higher impact journals. Teams of two reviewers will independently screen full texts of reports for eligibility, and abstract data, using standardized, pilot-tested extraction forms. We will conduct univariable and multivariable logistic regression analyses to examine the association of pre-specified study characteristics with reporting of subgroup analyses and with claims of subgroup effects for the primary and any other outcomes. DISCUSSION: A clear understanding of subgroup analyses, as currently conducted and reported in published randomized controlled trials, will reveal both strengths and weaknesses of this practice. Our findings will contribute to a set of recommendations to optimize the conduct and reporting of subgroup analyses, and claim and interpretation of subgroup effects in randomized trials.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.trialsjournal.com/content/10/1/101\&quot;&gt;http://www.trialsjournal.com/content/10/1/101&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Xin Sun, Matthias Briel, Jason Busse, et al. &lt;b&gt;Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials&lt;/b&gt;. Trials. 2009;10(1):101. &lt;i&gt;Abstract: \&quot;BACKGROUND: Subgroup analyses in randomized trials examine whether effects of interventions differ between subgroups of study populations according to characteristics of patients or interventions. However, findings from subgroup analyses may be misleading, potentially resulting in suboptimal clinical and health decision making. Few studies have investigated the reporting and conduct of subgroup analyses and a number of important questions remain unanswered. The objectives of this study are: 1) to describe the reporting of subgroup analyses and claims of subgroup effects in randomized controlled trials, 2) to assess study characteristics associated with reporting of subgroup analyses and with claims of subgroup effects, and 3) to examine the analysis, and interpretation of subgroup effects for each studyÊ1/4s primary outcome. METHODS: We will conduct a systematic review of 464 randomized controlled human trials published in 2007 in the 118 Core Clinical Journals defined by the National Library of Medicine. We will randomly select journal articles, stratified in a 1:1 ratio by higher impact versus lower impact journals. According to 2007 ISI total citations, we consider the New England Journal of Medicine, JAMA, Lancet, Annals of Internal Medicine, and BMJ as higher impact journals. Teams of two reviewers will independently screen full texts of reports for eligibility, and abstract data, using standardized, pilot-tested extraction forms. We will conduct univariable and multivariable logistic regression analyses to examine the association of pre-specified study characteristics with reporting of subgroup analyses and with claims of subgroup effects for the primary and any other outcomes. DISCUSSION: A clear understanding of subgroup analyses, as currently conducted and reported in published randomized controlled trials, will reveal both strengths and weaknesses of this practice. Our findings will contribute to a set of recommendations to optimize the conduct and reporting of subgroup analyses, and claim and interpretation of subgroup effects in randomized trials.\&quot;&lt;/i&gt; [Accessed February 23, 2011]. Available at: &lt;a href=\&quot;http://www.trialsjournal.com/content/10/1/101\&quot;&gt;http://www.trialsjournal.com/content/10/1/101&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Thomas V Perneger. &lt;b&gt;WhatÊ¼s wrong with Bonferroni adjustments&lt;/b&gt;. BMJ. 1998;316(7139):1236-1238. [Accessed March 10, 2009]. Available at: &lt;a href=\&quot;http://www.bmj.com/cgi/content/full/316/7139/1236\&quot;&gt;http://www.bmj.com/cgi/content/full/316/7139/1236&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Thomas V Perneger. &lt;b&gt;WhatÊ1/4s wrong with Bonferroni adjustments&lt;/b&gt;. BMJ. 1998;316(7139):1236-1238. [Accessed March 10, 2009]. Available at: &lt;a href=\&quot;http://www.bmj.com/cgi/content/full/316/7139/1236\&quot;&gt;http://www.bmj.com/cgi/content/full/316/7139/1236&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/MultipleDF.html  [1] &quot;c:/web/p1/MultipleDF.html&quot;
## c:/web/p1-clean/MultipleTimePoints.html  [1] &quot;c:/web/p1/MultipleTimePoints.html&quot;
## c:/web/p1-clean/MultipleVariables.html  [1] &quot;c:/web/p1/MultipleVariables.html&quot;
## c:/web/p1-clean/MultivariateModels.html  [1] &quot;c:/web/p1/MultivariateModels.html&quot;
## c:/web/p1-clean/MyPromotionApplication.html  [1] &quot;c:/web/p1/MyPromotionApplication.html&quot;
## c:/web/p1-clean/name.html  [1] &quot;c:/web/p1/name.html&quot;
## c:/web/p1-clean/NamesIntoModel.html  [1] &quot;c:/web/p1/NamesIntoModel.html&quot;
## c:/web/p1-clean/NamingConventions.html  [1] &quot;c:/web/p1/NamingConventions.html&quot;
## c:/web/p1-clean/NamingGenes.html  [1] &quot;c:/web/p1/NamingGenes.html&quot;
## c:/web/p1-clean/narrow.html  [1] &quot;c:/web/p1/narrow.html&quot;
## c:/web/p1-clean/negative.html  [1] &quot;c:/web/p1/negative.html&quot;
## c:/web/p1-clean/NegativeAutocorrelation.html  [1] &quot;c:/web/p1/NegativeAutocorrelation.html&quot;
## c:/web/p1-clean/NegativeInterval.html  [1] &quot;c:/web/p1/NegativeInterval.html&quot;
## c:/web/p1-clean/NegativeMicroarray.html  [1] &quot;c:/web/p1/NegativeMicroarray.html&quot;
## c:/web/p1-clean/negbin.html  [1] &quot;c:/web/p1/negbin.html&quot;
## c:/web/p1-clean/new04.html  [1] &quot;c:/web/p1/new04.html&quot;
## c:/web/p1-clean/NewCategories.html  [1] &quot;c:/web/p1/NewCategories.html&quot;
## c:/web/p1-clean/NewComputer.html  [1] &quot;c:/web/p1/NewComputer.html&quot;
## c:/web/p1-clean/NewDog.html  [1] &quot;c:/web/p1/NewDog.html&quot;
## c:/web/p1-clean/NewFlatRate.html  [1] &quot;c:/web/p1/NewFlatRate.html&quot;
## c:/web/p1-clean/NewForm.html  [1] &quot;c:/web/p1/NewForm.html&quot;
## [1] &quot;&lt;p&gt;6 ïƒ¨ 4. Inclusion Enrollment Report&lt;br&gt;&quot;
## [1] &quot;&lt;p&gt;6 iƒ¨ 4. Inclusion Enrollment Report&lt;br&gt;&quot;
## [1] &quot;7 ïƒ¨ 5. Bibliography and References Cited&lt;br&gt;&quot;
## [1] &quot;7 iƒ¨ 5. Bibliography and References Cited&lt;br&gt;&quot;
## [1] &quot;8 ïƒ¨ 6. Protection of Human Subjects&lt;br&gt;&quot;
## [1] &quot;8 iƒ¨ 6. Protection of Human Subjects&lt;br&gt;&quot;
## [1] &quot;9 ïƒ¨ 7. Inclusion of Women and Minorities&lt;br&gt;&quot;
## [1] &quot;9 iƒ¨ 7. Inclusion of Women and Minorities&lt;br&gt;&quot;
## [1] &quot;10 ïƒ¨ 8. Targeted Enrollment Table&lt;br&gt;&quot;
## [1] &quot;10 iƒ¨ 8. Targeted Enrollment Table&lt;br&gt;&quot;
## [1] &quot;11 ïƒ¨ 9. Inclusion of Children&lt;br&gt;&quot;
## [1] &quot;11 iƒ¨ 9. Inclusion of Children&lt;br&gt;&quot;
## [1] &quot;12 ïƒ¨ 10. Vertebrate Animals&lt;br&gt;&quot;
## [1] &quot;12 iƒ¨ 10. Vertebrate Animals&lt;br&gt;&quot;
## [1] &quot;13 ïƒ¨ 11. Select Agent Research&lt;br&gt;&quot;
## [1] &quot;13 iƒ¨ 11. Select Agent Research&lt;br&gt;&quot;
## [1] &quot;14 ïƒ¨ 12. Multiple PI/PD Leadership&lt;br&gt;&quot;
## [1] &quot;14 iƒ¨ 12. Multiple PI/PD Leadership&lt;br&gt;&quot;
## [1] &quot;15 ïƒ¨ 13. Consortium/Contractual Agreements&lt;br&gt;&quot;
## [1] &quot;15 iƒ¨ 13. Consortium/Contractual Agreements&lt;br&gt;&quot;
## [1] &quot;16 ïƒ¨ 14. Letters of Support&lt;br&gt;&quot;
## [1] &quot;16 iƒ¨ 14. Letters of Support&lt;br&gt;&quot;
## [1] &quot;17 ïƒ¨ 15. Resource Sharing Plan&lt;/p&gt;&quot;
## [1] &quot;17 iƒ¨ 15. Resource Sharing Plan&lt;/p&gt;&quot;
## c:/web/p1-clean/NewFormat-08.html  [1] &quot;c:/web/p1/NewFormat-08.html&quot;
## c:/web/p1-clean/NewFormat-08a.html  [1] &quot;c:/web/p1/NewFormat-08a.html&quot;
## c:/web/p1-clean/NewOffice-08.html  [1] &quot;c:/web/p1/NewOffice-08.html&quot;
## [1] &quot;    22nd Street. However, the entrance to our building faces Building M 2. It’s &quot;
## [1] &quot;    22nd Street. However, the entrance to our building faces Building M 2. It&#39;s &quot;
## [1] &quot;    our building’s entrance on its south side. Another route would be to exit &quot;
## [1] &quot;    our building&#39;s entrance on its south side. Another route would be to exit &quot;
## [1] &quot;    the Hospital Hill Center Building on Holmes and then walk ½ block north to &quot;
## [1] &quot;    the Hospital Hill Center Building on Holmes and then walk 1/2 block north to &quot;
## c:/web/p1-clean/NewOffice-08a.html  [1] &quot;c:/web/p1/NewOffice-08a.html&quot;
## [1] &quot;    22nd Street. However, the entrance to our building faces Building M 2. It’s &quot;
## [1] &quot;    22nd Street. However, the entrance to our building faces Building M 2. It&#39;s &quot;
## [1] &quot;    our building’s entrance on its south side. Another route would be to exit &quot;
## [1] &quot;    our building&#39;s entrance on its south side. Another route would be to exit &quot;
## [1] &quot;    the Hospital Hill Center Building on Holmes and then walk ½ block north to &quot;
## [1] &quot;    the Hospital Hill Center Building on Holmes and then walk 1/2 block north to &quot;
## c:/web/p1-clean/newton.html  [1] &quot;c:/web/p1/newton.html&quot;
## c:/web/p1-clean/NeymanBias.html  [1] &quot;c:/web/p1/NeymanBias.html&quot;
## c:/web/p1-clean/nhamcs.html  [1] &quot;c:/web/p1/nhamcs.html&quot;
## c:/web/p1-clean/nih.html  [1] &quot;c:/web/p1/nih.html&quot;
## c:/web/p1-clean/nihilism.html  [1] &quot;c:/web/p1/nihilism.html&quot;
## [1] &quot;    dimension to the level of confidence — or lack thereof — that chance &quot;
## [1] &quot;    dimension to the level of confidence - or lack thereof - that chance &quot;
## [1] &quot;    relation—which, in the final analysis, is the bedrock on which good medical &quot;
## [1] &quot;    relation-which, in the final analysis, is the bedrock on which good medical &quot;
## c:/web/p1-clean/NineOfThirtySix.html  [1] &quot;c:/web/p1/NineOfThirtySix.html&quot;
## c:/web/p1-clean/nnh.html  [1] &quot;c:/web/p1/nnh.html&quot;
## c:/web/p1-clean/NnhTalkUpdate.html  [1] &quot;c:/web/p1/NnhTalkUpdate.html&quot;
## c:/web/p1-clean/nnt.html  [1] &quot;c:/web/p1/nnt.html&quot;
## c:/web/p1-clean/NntForIndirectComparisons.html  [1] &quot;c:/web/p1/NntForIndirectComparisons.html&quot;
## c:/web/p1-clean/NntForRates.html  [1] &quot;c:/web/p1/NntForRates.html&quot;
## c:/web/p1-clean/nobrake.html  [1] &quot;c:/web/p1/nobrake.html&quot;
## c:/web/p1-clean/NoHumanInvestigation.html  [1] &quot;c:/web/p1/NoHumanInvestigation.html&quot;
## c:/web/p1-clean/NoLongerAlone.html  [1] &quot;c:/web/p1/NoLongerAlone.html&quot;
## c:/web/p1-clean/NoMechanism.html  [1] &quot;c:/web/p1/NoMechanism.html&quot;
## c:/web/p1-clean/noncomparable.html  [1] &quot;c:/web/p1/noncomparable.html&quot;
## c:/web/p1-clean/NondestructiveEditing.html  [1] &quot;c:/web/p1/NondestructiveEditing.html&quot;
## c:/web/p1-clean/nonlinear-04.html  [1] &quot;c:/web/p1/nonlinear-04.html&quot;
## c:/web/p1-clean/nonlinear-99.html  [1] &quot;c:/web/p1/nonlinear-99.html&quot;
## c:/web/p1-clean/Nonlinear.html  [1] &quot;c:/web/p1/Nonlinear.html&quot;
## c:/web/p1-clean/nonlinear_growth.html  [1] &quot;c:/web/p1/nonlinear_growth.html&quot;
## c:/web/p1-clean/NonlinearRegression.html  [1] &quot;c:/web/p1/NonlinearRegression.html&quot;
## c:/web/p1-clean/NonrandomSamples.html  [1] &quot;c:/web/p1/NonrandomSamples.html&quot;
## c:/web/p1-clean/NonspecificDiagnostic.html  [1] &quot;c:/web/p1/NonspecificDiagnostic.html&quot;
## c:/web/p1-clean/normal.html  [1] &quot;c:/web/p1/normal.html&quot;
## c:/web/p1-clean/NormalityAssumption.html  [1] &quot;c:/web/p1/NormalityAssumption.html&quot;
## c:/web/p1-clean/NormalPlot.html  [1] &quot;c:/web/p1/NormalPlot.html&quot;
## c:/web/p1-clean/NormalProbabilities.html  [1] &quot;c:/web/p1/NormalProbabilities.html&quot;
## c:/web/p1-clean/NormalSample.html  [1] &quot;c:/web/p1/NormalSample.html&quot;
## c:/web/p1-clean/NoStandardDeviation.html  [1] &quot;c:/web/p1/NoStandardDeviation.html&quot;
## c:/web/p1-clean/NotBlackAndWhilte.html  [1] &quot;c:/web/p1/NotBlackAndWhilte.html&quot;
## c:/web/p1-clean/NotEverything.html  [1] &quot;c:/web/p1/NotEverything.html&quot;
## c:/web/p1-clean/NotGatekeepers.html  [1] &quot;c:/web/p1/NotGatekeepers.html&quot;
## c:/web/p1-clean/NotYetAvailable.html  [1] &quot;c:/web/p1/NotYetAvailable.html&quot;
## c:/web/p1-clean/NovelDiagnostic.html  [1] &quot;c:/web/p1/NovelDiagnostic.html&quot;
## [1] &quot;     polypropylene “wool” captures volatile organic compounds in exhaled breath as breath &quot;
## [1] &quot;     polypropylene \&quot;wool\&quot; captures volatile organic compounds in exhaled breath as breath &quot;
## [1] &quot;    “go to work,” gave no “sit” or other verbal commands to the dog. Clicker signal by the &quot;
## [1] &quot;    \&quot;go to work,\&quot; gave no \&quot;sit\&quot; or other verbal commands to the dog. Clicker signal by the &quot;
## [1] &quot;     dog by saying “no.” Samples used in phases 1 and 2 (contaminated with food scent) were &quot;
## [1] &quot;     dog by saying \&quot;no.\&quot; Samples used in phases 1 and 2 (contaminated with food scent) were &quot;
## [1] &quot;     leaving the training room was the dog acknowledged with the phrase “good work!” During &quot;
## [1] &quot;     leaving the training room was the dog acknowledged with the phrase \&quot;good work!\&quot; During &quot;
## [1] &quot;   &lt;p&gt;&lt;i&gt;The dogs’ response to each of the 5 samples sniffed was included in our analysis; &quot;
## [1] &quot;   &lt;p&gt;&lt;i&gt;The dogs&#39; response to each of the 5 samples sniffed was included in our analysis; &quot;
## c:/web/p1-clean/NumbersTablesCharts.html  [1] &quot;c:/web/p1/NumbersTablesCharts.html&quot;
## c:/web/p1-clean/OATalk.html  [1] &quot;c:/web/p1/OATalk.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Dr. Fert, 69, and Dr. Grünberg, 68, each working independently in &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Dr. Fert, 69, and Dr. Grunberg, 68, each working independently in &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;SPARC ®, the Scholarly Publishing and Academic Resources Coalition, is &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;SPARC *, the Scholarly Publishing and Academic Resources Coalition, is &quot;
## [1] &quot;    collaboration with stakeholders – including authors, publishers, and &quot;
## [1] &quot;    collaboration with stakeholders - including authors, publishers, and &quot;
## [1] &quot;    libraries – builds on the unprecedented opportunities created by the &quot;
## [1] &quot;    libraries - builds on the unprecedented opportunities created by the &quot;
## [1] &quot;  &lt;li&gt;“Author pays” model&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;\&quot;Author pays\&quot; model&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;“Reader pays” model&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;\&quot;Reader pays\&quot; model&lt;/li&gt;&quot;
## [1] &quot;    single high-priced journal — subscriptions paid by university libraries &quot;
## [1] &quot;    single high-priced journal - subscriptions paid by university libraries &quot;
## [1] &quot;  &lt;li&gt;researchers studying research publications at the “Meta” level.&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;researchers studying research publications at the \&quot;Meta\&quot; level.&lt;/li&gt;&quot;
## [1] &quot;    not cited (relative risk = 1.3 [95% Confidence Interval: 1.1–1.6]; p = &quot;
## [1] &quot;    not cited (relative risk = 1.3 [95% Confidence Interval: 1.1-1.6]; p = &quot;
## [1] &quot;    relative risk = 2.6 [1.4–4.7]; p &amp;lt; 0.001). The average number of citations &quot;
## [1] &quot;    relative risk = 2.6 [1.4-4.7]; p &amp;lt; 0.001). The average number of citations &quot;
## [1] &quot;    assets at 30 September 2006 of over £13.4 billion ($26.8 billion). The &quot;
## [1] &quot;    assets at 30 September 2006 of over lb13.4 billion ($26.8 billion). The &quot;
## [1] &quot;    Wikipedia, The Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. &quot;
## [1] &quot;    Wikipedia, The Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. &quot;
## [1] &quot;    &lt;li&gt;&lt;i&gt;Don’t sign restrictive copyright agreements: amend them to retain &quot;
## [1] &quot;    &lt;li&gt;&lt;i&gt;Don&#39;t sign restrictive copyright agreements: amend them to retain &quot;
## c:/web/p1-clean/ObjectOrientedR.html  [1] &quot;c:/web/p1/ObjectOrientedR.html&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Class — the unit of definition of data and behavior (functionality) &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Class - the unit of definition of data and behavior (functionality) &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Object — an instance of a class, an object (for example, &amp;quot;Rin Tin &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Object - an instance of a class, an object (for example, &amp;quot;Rin Tin &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Encapsulation — a type of privacy applied to the data and some of &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Encapsulation - a type of privacy applied to the data and some of &quot;
## [1] &quot;      (namely, the class&#39;s public methods). Each object exposes an interface — &quot;
## [1] &quot;      (namely, the class&#39;s public methods). Each object exposes an interface - &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Inheritance — a mechanism for creating subclasses, inheritance &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Inheritance - a mechanism for creating subclasses, inheritance &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Abstraction — the ability of a program to ignore the details of an &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Abstraction - the ability of a program to ignore the details of an &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Polymorphism — polymorphism is behavior that varies depending on the &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;* Polymorphism - polymorphism is behavior that varies depending on the &quot;
## c:/web/p1-clean/ObservationalStudies.html  [1] &quot;c:/web/p1/ObservationalStudies.html&quot;
## [1] &quot;      March; 7(2): 36ï¿½37. doi: 10.1111/j.1535-7511.2007.00161.x. [Medline] &quot;
## [1] &quot;      March; 7(2): 36i¿1/237. doi: 10.1111/j.1535-7511.2007.00161.x. [Medline] &quot;
## [1] &quot;        controlled trials) are the ï¿½gold standardï¿½ for evaluation and that &quot;
## [1] &quot;        controlled trials) are the i¿1/2gold standardi¿1/2 for evaluation and that &quot;
## c:/web/p1-clean/ObsoleteImages.html  [1] &quot;c:/web/p1/ObsoleteImages.html&quot;
## c:/web/p1-clean/ObsoletePages.html  [1] &quot;c:/web/p1/ObsoletePages.html&quot;
## c:/web/p1-clean/OctoberFun.html  [1] &quot;c:/web/p1/OctoberFun.html&quot;
## c:/web/p1-clean/OddsFormBayes.html  [1] &quot;c:/web/p1/OddsFormBayes.html&quot;
## c:/web/p1-clean/oddsratio.html  [1] &quot;c:/web/p1/oddsratio.html&quot;
## c:/web/p1-clean/OddsRatios.html  [1] &quot;c:/web/p1/OddsRatios.html&quot;
## c:/web/p1-clean/OneOfTheNaturalists.html  [1] &quot;c:/web/p1/OneOfTheNaturalists.html&quot;
## c:/web/p1-clean/OneTail.html  [1] &quot;c:/web/p1/OneTail.html&quot;
## c:/web/p1-clean/OneTailed.html  [1] &quot;c:/web/p1/OneTailed.html&quot;
## c:/web/p1-clean/OneThird-08.html  [1] &quot;c:/web/p1/OneThird-08.html&quot;
## c:/web/p1-clean/OneThird-08a.html  [1] &quot;c:/web/p1/OneThird-08a.html&quot;
## c:/web/p1-clean/OnlineCalculators.html  [1] &quot;c:/web/p1/OnlineCalculators.html&quot;
## [1] &quot;    &lt;p&gt;Webpage: Richard Lowry. &lt;b&gt;VassarStats: Statistical Computation Web Site&lt;/b&gt; &lt;i&gt;Excerpt: \&quot;Welcome to the VassarStats website, which I hope you will find to be a useful and user-friendly tool for performing statistical computation. Each of the links in white text in the panel on the left will show an annotated list of the statistical procedures available under that rubric. The Â«Site MapÂ» display below will show a complete list of all available items.\&quot;&lt;/i&gt; [Accessed on June 17, 2011]. &lt;a href=\&quot;http://faculty.vassar.edu/lowry/VassarStats.html\&quot;&gt;http://faculty.vassar.edu/lowry/VassarStats.html&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;Webpage: Richard Lowry. &lt;b&gt;VassarStats: Statistical Computation Web Site&lt;/b&gt; &lt;i&gt;Excerpt: \&quot;Welcome to the VassarStats website, which I hope you will find to be a useful and user-friendly tool for performing statistical computation. Each of the links in white text in the panel on the left will show an annotated list of the statistical procedures available under that rubric. The  «Site Map » display below will show a complete list of all available items.\&quot;&lt;/i&gt; [Accessed on June 17, 2011]. &lt;a href=\&quot;http://faculty.vassar.edu/lowry/VassarStats.html\&quot;&gt;http://faculty.vassar.edu/lowry/VassarStats.html&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/OpenAccessJournals.html  [1] &quot;c:/web/p1/OpenAccessJournals.html&quot;
## c:/web/p1-clean/OpenAccessJournalsPart2.html  [1] &quot;c:/web/p1/OpenAccessJournalsPart2.html&quot;
## [1] &quot;    authors £10,000-£30,000 in order to move to an Open Access model&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;    authors lb10,000-lb30,000 in order to move to an Open Access model&lt;/i&gt;&lt;/li&gt;&quot;
## c:/web/p1-clean/OpenAccessJournalsPart2a.html  [1] &quot;c:/web/p1/OpenAccessJournalsPart2a.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Dr. Fert, 69, and Dr. Grünberg, 68, each working independently in 1988, &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Dr. Fert, 69, and Dr. Grunberg, 68, each working independently in 1988, &quot;
## [1] &quot;    &lt;li&gt;“Author pays” model&lt;/li&gt;&quot;
## [1] &quot;    &lt;li&gt;\&quot;Author pays\&quot; model&lt;/li&gt;&quot;
## [1] &quot;    &lt;li&gt;“Reader pays” model&lt;/li&gt;&quot;
## [1] &quot;    &lt;li&gt;\&quot;Reader pays\&quot; model&lt;/li&gt;&quot;
## [1] &quot;  high-priced journal — subscriptions paid by university libraries supported by &quot;
## [1] &quot;  high-priced journal - subscriptions paid by university libraries supported by &quot;
## [1] &quot;    &lt;li&gt;researchers studying research publications at the “Meta” level.&lt;/li&gt;&quot;
## [1] &quot;    &lt;li&gt;researchers studying research publications at the \&quot;Meta\&quot; level.&lt;/li&gt;&quot;
## [1] &quot;  (relative risk = 1.3 [95% Confidence Interval: 1.1–1.6]; p = 0.001). 6 mo &quot;
## [1] &quot;  (relative risk = 1.3 [95% Confidence Interval: 1.1-1.6]; p = 0.001). 6 mo &quot;
## [1] &quot;  [1.4–4.7]; p &amp;lt; 0.001). The average number of citations of OA articles was &quot;
## [1] &quot;  [1.4-4.7]; p &amp;lt; 0.001). The average number of citations of OA articles was &quot;
## [1] &quot;  £13.4 billion ($26.8 billion). The trust states its mission as being &amp;quot;to &quot;
## [1] &quot;  lb13.4 billion ($26.8 billion). The trust states its mission as being &amp;quot;to &quot;
## [1] &quot;  Wikipedia, The Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. &quot;
## [1] &quot;  Wikipedia, The Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. V. &quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Don’t sign restrictive copyright agreements: amend them to retain &quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Don&#39;t sign restrictive copyright agreements: amend them to retain &quot;
## [1] &quot;    authors £10,000-£30,000 in order to move to an Open Access model&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;    authors lb10,000-lb30,000 in order to move to an Open Access model&lt;/i&gt;&lt;/li&gt;&quot;
## c:/web/p1-clean/OpenEndedQuestions.html  [1] &quot;c:/web/p1/OpenEndedQuestions.html&quot;
## c:/web/p1-clean/OpenMindedness.html  [1] &quot;c:/web/p1/OpenMindedness.html&quot;
## [1] &quot;     and Oliver W. Prichard. (Original publication: July 31, 2001) &lt;i&gt;VALHALLA — &quot;
## [1] &quot;     and Oliver W. Prichard. (Original publication: July 31, 2001) &lt;i&gt;VALHALLA - &quot;
## [1] &quot;     hospital’s chief executive while she made her opening remarks. They talked &quot;
## [1] &quot;     hospital&#39;s chief executive while she made her opening remarks. They talked &quot;
## [1] &quot;     industry’s safety record, the Institute of Medicine in 2001 recommended &quot;
## [1] &quot;     industry&#39;s safety record, the Institute of Medicine in 2001 recommended &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;“The trend is not surprising given the similarities between health &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;\&quot;The trend is not surprising given the similarities between health &quot;
## [1] &quot;     care and aviation,” said Dr. David M. Gaba, associate dean of immersive and &quot;
## [1] &quot;     care and aviation,\&quot; said Dr. David M. Gaba, associate dean of immersive and &quot;
## [1] &quot;     Palo Alto, Calif. “Both involve hours of boredom punctuated by moments of &quot;
## [1] &quot;     Palo Alto, Calif. \&quot;Both involve hours of boredom punctuated by moments of &quot;
## [1] &quot;     sheer terror,” he said. In addition to sometimes having to make &quot;
## [1] &quot;     sheer terror,\&quot; he said. In addition to sometimes having to make &quot;
## [1] &quot;     is “fuzzier” than in aviation, where it is easier to identify a “foul-up” &quot;
## [1] &quot;     is \&quot;fuzzier\&quot; than in aviation, where it is easier to identify a \&quot;foul-up\&quot; &quot;
## [1] &quot;     and who was responsible. Health care providers’ fear of litigation and &quot;
## [1] &quot;     and who was responsible. Health care providers&#39; fear of litigation and &quot;
## [1] &quot;     by pilots without knowledge of health care realities can be “appallingly &quot;
## [1] &quot;     by pilots without knowledge of health care realities can be \&quot;appallingly &quot;
## [1] &quot;     bad,” he said.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;     bad,\&quot; he said.&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/OpenSite.html  [1] &quot;c:/web/p1/OpenSite.html&quot;
## c:/web/p1-clean/OppositeOddsRatio.html  [1] &quot;c:/web/p1/OppositeOddsRatio.html&quot;
## c:/web/p1-clean/OptimalThreshold.html  [1] &quot;c:/web/p1/OptimalThreshold.html&quot;
## c:/web/p1-clean/OrderEnteringInteractions.html  [1] &quot;c:/web/p1/OrderEnteringInteractions.html&quot;
## [1] &quot;       logistic regression because “competing for variance” is a bit hard to &quot;
## [1] &quot;       logistic regression because \&quot;competing for variance\&quot; is a bit hard to &quot;
## [1] &quot;       It’s unbalanced, but the contrast for the interaction is orthogonal to &quot;
## [1] &quot;       It&#39;s unbalanced, but the contrast for the interaction is orthogonal to &quot;
## [1] &quot;       &lt;p&gt;So you don’t have to worry? Well, not so fast. The test of main &quot;
## [1] &quot;       &lt;p&gt;So you don&#39;t have to worry? Well, not so fast. The test of main &quot;
## [1] &quot;       interaction between Factors 1 and 2? I’m not sure and I’d be very &quot;
## [1] &quot;       interaction between Factors 1 and 2? I&#39;m not sure and I&#39;d be very &quot;
## c:/web/p1-clean/OrdinalData.html  [1] &quot;c:/web/p1/OrdinalData.html&quot;
## c:/web/p1-clean/OrdinalEntropy.html  [1] &quot;c:/web/p1/OrdinalEntropy.html&quot;
## c:/web/p1-clean/OrdinalLogistic.html  [1] &quot;c:/web/p1/OrdinalLogistic.html&quot;
## c:/web/p1-clean/OrdinalSurprisals.html  [1] &quot;c:/web/p1/OrdinalSurprisals.html&quot;
## c:/web/p1-clean/OutcomesResearch.html  [1] &quot;c:/web/p1/OutcomesResearch.html&quot;
## [1] &quot;      chronic conditions—where cure is not always possible—end results include quality of life &quot;
## [1] &quot;      chronic conditions-where cure is not always possible-end results include quality of life &quot;
## c:/web/p1-clean/outliers.html  [1] &quot;c:/web/p1/outliers.html&quot;
## c:/web/p1-clean/OvarianCancer.html  [1] &quot;c:/web/p1/OvarianCancer.html&quot;
## [1] &quot;  cancers, and its false positive rate — detecting a cancer that was not there — &quot;
## [1] &quot;  cancers, and its false positive rate - detecting a cancer that was not there - &quot;
## [1] &quot;  was 0.6 percent. But Dr. Beth Y. Karlan, director of the Women’s Cancer &quot;
## [1] &quot;  was 0.6 percent. But Dr. Beth Y. Karlan, director of the Women&#39;s Cancer &quot;
## [1] &quot;  the most deadly type of ovarian cancer. “That’s really what we want to find,” &quot;
## [1] &quot;  the most deadly type of ovarian cancer. \&quot;That&#39;s really what we want to find,\&quot; &quot;
## c:/web/p1-clean/overfit.html  [1] &quot;c:/web/p1/overfit.html&quot;
## c:/web/p1-clean/OverfittingExample.html  [1] &quot;c:/web/p1/OverfittingExample.html&quot;
## c:/web/p1-clean/OvernightCamping.html  [1] &quot;c:/web/p1/OvernightCamping.html&quot;
## c:/web/p1-clean/page.html  [1] &quot;c:/web/p1/page.html&quot;
## c:/web/p1-clean/PageBreaksSPSS.html  [1] &quot;c:/web/p1/PageBreaksSPSS.html&quot;
## c:/web/p1-clean/PairedAvailability.html  [1] &quot;c:/web/p1/PairedAvailability.html&quot;
## c:/web/p1-clean/PairedRandomization.html  [1] &quot;c:/web/p1/PairedRandomization.html&quot;
## c:/web/p1-clean/Panhandler.html  [1] &quot;c:/web/p1/Panhandler.html&quot;
## c:/web/p1-clean/PapSmear.html  [1] &quot;c:/web/p1/PapSmear.html&quot;
## c:/web/p1-clean/ParallelControl.html  [1] &quot;c:/web/p1/ParallelControl.html&quot;
## c:/web/p1-clean/parametric-01.html  [1] &quot;c:/web/p1/parametric-01.html&quot;
## c:/web/p1-clean/parametric-04.html  [1] &quot;c:/web/p1/parametric-04.html&quot;
## c:/web/p1-clean/ParametricTestForRatio.html  [1] &quot;c:/web/p1/ParametricTestForRatio.html&quot;
## c:/web/p1-clean/ParetoCharts.html  [1] &quot;c:/web/p1/ParetoCharts.html&quot;
## [1] &quot;  [PDF]&lt;/strong&gt;&lt;/a&gt;. Ilías Ortega, Soren Bisgaard, published February 2000 in &quot;
## [1] &quot;  [PDF]&lt;/strong&gt;&lt;/a&gt;. Ilias Ortega, Soren Bisgaard, published February 2000 in &quot;
## [1] &quot;    designator, defects on U20, a .020” pitch QFP64 package on the top of the &quot;
## [1] &quot;    designator, defects on U20, a .020\&quot; pitch QFP64 package on the top of the &quot;
## [1] &quot;    this to the stencil print step, where a minute “dimple” was found in the &quot;
## [1] &quot;    this to the stencil print step, where a minute \&quot;dimple\&quot; was found in the &quot;
## c:/web/p1-clean/PastYear.html  [1] &quot;c:/web/p1/PastYear.html&quot;
## c:/web/p1-clean/PatientsReactions.html  [1] &quot;c:/web/p1/PatientsReactions.html&quot;
## c:/web/p1-clean/pca.html  [1] &quot;c:/web/p1/pca.html&quot;
## [1] &quot;  &lt;li&gt;motherï¿½s and fatherï¿½s profession (employed/unemployed) and education &quot;
## [1] &quot;  &lt;li&gt;motheri¿1/2s and fatheri¿1/2s profession (employed/unemployed) and education &quot;
## c:/web/p1-clean/PControlChart.html  [1] &quot;c:/web/p1/PControlChart.html&quot;
## c:/web/p1-clean/PControlChartAnswers.html  [1] &quot;c:/web/p1/PControlChartAnswers.html&quot;
## c:/web/p1-clean/PearsonCorrelation.html  [1] &quot;c:/web/p1/PearsonCorrelation.html&quot;
## c:/web/p1-clean/PediatricResearch.html  [1] &quot;c:/web/p1/PediatricResearch.html&quot;
## c:/web/p1-clean/PeerReview.html  [1] &quot;c:/web/p1/PeerReview.html&quot;
## c:/web/p1-clean/penston.html  [1] &quot;c:/web/p1/penston.html&quot;
## c:/web/p1-clean/percentage-02.html  [1] &quot;c:/web/p1/percentage-02.html&quot;
## c:/web/p1-clean/percentage-04.html  [1] &quot;c:/web/p1/percentage-04.html&quot;
## c:/web/p1-clean/percentage-12.html  [1] &quot;c:/web/p1/percentage-12.html&quot;
## c:/web/p1-clean/PercentileFormula.html  [1] &quot;c:/web/p1/PercentileFormula.html&quot;
## c:/web/p1-clean/PerfectionNotEnough.html  [1] &quot;c:/web/p1/PerfectionNotEnough.html&quot;
## c:/web/p1-clean/performance.html  [1] &quot;c:/web/p1/performance.html&quot;
## c:/web/p1-clean/PeritonealDialysis.html  [1] &quot;c:/web/p1/PeritonealDialysis.html&quot;
## c:/web/p1-clean/PermutationTests.html  [1] &quot;c:/web/p1/PermutationTests.html&quot;
## c:/web/p1-clean/PersonalPages.html  [1] &quot;c:/web/p1/PersonalPages.html&quot;
## c:/web/p1-clean/pesky.html  [1] &quot;c:/web/p1/pesky.html&quot;
## c:/web/p1-clean/PharmacogeneticsResearchNetwork.html  [1] &quot;c:/web/p1/PharmacogeneticsResearchNetwork.html&quot;
## c:/web/p1-clean/PharmaIqTalks.html  [1] &quot;c:/web/p1/PharmaIqTalks.html&quot;
## c:/web/p1-clean/PharmaIqTalksPart2.html  [1] &quot;c:/web/p1/PharmaIqTalksPart2.html&quot;
## c:/web/p1-clean/PharmaVersusAcademia.html  [1] &quot;c:/web/p1/PharmaVersusAcademia.html&quot;
## c:/web/p1-clean/PharmedOutWebsite.html  [1] &quot;c:/web/p1/PharmedOutWebsite.html&quot;
## [1] &quot;            Warner-Lambert conducted an unlawful marketing campaign for the drug Neurontin® (gabapentin) &quot;
## [1] &quot;            Warner-Lambert conducted an unlawful marketing campaign for the drug Neurontin* (gabapentin) &quot;
## c:/web/p1-clean/photographer.html  [1] &quot;c:/web/p1/photographer.html&quot;
## c:/web/p1-clean/PiecewiseLinear.html  [1] &quot;c:/web/p1/PiecewiseLinear.html&quot;
## c:/web/p1-clean/pilot-99.html  [1] &quot;c:/web/p1/pilot-99.html&quot;
## c:/web/p1-clean/pilot-personal.html  [1] &quot;c:/web/p1/pilot-personal.html&quot;
## c:/web/p1-clean/pilot1.html  [1] &quot;c:/web/p1/pilot1.html&quot;
## c:/web/p1-clean/PilotGrant.html  [1] &quot;c:/web/p1/PilotGrant.html&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;Faculty and research assistant salaries are permitted. However, no more than 10% of the PI&#39;s time (salary) should be allocated to the budget, and if grant funds are used to provide release time, that time must be matched by departmental release timeâ\200”e.g., if 10% of PI&#39;s salary is charged to the grant, another 10% must by donated for a total of 20% effort dedicated to the proposed project. NOTE: The actual monetary value of donated effort must be documented in the letter from the investigator&#39;s departmental chair. As noted above, the program encourages the development of proposals that promote collaboration between Frontiers investigators from different disciplines and/or from different institutions, and proposals that provide home departmental / institutional / organizational matching or contributed funds.&lt;/em&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;Faculty and research assistant salaries are permitted. However, no more than 10% of the PI&#39;s time (salary) should be allocated to the budget, and if grant funds are used to provide release time, that time must be matched by departmental release timeâ\200\&quot;e.g., if 10% of PI&#39;s salary is charged to the grant, another 10% must by donated for a total of 20% effort dedicated to the proposed project. NOTE: The actual monetary value of donated effort must be documented in the letter from the investigator&#39;s departmental chair. As noted above, the program encourages the development of proposals that promote collaboration between Frontiers investigators from different disciplines and/or from different institutions, and proposals that provide home departmental / institutional / organizational matching or contributed funds.&lt;/em&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/PilotStudies.html  [1] &quot;c:/web/p1/PilotStudies.html&quot;
## c:/web/p1-clean/PilotStudy.html  [1] &quot;c:/web/p1/PilotStudy.html&quot;
## c:/web/p1-clean/Pinewood.html  [1] &quot;c:/web/p1/Pinewood.html&quot;
## [1] &quot;&lt;title&gt;Steve, Cathy, and Nicholas -- Nicholas competes in his first Pinewood DerbyÂ (created 2011-02-28)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;Steve, Cathy, and Nicholas -- Nicholas competes in his first Pinewood Derby  (created 2011-02-28)&lt;/title&gt;&quot;
## c:/web/p1-clean/pivot.html  [1] &quot;c:/web/p1/pivot.html&quot;
## c:/web/p1-clean/placebo-01.html  [1] &quot;c:/web/p1/placebo-01.html&quot;
## [1] &quot;    &lt;li&gt;&lt;b&gt;Surgery for Emphysema — Not for Everyone. &lt;/b&gt;Jeffrey M. Drazen, M.D. &lt;i&gt;NEJM&lt;/i&gt;&lt;a href=\&quot;http://nejm.org/pdf/2001/20011011/10.pdf\&quot;&gt; &quot;
## [1] &quot;    &lt;li&gt;&lt;b&gt;Surgery for Emphysema - Not for Everyone. &lt;/b&gt;Jeffrey M. Drazen, M.D. &lt;i&gt;NEJM&lt;/i&gt;&lt;a href=\&quot;http://nejm.org/pdf/2001/20011011/10.pdf\&quot;&gt; &quot;
## [1] &quot;    &lt;li&gt;&lt;b&gt;Patients at High Risk of Death after Lung-Volume–Reduction Surgery. &lt;/b&gt;National &quot;
## [1] &quot;    &lt;li&gt;&lt;b&gt;Patients at High Risk of Death after Lung-Volume-Reduction Surgery. &lt;/b&gt;National &quot;
## [1] &quot;       underpinning of the randomised controlled trial &lt;font size=\&quot;+1\&quot;&gt;•&lt;/font&gt; FOR &lt;font size=\&quot;+1\&quot;&gt;&quot;
## [1] &quot;       underpinning of the randomised controlled trial &lt;font size=\&quot;+1\&quot;&gt;.&lt;/font&gt; FOR &lt;font size=\&quot;+1\&quot;&gt;&quot;
## [1] &quot;       •&lt;/font&gt; AGAINST. &lt;/strong&gt;Charles Weijer, Stanley H Shapiro, Kathleen Cranley Glass, and &quot;
## [1] &quot;       .&lt;/font&gt; AGAINST. &lt;/strong&gt;Charles Weijer, Stanley H Shapiro, Kathleen Cranley Glass, and &quot;
## c:/web/p1-clean/placebo-04.html  [1] &quot;c:/web/p1/placebo-04.html&quot;
## c:/web/p1-clean/PlaceboCartoon.html  [1] &quot;c:/web/p1/PlaceboCartoon.html&quot;
## c:/web/p1-clean/PlaceboControlledTrials.html  [1] &quot;c:/web/p1/PlaceboControlledTrials.html&quot;
## [1] &quot;      placebo (Latin for ï¿½I shall pleaseï¿½) is a medication or treatment believed by &quot;
## [1] &quot;      placebo (Latin for i¿1/2I shall pleasei¿1/2) is a medication or treatment believed by &quot;
## [1] &quot;      sugar pills or starch pills. Even ï¿½fakeï¿½ surgery and ï¿½fakeï¿½ psychotherapy are &quot;
## [1] &quot;      sugar pills or starch pills. Even i¿1/2fakei¿1/2 surgery and i¿1/2fakei¿1/2 psychotherapy are &quot;
## [1] &quot;      Foundation Fund 3929ï¿½Medical Reasoning.&amp;quot;&lt;/i&gt; [Accessed October 19, 2010]. &quot;
## [1] &quot;      Foundation Fund 3929i¿1/2Medical Reasoning.&amp;quot;&lt;/i&gt; [Accessed October 19, 2010]. &quot;
## c:/web/p1-clean/PlaceboRunIn.html  [1] &quot;c:/web/p1/PlaceboRunIn.html&quot;
## c:/web/p1-clean/Plagiarism.html  [1] &quot;c:/web/p1/Plagiarism.html&quot;
## c:/web/p1-clean/PlanSurvey.html  [1] &quot;c:/web/p1/PlanSurvey.html&quot;
## c:/web/p1-clean/PlugForAccrual.html  [1] &quot;c:/web/p1/PlugForAccrual.html&quot;
## c:/web/p1-clean/PocketCalculator.html  [1] &quot;c:/web/p1/PocketCalculator.html&quot;
## c:/web/p1-clean/PointlessAnalysis.html  [1] &quot;c:/web/p1/PointlessAnalysis.html&quot;
## c:/web/p1-clean/poiss_syntax.html  [1] &quot;c:/web/p1/poiss_syntax.html&quot;
## c:/web/p1-clean/poisson.html  [1] &quot;c:/web/p1/poisson.html&quot;
## c:/web/p1-clean/PoissonAccrual.html  [1] &quot;c:/web/p1/PoissonAccrual.html&quot;
## c:/web/p1-clean/PoissonBugs.html  [1] &quot;c:/web/p1/PoissonBugs.html&quot;
## c:/web/p1-clean/PoissonInteractions.html  [1] &quot;c:/web/p1/PoissonInteractions.html&quot;
## c:/web/p1-clean/PoissonPower.html  [1] &quot;c:/web/p1/PoissonPower.html&quot;
## c:/web/p1-clean/PoissonRegression-06.html  [1] &quot;c:/web/p1/PoissonRegression-06.html&quot;
## c:/web/p1-clean/PoissonRegression-category.html  [1] &quot;c:/web/p1/PoissonRegression-category.html&quot;
## c:/web/p1-clean/PoissonRegressionBooks.html  [1] &quot;c:/web/p1/PoissonRegressionBooks.html&quot;
## c:/web/p1-clean/PolarBears.html  [1] &quot;c:/web/p1/PolarBears.html&quot;
## c:/web/p1-clean/PoliticalEnd.html  [1] &quot;c:/web/p1/PoliticalEnd.html&quot;
## c:/web/p1-clean/PoliticalQuestions.html  [1] &quot;c:/web/p1/PoliticalQuestions.html&quot;
## c:/web/p1-clean/PoolingRisk.html  [1] &quot;c:/web/p1/PoolingRisk.html&quot;
## c:/web/p1-clean/population.html  [1] &quot;c:/web/p1/population.html&quot;
## c:/web/p1-clean/PopulationBased.html  [1] &quot;c:/web/p1/PopulationBased.html&quot;
## c:/web/p1-clean/PositiveStatements.html  [1] &quot;c:/web/p1/PositiveStatements.html&quot;
## c:/web/p1-clean/posthoc.html  [1] &quot;c:/web/p1/posthoc.html&quot;
## c:/web/p1-clean/PostHocComparisons.html  [1] &quot;c:/web/p1/PostHocComparisons.html&quot;
## c:/web/p1-clean/PostHocPower-05.html  [1] &quot;c:/web/p1/PostHocPower-05.html&quot;
## c:/web/p1-clean/PostHocPower-category.html  [1] &quot;c:/web/p1/PostHocPower-category.html&quot;
## c:/web/p1-clean/PostModernAssault.html  [1] &quot;c:/web/p1/PostModernAssault.html&quot;
## [1] &quot;     postmodern, in its very essence. This type of ‘counter-thought’ offers new &quot;
## [1] &quot;     postmodern, in its very essence. This type of &#39;counter-thought&#39; offers new &quot;
## [1] &quot;    &lt;p&gt;&amp;quot;&lt;i&gt;We believe that the existing paralysing ‘nursing order’, as it &quot;
## [1] &quot;    &lt;p&gt;&amp;quot;&lt;i&gt;We believe that the existing paralysing &#39;nursing order&#39;, as it &quot;
## [1] &quot;     pertains to knowledge development, must be replaced by ‘nursing chaos’. &quot;
## [1] &quot;     pertains to knowledge development, must be replaced by &#39;nursing chaos&#39;. &quot;
## [1] &quot;     certain trials.&lt;/i&gt; Jan P Vandenbroucke, &lt;b&gt;Experts’ views are still needed&lt;/b&gt;, &quot;
## [1] &quot;     certain trials.&lt;/i&gt; Jan P Vandenbroucke, &lt;b&gt;Experts&#39; views are still needed&lt;/b&gt;, &quot;
## [1] &quot;  &lt;p&gt;M Egger, T Zellweger-Zähner, M Schneider, et al. &lt;b&gt;Language bias in &quot;
## [1] &quot;  &lt;p&gt;M Egger, T Zellweger-Zahner, M Schneider, et al. &lt;b&gt;Language bias in &quot;
## [1] &quot;  &lt;p&gt;Dave Holmes, Amélie Perron, Gabrielle Michaud. &lt;b&gt;Nursing in corrections: &quot;
## [1] &quot;  &lt;p&gt;Dave Holmes, Amelie Perron, Gabrielle Michaud. &lt;b&gt;Nursing in corrections: &quot;
## [1] &quot;  &lt;p&gt;Amélie Perron, Carol Fluet, Dave Holmes. &lt;b&gt;Agents of care and agents of &quot;
## [1] &quot;  &lt;p&gt;Amelie Perron, Carol Fluet, Dave Holmes. &lt;b&gt;Agents of care and agents of &quot;
## [1] &quot;  &lt;p&gt;Amélie Perron, Carol Fluet, Dave Holmes. &lt;b&gt;Agents of care and agents of &quot;
## [1] &quot;  &lt;p&gt;Amelie Perron, Carol Fluet, Dave Holmes. &lt;b&gt;Agents of care and agents of &quot;
## c:/web/p1-clean/PostModernAssaultPart2.html  [1] &quot;c:/web/p1/PostModernAssaultPart2.html&quot;
## [1] &quot;     postmodern, in its very essence. This type of ‘counter-thought’ offers new &quot;
## [1] &quot;     postmodern, in its very essence. This type of &#39;counter-thought&#39; offers new &quot;
## [1] &quot;    &lt;p&gt;&amp;quot;&lt;i&gt;We believe that the existing paralysing ‘nursing order’, as it &quot;
## [1] &quot;    &lt;p&gt;&amp;quot;&lt;i&gt;We believe that the existing paralysing &#39;nursing order&#39;, as it &quot;
## [1] &quot;     pertains to knowledge development, must be replaced by ‘nursing chaos’. &quot;
## [1] &quot;     pertains to knowledge development, must be replaced by &#39;nursing chaos&#39;. &quot;
## [1] &quot;     certain trials.&lt;/i&gt; Jan P Vandenbroucke, &lt;b&gt;Experts’ views are still needed&lt;/b&gt;, &quot;
## [1] &quot;     certain trials.&lt;/i&gt; Jan P Vandenbroucke, &lt;b&gt;Experts&#39; views are still needed&lt;/b&gt;, &quot;
## [1] &quot;  &lt;p&gt;Olsen O, Ezzo J, Gøtzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh &quot;
## [1] &quot;  &lt;p&gt;Olsen O, Ezzo J, Gotzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh &quot;
## [1] &quot;   evidence-based practice. Nurs Inq 2002; 9: 156–61.&lt;/p&gt;&quot;
## [1] &quot;   evidence-based practice. Nurs Inq 2002; 9: 156-61.&lt;/p&gt;&quot;
## c:/web/p1-clean/PostModernAssaultPart3-07.html  [1] &quot;c:/web/p1/PostModernAssaultPart3-07.html&quot;
## [1] &quot;  &lt;p&gt;Olsen O, Ezzo J, Gøtzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh &quot;
## [1] &quot;  &lt;p&gt;Olsen O, Ezzo J, Gotzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh &quot;
## [1] &quot;   evidence-based practice. Nurs Inq 2002; 9: 156–61.&lt;/p&gt;&quot;
## [1] &quot;   evidence-based practice. Nurs Inq 2002; 9: 156-61.&lt;/p&gt;&quot;
## c:/web/p1-clean/PostModernAssaultPart3-08.html  [1] &quot;c:/web/p1/PostModernAssaultPart3-08.html&quot;
## c:/web/p1-clean/PostModernAssaultPart3-08a.html  [1] &quot;c:/web/p1/PostModernAssaultPart3-08a.html&quot;
## c:/web/p1-clean/PostmodernThought.html  [1] &quot;c:/web/p1/PostmodernThought.html&quot;
## c:/web/p1-clean/power.html  [1] &quot;c:/web/p1/power.html&quot;
## [1] &quot;&lt;title&gt;Updated:Â Three things you need for a power calculation (created 2001-11-08, revised 2011-04-26)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;Updated:  Three things you need for a power calculation (created 2001-11-08, revised 2011-04-26)&lt;/title&gt;&quot;
## c:/web/p1-clean/PowerExample.html  [1] &quot;c:/web/p1/PowerExample.html&quot;
## c:/web/p1-clean/powerpoint.html  [1] &quot;c:/web/p1/powerpoint.html&quot;
## c:/web/p1-clean/powerpoint1.html  [1] &quot;c:/web/p1/powerpoint1.html&quot;
## c:/web/p1-clean/powerpoint2.html  [1] &quot;c:/web/p1/powerpoint2.html&quot;
## c:/web/p1-clean/PowerPointA.html  [1] &quot;c:/web/p1/PowerPointA.html&quot;
## c:/web/p1-clean/PowerpointDefense.html  [1] &quot;c:/web/p1/PowerpointDefense.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;There have been extreme claims that PowerPoint both ï¿½editsï¿½ the thoughts &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;There have been extreme claims that PowerPoint both i¿1/2editsi¿1/2 the thoughts &quot;
## [1] &quot;  following: content cuttingï¿½eliminating informative text and graphical content &quot;
## [1] &quot;  following: content cuttingi¿1/2eliminating informative text and graphical content &quot;
## [1] &quot;  distortionï¿½the violation of the deckï¿½s logical hierarchy that can occur when &quot;
## [1] &quot;  distortioni¿1/2the violation of the decki¿1/2s logical hierarchy that can occur when &quot;
## [1] &quot;  flatteningï¿½the masking of hierarchical distinctions in the titles of slides. &quot;
## [1] &quot;  flatteningi¿1/2the masking of hierarchical distinctions in the titles of slides. &quot;
## c:/web/p1-clean/PowerStatements.html  [1] &quot;c:/web/p1/PowerStatements.html&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;We calculated power on an expected transition rate of 35 percent over eighteen months with a 50 percent reduction of transitions in the CBT-group. The sample we need for a 2-tailed test of the proportions with an alpha of .05 and a power of .80 is 2 Ã— 93 for the reduction of the transition to psychosis and 2 Ã— 82 for the persistence of ARMS and 2 Ã— 91 for the transition into psychosis. A conservative estimate of the drop-out rate is twenty percent per year in schizophrenia research [24]. With an estimated 30 percent drop-out over 18 months, we decided to include 240 persons in the trial. Interventions to minimize drop-outs are flexibility to location of therapy (the appointment can be at their home-address or some times by telephone or webcam), sending Christmas- and Birthday cards every year. For the participants that end up in the CBT-treatment group there is also the possibility for web-cam therapy. All the participants that complete the study will have a financial compensation for expenses made.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/11/1/30\&quot;&gt;http://www.trialsjournal.com/content/11/1/30&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;We calculated power on an expected transition rate of 35 percent over eighteen months with a 50 percent reduction of transitions in the CBT-group. The sample we need for a 2-tailed test of the proportions with an alpha of .05 and a power of .80 is 2 Ã- 93 for the reduction of the transition to psychosis and 2 Ã- 82 for the persistence of ARMS and 2 Ã- 91 for the transition into psychosis. A conservative estimate of the drop-out rate is twenty percent per year in schizophrenia research [24]. With an estimated 30 percent drop-out over 18 months, we decided to include 240 persons in the trial. Interventions to minimize drop-outs are flexibility to location of therapy (the appointment can be at their home-address or some times by telephone or webcam), sending Christmas- and Birthday cards every year. For the participants that end up in the CBT-treatment group there is also the possibility for web-cam therapy. All the participants that complete the study will have a financial compensation for expenses made.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/11/1/30\&quot;&gt;http://www.trialsjournal.com/content/11/1/30&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;For this study we assumed that the verum treatment is better than placebo by 2.7 Â± 6.0 (mean Â± standard deviation) HAM-D score points after 6 weeks (corresponding to a SMD = 0.45), that type II case history is better than type I by 2.7 Â± 6.0 score points (SMD = 0.45), and that both effects do not interact. If so, a Bonferoni-adjusted F-Test (multiple significance level Î± = 0.05, two-sided) has a power of 83.5% to detect the difference between verum and placebo and a power of 85.0% to detect the difference in case history taking, if 68 patients are included in groups 1 and 3, and 34 patients are included in groups 2 and 4. This leads to a total number of 228 patients, if one allows for a 10% drop-out rate per group.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/12/1/43\&quot;&gt;http://www.trialsjournal.com/content/12/1/43&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;For this study we assumed that the verum treatment is better than placebo by 2.7  +/- 6.0 (mean  +/- standard deviation) HAM-D score points after 6 weeks (corresponding to a SMD = 0.45), that type II case history is better than type I by 2.7  +/- 6.0 score points (SMD = 0.45), and that both effects do not interact. If so, a Bonferoni-adjusted F-Test (multiple significance level Î+/- = 0.05, two-sided) has a power of 83.5% to detect the difference between verum and placebo and a power of 85.0% to detect the difference in case history taking, if 68 patients are included in groups 1 and 3, and 34 patients are included in groups 2 and 4. This leads to a total number of 228 patients, if one allows for a 10% drop-out rate per group.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/12/1/43\&quot;&gt;http://www.trialsjournal.com/content/12/1/43&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;Sample size calculations are performed to determine the number of participants needed to detect effect sizes similar to those that have been reported in recent ADHD medication trials [56]. This study is powered to detect a 7.04 difference between the groups. A sample size of 32 per group is required to achieve 80% power with a 2-tailed significance level of .05, assuming an equivalent standard deviation of 9.9 in both groups. Estimating a 20% dropout during the study, a minimum of 80 total participants are needed to reach the target 32 participants per group [, Î¼c - Î¼t: Mean difference = 7.04, Ïƒ2 = Assumed Common Variance of both treatment and control group (Standard Deviation = 9.9), n = 32].&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/12/1/173\&quot;&gt;http://www.trialsjournal.com/content/12/1/173&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;Sample size calculations are performed to determine the number of participants needed to detect effect sizes similar to those that have been reported in recent ADHD medication trials [56]. This study is powered to detect a 7.04 difference between the groups. A sample size of 32 per group is required to achieve 80% power with a 2-tailed significance level of .05, assuming an equivalent standard deviation of 9.9 in both groups. Estimating a 20% dropout during the study, a minimum of 80 total participants are needed to reach the target 32 participants per group [, Î1/4c - Î1/4t: Mean difference = 7.04, Ïƒ2 = Assumed Common Variance of both treatment and control group (Standard Deviation = 9.9), n = 32].&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/12/1/173\&quot;&gt;http://www.trialsjournal.com/content/12/1/173&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;The aim of TREC-SAVE is to pilot methods, to generate data relevant for sample size calculations and, if possible, clinically useful data regarding whether either procedure is better in terms of clinically measures restriction and perceived treatment success. TREC-SAVE is, in part, a proof of concept study. Two main factors determine the number of people who should be recruited to in order for the trial to provide clear answers. They are the frequency of the investigated event and the size of the effect of treatment. It is important to avoid results that are erroneous. The probability of producing so called &#39;false-positive&#39; results (type I error-Î±) and &#39;false-negative&#39; findings (type II error-Î²) is minimised by having adequate sample size. However, we have no data at all from trials even to estimate adequate sample size [64] and so we recruited ten people as a very preliminary test of methods and, thereafter, aim to randomise 100 in total. Concerning the primary outcome, 100 patients were needed to give 80% power at a two-sided 5% significant level to detect a reduction in an assumed value of 50% to 30% or of 25% to 10%.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/12/1/180\&quot;&gt;http://www.trialsjournal.com/content/12/1/180&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;The aim of TREC-SAVE is to pilot methods, to generate data relevant for sample size calculations and, if possible, clinically useful data regarding whether either procedure is better in terms of clinically measures restriction and perceived treatment success. TREC-SAVE is, in part, a proof of concept study. Two main factors determine the number of people who should be recruited to in order for the trial to provide clear answers. They are the frequency of the investigated event and the size of the effect of treatment. It is important to avoid results that are erroneous. The probability of producing so called &#39;false-positive&#39; results (type I error-Î+/-) and &#39;false-negative&#39; findings (type II error-Î²) is minimised by having adequate sample size. However, we have no data at all from trials even to estimate adequate sample size [64] and so we recruited ten people as a very preliminary test of methods and, thereafter, aim to randomise 100 in total. Concerning the primary outcome, 100 patients were needed to give 80% power at a two-sided 5% significant level to detect a reduction in an assumed value of 50% to 30% or of 25% to 10%.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/12/1/180\&quot;&gt;http://www.trialsjournal.com/content/12/1/180&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;The primary outcome in this trial is the change of the Visual Analogue Score (VAS) of average pain in the menstrual period between the baseline (Visit 2) and after treatment (Visit 4). The hypothesis is H0: Î´=\0021-\0022=0 H1: Î´=\0021-\0022ôŒ‹¤0 \0021: The change of VAS score between Visit 4 and baseline in GJBNH group \0022: The change of VAS score between Visit 4 and baseline in placebo control As a reference, we have chosen the study of Choi et. al. [6] and Yeh LL.[9]. The mean (Â±standard deviation, SD) change of the VAS in GJBNH group (n=13) was 2.42 (Â±2.04) and those in placebo control group (n=38) was 1.08 (Â±2.14). We used the mean difference between groups, 1.34 (=2.42-1.08), as a clinically significant improvement worth to detect and 2.12 as its pooled standard deviation. With 5% of two-sided significance level and 80% of statistical power, we needed to randomly assign fifty participants in each group considering approximately 20% of drop-out rate.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/pdf/1745-6215-13-3.pdf\&quot;&gt;http://www.trialsjournal.com/content/pdf/1745-6215-13-3.pdf&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;The primary outcome in this trial is the change of the Visual Analogue Score (VAS) of average pain in the menstrual period between the baseline (Visit 2) and after treatment (Visit 4). The hypothesis is H0: Î´=\0021-\0022=0 H1: Î´=\0021-\0022ôŒ‹*0 \0021: The change of VAS score between Visit 4 and baseline in GJBNH group \0022: The change of VAS score between Visit 4 and baseline in placebo control As a reference, we have chosen the study of Choi et. al. [6] and Yeh LL.[9]. The mean ( +/-standard deviation, SD) change of the VAS in GJBNH group (n=13) was 2.42 ( +/-2.04) and those in placebo control group (n=38) was 1.08 ( +/-2.14). We used the mean difference between groups, 1.34 (=2.42-1.08), as a clinically significant improvement worth to detect and 2.12 as its pooled standard deviation. With 5% of two-sided significance level and 80% of statistical power, we needed to randomly assign fifty participants in each group considering approximately 20% of drop-out rate.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/pdf/1745-6215-13-3.pdf\&quot;&gt;http://www.trialsjournal.com/content/pdf/1745-6215-13-3.pdf&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;The trial aims to recruit 800 patients over a period of 2 years. Even allowing for a 25% loss to follow-up, this sample size will provide over 90% power to detect small (0.25 standard deviations) overall treatment effects on the primary outcome measures with 90% power at p &amp;lt; 0.01. It will also be sufficient to detect small differences (0.25 standard deviations) in the primary outcome measures at any one assessment point with 80% power at p &amp;lt; 0.05, and small to moderate differences (0.3 standard deviations) with 90% power at p &amp;lt; 0.05. These differences are equivalent to 1â\200“2 point improvements in the SMMSE and BADLS, which are considered the minimal clinically relevant differences. The sample size calculations assume a correlation between serial measurements of the SMMSE/BADLS of around 0.6 (multiplying factor of 0.34 based on 1 baseline and 4 post-randomization measurements, as described by Machin et al [41]) anticipating an analysis of covariance with repeated measures.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/10/1/57\&quot;&gt;http://www.trialsjournal.com/content/10/1/57&lt;/a&gt;&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;&lt;em&gt;The trial aims to recruit 800 patients over a period of 2 years. Even allowing for a 25% loss to follow-up, this sample size will provide over 90% power to detect small (0.25 standard deviations) overall treatment effects on the primary outcome measures with 90% power at p &amp;lt; 0.01. It will also be sufficient to detect small differences (0.25 standard deviations) in the primary outcome measures at any one assessment point with 80% power at p &amp;lt; 0.05, and small to moderate differences (0.3 standard deviations) with 90% power at p &amp;lt; 0.05. These differences are equivalent to 1â\200\&quot;2 point improvements in the SMMSE and BADLS, which are considered the minimal clinically relevant differences. The sample size calculations assume a correlation between serial measurements of the SMMSE/BADLS of around 0.6 (multiplying factor of 0.34 based on 1 baseline and 4 post-randomization measurements, as described by Machin et al [41]) anticipating an analysis of covariance with repeated measures.&lt;/em&gt; &lt;a href=\&quot;http://www.trialsjournal.com/content/10/1/57\&quot;&gt;http://www.trialsjournal.com/content/10/1/57&lt;/a&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/PracticeGuidelines.html  [1] &quot;c:/web/p1/PracticeGuidelines.html&quot;
## c:/web/p1-clean/PracticumOption.html  [1] &quot;c:/web/p1/PracticumOption.html&quot;
## c:/web/p1-clean/PrayerStudies.html  [1] &quot;c:/web/p1/PrayerStudies.html&quot;
## c:/web/p1-clean/predicted.html  [1] &quot;c:/web/p1/predicted.html&quot;
## c:/web/p1-clean/Preface.html  [1] &quot;c:/web/p1/Preface.html&quot;
## c:/web/p1-clean/prerequisites.html  [1] &quot;c:/web/p1/prerequisites.html&quot;
## c:/web/p1-clean/PresentingResearchData.html  [1] &quot;c:/web/p1/PresentingResearchData.html&quot;
## c:/web/p1-clean/prfnee.html  [1] &quot;c:/web/p1/prfnee.html&quot;
## c:/web/p1-clean/PriceKaplanMeier.html  [1] &quot;c:/web/p1/PriceKaplanMeier.html&quot;
## c:/web/p1-clean/PrinterFriendly.html  [1] &quot;c:/web/p1/PrinterFriendly.html&quot;
## c:/web/p1-clean/Prisons.html  [1] &quot;c:/web/p1/Prisons.html&quot;
## c:/web/p1-clean/privacy.html  [1] &quot;c:/web/p1/privacy.html&quot;
## [1] &quot;  Data Encryption Tutorial — Lesson 1&lt;/a&gt;&lt;/strong&gt;. Julie Meloni. Accessed on &quot;
## [1] &quot;  Data Encryption Tutorial - Lesson 1&lt;/a&gt;&lt;/strong&gt;. Julie Meloni. Accessed on &quot;
## c:/web/p1-clean/PrivacyHIPAA.html  [1] &quot;c:/web/p1/PrivacyHIPAA.html&quot;
## [1] &quot;    c) the information is compiled into a “limited data set” and a data use &quot;
## [1] &quot;    c) the information is compiled into a \&quot;limited data set\&quot; and a data use &quot;
## [1] &quot;    d) the activity qualifies as “preparatory to research”&lt;br&gt;&quot;
## [1] &quot;    d) the activity qualifies as \&quot;preparatory to research\&quot;&lt;br&gt;&quot;
## [1] &quot;    * A reference to the covered entity’s right to condition service on the &quot;
## [1] &quot;    * A reference to the covered entity&#39;s right to condition service on the &quot;
## [1] &quot;    * The subject’s right to a signed, dated copy of the authorization&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;    * The subject&#39;s right to a signed, dated copy of the authorization&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/PrivacyInResearch.html  [1] &quot;c:/web/p1/PrivacyInResearch.html&quot;
## [1] &quot;  laboratory equipment have made it possible to ï¿½mineï¿½ very large medical &quot;
## [1] &quot;  laboratory equipment have made it possible to i¿1/2minei¿1/2 very large medical &quot;
## [1] &quot;  ï¿½patientsï¿½).&amp;quot;&lt;/i&gt; [Accessed December 5, 2009]. Available at:&quot;
## [1] &quot;  i¿1/2patientsi¿1/2).&amp;quot;&lt;/i&gt; [Accessed December 5, 2009]. Available at:&quot;
## c:/web/p1-clean/PrivateConflicts.html  [1] &quot;c:/web/p1/PrivateConflicts.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Non-financial competing interests (sometimes called ï¿½private interestsï¿½) &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Non-financial competing interests (sometimes called i¿1/2private interestsi¿1/2) &quot;
## [1] &quot;    treatment efficacy. Clin Psychol Sci Prac 6: 95ï¿½106.&lt;/li&gt;&quot;
## [1] &quot;    treatment efficacy. Clin Psychol Sci Prac 6: 95i¿1/2106.&lt;/li&gt;&quot;
## [1] &quot;  which examines both the strengths and weaknesses of the EPAï¿½s implementation &quot;
## [1] &quot;  which examines both the strengths and weaknesses of the EPAi¿1/2s implementation &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;I also wanted to put on the table another issue, and itï¿½s one that I &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;I also wanted to put on the table another issue, and iti¿1/2s one that I &quot;
## [1] &quot;  thereï¿½s a grant that comes to the institution, not to me personally, to &quot;
## [1] &quot;  therei¿1/2s a grant that comes to the institution, not to me personally, to &quot;
## [1] &quot;  industry, even when you donï¿½t stand to personally profit from it, there is an &quot;
## [1] &quot;  industry, even when you doni¿1/2t stand to personally profit from it, there is an &quot;
## [1] &quot;  intellectual conflict of interest. Youï¿½re invested in it, itï¿½s your trial, you &quot;
## [1] &quot;  intellectual conflict of interest. Youi¿1/2re invested in it, iti¿1/2s your trial, you &quot;
## [1] &quot;  our persona out of the results of the trial, and itï¿½s really important to take &quot;
## [1] &quot;  our persona out of the results of the trial, and iti¿1/2s really important to take &quot;
## [1] &quot;  a step back and say ï¿½Iï¿½m going to be proud of this trial, and Iï¿½m going to be &quot;
## [1] &quot;  a step back and say i¿1/2Ii¿1/2m going to be proud of this trial, and Ii¿1/2m going to be &quot;
## [1] &quot;  proud to report this trial whether itï¿½s positive, negative, or neutral.ï¿½&lt;/i&gt;&quot;
## [1] &quot;  proud to report this trial whether iti¿1/2s positive, negative, or neutral.i¿1/2&lt;/i&gt;&quot;
## [1] &quot;  Financial conflicts can occur at variable levels ï¿½ some people have them, some &quot;
## [1] &quot;  Financial conflicts can occur at variable levels i¿1/2 some people have them, some &quot;
## [1] &quot;  people donï¿½t ï¿½ and they can be quantified, whereas intellectual conflicts are &quot;
## [1] &quot;  people doni¿1/2t i¿1/2 and they can be quantified, whereas intellectual conflicts are &quot;
## [1] &quot;  straight-forward methods to alleviate financial conflicts, whereas itï¿½s not &quot;
## [1] &quot;  straight-forward methods to alleviate financial conflicts, whereas iti¿1/2s not &quot;
## [1] &quot;    RP, Durbin CG Jr. Crit Care Med 2007; 35:2878ï¿½2880.&lt;/li&gt;&quot;
## [1] &quot;    RP, Durbin CG Jr. Crit Care Med 2007; 35:2878i¿1/22880.&lt;/li&gt;&quot;
## c:/web/p1-clean/ProbabilityConcepts.html  [1] &quot;c:/web/p1/ProbabilityConcepts.html&quot;
## [1] &quot;    &lt;li&gt;Posnanski J. A Drunkardï¿½s Walk Through Baseball Stats. Available at:&quot;
## [1] &quot;    &lt;li&gt;Posnanski J. A Drunkardi¿1/2s Walk Through Baseball Stats. Available at:&quot;
## c:/web/p1-clean/ProfessionalDetails.html  [1] &quot;c:/web/p1/ProfessionalDetails.html&quot;
## [1] &quot;      of us attempting to learn biostatistics. Iï¿½ve been struggling with a &quot;
## [1] &quot;      of us attempting to learn biostatistics. Ii¿1/2ve been struggling with a &quot;
## [1] &quot;      Iï¿½m not sure if you are currently accepting questions of this nature, and &quot;
## [1] &quot;      Ii¿1/2m not sure if you are currently accepting questions of this nature, and &quot;
## c:/web/p1-clean/ProfileAnalysis.html  [1] &quot;c:/web/p1/ProfileAnalysis.html&quot;
## c:/web/p1-clean/program.html  [1] &quot;c:/web/p1/program.html&quot;
## c:/web/p1-clean/ProgramOverview.html  [1] &quot;c:/web/p1/ProgramOverview.html&quot;
## c:/web/p1-clean/PromoteBook.html  [1] &quot;c:/web/p1/PromoteBook.html&quot;
## c:/web/p1-clean/promoting.html  [1] &quot;c:/web/p1/promoting.html&quot;
## c:/web/p1-clean/PromotingYourBook.html  [1] &quot;c:/web/p1/PromotingYourBook.html&quot;
## c:/web/p1-clean/Promotion.html  [1] &quot;c:/web/p1/Promotion.html&quot;
## c:/web/p1-clean/PropensityScores.html  [1] &quot;c:/web/p1/PropensityScores.html&quot;
## c:/web/p1-clean/PropensityScores1.html  [1] &quot;c:/web/p1/PropensityScores1.html&quot;
## c:/web/p1-clean/PropensityScores2.html  [1] &quot;c:/web/p1/PropensityScores2.html&quot;
## c:/web/p1-clean/ProperTreatment.html  [1] &quot;c:/web/p1/ProperTreatment.html&quot;
## c:/web/p1-clean/ProportionalVennDiagrams.html  [1] &quot;c:/web/p1/ProportionalVennDiagrams.html&quot;
## c:/web/p1-clean/ProposedPoster.html  [1] &quot;c:/web/p1/ProposedPoster.html&quot;
## c:/web/p1-clean/protocol.html  [1] &quot;c:/web/p1/protocol.html&quot;
## c:/web/p1-clean/ProvisionalMeans.html  [1] &quot;c:/web/p1/ProvisionalMeans.html&quot;
## c:/web/p1-clean/psa.html  [1] &quot;c:/web/p1/psa.html&quot;
## [1] &quot;    destined to cause death? One of the possibilities—and we don’t know for sure—is that &quot;
## [1] &quot;    destined to cause death? One of the possibilities-and we don&#39;t know for sure-is that &quot;
## [1] &quot;    rates [have fallen only marginally]. So screening by itself probably can’t prevent all &quot;
## [1] &quot;    rates [have fallen only marginally]. So screening by itself probably can&#39;t prevent all &quot;
## [1] &quot;    that a man should look at our data and say, “I should look at my risk based on my PSA &quot;
## [1] &quot;    that a man should look at our data and say, \&quot;I should look at my risk based on my PSA &quot;
## [1] &quot;    whether I have prostate cancer before my PSA [level] gets to 4.0.”&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;    whether I have prostate cancer before my PSA [level] gets to 4.0.\&quot;&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/PublicAccess.html  [1] &quot;c:/web/p1/PublicAccess.html&quot;
## c:/web/p1-clean/PublicationBias-04.html  [1] &quot;c:/web/p1/PublicationBias-04.html&quot;
## c:/web/p1-clean/PublicationBias-category.html  [1] &quot;c:/web/p1/PublicationBias-category.html&quot;
## [1] &quot;  &lt;li&gt;M Egger, T Zellweger-Zï¿½hner, M Schneider, et al. &lt;b&gt;Language bias in &quot;
## [1] &quot;  &lt;li&gt;M Egger, T Zellweger-Zi¿1/2hner, M Schneider, et al. &lt;b&gt;Language bias in &quot;
## [1] &quot;  &lt;li&gt;P C Gï¿½tzsche. &lt;b&gt;Multiple publication of reports of drug trials&lt;/b&gt;. Eur. &quot;
## [1] &quot;  &lt;li&gt;P C Gi¿1/2tzsche. &lt;b&gt;Multiple publication of reports of drug trials&lt;/b&gt;. Eur. &quot;
## [1] &quot;&lt;li&gt;Antje Timmer, Robert J. Hilsden, John Cole, David Hailey, Lloyd R. Sutherland. &lt;b&gt;Publication bias in gastroenterological research ï¿½ a retrospective cohort study based on abstracts submitted to a scientific meeting&lt;/b&gt; BMC Medical Research Methodology. 2002;2(1):7. &lt;i&gt;The aim of this study was to examine the determinants of publication and whether publication bias occurred in gastroenterological research.&lt;/i&gt; [Accessed on January 28, 2013]. http://www.biomedcentral.com/1471-2288/2/7&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Antje Timmer, Robert J. Hilsden, John Cole, David Hailey, Lloyd R. Sutherland. &lt;b&gt;Publication bias in gastroenterological research i¿1/2 a retrospective cohort study based on abstracts submitted to a scientific meeting&lt;/b&gt; BMC Medical Research Methodology. 2002;2(1):7. &lt;i&gt;The aim of this study was to examine the determinants of publication and whether publication bias occurred in gastroenterological research.&lt;/i&gt; [Accessed on January 28, 2013]. http://www.biomedcentral.com/1471-2288/2/7&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Mildred K. Cho, Lisa A. Bero. &lt;b&gt;The Quality of Drug Studies Published in Symposium Proceedings&lt;/b&gt; Ann Intern Med. 1996;124(5):485ï¿½489. &lt;i&gt;Objective: To compare the quality, relevance, and structure of drug studies published in symposium proceedings that are sponsored by drug companies with 1) articles from symposia with other sponsors and 2) articles in the peer-reviewed parent journals of symposium proceedings; and to study the relation between drug company sponsorship and study outcome.Design: Cross-sectional studies of clinical drug studies published in symposium proceedings or their parent medical journals.Measurements: The proportion of articles with no methods sections (which are necessary to assess quality); methodologic quality and clinical relevance scores; and the proportion of articles with outcomes favoring the drug of interest.Results: Symposia sponsored by single drug companies had more articles without methods sections (10%; 108 of 1064) than did symposia that had other sponsors (3%; 58 of 2314) or symposia that had no mentioned sponsor (2%; 29 of 1663) (P &lt; 0.001). The mean methodologic quality and relevance scores of articles were similar both by type of sponsorship and between articles published in symposia sponsored by single drug companies and articles from the parent journals. Significantly more articles with drug company support (98%; 39 of 40) than without drug company support (79%; 89 of 112) had outcomes favoring the drug of interest (P = 0.01).Conclusions: Articles in symposia sponsored by single drug companies were similar in quality and clinical relevance to articles with other sponsors and to articles published in the parent journals. Articles with drug company support are more likely than articles without drug company support to have outcomes favoring the drug of interest.&lt;/i&gt; [Accessed on January 28, 2013]. http://www.ncbi.nlm.nih.gov/pubmed/8602706&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Mildred K. Cho, Lisa A. Bero. &lt;b&gt;The Quality of Drug Studies Published in Symposium Proceedings&lt;/b&gt; Ann Intern Med. 1996;124(5):485i¿1/2489. &lt;i&gt;Objective: To compare the quality, relevance, and structure of drug studies published in symposium proceedings that are sponsored by drug companies with 1) articles from symposia with other sponsors and 2) articles in the peer-reviewed parent journals of symposium proceedings; and to study the relation between drug company sponsorship and study outcome.Design: Cross-sectional studies of clinical drug studies published in symposium proceedings or their parent medical journals.Measurements: The proportion of articles with no methods sections (which are necessary to assess quality); methodologic quality and clinical relevance scores; and the proportion of articles with outcomes favoring the drug of interest.Results: Symposia sponsored by single drug companies had more articles without methods sections (10%; 108 of 1064) than did symposia that had other sponsors (3%; 58 of 2314) or symposia that had no mentioned sponsor (2%; 29 of 1663) (P &lt; 0.001). The mean methodologic quality and relevance scores of articles were similar both by type of sponsorship and between articles published in symposia sponsored by single drug companies and articles from the parent journals. Significantly more articles with drug company support (98%; 39 of 40) than without drug company support (79%; 89 of 112) had outcomes favoring the drug of interest (P = 0.01).Conclusions: Articles in symposia sponsored by single drug companies were similar in quality and clinical relevance to articles with other sponsors and to articles published in the parent journals. Articles with drug company support are more likely than articles without drug company support to have outcomes favoring the drug of interest.&lt;/i&gt; [Accessed on January 28, 2013]. http://www.ncbi.nlm.nih.gov/pubmed/8602706&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;A. Richard Palmer. &lt;b&gt;QUASI-REPLICATION AND THE CONTRACT OF ERROR: Lessons from Sex Ratios, Heritabilities and Fluctuating Asymmetry&lt;/b&gt; Annual Review of Ecology and Systematics. 2000;31(1):441ï¿½480. &lt;i&gt;Selective reportingï¿½e.g., the preferential publication of results that are statistically significant, or consistent with theory or expectationï¿½presents a challenge to meta-analysis and seriously undermines the quest for generalizations. Funnel graphs (scatterplots of effect size vs. sample size) help reveal the extent of selective reporting. They also allow the strength of biological effects to be judged easily, and they reaffirm the value of graphical presentations of data over statistical summaries. Funnel graphs of published results, including: (a) sex-ratio variation in birds, (b) field estimates of heritabilities, and (c) relations between fluctuating asymmetry and individual attractiveness or fitness, suggest selective reporting is widespread and raise doubts about the true magnitude of these phenomena. Quasireplicationï¿½the \&quot;replication\&quot; of previous studies using different species or systemsï¿½has almost completely supplanted replicative research in ecology and evolution. Without incentives for formal replicative studies, which could come from changes to editorial policies, graduate training programs, and research funding priorities, the contract of error will continue to thwart attempts at robust generalizations. \&quot;For as knowledges are now delivered, there is a kind of contract of error between the deliverer and the receiver: for he that delivereth knowledge desireth to deliver it in such a form as may be best believed, and not as may be best examined; and he that receiveth knowledge desireth rather present satisfaction than expectant inquiry; and so rather not to doubt than not to err: glory making the author not to lay open his weakness, and sloth making the disciple not to know his strength.\&quot; The Advancement of Learning, Francis Bacon, 1605 (8:170ï¿½171)&lt;/i&gt; [Accessed on January 28, 2013]. http://www.annualreviews.org/doi/abs/10.1146/annurev.ecolsys.31.1.441&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;A. Richard Palmer. &lt;b&gt;QUASI-REPLICATION AND THE CONTRACT OF ERROR: Lessons from Sex Ratios, Heritabilities and Fluctuating Asymmetry&lt;/b&gt; Annual Review of Ecology and Systematics. 2000;31(1):441i¿1/2480. &lt;i&gt;Selective reportingi¿1/2e.g., the preferential publication of results that are statistically significant, or consistent with theory or expectationi¿1/2presents a challenge to meta-analysis and seriously undermines the quest for generalizations. Funnel graphs (scatterplots of effect size vs. sample size) help reveal the extent of selective reporting. They also allow the strength of biological effects to be judged easily, and they reaffirm the value of graphical presentations of data over statistical summaries. Funnel graphs of published results, including: (a) sex-ratio variation in birds, (b) field estimates of heritabilities, and (c) relations between fluctuating asymmetry and individual attractiveness or fitness, suggest selective reporting is widespread and raise doubts about the true magnitude of these phenomena. Quasireplicationi¿1/2the \&quot;replication\&quot; of previous studies using different species or systemsi¿1/2has almost completely supplanted replicative research in ecology and evolution. Without incentives for formal replicative studies, which could come from changes to editorial policies, graduate training programs, and research funding priorities, the contract of error will continue to thwart attempts at robust generalizations. \&quot;For as knowledges are now delivered, there is a kind of contract of error between the deliverer and the receiver: for he that delivereth knowledge desireth to deliver it in such a form as may be best believed, and not as may be best examined; and he that receiveth knowledge desireth rather present satisfaction than expectant inquiry; and so rather not to doubt than not to err: glory making the author not to lay open his weakness, and sloth making the disciple not to know his strength.\&quot; The Advancement of Learning, Francis Bacon, 1605 (8:170i¿1/2171)&lt;/i&gt; [Accessed on January 28, 2013]. http://www.annualreviews.org/doi/abs/10.1146/annurev.ecolsys.31.1.441&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Laurence Hirsch. &lt;b&gt;Randomized clinical trials: What gets published, and when?&lt;/b&gt; CMAJ. 2004;170(4):481ï¿½483. [Accessed on January 28, 2013]. &lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Laurence Hirsch. &lt;b&gt;Randomized clinical trials: What gets published, and when?&lt;/b&gt; CMAJ. 2004;170(4):481i¿1/2483. [Accessed on January 28, 2013]. &lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Journal article: S. Garattini. &lt;b&gt;The risk of bias from omitted research&lt;/b&gt; BMJ. 2000;321(7265):845ï¿½846. [Accessed on January 28, 2013]. http://www.bmj.com/content/321/7265/845.full&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Journal article: S. Garattini. &lt;b&gt;The risk of bias from omitted research&lt;/b&gt; BMJ. 2000;321(7265):845i¿1/2846. [Accessed on January 28, 2013]. http://www.bmj.com/content/321/7265/845.full&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Deborah E. Barnes, Lisa A. Bero. &lt;b&gt;Scientific quality of original research articles on environmental tobacco smoke&lt;/b&gt; Tob Control. 1997;6(1):19ï¿½26. &lt;i&gt;Objective To evaluate the scientific quality of original research articles on the health effects of environmental tobacco smoke; to determine whether poor article quality is associated with publication in non-peer-reviewed symposium proceedings or with other article characteristics.&quot;
## [1] &quot;&lt;li&gt;Deborah E. Barnes, Lisa A. Bero. &lt;b&gt;Scientific quality of original research articles on environmental tobacco smoke&lt;/b&gt; Tob Control. 1997;6(1):19i¿1/226. &lt;i&gt;Objective To evaluate the scientific quality of original research articles on the health effects of environmental tobacco smoke; to determine whether poor article quality is associated with publication in non-peer-reviewed symposium proceedings or with other article characteristics.&quot;
## [1] &quot;&lt;li&gt;M. L Callaham, E. Weber, G. Young, R. Wears, C. Barton. &lt;b&gt;Time to publication of studies was not affected by whether results were positive&lt;/b&gt; BMJ. 1998;316(7143):1536ï¿½1536. [Accessed on January 28, 2013]. &lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;M. L Callaham, E. Weber, G. Young, R. Wears, C. Barton. &lt;b&gt;Time to publication of studies was not affected by whether results were positive&lt;/b&gt; BMJ. 1998;316(7143):1536i¿1/21536. [Accessed on January 28, 2013]. &lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Deborah A. Zarin, Tony Tse, Nicholas C. Ide. &lt;b&gt;Trial Registration at ClinicalTrials.gov between May and October 2005&lt;/b&gt; New England Journal of Medicine. 2005;353(26):2779ï¿½2787. &lt;i&gt;Concern about previously undisclosed safety problems with drugs such as paroxetine (Paxil, GlaxoSmithKline) and rofecoxib (Vioxx, Merck) has increased the public&#39;s desire for more complete information about clinical research studies.1,2 The provision of basic information about clinical trial protocols in a publicly accessible registry and the public identification of all trials, whether or not their results are subsequently published, have been advocated as ways to address this issue.3ï¿½6 Numerous groups have called for comprehensive registration by issuing statements or convening meetings to discuss policy and implementation details.7ï¿½15 In the United States, the Food and Drug Administration (FDA) . . .&lt;/i&gt; [Accessed on January 28, 2013]. http://www.nejm.org/doi/full/10.1056/NEJMsa053234&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Deborah A. Zarin, Tony Tse, Nicholas C. Ide. &lt;b&gt;Trial Registration at ClinicalTrials.gov between May and October 2005&lt;/b&gt; New England Journal of Medicine. 2005;353(26):2779i¿1/22787. &lt;i&gt;Concern about previously undisclosed safety problems with drugs such as paroxetine (Paxil, GlaxoSmithKline) and rofecoxib (Vioxx, Merck) has increased the public&#39;s desire for more complete information about clinical research studies.1,2 The provision of basic information about clinical trial protocols in a publicly accessible registry and the public identification of all trials, whether or not their results are subsequently published, have been advocated as ways to address this issue.3i¿1/26 Numerous groups have called for comprehensive registration by issuing statements or convening meetings to discuss policy and implementation details.7i¿1/215 In the United States, the Food and Drug Administration (FDA) . . .&lt;/i&gt; [Accessed on January 28, 2013]. http://www.nejm.org/doi/full/10.1056/NEJMsa053234&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;I Chalmers. &lt;b&gt;Underreporting research is scientific misconduct&lt;/b&gt; JAMA. 1990;263(10):1405ï¿½1408. &lt;i&gt;Substantial numbers of clinical trials are never reported in print, and among those that are, many are not reported in sufficient detail to enable judgments to be made about the validity of their results. Failure to publish an adequate account of a well-designed clinical trial is a form of scientific misconduct that can lead those caring for patients to make inappropriate treatment decisions. Investigators, research ethics committees, funding bodies, and scientific editors all have responsibilities to reduce underreporting of clinical trials. An extended use of prospective registration of trials at inception, as well as benefiting clinical research in other ways, could help people to play their respective roles in reducing underreporting of clinical trials.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;I Chalmers. &lt;b&gt;Underreporting research is scientific misconduct&lt;/b&gt; JAMA. 1990;263(10):1405i¿1/21408. &lt;i&gt;Substantial numbers of clinical trials are never reported in print, and among those that are, many are not reported in sufficient detail to enable judgments to be made about the validity of their results. Failure to publish an adequate account of a well-designed clinical trial is a form of scientific misconduct that can lead those caring for patients to make inappropriate treatment decisions. Investigators, research ethics committees, funding bodies, and scientific editors all have responsibilities to reduce underreporting of clinical trials. An extended use of prospective registration of trials at inception, as well as benefiting clinical research in other ways, could help people to play their respective roles in reducing underreporting of clinical trials.&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Gerd Antes, Iain Chalmers. &lt;b&gt;Under-reporting of clinical trials is unethical&lt;/b&gt; Lancet. 2003;361(9362):978ï¿½979. http://www.ncbi.nlm.nih.gov/pubmed/12660049&lt;/li&gt;&quot;
## [1] &quot;&lt;li&gt;Gerd Antes, Iain Chalmers. &lt;b&gt;Under-reporting of clinical trials is unethical&lt;/b&gt; Lancet. 2003;361(9362):978i¿1/2979. http://www.ncbi.nlm.nih.gov/pubmed/12660049&lt;/li&gt;&quot;
## c:/web/p1-clean/PublicationBias1.html  [1] &quot;c:/web/p1/PublicationBias1.html&quot;
## c:/web/p1-clean/PublicationBias2.html  [1] &quot;c:/web/p1/PublicationBias2.html&quot;
## c:/web/p1-clean/PublicationQuality.html  [1] &quot;c:/web/p1/PublicationQuality.html&quot;
## c:/web/p1-clean/Publicity.html  [1] &quot;c:/web/p1/Publicity.html&quot;
## c:/web/p1-clean/Publicon.html  [1] &quot;c:/web/p1/Publicon.html&quot;
## c:/web/p1-clean/PubMedTags.html  [1] &quot;c:/web/p1/PubMedTags.html&quot;
## c:/web/p1-clean/pumpkin.html  [1] &quot;c:/web/p1/pumpkin.html&quot;
## c:/web/p1-clean/puzzle.html  [1] &quot;c:/web/p1/puzzle.html&quot;
## c:/web/p1-clean/Puzzler.html  [1] &quot;c:/web/p1/Puzzler.html&quot;
## [1] &quot;&amp;quot;&lt;i&gt;This was sent in by Norm Loveless. Imagine youï¿½re at home in a city &quot;
## [1] &quot;&amp;quot;&lt;i&gt;This was sent in by Norm Loveless. Imagine youi¿1/2re at home in a city &quot;
## [1] &quot;and soon are stupefied to find a sign saying, ï¿½Welcome to State Xï¿½! There is &quot;
## [1] &quot;and soon are stupefied to find a sign saying, i¿1/2Welcome to State Xi¿1/2! There is &quot;
## [1] &quot;travel due west and soon are stupefied to find a sign saying, ï¿½Welcome to State &quot;
## [1] &quot;travel due west and soon are stupefied to find a sign saying, i¿1/2Welcome to State &quot;
## [1] &quot;Xï¿½! &lt;/i&gt;&amp;quot; Since you are traveling west across water and not land to reach &quot;
## [1] &quot;Xi¿1/2! &lt;/i&gt;&amp;quot; Since you are traveling west across water and not land to reach &quot;
## c:/web/p1-clean/PvalueEqualsOne.html  [1] &quot;c:/web/p1/PvalueEqualsOne.html&quot;
## c:/web/p1-clean/PvalueQuiz.html  [1] &quot;c:/web/p1/PvalueQuiz.html&quot;
## c:/web/p1-clean/Pvalues.html  [1] &quot;c:/web/p1/Pvalues.html&quot;
## [1] &quot;      12.2, 95% confidence interval [CI] = 1.5ï¿½101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;      12.2, 95% confidence interval [CI] = 1.5i¿1/2101; P &amp;lt; 0.05), but there was no &quot;
## [1] &quot;      0.8ï¿½5.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;      0.8i¿1/25.4; P &amp;lt; 0.15). Total hospital costs (estimated from direct and indirect &quot;
## [1] &quot;      US$22,573ï¿½45,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## [1] &quot;      US$22,573i¿1/245,280; P &amp;lt; 0.01). Conclusion: Extubation failure in a community &quot;
## c:/web/p1-clean/qqplot.html  [1] &quot;c:/web/p1/qqplot.html&quot;
## c:/web/p1-clean/QuadraticRegression.html  [1] &quot;c:/web/p1/QuadraticRegression.html&quot;
## c:/web/p1-clean/qualified.html  [1] &quot;c:/web/p1/qualified.html&quot;
## c:/web/p1-clean/qualitative.html  [1] &quot;c:/web/p1/qualitative.html&quot;
## c:/web/p1-clean/QualitativeData.html  [1] &quot;c:/web/p1/QualitativeData.html&quot;
## [1] &quot;&lt;p&gt;Dave &lt;a name=\&quot;Holmes\&quot;&gt;&lt;/a&gt;Holmes, AmÃ©lie Perron, Gabrielle Michaud. &lt;b&gt;Nursing in corrections: &quot;
## [1] &quot;&lt;p&gt;Dave &lt;a name=\&quot;Holmes\&quot;&gt;&lt;/a&gt;Holmes, AmÃ(c)lie Perron, Gabrielle Michaud. &lt;b&gt;Nursing in corrections: &quot;
## c:/web/p1-clean/QualitativeReview.html  [1] &quot;c:/web/p1/QualitativeReview.html&quot;
## c:/web/p1-clean/QualitativeSampleSize.html  [1] &quot;c:/web/p1/QualitativeSampleSize.html&quot;
## c:/web/p1-clean/quality-04.html  [1] &quot;c:/web/p1/quality-04.html&quot;
## c:/web/p1-clean/quality-99.html  [1] &quot;c:/web/p1/quality-99.html&quot;
## c:/web/p1-clean/QualityControl.html  [1] &quot;c:/web/p1/QualityControl.html&quot;
## [1] &quot;      times players ï¿½check inï¿½ at every locale, automatically building a detailed &quot;
## [1] &quot;      times players i¿1/2check ini¿1/2 at every locale, automatically building a detailed &quot;
## [1] &quot;      Nintendoï¿½s Wii Fit, a device that allows players to stand on a platform, &quot;
## [1] &quot;      Nintendoi¿1/2s Wii Fit, a device that allows players to stand on a platform, &quot;
## [1] &quot;      York Times. 2010. &lt;i&gt;Excerpt: &amp;quot;The program, called ï¿½continuous performance &quot;
## [1] &quot;      York Times. 2010. &lt;i&gt;Excerpt: &amp;quot;The program, called i¿1/2continuous performance &quot;
## [1] &quot;        improvement,ï¿½ or C.P.I., examines every aspect of patientsï¿½ stays at the &quot;
## [1] &quot;        improvement,i¿1/2 or C.P.I., examines every aspect of patientsi¿1/2 stays at the &quot;
## [1] &quot;        Childrenï¿½s costs per patient by 3.7 percent, for a total savings of $23 &quot;
## [1] &quot;        Childreni¿1/2s costs per patient by 3.7 percent, for a total savings of $23 &quot;
## c:/web/p1-clean/QualityControlExercises.html  [1] &quot;c:/web/p1/QualityControlExercises.html&quot;
## c:/web/p1-clean/QualityControlExercsiesPart2.html  [1] &quot;c:/web/p1/QualityControlExercsiesPart2.html&quot;
## c:/web/p1-clean/QualityControlHumor.html  [1] &quot;c:/web/p1/QualityControlHumor.html&quot;
## c:/web/p1-clean/QuantifyingPredictions.html  [1] &quot;c:/web/p1/QuantifyingPredictions.html&quot;
## c:/web/p1-clean/questionnaire-02.html  [1] &quot;c:/web/p1/questionnaire-02.html&quot;
## c:/web/p1-clean/questionnaire-12.html  [1] &quot;c:/web/p1/questionnaire-12.html&quot;
## c:/web/p1-clean/questions.html  [1] &quot;c:/web/p1/questions.html&quot;
## c:/web/p1-clean/quick.html  [1] &quot;c:/web/p1/quick.html&quot;
## [1] &quot;&lt;title&gt;Updated:Â Quick sample size calculations (created 2001-10-11, revised 2011-04-26)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;Updated:  Quick sample size calculations (created 2001-10-11, revised 2011-04-26)&lt;/title&gt;&quot;
## c:/web/p1-clean/QuietYear.html  [1] &quot;c:/web/p1/QuietYear.html&quot;
## c:/web/p1-clean/quota.html  [1] &quot;c:/web/p1/quota.html&quot;
## c:/web/p1-clean/QuotesFebruary.html  [1] &quot;c:/web/p1/QuotesFebruary.html&quot;
## c:/web/p1-clean/QuotesJanuary.html  [1] &quot;c:/web/p1/QuotesJanuary.html&quot;
## c:/web/p1-clean/QuotesMarch.html  [1] &quot;c:/web/p1/QuotesMarch.html&quot;
## c:/web/p1-clean/QuotientRule.html  [1] &quot;c:/web/p1/QuotientRule.html&quot;
## c:/web/p1-clean/r-syllabus.html  [1] &quot;c:/web/p1/r-syllabus.html&quot;
## [1] &quot;ï»¿&lt;!DOCTYPE html PUBLIC \&quot;-//W3C//DTD XHTML 1.0 Transitional//EN\&quot; \&quot;http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\&quot;&gt;&quot;
## [1] &quot;i»¿&lt;!DOCTYPE html PUBLIC \&quot;-//W3C//DTD XHTML 1.0 Transitional//EN\&quot; \&quot;http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\&quot;&gt;&quot;
## c:/web/p1-clean/r.html  [1] &quot;c:/web/p1/r.html&quot;
## c:/web/p1-clean/RaceEthnicity.html  [1] &quot;c:/web/p1/RaceEthnicity.html&quot;
## c:/web/p1-clean/random.html  [1] &quot;c:/web/p1/random.html&quot;
## c:/web/p1-clean/random42.html  [1] &quot;c:/web/p1/random42.html&quot;
## c:/web/p1-clean/RandomEffects-08.html  [1] &quot;c:/web/p1/RandomEffects-08.html&quot;
## c:/web/p1-clean/RandomEffects-08a.html  [1] &quot;c:/web/p1/RandomEffects-08a.html&quot;
## c:/web/p1-clean/RandomID.html  [1] &quot;c:/web/p1/RandomID.html&quot;
## c:/web/p1-clean/randomization.html  [1] &quot;c:/web/p1/randomization.html&quot;
## c:/web/p1-clean/RandomizationInResearch.html  [1] &quot;c:/web/p1/RandomizationInResearch.html&quot;
## [1] &quot;  &lt;p&gt;Journal article: A G Randolph, D J Cook, C A Gonzales, M Andrew. &lt;b&gt;Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials&lt;/b&gt; BMJ. 1998;316(7136):969â\200“975. &lt;i&gt;Abstract: \&quot;OBJECTIVE: To evaluate the effect of heparin on duration of catheter patency and on prevention of complications associated with use of peripheral venous and arterial catheters. DESIGN: Critical appraisal and meta-analysis of 26 randomised controlled trials that evaluated infusion of heparin intermittently or continuously. Thirteen trials of peripheral venous catheters and two of peripheral arterial catheters met criteria for inclusion. MAIN OUTCOME MEASURES: Data on the populations, interventions, outcomes, and methodological quality. RESULTS: For peripheral venous catheters locked between use flushing with 10 U/ml of heparin instead of normal saline did not reduce the incidence of catheter clotting and phlebitis or improve catheter patency. When heparin was given as a continuous infusion at 1 U/ml the risk of phlebitis decreased (relative risk 0.55; 95% confidence interval 0.39 to 0.77), the duration of patency increased, and infusion failure was reduced (0.88; 0.72 to 1.07). Heparin significantly prolonged duration of patency of radial artery catheters and decreased the risk of clot formation (0.51; 0.42 to 0.61). CONCLUSIONS: Use of intermittent heparin flushes at doses of 10 U/ml in peripheral venous catheters locked between use had no benefit over normal saline flush. Infusion of low dose heparin through a peripheral arterial catheter prolonged the duration of patency but further study is needed to establish its benefit for peripheral venous catheters.\&quot;&lt;/i&gt; [Accessed on March 5, 2012]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/9550955\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/9550955&lt;/a&gt;. Description: &lt;i&gt;This article is a &quot;
## [1] &quot;  &lt;p&gt;Journal article: A G Randolph, D J Cook, C A Gonzales, M Andrew. &lt;b&gt;Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials&lt;/b&gt; BMJ. 1998;316(7136):969â\200\&quot;975. &lt;i&gt;Abstract: \&quot;OBJECTIVE: To evaluate the effect of heparin on duration of catheter patency and on prevention of complications associated with use of peripheral venous and arterial catheters. DESIGN: Critical appraisal and meta-analysis of 26 randomised controlled trials that evaluated infusion of heparin intermittently or continuously. Thirteen trials of peripheral venous catheters and two of peripheral arterial catheters met criteria for inclusion. MAIN OUTCOME MEASURES: Data on the populations, interventions, outcomes, and methodological quality. RESULTS: For peripheral venous catheters locked between use flushing with 10 U/ml of heparin instead of normal saline did not reduce the incidence of catheter clotting and phlebitis or improve catheter patency. When heparin was given as a continuous infusion at 1 U/ml the risk of phlebitis decreased (relative risk 0.55; 95% confidence interval 0.39 to 0.77), the duration of patency increased, and infusion failure was reduced (0.88; 0.72 to 1.07). Heparin significantly prolonged duration of patency of radial artery catheters and decreased the risk of clot formation (0.51; 0.42 to 0.61). CONCLUSIONS: Use of intermittent heparin flushes at doses of 10 U/ml in peripheral venous catheters locked between use had no benefit over normal saline flush. Infusion of low dose heparin through a peripheral arterial catheter prolonged the duration of patency but further study is needed to establish its benefit for peripheral venous catheters.\&quot;&lt;/i&gt; [Accessed on March 5, 2012]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/9550955\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/9550955&lt;/a&gt;. Description: &lt;i&gt;This article is a &quot;
## [1] &quot;&lt;pi&gt;Journal article: Paul &lt;a name=\&quot;Glasziou\&quot;&gt;&lt;/a&gt;Glasziou, Iain Chalmers, Michael Rawlins, Peter McCulloch. &lt;b&gt;When are randomised trials unnecessary? Picking signal from noise&lt;/b&gt; BMJ. 2007;334(7589):349â\200“351. &lt;i&gt;Abstract: \&quot;Although randomised trials are widely accepted as the ideal way of obtaining unbiased estimates of treatment effects, some treatments have dramatic effects that are highly unlikely to reflect inadequately controlled biases. We compiled a list of historical examples of such effects and identified the features of convincing inferences about treatment effects from sources other than randomised trials. A unifying principle is the size of the treatment effect (signal) relative to the expected prognosis (noise) of the condition. A treatment effect is inferred most confidently when the signal to noise ratio is large and its timing is rapid compared with the natural course of the condition. For the examples we considered in detail the rate ratio often exceeds 10 and thus is highly unlikely to reflect bias or factors other than a treatment effect. This model may help to reduce controversy about evidence for treatments whose effects are so dramatic that randomised trials are unnecessary.\&quot;&lt;/i&gt; [Accessed on March 5, 2012]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/17303884\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/17303884&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;pi&gt;Journal article: Paul &lt;a name=\&quot;Glasziou\&quot;&gt;&lt;/a&gt;Glasziou, Iain Chalmers, Michael Rawlins, Peter McCulloch. &lt;b&gt;When are randomised trials unnecessary? Picking signal from noise&lt;/b&gt; BMJ. 2007;334(7589):349â\200\&quot;351. &lt;i&gt;Abstract: \&quot;Although randomised trials are widely accepted as the ideal way of obtaining unbiased estimates of treatment effects, some treatments have dramatic effects that are highly unlikely to reflect inadequately controlled biases. We compiled a list of historical examples of such effects and identified the features of convincing inferences about treatment effects from sources other than randomised trials. A unifying principle is the size of the treatment effect (signal) relative to the expected prognosis (noise) of the condition. A treatment effect is inferred most confidently when the signal to noise ratio is large and its timing is rapid compared with the natural course of the condition. For the examples we considered in detail the rate ratio often exceeds 10 and thus is highly unlikely to reflect bias or factors other than a treatment effect. This model may help to reduce controversy about evidence for treatments whose effects are so dramatic that randomised trials are unnecessary.\&quot;&lt;/i&gt; [Accessed on March 5, 2012]. &lt;a href=\&quot;http://www.ncbi.nlm.nih.gov/pubmed/17303884\&quot;&gt;http://www.ncbi.nlm.nih.gov/pubmed/17303884&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/RandomizedTrials.html  [1] &quot;c:/web/p1/RandomizedTrials.html&quot;
## c:/web/p1-clean/RandomizedTrialsA.html  [1] &quot;c:/web/p1/RandomizedTrialsA.html&quot;
## [1] &quot;    contains two scenarios—VICTOR, a placebo controlled colorectal cancer &quot;
## [1] &quot;    contains two scenarios-VICTOR, a placebo controlled colorectal cancer &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Module 3 includes two scenarios of palliative trials—Myeloma VII, a &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Module 3 includes two scenarios of palliative trials-Myeloma VII, a &quot;
## [1] &quot;    cuttings—in the MRC CLASICC trial, a surgical trial for bowel cancer, and &quot;
## [1] &quot;    cuttings-in the MRC CLASICC trial, a surgical trial for bowel cancer, and &quot;
## c:/web/p1-clean/RandomlyDividingData.html  [1] &quot;c:/web/p1/RandomlyDividingData.html&quot;
## c:/web/p1-clean/RandomMath.html  [1] &quot;c:/web/p1/RandomMath.html&quot;
## c:/web/p1-clean/RandomSelection.html  [1] &quot;c:/web/p1/RandomSelection.html&quot;
## c:/web/p1-clean/RankingOrdinalScales.html  [1] &quot;c:/web/p1/RankingOrdinalScales.html&quot;
## c:/web/p1-clean/Rates.html  [1] &quot;c:/web/p1/Rates.html&quot;
## c:/web/p1-clean/RatioObsIvs.html  [1] &quot;c:/web/p1/RatioObsIvs.html&quot;
## c:/web/p1-clean/ReadingAbstracts.html  [1] &quot;c:/web/p1/ReadingAbstracts.html&quot;
## c:/web/p1-clean/readme.html  [1] &quot;c:/web/p1/readme.html&quot;
## c:/web/p1-clean/ReadyToRace.html  [1] &quot;c:/web/p1/ReadyToRace.html&quot;
## c:/web/p1-clean/RebuttingReviewer.html  [1] &quot;c:/web/p1/RebuttingReviewer.html&quot;
## c:/web/p1-clean/RecallBias.html  [1] &quot;c:/web/p1/RecallBias.html&quot;
## c:/web/p1-clean/RecommendationsSackett.html  [1] &quot;c:/web/p1/RecommendationsSackett.html&quot;
## c:/web/p1-clean/redefined.html  [1] &quot;c:/web/p1/redefined.html&quot;
## c:/web/p1-clean/ReformingCoi.html  [1] &quot;c:/web/p1/ReformingCoi.html&quot;
## c:/web/p1-clean/RefusalReasons.html  [1] &quot;c:/web/p1/RefusalReasons.html&quot;
## c:/web/p1-clean/RefusalsAndExclusions-08.html  [1] &quot;c:/web/p1/RefusalsAndExclusions-08.html&quot;
## c:/web/p1-clean/RefusalsAndExclusions-08a.html  [1] &quot;c:/web/p1/RefusalsAndExclusions-08a.html&quot;
## c:/web/p1-clean/RefusingToAnalyze.html  [1] &quot;c:/web/p1/RefusingToAnalyze.html&quot;
## c:/web/p1-clean/regression.html  [1] &quot;c:/web/p1/regression.html&quot;
## c:/web/p1-clean/RegressionAndAnova.html  [1] &quot;c:/web/p1/RegressionAndAnova.html&quot;
## c:/web/p1-clean/RegularExpressions-05.html  [1] &quot;c:/web/p1/RegularExpressions-05.html&quot;
## c:/web/p1-clean/RegularExpressions-06.html  [1] &quot;c:/web/p1/RegularExpressions-06.html&quot;
## c:/web/p1-clean/RegularExpressionsA.html  [1] &quot;c:/web/p1/RegularExpressionsA.html&quot;
## c:/web/p1-clean/reliability.html  [1] &quot;c:/web/p1/reliability.html&quot;
## [1] &quot;       &lt;p&gt;&lt;strong&gt;&lt;a href=\&quot;http://www.skepdic.com/myersb.html\&quot;&gt;Myers-Briggs Type Indicator®&lt;/a&gt;&lt;/strong&gt;. &quot;
## [1] &quot;       &lt;p&gt;&lt;strong&gt;&lt;a href=\&quot;http://www.skepdic.com/myersb.html\&quot;&gt;Myers-Briggs Type Indicator*&lt;/a&gt;&lt;/strong&gt;. &quot;
## [1] &quot;       &lt;p&gt;&lt;strong&gt;&lt;a href=\&quot;http://www.spss.com/tech/stat/macros/Iccsf.htm\&quot;&gt;Technical Support – &quot;
## [1] &quot;       &lt;p&gt;&lt;strong&gt;&lt;a href=\&quot;http://www.spss.com/tech/stat/macros/Iccsf.htm\&quot;&gt;Technical Support - &quot;
## c:/web/p1-clean/ReliableDiagnosis.html  [1] &quot;c:/web/p1/ReliableDiagnosis.html&quot;
## c:/web/p1-clean/Reminder.html  [1] &quot;c:/web/p1/Reminder.html&quot;
## c:/web/p1-clean/RepeatedMeasurements-08.html  [1] &quot;c:/web/p1/RepeatedMeasurements-08.html&quot;
## c:/web/p1-clean/RepeatedMeasurements-08a.html  [1] &quot;c:/web/p1/RepeatedMeasurements-08a.html&quot;
## c:/web/p1-clean/RepeatedMeasures.html  [1] &quot;c:/web/p1/RepeatedMeasures.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;I’ve been struggling with a design/analysis question related to repeated &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;I&#39;ve been struggling with a design/analysis question related to repeated &quot;
## c:/web/p1-clean/RepeatedMeasuresPart2.html  [1] &quot;c:/web/p1/RepeatedMeasuresPart2.html&quot;
## c:/web/p1-clean/RepeatedMeasuresPower.html  [1] &quot;c:/web/p1/RepeatedMeasuresPower.html&quot;
## c:/web/p1-clean/report.html  [1] &quot;c:/web/p1/report.html&quot;
## c:/web/p1-clean/ReportCards-04.html  [1] &quot;c:/web/p1/ReportCards-04.html&quot;
## c:/web/p1-clean/ReportCards-05.html  [1] &quot;c:/web/p1/ReportCards-05.html&quot;
## c:/web/p1-clean/ReportingFishersExact.html  [1] &quot;c:/web/p1/ReportingFishersExact.html&quot;
## c:/web/p1-clean/ReportingTransformedData.html  [1] &quot;c:/web/p1/ReportingTransformedData.html&quot;
## c:/web/p1-clean/ResamplingMethods.html  [1] &quot;c:/web/p1/ResamplingMethods.html&quot;
## [1] &quot;      hand, it was written to accompany a set of Windowsï¿½ programs that I have &quot;
## [1] &quot;      hand, it was written to accompany a set of Windowsi¿1/2 programs that I have &quot;
## c:/web/p1-clean/research.html  [1] &quot;c:/web/p1/research.html&quot;
## c:/web/p1-clean/ResearchDesigns.html  [1] &quot;c:/web/p1/ResearchDesigns.html&quot;
## c:/web/p1-clean/ResearchIntegrity.html  [1] &quot;c:/web/p1/ResearchIntegrity.html&quot;
## c:/web/p1-clean/ResearchInvolvingChildren.html  [1] &quot;c:/web/p1/ResearchInvolvingChildren.html&quot;
## c:/web/p1-clean/ResidualConfounding.html  [1] &quot;c:/web/p1/ResidualConfounding.html&quot;
## [1] &quot;  can be negativeï¿½resulting in underestimation of the exposure effectï¿½or &quot;
## [1] &quot;  can be negativei¿1/2resulting in underestimation of the exposure effecti¿1/2or &quot;
## c:/web/p1-clean/Resources-08.html  [1] &quot;c:/web/p1/Resources-08.html&quot;
## c:/web/p1-clean/Resources-evidence.html  [1] &quot;c:/web/p1/Resources-evidence.html&quot;
## c:/web/p1-clean/ResourcesForFellows.html  [1] &quot;c:/web/p1/ResourcesForFellows.html&quot;
## c:/web/p1-clean/ResourcesForGrantWriters.html  [1] &quot;c:/web/p1/ResourcesForGrantWriters.html&quot;
## c:/web/p1-clean/resume.html  [1] &quot;c:/web/p1/resume.html&quot;
## c:/web/p1-clean/resume_extras.html  [1] &quot;c:/web/p1/resume_extras.html&quot;
## c:/web/p1-clean/RetractedArticles.html  [1] &quot;c:/web/p1/RetractedArticles.html&quot;
## c:/web/p1-clean/RetroactivePrayer.html  [1] &quot;c:/web/p1/RetroactivePrayer.html&quot;
## c:/web/p1-clean/retrospective.html  [1] &quot;c:/web/p1/retrospective.html&quot;
## c:/web/p1-clean/reviews-08.html  [1] &quot;c:/web/p1/reviews-08.html&quot;
## [1] &quot;  be a lot of idioms that translate poorly (example: &amp;quot;Evidence based Medicine – &quot;
## [1] &quot;  be a lot of idioms that translate poorly (example: &amp;quot;Evidence based Medicine - &quot;
## [1] &quot;  EBM – is for some time in all mouth&amp;quot;). The reviewer seems to like the &quot;
## [1] &quot;  EBM - is for some time in all mouth&amp;quot;). The reviewer seems to like the &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Stephen Simon’s Statistical Evidence in Medical Trials is an enjoyable &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Stephen Simon&#39;s Statistical Evidence in Medical Trials is an enjoyable &quot;
## [1] &quot;     borders on the side of being revolutional—a statistics book without &quot;
## [1] &quot;     borders on the side of being revolutional-a statistics book without &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Despite its title, ‘Statistical Evidence in Medical Trials’ (Stephen D &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Despite its title, &#39;Statistical Evidence in Medical Trials&#39; (Stephen D &quot;
## [1] &quot;     Simon, Oxford Statistics) is not a statistics textbook – instead, it aims &quot;
## [1] &quot;     Simon, Oxford Statistics) is not a statistics textbook - instead, it aims &quot;
## [1] &quot;     to some of the ‘softer’ issues that are often ignored in statistics texts, &quot;
## [1] &quot;     to some of the &#39;softer&#39; issues that are often ignored in statistics texts, &quot;
## [1] &quot;     Non-medics will also benefit from reading the book – although the many &quot;
## [1] &quot;     Non-medics will also benefit from reading the book - although the many &quot;
## c:/web/p1-clean/reviews-evidence.html  [1] &quot;c:/web/p1/reviews-evidence.html&quot;
## [1] &quot;  be a lot of idioms that translate poorly (example: &amp;quot;Evidence based Medicine – &quot;
## [1] &quot;  be a lot of idioms that translate poorly (example: &amp;quot;Evidence based Medicine - &quot;
## [1] &quot;  EBM – is for some time in all mouth&amp;quot;). The reviewer seems to like the &quot;
## [1] &quot;  EBM - is for some time in all mouth&amp;quot;). The reviewer seems to like the &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Stephen Simon’s Statistical Evidence in Medical Trials is an enjoyable &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Stephen Simon&#39;s Statistical Evidence in Medical Trials is an enjoyable &quot;
## [1] &quot;     borders on the side of being revolutional—a statistics book without &quot;
## [1] &quot;     borders on the side of being revolutional-a statistics book without &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Despite its title, ‘Statistical Evidence in Medical Trials’ (Stephen D &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Despite its title, &#39;Statistical Evidence in Medical Trials&#39; (Stephen D &quot;
## [1] &quot;     Simon, Oxford Statistics) is not a statistics textbook – instead, it aims &quot;
## [1] &quot;     Simon, Oxford Statistics) is not a statistics textbook - instead, it aims &quot;
## [1] &quot;     to some of the ‘softer’ issues that are often ignored in statistics texts, &quot;
## [1] &quot;     to some of the &#39;softer&#39; issues that are often ignored in statistics texts, &quot;
## [1] &quot;     Non-medics will also benefit from reading the book – although the many &quot;
## [1] &quot;     Non-medics will also benefit from reading the book - although the many &quot;
## c:/web/p1-clean/ReviewStatisticalMethods.html  [1] &quot;c:/web/p1/ReviewStatisticalMethods.html&quot;
## c:/web/p1-clean/RevisingDefinitions.html  [1] &quot;c:/web/p1/RevisingDefinitions.html&quot;
## c:/web/p1-clean/ReweightingData.html  [1] &quot;c:/web/p1/ReweightingData.html&quot;
## c:/web/p1-clean/RiskFactorsDiagnosticTest.html  [1] &quot;c:/web/p1/RiskFactorsDiagnosticTest.html&quot;
## c:/web/p1-clean/roc.html  [1] &quot;c:/web/p1/roc.html&quot;
## c:/web/p1-clean/RocCurve-08.html  [1] &quot;c:/web/p1/RocCurve-08.html&quot;
## [1] &quot;  &lt;p&gt;There’s a lot of literature about less than perfect gold standards, and you &quot;
## [1] &quot;  &lt;p&gt;There&#39;s a lot of literature about less than perfect gold standards, and you &quot;
## c:/web/p1-clean/RocCurve-08a.html  [1] &quot;c:/web/p1/RocCurve-08a.html&quot;
## [1] &quot;  &lt;p&gt;There’s a lot of literature about less than perfect gold standards, and you &quot;
## [1] &quot;  &lt;p&gt;There&#39;s a lot of literature about less than perfect gold standards, and you &quot;
## c:/web/p1-clean/ROCcurve.html  [1] &quot;c:/web/p1/ROCcurve.html&quot;
## c:/web/p1-clean/RocLayout.html  [1] &quot;c:/web/p1/RocLayout.html&quot;
## c:/web/p1-clean/RotatingLocations.html  [1] &quot;c:/web/p1/RotatingLocations.html&quot;
## c:/web/p1-clean/RoundingNumbers.html  [1] &quot;c:/web/p1/RoundingNumbers.html&quot;
## c:/web/p1-clean/RSoftware.html  [1] &quot;c:/web/p1/RSoftware.html&quot;
## [1] &quot;    &lt;p&gt;Vance A. &lt;b&gt;Data Analysts Captivated by Rï¿½s Power&lt;/b&gt;. The New York &quot;
## [1] &quot;    &lt;p&gt;Vance A. &lt;b&gt;Data Analysts Captivated by Ri¿1/2s Power&lt;/b&gt;. The New York &quot;
## [1] &quot;        letter of the alphabet. To others, itï¿½s the rating on racy movies, a measure &quot;
## [1] &quot;        letter of the alphabet. To others, iti¿1/2s the rating on racy movies, a measure &quot;
## [1] &quot;        of an atticï¿½s insulation or what pirates in movies say. R is also the name &quot;
## [1] &quot;        of an attici¿1/2s insulation or what pirates in movies say. R is also the name &quot;
## [1] &quot;        interface to R called the ï¿½R Commander.ï¿½ The design objectives of the R &quot;
## [1] &quot;        interface to R called the i¿1/2R Commander.i¿1/2 The design objectives of the R &quot;
## [1] &quot;        memory, only one is ï¿½activeï¿½ at any given time. There may also be an active &quot;
## [1] &quot;        memory, only one is i¿1/2activei¿1/2 at any given time. There may also be an active &quot;
## c:/web/p1-clean/rsquared.html  [1] &quot;c:/web/p1/rsquared.html&quot;
## c:/web/p1-clean/RunWithCows.html  [1] &quot;c:/web/p1/RunWithCows.html&quot;
## c:/web/p1-clean/RWebServer-08.html  [1] &quot;c:/web/p1/RWebServer-08.html&quot;
## c:/web/p1-clean/RWebServer-08a.html  [1] &quot;c:/web/p1/RWebServer-08a.html&quot;
## c:/web/p1-clean/RWiki.html  [1] &quot;c:/web/p1/RWiki.html&quot;
## c:/web/p1-clean/Sackettisation.html  [1] &quot;c:/web/p1/Sackettisation.html&quot;
## c:/web/p1-clean/SafetyMiner.html  [1] &quot;c:/web/p1/SafetyMiner.html&quot;
## [1] &quot;  &lt;p&gt;I attended a web seminar by Michael O’Connell, &amp;quot;Applications in Drug Discovery and &quot;
## [1] &quot;  &lt;p&gt;I attended a web seminar by Michael O&#39;Connell, &amp;quot;Applications in Drug Discovery and &quot;
## [1] &quot;       Development. S-PLUS® Clinical Safety Miner.&amp;quot; Michael O’Connell is the Director, Life Science &quot;
## [1] &quot;       Development. S-PLUS* Clinical Safety Miner.&amp;quot; Michael O&#39;Connell is the Director, Life Science &quot;
## c:/web/p1-clean/Salary.html  [1] &quot;c:/web/p1/Salary.html&quot;
## c:/web/p1-clean/samplesize-04.html  [1] &quot;c:/web/p1/samplesize-04.html&quot;
## c:/web/p1-clean/SampleSize-05.html  [1] &quot;c:/web/p1/SampleSize-05.html&quot;
## c:/web/p1-clean/SampleSize-08.html  [1] &quot;c:/web/p1/SampleSize-08.html&quot;
## c:/web/p1-clean/SampleSize-10.html  [1] &quot;c:/web/p1/SampleSize-10.html&quot;
## c:/web/p1-clean/samplesize-13.html  [1] &quot;c:/web/p1/samplesize-13.html&quot;
## c:/web/p1-clean/SampleSizeA.html  [1] &quot;c:/web/p1/SampleSizeA.html&quot;
## c:/web/p1-clean/SampleSizeB.html  [1] &quot;c:/web/p1/SampleSizeB.html&quot;
## c:/web/p1-clean/SampleSizeBinary.html  [1] &quot;c:/web/p1/SampleSizeBinary.html&quot;
## c:/web/p1-clean/SampleSizeDiagnostic.html  [1] &quot;c:/web/p1/SampleSizeDiagnostic.html&quot;
## c:/web/p1-clean/SampleSizeJustification.html  [1] &quot;c:/web/p1/SampleSizeJustification.html&quot;
## [1] &quot;    measures designs (created 2008-09-25)&lt;/a&gt;. &lt;i&gt;Iï¿½ve been struggling with a &quot;
## [1] &quot;    measures designs (created 2008-09-25)&lt;/a&gt;. &lt;i&gt;Ii¿1/2ve been struggling with a &quot;
## [1] &quot;      and participantsï¿½ altruistic satisfaction.&amp;quot;&lt;/i&gt; [Accessed July 7, 2010]. &quot;
## [1] &quot;      and participantsi¿1/2 altruistic satisfaction.&amp;quot;&lt;/i&gt; [Accessed July 7, 2010]. &quot;
## [1] &quot;      large trials (2ï¿½4). Heretofore, the defenders of smaller trials have &quot;
## [1] &quot;      large trials (2i¿1/24). Heretofore, the defenders of smaller trials have &quot;
## [1] &quot;      a testï¿½s sensitivity or specificity. Results: The nomograms could be easily &quot;
## [1] &quot;      a testi¿1/2s sensitivity or specificity. Results: The nomograms could be easily &quot;
## c:/web/p1-clean/SampleSizeLogistic.html  [1] &quot;c:/web/p1/SampleSizeLogistic.html&quot;
## c:/web/p1-clean/SampleSizeMicroarray.html  [1] &quot;c:/web/p1/SampleSizeMicroarray.html&quot;
## c:/web/p1-clean/SampleSizeR.html  [1] &quot;c:/web/p1/SampleSizeR.html&quot;
## c:/web/p1-clean/sas.html  [1] &quot;c:/web/p1/sas.html&quot;
## c:/web/p1-clean/SasOrR.html  [1] &quot;c:/web/p1/SasOrR.html&quot;
## c:/web/p1-clean/sbir.html  [1] &quot;c:/web/p1/sbir.html&quot;
## c:/web/p1-clean/ScholarshipProgram.html  [1] &quot;c:/web/p1/ScholarshipProgram.html&quot;
## [1] &quot;ï»¿&lt;html&gt;&quot;
## [1] &quot;i»¿&lt;html&gt;&quot;
## c:/web/p1-clean/ScienceBasedMedicine.html  [1] &quot;c:/web/p1/ScienceBasedMedicine.html&quot;
## c:/web/p1-clean/ScienceBasedMedicinePt2.html  [1] &quot;c:/web/p1/ScienceBasedMedicinePt2.html&quot;
## [1] &quot;  trials) are the ï¿½gold standardï¿½ for evaluation and that observational methods &quot;
## [1] &quot;  trials) are the i¿1/2gold standardi¿1/2 for evaluation and that observational methods &quot;
## [1] &quot;  patient values&amp;quot; Sackett DL, Straus SE, Richardson WS, et al. Evidenceï¿½based &quot;
## [1] &quot;  patient values&amp;quot; Sackett DL, Straus SE, Richardson WS, et al. Evidencei¿1/2based &quot;
## [1] &quot;  &lt;p&gt;We do not criticize EBM for an ï¿½exclusiveï¿½ reliance on RCTs but rather for &quot;
## [1] &quot;  &lt;p&gt;We do not criticize EBM for an i¿1/2exclusivei¿1/2 reliance on RCTs but rather for &quot;
## [1] &quot;  empirical evidence to adjudicate the controversy. Without such evidence, weï¿½ll &quot;
## [1] &quot;  empirical evidence to adjudicate the controversy. Without such evidence, wei¿1/2ll &quot;
## [1] &quot;  thoughtfully and carefully, and donï¿½t see the need for a new label.&lt;/p&gt;&quot;
## [1] &quot;  thoughtfully and carefully, and doni¿1/2t see the need for a new label.&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Thereï¿½s a group trying to replace the term ï¿½evidence based medicineï¿½ with &quot;
## [1] &quot;  &lt;p&gt;Therei¿1/2s a group trying to replace the term i¿1/2evidence based medicinei¿1/2 with &quot;
## [1] &quot;  ï¿½value based medicineï¿½ and I see the same problems here. In my experience, &quot;
## [1] &quot;  i¿1/2value based medicinei¿1/2 and I see the same problems here. In my experience, &quot;
## [1] &quot;  see lacking overall in the term ï¿½evidence based medicine.ï¿½&lt;/p&gt;&quot;
## [1] &quot;  see lacking overall in the term i¿1/2evidence based medicine.i¿1/2&lt;/p&gt;&quot;
## [1] &quot;  &lt;p&gt;Simon then appeals to there being some sort of ï¿½societal valueï¿½ to test &quot;
## [1] &quot;  &lt;p&gt;Simon then appeals to there being some sort of i¿1/2societal valuei¿1/2 to test &quot;
## [1] &quot;  homeopaths that homeopathy doesnï¿½t work. Witness Dana Ullman if you donï¿½t &quot;
## [1] &quot;  homeopaths that homeopathy doesni¿1/2t work. Witness Dana Ullman if you doni¿1/2t &quot;
## [1] &quot;  so over the next few years. From a societal perspective, itï¿½s very hard to &quot;
## [1] &quot;  so over the next few years. From a societal perspective, iti¿1/2s very hard to &quot;
## [1] &quot;  homeopathy, knowing that those are funds that wonï¿½t be going to treatment &quot;
## [1] &quot;  homeopathy, knowing that those are funds that woni¿1/2t be going to treatment &quot;
## [1] &quot;  &lt;p&gt;But Iï¿½m still confused about the Bayesian argument you are making on this &quot;
## [1] &quot;  &lt;p&gt;But Ii¿1/2m still confused about the Bayesian argument you are making on this &quot;
## [1] &quot;  research that requires going ï¿½against huge swaths of science that has been &quot;
## [1] &quot;  research that requires going i¿1/2against huge swaths of science that has been &quot;
## [1] &quot;  well-characterized for centuries.ï¿½ I can even imagine a Bayesian having ï¿½a bit &quot;
## [1] &quot;  well-characterized for centuries.i¿1/2 I can even imagine a Bayesian having i¿1/2a bit &quot;
## [1] &quot;  of a soft spot for the olï¿½ woo.ï¿½ In each case, the Bayesians would incorporate &quot;
## [1] &quot;  of a soft spot for the oli¿1/2 woo.i¿1/2 In each case, the Bayesians would incorporate &quot;
## [1] &quot;  Iï¿½ll get around to reading the rest. But, please, please, Mr. Simon fix that &quot;
## [1] &quot;  Ii¿1/2ll get around to reading the rest. But, please, please, Mr. Simon fix that &quot;
## c:/web/p1-clean/ScienceMentoring.html  [1] &quot;c:/web/p1/ScienceMentoring.html&quot;
## c:/web/p1-clean/ScientificBasis.html  [1] &quot;c:/web/p1/ScientificBasis.html&quot;
## [1] &quot;  accept to prevent eight strokes—four minor and four major—in 100 patients. The &quot;
## [1] &quot;  accept to prevent eight strokes-four minor and four major-in 100 patients. The &quot;
## c:/web/p1-clean/ScientificMisconduct.html  [1] &quot;c:/web/p1/ScientificMisconduct.html&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;In May 2004 an anonymous whistleblower charged Dr LeFever with “scientific &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;In May 2004 an anonymous whistleblower charged Dr LeFever with \&quot;scientific &quot;
## [1] &quot;      misconduct.” The whistleblower pointed out a discrepancy between Dr LeFever’s published &quot;
## [1] &quot;      misconduct.\&quot; The whistleblower pointed out a discrepancy between Dr LeFever&#39;s published &quot;
## [1] &quot;      study. In the original survey parents were asked: “&lt;/i&gt;Does your child have attention or &quot;
## [1] &quot;      study. In the original survey parents were asked: \&quot;&lt;/i&gt;Does your child have attention or &quot;
## [1] &quot;      hyperactivity problems, known as ADD or ADHD?&lt;i&gt;” The published version of the question &quot;
## [1] &quot;      hyperactivity problems, known as ADD or ADHD?&lt;i&gt;\&quot; The published version of the question &quot;
## [1] &quot;        was “&lt;/i&gt;Has your child been diagnosed with attention or hyperactivity problems known as &quot;
## [1] &quot;        was \&quot;&lt;/i&gt;Has your child been diagnosed with attention or hyperactivity problems known as &quot;
## [1] &quot;      ADD or ADHD?&lt;i&gt;”&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;      ADD or ADHD?&lt;i&gt;\&quot;&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;      condition had been diagnosed in 17% of children in grades 2 to 5. He said, “&lt;/i&gt;When &quot;
## [1] &quot;      condition had been diagnosed in 17% of children in grades 2 to 5. He said, \&quot;&lt;/i&gt;When &quot;
## [1] &quot;      research, it minimises a very real problem. Parents won’t bring their children in for &quot;
## [1] &quot;      research, it minimises a very real problem. Parents won&#39;t bring their children in for &quot;
## [1] &quot;      They think it’s a bad thing and the sole treatment. But medication can have significant &quot;
## [1] &quot;      They think it&#39;s a bad thing and the sole treatment. But medication can have significant &quot;
## [1] &quot;      benefits.&lt;i&gt;”&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;      benefits.&lt;i&gt;\&quot;&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;      representation – a right that has benefited the entire scientific community.&lt;/i&gt;&quot;
## [1] &quot;      representation - a right that has benefited the entire scientific community.&lt;/i&gt;&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Not everyone was impressed with Needleman’s work, though. Critics uncovered many &quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Not everyone was impressed with Needleman&#39;s work, though. Critics uncovered many &quot;
## [1] &quot;      problems. Needleman didn’t control for the confounding factor of child’s age. Factoring &quot;
## [1] &quot;      problems. Needleman didn&#39;t control for the confounding factor of child&#39;s age. Factoring &quot;
## [1] &quot;      who were “lead poisoned” but without impaired intelligence. Needleman omitted other &quot;
## [1] &quot;      who were \&quot;lead poisoned\&quot; but without impaired intelligence. Needleman omitted other &quot;
## [1] &quot;      results that didn’t support his conclusion. Needleman was subsequently accused of &quot;
## [1] &quot;      results that didn&#39;t support his conclusion. Needleman was subsequently accused of &quot;
## [1] &quot;      he wasn’t vindicated either.&lt;/i&gt;&quot;
## [1] &quot;      he wasn&#39;t vindicated either.&lt;/i&gt;&quot;
## [1] &quot;      the drug company with “repeated and persistent fraud” in concealing the results of &quot;
## [1] &quot;      the drug company with \&quot;repeated and persistent fraud\&quot; in concealing the results of &quot;
## c:/web/p1-clean/ScientificPapersServe.html  [1] &quot;c:/web/p1/ScientificPapersServe.html&quot;
## c:/web/p1-clean/ScientificValidity.html  [1] &quot;c:/web/p1/ScientificValidity.html&quot;
## c:/web/p1-clean/scientist.html  [1] &quot;c:/web/p1/scientist.html&quot;
## c:/web/p1-clean/sculptor.html  [1] &quot;c:/web/p1/sculptor.html&quot;
## c:/web/p1-clean/scurve-04.html  [1] &quot;c:/web/p1/scurve-04.html&quot;
## c:/web/p1-clean/scurve-99.html  [1] &quot;c:/web/p1/scurve-99.html&quot;
## c:/web/p1-clean/SdTooBig.html  [1] &quot;c:/web/p1/SdTooBig.html&quot;
## c:/web/p1-clean/SearchingEvidence.html  [1] &quot;c:/web/p1/SearchingEvidence.html&quot;
## c:/web/p1-clean/SearchingPediatricArticles.html  [1] &quot;c:/web/p1/SearchingPediatricArticles.html&quot;
## c:/web/p1-clean/SearchInternet.html  [1] &quot;c:/web/p1/SearchInternet.html&quot;
## c:/web/p1-clean/SearchLiterature.html  [1] &quot;c:/web/p1/SearchLiterature.html&quot;
## c:/web/p1-clean/SearchLiteratureA.html  [1] &quot;c:/web/p1/SearchLiteratureA.html&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;The Working Group’s Recommendations for Women In Low Risk Pregnancy:&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;The Working Group&#39;s Recommendations for Women In Low Risk Pregnancy:&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/SearchLiteratureB.html  [1] &quot;c:/web/p1/SearchLiteratureB.html&quot;
## [1] &quot;    &lt;p&gt;In a patient (2 months – 2 years of age) with a fever &amp;gt; 38.5 (rectal) at what CRP &quot;
## [1] &quot;    &lt;p&gt;In a patient (2 months - 2 years of age) with a fever &amp;gt; 38.5 (rectal) at what CRP &quot;
## c:/web/p1-clean/SearchLiteratureC.html  [1] &quot;c:/web/p1/SearchLiteratureC.html&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode “Pediatrics”/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode \&quot;Pediatrics\&quot;/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode “Thermometers”/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode \&quot;Thermometers\&quot;/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode “Ear-External”/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode \&quot;Ear-External\&quot;/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode “Tympanic-Membrane”/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode \&quot;Tympanic-Membrane\&quot;/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode “Rectum”/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;explode \&quot;Rectum\&quot;/ all subheadings&lt;/i&gt;&lt;/li&gt;&quot;
## c:/web/p1-clean/secondary.html  [1] &quot;c:/web/p1/secondary.html&quot;
## c:/web/p1-clean/SecondaryAppointments.html  [1] &quot;c:/web/p1/SecondaryAppointments.html&quot;
## c:/web/p1-clean/SecondaryUses.html  [1] &quot;c:/web/p1/SecondaryUses.html&quot;
## c:/web/p1-clean/SecondBook.html  [1] &quot;c:/web/p1/SecondBook.html&quot;
## c:/web/p1-clean/SecondGrant.html  [1] &quot;c:/web/p1/SecondGrant.html&quot;
## c:/web/p1-clean/SecondGrantPart2.html  [1] &quot;c:/web/p1/SecondGrantPart2.html&quot;
## c:/web/p1-clean/SecondGrantPart3.html  [1] &quot;c:/web/p1/SecondGrantPart3.html&quot;
## c:/web/p1-clean/SecondInvitation.html  [1] &quot;c:/web/p1/SecondInvitation.html&quot;
## c:/web/p1-clean/SecondReviewer.html  [1] &quot;c:/web/p1/SecondReviewer.html&quot;
## c:/web/p1-clean/SecurityTendsToBe.html  [1] &quot;c:/web/p1/SecurityTendsToBe.html&quot;
## [1] &quot;       damage that medical data can do in the wrong hands. Today computer ‘security’ is typically &quot;
## [1] &quot;       damage that medical data can do in the wrong hands. Today computer &#39;security&#39; is typically &quot;
## c:/web/p1-clean/Segmented.html  [1] &quot;c:/web/p1/Segmented.html&quot;
## c:/web/p1-clean/SelectionBias.html  [1] &quot;c:/web/p1/SelectionBias.html&quot;
## c:/web/p1-clean/SelectiveReporting.html  [1] &quot;c:/web/p1/SelectiveReporting.html&quot;
## c:/web/p1-clean/SelfCritical.html  [1] &quot;c:/web/p1/SelfCritical.html&quot;
## c:/web/p1-clean/SelfEvaluation.html  [1] &quot;c:/web/p1/SelfEvaluation.html&quot;
## c:/web/p1-clean/SelfExperimentation.html  [1] &quot;c:/web/p1/SelfExperimentation.html&quot;
## c:/web/p1-clean/SensitivityError.html  [1] &quot;c:/web/p1/SensitivityError.html&quot;
## c:/web/p1-clean/SensitivityMoreImportant.html  [1] &quot;c:/web/p1/SensitivityMoreImportant.html&quot;
## c:/web/p1-clean/SeOddsRatio.html  [1] &quot;c:/web/p1/SeOddsRatio.html&quot;
## c:/web/p1-clean/SequenceLogo.html  [1] &quot;c:/web/p1/SequenceLogo.html&quot;
## c:/web/p1-clean/ses.html  [1] &quot;c:/web/p1/ses.html&quot;
## c:/web/p1-clean/SessionProposal.html  [1] &quot;c:/web/p1/SessionProposal.html&quot;
## c:/web/p1-clean/SevenFormulas.html  [1] &quot;c:/web/p1/SevenFormulas.html&quot;
## c:/web/p1-clean/SevenSins.html  [1] &quot;c:/web/p1/SevenSins.html&quot;
## c:/web/p1-clean/SeventeenYears.html  [1] &quot;c:/web/p1/SeventeenYears.html&quot;
## c:/web/p1-clean/SexAsOutcome.html  [1] &quot;c:/web/p1/SexAsOutcome.html&quot;
## c:/web/p1-clean/sharing.html  [1] &quot;c:/web/p1/sharing.html&quot;
## [1] &quot;&lt;p&gt;Journal article: F. Godlee. &lt;b&gt;Clinical trial data for all drugs in current use&lt;/b&gt; BMJ. 2012;345(oct29 2):e7304â\200“e7304. &lt;i&gt;Excerpt: \&quot;The drug industry does many good things. It produces medicines that can improve health and save lives. It creates jobs and stimulates economic growth. Sadly it does bad things too. Persistently and systematically over decades it has withheld and misreported data from clinical trials. As a result, a whole range of widely used drugs across all fields of medicine have been represented as safer and more effective than they are, endangering people&#39;s lives and wasting public money. Such wilful distortion is scientific misconduct. It is not something we can forgive because of the good things drug companies do. As Ben Goldacre says in the introduction to his new book Bad Pharma, \&quot;Drug companies around the world have produced some of the most amazing innovations of the past fifty years, saving lives on an epic scale. But that does not allow them to hide data, mislead doctors, and harm patients.&lt;/i&gt; [Accessed on November 20, 2012]. &lt;a href=\&quot;http://www.bmj.com/cgi/doi/10.1136/bmj.e7304\&quot;&gt;http://www.bmj.com/cgi/doi/10.1136/bmj.e7304&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Journal article: F. Godlee. &lt;b&gt;Clinical trial data for all drugs in current use&lt;/b&gt; BMJ. 2012;345(oct29 2):e7304â\200\&quot;e7304. &lt;i&gt;Excerpt: \&quot;The drug industry does many good things. It produces medicines that can improve health and save lives. It creates jobs and stimulates economic growth. Sadly it does bad things too. Persistently and systematically over decades it has withheld and misreported data from clinical trials. As a result, a whole range of widely used drugs across all fields of medicine have been represented as safer and more effective than they are, endangering people&#39;s lives and wasting public money. Such wilful distortion is scientific misconduct. It is not something we can forgive because of the good things drug companies do. As Ben Goldacre says in the introduction to his new book Bad Pharma, \&quot;Drug companies around the world have produced some of the most amazing innovations of the past fifty years, saving lives on an epic scale. But that does not allow them to hide data, mislead doctors, and harm patients.&lt;/i&gt; [Accessed on November 20, 2012]. &lt;a href=\&quot;http://www.bmj.com/cgi/doi/10.1136/bmj.e7304\&quot;&gt;http://www.bmj.com/cgi/doi/10.1136/bmj.e7304&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Journal article: D. Payne. &lt;b&gt;Tamiflu: the battle for secret drug data&lt;/b&gt; BMJ. 2012;345(oct29 2):e7303â\200“e7303. &lt;i&gt;Excerpt: \&quot;This week the BMJ, as part of its ongoing open data campaign, has launched a dedicated website aimed at persuading Roche to give doctors and patients access to the full data on oseltamivir (Tamiflu). The new site, www.bmj.com/tamiflu, displays emails and letters dating back to September 2009, when researcher Tom Jefferson first asked the company for the unpublished dataset used in a Roche supported analysis, published in 2003.\&quot;&lt;/i&gt; [Accessed on November 20, 2012]. &lt;a href=\&quot;http://www.bmj.com/content/345/bmj.e7303\&quot;&gt;http://www.bmj.com/content/345/bmj.e7303&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Journal article: D. Payne. &lt;b&gt;Tamiflu: the battle for secret drug data&lt;/b&gt; BMJ. 2012;345(oct29 2):e7303â\200\&quot;e7303. &lt;i&gt;Excerpt: \&quot;This week the BMJ, as part of its ongoing open data campaign, has launched a dedicated website aimed at persuading Roche to give doctors and patients access to the full data on oseltamivir (Tamiflu). The new site, www.bmj.com/tamiflu, displays emails and letters dating back to September 2009, when researcher Tom Jefferson first asked the company for the unpublished dataset used in a Roche supported analysis, published in 2003.\&quot;&lt;/i&gt; [Accessed on November 20, 2012]. &lt;a href=\&quot;http://www.bmj.com/content/345/bmj.e7303\&quot;&gt;http://www.bmj.com/content/345/bmj.e7303&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Webpage: Iain Hrynaszkiewicz. &lt;b&gt;BMC Research Notes â\200“ adding value to your data&lt;/b&gt; &lt;i&gt;Posted on the BioMEd Central Blog, Thursdy, September 2, 2010. Excerpt: \&quot;Support for scientific data sharing is gathering more and more  support in 2010, so rather than \&quot;why share data?\&quot; the question now is &#39;how?&#39;. Making data available in readily interpretable formats is vital to realising its value in driving new knowledge discovery, and BMC Research Notes today launches a new initiative aimed at promoting best practice in sharing and publishing data, with a focus on standardized, re-useable formats.\&quot;&lt;/i&gt; [Accessed on September 3, 2010]. &lt;a href=\&quot;http://blogs.openaccesscentral.com/blogs/bmcblog/entry/bmc_research_notes_wants_your\&quot;&gt;http://blogs.openaccesscentral.com/blogs/bmcblog/entry/bmc_research_notes_wants_your&lt;/a&gt;.&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;Webpage: Iain Hrynaszkiewicz. &lt;b&gt;BMC Research Notes â\200\&quot; adding value to your data&lt;/b&gt; &lt;i&gt;Posted on the BioMEd Central Blog, Thursdy, September 2, 2010. Excerpt: \&quot;Support for scientific data sharing is gathering more and more  support in 2010, so rather than \&quot;why share data?\&quot; the question now is &#39;how?&#39;. Making data available in readily interpretable formats is vital to realising its value in driving new knowledge discovery, and BMC Research Notes today launches a new initiative aimed at promoting best practice in sharing and publishing data, with a focus on standardized, re-useable formats.\&quot;&lt;/i&gt; [Accessed on September 3, 2010]. &lt;a href=\&quot;http://blogs.openaccesscentral.com/blogs/bmcblog/entry/bmc_research_notes_wants_your\&quot;&gt;http://blogs.openaccesscentral.com/blogs/bmcblog/entry/bmc_research_notes_wants_your&lt;/a&gt;.&lt;/p&gt;&quot;
## c:/web/p1-clean/sheet.html  [1] &quot;c:/web/p1/sheet.html&quot;
## c:/web/p1-clean/shoes.html  [1] &quot;c:/web/p1/shoes.html&quot;
## c:/web/p1-clean/ShortBio.html  [1] &quot;c:/web/p1/ShortBio.html&quot;
## c:/web/p1-clean/ShortBiography-08.html  [1] &quot;c:/web/p1/ShortBiography-08.html&quot;
## c:/web/p1-clean/ShortBiography-08a.html  [1] &quot;c:/web/p1/ShortBiography-08a.html&quot;
## c:/web/p1-clean/ShortBiography-09.html  [1] &quot;c:/web/p1/ShortBiography-09.html&quot;
## c:/web/p1-clean/ShortfallSampleSize.html  [1] &quot;c:/web/p1/ShortfallSampleSize.html&quot;
## c:/web/p1-clean/Shovel.html  [1] &quot;c:/web/p1/Shovel.html&quot;
## c:/web/p1-clean/shoveling.html  [1] &quot;c:/web/p1/shoveling.html&quot;
## c:/web/p1-clean/SideEffects-04.html  [1] &quot;c:/web/p1/SideEffects-04.html&quot;
## [1] &quot;    prevention study; and the Alleve data came from an Alzheimer’s prevention &quot;
## [1] &quot;    prevention study; and the Alleve data came from an Alzheimer&#39;s prevention &quot;
## c:/web/p1-clean/SideEffects-05.html  [1] &quot;c:/web/p1/SideEffects-05.html&quot;
## c:/web/p1-clean/sigma.html  [1] &quot;c:/web/p1/sigma.html&quot;
## c:/web/p1-clean/SignificantPilot.html  [1] &quot;c:/web/p1/SignificantPilot.html&quot;
## c:/web/p1-clean/SignUp.html  [1] &quot;c:/web/p1/SignUp.html&quot;
## c:/web/p1-clean/signup1.html  [1] &quot;c:/web/p1/signup1.html&quot;
## c:/web/p1-clean/SillyGraph.html  [1] &quot;c:/web/p1/SillyGraph.html&quot;
## c:/web/p1-clean/simon.html  [1] &quot;c:/web/p1/simon.html&quot;
## [1] &quot; &lt;a href=\&quot;../01/china_pictures.html\&quot;&gt;pictures&lt;/a&gt; of my then fiancée, Cathy Ong, and me &quot;
## [1] &quot; &lt;a href=\&quot;../01/china_pictures.html\&quot;&gt;pictures&lt;/a&gt; of my then fiancee, Cathy Ong, and me &quot;
## c:/web/p1-clean/SimpleCrossover.html  [1] &quot;c:/web/p1/SimpleCrossover.html&quot;
## c:/web/p1-clean/SimpleKm-08.html  [1] &quot;c:/web/p1/SimpleKm-08.html&quot;
## c:/web/p1-clean/SimpleKm-08a.html  [1] &quot;c:/web/p1/SimpleKm-08a.html&quot;
## c:/web/p1-clean/SimpleMicroarray.html  [1] &quot;c:/web/p1/SimpleMicroarray.html&quot;
## c:/web/p1-clean/SimpsonsParadox.html  [1] &quot;c:/web/p1/SimpsonsParadox.html&quot;
## c:/web/p1-clean/SingleIdea.html  [1] &quot;c:/web/p1/SingleIdea.html&quot;
## c:/web/p1-clean/SingleMean.html  [1] &quot;c:/web/p1/SingleMean.html&quot;
## c:/web/p1-clean/SingleModel.html  [1] &quot;c:/web/p1/SingleModel.html&quot;
## c:/web/p1-clean/SingleObservation.html  [1] &quot;c:/web/p1/SingleObservation.html&quot;
## c:/web/p1-clean/SixtyDegrees.html  [1] &quot;c:/web/p1/SixtyDegrees.html&quot;
## c:/web/p1-clean/SixtyPercentDrop.html  [1] &quot;c:/web/p1/SixtyPercentDrop.html&quot;
## c:/web/p1-clean/SizeEquivalence.html  [1] &quot;c:/web/p1/SizeEquivalence.html&quot;
## c:/web/p1-clean/skater.html  [1] &quot;c:/web/p1/skater.html&quot;
## c:/web/p1-clean/Skeptic.html  [1] &quot;c:/web/p1/Skeptic.html&quot;
## c:/web/p1-clean/skew.html  [1] &quot;c:/web/p1/skew.html&quot;
## c:/web/p1-clean/skills.html  [1] &quot;c:/web/p1/skills.html&quot;
## c:/web/p1-clean/SkipBonferroni.html  [1] &quot;c:/web/p1/SkipBonferroni.html&quot;
## c:/web/p1-clean/SkipFields.html  [1] &quot;c:/web/p1/SkipFields.html&quot;
## c:/web/p1-clean/SlashAndBurn-06.html  [1] &quot;c:/web/p1/SlashAndBurn-06.html&quot;
## c:/web/p1-clean/SlashAndBurn-08.html  [1] &quot;c:/web/p1/SlashAndBurn-08.html&quot;
## c:/web/p1-clean/sledder.html  [1] &quot;c:/web/p1/sledder.html&quot;
## c:/web/p1-clean/sliderule.html  [1] &quot;c:/web/p1/sliderule.html&quot;
## c:/web/p1-clean/SlippedDeadlines-08.html  [1] &quot;c:/web/p1/SlippedDeadlines-08.html&quot;
## c:/web/p1-clean/SlippedDeadlines-08a.html  [1] &quot;c:/web/p1/SlippedDeadlines-08a.html&quot;
## c:/web/p1-clean/SlowMonth.html  [1] &quot;c:/web/p1/SlowMonth.html&quot;
## c:/web/p1-clean/SlowProgress.html  [1] &quot;c:/web/p1/SlowProgress.html&quot;
## c:/web/p1-clean/small.html  [1] &quot;c:/web/p1/small.html&quot;
## c:/web/p1-clean/SmallCellSizes.html  [1] &quot;c:/web/p1/SmallCellSizes.html&quot;
## c:/web/p1-clean/SmallPvalue.html  [1] &quot;c:/web/p1/SmallPvalue.html&quot;
## c:/web/p1-clean/SmallRelativeRisk.html  [1] &quot;c:/web/p1/SmallRelativeRisk.html&quot;
## c:/web/p1-clean/SmallRisk.html  [1] &quot;c:/web/p1/SmallRisk.html&quot;
## c:/web/p1-clean/SmallSample.html  [1] &quot;c:/web/p1/SmallSample.html&quot;
## c:/web/p1-clean/SmallSampleSizeIssues.html  [1] &quot;c:/web/p1/SmallSampleSizeIssues.html&quot;
## [1] &quot;        sequential designs, ï¿½within-subjectï¿½ designs, decision analysis-based &quot;
## [1] &quot;        sequential designs, i¿1/2within-subjecti¿1/2 designs, decision analysis-based &quot;
## c:/web/p1-clean/SmallStdDev.html  [1] &quot;c:/web/p1/SmallStdDev.html&quot;
## [1] &quot;&lt;title&gt;P.Mean:Â Why is my standard deviation so small? (created 2011-05-02)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean:  Why is my standard deviation so small? (created 2011-05-02)&lt;/title&gt;&quot;
## c:/web/p1-clean/smoking.html  [1] &quot;c:/web/p1/smoking.html&quot;
## c:/web/p1-clean/snowball.html  [1] &quot;c:/web/p1/snowball.html&quot;
## c:/web/p1-clean/snowfun.html  [1] &quot;c:/web/p1/snowfun.html&quot;
## c:/web/p1-clean/snowrun.html  [1] &quot;c:/web/p1/snowrun.html&quot;
## c:/web/p1-clean/SocialMedia.html  [1] &quot;c:/web/p1/SocialMedia.html&quot;
## [1] &quot;&lt;p&gt;An &lt;strong&gt;electronic mailing list&lt;/strong&gt; &amp;quot;is a special usage of email that allows for widespread distribution of information to many Internet users. It is similar to a traditional mailing list â\200” a list of names and addresses â\200” as might be kept by an organization for sending publications to its members or customers, but typically refers to four things â\200” a list of email addresses, the people (&amp;quot;subscribers&amp;quot;) receiving mail at those addresses, the publications (email messages) sent to those addresses, and a reflector, which is a single email address that, when designated as the recipient of a message, will send a copy of that message to all of the subscribers.&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;&lt;p&gt;An &lt;strong&gt;electronic mailing list&lt;/strong&gt; &amp;quot;is a special usage of email that allows for widespread distribution of information to many Internet users. It is similar to a traditional mailing list â\200\&quot; a list of names and addresses â\200\&quot; as might be kept by an organization for sending publications to its members or customers, but typically refers to four things â\200\&quot; a list of email addresses, the people (&amp;quot;subscribers&amp;quot;) receiving mail at those addresses, the publications (email messages) sent to those addresses, and a reflector, which is a single email address that, when designated as the recipient of a message, will send a copy of that message to all of the subscribers.&amp;quot;&lt;/p&gt;&quot;
## c:/web/p1-clean/SocialNetworking.html  [1] &quot;c:/web/p1/SocialNetworking.html&quot;
## [1] &quot;  attention-seeking teenagers, it’s time to reconsider.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;  attention-seeking teenagers, it&#39;s time to reconsider.&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/software-00.html  [1] &quot;c:/web/p1/software-00.html&quot;
## c:/web/p1-clean/software-04.html  [1] &quot;c:/web/p1/software-04.html&quot;
## c:/web/p1-clean/software-14.html  [1] &quot;c:/web/p1/software-14.html&quot;
## c:/web/p1-clean/Software.html  [1] &quot;c:/web/p1/Software.html&quot;
## c:/web/p1-clean/SoftwareForBootstrap.html  [1] &quot;c:/web/p1/SoftwareForBootstrap.html&quot;
## c:/web/p1-clean/SoftwarePatents.html  [1] &quot;c:/web/p1/SoftwarePatents.html&quot;
## c:/web/p1-clean/SoftwareSem.html  [1] &quot;c:/web/p1/SoftwareSem.html&quot;
## c:/web/p1-clean/SourcesOfConfusion.html  [1] &quot;c:/web/p1/SourcesOfConfusion.html&quot;
## c:/web/p1-clean/SpacingHtml.html  [1] &quot;c:/web/p1/SpacingHtml.html&quot;
## c:/web/p1-clean/SpcHealthcare.html  [1] &quot;c:/web/p1/SpcHealthcare.html&quot;
## c:/web/p1-clean/SpecialSectionForQuotations.html  [1] &quot;c:/web/p1/SpecialSectionForQuotations.html&quot;
## c:/web/p1-clean/SpectrumBias.html  [1] &quot;c:/web/p1/SpectrumBias.html&quot;
## c:/web/p1-clean/SpermMorphology.html  [1] &quot;c:/web/p1/SpermMorphology.html&quot;
## c:/web/p1-clean/SpittingMatches.html  [1] &quot;c:/web/p1/SpittingMatches.html&quot;
## c:/web/p1-clean/splines.html  [1] &quot;c:/web/p1/splines.html&quot;
## c:/web/p1-clean/SplusCorrelatedData.html  [1] &quot;c:/web/p1/SplusCorrelatedData.html&quot;
## c:/web/p1-clean/SplusVersion7.html  [1] &quot;c:/web/p1/SplusVersion7.html&quot;
## c:/web/p1-clean/spss.html  [1] &quot;c:/web/p1/spss.html&quot;
## c:/web/p1-clean/Spss17.html  [1] &quot;c:/web/p1/Spss17.html&quot;
## c:/web/p1-clean/SpssAdvantages.html  [1] &quot;c:/web/p1/SpssAdvantages.html&quot;
## c:/web/p1-clean/SPSSorSTATA.html  [1] &quot;c:/web/p1/SPSSorSTATA.html&quot;
## c:/web/p1-clean/SpssPrice.html  [1] &quot;c:/web/p1/SpssPrice.html&quot;
## c:/web/p1-clean/SpssSoftware.html  [1] &quot;c:/web/p1/SpssSoftware.html&quot;
## [1] &quot;      statistics in the health sciences are often asked to recommend ï¿½a good &quot;
## [1] &quot;      statistics in the health sciences are often asked to recommend i¿1/2a good &quot;
## [1] &quot;      introductory statistics bookï¿½. This request is frequently made by &quot;
## [1] &quot;      introductory statistics booki¿1/2. This request is frequently made by &quot;
## [1] &quot;      Marija Norusisï¿½ book ï¿½SPSSï¿½ 12.0 Guide to Data Analysisï¿½ fills this niche &quot;
## [1] &quot;      Marija Norusisi¿1/2 book i¿1/2SPSSi¿1/2 12.0 Guide to Data Analysisi¿1/2 fills this niche &quot;
## c:/web/p1-clean/SpssTtest.html  [1] &quot;c:/web/p1/SpssTtest.html&quot;
## c:/web/p1-clean/SPSSversion13.html  [1] &quot;c:/web/p1/SPSSversion13.html&quot;
## c:/web/p1-clean/SPSSversion14.html  [1] &quot;c:/web/p1/SPSSversion14.html&quot;
## c:/web/p1-clean/srv_data-02.html  [1] &quot;c:/web/p1/srv_data-02.html&quot;
## c:/web/p1-clean/srv_data-99.html  [1] &quot;c:/web/p1/srv_data-99.html&quot;
## c:/web/p1-clean/StackOverflow.html  [1] &quot;c:/web/p1/StackOverflow.html&quot;
## [1] &quot;&lt;p&gt;Robert Cartaino. &lt;b&gt;Changes to Stack Exchange - Blog ï¿½ Stack Overflow&lt;/b&gt;. &lt;i&gt;&quot;
## [1] &quot;&lt;p&gt;Robert Cartaino. &lt;b&gt;Changes to Stack Exchange - Blog i¿1/2 Stack Overflow&lt;/b&gt;. &lt;i&gt;&quot;
## [1] &quot;on every imaginable topic. Some people did (yay!), but it wasnï¿½t the flood of &quot;
## [1] &quot;on every imaginable topic. Some people did (yay!), but it wasni¿1/2t the flood of &quot;
## [1] &quot;high quality sites we were hoping for. So weï¿½re making a few changes. Briefly: &quot;
## [1] &quot;high quality sites we were hoping for. So wei¿1/2re making a few changes. Briefly: &quot;
## [1] &quot;1. Stack Exchange will now be free. 2. Weï¿½re changing the way that new Stack &quot;
## [1] &quot;1. Stack Exchange will now be free. 2. Wei¿1/2re changing the way that new Stack &quot;
## [1] &quot;English). The site will help R bloggers and users to connect and follow the ï¿½R &quot;
## [1] &quot;English). The site will help R bloggers and users to connect and follow the i¿1/2R &quot;
## [1] &quot;blogosphereï¿½. How does R-Bloggers operate? This site will aggregate feeds (only &quot;
## [1] &quot;blogospherei¿1/2. How does R-Bloggers operate? This site will aggregate feeds (only &quot;
## [1] &quot;participating blogï¿½s posts will automatically be displayed on the main page with &quot;
## [1] &quot;participating blogi¿1/2s posts will automatically be displayed on the main page with &quot;
## [1] &quot;links in the ï¿½Contributorsï¿½ section of our sidebar&amp;quot;&lt;/i&gt; [Accessed June 30, &quot;
## [1] &quot;links in the i¿1/2Contributorsi¿1/2 section of our sidebar&amp;quot;&lt;/i&gt; [Accessed June 30, &quot;
## [1] &quot;engine) ï¿½ is waiting for you | R-statistics blog&lt;/b&gt;. &lt;i&gt;Excerpt: &amp;quot;The bottom &quot;
## [1] &quot;engine) i¿1/2 is waiting for you | R-statistics blog&lt;/b&gt;. &lt;i&gt;Excerpt: &amp;quot;The bottom &quot;
## [1] &quot;356 moreï¿½&amp;quot;&lt;/i&gt; [Accessed June 30, 2010]. Available at:&quot;
## [1] &quot;356 morei¿1/2&amp;quot;&lt;/i&gt; [Accessed June 30, 2010]. Available at:&quot;
## c:/web/p1-clean/StairStep.html  [1] &quot;c:/web/p1/StairStep.html&quot;
## c:/web/p1-clean/StandardDeviation-06.html  [1] &quot;c:/web/p1/StandardDeviation-06.html&quot;
## c:/web/p1-clean/StandardDeviation-08.html  [1] &quot;c:/web/p1/StandardDeviation-08.html&quot;
## [1] &quot;    Journal of Investigative Dermatology (2007) 127, 1264–1266. &quot;
## [1] &quot;    Journal of Investigative Dermatology (2007) 127, 1264-1266. &quot;
## c:/web/p1-clean/StandardDeviation-11.html  [1] &quot;c:/web/p1/StandardDeviation-11.html&quot;
## c:/web/p1-clean/StandardDeviationRatio.html  [1] &quot;c:/web/p1/StandardDeviationRatio.html&quot;
## c:/web/p1-clean/StandardError.html  [1] &quot;c:/web/p1/StandardError.html&quot;
## [1] &quot;    increase in damage score compared to non-infarcted myocardium: 6.2 ± 2.0 &quot;
## [1] &quot;    increase in damage score compared to non-infarcted myocardium: 6.2 +/- 2.0 &quot;
## [1] &quot;    vs. 4.3 ± 1.5 (mean ± standard deviation), (p = 0.004). In the infarcted &quot;
## [1] &quot;    vs. 4.3 +/- 1.5 (mean +/- standard deviation), (p = 0.004). In the infarcted &quot;
## [1] &quot;    damage scores: 8.1 ± 1.7 vs. 6.2 ± 2.0 (p = 0.027). &lt;b&gt;Conclusion&lt;/b&gt; Our &quot;
## [1] &quot;    damage scores: 8.1 +/- 1.7 vs. 6.2 +/- 2.0 (p = 0.027). &lt;b&gt;Conclusion&lt;/b&gt; Our &quot;
## c:/web/p1-clean/StandardizedBetas.html  [1] &quot;c:/web/p1/StandardizedBetas.html&quot;
## c:/web/p1-clean/startup.html  [1] &quot;c:/web/p1/startup.html&quot;
## c:/web/p1-clean/stata.html  [1] &quot;c:/web/p1/stata.html&quot;
## c:/web/p1-clean/StataMacro.html  [1] &quot;c:/web/p1/StataMacro.html&quot;
## c:/web/p1-clean/StatisticalComputing.html  [1] &quot;c:/web/p1/StatisticalComputing.html&quot;
## [1] &quot;      Excerpt: In this talk I will illustrate Excelï¿½s serious deficiencies in five &quot;
## [1] &quot;      Excerpt: In this talk I will illustrate Exceli¿1/2s serious deficiencies in five &quot;
## [1] &quot;    Michael Oï¿½Connell, &amp;quot;Applications in Drug Discovery and Development. S-PLUSï¿½ &quot;
## [1] &quot;    Michael Oi¿1/2Connell, &amp;quot;Applications in Drug Discovery and Development. S-PLUSi¿1/2 &quot;
## [1] &quot;    Clinical Safety Miner.&amp;quot; Michael Oï¿½Connell is the Director, Life Science &quot;
## [1] &quot;    Clinical Safety Miner.&amp;quot; Michael Oi¿1/2Connell is the Director, Life Science &quot;
## c:/web/p1-clean/StatisticalConcernsChildren.html  [1] &quot;c:/web/p1/StatisticalConcernsChildren.html&quot;
## c:/web/p1-clean/StatisticalConsultants.html  [1] &quot;c:/web/p1/StatisticalConsultants.html&quot;
## c:/web/p1-clean/StatisticalEvidence.html  [1] &quot;c:/web/p1/StatisticalEvidence.html&quot;
## c:/web/p1-clean/StatisticalEvidenceReview.html  [1] &quot;c:/web/p1/StatisticalEvidenceReview.html&quot;
## c:/web/p1-clean/StatisticalKoan1.html  [1] &quot;c:/web/p1/StatisticalKoan1.html&quot;
## c:/web/p1-clean/StatisticalKoan2.html  [1] &quot;c:/web/p1/StatisticalKoan2.html&quot;
## c:/web/p1-clean/StatisticalKoan3.html  [1] &quot;c:/web/p1/StatisticalKoan3.html&quot;
## c:/web/p1-clean/StatisticalLiteracy.html  [1] &quot;c:/web/p1/StatisticalLiteracy.html&quot;
## c:/web/p1-clean/StatisticalSoftware.html  [1] &quot;c:/web/p1/StatisticalSoftware.html&quot;
## c:/web/p1-clean/StatisticalTheory.html  [1] &quot;c:/web/p1/StatisticalTheory.html&quot;
## c:/web/p1-clean/StatisticGods.html  [1] &quot;c:/web/p1/StatisticGods.html&quot;
## c:/web/p1-clean/StatisticsAgriculture.html  [1] &quot;c:/web/p1/StatisticsAgriculture.html&quot;
## c:/web/p1-clean/StatisticsForBoards-08.html  [1] &quot;c:/web/p1/StatisticsForBoards-08.html&quot;
## [1] &quot;  don’t ask me to write these exams. Normality is never an issue for the &quot;
## [1] &quot;  don&#39;t ask me to write these exams. Normality is never an issue for the &quot;
## [1] &quot;  classification scheme, but don’t worry about these. The goal of the boards is &quot;
## [1] &quot;  classification scheme, but don&#39;t worry about these. The goal of the boards is &quot;
## [1] &quot;&lt;p&gt;Here’s a simple description of the statistical methods that are typically &quot;
## [1] &quot;&lt;p&gt;Here&#39;s a simple description of the statistical methods that are typically &quot;
## [1] &quot;   applied. I want to provide some of the “buzzwords” that you are likely to &quot;
## [1] &quot;   applied. I want to provide some of the \&quot;buzzwords\&quot; that you are likely to &quot;
## [1] &quot;   recommend a continuity correction or the use of Fisher’s Exact Test. In &quot;
## [1] &quot;   recommend a continuity correction or the use of Fisher&#39;s Exact Test. In &quot;
## [1] &quot;   looking for or mentioning this option. It’s possible that the exam writers &quot;
## [1] &quot;   looking for or mentioning this option. It&#39;s possible that the exam writers &quot;
## [1] &quot;   are looking for an odds ratio here or a relative risk. Don’t suggest a &quot;
## [1] &quot;   are looking for an odds ratio here or a relative risk. Don&#39;t suggest a &quot;
## [1] &quot;  Fisher’s Exact Test will not be an option. Technically, an extension is &quot;
## [1] &quot;  Fisher&#39;s Exact Test will not be an option. Technically, an extension is &quot;
## c:/web/p1-clean/StatisticsForBoards-08a.html  [1] &quot;c:/web/p1/StatisticsForBoards-08a.html&quot;
## [1] &quot;   don’t ask me to write these exams. Normality is never an issue for the &quot;
## [1] &quot;   don&#39;t ask me to write these exams. Normality is never an issue for the &quot;
## [1] &quot;   classification scheme, but don’t worry about these. The goal of the boards is &quot;
## [1] &quot;   classification scheme, but don&#39;t worry about these. The goal of the boards is &quot;
## [1] &quot;  &lt;p&gt;Here’s a simple description of the statistical methods that are typically &quot;
## [1] &quot;  &lt;p&gt;Here&#39;s a simple description of the statistical methods that are typically &quot;
## [1] &quot;   applied. I want to provide some of the “buzzwords” that you are likely to &quot;
## [1] &quot;   applied. I want to provide some of the \&quot;buzzwords\&quot; that you are likely to &quot;
## [1] &quot;   recommend a continuity correction or the use of Fisher’s Exact Test. In &quot;
## [1] &quot;   recommend a continuity correction or the use of Fisher&#39;s Exact Test. In &quot;
## [1] &quot;   looking for or mentioning this option. It’s possible that the exam writers &quot;
## [1] &quot;   looking for or mentioning this option. It&#39;s possible that the exam writers &quot;
## [1] &quot;   are looking for an odds ratio here or a relative risk. Don’t suggest a &quot;
## [1] &quot;   are looking for an odds ratio here or a relative risk. Don&#39;t suggest a &quot;
## [1] &quot;   Fisher’s Exact Test will not be an option. Technically, an extension is &quot;
## [1] &quot;   Fisher&#39;s Exact Test will not be an option. Technically, an extension is &quot;
## c:/web/p1-clean/StatisticsLibrarians.html  [1] &quot;c:/web/p1/StatisticsLibrarians.html&quot;
## c:/web/p1-clean/StatisticsSoftware.html  [1] &quot;c:/web/p1/StatisticsSoftware.html&quot;
## c:/web/p1-clean/stein.html  [1] &quot;c:/web/p1/stein.html&quot;
## c:/web/p1-clean/StepwiseRegression.html  [1] &quot;c:/web/p1/StepwiseRegression.html&quot;
## c:/web/p1-clean/stopearly.html  [1] &quot;c:/web/p1/stopearly.html&quot;
## [1] &quot;  violates Helsinki principles&lt;/strong&gt; Michel Lièvre, Joël Ménard, Eric &quot;
## [1] &quot;  violates Helsinki principles&lt;/strong&gt; Michel Lievre, Joel Menard, Eric &quot;
## [1] &quot;  Bruckert, Joël Cogneau, François Delahaye, Philippe Giral, Eran Leitersdorf, &quot;
## [1] &quot;  Bruckert, Joel Cogneau, Francois Delahaye, Philippe Giral, Eran Leitersdorf, &quot;
## [1] &quot;  Gérald Luc, Luis Masana, Philippe Moulin, Philippe Passa, Denis Pouchain, &quot;
## [1] &quot;  Gerald Luc, Luis Masana, Philippe Moulin, Philippe Passa, Denis Pouchain, &quot;
## [1] &quot;  Gérard Siest, and K Boyd. BMJ 2001; 322: 603-606.&quot;
## [1] &quot;  Gerard Siest, and K Boyd. BMJ 2001; 322: 603-606.&quot;
## c:/web/p1-clean/StoppingRules.html  [1] &quot;c:/web/p1/StoppingRules.html&quot;
## c:/web/p1-clean/StopStudy.html  [1] &quot;c:/web/p1/StopStudy.html&quot;
## c:/web/p1-clean/strata.html  [1] &quot;c:/web/p1/strata.html&quot;
## c:/web/p1-clean/StratifiedCoxRegression.html  [1] &quot;c:/web/p1/StratifiedCoxRegression.html&quot;
## c:/web/p1-clean/StratifiedRandomization.html  [1] &quot;c:/web/p1/StratifiedRandomization.html&quot;
## c:/web/p1-clean/StringsR.html  [1] &quot;c:/web/p1/StringsR.html&quot;
## c:/web/p1-clean/StubbornInsistence.html  [1] &quot;c:/web/p1/StubbornInsistence.html&quot;
## c:/web/p1-clean/subgroup.html  [1] &quot;c:/web/p1/subgroup.html&quot;
## c:/web/p1-clean/SubgroupAnalysis.html  [1] &quot;c:/web/p1/SubgroupAnalysis.html&quot;
## [1] &quot;  &lt;li&gt;&lt;strong&gt;&lt;a href=\&quot;http://www.policyreview.org/DEC01/satel.html\&quot;&gt;Medicine’s &quot;
## [1] &quot;  &lt;li&gt;&lt;strong&gt;&lt;a href=\&quot;http://www.policyreview.org/DEC01/satel.html\&quot;&gt;Medicine&#39;s &quot;
## c:/web/p1-clean/SubgroupsInResearch.html  [1] &quot;c:/web/p1/SubgroupsInResearch.html&quot;
## c:/web/p1-clean/SuboptimalApproach.html  [1] &quot;c:/web/p1/SuboptimalApproach.html&quot;
## c:/web/p1-clean/subset.html  [1] &quot;c:/web/p1/subset.html&quot;
## c:/web/p1-clean/SummaryROC.html  [1] &quot;c:/web/p1/SummaryROC.html&quot;
## c:/web/p1-clean/summer.html  [1] &quot;c:/web/p1/summer.html&quot;
## c:/web/p1-clean/SummitAbstract.html  [1] &quot;c:/web/p1/SummitAbstract.html&quot;
## c:/web/p1-clean/SurprisalMatrix.html  [1] &quot;c:/web/p1/SurprisalMatrix.html&quot;
## [1] &quot;  p&lt;sub&gt;2&lt;/sub&gt;, ï¿½, p&lt;sub&gt;k&lt;/sub&gt;, then the entropy of this random variable is &quot;
## [1] &quot;  p&lt;sub&gt;2&lt;/sub&gt;, i¿1/2, p&lt;sub&gt;k&lt;/sub&gt;, then the entropy of this random variable is &quot;
## [1] &quot;  ï¿½, p&lt;sub&gt;kj&lt;/sub&gt;, then the marginal entropy is defined as&lt;/p&gt;&quot;
## [1] &quot;  i¿1/2, p&lt;sub&gt;kj&lt;/sub&gt;, then the marginal entropy is defined as&lt;/p&gt;&quot;
## c:/web/p1-clean/SurrogateOutcomes.html  [1] &quot;c:/web/p1/SurrogateOutcomes.html&quot;
## c:/web/p1-clean/SurromedDecisionSite.html  [1] &quot;c:/web/p1/SurromedDecisionSite.html&quot;
## c:/web/p1-clean/SurveyDesign.html  [1] &quot;c:/web/p1/SurveyDesign.html&quot;
## c:/web/p1-clean/SurveyLibrarians.html  [1] &quot;c:/web/p1/SurveyLibrarians.html&quot;
## c:/web/p1-clean/SurveyMistakes.html  [1] &quot;c:/web/p1/SurveyMistakes.html&quot;
## c:/web/p1-clean/SurveyScale.html  [1] &quot;c:/web/p1/SurveyScale.html&quot;
## c:/web/p1-clean/survival-02.html  [1] &quot;c:/web/p1/survival-02.html&quot;
## c:/web/p1-clean/survival-04.html  [1] &quot;c:/web/p1/survival-04.html&quot;
## c:/web/p1-clean/SurvivalAnalysis.html  [1] &quot;c:/web/p1/SurvivalAnalysis.html&quot;
## [1] &quot;    20:145ï¿½57.&quot;
## [1] &quot;    20:145i¿1/257.&quot;
## c:/web/p1-clean/swimmer.html  [1] &quot;c:/web/p1/swimmer.html&quot;
## c:/web/p1-clean/SystematicOverviews.html  [1] &quot;c:/web/p1/SystematicOverviews.html&quot;
## [1] &quot;      provided to supplement the primary analysis. Copyright ï¿½ 2009 John Wiley &amp;amp; &quot;
## [1] &quot;      provided to supplement the primary analysis. Copyright i¿1/2 2009 John Wiley &amp;amp; &quot;
## [1] &quot;      recommendations for diagnostic tests and GRADEï¿½s framework for tackling the &quot;
## [1] &quot;      recommendations for diagnostic tests and GRADEi¿1/2s framework for tackling the &quot;
## [1] &quot;      turns ï¿½foodï¿½ into a ï¿½delicious dishï¿½. However, meta-analyses are like &quot;
## [1] &quot;      turns i¿1/2foodi¿1/2 into a i¿1/2delicious dishi¿1/2. However, meta-analyses are like &quot;
## [1] &quot;      Copyright ï¿½ 2002 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed December 18, 2009]. &quot;
## [1] &quot;      Copyright i¿1/2 2002 John Wiley &amp;amp; Sons, Ltd.&amp;quot;&lt;/i&gt; [Accessed December 18, 2009]. &quot;
## [1] &quot;    ï¿½combining data from multiple studies into single estimates of treatment &quot;
## [1] &quot;    i¿1/2combining data from multiple studies into single estimates of treatment &quot;
## c:/web/p1-clean/t.html  [1] &quot;c:/web/p1/t.html&quot;
## c:/web/p1-clean/table.html  [1] &quot;c:/web/p1/table.html&quot;
## c:/web/p1-clean/TaguchiMethods.html  [1] &quot;c:/web/p1/TaguchiMethods.html&quot;
## c:/web/p1-clean/tail-04.html  [1] &quot;c:/web/p1/tail-04.html&quot;
## c:/web/p1-clean/tail-99.html  [1] &quot;c:/web/p1/tail-99.html&quot;
## c:/web/p1-clean/TeachBayes.html  [1] &quot;c:/web/p1/TeachBayes.html&quot;
## c:/web/p1-clean/TeachingClasses.html  [1] &quot;c:/web/p1/TeachingClasses.html&quot;
## c:/web/p1-clean/TeachingPhilosophy.html  [1] &quot;c:/web/p1/TeachingPhilosophy.html&quot;
## c:/web/p1-clean/TeachingResources.html  [1] &quot;c:/web/p1/TeachingResources.html&quot;
## c:/web/p1-clean/TeachingStatistics.html  [1] &quot;c:/web/p1/TeachingStatistics.html&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Section 1 Students’ Understanding&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;    &lt;p&gt;&lt;i&gt;Section 1 Students&#39; Understanding&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Secondary Students’ Concepts of Probability R Madsen&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Secondary Students&#39; Concepts of Probability R Madsen&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Don’t get t out of proportion! G Goodall &lt;/i&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Don&#39;t get t out of proportion! G Goodall &lt;/i&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;How Long will it take to Build Jack’s House R Riddiough &amp;amp; J McColl!&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;How Long will it take to Build Jack&#39;s House R Riddiough &amp;amp; J McColl!&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Testing Colour Proportions of M&amp;amp;M’s R W Johnson&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Testing Colour Proportions of M&amp;amp;M&#39;s R W Johnson&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;The ‘Golden Egg’ (P) H Kimber&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;The &#39;Golden Egg&#39; (P) H Kimber&lt;/i&gt;&lt;/li&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Murphy’s Law of Maps (P) R Matthews &lt;/i&gt;&quot;
## [1] &quot;      &lt;li&gt;&lt;i&gt;Murphy&#39;s Law of Maps (P) R Matthews &lt;/i&gt;&quot;
## c:/web/p1-clean/TeamExercise.html  [1] &quot;c:/web/p1/TeamExercise.html&quot;
## c:/web/p1-clean/TechnometricsReview.html  [1] &quot;c:/web/p1/TechnometricsReview.html&quot;
## [1] &quot;            and number needed to harm (NNH) as “the most easily interpretable measures of risk” (p. &quot;
## [1] &quot;            and number needed to harm (NNH) as \&quot;the most easily interpretable measures of risk\&quot; (p. &quot;
## [1] &quot;            99% versus 97% success — yet the NNT is 50 in each case.&lt;/i&gt;&lt;/p&gt;&quot;
## [1] &quot;            99% versus 97% success - yet the NNT is 50 in each case.&lt;/i&gt;&lt;/p&gt;&quot;
## c:/web/p1-clean/template.html  [1] &quot;c:/web/p1/template.html&quot;
## c:/web/p1-clean/template201107.html  [1] &quot;c:/web/p1/template201107.html&quot;
## c:/web/p1-clean/template201107a.html  [1] &quot;c:/web/p1/template201107a.html&quot;
## c:/web/p1-clean/template201109.html  [1] &quot;c:/web/p1/template201109.html&quot;
## c:/web/p1-clean/template201111.html  [1] &quot;c:/web/p1/template201111.html&quot;
## c:/web/p1-clean/template20120101.html  [1] &quot;c:/web/p1/template20120101.html&quot;
## c:/web/p1-clean/template20120305.html  [1] &quot;c:/web/p1/template20120305.html&quot;
## c:/web/p1-clean/temporality.html  [1] &quot;c:/web/p1/temporality.html&quot;
## c:/web/p1-clean/TensionScienceEthics.html  [1] &quot;c:/web/p1/TensionScienceEthics.html&quot;
## c:/web/p1-clean/TenStudies.html  [1] &quot;c:/web/p1/TenStudies.html&quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Some proponents now insist that the “intentionality” of the &quot;
## [1] &quot;  &lt;p&gt;&lt;i&gt;Some proponents now insist that the \&quot;intentionality\&quot; of the &quot;
## [1] &quot;    O’Keefe JH, McCallister BD. Archives of Internal Medicine 1999: 159(19); &quot;
## [1] &quot;    O&#39;Keefe JH, McCallister BD. Archives of Internal Medicine 1999: 159(19); &quot;
## c:/web/p1-clean/TenStudiesA.html  [1] &quot;c:/web/p1/TenStudiesA.html&quot;
## c:/web/p1-clean/TenStudiesB.html  [1] &quot;c:/web/p1/TenStudiesB.html&quot;
## c:/web/p1-clean/TenStudiesPart4.html  [1] &quot;c:/web/p1/TenStudiesPart4.html&quot;
## [1] &quot;      Strychacz CP, Vacek JL, Jones PG, Forker A, O’Keefe JH, McCallister BD. Archives of &quot;
## [1] &quot;      Strychacz CP, Vacek JL, Jones PG, Forker A, O&#39;Keefe JH, McCallister BD. Archives of &quot;
## c:/web/p1-clean/TentativeTraining.html  [1] &quot;c:/web/p1/TentativeTraining.html&quot;
## c:/web/p1-clean/testing.html  [1] &quot;c:/web/p1/testing.html&quot;
## c:/web/p1-clean/TestsNormality.html  [1] &quot;c:/web/p1/TestsNormality.html&quot;
## c:/web/p1-clean/TextFiles.html  [1] &quot;c:/web/p1/TextFiles.html&quot;
## c:/web/p1-clean/tgn01.html  [1] &quot;c:/web/p1/tgn01.html&quot;
## c:/web/p1-clean/tgn02.html  [1] &quot;c:/web/p1/tgn02.html&quot;
## c:/web/p1-clean/tgn99.html  [1] &quot;c:/web/p1/tgn99.html&quot;
## c:/web/p1-clean/ThanksToProofreaders.html  [1] &quot;c:/web/p1/ThanksToProofreaders.html&quot;
## c:/web/p1-clean/ThankYou.html  [1] &quot;c:/web/p1/ThankYou.html&quot;
## c:/web/p1-clean/TheGlitterOf.html  [1] &quot;c:/web/p1/TheGlitterOf.html&quot;
## [1] &quot;       Hill, “The Environment and Disease: Association or Causation?,” &quot;
## [1] &quot;       Hill, \&quot;The Environment and Disease: Association or Causation?,\&quot; &quot;
## c:/web/p1-clean/TheoryOrPractice.html  [1] &quot;c:/web/p1/TheoryOrPractice.html&quot;
## c:/web/p1-clean/TherapeuticOrphans.html  [1] &quot;c:/web/p1/TherapeuticOrphans.html&quot;
## [1] &quot;            information were: &amp;lt; 1 month (80.5%), 1–3 months (79.1%), 3 months–2 years (77.5%), 2–6 &quot;
## [1] &quot;            information were: &amp;lt; 1 month (80.5%), 1-3 months (79.1%), 3 months-2 years (77.5%), 2-6 &quot;
## [1] &quot;            years (73.2%), and 6–12 years (71.6%). The proportions, for each age group, of PIs that &quot;
## [1] &quot;            years (73.2%), and 6-12 years (71.6%). The proportions, for each age group, of PIs that &quot;
## [1] &quot;            were: &amp;lt; 1 month (26.5%), 1–3 months (25.1%), 3 months–2 years (23.3%), 2–6 years &quot;
## [1] &quot;            were: &amp;lt; 1 month (26.5%), 1-3 months (25.1%), 3 months-2 years (23.3%), 2-6 years &quot;
## [1] &quot;            (21.9%), and 6–12 years (24.0%).&lt;/i&gt; (Source: &lt;b&gt;Dosing information for paediatric &quot;
## [1] &quot;            (21.9%), and 6-12 years (24.0%).&lt;/i&gt; (Source: &lt;b&gt;Dosing information for paediatric &quot;
## [1] &quot;            patients: are they really “therapeutic orphans”?&lt;/b&gt; Tan E, Cranswick NE, Rayner CR, &quot;
## [1] &quot;            patients: are they really \&quot;therapeutic orphans\&quot;?&lt;/b&gt; Tan E, Cranswick NE, Rayner CR, &quot;
## c:/web/p1-clean/ThesisOption.html  [1] &quot;c:/web/p1/ThesisOption.html&quot;
## c:/web/p1-clean/TheTest.html  [1] &quot;c:/web/p1/TheTest.html&quot;
## c:/web/p1-clean/ThousandPages.html  [1] &quot;c:/web/p1/ThousandPages.html&quot;
## c:/web/p1-clean/ThreeArmPower.html  [1] &quot;c:/web/p1/ThreeArmPower.html&quot;
## c:/web/p1-clean/ThreeDimensionalCharts.html  [1] &quot;c:/web/p1/ThreeDimensionalCharts.html&quot;
## [1] &quot;      of aesthetically appealing elements can greatly increase a design’s appeal, &quot;
## [1] &quot;      of aesthetically appealing elements can greatly increase a design&#39;s appeal, &quot;
## [1] &quot;      care, this “sizzle” can reduce the effectiveness of the visualization by &quot;
## [1] &quot;      care, this \&quot;sizzle\&quot; can reduce the effectiveness of the visualization by &quot;
## c:/web/p1-clean/ThreeLevels.html  [1] &quot;c:/web/p1/ThreeLevels.html&quot;
## c:/web/p1-clean/ThreeRows.html  [1] &quot;c:/web/p1/ThreeRows.html&quot;
## c:/web/p1-clean/ThreeSimpleRules.html  [1] &quot;c:/web/p1/ThreeSimpleRules.html&quot;
## c:/web/p1-clean/TimeSeries.html  [1] &quot;c:/web/p1/TimeSeries.html&quot;
## c:/web/p1-clean/tmp.html  [1] &quot;c:/web/p1/tmp.html&quot;
## c:/web/p1-clean/ToleranceAmbiguity.html  [1] &quot;c:/web/p1/ToleranceAmbiguity.html&quot;
## [1] &quot;     Real Applications in Science, American Statistician 51:241–246 (1997), as &quot;
## [1] &quot;     Real Applications in Science, American Statistician 51:241-246 (1997), as &quot;
## c:/web/p1-clean/ToleranceLimits.html  [1] &quot;c:/web/p1/ToleranceLimits.html&quot;
## c:/web/p1-clean/TooManyToys.html  [1] &quot;c:/web/p1/TooManyToys.html&quot;
## c:/web/p1-clean/TooMuchPower-08.html  [1] &quot;c:/web/p1/TooMuchPower-08.html&quot;
## c:/web/p1-clean/TooMuchPower-08a.html  [1] &quot;c:/web/p1/TooMuchPower-08a.html&quot;
## c:/web/p1-clean/TooSensitive.html  [1] &quot;c:/web/p1/TooSensitive.html&quot;
## c:/web/p1-clean/toothfairy.html  [1] &quot;c:/web/p1/toothfairy.html&quot;
## c:/web/p1-clean/toothless.html  [1] &quot;c:/web/p1/toothless.html&quot;
## c:/web/p1-clean/TopicListIsComplete.html  [1] &quot;c:/web/p1/TopicListIsComplete.html&quot;
## c:/web/p1-clean/TouchscreenInterface.html  [1] &quot;c:/web/p1/TouchscreenInterface.html&quot;
## c:/web/p1-clean/TrackingAdverseEvents.html  [1] &quot;c:/web/p1/TrackingAdverseEvents.html&quot;
## c:/web/p1-clean/TrackingAdverseEventsPart2.html  [1] &quot;c:/web/p1/TrackingAdverseEventsPart2.html&quot;
## c:/web/p1-clean/traffic.html  [1] &quot;c:/web/p1/traffic.html&quot;
## c:/web/p1-clean/training-08.html  [1] &quot;c:/web/p1/training-08.html&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Confidence Intervals and P-Values”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Confidence Intervals and P-Values\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Apples or Oranges?”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Apples or Oranges?\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Using SPSS to Describe Your Data” &lt;/p&gt;&quot;
## [1] &quot;   \&quot;Using SPSS to Describe Your Data\&quot; &lt;/p&gt;&quot;
## [1] &quot;   1:00 – 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   1:00 - 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Odds Ratios and Relative Risks”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Odds Ratios and Relative Risks\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Who Was Left Out?”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Who Was Left Out?\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Using SPSS to Develop a Linear Regression Model” &lt;/p&gt;&quot;
## [1] &quot;   \&quot;Using SPSS to Develop a Linear Regression Model\&quot; &lt;/p&gt;&quot;
## [1] &quot;   1:00 – 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   1:00 - 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Likelihood Ratios”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Likelihood Ratios\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Mountain or Molehill”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Mountain or Molehill\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Using SPSS to Develop a Logistic Regression Model” &lt;/p&gt;&quot;
## [1] &quot;   \&quot;Using SPSS to Develop a Logistic Regression Model\&quot; &lt;/p&gt;&quot;
## [1] &quot;   1:00 – 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   1:00 - 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Regression Coefficients”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Regression Coefficients\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Do the Pieces Fit Together?”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Do the Pieces Fit Together?\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## c:/web/p1-clean/training-08a.html  [1] &quot;c:/web/p1/training-08a.html&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Confidence Intervals and P-Values”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Confidence Intervals and P-Values\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Apples or Oranges?”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Apples or Oranges?\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Using SPSS to Describe Your Data” &lt;/p&gt;&quot;
## [1] &quot;   \&quot;Using SPSS to Describe Your Data\&quot; &lt;/p&gt;&quot;
## [1] &quot;   1:00 – 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   1:00 - 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Odds Ratios and Relative Risks”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Odds Ratios and Relative Risks\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Who Was Left Out?”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Who Was Left Out?\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Using SPSS to Develop a Linear Regression Model” &lt;/p&gt;&quot;
## [1] &quot;   \&quot;Using SPSS to Develop a Linear Regression Model\&quot; &lt;/p&gt;&quot;
## [1] &quot;   1:00 – 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   1:00 - 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Likelihood Ratios”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Likelihood Ratios\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Mountain or Molehill”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Mountain or Molehill\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Using SPSS to Develop a Logistic Regression Model” &lt;/p&gt;&quot;
## [1] &quot;   \&quot;Using SPSS to Develop a Logistic Regression Model\&quot; &lt;/p&gt;&quot;
## [1] &quot;   1:00 – 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   1:00 - 4:00 p.m.&lt;/p&gt;&quot;
## [1] &quot;   “What Do All These Numbers Mean?&amp;nbsp; Regression Coefficients”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;What Do All These Numbers Mean?&amp;nbsp; Regression Coefficients\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   “Statistical Evidence:&amp;nbsp; Do the Pieces Fit Together?”&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## [1] &quot;   \&quot;Statistical Evidence:&amp;nbsp; Do the Pieces Fit Together?\&quot;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&quot;
## c:/web/p1-clean/TransformingThePrior.html  [1] &quot;c:/web/p1/TransformingThePrior.html&quot;
## c:/web/p1-clean/Translational.html  [1] &quot;c:/web/p1/Translational.html&quot;
## c:/web/p1-clean/translational1.html  [1] &quot;c:/web/p1/translational1.html&quot;
## c:/web/p1-clean/traveler.html  [1] &quot;c:/web/p1/traveler.html&quot;
## c:/web/p1-clean/TravelingCourse.html  [1] &quot;c:/web/p1/TravelingCourse.html&quot;
## c:/web/p1-clean/TrialRegistration.html  [1] &quot;c:/web/p1/TrialRegistration.html&quot;
## c:/web/p1-clean/TrickR.html  [1] &quot;c:/web/p1/TrickR.html&quot;
## c:/web/p1-clean/TroubleWithApples.html  [1] &quot;c:/web/p1/TroubleWithApples.html&quot;
## c:/web/p1-clean/ttest-12.html  [1] &quot;c:/web/p1/ttest-12.html&quot;
## c:/web/p1-clean/ttest-16.html  [1] &quot;c:/web/p1/ttest-16.html&quot;
## c:/web/p1-clean/ttest-99.html  [1] &quot;c:/web/p1/ttest-99.html&quot;
## c:/web/p1-clean/TtestWith3and2.html  [1] &quot;c:/web/p1/TtestWith3and2.html&quot;
## c:/web/p1-clean/TukeyTest.html  [1] &quot;c:/web/p1/TukeyTest.html&quot;
## c:/web/p1-clean/TurkeyDay.html  [1] &quot;c:/web/p1/TurkeyDay.html&quot;
## c:/web/p1-clean/TwasTheNightBeforeSurgery.html  [1] &quot;c:/web/p1/TwasTheNightBeforeSurgery.html&quot;
## c:/web/p1-clean/Twitter.html  [1] &quot;c:/web/p1/Twitter.html&quot;
## c:/web/p1-clean/TwoByTwo.html  [1] &quot;c:/web/p1/TwoByTwo.html&quot;
## c:/web/p1-clean/TwoByTwoPart1.html  [1] &quot;c:/web/p1/TwoByTwoPart1.html&quot;
## c:/web/p1-clean/TwoByTwoPart2.html  [1] &quot;c:/web/p1/TwoByTwoPart2.html&quot;
## c:/web/p1-clean/TwoByTwoPart3.html  [1] &quot;c:/web/p1/TwoByTwoPart3.html&quot;
## c:/web/p1-clean/TwoByTwoPart4.html  [1] &quot;c:/web/p1/TwoByTwoPart4.html&quot;
## c:/web/p1-clean/TwoByTwoPart5.html  [1] &quot;c:/web/p1/TwoByTwoPart5.html&quot;
## c:/web/p1-clean/TwoByTwoPart6.html  [1] &quot;c:/web/p1/TwoByTwoPart6.html&quot;
## c:/web/p1-clean/TwoByTwoTable.html  [1] &quot;c:/web/p1/TwoByTwoTable.html&quot;
## c:/web/p1-clean/TwoControlGroups.html  [1] &quot;c:/web/p1/TwoControlGroups.html&quot;
## c:/web/p1-clean/TwoEventsWorrisome.html  [1] &quot;c:/web/p1/TwoEventsWorrisome.html&quot;
## c:/web/p1-clean/TwoProportions.html  [1] &quot;c:/web/p1/TwoProportions.html&quot;
## c:/web/p1-clean/TypeIand IIErrors.html  [1] &quot;c:/web/p1/TypeIand IIErrors.html&quot;
## c:/web/p1-clean/TypeIII-08.html  [1] &quot;c:/web/p1/TypeIII-08.html&quot;
## c:/web/p1-clean/TypeIII-08a.html  [1] &quot;c:/web/p1/TypeIII-08a.html&quot;
## c:/web/p1-clean/typetwo.html  [1] &quot;c:/web/p1/typetwo.html&quot;
## c:/web/p1-clean/UmkcOffice.html  [1] &quot;c:/web/p1/UmkcOffice.html&quot;
## c:/web/p1-clean/UnadjustedEstimates-08.html  [1] &quot;c:/web/p1/UnadjustedEstimates-08.html&quot;
## c:/web/p1-clean/UnadjustedEstimates-08a.html  [1] &quot;c:/web/p1/UnadjustedEstimates-08a.html&quot;
## c:/web/p1-clean/UnblindingStudy.html  [1] &quot;c:/web/p1/UnblindingStudy.html&quot;
## c:/web/p1-clean/UndeclaredMissingCode.html  [1] &quot;c:/web/p1/UndeclaredMissingCode.html&quot;
## c:/web/p1-clean/UndeservingOfFurtherStudy.html  [1] &quot;c:/web/p1/UndeservingOfFurtherStudy.html&quot;
## c:/web/p1-clean/unequal.html  [1] &quot;c:/web/p1/unequal.html&quot;
## c:/web/p1-clean/UnequalSampleSizes.html  [1] &quot;c:/web/p1/UnequalSampleSizes.html&quot;
## c:/web/p1-clean/UnivariateClustering.html  [1] &quot;c:/web/p1/UnivariateClustering.html&quot;
## c:/web/p1-clean/UnixHumor.html  [1] &quot;c:/web/p1/UnixHumor.html&quot;
## c:/web/p1-clean/UnmeasuredCovariate.html  [1] &quot;c:/web/p1/UnmeasuredCovariate.html&quot;
## c:/web/p1-clean/UnnecessaryTests.html  [1] &quot;c:/web/p1/UnnecessaryTests.html&quot;
## c:/web/p1-clean/unrealistic.html  [1] &quot;c:/web/p1/unrealistic.html&quot;
## c:/web/p1-clean/UnscientificTherapies.html  [1] &quot;c:/web/p1/UnscientificTherapies.html&quot;
## c:/web/p1-clean/UnusualData.html  [1] &quot;c:/web/p1/UnusualData.html&quot;
## [1] &quot;    &lt;p&gt;Micheloud F. &lt;b&gt;Jean Paul Benzï¿½cri&#39;s Correspondence Analysis&lt;/b&gt;. &quot;
## [1] &quot;    &lt;p&gt;Micheloud F. &lt;b&gt;Jean Paul Benzi¿1/2cri&#39;s Correspondence Analysis&lt;/b&gt;. &quot;
## c:/web/p1-clean/UpcomingTalks.html  [1] &quot;c:/web/p1/UpcomingTalks.html&quot;
## c:/web/p1-clean/UpcomingTopics-08.html  [1] &quot;c:/web/p1/UpcomingTopics-08.html&quot;
## [1] &quot;  &lt;li&gt;Poisson models versus “time to event” models.&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;Poisson models versus \&quot;time to event\&quot; models.&lt;/li&gt;&quot;
## c:/web/p1-clean/UpcomingTopics-08a.html  [1] &quot;c:/web/p1/UpcomingTopics-08a.html&quot;
## [1] &quot;    &lt;li&gt;Poisson models versus “time to event” models.&lt;/li&gt;&quot;
## [1] &quot;    &lt;li&gt;Poisson models versus \&quot;time to event\&quot; models.&lt;/li&gt;&quot;
## c:/web/p1-clean/update.html  [1] &quot;c:/web/p1/update.html&quot;
## c:/web/p1-clean/Update060228-08.html  [1] &quot;c:/web/p1/Update060228-08.html&quot;
## c:/web/p1-clean/Update060228-evidence.html  [1] &quot;c:/web/p1/Update060228-evidence.html&quot;
## c:/web/p1-clean/Update060308-08.html  [1] &quot;c:/web/p1/Update060308-08.html&quot;
## c:/web/p1-clean/Update060308-evidence.html  [1] &quot;c:/web/p1/Update060308-evidence.html&quot;
## c:/web/p1-clean/Update060315-08.html  [1] &quot;c:/web/p1/Update060315-08.html&quot;
## c:/web/p1-clean/Update060315-evidence.html  [1] &quot;c:/web/p1/Update060315-evidence.html&quot;
## c:/web/p1-clean/Update060802-08.html  [1] &quot;c:/web/p1/Update060802-08.html&quot;
## c:/web/p1-clean/Update060802-evidence.html  [1] &quot;c:/web/p1/Update060802-evidence.html&quot;
## c:/web/p1-clean/updates.html  [1] &quot;c:/web/p1/updates.html&quot;
## c:/web/p1-clean/Updates2008.html  [1] &quot;c:/web/p1/Updates2008.html&quot;
## c:/web/p1-clean/Updates2009.html  [1] &quot;c:/web/p1/Updates2009.html&quot;
## c:/web/p1-clean/Updates2010.html  [1] &quot;c:/web/p1/Updates2010.html&quot;
## c:/web/p1-clean/UpTo.html  [1] &quot;c:/web/p1/UpTo.html&quot;
## c:/web/p1-clean/UseForTalks.html  [1] &quot;c:/web/p1/UseForTalks.html&quot;
## c:/web/p1-clean/UseMaterial.html  [1] &quot;c:/web/p1/UseMaterial.html&quot;
## c:/web/p1-clean/User2007.html  [1] &quot;c:/web/p1/User2007.html&quot;
## c:/web/p1-clean/UsingGoogle.html  [1] &quot;c:/web/p1/UsingGoogle.html&quot;
## c:/web/p1-clean/UsingRealExamples.html  [1] &quot;c:/web/p1/UsingRealExamples.html&quot;
## [1] &quot;            problems are necessary but not sufficient. It is not enough to have “data examples.” &quot;
## [1] &quot;            problems are necessary but not sufficient. It is not enough to have \&quot;data examples.\&quot; &quot;
## [1] &quot;            relates to the study’s design, and talk about any additional, broader issues of data &quot;
## [1] &quot;            relates to the study&#39;s design, and talk about any additional, broader issues of data &quot;
## c:/web/p1-clean/Validation.html  [1] &quot;c:/web/p1/Validation.html&quot;
## c:/web/p1-clean/validity.html  [1] &quot;c:/web/p1/validity.html&quot;
## [1] &quot;  &lt;li&gt;Carroll, R. T. Myers-Briggs Type Indicator®. www.skepdic.com/myersb.html&lt;/li&gt;&quot;
## [1] &quot;  &lt;li&gt;Carroll, R. T. Myers-Briggs Type Indicator*. www.skepdic.com/myersb.html&lt;/li&gt;&quot;
## c:/web/p1-clean/ValidityReliabilitySampleSize.html  [1] &quot;c:/web/p1/ValidityReliabilitySampleSize.html&quot;
## c:/web/p1-clean/ValueLabels.html  [1] &quot;c:/web/p1/ValueLabels.html&quot;
## c:/web/p1-clean/VariableNumberOfMeasures.html  [1] &quot;c:/web/p1/VariableNumberOfMeasures.html&quot;
## c:/web/p1-clean/VarianceRatio.html  [1] &quot;c:/web/p1/VarianceRatio.html&quot;
## c:/web/p1-clean/vegetable.html  [1] &quot;c:/web/p1/vegetable.html&quot;
## c:/web/p1-clean/vet.html  [1] &quot;c:/web/p1/vet.html&quot;
## c:/web/p1-clean/ViewingOutput.html  [1] &quot;c:/web/p1/ViewingOutput.html&quot;
## c:/web/p1-clean/voices2013.html  [1] &quot;c:/web/p1/voices2013.html&quot;
## c:/web/p1-clean/volunteer.html  [1] &quot;c:/web/p1/volunteer.html&quot;
## c:/web/p1-clean/VolunteerQuestions.html  [1] &quot;c:/web/p1/VolunteerQuestions.html&quot;
## c:/web/p1-clean/VoteForMe.html  [1] &quot;c:/web/p1/VoteForMe.html&quot;
## c:/web/p1-clean/WaiverInformedConsent.html  [1] &quot;c:/web/p1/WaiverInformedConsent.html&quot;
## [1] &quot;    Jones, A. Forker, J.H. O’Keefe, B.D. McCallister. Archives of Internal &quot;
## [1] &quot;    Jones, A. Forker, J.H. O&#39;Keefe, B.D. McCallister. Archives of Internal &quot;
## c:/web/p1-clean/WakefieldMmrStudy.html  [1] &quot;c:/web/p1/WakefieldMmrStudy.html&quot;
## [1] &quot;            &lt;p&gt;&amp;quot;...&lt;i&gt;but this is again my son’s birthday party, 32 healthy controls. And you line &quot;
## [1] &quot;            &lt;p&gt;&amp;quot;...&lt;i&gt;but this is again my son&#39;s birthday party, 32 healthy controls. And you line &quot;
## [1] &quot;            them up - with parental informed consent, of course. They all get paid £5, which doesn’t &quot;
## [1] &quot;            them up - with parental informed consent, of course. They all get paid lb5, which doesn&#39;t &quot;
## [1] &quot;            translate into many dollars I’m afraid. But, and, they put their arms out and they have &quot;
## [1] &quot;            translate into many dollars I&#39;m afraid. But, and, they put their arms out and they have &quot;
## c:/web/p1-clean/WarningMessage.html  [1] &quot;c:/web/p1/WarningMessage.html&quot;
## c:/web/p1-clean/wavelet.html  [1] &quot;c:/web/p1/wavelet.html&quot;
## c:/web/p1-clean/wavelets.html  [1] &quot;c:/web/p1/wavelets.html&quot;
## c:/web/p1-clean/WeakEvidence.html  [1] &quot;c:/web/p1/WeakEvidence.html&quot;
## c:/web/p1-clean/wealth.html  [1] &quot;c:/web/p1/wealth.html&quot;
## c:/web/p1-clean/web20.html  [1] &quot;c:/web/p1/web20.html&quot;
## [1] &quot;&lt;title&gt;P.Mean: Promoting your consulting career in the era of Web 2.0Â (created 2011-05-20)&lt;/title&gt;&quot;
## [1] &quot;&lt;title&gt;P.Mean: Promoting your consulting career in the era of Web 2.0  (created 2011-05-20)&lt;/title&gt;&quot;
## c:/web/p1-clean/WebcastTopics.html  [1] &quot;c:/web/p1/WebcastTopics.html&quot;
## c:/web/p1-clean/WebLinksApril.html  [1] &quot;c:/web/p1/WebLinksApril.html&quot;
## c:/web/p1-clean/WebLinksAugust.html  [1] &quot;c:/web/p1/WebLinksAugust.html&quot;
## [1] &quot;       &lt;p&gt;&lt;strong&gt;&lt;a href=\&quot;http://insidehighered.com/news/2005/08/15/irb\&quot;&gt;The Sociology of IRB’s&lt;/a&gt;&lt;/strong&gt;. &quot;
## [1] &quot;       &lt;p&gt;&lt;strong&gt;&lt;a href=\&quot;http://insidehighered.com/news/2005/08/15/irb\&quot;&gt;The Sociology of IRB&#39;s&lt;/a&gt;&lt;/strong&gt;. &quot;
## [1] &quot;            involving human subjects. The IRB’s, as they are called, are best known for their work &quot;
## [1] &quot;            involving human subjects. The IRB&#39;s, as they are called, are best known for their work &quot;
## [1] &quot;            which sociologists conduct surveys or do interviews — even though such work doesn’t pose &quot;
## [1] &quot;            which sociologists conduct surveys or do interviews - even though such work doesn&#39;t pose &quot;
## [1] &quot;            drug companies announce the final results. But elite Wall Street firms — looking to make &quot;
## [1] &quot;            drug companies announce the final results. But elite Wall Street firms - looking to make &quot;
## [1] &quot;            quick profits — have found a way to harvest these secrets: They pay doctors to divulge &quot;
## [1] &quot;            quick profits - have found a way to harvest these secrets: They pay doctors to divulge &quot;
## c:/web/p1-clean/WebLinksDecember-04.html  [1] &quot;c:/web/p1/WebLinksDecember-04.html&quot;
## c:/web/p1-clean/WebLinksDecember-05.html  [1] &quot;c:/web/p1/WebLinksDecember-05.html&quot;
## c:/web/p1-clean/WebLinksFebruary-05.html  [1] &quot;c:/web/p1/WebLinksFebruary-05.html&quot;
## c:/web/p1-clean/WebLinksFebruary-06.html  [1] &quot;c:/web/p1/WebLinksFebruary-06.html&quot;
## c:/web/p1-clean/WebLinksJanuary-05.html  [1] &quot;c:/web/p1/WebLinksJanuary-05.html&quot;
## c:/web/p1-clean/WebLinksJanuary-06.html  [1] &quot;c:/web/p1/WebLinksJanuary-06.html&quot;
## [1] &quot;       Fidler F, Williams J, Cumming G. Psychological Methods 2005, Vol. 10, No. 4, 389–396 2005: &quot;
## [1] &quot;       Fidler F, Williams J, Cumming G. Psychological Methods 2005, Vol. 10, No. 4, 389-396 2005: &quot;
## [1] &quot;            &lt;p&gt;[Abstract] &lt;i&gt;Little is known about researchers’ understanding of confidence &quot;
## [1] &quot;            &lt;p&gt;[Abstract] &lt;i&gt;Little is known about researchers&#39; understanding of confidence &quot;
## c:/web/p1-clean/WebLinksJuly.html  [1] &quot;c:/web/p1/WebLinksJuly.html&quot;
## c:/web/p1-clean/WebLinksJune.html  [1] &quot;c:/web/p1/WebLinksJune.html&quot;
## c:/web/p1-clean/WebLinksMarch.html  [1] &quot;c:/web/p1/WebLinksMarch.html&quot;
## c:/web/p1-clean/WebLinksMay.html  [1] &quot;c:/web/p1/WebLinksMay.html&quot;
## c:/web/p1-clean/WeblinksOctober.html  [1] &quot;c:/web/p1/WeblinksOctober.html&quot;
## c:/web/p1-clean/WebLinksSeptember.html  [1] &quot;c:/web/p1/WebLinksSeptember.html&quot;
## c:/web/p1-clean/webpoll.html  [1] &quot;c:/web/p1/webpoll.html&quot;
## c:/web/p1-clean/WebResearch.html  [1] &quot;c:/web/p1/WebResearch.html&quot;
## [1] &quot;      Here are some guidelines loosely based on the Health on the Net Foundation’s code of &quot;
## [1] &quot;      Here are some guidelines loosely based on the Health on the Net Foundation&#39;s code of &quot;
## c:/web/p1-clean/WebsiteDetails.html  [1] &quot;c:/web/p1/WebsiteDetails.html&quot;
## c:/web/p1-clean/WebsiteLogo.html  [1] &quot;c:/web/p1/WebsiteLogo.html&quot;
## c:/web/p1-clean/websites.html  [1] &quot;c:/web/p1/websites.html&quot;
## c:/web/p1-clean/WebsiteTraffic.html  [1] &quot;c:/web/p1/WebsiteTraffic.html&quot;
## [1] &quot;    letters long). Donï¿½t make your URLs cryptic by using a lot of abbreviations &quot;
## [1] &quot;    letters long). Doni¿1/2t make your URLs cryptic by using a lot of abbreviations &quot;
## [1] &quot;    (statistics) thereï¿½s a lot written about sample size calculations, so even &quot;
## [1] &quot;    (statistics) therei¿1/2s a lot written about sample size calculations, so even &quot;
## c:/web/p1-clean/WhaleWatching.html  [1] &quot;c:/web/p1/WhaleWatching.html&quot;
## c:/web/p1-clean/WhatDistribution.html  [1] &quot;c:/web/p1/WhatDistribution.html&quot;
## c:/web/p1-clean/WhatDoYouCall.html  [1] &quot;c:/web/p1/WhatDoYouCall.html&quot;
## c:/web/p1-clean/WhatImWorkingOn.html  [1] &quot;c:/web/p1/WhatImWorkingOn.html&quot;
## c:/web/p1-clean/WhatIsAChild.html  [1] &quot;c:/web/p1/WhatIsAChild.html&quot;
## c:/web/p1-clean/WhatStatistic-08.html  [1] &quot;c:/web/p1/WhatStatistic-08.html&quot;
## c:/web/p1-clean/WhatStatistic-08a.html  [1] &quot;c:/web/p1/WhatStatistic-08a.html&quot;
## c:/web/p1-clean/WhatToMeasure.html  [1] &quot;c:/web/p1/WhatToMeasure.html&quot;
## c:/web/p1-clean/WhenITalk.html  [1] &quot;c:/web/p1/WhenITalk.html&quot;
## c:/web/p1-clean/WhenToLog.html  [1] &quot;c:/web/p1/WhenToLog.html&quot;
## [1] &quot;  transformation for this type of data. You don’t have to have a precedent, but &quot;
## [1] &quot;  transformation for this type of data. You don&#39;t have to have a precedent, but &quot;
## [1] &quot;  as the saying goes, &amp;quot;there’s safety in numbers.&amp;quot;&lt;/p&gt;&quot;
## [1] &quot;  as the saying goes, &amp;quot;there&#39;s safety in numbers.&amp;quot;&lt;/p&gt;&quot;
## c:/web/p1-clean/WhereToGo.html  [1] &quot;c:/web/p1/WhereToGo.html&quot;
## c:/web/p1-clean/WhichExpert.html  [1] &quot;c:/web/p1/WhichExpert.html&quot;
## c:/web/p1-clean/WhichVersion.html  [1] &quot;c:/web/p1/WhichVersion.html&quot;
## c:/web/p1-clean/whiskers.html  [1] &quot;c:/web/p1/whiskers.html&quot;
## c:/web/p1-clean/WholeNumbers-08.html  [1] &quot;c:/web/p1/WholeNumbers-08.html&quot;
## c:/web/p1-clean/WholeNumbers-08a.html  [1] &quot;c:/web/p1/WholeNumbers-08a.html&quot;
## c:/web/p1-clean/WhoWrote.html  [1] &quot;c:/web/p1/WhoWrote.html&quot;
## c:/web/p1-clean/why95.html  [1] &quot;c:/web/p1/why95.html&quot;
## c:/web/p1-clean/WhyBayesian-08.html  [1] &quot;c:/web/p1/WhyBayesian-08.html&quot;
## c:/web/p1-clean/WhyBayesian-08a.html  [1] &quot;c:/web/p1/WhyBayesian-08a.html&quot;
## c:/web/p1-clean/WhyResearch.html  [1] &quot;c:/web/p1/WhyResearch.html&quot;
## [1] &quot;      cover article of Time magazine dated May 15, 2006 was entitled, “New &quot;
## [1] &quot;      cover article of Time magazine dated May 15, 2006 was entitled, \&quot;New &quot;
## [1] &quot;      Insights Into the Hidden World of Autism.” The article began with the story &quot;
## [1] &quot;      Insights Into the Hidden World of Autism.\&quot; The article began with the story &quot;
## [1] &quot;      of a 13-year old profoundly autistic girl whose language was “limited to &quot;
## [1] &quot;      of a 13-year old profoundly autistic girl whose language was \&quot;limited to &quot;
## [1] &quot;      snatches of songs, echoed dialogue, and unintelligible utterances” and who &quot;
## [1] &quot;      snatches of songs, echoed dialogue, and unintelligible utterances\&quot; and who &quot;
## [1] &quot;      was “most likely retarded.” However, a few days before her 13th birthday, &quot;
## [1] &quot;      was \&quot;most likely retarded.\&quot; However, a few days before her 13th birthday, &quot;
## [1] &quot;      communication. This is technique whereby a “facilitator” helps stabilize an &quot;
## [1] &quot;      communication. This is technique whereby a \&quot;facilitator\&quot; helps stabilize an &quot;
## [1] &quot;      autistic person’s hand and arm so that they are able to type a message on a &quot;
## [1] &quot;      autistic person&#39;s hand and arm so that they are able to type a message on a &quot;
## [1] &quot;      keyboard. On that day, the girl was asked by the facilitator, “Is there &quot;
## [1] &quot;      keyboard. On that day, the girl was asked by the facilitator, \&quot;Is there &quot;
## [1] &quot;      anything you’d like to say, Hannah?” Hannah, with the assistance of the &quot;
## [1] &quot;      anything you&#39;d like to say, Hannah?\&quot; Hannah, with the assistance of the &quot;
## [1] &quot;      facilitator, then typed out, “I love Mom.” A year and a half later, Hannah &quot;
## [1] &quot;      facilitator, then typed out, \&quot;I love Mom.\&quot; A year and a half later, Hannah &quot;
## c:/web/p1-clean/WideConfidenceInterval.html  [1] &quot;c:/web/p1/WideConfidenceInterval.html&quot;
## [1] &quot;       “kissing distance” of the null value is evidence of a borderline effect. &quot;
## [1] &quot;       \&quot;kissing distance\&quot; of the null value is evidence of a borderline effect. &quot;
## c:/web/p1-clean/WideInterval.html  [1] &quot;c:/web/p1/WideInterval.html&quot;
## c:/web/p1-clean/WikiPages.html  [1] &quot;c:/web/p1/WikiPages.html&quot;
## [1] &quot;    visual stories. Some of Mr. McCandlessï¿½s notable projects include &quot;
## [1] &quot;    visual stories. Some of Mr. McCandlessi¿1/2s notable projects include &quot;
## [1] &quot;    &amp;quot;If youï¿½re a man, donï¿½t smile in your profile picture, and donï¿½t look into &quot;
## [1] &quot;    &amp;quot;If youi¿1/2re a man, doni¿1/2t smile in your profile picture, and doni¿1/2t look into &quot;
## [1] &quot;    the camera. If youï¿½re a woman, skip photos that focus on your physical &quot;
## [1] &quot;    the camera. If youi¿1/2re a woman, skip photos that focus on your physical &quot;
## [1] &quot;    Chance News 60. Baby Einstein wants data&lt;/a&gt;. ï¿½Baby Einsteinï¿½ Founder Goes &quot;
## [1] &quot;    Chance News 60. Baby Einstein wants data&lt;/a&gt;. i¿1/2Baby Einsteini¿1/2 Founder Goes &quot;
## [1] &quot;    2009. Study Raises Questions About Cholesterol Drugï¿½s Benefit, Natasha &quot;
## [1] &quot;    2009. Study Raises Questions About Cholesterol Drugi¿1/2s Benefit, Natasha &quot;
## [1] &quot;    management theory applied to the practice of medicine. ï¿½Iï¿½ve wanted to go &quot;
## [1] &quot;    management theory applied to the practice of medicine. i¿1/2Ii¿1/2ve wanted to go &quot;
## [1] &quot;    for years,ï¿½ Janet Porter, the chief operating officer of the Dana-Farber &quot;
## [1] &quot;    for years,i¿1/2 Janet Porter, the chief operating officer of the Dana-Farber &quot;
## c:/web/p1-clean/Wikipedia.html  [1] &quot;c:/web/p1/Wikipedia.html&quot;
## c:/web/p1-clean/WikipediaContribution.html  [1] &quot;c:/web/p1/WikipediaContribution.html&quot;
## c:/web/p1-clean/WikipediaEntry.html  [1] &quot;c:/web/p1/WikipediaEntry.html&quot;
## [1] &quot;            The Wilson’s dcore interval is a compromise between the exact methods and the Wald large &quot;
## [1] &quot;            The Wilson&#39;s dcore interval is a compromise between the exact methods and the Wald large &quot;
## c:/web/p1-clean/WikipediaEntryPt2.html  [1] &quot;c:/web/p1/WikipediaEntryPt2.html&quot;
## c:/web/p1-clean/WikipediaEntryPt3.html  [1] &quot;c:/web/p1/WikipediaEntryPt3.html&quot;
## c:/web/p1-clean/WikipediaEntryPt4.html  [1] &quot;c:/web/p1/WikipediaEntryPt4.html&quot;
## c:/web/p1-clean/WinterBiker.html  [1] &quot;c:/web/p1/WinterBiker.html&quot;
## c:/web/p1-clean/Withdawing.html  [1] &quot;c:/web/p1/Withdawing.html&quot;
## c:/web/p1-clean/WithholdingInformation.html  [1] &quot;c:/web/p1/WithholdingInformation.html&quot;
## c:/web/p1-clean/WithholdingPHI.html  [1] &quot;c:/web/p1/WithholdingPHI.html&quot;
## c:/web/p1-clean/Within.html  [1] &quot;c:/web/p1/Within.html&quot;
## c:/web/p1-clean/WorkshopHandouts.html  [1] &quot;c:/web/p1/WorkshopHandouts.html&quot;
## c:/web/p1-clean/WriteGrant.html  [1] &quot;c:/web/p1/WriteGrant.html&quot;
## [1] &quot;            and disease. The K25 award will provide support and “protected time” for a period of &quot;
## [1] &quot;            and disease. The K25 award will provide support and \&quot;protected time\&quot; for a period of &quot;
## c:/web/p1-clean/WritingResearchPapers.html  [1] &quot;c:/web/p1/WritingResearchPapers.html&quot;
## [1] &quot;      (Case Reports and Technical Notes), 5ï¿½10 authors (retrospective full-length &quot;
## [1] &quot;      (Case Reports and Technical Notes), 5i¿1/210 authors (retrospective full-length &quot;
## [1] &quot;      articles), 10ï¿½15 (prospective, often grant-funded articles), more than 15 &quot;
## [1] &quot;      articles), 10i¿1/215 (prospective, often grant-funded articles), more than 15 &quot;
## [1] &quot;      one of the many products stemming from ORIï¿½s educational initiatives in the &quot;
## [1] &quot;      one of the many products stemming from ORIi¿1/2s educational initiatives in the &quot;
## [1] &quot;  &lt;p&gt;Iain Hrynaszkiewicz. &lt;b&gt;BMC Research Notes ï¿½ adding value to your data&lt;/b&gt;.&quot;
## [1] &quot;  &lt;p&gt;Iain Hrynaszkiewicz. &lt;b&gt;BMC Research Notes i¿1/2 adding value to your data&lt;/b&gt;.&quot;
## [1] &quot;      2010, so rather than ï¿½why share data?ï¿½ the question now is ï¿½how?ï¿½. Making data &quot;
## [1] &quot;      2010, so rather than i¿1/2why share data?i¿1/2 the question now is i¿1/2how?i¿1/2. Making data &quot;
## [1] &quot;    Excerpt: &amp;quot;Editorï¿½s Note: It seems appropriate, in this issue of JSS containing &quot;
## [1] &quot;    Excerpt: &amp;quot;Editori¿1/2s Note: It seems appropriate, in this issue of JSS containing &quot;
## [1] &quot;    you do your workï¿½in the web browser itself. &amp;quot;&lt;/i&gt; [Accessed March 4, 2009]. &quot;
## [1] &quot;    you do your worki¿1/2in the web browser itself. &amp;quot;&lt;/i&gt; [Accessed March 4, 2009]. &quot;
## c:/web/p1-clean/xAsaPressroom-0000images.html  [1] &quot;c:/web/p1/xAsaPressroom-0000images.html&quot;
## c:/web/p1-clean/xAsaPressroom-00files.html  [1] &quot;c:/web/p1/xAsaPressroom-00files.html&quot;
## c:/web/p1-clean/xAsaPressroom-08.html  [1] &quot;c:/web/p1/xAsaPressroom-08.html&quot;
## c:/web/p1-clean/xAsaPressroom-08a.html  [1] &quot;c:/web/p1/xAsaPressroom-08a.html&quot;
## c:/web/p1-clean/XbarSControlChart.html  [1] &quot;c:/web/p1/XbarSControlChart.html&quot;
## c:/web/p1-clean/XbarSControlChartAnswers.html  [1] &quot;c:/web/p1/XbarSControlChartAnswers.html&quot;
## c:/web/p1-clean/XbarSymbol.html  [1] &quot;c:/web/p1/XbarSymbol.html&quot;
## c:/web/p1-clean/xKidneyBiopsy-0000images.html  [1] &quot;c:/web/p1/xKidneyBiopsy-0000images.html&quot;
## c:/web/p1-clean/xKidneyBiopsy-00files.html  [1] &quot;c:/web/p1/xKidneyBiopsy-00files.html&quot;
## c:/web/p1-clean/xKidneyBiopsy-08.html  [1] &quot;c:/web/p1/xKidneyBiopsy-08.html&quot;
## c:/web/p1-clean/xKidneyBiopsy-08a.html  [1] &quot;c:/web/p1/xKidneyBiopsy-08a.html&quot;
## c:/web/p1-clean/xlin_int-0000images.html  [1] &quot;c:/web/p1/xlin_int-0000images.html&quot;
## c:/web/p1-clean/xlin_int-00files.html  [1] &quot;c:/web/p1/xlin_int-00files.html&quot;
## c:/web/p1-clean/xlin_int-02.html  [1] &quot;c:/web/p1/xlin_int-02.html&quot;
## c:/web/p1-clean/xml-04.html  [1] &quot;c:/web/p1/xml-04.html&quot;
## c:/web/p1-clean/xml-12.html  [1] &quot;c:/web/p1/xml-12.html&quot;
## c:/web/p1-clean/xnonlinear.html  [1] &quot;c:/web/p1/xnonlinear.html&quot;
## c:/web/p1-clean/xpilot1.html  [1] &quot;c:/web/p1/xpilot1.html&quot;
## c:/web/p1-clean/xswimmer.html  [1] &quot;c:/web/p1/xswimmer.html&quot;
## c:/web/p1-clean/xx.html  [1] &quot;c:/web/p1/xx.html&quot;
## [1] &quot;  misconduct: can Australia learn from the UK’s stuttering system? (July 9, &quot;
## [1] &quot;  misconduct: can Australia learn from the UK&#39;s stuttering system? (July 9, &quot;
## c:/web/p1-clean/xxHelpFromFriends-0000images.html  [1] &quot;c:/web/p1/xxHelpFromFriends-0000images.html&quot;
## c:/web/p1-clean/xxHelpFromFriends-00files.html  [1] &quot;c:/web/p1/xxHelpFromFriends-00files.html&quot;
## c:/web/p1-clean/xxHelpFromFriends-08.html  [1] &quot;c:/web/p1/xxHelpFromFriends-08.html&quot;
## c:/web/p1-clean/YouHaveToMake.html  [1] &quot;c:/web/p1/YouHaveToMake.html&quot;
## c:/web/p1-clean/zero.html  [1] &quot;c:/web/p1/zero.html&quot;
## c:/web/p1-clean/zeroevents.html  [1] &quot;c:/web/p1/zeroevents.html&quot;
## c:/web/p1-clean/Zhenya.html  [1] &quot;c:/web/p1/Zhenya.html&quot;
## c:/web/p1-clean/ZoteroStyle.html  [1] &quot;c:/web/p1/ZoteroStyle.html&quot;
## c:/web/p1-clean/zz-0000images.html  [1] &quot;c:/web/p1/zz-0000images.html&quot;
## c:/web/p1-clean/zz-00files.html  [1] &quot;c:/web/p1/zz-00files.html&quot;
## c:/web/p1-clean/zz-01.html  [1] &quot;c:/web/p1/zz-01.html&quot;
## c:/web/p1-clean/zz-02.html  [1] &quot;c:/web/p1/zz-02.html&quot;
## c:/web/p1-clean/zz-03.html  [1] &quot;c:/web/p1/zz-03.html&quot;
## c:/web/p1-clean/zz-04.html  [1] &quot;c:/web/p1/zz-04.html&quot;
## c:/web/p1-clean/zz-05.html  [1] &quot;c:/web/p1/zz-05.html&quot;
## c:/web/p1-clean/zz-06.html  [1] &quot;c:/web/p1/zz-06.html&quot;
## c:/web/p1-clean/zz-07.html  [1] &quot;c:/web/p1/zz-07.html&quot;
## c:/web/p1-clean/zz-08.html  [1] &quot;c:/web/p1/zz-08.html&quot;
## c:/web/p1-clean/zz-10.html  [1] &quot;c:/web/p1/zz-10.html&quot;
## c:/web/p1-clean/zz-11.html  [1] &quot;c:/web/p1/zz-11.html&quot;
## c:/web/p1-clean/zz-12.html  [1] &quot;c:/web/p1/zz-12.html&quot;
## c:/web/p1-clean/zz-13.html  [1] &quot;c:/web/p1/zz-13.html&quot;
## c:/web/p1-clean/zz-99.html  [1] &quot;c:/web/p1/zz-99.html&quot;
## c:/web/p1-clean/zz_copy(1)-0000images.html  [1] &quot;c:/web/p1/zz_copy(1)-0000images.html&quot;
## c:/web/p1-clean/zz_copy(1)-00files.html  [1] &quot;c:/web/p1/zz_copy(1)-00files.html&quot;
## c:/web/p1-clean/zz_copy(1)-02.html  [1] &quot;c:/web/p1/zz_copy(1)-02.html&quot;
## c:/web/p1-clean/zzz-00.html  [1] &quot;c:/web/p1/zzz-00.html&quot;
## c:/web/p1-clean/zzz-0000images.html  [1] &quot;c:/web/p1/zzz-0000images.html&quot;
## c:/web/p1-clean/zzz-00files.html  [1] &quot;c:/web/p1/zzz-00files.html&quot;
## c:/web/p1-clean/zzz-01.html  [1] &quot;c:/web/p1/zzz-01.html&quot;
## c:/web/p1-clean/zzz-02.html  [1] &quot;c:/web/p1/zzz-02.html&quot;
## c:/web/p1-clean/zzz-03.html  [1] &quot;c:/web/p1/zzz-03.html&quot;
## c:/web/p1-clean/zzz-04.html  [1] &quot;c:/web/p1/zzz-04.html&quot;
## c:/web/p1-clean/zzz-05.html  [1] &quot;c:/web/p1/zzz-05.html&quot;
## c:/web/p1-clean/zzz-06.html  [1] &quot;c:/web/p1/zzz-06.html&quot;
## c:/web/p1-clean/zzz-07.html  [1] &quot;c:/web/p1/zzz-07.html&quot;
## c:/web/p1-clean/zzz-11.html  [1] &quot;c:/web/p1/zzz-11.html&quot;
## c:/web/p1-clean/zzz-12.html  [1] &quot;c:/web/p1/zzz-12.html&quot;
## c:/web/p1-clean/zzz-13.html  [1] &quot;c:/web/p1/zzz-13.html&quot;
## c:/web/p1-clean/zzz-99.html  [1] &quot;c:/web/p1/zzz-99.html&quot;</code></pre>
<p>Look for things like u0097.</p>
<p>Save everything.</p>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
